EMPLOYEE_ID	DESCRIPTION
1000176	Clinical:  Analytical flow cytometry.  I am the Medical Director of Flow Cytometry Laboratory at Northwestern Memorial Hospital.  <br><br>Research:  Investigation of the basic cell biology of B chronic lymphocytic leukemia (CLL) is the major research interest of the laboratory. B-CLL is characterized by malignant cells having an anti-apoptotic phenotype and the accumulation of malignant cells is thought to be primarily driven by a block in apoptosis. However, when B-CLL cells are placed in in vitro culture, rapid apoptosis occurs raising the question of whether there are inherent defects in the apoptotic regulatory machinery or whether the dysregualtion seen is due to paracrine and/or autocrine factors. We are currently investigating potential paracrine/autocrine loops regulating apoptosis in the malignant B cell population. Specifically, the potential role of altered cytokine production by tumor specific oligoclonal T cells in these patients and its relationship to apoptosis control in the malignant B cells is being studied.    Although proliferation centers are seen in B-CLL, an additional abnormality is dysregulation of proliferation control in the malignant B cells with few proliferating cells seen in vivo and a lack of proliferative response to a number of normal B cell mitogens. In fact, although non-proliferative, the B cells in B-CLL patients may not be blocked in G0 but rather at a later point in the cell cycle. The other major area of investigation in the laboratory is elucidation of the mechanisms of proliferation dysregulation in these patients.    The laboratory is also involved in development of a number of complex multiparametric flow cytometry based clinical analyses both for diagnostic purposes and for patient specific therapeutic decision/monitoring purposes including assessment of signal transduction pathways in the setting of kinase inhibtor therapies.
1000184	Autopsy pathology, Cardiac pathology<BR><BR>Lipids are important regulators of the activity of many proteins including those involved in cardiac, vascular, pulmonary, and neural regulation, yet little is known about the molecular mechanisms mediating these effects. My laboratory staff members are engaged in a program of basic research to elucidate the molecular mechanisms by which lipids act as specific ligands to regulate cellular responses, and to investigate in select areas of cardiovascular disease how aberrations of signaling pathways may play a vital role in the pathogenesis of human disease.We have used the family of phosphoinositide-specific phospholipase C isoforms as a model to study protein-lipid interactions. Upon stimulation by various hormones these membrane associated enzymes hydrolyze polyphosphoinositides to yield second messengers such diacylglycerol and inositol 1,4,5-trisphosphate. The determinants of enzyme function are complex and can be broken down into several primary components: substrate binding and catalysis, enzyme translocation, and regulation. During the past several years we have identified the structural motifs in the PLC delta 1 isoform that mediate each of the three primary functions. All three motifs require the binding of a specific lipid for function. The structural motif mediating translocation also modulates the rate catalysis, and is encoded by a unique domain termed the pleckstrin homology or PH domain. This newly discovered protein module of 100 amino acids exists in many molecules (including PLC d1) that participate in signal transduction. Our research is among the first to demonstrate a clear function in signal transduction for the PH domain, and serves a paradigm for the activation and regulation of many signaling molecules.
1000332	My primary focus is the development and application of neuroimaging methods to better understand human development and physiology. Work in the lab draws from many disciplines such as biomedical engineering, physics, biophysics, statistics, electrical engineering, computer science, neuroscience, physiology, biology, and anatomy. While typical development occurs in normal healthy volunteers, a major effort is made to investigate the underlying physiology and function in a variety of disease conditions.
1000359	Messenger RNA stability, regulation of gene expression by protein kinase; signal transduction
1000436	neural networks, functional imaging, dementia, cerebral cortex, cholinergic pathways
1000444	Cell  movemnet, cytoskeleton, biological forces
1000475	Alzheimer's disease, Memory disorders, Neuropsychology, Early Onset Dementia, Primary Progressive Aphasia, Frontotemporal Dementia, Superaging.The ability to use language can be progressively disrupted by neurodegenerative diseases of the brain that target circumscribed regions that normally mediate language in healthy individuals.  My clinical and research interests focus on Individuals with Primary Progressive Aphasia, Frontotemporal Dementia and Alzheimer's Disease.  Research projects address the neuropsychological, neuroimaging and neuropathological variables associated with these syndromes, in order to contribute to our understanding of risk and the genetic factors that determine regional brain vulnerability to these diseases and to identify biomarkers that can be used in diagnosis during the patient's lifetime.  To date, there are no biomarkers that definitively predict the type of the neuropathology in these clinical syndromes in the individual patient.  Additional interests in the area of brain aging and its effects on cognition lie in determining factors associated with 'Superaging', the maintenance of a high level of cognitive ability into the 9th decade of life and beyond.
1000531	Acute medical problems in primary care, Palliative care
1000554	Gynecological malignancies, Gynecology early detection, Ovarian Cancer Early Detection
1000634	My main focus of interest is primary care pediatrics.  I practice at the Childrens Memorial Hospital Uptown Clinic, an academic community health center. I am also very committed to teaching residents and medical students. One of my main focus areas is literacy promotion in pediatrics.  I am the Medical Director of Reach Out and Read (ROR) Illinois.  I am also the Chairperson of the Leyendo Juntos (Reading Together) National Advisory Committee for Reach Out and Read, working to improve RORs impact in the Latino community.  My other primary area of interest is health literacy. From 2006-9 I was a member of the AAP Pediatric Advisory Committee on Health Literacy (HL), and helped develop a Pediatric HL guide with plain language handouts, and a Pedialink module.  My other areas of interest include health disparities in Latino families, monolingual and bilingual language development and improving links between pediatricians and schools.
1000654	Primary research focused on clinical outcome measures in SMA and surrogate outcomes for clinical trials
1000727	Dr. Leikin joined the administration of the Robert H. Lurie Comprehensive Cancer Center in 1989 and has served as the Scientific Program Director of the Lurie Cancer Center for more than twelve years. She has 16 peer reviewed publications from her laboratory research years.  Dr. Leikin has considerable expertise in integrating multi-investigator and training programs. She was instrumental in the Cancer Center obtaining a Breast Program Planning Grant (CA65764), a Prostate Program Planning Grant (CA69851), the SPORE in Breast Cancer (CA89018) and the SPORE in Prostate Cancer (CA90386).  Dr. Leikin has also served continuously as Administrative Director for the NCI-funded Training Program in Signal Transduction and Cancer (T32 CA070085), the Clinical Oncology Research Training Program (T32 CA079447), the Training Program in Oncogenesis and Developmental Biology (T32 CA080621) and the SPORE in Prostate Cancer (P50 CA090386).  Since 1999 Dr. Leikin has served as Director for the CURE  supplement to the Lurie Cancer Centers Core grant (P30 CA60553)that enables underserved minority undergraduate students to conduct biomedical research during the summer months. Over 100 students have participated in the CURE Program.
1000732	<p><b>Clinical Interests:</b>  Brain aneurysm, cerebral arteriovenous malformation, dural fistulas, cavernous malformations, hemifacial spasm, trigeminal neuralgia, Chiari I malformation</p><p><b>Research Interests:</b>  High resolution imaging for hyperactive cranial nerve syndromes (trigeminal neuralgia and hemifacial spasm), volume staged radiosurgery for complex arteriovenous malformations</p>
1000734	Areas of interest and expertise include robotics, neurobiology of the sensory-motor system and computational neuroscience. Among Dr. Mussa-Ivaldis achievements are the first measurement of human arm multi-joint impedance, the development of a technique for investigating the mechanisms of motor learning through the application of deterministic force fields, the discovery of a family of  integrable generalized inverses for redundant kinematic chains, the discovery of functional modules within the spinal cord that generate a discrete family of  force-fields, the development of a theoretical framework for the representation, generation and learning of limb movements and the development of the first neurorobotic system in which a neural preparation in-vitro - the brainstem of a lamprey - controls the behavior of a mobile-robot through a closed-loop interaction.
1000810	Role of sonic hedgehog and Bmp4 in prostate development
1000851	Comprehensive care of adults, Perioperative medical consultations, Preventive medicine
1000867	My research focuses on the evolutionary mechanisms underlying host-pathogen interactions, and their role in the emergence, spread, and containment of infectious diseases such as HIV/AIDS. The work seeks to understand how viral genetic variation, driven by host genetics and immunity, affects HIV infection dynamics and epidemic behavior. This connection is central to the evolution of virulence and drug resistance, and to vaccine design.
1000867	My research focuses on the evolutionary mechanisms underlying hostpathogen interactions, and their role in the emergence, spread, and containment of infectious diseases such as HIV/AIDS. Studies examine the nature and extent of HIV genetic variation, the biological and evolutionary processes that have produced the observed patterns, and the human genes and their relevant genetic variants that contribute to virus evolution. The work seeks to understand how viral genetic variation, driven by host genetics and immunity, affects HIV infection dynamics and epidemic behavior. This connection is central to the evolution of virulence and drug resistance, and to vaccine design.
1000886	Coagulation
1000906	Transcatheter valve therapy,Coronary angioplasty, Stents, Cardiac catheterization, Diabetic heart disease
1000909	Our research focuses on cell cycle deregulation by DNA tumor virus oncogenes (Adenovirus E1A, Simian virus 40 large T, and human papilloma virus E6 and E7).  In particular, we are interested to find out how binding of these viral tumor antigens to cellular proteins such as pRb, p300/CBP and other proteins affect G1/S phase transition.  We use molecular genetic approaches to study these aspects.
1000927	physician-patient communication and decision making
1001011	Hematopathology
1001018	My research deals primarily with the characterization of morphological and chemical phenotypes of specific classes of neural cells, and how they develop and change under experimental conditions and disease processes.
1001027	Health services for college / graduate students, Hospital-based care of the medical patient, Perioperative medical consultations
1001035	My primary interest is in public health education of health care professionals.  My secondary interest is ethical conduct of human subjects research particularly in the area of medical research and Institutional Review Board (IRB) oversight of research.
1001070	Occupational lung disease
1001109	Depression, Eating Disorders
1001130	Prenatal screening and diagnosis of genetic disorders.
1001131	Gynecologic surgery, Gynecology
1001200	My primary research is in the area of health economics, applied to the specific areas of aging and disability, markets for hospital and rehabilitation care, cost effectiveness of medical procedures, and arthritis care. Much of my work has used large existing data sets, including Medicare claims data, to examine healthcare market performance in response to policy changes.  
1001204	Coronary critical care, Echocardiography, General and preoperative consultative cardiology
1001208	My primary research interest is the pathophysiology of viral infections in immunocompromised vs. normal hosts.  The main viruses with which I have worked include Epstein-Barr virus, adenovirus and the respiratory viruses (respiratory syncitial virus and influenza).  I also have done research on post-viral (chronic) fatigue syndrome and chronic granulomatous disease.
1001220	My primary research interests include developmental psychopathology, sensory processing disorders, therapeutic interventions and outcomes for children and adolescents, and family therapy.
1001222	Research interests include medical student mental health, personality traits, and the limits of evidence-based psychotherapy.  Clinical interests include career consultation and individual psychotherapy.
1001264	Inflammatory and infectious diseases the the retina, hereditary diseases of the retina,macular degeneration, diabetic retinopathy
1001320	The  generation and mechanism of activity of Angiostatin.
1001348	I am interested in clinical skills assessment, standard setting and improving quality of care through medical education
1001386	My research and clinical intereats include topics in pediatric emergency medicine such as analgesia and sedation, pediatric resuscitation, asthma care, prehospital (EMS) care of children, and education of those involved in emergency care of children.I am involved in the Illinois Emergency Medical Services for Children program and have helped to establish prehospital pediatric protocols, and criteria to assure that emergency departments throughout Illinois are equipped to care for children (facility recognition).
1001402	My primary research and clinical interest centers around image guided therapy.  Specifically, its application to the treatment of uterine fibroids through minimally invasive techniques via uterine artery embolization.
1001411	My research interests have revolved around lung infections, particularly those involving mycobacteria, especially M. tuberculosis, and those occurring in association with human immunodeficiency virus (HIV) coinfection.  My focus has been on lung infections most closely related to epidemiologic questions as well as to methods for more efficiently diagnosing and allocating resources to dealing with these problems.
1001431	Tay-Sachs disease and other gangliosidosesDelineating the relationship between genetic abnormalities and specific phenotypes, with emphasis on the natural history of genetic disordersMethods and pitfalls in population screening for genetic disordersNatural history of neurofibromatosis-1 during childhoodNatural history and treatment of Gaucher disease and other lysosomal storage diseases
1001443	Head and neck radiology, Interventional neuroradiology, Neuroradiology, Spine imaging / intervention, Vascular imaging
1001472	electrocardiography, QT interval, heart rate, cardiology clinical trials
1001554	Hypertension, Obesity, Pheochromocytoma
1001574	We are using single photon confocal microscopy to measure intracellular Ca cycling in individual myocytes of intact rat and mouse hearts. Hearts are loaded with the Ca indicator fluo-4AM, allowing us to measure intracellular Ca at the submicron level. Ongoing projects include study of changes in Ca cycling in animal models of heart failure, catecholaminergic polymorphic ventricular tachycardia, spontaneous Ca release and cardiac arrhythmias.
1001575	Emergency medical services for children, emergency and disaster preparedness, health care access, pediatric trauma care, pediatric patient safety, pediatric emergency medicine
1001581	Valvular and Coronary heart disease. Cardiac Imaging.
1001613	adenosine, synaptic transmission, neurotransmitter release, secretion, ion channels, neuromuscular junction, 
1001653	Our laboratory studies Legionella pneumophila, the bacterial agent of Legionnaires' Disease pneumonia and Pontiac Fever.  Research efforts include understanding the protein secretion systems and iron acquisition pathways that contribute to the organism's ability to infect host cells and the lung.  Our laboratory has also idsentified a new species of Legionella (L. cardiaca) that is linked to heart infection.  Finally, we study Stenotrophomonas maltophilia, a highly antibiotic resistant bacterium that is increasingly associated with human infections.
1001662	General surgical pathology, Gynecological pathology
1001676	Foot & ankle problems, General Orthopaedics, Limb lengthening & deformities, Osteomyelitis, Treatment of complex fractures
1001679	Dr. Goodman's research interests include health services research, evidence-based medicine, outcomes analysis, and clinical studies of new therapies.  She obtained her Masters of Science in Epidemiology from the Harvard School of Public Health in 2001.  She has most recently participated in several studies using large databases, such as the Pediatric Health Information System of the Child Health Corporation of America, and the Virtual PICU dataset.  She is an active member of the research network Pediatric Acute Lung Injury and Sepsis Investigators (PALISI).  She is the local PI for the NIH-funded study Therapeutic Hypothermia after Pediatric Cardiac Arrest (THAPCA, www.thapca.org).Dr. Goodman is also very involved in medical education, particularly graduate medical education.  She has participated in administrative, educational, and scholarly work in this area and oversees all fellowships at Children's Memorial Hospital.Clinical interests center around pediatric critical care medicine, pediatric cardiac critical care, ECMO, and cardiac and respiratory dysfunction and innovative approaches to management.
1001725	Colon cancer, Gastric cancer, Pancreas cancer, Rectal cancer
1001728	General cardiology, Preventive cardiology, Stress testing, Nuclear cardiology, Cardiac MRI
1001728	Research interests include testing of new pharmacologic stress agents, myocardial perfusion imaging (nuclear), and assessment of myocardial perfusion and viability by MRI.
1001774	Alzheimer's and Frontal dementias, Other dementias, Aphasia, Learning disabilities and ADD/ADHD, Functional Brain Imaging, Disorders of higher cortical function (amnesia, agnosia, neglect, etc.) due to stroke, epilepsy, dementia, etc.
1001785	Kidney transplantation, nephrotic syndrome, pediatric kidney diseases
1001786	I am interested in streptococcal pharyngitis, injury prevention, and medical education.
1001801	I study the natural history and treatment of optic pathway tumors in children who have neurofibromatosis-1.
1001848	The focus of my clinical practice is general gynecology.  I treat the full range of gynecologic problems, including fibroids, ovarian cysts, sexually transmitted diseases, abnormal paps, post-menopausal bleeding, menopause, hormone replacement therapy, peri-menopause, & osteoporosis.
1001883	How memory is stored in the brain: molecular and cellular bases
1001887	Autoimmunity & Tolerance to Nucleosomes, Apoptosis, Peptide Epitope Therapy, Signaling Threshold, Lupus.
1001887	We have established that in systemic lupus (SLE), the immune system responds abnormally to nucleosomes, the major products of body's own cells undergoing apoptosis (J. Exp. Med. 177:1367, 1993). Our main research programs involve studies on the origins of autoimmune response to nucleosomes, and signaling defects in autoimmune T and B cells that lead to abnormal co-stimulation and apoptosis-resistance. Work is progressing in parallel in lupus patients and mouse models of lupus we developed (Nature 263:412, 1976). We have identified nucleosomal peptide epitopes critical for cognate interactions between the autoimmune T helper (Th) cells and anti-DNA B cells in murine and human lupus (J. Exp. Med. 183:2459, 1996). Recognition of these autoepitopes by lupus T cell receptors (TCR) is highly promiscuous which makes the peptides extremely potent for therapy of established lupus autoimmunity by a mechanism we call 'tolerance spreading'. We have also developed transgenic mice, bearing nucleosome-specific TCR genes, to determine how the autoimmune T cells escape censorship in the thymus despite exposure to apoptosis products, and how they could be regulated in the periphery. Moreover, we found that the Th and B cells of lupus have defects that lower their threshold for costimulatory signaling and make them resistant to anergy induction. These defects lead to sustained production of pathogenic autoantibodies. We are studying new pathways for resistance to anergy and activation induced death in autoimmune T cells of lupus, as revealed by differential gene expression profiling.
1001926	I am interesting in medical education in the field of radiology at multiple levels, as well as overall health care policy and quality. Radiation exposure for medical imaging is becoming a big quality and safety issue. Within the field of radiology I am most interesed in ultrasound. 
1001944	My current research interests lie in 1) understanding the relationship between community factors and clinical ones, particularly related to childhood obesity; 2) early origins of childhood obesity; 3) means to intervene to reduce obesity and its co-morbidities in young children; 4) the effects of community based interventions on obesity prevalence and health behaviors.
1001981	We are primarily conducting translational research, some of which is in conjunction with a colleague in anthropology, Dr. Gillian Bentley.  We have studied hormone differences between populations of women in the developing countries of Bolivia and Bangladesh and the Western countries, US and UK.  Salivary progesterone concentrations are significantly lower in women of developing countries, and migrant studies show that the age of the migrants is critical in the adaptation of the Western hormone patterns.  Adult migrants do not adapt to the higher progesterone levels.  Salivary estradiol is not significantly different between these population groups.  We are interested in the relation of hormone levels to fertility and to breast cancer incidence.  Other studies involve Dr. Seema Khan, Department of Surgery.  We are studying hormone and products of hormone action in nipple aspirate fluid and breast random fine-needle aspirates from women with different levels of breast cancer risk to ascertain the associations of hormones with the potential for breast cancer development.  The very small samples obtained make the procedure more acceptable than other biopsy procedures but the amount of biomarkers in the samples are limiting.  For this purpose we are working with Dr. Chad Mirkin and others in the Nanotechnology Program to develop assays with several-fold greater sensitivities than the current immunoassays.  We are also funded to study the potential for transdermal application of the biologically active metabolite of tamoxifen to the breast as an alternative to oral administration of tamoxifen.  We are working with Dr. Dean Ho of the Bioengineering Faculty to develop more efficient delivery systems for this application.  Potentially, this will eliminate some of the undesirable side-effects of tamoxifen that cause a majority of women to reject the prophylactic use of tamoxifen.  
1002007	Interventional cardiology. Catheter closure of VSD, PDA, ASD, Arteriovenous malformations. Catheter therapy of valvar and vascular obstruction: pulmonary valve stenosis, aortic valve stenosis, coarctation of the aorta, pulmonary artery stenosis.Transcatheter implantation of the Melody Pulmonary Valve
1002030	Dr. Mala Shanmugams research focuses on targeting abnormal glucose metabolism in the hematologic malignancies: multiple myeloma, CLL and mantle cell lymphoma. Elevated glucose consumption is a hall mark of numerous cancers. This phenomenon while forming the basis for clinical imaging of cancer has not yet been targeted for therapy. Dr. Shanmugam has identified a uniquely regulated subset of tumor-specific glucose transporters that facilitate elevated glucose entry in myeloma and are proving to be promising targets for therapy. Suppression of these uniquely regulated/expressed transporters has been found to engage the intrinsic pathway of apoptosis via regulation of specific signaling cascades. Recent work has identified abnormalities in trafficking proteins that enable abnormal plasma membrane localization of these glucose transporters. She is also investigating metabolic reprogramming in resistance mechanisms elicited in response to glucose deprivation. Her research spans from understanding basic mechanism to pre-clinical translational studies in order to target tumor-specific glucose utilization. Dr. Shanmugams research has been funded by the Illinois Division of the American Cancer Society, the Wendy Wills Case Foundation and more recently the National American Cancer Society.
1002038	General cardiology, Heart failure, Ischemic heart disease, Prevention of heart disease
1002038	Mihai Gheorghiade, MD, FACC, FCCP, FACPDr. Gheorghiade is currently Professor of Medicine and Surgery, Associate Chief of the Division of Cardiology, Chief of the Cardiology Clinical Service, and Director of the Telemetry Unit at Northwestern University Feinberg School of Medicine.  He obtained his MD, Magna Cum Laude, from the University of Rome in 1972 and did his training in internal medicine and cardiology at Brown University.  Subsequently, he moved to Virginia, where he became Chief of Cardiology at the Salem VA and Associate Professor of Medicine at the University of Virginia.  Then, he became Chief of the Cardiac Intensive Care Unit at the Henry Ford Hospital in Detroit, Michigan and Associate Professor of Clinical Medicine at the University of Michigan.  From there, he moved to his current position in Chicago.  Dr. Gheorghiade was a visiting professor at the major universities in the United States and abroad and received numerous awards for teaching from both medical students and residents.  He is a member of many national and international committees and serves on the editorial board of many journals including the American Heart Journal, The American Journal of Cardiology, and the Journal of the American College of Cardiology.  Dr. Gheorghiade served as a guest editor on numerous occasions for the American Journal of Cardiology, American Heart Journal, and American Journal of Medicine.  He was/is Chairman of the Steering Committee for many heart failure trials including OPTIME, ACTIV, IMPACT, PRESERVD, STEP-CHF, URGENT, and HORIZON.  He is co chairing the ongoing, international EVEREST trial and was a member of the Steering Committee of RADIANCE, FIRST, CARS, RITZ 4, EPHESUS,  OPTIMIZE-HF, and IMPROVE-HF Dr. Gheorghiade is the author of more than 300 publications.  He was the Chairman/Co-chairman of numerous international and national meetings.  At present, his research interests are related to the pathophysiology, prognosis, and management of hospitalized patients with heart failure and the roles of vasopressin antagonist in heart failure.  
1002042	Neuropathology
1002052	PACS, Workstation, RIS, DICOM, HL7, Data Mining, 
1002062	Hodgkin's disease, Leukemia, Lymphoma
1002062	I have been studying biologic correlates of outcome measures in the context of the US Intergroup CHOP vs. Rituximab(R)-CHOP clinical trial for diffuse, large B-cell lymphoma (DLBCL). The addition of R to conventional CHOP chemotherapy either as induction or maintenance has now been shown to improve outcome in patients with DLBCL (both US and European trials).  My findings suggest this improvement in outcome is primarily due to the beneficial effect of R added to CHOP in the bcl-6 negative subset of DLBCL. Furthermore, addition of rituximab to CHOP chemotherapy, does NOT benefit patients who are bcl-6+, the majority of cases.  Differences between the clinical behavior of bcl-6 positive and negative lymphoma provide clues to the underlying biologic nature of DLBCL. Different therapeutic strategies may be designed to specifically target bcl-6-positive and negative DLBCL based upon differences in their underlying cell survival mechanisms and sensitivity to chemotherapy and rituximab. Analysis of additional biologic markers (p53, p21) is in progress.  Along with Dr. John Reed of the Burnham Institute, a long-standing collaborator, we are investigating protein expression of paracaspase in  lymphomas.In collaboration with Dr. E. Terry Papoutsakis of the Department of Chemical Engineering, NU, we are creating  gene expression arrays on follicular lymphomas to identify patterns of gene expression reflective of the nonmalignant cells component of the biopsy specimen, and their relationship to clinical outcome.Radioimmunotherapy using anti-CD20 reagents targets radiation to the malignant lymphocytes and their immediate neighbors by means of the cross-fire effect.  To improve outcomes, we have added Y-90-ibritumomab tiuxetan to conventional BEAM chemotherapy for patients undergoing autologous stem cell transplant.  This was an investigator initiated phase I trial conducted under an investigator-held IND.  Colleagues at the Mayo Clinic were our co-investigators.  Forty-three patients were accrued to this study;  the maximal tolerated dose of Y-90-Ibritumomab tiuxetan is one that will deliver 1500 cGy to critical organs.  We are recommending a phase II trial of this radioimmunotherapeutic at 1.0 mCi/kg administering higher doses of Y-90-ibritumomab  tiuxetan be conducted prior to proceeding to a phase III randomized trial.Continuing in our efforts to develop novel therapies for patients with non-Hodgkin lymphoma, I have written a phase I trial to combine bortezomib, the proteosome inhibitor, with Y-90-ibritumomab tiuxetan for patients with follicular lymphoma. This study has just opened. Other clinical investigations include anti-idiotype vaccines, novel targeted agents such as histone deacetylase inhibitors and new monoclonal reagents such as the  anti-CD40 monoclonal antibody and an anti-CD22 chemoimmunoconjugate. In the context of our recently submitted SPORE in Lymphoma application, I will lead studies of targeted 'nanobins' created by Dr. O'Halloran, and help to develop bcl-6 peptide inhibitors for clinical use with Drs. Licht and Melnick (Albert Einstein).  
1002064	Dr Kahrilas' research focus is on esophageal and oropharyngeal physiology and pathophysiology.  Oropharyngeal studies are aimed at describing the normal mechanics of swallowing and the modifiability that can be imposed therapeutically.  These studies use computerized analysis of manometric and videofluorographic swallowing studies.  Pathophysiologic studies of the oropharynx focus on mechanisms that result in dysphagia and the efficacy of volitional compensatory strategies in modifying these defects.  Esophageal research has centered on the motor activity of the upper esophageal sphincter, peristaltic function, the pathophysiology of esophageal motor disorders, and the pathophysiology of gastroesophageal reflux disease.  Upper esophageal sphincter investigations utilized manometry and videofluoroscopy to describe reflexive response to esophageal stimuli, as well as normal activity during sleep, acid reflux, meals, and swallowing.  Studies of the esophageal body have described the contractile pattern of longitudinal muscle during peristalsis and are examining the efficacy of peristaltic function in effecting volume clearance and relating this quantitative assessment of peristaltic efficacy to the subjective experience of dysphagia.  Investigations of reflux disease are examining the mechanisms by which anatomic variables, inclusive of but not limited to hiatus hernia, interact with physiological responses to modulate disease severity.  A current research focus is on applying high-resolution solid-state manometry to the analysis of esophagogastric junction pathophysiology both with respect to reflux disease and esophageal motor disorders. Previous research interests have included central nervous system neurophysiology, autonomic nervous system neurophysiology as it relates to sodium homeostasis, and screening for esophageal cancer. 
1002064	Esophageal disorders, Gastroesophageal reflux disease, Swallowing disorders
1002079	competitive, inhibition, uterine, contractions, preterm- labor, peptides, oxytocin, antagonists, breakdown, metabolism
1002095	Adolescent Psychiatry, Normality, Longitudinal Studies
1002126	My research interests include co-occurring disorders (dual diagnosis), HIV prevention for high risk populations, health promotion with underserved populations, incarcerated or newly released individuals, post traumatic Stress disorder (PTSD) and other affective disorders
1002139	Asthma, Lung Function, Clinical Trials
1002139	I am exploring the role of diet in asthma severity, especially the effect of dietary antioxidants and soy isoflavones.
1002194	global control of cell functiongenome sequence architecture and genome navigation
1002205	My primary research/clinical interest of longest standing is in the area of medical anthropology; specifically, dealing with all of those factors, processes, and practices--biological and cultural--that are associated with either promoting or impeding healing in all of its aspects (i.e., from somatic wound healing to psychic healing).  Regarding healing, I have particular interest in mind-body integration and psychoneuroimmunology.  In the area of my own professional clinical activity, my longest standing interest is in bringing existentially informed approaches to the practice of making effective healing relationships with individuals and their families who are contending with serious medical problems and/or life-shattering events which have a medical dimension. 
1002238	Primary clinical interest is in administration of correctional psychiatry programs in the Cook County Jail and the Juvenile Temporary Detention Center.
1002248	My primary clinical interest is preventative health care strategies for women of all ages with a special focus on Menopause, Bone health/Densitomety and cardiovascular health. I am also very interested in minimally invasive surgery such as endometrial ablation for abnormal bleeding and hysteroscopic sterilization.
1002252	I am a clinical psychologist who is primarily interested in providing psychotherapy to individuals and couples coping with mental health symptoms, life transitions and the diagnosis and treament of cancer.  My research interests include psychological sequelae of a cancer diagnosis.
1002340	I have been interested in community mental health and have published in the field of rural psychiatry.  I am currently interested in cognitive disorders and associated psychiatric syndromes in my work at the Cognitive Neurology and Alzheimer's Disease Center. 
1002357	Development of novel therapeutics; cancer signaling; cancer metabolism
1002357	Steven Rosen, MD, FACP, is Genevieve Teuton Professor of Medicine, at the Feinberg School of Medicine, Northwestern University and Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Director of Cancer Programs at Northwestern Memorial Hospital.  Following his graduation with distinction from Northwestern University Medical Schools Six-Year Honors Program in 1976, Dr. Rosen completed his residency in Internal Medicine at Northwestern and a fellowship in Medical Oncology at the National Cancer Institute. Dr. Rosens laboratory research focuses on experimental therapeutics and hematologic malignancies.  Dr. Rosen has received numerous grants awards and contracts and has published more than 200 scientific papers.  As Director of the Cancer Center, Dr. Rosen has successfully competed for an NCI Cancer Center Support Grant, NCI grants for his laboratory research, an NCI RAID Contract grant for the development of a novel purine analog, and grants from the Leukemia and Lymphoma Society of America and the American Cancer Society.Dr. Rosen serves on several editorial boards and is editor of Cancer Treatment & Research.  He is a member of all major national associations that focus on oncology and has held leadership positions in the Eastern Cooperative Oncology Group, the American Association of Cancer Institutes and the National Comprehensive Cancer Network.  He serves on the advisory boards of several NCI-designated Cancer Centers, the Leukemia and Lymphoma Society of America, the Multiple Myeloma Research Foundation, the Lymphoma Research Foundation and the Wendy Will Cancer Research Foundation.  He has also served as an advisor to Great Britains Cancer Research Campaign.  Dr. Rosen was the recipient of Northwestern University Medical Schools Alumni Achievement Award (1994), the Martin Luther King Humanitarian Award from Northwestern Memorial Hospital (1995), the Marv Samuel Award from the Chicago Baseball Cancer Charities (1996) and recognition from the Womens Board of Northwestern Memorial Hospital for Compassionate Care (1996).  He is acknowledged in Best Doctors in America and Best Doctors in Chicago.
1002413	transformation, mesothelioma, cyclins, phosphatases, apoptosis, transactivation
1002417	Clinical research interests include pituitary disease leading to hypopituitarism or hormonal excess syndroms, such as acromegaly, hyperprolactinemia and Cushing's disease.  Basic research interests are focused on the growth hormone-IGF I axis.  Currently ongoing studies include the characterization of genetic GHRH receptor deficiency and the evaluation of tissue-specific growth hormone actions using a growth hormone receptor knockout model.
1002417	growth hormone, growth hormone action, growth hormone receptor, growth hormone binding protein, growth hormone releasing hormone receptor, insulin-like growth factor, growth, development, metabolism
1002485	Dr. Rothke's clinical work and research involves professional issues in neuropsychology such as expert testimony, disability determination, competency evaluation (ability to work, manage finances, and manage personal affairs, and assessment of testamentary capacity), development of job modifications to accommodate a mental or emotional disability, evaluation of risk for violence and determination of fitness-for-duty, and assessment of malingering and exaggerated claims of impairment.  
1002521	learning and memory, multiple single-unit electrophysiology, behavior, classical conditioning, transgenic mice, knockout mice, alzheimer's disease, hippocampus, cerebellum, aging
1002526	Research Interests: Comparative Anatomy of the Larynx                                    Neuromuscular Physiology of the Larynx                                     History of MedicineClinical Interests:   Clinical Human Anatomy                                        Head & Neck Region
1002530	My research and clinical interests focus on children with arthritis, and the use of informatics to improve quality and research projects, by coordinating flow of data from diverse sources, including the electronic medical record.  I participate in a multi-center Quality Improvement network as well as multi-center trials of novel treatments of children with arthritis.
1002615	I am primarily involved in health literacy advocacy, research and incorporation of this into clinical care, as well as medical home and medical education about the medically complex child
1002617	Gonadal Development, Pituitary, Gonadotropins, Activin, LH, FSH
1002617	My overall interests are in mammalian reproduction. In previous years, I studied the regulation of pituitary gondaotropin gene expression and hormone secretion. More recently, I have been working on two topics. The first is trying to determine the genetic cascades involved in male/female sex determination and subsequent development of the gonad. Most of this time is spent on a genome-wide mutagenesis screen for genes involved in spermatogenesis. The second is the control of gene expression by estrogen receptor alpha via mechanisms that do not involve the classical estrogen response element in DNA (the so-called 'non-classical' mechanisms).
1002633	Angina with normal coronary arteries, Coronary artery disease, Coronary circulatory abnormalities
1002643	epidemiology of systemic lupus erythematosus, pregnancy and rheumatic diseases, osteoporosis, steroid-induced osteoporosis, clinical drug trials in lupus
1002644	gender and arrhytmias, dynamics of fibrillation
1002699	I. The Sonic hedgehog signal in vertebrates is mediated by three C2H2 zinc finger transcription factors, GLI1, GLI2 and GLI3. Near identity of gene sequence exists between mouse and human GLI1.  We have shown that GLI1 functions as a transcription factor and that a critical domain in the COOH end of the protein is a transactivator with VP16-like structure. We established that GLI1 protein regulates a set of genes that coordinately control proliferation and may in part explain malignant transformation by mis-expression of GLI1. Post-transcriptional regulation of protein levels of GLI1 occur via the 3UTR of the human gene and this is an active area of research in the lab.                    II. The use of genetic mosaics in developmental analysis has been important for over 80 years.  Recently however, it has been possible to use mammalian mosaics and to perform analysis in situ allowing identification of cell lineage in visceral organs.  I used this system to establish that chemical induced tumors and preneoplastic lesions are clonal. The patterns observed in tissues of these animals derive from the allocation of stem cells during development and are the result of the primary forces : cell death, cell movement, and cell division.  We have shown that the patterns are conserved and regulated within the various tissues of the animals examined.  By using a combination of geometric analysis and computer simulation we have shown that the patterns are fractal, likely arise from iterating simple division rules, and do not require cell movement for complex highly variegated patterns to form. One of the prototypical patterns is evident in the cornea where epithelial cells are assorted in a whorled or pinwheel distribution.  We are using a variety of models; rat chimeras, mouse transgenics, live whole animal second harmonic imaging and explant culture to try and understand how this distribution occurs.
1002702	Adrenal tumors, Endocrine tumors, Hyperparathyroidism, Islet cell tumors of pancreas, Laparoscopic adrenal surgery, Minimally invasive parathyroid surgery, Parathyroid tumors, Pheocromocytoma, Thyroid cancer, Thyroid tumors
1002719	Clinical research in methods of testing for diabetic peripheral neuropathy
1002721	Education Processes, Teaching Learning, Gender issues in Health care
1002791	My primary research relates to the signaling pathways involved in hormone action on osteoblasts and osteoclasts, and its implications for osteoporosis, cancer metastases to bone and women's health.  More details are available on the Web page, http://www.feinberg.northwestern.edu/igp/facindex/SternP.html.
1002793	General practice of Adult Psychiatry, with concentration on Mood and Anxiety Disorders. I also have a particular interest in Alzheimers and other dementias.
1002798	Clinical interests include taking care of premature babies and other ill neanates in the Intensive Care Nursery, and in the process training medical students and other hospitalists. Of special interest is mastering procedures needed in the care of neonates.  A final priority is to continue to develop and execute a comprehensive approach to economically disadvantaged community youth
1002799	Comprehensive care of adults
1002801	I am a general child neurologist with particular interest in neurology of the newborn, and currently pursuing projects regarding treatment of hypoxic ischemic injury and stroke in the newborn.  I have research experience in the psychophysics of vision.
1002912	Bioreductive drugs, hypoxia, adjuvant therapy, radiosensitization, metalloproteinase-inhibitors, imaging for hypoxia, 19F-MRS, spermidine-derivatives,drug activation.
1002958	Cardiovascular healthcare quality, outcomes reserach, Hypertrophic cardiomyopathy, Valve disease, heart failure
1002979	Children in technology, POSTTRAUMATIC STRESS DISORDERINTERACTIVE DIGITAL TECHNOLOGY, CHILD DEVELOPMENT, FAMILY LIFE, VIDEO GAMES, INTERNET, CELL PHONES, COMPUTER
1003038	public psychiatry, behavioral health & human service systems, public health, public policy
1003070	Hypertension; Racial differences in electrolyte metabolism and water balance.
1003094	Breast Surgical Oncology
1003154	Management of chronic ear disease in developing coutriesAcoustic analysis of snoring and respiration and localization of site of airway restriction in sleep apnea.
1003171	Laura A Miller is a prosthetist at the Rehabilitation Institute of Chicago and an Assistant Professor in Physical Medicine and Rehabilitation at Northwestern University, participating in research through the Neural Engineering Center for Artificial Limbs (NECAL). She completed her MS and PhD in Biomedical Engineering at Northwestern University.  She has multiple publications in the area of normal gait and lower limb prosthetics.  She also has an interest in and has been an author in the area of high-level upper limb prosthetic fittings. Laura is an ABC and Illinois licensed prosthetist and a member of the AAOP and the ISPO.   
1003176	Regulation of the cardiac L-type calcium channel at the molecular level
1003231	Exploration of the clinical and epidemiologic significnce of the I1307K APC mutation associated with colorectal cancer in Ashkenazi Jews.
1003231	clinical significance of the I1307k APC mutation in colorectal carcinoma; aromatase inhibitors breast cancer
1003275	Management of chronic pain (low back, neuropathic, cancer, myofascial).Management of acute postoperative pain.Regional anesthesia.Outcome measures in pain research.Safety and neuraxial and regional anesthesia (e.g. anticoagulation and regional anesthesia)
1003295	Dr. Molitch performs clinical research in the fields of pituitary hormone regulation, pathogenesis and treatment of pituitary tumors, and diabetes complications. His research is conducted primarily in the Clinical Research Center.
1003295	Pathogenesis & treatment of pituitary tumors, treatment of diabetic complications 
1003302	Ambulatory anesthesia, Neurosurgical anesthesia
1003356	My clinical training is in cardiology and my research training is in stem cell therapies for cardiovascular diseases and molecular strategies to improve recovery after myocardial infarction.  I am interested in discovering novel treatments for myocardial infarction and heart failure.
1003361	Neuropsychology
1003390	Health services research, Prostate, Public policy
1003403	Oral Pathology <BR>Diagnostic Oral & Maxillofacial Pathology
1003414	The body of work explores early detection of melanoma by skin self-examination (SSE) by those at risk to develop a melanoma. A research focus is the role of the dyadic relationship in performance of SSE. This research evolved from qualitative research in focus group testing of rulers and magnifying glasses to assist with SSE to a randomized trial of the educational and skills training intervention with qualitative measures by self-reported surveys and diaries.In order to improve the early detection of melanoma by physicians providing care, Dr. Robinson's research seeks to move beyond the usual didactic lectures with skin simulation models. The current model with multiple pigmented lesions affords medical students and primary care resident trainees the opportunity to learn the skills needed for early detection of melanoma. Simulation training modules build selfconfidence as the students and trainees master the skills of early detection of melanoma, counseling the patient, and performing a skin biopsy of a clinically suspicious pigmented lesion. The skin simulation interactive learning will enhance the reliability of healthcare provided by primary care physicians via opportunistic screening.Dr. Robinson's research interest over the last decade has also included prevention of skin cancer by harm reduction messages and educational interventions with teens and young adults with a particular focus on reducing indoor tanning and sun protection.
1003426	Neisseria gonorrhoeae, gonorrhea, pilus, antigenic variation, DNA transformation, DNA replication, DNA repair, antioxidant functions, neutrophil interactions. epithelium interactions
1003444	The laboratory is interested in understanding the mechanisms underlying the pathogenesis and immunoregulation of T cell-mediated autoimmune diseases, allergic disease, and rejection of tissue and organ transplants.  In particular, we are studying the therapeutic use of specific immune tolerance for the treatment of animal models of multiple sclerosis and type 1 diabetes, allergic airway disease, as well as using tolerance for specific prevention of rejection of allogeneic and xenogeneic tissue and organ transplants.
1003466	Clinical trials/ Women's health iniative. 
1003502	Expertise in care of children with a variety of cancers, especially pediatric leukemia, palliative care and hemophagocytic syndromeExpertise in palliative care and pain managementExpertise in clinical bioethics
1003627	Research Interests: Treatment Outcome, Serious Mental IllnessClinical Interests: Depression, Anxiety, Relationship Issues
1003628	Sinus problems, trans nasal resection of skull base tumors, snoring and sleep apnea, Taste and smell disorders
1003634	Diabetes in pregnancy, High risk pregnancies
1003637	Male and female sexual dysfunctions ...  Erectile dysfunction ... Low sexual desire ...Sexual arousal problems ...Sexual pain ...Compulsive sexual behavior / Sexual addiction ... Gender identity issues ... Professional sexual misconduct ... Sexual abuse issues ...Sexual orientation isues ...Relationship and marital problems
1003653	Signal transduction, proteomics, systems biology, neurodegenerative disease, vascular disease
1003694	Dr. Young's research focuses on the sympathetic nervous system and the adrenal medulla. His laboratory is investigating the impact of environmental exposures during fetal and neonatal life on sympathoadrenal development. The hypothesis being tested is that development events 'program' how the sympathoadrenal system functions throughout life. Recently, the laboratory has begun to explore the role of estrogens in both male and female animals in this programming process. The implications of such changes during early development on the phenotypic expression of obesity and hypertension in adults are also under examination.
1003694	Physiological regulation of the sympathoadrenal system; Developmental neurobiology of the sympathoadrenal system; Physiological and pathophysiological roles of catecholamines in regulation of blood pressure and energy metabolism.
1003731	Breast cancer surgery
1003772	SOFT TISSUE AND BONE PATHOLOGY
1003787	Breast cancer, General oncology
1003800	Dr. Chang is a rheumatologist with more than 20 years of clinical experience.  His major clinical interest is in rehabilitative rheumatology, and he is regarded as an expert in this field.  He is the Director of the Rehabilitation Institute of Chicago Arthritis Center and Immediate Past Chair of the Rehabilitation Section of the American College of Rheumatology.  He is co-author of the rehabilitation chapter in Koopmans and Moreland's textbook, Arthritis and Allied Conditions, one of the major international rheumatology textbooks. Dr. Chang has been the Director of the Northwestern University Master of Public Health Program since its reorganization in 1996.   During this time he has led the program to achieve pre-accreditation by the Council on Education for Public Health in 2000 and full accreditation from CEPH in 2003.  The program focuses on public health education for medical students and health professionals and trains its students to become effective boundary-spanners between the fields of medicine and public health, an appropriate description of Dr. Chang's professional career.  In September, 2005, Dr. Chang was appointed Acting Chair of the Department of Preventive Medicine.  Dr. Chang is noted for his clinical epidemiologic/health services research focused on the outcomes of rehabilitation and orthopaedic surgical treatments for persons with arthritis and the determinants of functional limitation in clinical and community populations with arthritis.  Much of his community population work has been done in collaboration with Dorothy Dunlop, PhD and Larry Manheim, PhD.  He also has experience performing decision analysis and cost-effective analysis in collaboration with Dr. Manheim and Gordon Hazen, PhD.  With several research and clinical colleagues, Dr. Chang is currently developing and testing a physical activity promotion program for patients with arthritis.  Dr. Chang's public health oriented research, reflective of his formal public health training and interests, has also led to his prominence in the arthritis public health community both at the state and national level.  As a volunteer for the Arthritis Foundation as well as a representative of the Northwestern University Multidisciplinary Clinical Research Center in Rheumatology and the Rehabilitation Institute of Chicago's Arthritis Center, Dr. Chang is a major contributor to the new state-based arthritis prevention program based in the Illinois Department of Public Health.  He is an active volunteer for the Arthritis Foundation, where he is a Co-Chair of the National Office's Public Health Council and the immediate past Chair of the Foundation's Greater Chicago Chapter.
1003800	Dr. Chang is noted for his clinical epidemiologic/health services research focused on the outcomes of rehabilitation and orthopaedic surgical treatments for persons with arthritis and the determinants of functional limitation in clinical and community populations with arthritis.  Much of his community population work has been done in collaboration with Dorothy Dunlop, PhD.  He also has experience performing decision analysis and cost-effective analysis.  With several research and clinical colleagues, Dr. Chang developed and tested a physical activity promotion program for patients with arthritis, supported by a five-year investigator-initiated R01 grant funded by the National Institutes of Health. The project was titled, Improving Motivation for Physical Activity in Arthritis Clinical Trial (IMPAACT).  With the support of an R21 grant, Dr. Chang's team is now developing a worksite intervention that promotes healthy physical activity/dietary behaviors for overweight/obese persons with chronic knee symptoms called JointADventure.
1003810	prostate cancer, androgen-response genes, growth control
1003837	The PI has three major areas of hypothesis-driven research hat are studied and supported:  urinary proteomics in genetic kidney stone diseases; genetic and environmental influences on vitamin D metabolism, osteoporosis, and cardio-renal diseases; mechanisms of vasculopathy in chronic kidney diseases.
1003863	Chrinic fatigue symdrome and chlamydia and adolescentimmunizations ,especially flu
1003874	Dr. Lowe's research focuses on various aspects of growth factors and metabolism.  He has a long-standing interest in the insulin-like growth factors and has recently investigated the role of the insulin-like growth factors in pancreatic islet cell biology, especially in the context of islet cell transplantation.  Other research interests include the generation of insulin-secreting cells from embryonic stem cells and the genetics of complex diseases.
1003874	The Lowe lab has two areas of research interest.  One area of study is the genetics of maternal glycemia during pregnancy and fetal growth and their interaction.  A cohort of ~13,000 mothers and their babies are being used in genome wide association and related studies to define genetic variation affecting these traits.  A second area of study is the development of bioactive materials to enhance islet transplantation.  These studies are being conducted in the context of a research team that includes islet biologists, bioengineers and transplant surgeons.  In related studies, the mechanisms for islet expansion during pregnancy are being examined to define mechanisms for islet cell expansion.
1003883	I am interested in how neural networks control posture and balance.
1003916	Hepatic disease, Hepatitis B and C, Viral infections
1003916	Steven L. Flamm, MD is a Professor of Medicine in the Division of Hepatology at Northwestern University Feinberg School of Medicine in Chicago, Illinois.  He also serves as the Medical Director of Liver Transplantation.Dr. Flamm is a member of the American Gastroenterological Association (AGA) and the American Association for the Study of Liver Diseases (AASLD).  He has served as the Region 7 Representative to the UNOS Liver and Intestine Committee and on the Publication and Practice Guidelines Committees of the AALSD.Dr. Flamm has published widely in the field of hepatic diseases and has spoken both nationally and internationally on many other liver-related topics including viral Hepatitis, autoimmune hepatitis, hepatic encephalopathy, and liver transplantation.  He has an active clinical research program in chronic viral hepatitis (HBV and HCV) and autoimmune hepatitis.
1003933	Independent work in Pharmacovigilance;  Post-Marketing Safety Surveillance of Drugs and Medical Devices
1003978	Dr. Chmiels current research interests are in the epidemiology of HIV-1 infection, statistical methods for the design and analysis of clinical and epidemiological studies of cancer, osteoarthritis and AIDS, and clinical trial design and analysis.
1004010	Benign Hematology, Clotting, Phlebitis
1004010	Co-investigator in the MultiEthnic Study of Atherosclerosis (MESA) and Walking and Leg Circulation Study (WALCS)Laboratory evaluation of hemostasis and thrombosis in various clinical models
1004023	A Phase II, Randomized, Parallel-Group, Open-Label, Multicenter Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects with Active Rheumatoid ArthritisReceiving Background Methotrexate (Protocol# U3374g), Genentech, Inc.
1004023	A Randomized, Placebo Controlled, Double-Blind,Parallel Group, International Study to Evaluate the Safety and Efficacy ofRituximab (MabThera /Rituxan) in Combination with Methotrexate, Compared toMethotrexate Monotherapy, in Patients with Active Rheumatoid Arthritis (Protocol Number U2973G), Genentech, Inc.
1004023	A randomized, multifactorial, double-blind, parallel-group, dose ranging study of the efficacy and safety of Rituximab (mab Thera R/Rituxan) in combination with methotrexate in patients with active rheumatoid arthritis. Sponsored by Roche Products Ltd,/Genetech, Inc.
1004023	A randomized, phase 3, controlled, double-blind, parallel-group, multicenter study to evaluate the safety and efficacy of rituximab in combination with methotrexate (MTX) compared to MTX alone, in methotrexate-nave patients with active rheumatoid arthritis. (Protocol WA17047/U3373g), Genentech, Inc.
1004023	An Open-label Study of the Efficacy and Safety of Re- Treatment with Rituximab (MabThera/Rituxan) in patients with Active Rheumatoid Arthritis (Protocol WA 16855/U2653g). Roche Products Ltd,/Genetech, Inc..
1004023	Humira Efficacy Response Optimization Study in Subjects with Active Rheumatoid Arthritis (HERO). Abbott Laboratories M04-684,
1004025	I am a board certified Otolaryngologist, with subspecialty certification in Neurotology.  I completed a fellowship in Otology and Neurotology, which is a subspecialty in Otolaryngology that deals with disorders and surgery of the ear and ear related skull base structures.  My interests are in cochlear implants, cochlear implant research, middle ear implants, diseases of ear, skull base surgery, skull base tumors, Gamma Knife surgery, acoustic neuromas, neurofibromatosis type II, otosclerosis and facial nerve disorers.
1004037	Early phase cancer studies, diagnostic and screening studies, study design and smaple size determination, statistical analysis
1004062	I maintain a generalist psychotherapy practice, seeing patients with anxiety, depression, life transition, stress, and relationship problems.  I maintain an ongoing interest in substance use disorders.
1004070	Cardiovascular anesthesia, Thoracic anesthesia, Transplantation anesthesia, Pharmacokinetics of inhaled anesthetics
1004121	I am both a general and a child/adolescent psychiatrist.  I am interested in treating mood disorders in children and adults, especially bipolar disorder.  I emphasize medication management coupled with psychotherapy.  I also treat ADHD; it has a high frequency as a comorbidity with mood disorders.  
1004130	Application of technology within public mental health services systems to facilitate system planning, improve service accessibility and utilization, and monitoring of outcomes; as well as child welfare policy and administration.  
1004250	Epidemiology of gestational diabetes, relationship between blood glucose during pregnancy and various outcomes, including pediatric obesity.
1004289	     1.  2003-2004   Principal Investigator: A 52 week randomized, double-blinded, single dummy, parallel group, multi-center, Phase III study comparing the long-term safety of Symbicort pMBI 160/4.5 x 4 actuations twice daily to Symbicort pMDI 160/4.5 x 2 actuations twice daily, and Budesonide HFA pMDI 160 x 4 actuations twice daily, in adult and adolescent subjects with asthma.     ......2. 2001-2003  Principal Investigator:  A multi-center, randomized, double-blinded, double-dummy, parallel group, 16-week comparison of Asthma control in adolescents and adults receiving either Fluticasone/Salmeterol Discus combination, Fluticasone Discus, Salmeterol Discus or oral Montelukast.     .......3. 2001-2002  Principal Investigator:  An open label extension study of Omalizamab in Moderate to Severe , Persistent Asthma subjects who completed Study ALTO     .......4. 2000-2001  Principal Investigator:  A multi-center, randomized, controlled, open-label study to evaluate the safety of Omalizumab (monoclonal anti-IgE) in Moderate to Severe, Persistent Asthma subjects already treated with other therapies.     ...........5. 2000  Principal Investigator:  An observational study of the epidemiology and natural history of Asthma: outcomes and treatment regimens.     ......6. 2000  Principal Investigator:  A randomized, double-blind, placebo controlled, multi-center study of the efficacy and safety of Cetirizine-Sudafed vs. Loratadine-sudafed vs placebo in the treatment of Seasonal Allergic Rhinitis.     .........7. 1998  Principal Investigator:  A randomized, double-blind, placebo controlled, multi-center study of the efficacy, safety, and effect on quality of life, work productivity and activity impairment of Cetirizine vs. placebo in the treatment of Seasonal Allergic Rhinitis     ......8. 1998  Principal Investigator:  A multi-center, double-blind, placebo-controlled, randomized, parallel trial evaluating the efficacy and safety of HFA Flunisolide vs. CFC flunisolide in Pediatric patients with Mild to Moderate Asthma.
1004322	Benign hema, Blood coagulation
1004324	Effective psychological treatment today requires a flexibility of approach as well as the ability to ask the right psychological questions. By engaging patients quickly and thoroughly assessing clinical needs and resources, I am able to work with the patient in order to develop the proper mix of problem-focused interventions and more traditional psychotherapy. Each patient's problems and strengths must be evaluated on an individual basis. I view psychotherapy as a collaborative proceess in which the patient(s) and I work together in order to understand how current situations and past influences impact the well-being of the patient's current life and future goals. In addition to using a flexible approach to treatment, when appropriate, I communicate clearly with other professionals involved in treating the patient, couple, or family. I work with adults as individuals, couples, or parents, and with adolescents and families. Having trained in both clinical and developmental psychology gives me a unique life-span perspective in both normal and pathological psychological processes. 
1004331	Comorbid psychiatric disorders, Trauma and loss, Mental health needs, substance use and risky behaviors of offenders, HIV/AIDS/STIs, Criminalization of mentally ill
1004333	Primary care internal medicine, Women's healthcare
1004356	I am interested in identifying why learning becomes progressively more difficult with normal aging. With this broad goal in mind, I am studying the cellular properties of principle neurons of the hippocampus as an animal ages and after an animal has learned a task that involve the hippocampus. Thus far, my colleagues and I have identified that hippocampal pyramidal neurons (the principle output neurons of the hippocampus) become more excitable (that is, they are able to fire more action potentials) following successful learning. More importantly, the same population of neurons become less excitable with normal aging. Thus, it is our working hypothesis that the reduced excitability levels of the hippocampal pyramidal neurons with normal aging is a cause of the learning deficits observed in the aging population. We are currently using state of the art calcium imaging techniques to further characterize the changes in the hippocampal pyramidal neurons following learning and with normal aging. By systematically examining these cellular changes that occur following successful learning and with normal aging, a goal is to identify potential pharmacological targets to ameliorate and/or reverse the normal aging-related cognitive deficits. In addition, given that incidence of Alzheimer's disease increases with age, it is another goal of our research to translate our findings and approach to identify the cellular changes that occur in this debilitating condition.
1004377	My current clinical research interests include critical care medicine with a focus on the neurologically injured patient population.  However, as Medical Director of the Northwestern Memorial Hospital Emergency Response Team, I am also interested in the systems analyses of in-hospital resuscitation teams which are being described and investigated using an IRB approved research database.  Additionally, as Clerkship Co-Director of the NUFSM ICU M4 Clerkship, I have begun work on investigating the use of patient simulation in undergraduate medical education as an educational adjunct.
1004379	Carework, caring in long-term care, direct care workers, long-term care
1004379	Dr. Berdes, a sociologist, does research in the field of long-term care. She is involved in the study of person-centered care, particularly in the nature of caring relationships between people living in residential care and their paid caregivers.
1004381	I have focused my research and clinical career on the field of Pediatric HIV/AIDS, where I serve as Associate Director of the Section of Pediatric, Adolescent and Maternal HIV Infection at the Children's Memorial Hospital. As a member of the NIH-funded International Maternal Pediatric Adolescent AIDS Clinical Trial (IMPAACT) network, I am chairperson of domestic and international protocols investigating the pharmacokinetics, pharmacogenomics and efficacy of new antiretroviral agents and approaches to therapy for HIV-infected infants. In response to the growth of Pediatric AIDS in international settings, I have traveled to several African nations to train physicians about prevention of mother to child transmission of HIV and the scale-up of antiretroviral therapy for HIV-infected children. As Associate Chair for Education, I oversee the education mission for the Department of Pediatrics.
1004426	cancer, epidemiology, prevention, intermediate biomarkers, prostate cancer, breast cancer, diet, hormones
1004472	Our laboratory has spent the past 15 years seeking to understand the mechanisms of fibrosis that occur in chronic, progressive kidney disease.  We have been studying the role of transforming growth factor (TGF-) because it has been associated with a number of kidney diseases.  However, the classically described TGF-/Smad signaling pathway is too simple to account for the multiple, sometimes contradictory effects of TGF- on cell function. Therefore, we have sought to understand how cell phenotype and the molecular signature of a cell determine whether TGF- signaling leads to fibrosis.  We have identified a number of non-canonical signaling pathways that interact with classical Smad signaling, and begun to establish the hierarchy among these pathways.  We are studying the manipulation of these pathways in vitro and in mouse models in an effort to translate our basic findings into therapeutic approaches to halting or preventing the progression of kidney disease.
1004570	Atopic dermatitis, blistering skin disease, basement membrane, animal model, cytokine, chemokine, autoimmunity, autoantibody, autoantigen, immunogenetic
1004642	The research in the Ferreira lab is focused on the mechanisms underlying neurite degeneration and synapse loss in neurodegenerative diseases
1004646	Amyotrophic lateral sclerosis, Amyotrophic lateral sclerosis (ALS), Muscular dystrophies, Myasthenia gravis, Neurogenetic disorders, Neuromuscular diseases, Peripheral neuropathies
1004676	Neuroimmunology, demyelinating disease
1004707	Dr. Levenson's laboratory concentrates on understanding the molecular mechanisms of development and progression of prostate cancer bone metastases. Her research focuses on understanding epigenic mechanisms of anticancer effects of the dietary compound resveratrol (found in red wine), and on exploring chemopreventive and chemotherapeutic potential of resveratrol in prostate cancer.
1004817	Dr. Lee's research interests include prostate biology, prostate cancer, cell differentiation, growth factor signaling, apoptosis, gene therapy, cell-cell interaction, TGF-beta, and benign prostate growth.
1004883	Dr. Jameson's research focuses on molecular endocrinology. His laboratory investigates fundamental mechanisms that control the transcription of endocrine genes. Concerted efforts are made to bridge laboratory studies with clinical endocrinology using recombinant DNA methods to investigate the pathophysiology of endocrine disorders.
1004883	Nuclear receptors, SF-1, Dax-1, Gonadal development, Transgenic mice, Reproduction, Thyroid
1004892	Care of patients with HIV infection, Primary care internal medicine
1004893	Dr. Kiang Liu received his BS degree in mathematics from Fu-Jen University, Taiwan, in 1970 and his PhD degree in statistics from the University of North Carolina, Chapel Hill, in 1976. That year, he joined the Northwestern University Feinberg School of Medicine as a postdoctoral fellow in the Department of Community Health and Preventive Medicine's training program in cardiovascular epidemiology, sponsored by the National Heart, Lung and Blood Institute (NHLBI). Following his post-doctoral training, he received a research career development award from the NHLBI in 1979 and became an assistant professor in the department. In 1983 he was promoted to associate professor, and since 1988 he has been a full professor in the renamed Department of Preventive Medicine.Dr. Liu's research interests are in cardiovascular epidemiology and statistical methodology for epidemiologic research, topics on which he has authored or co-authored more than 350 publications. He is Principal Investigator of the Chicago Field Center for the the Coronary Artery Risk Development in (Young) Adults (CARDIA) Study, an NHLBI-funded longitudinal collaborative study on lifestyle and evolution of cardiovascular risk factors in young adults.  He is also Principal Investigator of the Chicago Field Center of the Multi-Ethnic Study of Atherosclerosis (MESA), an NHLBI-funded longitudinal study on factors related to subclinical cardiovascular disease. He is also Principal Investigator of the MESA Family Study.
1004916	Flow Cytometry   Immunology<BR><BR>Diagnostic Test Development, Functional Flow Cytometry Test Development, Pediatric Immune Deficiency, Immune Regulation in Autoimmune disease
1005031	proteinase regulation, extracellular matrix proteolysis, adhesion molecules, ovarian cancer, oral squamous cell carcinoma, matrix metalloproteinases, plasminogen activators
1005100	Research in the Longnecker laboratory focuses on herpes simplex virus (HSV) and Epstein-Barr virus (EBV).  These viruses typically cause self-limiting disease within the human population but both can be associated with serious complications. EBV is associated with variety of hematopoietic cancers such as African Burkitt's lymphoma, Hodgkin's and adult T-cell leukemia.  EBV-associated lymphoproliferative disease occurs in individuals with congenital or acquired cellular immune deficiencies.  The two notable epithelial diseases associated with EBV infection are nasopharyngeal cancer and oral hairy leukoplakia.  Similar to EBV, HSV latent infections are very common in humans.  HSV typically does not cause severe disease but is associated with localized mucocutaneous lesions, but in some cases can cause meningitis and encephalitis. The Longnecker laboratory focuses on several aspects of EBV and HSV replication and pathogenesis.  First, the molecular basis EBV transformation and how it relates to cancer is being investigated. The laboratory is currently screening selective inhibitors that may be beneficial in EBV-associated cancers such as Hodgkin's lymphoma and proliferative disorders that occur in HIV/AIDS and transplant patients.  Second, the laboratory is investigating herpesvirus latency in human host.  In this regard, the laboratory is developing animal models for EBV latent infections. Finally, the laboratory is investigating the function of herpesvirus encoded proteins that are important in for infection and the interactions required with cellular receptors required for pathogenesis. Ultimately, studies by the Longnecker may provide insight for the development of novel therapeutics for the treatment of herpesvirus infections in humans and better understanding of the herpesvirus life cycle in the human host.
1005132	depression, psychiatry, affective disorders, treatment, experimental models, circadian rhythms
1005141	Clinical expertise: pain management. Populations include Complex Regional Pain Syndrome (also known as RSD), Fibromyalgia, neuropathic pain, pain in older patients, pain in rehabilitation diagnoses, Myofascial Pain Syndrome and headache.Research: primarily focused on the study of Post Amputation Pain, Spinal Cord Injury pain, Complex Regional Pain Syndromes, musculoskeletal pain, neuropathic pain, osteoarthritis and headaches. The Center for Pain Studies under his direction conducts pharmacological trials, outcomes development and validation and Model validation.
1005197	CLINICAL INTERESTS: Neuropsychological evaluation of adults including effects of subtance use and ADHD. Psychological evaluation of adults including psychotic, mood, and anxiety disorders.
1005219	Organization, financing of health care, health law, child health
1005227	Vestibular, Oculomotor, Vision, Otoliths, Neurophysiology, Neuroanatomy, Behavior, Electromyography
1005231	Gastrointestinal Disease and Surgery; Gallbladder Disorders, Hernia, Minimally Invasive Techniques, Skin Lesions
1005232	My current research interests include the administration of Substance P to improve allergen immunotherapy, the role of staphylococcal enterotoxins in the immunopathogenesis of chronic rhinosinusitis, TLR signaling in food allergy, and health disparities in asthma outcomes.Other research interests on which I have previously published include allergen immunotherapy, drug hypersensitvity, hypersensitivity pneumonitis, occupational asthma, and asthma in the disadvantaged elderly.
1005232	modification of allergen immunotherapy; immunopathogenesis of allergic diseases including asthma, rhinosinusitis & drug hypersensitivity; asthma disparities; asthma in the elderly; asthma & obesity
1005233	Full time Associate Director of the Integrated Graduate Program in the Life Sciences, the umbrella PhD program for the Feinberg School of Medicine at Northwestern University.
1005241	In vitro fertilization, Infertility, polycystic ovary syndrome, fertility preservation
1005250	Regulation of gene expression, especially functions and mechanisms of cis-acting elements; role of histone modifications in transcriptional regulation; functions of transcription factors; interactions between cis-acting elements, transcription factors and epigenetic changes
1005265	Our research aims to elucidate the mechanisms by which chronic activation of glia in the brain, especially astrocytes and microglia, leads to damage of the neurons and progressive neurodegeneration in diseases like Alzheimer's disease. The overall goal is to utilize knowledge of potentially 'druggable' pathways to develop new therapeutics. The normal role of the glia is to cooperate with the neurons to keep the brain operating smoothly. When an injury or change in the brain occurs, the glia mount an inflammation response to fight off the insult and restore the brain to its proper functioning. But in neurodegenerative diseases, the glia are over-activated, producing a state called neuroinflammation. Neuroinflammation can lead to nerve cell dysfunction or death, which is manifest as dementia. Although neuroinflammation appears to play a pivotal role in the development and progression of neurodegeneration, the molecular mechanisms underlying the process and approaches to downregulate the neuroinflammation have received little attention.
1005304	The elucidation of eukaryotic signal transduction pathways, the study of signal transduction pathway perturbation in disease or injury, and the utilization of this knowledgebase for rational drug discovery and development.
1005318	herpesviruses, viral entry, cell fusion
1005327	Treatment of arrhythmias in patients with repaired congenital heart disease, including adults. Surgical therapy of arrhythmias. Evaluation of autonomic dysfunction disorders in adolescents. Evaluation of patients with a family history of sudden cardiac death. Long QT syndrome.
1005411	Epidemiology of HIV infectionTreatment of HIV infection
1005415	Sports Medicine
1005437	Clinical Interest: Kawasaki Disease, Pediatric Infections, Infective Endocarditis, Rheumatic Fever, Group A Strep Infections, History of MedicineResearch Interest:Dr. Shulmans research interest focuses on the epidemiology and antibiotic resistance of Group A streptococci and streptococcal and post-streptococcal illnesses. He is also involved in several aspects of Kawasaki Disease, including studies relating to the etiology, pathogenesis, and treatment of this disease. As chairman of the Infection Prevention and Control Committee, his interests also involve the areas of hospital and community epidemiology of pediatric infectious diseases and nosocomial infections. He is also interested in the history of medicine, particularly as relates to pediatrics and infectious diseases.
1005472	Abnormal PAP smears, Gynecologic surgery, Pelvic relaxation
1005483	Adolescent gynecology, General obstetrics and gynecology, Pediatric gynecology
1005622	Addictions psychiatry, Forensic psychiatry
1005723	Critical care medicine, Phrenic nerve pacers
1005724	Primary Care, Clinical Director, Resident and Medical Student Education
1005807	Primary current concentration is in pediatric cardiology and echocardiography of congenital heart disease.  Interests also include telemedicine, outcomes research, epidemiology of congenital heart disease and medical education.
1005814	Diagnostic immunology, Renal pathology, Urologic cancers
1005815	Asthma, COPD
1005849	papillomaviruses, cervical cancer, epithelila cells, diffrentiation
1005925	Cataract surgery, Comprehensive ophthalmology
1005930	Gastrointestinal cancers, Breast cancer, Stereotactic Body Radiotherapy (SBRT), and Sarcomas
1005937	Surgical Pathology
1005994	Breast pathology, General surgical pathology
1006032	The Paller laboratory is investigating the role of gangliosides in keratinocyte function. Gangliosides are cell-specific sialylated glycosphingolipids of eukaryotic membranes that affect cell-cell recognition, cell-substratum interactions, cell growth regulation, differentiation, and oncogenic transformation.  Most recently, the Paller lab has been testing the role of gangliosides on wound healing.  In collaborative research with the Mirkin laboratory in the International Institute of Nanotechnology at Northwestern, the Paller lab is also investigating the ability of topically applied siRNA  conjugated gold nanoparticles as a single agent in gene suppression.  The laboratory has demonstrated ~100% uptake of the oligonucleotide- conjugated nanoparticles in cultured keratinocyte and excellent uptake through the epidermal barrier of mouse and human skin when topically applied, leading to gene knockdown in skin. Current studies are addressing knockdown through topical application of Ras-mediated epidermal hyperplasia, metastatic melanoma, diabetes, and genetic skin disorders.  Dr. Paller is also the director of cutaneous clinical trials research at Children's Memorial Hospital.  She has been involved in more than 70 clinical trials, and currently is conducting research on atopic dermatitis, psoriasis, localized scleroderma, and epidermolysis bullosa.
1006034	Stroke, Arm Dysfunction following stroke, Electrical Stimulation, Fitness following Stroke
1006055	1.  Clinical interests: ' interstitial lung disease' copd / asthma' dyspnea' drug-induced lung disease2.  Research interests' Mechanism of alveolar epithelial cell injury: role of iron-derived free radicals, the mitochondria, p53 and DNA damage' Asbestos and airborne particulate matter
1006058	Dr. Greenland's research, teaching and clinical interests focus on theprevention of cardiovascular diseases. He has authored or coauthored 300 research papers, book chapters, and monographson topics related to heart disease prevention, heart disease in women,and other aspects of heart disease. Dr. Greenland's current researchinvolves heart diseases in women, risk factors for cardiovasculardisease, peripheral vascular disease epidemiology, and prediction and early detection of CVD. Dr. Greenland was also Principal Investigator (PI) for several NIH-funded training programsincluding the Northwestern University Mentored Clinical ScholarsProgram (K12), and the Post-doctoral Training Program (T32) inCardiovascular Disease Epidemiology and Prevention. He wasPI for Northwestern's CTSA program from 2007-2012.
1006058	My research, teaching and clinical interests all focus on the prevention of cardiovascular diseases. My current collaborative research focuses on women's health, heart diseases in women, risk factors for cardiovascular disease, peripheral vascular disease epidemiology, and nutritional aspects of high blood pressure. I am Principal Investigator for the NIH-funded 'CV and non-CV Risks in Four Cohorts.'I am also Principal Investigator of several NIH-funded training programs including the Clinical Research Curriculum Award (K-30), the Mentored Clinical Scholars Program (K-12), and the Post-doctoral Training Program (T32) in Cardiovascular Disease Epidemiology and Prevention.
1006210	the role of nutrition in prevention and public health
1006247	Clinical Neurology with an emphasis on peripheral nerve disorders.We have also expanded our services to include pain management for those with neck and back disorders predominantly. Additionally, we have introduced vestibular testing and therapy for dizziness. Furthermore, we have a massage therapist who works with our pain patients and can also provide prenatal massage. Please check out our webpage: www.neurometriks.com
1006275	Blood banking, Transfusion medicine<BR><BR>Our transfusion service has a strong emphasis on the quality improvement of laboratory testing and clinical support. We were the first hospital in the US to install a newly approved system for full automation of pretransfusion testing, and we have implemented blood group genotyping in the transfusion service as a routine part of our antibody problem-solving. We have implemented innovative systems for managing blood component recalls and preventing errors in transfusions and organ transplants. Our work has been published in a broad range of areas in transfusion medicine and immunohematology, and we have contributed recurrent chapters to several widely read textbooks. Through various professional and federal committees, we have contributed to national forums for blood banking policies, accreditation, and disaster planning.
1006301	Chronic pain syndromes, Stereotactic radiosurgery, Tumors of the brain and spine
1006308	My primary research interest involves understanding the mechanisms by which extracellular matrix influences the behavior of keratinocytes and lung cells.
1006346	Inflammatory arthritis, General rheumatology, Regional musculoskeletal disorders
1006385	Dr. Zelko has conducted research on neurocognitive functioning with a number of pediatric populations including epilepsy, lupus, kidney disease, liver disease, and spina bifida, and has a number of publications and scientific presentations.  He is presently participating in multi-site studies of the cognitive sequalue of sickle cell disease, pediatric lupus, childhood absence epilepsy, chronic kidney disease, liver transplant, peditric cancer, and phenylketonuria.  His primary focus at present is upon pediatric epilepsy, with a particular emphasis upon attention and executive skills deficits.
1006470	Dr. Ford-Paz is the Coordinating Psychologist of the Mood & Anxiety Program at Children's Memorial Hospital and provides evidence-based evaluation and individual, family, and group cognitive behavioral therapy in Spanish and English for a variety of anxiety and depressive disorders.  Dr. Ford-Paz also has clinical and research interests in the reduction of mental health disparities for Latino youth and families. More specifically, she is interested in the cultural adaptation of evidence-based treatment to improve treatment retention and outcomes for Latino youth. Currently, she is involved in community-based participatory research with 3 agency partners: Healthcare Alternative Systems, Alternatives, Inc., and Alivio Medical Center to target the prevention of depression in Latino youth.
1006492	General diagnostic radiology
1006495	I am interested in the development of teaching resources for undergraduate medical education.  I have authored an embryology book and co-authored an imaging book, created two websites for imaging and radiologic anatomy, a website of electron micrographs, and converted the M1 histology laboratories from the use of microscopes to the study of digital slides.
1006570	CLINICAL: Melanoma and Skin Cancers; Sarcoma and Soft Tissue Tumors; Breast Cancer; Sentinel Node Biopsy, Locally and Regionally Advanced Melanoma, Isolated Limb Infusion                           RESEARCH: Surgical Health Services, Outcomes, and Quality Improvement Research; Oncology Quality Measurement; Melanoma Quality and Outcomes Assessment
1006593	Abdominal wall reconstruction, hernia repair, breast reconstruction, hand surgery, treatment of hand ischemia, peripheral nerve surgery, surgery for amputees, reconstructive microsurgery
1006601	Quantitative MR strategies for in vivo measurement of structural and functional status. Early HIV infection. Risk factors and biomarkers (particularly cytokines and chemokines)of brain injury and cognitive decline in HIV infection and in CNS disorders.
1006641	I am a member of a group of investigators under the leadership of Leema Sharma, MD and funded by the National Institutes of Health to study mechanical influences on the progression of knee osteoarthritis. 
1006773	1. Severe Asthma-We are investigating the associated conditions and immunologic mechanisms of excessive loss of lung function in patients wtih 'irreversible asthma'-a condition first described here. 2. Drug Allergy-We are continuing our series of penicillin testing and protocol development for patients allergic to newer agents including immunomodulatory therapies. 3. Allergic Bronchopulmonary Aspergillosis-Our series of patients is over 25; we are testing the notion that impaired responses by the innate immune defenses allow for Aspergillus fumigatus to escape containment and grow in the bronchial mucus. We continue to explore the utility of recombinant Aspergillus fumigatus allergens for diagnostic testing.4. Reduction in allergic antibody in human allergic subjects- we are testing the notion that the combination of the neuropeptide, Substance P with low dose allergen administration can decrease the immediate cutaneous and clinical reactivity. The initial results of 8 allergic rhinitis subjects have been published. There is an active IND with the FDA, and we are enrolling more subjects for the controlled study and investigation into the mechanisms involved. 
1006773	Allergic bronchopulmonary aspergillosis, Anaphylaxis, Drug allergy, Severe asthma, Urticaria. Suppression of allergic antibodies in human subjects.
1006778	Addictions psychiatry, General adult psychiatry, Mood Disorders, Psychopharmacology
1006781	Family and Cosmetic Dentistry including veneers, crowns, implants, dentures, root canal, TMJ disorders, periodontal (gum) diseases, dentistry with sedation, sleep apnea , upper airway resistance syndrome, snoring
1006815	The three fundamental goals of my research are the following: 1) To understand the nature of the brain's own signals -- the 'language' in which movement commands are expressed by neurons in the central nervous system. 2) To understand the mechanisms by which these signals are produced -- the nature of the connections among networks of neurons, and the transformations that occur in the signals as they propagate throughout these networks. 3) To develop applications of these basic principles that could be of therapeutic value to human patients. Much of this work is done in collaboration with students and faculty from the Biomedical Engineering Department and the Interdepartmental Neuroscience Program (NUIN).
1006832	Injury epidemiology, injury prevention
1006854	Patientsafety/medical error, Iatrogenesis
1006854	Research Interests include funding and delivery of health care and health disparities.
1006865	Neurobiology of the mammalian spinal cord
1006981	Dr. Schaeffer's clinical and research interests involve urinary tract infections, prostatitis, and chronic pelvic pain syndrome.
1007010	I practice primary care sports medicine, a newer field geared towards the non-surgical management of muskuloskeletal complaints.  Currently a team physician for the Chicago Bears (NFL) and US Soccer Men's National Team.
1007084	ARDS, Sepsis, Cystic fibrosis, mechanisms of fibrosis in lung disease.
1007084	Director of Adult Cystic Fibrosis Services
1007103	Prevention, detection and treatment of child maltreatment with a special interest in clinical decision making in the office setting.  I am also interested in the influence of childhood adversities on child health.
1007161	Multiple pregnancy has long been a major focus of my work in which I have co-authored 5 definitive monographs.  Recently, my interests have turned to all aspects of the prevention and treatment of post-partum hemorrhage.
1007168	Dr. Pachman's translational team studies juvenile dermatomyositis (JDM), an often chronic pediatric systemic vasculopathy associated with skin inflammation and proximal muscle weakness of unknown etiology. Her laboratory has identified genetic and environmental factors that play a role in the onset of symptoms and govern outcome. The TNF-a-308 promoter A polymorphism is associated with prolonged disease course. Increased production of TNF-a protein is associated with the A allele throughout disease course, in contrast to serum levels of IFN-a activity, elevated early in the disease. Gene expression micro array studies of untreated children's diagnostic muscle biopsies identified massive dysregulation of IFN-a induced genes in JDM, similar to anti-viral immune model, which also shared features of the IFN-a signature characteristic of systemic lupus erythematosus (SLE). Epigenetic and miRNA studies of diagnostic muscle biopsies indicate critical differences associated with disease duration. Dr. Pachmans search for clinically useful biomarkers of immune activation has identified CD3- natural killer cells and von Willebrand factor antigen, released from damaged endothelial cells.  With chronic inflammation, progressive endothelial damage is reflected by loss of nailfold capillary end row loops (they developed a quantitative system of analysis)associated with lack of absorption of oral prednisone.  In addition, her lab maintains a patient-derived sample repository of diagnostic muscle and skin biopsies, sequential sera, peripheral blood lymphocytes, lymphocyte culture supernatant fluid, and dystrophic calcifications samples keyed to a sequential database and an analytical database software and bio-informatics system. In summary, this intensive research effort broadens the clinical, genetic and immunological characterization of the child with JDM, which is a critical aid in guiding current therapy and may lead to novel targeted interventions.
1007177	I am interested primarily in the therapeutic action of psychoanalytic therapy.  I investigate from a clinical perspective what factors are decisive in changing psychic experience and psychic strucuture.  To this end, I use object relations theories.  My theoretical work has been focused on applying these theories, in all their iterations, to the therapeutic process.  My secondary interest is in the application of psychoanalytic thinking to social and cultural issues.
1007180	Psychotherapy, Psychoanalysis
1007188	General urology, Prostate cancer, Urologic oncology
1007196	My research interests include outcome measure development, evaluating the impact of chronic diseases (particularly neurological) and their treatments on patient-reported and clinical outcomes, and using health information technology to improve quality of care and patient outcomes.
1007298	Regional Anesthesia in ChildrenPain Management in Children
1007337	breast, cancer, tumorigenesis, estrogen, receptor, coactivator, transcription, regulation, knockout, transgenic<BR><BR>To understand the role of nuclear receptor coactivators in regulation of cell specific gene transcriptional activation by estrogen receptor, and how the interruption to this regulation contributes to breast tumorigenesis.
1007375	Addictions psychiatry, Chemical dependence
1007378	Martin McCarthy is a health psychologist and a health services researcher with two main interests -- the use of behavioral and information technologies in health promotion and the assessment of patient-level outcomes of medical care. Dr. McCarthy holds an AB degree in History from Georgetown University, an MA in Experimental Psychology from Columbia University, a PhD in Community Psychology from New York University, and he completed a Post-Doctoral Fellowship in Health Psychology at Northwestern's Feinberg School of Medicine. He is a trained psychotherapist and is licensed to practice as a clinical psychologist in New York State and in Illinois. Previous academic appointments were at the Center for Health Services and Policy Research at Northwestern University, the Center for Geriatrics and Gerontology in the School of Public Health at Columbia University, and the Milhauser Laboratories at New York University Medical Center. Internet-based multimedia interventions have been developed for use in health plans, clinics, school systems, and patients' homes. Projects have focused on reducing childrens experimentation with tobacco products, preventing sexually transmitted diseases in adolescents, promoting skin cancer control in a range of age groups, improving management of risk factors in diabetic patients, promoting the early detection of breast cancer in older women, teaching multimodal pain management to patients with acute and chronic back injuries, and preventing and managing depression in patients with comorbid health problems. Health services research projects focus on the assessment of functional status, health-related quality of life, and psychosocial risk factors via Computerized Adaptive Testing. Previous studies have examined the impact of processes and structures of care on outcomes of cardiac surgery; outcomes of laparascopic and open surgical procedures; and behavioral risk factors in the epidemiology of cardiovascular disease.
1007424	Doctor Spatafora is Assistant Professor of Clinical Psychiatry at Northwestern University Feinberg School of Medicine, and he supervises psychiatry resident trainees at Northwestern Memorial Hospital. He maintains a private psychiatric practice, seeing individuals both for psychotherapy and pharmacotherapy. His sub-specialty training is in Addiction Medicine, and he serves as the Medical Director of the National Football League Program for Substances of Abuse. In his clinical approach, he strives to understand individual patients based both upon science-based knowledge and upon the evidence that emerges within the care of the specific individual.
1007443	Clinical research involving tuberculosis and other HIV-related infections. 
1007508	Abnormal gynecological bleeding, Fibroids, Vaginitis
1007711	Stroke rehabilitation, neurorehabilitation, geriatric rehabilitation, outcomes research, medical comorbidities
1007774	My clinical interests are in pediatric neuro-oncology and tumors in patients with Neurofibromatosis Type I.The focus of my research is on biomarkers in CNS tumors.  In particular, I am interested in microRNAs as disease markers in central nervous system tumors.  I also conduct a research study investigating the utility of acupuncture in pediatric patients with CNS Tumors.  As a team, we also participate in phase I, II and III trials for new agents in the treatment pediatric brain and spinal cord tumors.
1007928	Dr. Kaplan specializes in pediatric urology, pediatric neurourology and urodynamics, and pediatric genitourinary reconstruction.
1007950	Medical care of the patient with diabetes, Medical care of the patient with hypertension, Primary care internal medicine
1007979	I maintain an active practice focusing primarily on Cornea and External Eye Disease.  I have a high volume of cornea transplantation patients and am amongst the first in the nation to perform modern endothelial keratoplasty surgery.  I also continue to explore areas of corneal stem cell transplantation and traditional corneal transplantation, infectious disease, and oncology of the ocular surface.
1007992	Erectile dysfunction (ED) is a significant medical condition and current treatment options are ineffective in diabetic patients and in prostate cancer patients treated by prostatectomy.  Sonic hedgehog (SHH) is an essential regulator of penile smooth muscle, cavernous nerve (CN) integrity and CN regeneration that has significant potential to be developed as a treatment to prevent ED by regenerating the CN and by suppressing penile apoptosis.  In our laboratory we examine fundamental mechanisms that underlie cavernous nerve regulation of penile morphology during development, how these mechanisms become altered with peripheral neuropathy of the cavernous nerve in diabetic rats and how manipulation of SHH signaling can be used to speed cavernous nerve repair in diabetic models. 
1008044	Dentin phosphophoryn (DPP), the major noncollagenous protein of tooth dentin matrix is synthesized as dentin sialophosphoprotein (DSPP) by the mesenchyme-derived odontoblasts. We have found a spatio-temporal expression during mouse embryonic development in cells of epithelial origin. At day-13 of embryonic gestation, DPP was localized to the enamel organ at  the developing tooth cap stage, with heaviest immuno-histochemical staining at the oral ectoderm but was also prominent in the inner enamel epithelium. Interestingly, at the same embryonic stage, DPP was also expressed in the ureteric bud branches of the metanephric kidney and in the alveolar epithelial buds of the developing lung. No expression was seen in the mesenchymal component of either organ. Interestingly inclusion of anti-DPP antibodies in E-13 organ cultures of kidneys harvested from wild type mice, altered ureteric bud morphogenesis and caused looseness of the metanephric mesenchyme. These findings suggest that besides its role in mineralization of the dentin, DPP modulates epithelial-mesenchymal interactions in meristic tissues during embryonic development.Another focus in our laboratory has been studies directed towards understanding the mechanism of mineralization in vertebrate tissues such as bone and tooth and in sea urchin tooth in invertebrates and the role of extracellular constituents of connective tissue in this complex process.  The acidic protein constituent part of extracellular matrix has been implicated in mineral deposition but the precise series of molecular reaction mechanism remains undefined. In invertebrate systems, where the mineral part is calcite or aragonite the mechanisms of molecular calcification remains even much less understood compared to vertebrates where mineral deposition is chiefly calcium hydroxyapatite. We are studying whether it is the nature of the protein or environment that determines whether we get Calcium Carbonate  or Calcium Phosphate crystals
1008161	Primary research interest in using structural biology to further understanding of signal transduction systems.
1008164	Breast cancer clinical/translational trials investigating novel chemotherapeutic agents , endocrine therapy and targeted therapy.  These trials are conducted in the advanced and early stage disease setting
1008164	Breast cancer, Sarcoma
1008165	Anxiety disorders, Medical education
1008334	Most of my research has focused on improving clinical care for obese children. Thus, I have first-hand experience in the bi-directional processes of integrating research knowledge into clinical care and developing research questions based on clinical experience. I have past experience mentoring research of students and young investigators. I have participated in pediatric practice-based research through the Pediatric Practice Research Group (PPRG) and have been the Associate Director of the PPRG for the past 9 years. As principal investigator and co-investigator for research projects funded by federal and private agencies. I have completed a wide range of studies through the PPRG, including studies of prevalence, natural history, perceptions, screening, and interventions evaluating changes to practice operations that foster clinical care improvements. I am particularly interested in identifying ways for effective preventive care delivery in primary care settings, with special emphasis on identifying clinical care concerns among Hispanic families and identifying ways to address their needs.
1008360	blood coagulation, thrombolysis, cataract, neurodegenerative disease, celiac disease, transglutaminases, cell aging, proteolytic enzymes, apoptosis, terminal differentiation
1008377	As a practicing pediatrician, I spend a great deal of my time educating children and their families about good nutrition and weight management.
1008387	My research and public policy interests include health informatics standards, security, and adoption; public health informatics; public health emergency preparedness and response; communicable disease epidemiology; and HPV immunization.
1008443	I am interested in pediatric emergency medicine.  My interests included, medical liability, disaster planning and appendicitis.
1008614	Primary research and clinical interest in female infertility including the impact of infertility on mood and functioning.  Also, psychological aspects of ooycte donation.
1008667	Adult Congenital Heart diseaseHeart disease and Pregnancy with ongoing research in Preconception evaluationWomen's cardiovascular health during her lifetime
1008692	General infectious disease, HIV infection
1008791	Prevention of traumatic brain injury induced immune cell apoptosis
1008881	Diabetes complications of the eye, PDT laser treatment, Vitreo-retinal diseases
1008921	Primary care internal medicine, Women's healthcare, intimate partner violence
1008931	Pediatric neurosurgery with special interest in pediatric brain tumors
1008950	I am interested in ensuring the health and well-being through my clinical care of newborns.  I am also interested in developmental outcomes of high-risk newborns.
1008963	Neurologic communication disorders, aphasia, traumatic brain injury, right hemisphere stroke, discourse, neglect
1008970	The major cause of mortality from prostate cancer is metastatic disease for which there is currently no effective cure.  For reasons that remain incompletely understood, bone is the most common site for prostate cancer metastasis.  Reciprocal signaling between invading prostate cancer cells and host bone stromal cells is central to metastatic tumor development.  Understanding these cell-cell interactions will lead to effective diagnostic and therapeutic strategies to prevent/arrest metastatic spread of prostate carcinoma. My current research stems from the hypothesis that prostate cancer cells and bone cells interact via the hedgehog signaling pathway to promote bone metastasis.  Sonic hedgehog (Shh) is a member of the hedgehog family of ligands that activate an intracellular signaling cascade upon binding to transmembrane receptors (Patched) leading to transcriptional regulation of specific target genes by the Gli family of transcription factors.  Our previous work has demonstrated that Shh-expressing epithelial cells and Gli-expressing mesenchymal cells in embryonic mouse prostate interact via the Shh-Gli pathway to promote cell proliferation and ductal morphogenesis.  We have also shown that the genes for Shh and Gli are expressed in human prostate cancer, and that Shh-expressing prostate cancer cells and Gli-expressing stroma collaborate to promote prostate tumor growth in a mouse xenograft model.  Our present research extends these observations and investigates signaling interactions via the Shh-Gli pathway between prostate cancer cells and bone cells to promote prostate carcinoma metastasis, using both in vitro and in vivo models.
1008991	Cutaneous T-cell lymphoma, Dermatopathology, Skin cancer prevention and detection
1009039	cancer, aging, senescence, stress resistance, cell death, life span, aging associated diseases.
1009098	My clinical interests are in long- and short-term, psychodynamically informed psychotherapy with both high-functioning and severely mentally ill adult outpatients, marital/couples therapy and clinical supervision.  My research interests include psychoanalytic theory, gender theory, fantasy, creativity, psychodynamically-informed developmental theory, the relationships between clinical work, psychological theory, and the arts and humanities, psychoanalysis and culture theory, and psychoanalytic politics.
1009110	Investigations of nerve cell behavior in vivo and in vitro; live cell imaging; phototoxicity
1009129	Rheumatoid arthritis
1009168	aging, age-related memory loss, synapses, synapse number, synapse structure
1009325	Cosmetic, Reconstructive breast surgery, Reconstructive surgery
1009330	I am a computer programmer and database manager involved in long-term observational studies in the field of cardiovascular epidemiology.  I have been associated with the Western Electric Study (WE), Chicago Heart Association Detection Project in Industry (CHA), CARDIA, MESA, Womens Health Initiative, the Walking and Leg Circulation Studies, the Chicago Healthy Aging Study (continuation of CHA), and the Hispanic Community Health Study / Study of Latinos as well as many clinical trials in cardiovascular disease prevention.
1009340	I am interested in how robotic interactions can be used to improve reaching performance. My methods involve dynamic modeling, optimization, robotics, and adaptive control. Applications include rehabilitation of brain injured individuals. 
1009343	Antimicrobial resistance, Infection of the immunocompromised host, Nosocomial infections
1009343	My research interests have focused primarily on the epidemiology of healthcare associated infections and antimicrobial resistance.  Specifically, this includes investigations into the epidemiology, transmission and management of vancomycin resistant enterococci as well as other multidrug resistant bacteria.  More recently, my focus has expanded to include research into patient safety.  This includes understanding the epidemiology of medication errors and other adverse events associated with hospitalization.
1009346	My main clinical and research interests involve radionuclide imaging and therapy, including but not limited to general Nuclear Medicine imaging and therapy, positron emission tomography (PET) and PET-CT imaging, molecular imaging and Nuclear Cardiology.
1009347	I am Chairman of Panel C of the Institutional Review Board at Northwestern, and CoChair of the combined Northwestern/University of Illnois VA IRB.I have a private practice with and emphais on Adult Attention Deficit Disorder and Mens Health.
1009379	My clinical interest is in long and short-term psychodynamic psychotherapy with adult outpatients.  I am particularly interested in the developmental sequelae of trauma and loss on later personality functioning and attachment/relationship patterns, as well as the therapeutic factors that affect change.  I am also interested in providing clinical supervision.
1009475	Bone Health and OsteoporosisClinical densitometry
1009475	Dementia, Osteoporosis
1009528	I have a particular interest in anesthesia for ENT surgery and resident education.
1009559	Identify children at risk CAD.  Utlize the new NHLBI guidelines (member expert panel) to reduce cardiovascuar disease in children and adolescents.Provide tools, support, and acknnowledgement for pediatric office based education and to engage community pediatricians to provide more teaching to medical students, residents, and other trainees.
1009562	Epidemiologic characteristics and health service needs of special populations, HIV/AIDS risk behaviors, and mental health service utilization
1009564	Chronic mental illness, General adult psychiatry, Schizophrenia
1009628	I am especially interested in anxiety disorders and their link to other health concerns, including cardiovascular risks, autoimmune diseases, and obesity.  I am also interested in an integrated approach to psychiatric problems that encompasses more in depth integration of biopsychosocial aspects.  Finally, I am especially interested in communicating effectively complex ideas related to my profession to medical/professional colleagues in related or other diverse fields and the public at large.  My published essays reflect my ability to reach a diverse audience.
1009779	Dr. Pope directs a basic science laboratory, which is focused on rheumatoid arthritis, a disease that affects women much more commonly than men.  Dr. Pope's laboratory has focused on characterizing the basic mechanisms that contribute to the pathogenesis of rheumatoid arthritis.  The work focuses on the role of macrophages and synovial fibroblasts.  His studies are directed at defining the mechanisms that promote resistance to apoptosis or programmed cell death.  They are aimed at defining the potential role of the induction of apoptosis as a therapeutic approach in this disease.  To this end his laboratory is characterizing the mechanisms that protect rheumatoid arthritis macrophages and synovial fibroblasts from apoptosis.  Investigators in his laboratory identified the upregulation of the anti-apoptotic protein, Flice Like Inhibitory Protein (FLIP), during monocyte to macrophage differentiation.  They have demonstrated that FLIP is highly expressed in the rheumatoid joint and is responsible for protecting rheumatoid arthritis macrophages from Fas-mediated apoptosis.  His laboratory is further characterizing the mechanisms for the basal expression of FLIP, and that observed following activation by cytokines and toll-like receptor ligands.  Further, studies are aimed at defining the mechanisms of macrophage cell death that occurs following TNF or Toll-like receptor ligation when NF-kB activation is suppressed.  The aim of these studies is to identify potential therapeutic targets for intervention in rheumatoid arthritis.  Additional studies are directed at determining the role of Fas-Fas ligand interactions on the promotion of chronic inflammation, which occurs by sensitizing the macrophages to activation through the Toll/IL-1 receptor pathway.  Additional studies have identified Mcl-1, another Bcl-2 family member, which is critical for the survival of macrophages and synovial fibroblasts.  Studies have demonstrated that Mcl-1 is highly expressed in the rheumatoid joint, in both macrophages and synovial fibroblasts.  Ongoing studies are directed at defining the unique mechanisms that control the expression of Mcl-1 in macrophages and synovial fibroblasts.  Both cell types appear critically dependent on Mcl-1 for survival and ongoing studies are aimed at defining the potential role of modulating mcl-1 expression or function as a therapeutic target in experimental models of rheumatoid arthritis.The goal of this program is to develop new therapies, employing apoptosis as a therapeutic tool.  Dr. Popes laboratory also collaborates with Dr. Ramsey-Goldman, developing and performing some of the assays used to evaluate osteoporosis in her patients with lupus.  These include assays to quantitative osteoprotegerin and Rank ligand as well as microarray analysis of monocytes and macrophages from patients with lupus.  
1009779	Rheumatoid Arthritis, Macrophage, Apoptosis, Cytokine, Gene Regulation
1009786	Primary interest is in childhood bereavement.
1009999	Extensive experience in Cleft Lip and Palate and Craniofacial Surgery.Director: Head Shape Evaluation ProgramThis is a multispecialty clinic dedicated to the evaluation and treatment of children with congenital and acquired deformities of the craniofacial skeleton.
1010008	Research Interests: Organizational behavior, translational research/implementation of evidence into clinical practice, long-term care and utilization of health care services, including community care, assisted living and nursing home care. Spinal cord injury - variability in proactive, self-management, prevention of pressure ulcers.
1010177	genomics, genome, genome structure, genome annotation, transcriptome, SAGE, gene identification
1010207	prosthetics, orthotics, rehabilitation engineering
1010213	My primary clinical and research interests include Neuro-ophthalmologic problems such as double vision, optic nerve problems and vision problems related to neurologic or neurosurgical problems such as tumors, trauma and strokes.  My surgical interests include refractive procedures; such as LASIK and PRK, cataract surgery; including presbyopia (reading) corrective intraocular implants and eye muscle surgery; for patients with double vision or strabismus (abnormal eye alignment).
1010235	diet, nutrition, prevention, treatment, cardiovascular epidemiology, breast cancer, child health, obesity prevention, obesity treatment, maternal nutrition, nutritional assessment, diet intervention, Medical Nutrition Education
1010236	Acute myocardial infarction, Angioplasty, Coronary disease, Interventional cardiology, Rotablator, Stents
1010239	My primary clincal and research interest is in the field of fetal cardiology. I am interested in advancing screening fetal echocardiograms in addition to continuing my research in fetal arrhythmias, congenital heart disease, and pulmonary hypertension in the neonatal period.
1010249	Dr. Moretti has had a career-long interest in the applications of hypnosis, meditation, biofeedback, and relaxation training to various disorders. As a psychotherapist, he uses both analytic and cognitive behavioral methods, tailoring the approach to the individual needs of the patient.
1010263	Contributed a large body of work to the literature addressing the diagnosis, biology, and treatment of acute leukemia and other hematologic malignancies.  This work includes original research articles in peer-reviewed journals, textbook chapters and reviews, monographs, editorials and abstracts.  He has spoken as an invited lecturer and chair at many national and international symposia, conferences, and meetings, including the American Society of Hematology and American Society of Clinical Oncology Annual Meetings.   
1010263	Hodgkin's disease, Leukemia, Lymphoma, Transplantation
1010271	Psychological reactions and coping with medical problems;Biofeedback and Neurofeedback therapies;Health and wellness assessment;Health psychology program evaluation
1010291	pediatric oncology, neuroblastoma, angiogenesis, clinical trials, tumor biology 
1010292	Cardiovascular anesthesia, Thoracic anesthesia, Transplantation anesthesia
1010302	My primary interests are in physical activity in aging. Promoting physical activity in the community in collaboration with community based organizations.  I am also interested in community based interventions for older adults with osteoarthritis.  Finally, how physical therapists can contribute to health promotion for older adults.
1010352	Gastrointestinal cancer surgery, Melanoma / sarcoma, Pancreatic / liver cancer  surgery, Surgical oncology
1010367	Bronchoscopy, Exercise physiology, Lung cancer
1010477	My research is focused on sensory neuroscience with special interest in espins, a novel family of multifunctional actin-bundling proteins. These proteins are present at high concentration in the parallel actin bundle of hair cell stereocilia, in the microvilli of taste receptor cells, solitary chemoreceptor cells, vomeronasal sensory neurons and Merkel cells. Mutations in espin gene cause deafness and vestibular dysfunction in mice and humans. I am investigating the effect of these mutations on the sensory systems during development and adulthood. 
1010479	Development of cochlear implants including novel devices based on neural infrared stimulation, use of laser in clinical settings, micromechanics of the cochlea, imaging
1010557	Ischemic heart disease
1010571	Certified Registered Nurse Anesthetist, Advance Practice Nurse; Liver Transplantation, Neurosurgical Spine Surgery, Outpatient Anesthesia and General Anesthesia.
1010600	Prosthetics, Orthotics, Mechanics, Rehabilitation
1010604	High risk pregnancies, HIV infection - perinatal, Perinatal infectious disease
1010952	Microbiology/Virology <BR><BR>My research work is focused on studying the mechanisms that regulate the transcriptional activities of nuclear receptors. Nuclear receptors are transcription factors involved in regulation of many biological processes. In order to initiate transcription, additional factors are required to interact with nuclear receptors and to regulate their activities. These factors are collectively called as nuclear receptor co-factors. Several such co-factors have been identified by our studies. Generating mouse models using gene targeting technology to investigate the functions of these genes is in progress.
1011026	Neonatal infectious diseases, anemia/erythropoietin, nutrition for sick newborns.
1011040	Pre - hospital emergency care
1011074	CBT for mood and anxiety disorders in adolescence and adulthood
1011077	Community health, safety-net health care, preventive services, health care delivery.
1011092	Dr. Lee is interested in coronary artery disease, ischemic and structural heart disease, cardiac stress testing, nuclear cardiology and cardiac magnetic resonance imaging (MRI). Dr. Lee has extensive experience with cardiac imaging and how it impacts the diagnosis and management of patients with cardiovascular disease. He is also the recipient of research grants from the American Heart Association and St. Jude Medical, Inc. His research focuses on cardiac MRI in acute and chronic ischemic heart disease, valvular heart disease, ischemia evaluation, drug/device treatments and prevention.
1011095	We are currently studying the anatomyand physiology of myocardial scar (infarction) and how this predisposes to ventriculartachycardia. We are utilizing advanced mapping systems to develop more effective ablationtechniques for this arrhythmia.
1011128	General surgical pathology, Pulmonary pathology<BR><BR>
1011185	My research interests are to understand the neuro-mechanical factors related to disease onset, disease progression, physical function, and pain in knee osteoarthritis; and to develop and implement novel intervention strategies to address these underlying neuro-mechanical factors and to delay disease progression, improve function and pain.
1011244	Ethics & economics of organ transplantation, Kidney transplantation, Living donor kidney transplant
1011272	Atrial fibrillation, Arrhythmia detection, Computerized ECG, Arrhythmia mapping, Signal processing for arrhythmias
1011279	normal swallowing physiology, speech/swallowing dysfunction, voice disorders
1011314	The quality of parent-child relationships during infancy has long-term and significant implications for a child's healthy adaptation. Primary care pediatricians have unique opportunities to support early family relationships because of their repeated encounters with families for well child care. My research and teaching interests have been focused on how emerging parent-infant relationships can be supported by pediatricians and on the impact that the quality of those relationships can have on the practice of primary care pediatrics. In the initial phase of my research, I developed and validated a research protocol for observing and understanding meaningful patterns of interaction that occur between parents and infants during well child visits. Next, I modified the observational system for clinical use, integrated it into Developmental-Behavioral Pediatrics training for pediatric residents and studied its influence on recognition, guidance and documentation in well child care visits. My present interests revolve around exploring mechanisms by which the parent-child relationship may contribute to aspects of child health and behavior that are integral to the provision of comprehensive pediatric primary care. I am currently exploring whether there are pathways that include parent-child relationship quality that predict early childhood obesity. I hope this research will lead to identifying families with children at-risk for early obesity who might benefit from early intervention targeting parent-child interactions, parental sensitivity to infant cues and, more broadly, parent-child relationships in lieu of, or in addition to, traditional interventions for obesity. A second line of current research examines parental perceptions and actions around early infant regulation. The purpose of this study is to explore the relationship of feeding methods, parenting practices, parent and infant characteristics on the development of infant regulation over the first 18 months.
1011512	Arthritis disorders of the Hip and Knee including Joint Replacement surgery of the Hip and Knee;Bone health and Osteoporosis issues in orthopaedic patients
1011521	Dr. McGaghie's research and scholarship address medical and health professions education, esp. skill acquisition and maintenance, outcome measurement, simulation technology, faculty development, and team science.
1011552	As a clinical psychologist, I am interested in growth and development throughout the life span.  My clinical training has ranged from childhood to older adult development and treatment.  My publications focus on child therapy as well as childless older adult women.
1011559	Project 1. Atherosclerosis - the main cause of cardiovascular disease - is now understood to result from a chronic inflammation of large arterial blood vessels superimposed upon by high plasma LDL levels, as well as other risk factors. Plasma LDL levels are controlled, in part, by the rate of their clearance from circulation. About 60% of the LDL cleared fron the plasma occurs through the mediation of the LDL receptor, mainly in the liver. The remaining is cleared by an as yet uncharacterized hepatic LDL receptor-independent mechanism. We are currently investigating the possibility that the LDL receptor-related protein 6 (LRP6), a trans-membrane co-receptor for Wnt signaling, mediates the clearance of LDL from the plasma. Project 2. Considerable evidence suggests that auto-immunity plays a significant role in the development of atherosclerosis. In collaboration with Dr. Stephen Miller (Microbiology) we are investigating the effectiveness of tolerance-induced by atherosclerosis-specific antigen-coupled cells in preventing the formation of atherosclerotic lesions in mouse-models of this disease. .
1011587	Psychomatic Obstetrics and Gynecology and Women's Developmental Issues during childbearing years:  Psychological aspects of fertility, pregnancy, loss, parenting, aging, breast and gynecological cancer; pharmacologic questions regarding psychotropic exposure in pregnancy and lactation; hormonally mediated mood disorders.Psychiatric care of medically ill patients.
1011595	Apinal oncology, Complex spine surgery, Deformity and reconstructive spine surgery, Rheumatoid diseases
1011618	Neuro-immune and bacterial mechanisms of bladder inflammation.
1011643	Trauma psychiatryInterpersonal relationshipsBipolar disorderAnxiety disorderGrief counseling Career and peer issues/relationshipsComprehensive Psychiatric Second opinion evaluations
1011657	Cardiovascular anesthesia, Thoracic anesthesia, Transplantation anesthesia
1011750	Dr. Ma' clinical and research interests are focused on chronic lymphoid malignancies,including chronic lymphocytic leukemia and non-Hodgkin lymphoma.  Dr. Ma directs the translational research initiatives in chronic lymphocytic leukemia (CLL) to develop and study novel treatment agents for the treatment of CLL. Her translational investigations have included novel biologic agents, mechanisms of drug resistance and immunotherapy. Dr. Ma is the Principal Investigator for a number of investigator-initiated and industry-sponsored clinical trials studying new exciting treatments agents for CLL and lymphoma. She collaborates with investigators at Northwestern University, other US institutions and international institutions in developing novel therapeutic approaches in hematologic malignancies.
1011815	Dermatopharmacology
1011821	AIDS / HIV related, Breast cancer, Palliative Care
1011822	My two current intersts/areas of subspecialization are working with adults who have personality disorders (usually people in their 30s who are having trouble sustaining intimate relationships or satisfying careers) and with couples.  I do both psychoanalysis and conjoint couples therapy.  My interest in the problems of couples has led to my creating and teaching an undergraduate course at Northwestern, 'Marriage 101: Building Loving and Lasting Relationships.'  I am a coauthor of a paper on how couples therapists and individual therapists can collaborate.
1011837	Cataract and Implant Surgery, Glaucoma Medical and Surgical Management, Laser Surgery, Early Detection Glaucoma
1011901	At Northwestern Memorial Hospital, Dr. Slutzky sees both general neurology and epilepsy patients. In addition to his clinical responsibilities, Dr. Slutzky pursues research interests in neural prosthetics, specifically brain-machine interfacing (BMI).  A device that records signals from the cerebral cortex, decodes them, and uses them to control a variety of outputs such as a computer cursor, prosthetic limb, or electrically-stimulated muscles in a paralyzed limb, a brain-machine interface could allow a severely motor impaired patient (quadriplegic or locked-in, for example from ALS or spinal cord injury) to interact with his or her environment and potentially regain the use of a limb again. In addition, this technology provides a powerful new way to study normal in vivo brain physiology. Dr. Slutzkys ultimate goal is to refine BMIs to the point that they can safely and effectively be used in humans for long-term applications. He recently received a NIH K08 career development award to investigate different brain signal sources as inputs to a BMI.
1011912	Woodruffs role in understanding inhibin fluctuation in the ovary led to questions about ovarian follicle formation and persistence, which provides new ways to think about fertility preservation for young women with fertility-threatening conditions (NEJM, 2009).  She examined the regulation of follicle function in vitro and established a collaboration with a biomaterial scientist, Lonnie Shea, to develop a 3-dimensional support system that would provide the necessary bio-integrity for follicle growth (Tissue Eng. 9:1013, 2003; News and Views in Nat. Med. 14:1178, 2008 and Nat. Med. 14:1182).  These studies have been very productive and the current culture system supports live births of mice. The system is being adopted to non-human primate and human ovarian follicles. She coined the term oncofertility to describe this work.  Finally, she has used physiological studies together with mathematical modeling to explore the kinetics of follicle formation and persistence in the mouse (Dev. Biol. 298:149 and Dev. Biol. 298:132). These studies reveal the necessary and sufficient nature of the initial follicle pool established in the ovary during the time of development (Nature Med, 14:1190, 2008). Hallmarks of Woodruff career have included a strong focus on ovarian biology, on interdisciplinary approaches to problems, and application of the overall health of women.
1011952	General surgical pathology
1012074	General diagnostic radiology
1012081	gross anatomy, histology, cellular electrophysiology, sinoventricular conduction system, muscular valvular apparatus, heart
1012104	Pediatric anesthesiology
1012150	Comprehensive care of adults, Hospital-based care of the medical patient, Medical consultations
1012293	Lung surgery, Thoracic surgery
1012336	Cytomegalovirus is a ubiquitous herpesvirus which latently infects the majority of adults.  Reactivation of latent virus occurs frequently, and in immunocompromised individuals, such as recipients of solid organ and bone marrow transplants, reactivation of CMV is associated with significant morbidity and mortality. The primary focus of research in our lab is the elucidation of the molecular mechanisms by which cytomegalovirus (CMV) establishes latent infection, in which the DNA is present but no virus is produced, and the mechanisms by which the virus reactivates, starts actively replicating and induces disease in vivo.  Using murine CMV as a model system, our studies have shown that the virus establishes latency by shutting down viral gene expression through recruitment of transcriptional repressors to the viral genome.  We have developed a unique kidney transplant model for studying reactivation of the virus which closely approximates clinical settings in which reactivation occurs, and we are investigating molecular signaling pathways that lead to transcriptional reactivation of viral gene expression.  This may lead to identification of novel targets for therapeutic intervention which could prevent reactivation of CMV and its associated pathologies.
1012362	Interest includes the care and medical issues of adults with cerebral palsy. Also have interest  in spasticity management in a variety of upper motor neuron disorders.
1012450	cell-matrix adhesion, epithelial cells, pulmonary biology, mechanosignal transduction, hemidesmosomes, focal contacts, laminins
1012547	child, adolescent, adult psychology.  Family and couples therapy
1012560	General obstetrics and gynecology, Ultrasound (obstetrics and gynecology)
1012562	Oculofacial and Reconstructive Plastic Surgery. Board Certified Ophthalmologist
1012563	The overarching goal of my involvement in translational research is to improve the outcome of patients with lymphoma.  With scientists in the US and abroad, we are currently investigating novel signaling pathways in lymphoma, using cell lines and animal model systems.  More specifically, our research focuses on the biology of reactive oxygen species signaling pathways in lymphoma.  Active investigations include: 1) the biology of the lactone diterpenoids in lymphoma; 2) the development of all trans retinoic acid (ATRA) and curcumin loaded nanodisks as a drug delivery vehicle in mantle cell lymphoma (MCL), in collaboration with investigators from the Childrens Hospital Research Institute (CHORI) in Oakland, CA  3) The characterization of cholesterol efflux pumps as a target in lymphoma, in collaboration with Dr Colby Shad Thaxton from the Department of Urology and the Northwestern University Center of Cancer Nanotechnology excellence; 4) the study of hypoxia inducible factor (HIF) in lymphoma, in collaboration with Dr. Paul Schumacker. Clinical research interests include the study of novel immune stimulatory strategies following stem cell transplant in lymphoma with collaborators in Israel, Europe and the US, new approaches to the use of radioimmunotherapy (RIT) in lymphoma, and new treatment paradigms based on the basic investigations described above  Clinical research studies are carried out through the Northwestern University Lymphoma Program and through national co-operative groups such as the Eastern Cooperative Oncology Group (ECOG), SPORE programs in lymphoma and through the NCI Phase II Consortium in collaboration with investigators at the University of Chicago.
1012563	We are investigating the mechanism of reactive oxygen species (ROS) mediated apoptosis in myeloma and lymphoma. We are looking at both the intrinsic and extrinsic caspase system and the role of ROS in cellular signalling
1012598	Clinically, I predominantly treat inflammatory bowel disease patients where I specialize in the use of immunomodulatory therapies. On a research level, my lab is involved in understanding the mechanisms for colitis-induced colon cancer. We focus on regulation of intestinal stem cells using genetically altered mouse models and analysis of human biopsy tissue.
1012598	The Barrett lab investigates mechanisms of epithelial stem cell activation in mouse and human models of Inflammatory Bowel Disease (IBD). Areas of interest include studying the cooperation between phosphoinositide 3-kinase (PI3K) and Wnt in activating beta catenin signaling (He et al Nat Gen 2007). We find that intestinal inflammation increases PI3K-activated beta catenin in intestinal epithelial progenitor and stem cell populations. We propose that this pathway will be a novel target in strategies for chemoprevention (e.g. colitis-induced cancer) and recovery from radiation-induced stem cell injury (e.g. after nuclear attack). In all projects of the lab we strive to have strong translational components by testing lab-generated hypotheses in patient material.
1012615	Preventive medicine, Primary care internal medicine, Women's healthcare
1012787	Dementia, Internal medicine
1012808	Dr. Dalton has special interest in the management of prostate, kidney, and bladder cancers with an emphasis on robotic surgery.
1012834	I've had thirty years of experience as a psychiatric clinician.  in addition to my private practice I work in two community programs providing treatment to individuals with chronic and severe mental illness, Trilogy and Housing Options for the Mentally Ill in Evanston.
1013067	HIV infection, viral hepatitis, antiviral drug development, global health research
1013067	Principal Investigator, Northwestern AIDS Clinical Trails Group/NIH/NIAID.Principal Investigator, Northwestern AIDS International Training and Research Program, NIH/Fogarty International Center.Principal Investigator, Northwestern Strategy for Developing and Institutionalizing Global Health Programs, NIH/Fogarty International Center.Nigeria Country Director (Harvard University primary grantee), President's Emergency Program for AIDS Relief, DHHS.Clinical Director (David Kelso PI, Northwestern), Diagnostic point of care development,Gates Foundation.Clinical Director (James Baker PI, U Michigan), Intranasal vaccine administration.   
1013078	I help patients who struggle with emotional and compulsive overeating understand the connection between their experience of stress and their lack of control over their eating. Understanding this connection helps motivate patients to focus on the cause of the problem rather than the effect, and to develop more effective coping strategies to overcome their reliance on food as a short-term coping mechanism.My research interests include psychological models of behavioral self-control, motivation for healthy lifestyle change, and the causes and treatment of patient non-adherence.
1013105	We are using multiple myeloma as a model to understand the actions of glucocorticoids (GC) and the glucocorticoid receptor (GR).  Development of resistance to GCs remains a critical clinical problem which involves the loss of GR expression.  We are exploring post-transcriptional mechanisms to understand the loss of receptor expression.  In addition we are investigating new drugs for the treatment of myeloma.  We have discovered novel nucleoside analogs that are effective in both GC-sensitive and -resistant cells.  We are working on bringing these compounds to clinic.
1013131	Coronary bypass surgery, Minimally invasive valve repair and replacement, Transmyocardial laser revascularization
1013138	Food Allergy: My interests include pathogenesis of allergen sensitization and food allergy, as well as research regarding immunomodulatory interventions for food allergy.Asthma: My interests lie in understanding the factors which contribute to inner-city asthma and its greater morbidity/mortality as compared to non-inner city populations.  I am especially interested in the relationships between allergen sensitization, exposure and morbidity for cockroach, rodents and fungi.  I am interested in psycho-social factors which contribute to the burden of asthma in this population.  I am also engaged in clinical trials to improve therapy for childhood asthma.
1013310	I have a variety of research interests with most relating to abdominal imaging (GI/GU) especially abdominal MR and CT.  These include pancreaticobiliary and hepatic imaging and new evolving imaging techniques related especially to MR.
1013336	Emergency Medicine, Hospital-based care of the medical patient
1013371	HIV infection, Sexually-transmitted diseases
1013382	Asthma, Hay fever, Idiopathic anaphylaxis, Sinusitis, Urticaria
1013382	I am conducting clinical research on chronic idiopathic urticaria and angioedema in collaboration with Marianna Kulka PhD who is a mast cell expert and has a mast cell line. We will attempt to elucidate the pathgenesis of the disease, identifying histamine releasing factor in the sera and also identifying mediators that may be released locally.  We will do this with a blister chamber that raises a small fluid filled blister.  We will identify cytokines and local mediators at the site of lesions and compare this with  unaffected skin.  We will also take biopsies of lesions.  We have IRB approval, have collected sera from several patienets and are recruiting for these further studies.I am working with several faculty in GI and Paul Bryce, PhD on developing research in eosinophilic esophagitis.
1013524	Psychiatric Treatment of Adults/Older Adults; Depression; Management and Treatment of Patients with medical illness, dementia, or end-of-life issuers; assistance to families and caretakers of such patients.
1013559	Being on the pioneering team of lasers in dental surgery and from co-authoring the first textbook on the subject, I have always been interested in Lasers and their clinical use in dental surgery. Also, their effects on tissues versus those effects of more conventional means and how lasers improve the quality of life of our patients.  I have another large interest in the use of Connective Tissue for Dental Surgical Grafting and further its use via minimally invasive surgical techniques.  With connective tissue we are now able to make complete repairs on exposed roots of teeth. With the Subepithelial Connective Tissue Graft and with the correct indicators we can create for a 100 per cent repair of tissue and bone and hence complete root coverage and the saving of teeth and surrounding structures.  Also, the use of mathematical formulas to create for correct width to length ratios when creating surgical aesthetic crown lengthening procedures as part of surgical-restorative procedures and reconstruction.  Finally, the use of immediate dental implants and their placement relative to the extraction socket and via the use of a minimally invasive technique (an atraumatic incisionless-flapless-no suturing technique) to yield predictable restorative outcomes and hence better aesthetics, minimal pain, bleeding and swelling and therefore a better quality of life for our patients.
1013561	My primary research interest is in development of better, cheaper, faster and greener appropriate prosthetics and orthotics technologies for low-income countries.
1013622	Research interests include use of innovative treatment modalities for head and neck cancer in order to obtain better tumor control and decrease toxicity of treatment.
1013766	Boyd Metzger, M.D. is the Tom D Spies Professor of Metabolism and Nutrition in the Division of Endocrinology, Metabolism & Molecular Medicine at Northwestern University Feinberg School of Medicine. Dr. Metzger obtained his undergraduate education at the University of South Dakota and earned his M.D. at the State University of Iowa. He was an Intern, Medical Resident and Clinical Fellow in Metabolism at Michael Reese Hospital in Chicago and a Postdoctoral Fellow in Biological Chemistry at Washington University in St Louis. Dr. Metzger's memberships in professional organizations include: the Endocrine Society, the American Diabetes Association (ADA), the American Federation for Medical Research, the Central Society for Clinical Investigation and American Association for the Advancement of Science (Fellow). Dr. Metzger has had a career-long interest in the impact of gestational diabetes pre existing diabetes and states of altered nutrition during pregnancy on the intrauterine, perinatal and lifelong health of offspring. He has served on the editorial board of Diabetes and of Diabetologia and has been a member of the Organizing Committee of each of the four ADA sponsored International Workshop Conferences on gestational diabetes mellitus (GDM) and Chairman and Proceedings Editor of the last two. He will serve in the same capacity for the upcoming fifth workshop conference to be held November 11-13, 2005. He has published more than 200 journal articles and book chapters. Currently, he is Principal Investigator of the NICHD/NIDDK funded Hyperglycemia & Adverse Pregnancy Outcome (HAPO) study. The immediate objective of HAPO is to establish the level of maternal hyperglycemia that is associated with a clinically significant risk of adverse perinatal outcome. It is hoped that future risks for obesity and metabolic disturbances can also be established through long-term follow-up.
1013766	Regulation of Fuel Metabolism, Hypoglycemic Disorders, Nutrition and Metabolism in Pregnancy, Diabetes and Pregnancy: Basic and Clinical Aspects, Gestational Diabetes mellitus, Diabetes mellitus, Thyroid disease
1013771	intensive care, respiratory failure, mechanical ventilation, chronic respiratory insufficiency, clinical pharmacology
1013783	Blood group isoimmunization and other conditions requiring intruterine fetal transfusions
1013810	Evaluation and treatment of sports and musculoskeletal injuries
1013825	Research focused on health literacy within emergency room and office based waiting areas. Interests in community medicine and child legislative advocacy.
1013835	Upper and Lower Limb Prosthetics, Amputation Management
1013854	Obstetric anesthesia
1013855	My major research interests are developing new therapies for cystic fibrosis, characterizing and treating early lung disease in infants and young children with cystic fibrosis, improving CF care and reducing outcomes disparities in high risk patients.
1013880	Comprehensive care of adults, Hospital-based care of the medical patient, Medical care of the patient with diabetes
1014038	Clinical dermatology and clinico-pathological correlations.
1014075	Aneursyms, venous problems, Arterial disease, General vascular surgery
1014076	Eyelid and orbital diseases and surgeries, Lacrimal[tearing] and reconstructive surgeries, Ophthalmic plastics / laser surgeries; Cosmetic fillers and Botox use; Cosmetic eyelid surgeies; ptosis[drooping lids]; Thyroid related eye disease;
1014079	Inpatient teaching attending at Jesse Brown VA; focus of teaching is hospital medicine and clinical problem solving
1014121	General surgical pathology, cytopathology, GI/liver, gynecologic pathology
1014287	diagnosis&treatment
1014300	Medical Education, particularly basic clinical skilla and medical education methodology.
1014318	Diagnostic radiology, General radiology, Outpatient radiology
1014338	Adoption and Foster Care, Fetal Alcohol Syndrome
1014350	Dr. George Cybulski is a National Cancer Institute investigator in Radiation Therapy Oncology Group trials for treatment of malignant gliomas.  His primary clinical interests include surgical treatment of diseases of the spine, surgical treatment of spinal cord injury, surgical treatment of tumors of the brain (including pituitary tumors and gliomas) and spinal cord (including schwannomas and meningiomas).
1014368	My primary clinical interests are in the area of complex urinary tract reconstructive surgery in children with a special emphasis on hypospadias and the neurogenic bladder.  My basic science focus is on tissue engineering of bladder tissue and bladder smooth muscle physiology.
1014483	My clinical specialties include psychological aspects of women's reporoductive health including treatment of post-partum depression, infertility, pregnancy loss, and psychological aspects of breast and gynecologic cancer.  In addition, my clinical practice focuses on the treatment of anxiety and depression, individual and couples psychotherapy.
1014587	The treatment of Head and Neck Cancer challenges the oncologic and reconstructive skills of the surgeon as no other. Only through an experienced team approach can the patients recieve optimal disease control and functional and cosmetic results that allow them to resume their occupational and social roles in society. This has been my passion for over twenty five years. 
1014614	Health Services Research
1014614	Joe Feinglass, PhD is a Research Professor of Medicine in the Division of General Internal Medicine and the Institute for Healthcare Studies.  Dr. Feinglass is a health services researcher with a degree in Public Policy Analysis.  He has over 20 years of experience in health policy, quality improvement, health disparities, medical informatics, patient safety, and social epidemiology research with over 120 peer reviewed publications.
1014634	Dr. Kundu's research focuses on the diagnosis and therapy of skin disorders that occur more frequently in individuals with skin of color or ethnic skin.
1014824	Cytopathology, Fine needle aspiration of peripheral and deep organ(s)<BR><BR>Cytopathology
1014856	Treatment Resistant Depression, Bipolar Disorders, TMS, Psychopharmacology
1014857	Dr. McVary's primary clinical areas are prostate diseases, including prostate cancer and BPH, as well as the evaluation and treatment of sexual function. Dr. McVary has an active research laboratory that investigates the molecular mechanisms controlling the neural role in erectile dysfunction as well as the neural control of prostate development and function, and he is the principal investigator on two clinical trials studying medical and surgical therapies for prostate disease.
1014980	My primary research focus at FSM is placed on understanding cellular and molecular mechanisms underlying endogenous mediator-mediated protection against tissue injury and regulation of immunity at intestinal mucosa.  I have established and sustained an R01 research program in the area of gastroenterology.  My research group has shown that: (1) Trefoil factor 3 (TFF3), a goblet cell-derived protein, protects intestinal epithelial cells against injury through an NF-kappaB dependent mechanism.  Furthermore, we demonstrated that TFF3 triggers a transient activation of NF-kappaB and prolonged upregulation of Twist protein (a molecule essential for downregulation of NF-kappaB activity in vivo) in intestinal epithelial cells via an ERK kinase-mediated pathway. (2) Milk fat globule-EGF factor 8 (MFG-E8, macrophage-derived protein) promotes the migration of intestinal epithelial cells through a PKCepsilon-dependent mechanism.  It plays an important role in the maintenance of intestinal epithelial homeostasis and the promotion of mucosal healing. (3) Peptidoglycan, a potent immune adjuvant derived from bacterial cell walls, is taken up and crosses intestinal barrier by crypt-based immature intestinal epithelial cells.  Furthermore, we defined a novel cellular mechanism/pathway through which intestinal luminal peptidoglycan is transcytosed across intestinal epithelia.  In addition, we revealed that the absorbed peptidoglycan targets macrophages, which may facilitate intestinal immune homeostasis.  Together, our findings in conjunction with previous investigations, have elucidated molecular mechanisms underlying the trialogue occurred among lumenal contents, epithelial lining, and cells in lamina propria that directs process for the maintenance of intestinal barrier homeostasis, integrity, and immunity.
1015007	Dr. Kopp's research focuses on various forms of thyroid disease. Principal areas of interests are the molecular genetics of congenital hypothyroidism and Pendred's syndrome. Pendred's syndrome is an autosomal recessive disorder characterized by congenital sensorineural deafness, goiter and impaired iodide organification. It is caused by mutations in the PDS (Pendred syndrome) gene that encodes pendrin, an anion transporter belonging to the solute carrier family 26A (SCL26A). Other areas of active research include the molecular genetics of endocrine diseases such as neurohypophyseal and nephrogenic diabetes insipidus, and the analysis of polymorphisms in genes involved in androgen metabolism in order to define determinants of steroid hormones and prostate cancer risk in men.His clinical activities are primarily focusing on patients with thyroid dysfunction, thyroid nodules and thyroid cancer.
1015007	Dr. Kopps research interests focus primarily on the genetic basis of endocrine disorders, in particular inborn errors of thyroid development and thyroid hormone synthesis, as well as disorders of water metabolism (diabetes insipidus).His clinical activities focus primarily on patients with thyroid dysfunction and thyroid cancer, but also include the care of patients with pituitary disorders, adrenal disorders and rare genetic endocrine disorders.
1015036	Neurogenic communication disorders, aphasia, right hemisphere stroke, neglect
1015048	neuroreceptor, ion channel, neuropharmacology, neurotoxicology, neurophysiology, electrophysiology, alcohol, insecticide, anesthetic, Alzheimer's drug
1015071	I work with both psychotherapy and pharmacotherapy, often combined.  Interests include depression, anxiety disorders, post-traumatic stress disorder, adult attention-deficit-disorder/attention-deficit-hyperactivity-disorder, and psychologic problems of persons coping with medical illness.
1015091	Uterine Fibroid Embolization (UFE), Vascular and interventional radiology
1015102	Sarah L. Chamlin, M.D. is an Associate Professor of Pediatrics and Dermatology at Northwestern University Feinberg School of Medicine and an Attending Physician, Childrens Memorial Hospital specializing in Pediatric Dermatology.  Her clinical interests include hemangiomas and other vascular lesions, hair and nails and general Pediatric Dermatology.  Her research interests include quality-of-life measurement in children and teens with skin disease and hemangiomas.  She is an active member of the Hemangioma Investigator Group.
1015113	Colposcopy, Hysterectomy, Teen pregnancy
1015205	Cytopathology   Surgical Pathology   Pediatric PathologyPediatric tumors, cytology
1015262	Dr. Volpert's main area of study focuses on the molecular mechanisms of angiogenesis, the process by which new vascular bed forms.
1015324	aaaaaaaaaaa
1015337	mechansims underlying cytotoxic cell granule mediated apoptosis
1015340	Surgical Education Research at the Undergraduate or Graduate level; Faculty Development; Resident Recruitment; Technical Skill Acquisition; Curriculum and Instructional Design
1015350	Dr. Lurain's primary research interests are related to the clinical factors associated with prognosis and treatment of gestational trophoblastic diseases (hydatidiform mole, choriocarcinoma, and placental site trophoblastic tumor) as well as  uterine and ovarian cancers.. He has received research support from the American Cancer Society, the National Cancer Institute, pharmaceutical companies, as well as charitable groups, such as the Chicago Baseball Cancer Charities, the Cancer Research Foundation, the Stenn Fund for Ovarian Cancer Research, the Holly Missner Fund for Ovarian Cancer Research, the Kathleen Warble Foundation, the Cheryl Halat Memorial Fund for Ovarian Cancer Research,  and the Eileen M. Arder Fund for Endometrial Cancer Research.  Dr. Lurain is an author on more than 190 publications, including scientific articles, reviews, chapters, and books.
1015379	Pain sensitivity & threshold and postoperative pain, Obesity and anesthesia, Sleep apnea and postoperative outcomes, Minimally invaseive surgery outcomes, faculty career development
1015450	All aspects of echocardiographic imaging.
1015471	Associate Clinical Director of the Northwestern Scleroderma (SSc) Program,Director of the Scleroderma Patient Registry and biorepository.  
1015529	Pain medicine
1015570	Anti-thrombotic therapy, Atrial fibrillation, Cardiac stress testing, Cardiovascular critical care, Coronary heart disease, Ischemic heart disease, Nuclear cardiology
1015570	My research interests are in the areas of antithrombotic therapy, particularly in the acute coronary syndrome patient, lipid management and reduction of cardiac risk, antihypertensive therapies, and nuclear cardiac imaging.
1015615	Echocardiography, Valve disease, Women's cardiovascular health
1015615	The assessment if valvular regurgitation using 2D and 3D echocardiography
1015812	Preschooler's behavior problems; Psychological interventions in pediatric primary care
1015829	Spinal cord injury, rehabilitation, male infertility
1016037	Professor Emeritus
1016048	Preventive medicine through lifestyle counseling, early detection, and treatment to achieve optimal control and avoid complicatons.
1016050	I have taught a 3 quarter course: The Opening Phase of the Psychoanalytic Process: Basic Concepts and Fundamental Principles from 1996 to the present in the Chicago Institute Analytic training program.I have presented a series of symposia, The Reluctant Patient, to a number of mental health agencies in the Chicago area. I am a member of the American Psychoanalytic Association and the Chicago Psychoanalytic Society and serve as a clinical assistant professor in the Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University.My clinical focus is the psychoanalytic and psychotherapeutic treatment of adolescents and adults. 
1016062	Dr. Carol Rosenberg serves as the Director of Preventive Health Initiatives for Evanston Northwestern Healthcare.She is Chair of the Cancer Survivorship Program task force for Evanston Northwestern Healthcare.Dr. Rosenberg is a lead investigator and writing group chair for the national Women's Health Initiative Study.Dr Rosenberg is the founder and Director of the Living in the Future (LIFE) Cancer Survivorship Program of Evanston Northwestern Healthcare, for which she was awarded a Lance Armstrong Foundation grant during the program's implementation phase.
1016078	Dr. Garnett has special interest in the management of prostate, kidney, and bladder cancers with an emphasis on robotic surgery.
1016113	My clinical interests are Pediatric and Adult Neuro-Oncology, Thoracic Oncology, Cranial and Body Sterotactic Radiosurgery, Palliative/Hospice/End of Life Care and Medical Ethics as Related to Death and Dying.
1016221	My primary research interest is in mechanisms of low bone density at diagnosis of acute lymphoblastic leukemia in pediatric patients.  I hypothesize that dysregulation of mesenchymal stem cells in the bone marrow microenvironment leads to aberrant preference for adipocyte development over osteoblast development.  I also do clinical research related to long-term outcomes after cancer therapy and stem cell transplant during childhood.
1016296	Glomerular diseases, Hypertension, Transplant Nephrology
1016299	Echocardiography, General cardiology, Prosthetic heart valve disease
1016313	Comprehensive care of adults, Preventive medicine
1016319	My primary area of research in recent years has been in the use of simulation for training medical care givers in their various fields.
1016392	My primary research interests include unique combinations of radiotherapy with biologically targeted agents, the amelioration of radiation toxicity and unique method of delivering radiotherapy. I currently focus on gynecological, gastrointestinal and breast cancers. I have been committed to advancing our understanding and treatment of gynecological, gastrointestinal and breast cancers, particularly through clinical trials.  I have national and international leadership positions and I am actively working on improving cancer care, especially cervical cancer, throughout the world with particular emphasis on underdeveloped countries.  Being active in the field of oncologic research, I am eager to explore new solutions to improve the efficacy and side-effects caused by radiation therapy and to improve access to clinical trials and state of the art therapies.  My interest in radiation oncology and research is exemplified through my clinical work, research, and continuing education.
1016513	Voluntary psychiatric consultations.
1016521	I am interested in all types of abdominal wall, incisional and inguinal hernias.
1016527	Lipid Disorders, Cardiovascular Nutrition, Coronary Disease in Women, Premature Coronary Disease
1016527	Lipid metabolism, cardiovascular nutrition; premature coronary heart disease
1016528	Achalasia, Gallstones, GERD, Hernia, Laparoscopic cholecystectomy, Laparoscopic Heller myotomy, Laparoscopic Nissen fundoplication, Laparoscopic Splenectomy, Laparoscopic ventral hernia repair, Pancreatitis and Pancreatic Cancer
1016548	Pediatric spine/spine deformity; growth and etiology of idiopathic scoliosis; medical education/surgical skills acquisition training.
1016555	Myeloma Research, Stem Cell Transplant
1016711	To clarify function of ion channels, physiological snd pharmacological research are on going using various techniques including patch-clamp, and live cell imaging.
1016756	International Healthcare Systems, Health Insurance, Healthcare Quality, Ambulatory Care
1016759	Clinical treatment and translational research in Multiple Sclerosis, CNS Demyelinating disease, Neurologic complications of AIDS
1016762	Family decision-making, protective services for the elderly, disability and public policy, community services evaluation
1016763	Endoscopic ultrasound, Ulcer disease
1016763	General gastroenterology, colon cancer screening is a particular interest. In addition, acid peptic disease and gastrointestinal complications of NSAIDS. 
1016768	Acne, Chemical peels, Tumescent liposuction
1016805	Cataract surgery, Cornea disease, Cornea transplant surgery, Lasik surgery, Refractive surgery
1016930	NFAT, Calcineurin, Transcription Factors, Signal transduction, Gene Regulation, T cell activation, Th1/Th2, Adipogenesis, Cancer, Oncogenes
1016969	Dr. Lees research focuses on regeneration therapy of endocrine insufficiency. He uses gene therapy tool (Adenovirus and Ad/AAV hybrid vectors) for the directed differentiation of adult stem cells.  He is also currently interested in pre-mRNA splicing in human cancer cells. 
1016969	Gene tharpy, regeneration therapy,  endocrine insuffciency, diabetes, endocrine cell differentiation, endocrine tumor
1017008	My research interests include the development of mesh for hernia repair.  Our polyurethane coated polypropylene mesh at PSD, LLC was given 510K FDA approval for marketing in January 2010. The polyurethane material has been licensed to K2M in Canada for repair and replacement of nucleus pulposus in the human spine. My work on the SAGES Laparoscopic Cholecystectomy Pearls series proceeds nicely.  Last year I satisfied the credentialing requirements of the ARDMS for the RVT and RPVI credentials.  These ultrasound credentials are beneficial to another of my interests, the diagnosis and treatment of venous disorders using ultrasound guided endovenous treatments. I remain active in committees CME and Patient Safety and Outcomes for SAGES and for American College of Phlebology where I chair the Distance Learning Committee and as a member of the CME/outcomes committee.
1017032	Pediatric radiology,Pediatric nuclear medicine,Metabolic bone disease
1017036	Dr. Avrams research interests include pharmacokinetics (PKs) and pharmacodynamics (PDs) of hypnotics, sedatives, opioids, analgesics, non-depolarizing neuromuscular blockers, chemotherapeutics, etc.  His major research focus has been the development and evaluation of detailed PK models of rapidly acting intravanously administered drugs from the moment of injection to serve as the basis for understanding the PK basis of interindividual variability in response to these agents, which often have low clinical margins of safety.
1017061	Chorea, Dystonia, Essential tremor, Multiple systems atrophy (MSA), Myoclonus, Neuro-ophthalmology, Parkinson's disease, Progressive supranuclear palsy ( PSP), Tics
1017082	Comprehensive care of adults, Occupational medicine
1017092	Herpes Virus, HIV Infection
1017153	intercellular junctions, adhesion, desmosomes, adherens junctions, signal transduction, cell motility, skin disease, cadherins, cancer metastasis.<BR><BR>I am interested in the regulation of the intercellular adhesive junction, the desmosome, during processes such as wound healing and morphogenesis. Currently my studies are focused on the plakin protein, desmoplakin, an obligate member of the desmosomal plaque, which mediates the interaction between the plaque and the intermediate filament network. This interaction with the intermediate filament network is required for maintaining tissue integrity, particularly those tissues undergoing large amounts of stress, such as the heart and skin. The importance of desmoplakin in maintaining adhesive strength is highlighted by cardiomyopathies and skin diseases, which result from desmoplakin mutations. Utilizing biochemistry and fixed and live cell imaging techniques we are analyzing the dynamics of desmoplakin during desmosome formation and the roles the intermediate filament and microfilament networks play in that process.
1017219	Intervention cardiology
1017224	Spinal disorders, Spinal reconstruction, Sports medicine
1017234	Dr. Sharon Unti is currently the Director of the Pediatric Residency for Northwestern University Feinberg School of Medicine based at Children's Memorial Hospital.  Her interests include both graduate and undergraduate medical education, particularly curriculum design and evaluation processes.
1017247	retinal detachment, diabetic retinopathy, macular degeneration, uveitis/retinitis, intravitreal injections, laser treatment, Retina diseases and surgery
1017256	I carry out clinical and basic research related to dizziness and vocal motor control.  My clinical research mainly concerns vestibular evoked myogenic potentials and cervical vertigo.  My basic science research mainly concerns mathematical modeling of feedback control of voice F0 and amplitude.Clinically, I am the 'dizzy doctor' at Northwestern, and see a large array of patients with inner ear disorders as well as more complex pictures.
1017340	Comprehensive care of adults, Women's healthcare
1017341	Advanced laparoscopic surgery, In-vitro fertilization, Infertility
1017403	Primary current research interests are the mechanisms of biomineralization in bones and teeth, and the role of non-collagenous 'SIBLING' proteins in regulation of mineral placement in collagen matricies. The second major interest is in the structure and assembly of collagen molecules and fibrils. We have recently completed studies of the role of amelogenin splice product peptides in the epithelial-mesenchymal signaling during embryonic tooth formation.
1017423	My research focuses on adaptation of stroke survivors and their family caregivers, including prevention and amelioration of depression and promoting preparedness for the caregiving role.  In addition, I am interested in prevention of pressure ulcers in persons with spinal cord injury.
1017499	nuclear transport, nuclear structure, nuclear pore complex, nuclear envelope, nuclear lamins
1017506	General diagnostic radiology
1017510	Dr. Nadlers specific areas of interest include robotic prostatectomy, concentrating his efforts on outcomes of robotic prostatectomy patients specifically pertaining to erectile function and margin rates. He is also pioneering a technique of robotic partial nephrectomy, which avoids clamping the renal hilum to better preserve kidney function during robotic partial nephrectomy for renal cell cancer. He also continues to do work in the minimally invasive surgical management of complex kidney stones and renal pelvis tumors.
1017531	Perinatal pathology
1017687	I mainly work with adult individuals suffering from treatment resistant mood and anxiety disorders. In addition, I work with a number of patients with chronic pain issues. 
1017700	Comprehensive care of adults, Preventive medicine
1017700	Within Medical Humanities, my interest is in the use of reflective writing in the education and professional development of physicians.   
1017737	Cancer prevention and screening, Primary care internal medicine, Women's healthcare
1017743	Neuropathology<br><br>As a neuropathologist with principal clinico-academic effort in diagnostic surgical neuropathology, my research interest encompasses translational-collaborative  studies related to bio-predictive markers for adult diffuse-type gliomas.
1017877	My primary interest is the psychiatric care of the older adult with chronic or new onset mental illness.  My work includes providing consultations to  physicians requesting recommendations regarding the care of their older adult patients with mental illness.  Another focus involves teaching geriatric fellows, psychiatry residents and medical students in a biopsychosocial approach to the diagnosis and treatment of older adults with mental illness. I am also interested in developing interventions addressing geriatric anxiety and depression.
1017968	Comprehensive care of adults, Medical care of the patient with hypertension, Preventive medicine
1017971	Comprehensive care of adults, Medical care of business executives, Perioperative medical consultations
1017983	Certified Registered Nurse Anesthetist, Advance Practice Nurse in IL and MIOupatient Anesthesia, Positioning and safety issues for both the OR Staff and Patient,and preventive methods for pain management.
1018009	A primary goal of my work is to establish the approaches and benefits of genomics informed personalized medicine.  A key element of this is participation in the eMERGE consortium (http://gwas.net), where I serve as the steering committee chair.  This project uses Electronic Health Records linked biobank samples (www.nugene.org) to study the genetics of disease susceptibility, therapeutic outcomes and pharmacogenomics.  My group is also interested in genome informatics, particularly genome annotation and visualization technology.
1018012	During her years of work in pediatric practice-based research, Dr. Binns has participated in research studies on a wide array to topics relevant to primary care practice.  Studies she has led in community primary care settings have focused on preventive care delivery, lead poisoning, obesity, and tobacco addiction.  Other research studies she has completed on these topics gathered samples from hosiptal and out-patient clinical settings.
1018049	Dr. Fiebig coordinates the Cochlear Implant Program at Northwestern.   She has worked with the program since it began in 1993.
1018091	Acid-base and electrolytes, Hypertension; diabetic nephropathy, Nephrology
1018091	Dr. Batlle's research interests are in the area of acid/base and potassium physiology and pathophysiology, with special emphasis in the area of distal renal tubular acidosis. At the bench level, Dr. Batlle's research team is interested in examining the cellular and molecular events involved in the development of hypertension and nephropathy in patients with diabetes. His laboratory has taken a holistic research approach that incorporates modern techniques of molecular biology, cell biology, whole animal studies, and studies using cells derived from human subjects. The predisposition to the development of kidney disease in some diabetic patients is being examined at the level of cell cycle regulatory proteins using skin fibroblasts as a surrogate cell model.  More recent work is focusing on ACE2 and its interaction with ACE in animal models of diabetes.
1018134	Immunotherapy strategies for treatment of melanoma, renal cell cancer, other urologic tumors and Mycosis fungoides
1018134	Interests include experimental therapeutics for the treatment of genitourinary malignancies and skin lymphomas and cancers.  Immunotherapeutic and anti-angiogenic approaches remain a major focus for such diseases as renal cell carcinoma, melanoma and cutaneous T-cell lymphomas.
1018163	Previous research has focused on investigations of the Physical Therapist Clinical Performance Instrument, mentoring of physical therapist students, balancing career and family choices in female physical therapists and physical therapist students, osteoporosis, and using online resources in patient and clinical education. Current research the development of international health opportunities for physical therapist students.
1018167	Clinical Interests: asthma, chronic obstructive oulmonary disease (COPD), interstitial Lung Disease, sarcoidosis. Research Interests: airway inflammation and remodeling in asthma and COPD; effects of hypercapnia (elevated levels of CO2) on innate immunity and host defense in the lung.
1018168	Metabolic bone diseases, kidney stones, hyperparathyroidism, glomerulonephritis, renal osteodystrophy
1018220	Chemical dependence, Medical / surgical psychiatry
1018246	The long-term goal of my lab is to identify and investigate molecules that play important roles in mammalian hearing, thus to enrich our understanding of cochlear physiology, and to further develop a better strategy to prevent hearing loss.  Outer hair cells (OHCs) are essential for providing high sensitivity and frequency selectivity of hearing.  They are also the most vulnerable cells in the inner ear and are involved in most sensorineural hearing loss that affects the hearing of millions of people.  It is known that OHC death is strongly connected with the generation of reactive oxygen species (ROS).  Yet, it is not fully understood why OHCs, as compared to other cells in the organ of Corti, are more vulnerable to ROS.  The main function of OHCs is to amplify mechanical signals through their somatic electromotility.  This exclusive property is executed by a unique motor protein called prestin (Zheng et al., Nature, 2000).  We are currently investigating prestins protective role against oxidative stress in the ear using different prestin-expressing cell lines and prestin-knockout/prestin-knockin animal models.  We are focused on understanding the molecular mechanism of motor protein prestin using various cellular, biochemical and molecular biological methods including high throughput small molecule compound library screening procedures.  These studies will not only expand knowledge of prestin as the OHC-based cochlear amplifier at the molecular level, but also produce a deeper understanding of mechanisms associated with outer hair cells loss, and may offer new methods for the prevention of OHC damage.
1018341	Preventive medicine, Women's healthcare
1018377	Airway managementEducation in airway managementEducation in Simulation Research
1018454	Cross-sectional imaging of the body, CT angiography, Multislice computed tomography (CT)
1018461	Dr Kibbe is the principal investigator for the Patient Study Calendar module software development project, the caBIG development project that has developed a syntactically and semantically harmonized interoperable patient study calendar using agile design practices. Dr. Kibbe is the co-PI of the NIH-funded Dictyostelium Model Organism Database dictyBase. He is a proponent of Agile software development methodologies and the Agile Unified Process Framework and the application of these to biomedical research problems. Dr. Kibbe's group has developed NOTIS, the clinical trial information management system used for all cancer trials at Northwestern and by the genotype/phenotype biorepository NUgene (http://www.nugene.org) as the source of identified information on participant in NUgene. In NUCATS, the Northwestern CTSA organization, Dr. Kibbe recently received ARRA funding to extend NOTIS to all disease areas at Northwestern, and release the eNOTIS project as a CTSA-sponsored open source project. He is also a key participant in building a computable research representation of clinical data, through his work with the Northwestern Medicine Enterprise Data Warehouse, the caBIG Clinical Annotations Engine (which is designed to build a computable representation of pathology reports from the Cerner and Epic EMR systems), and ontology efforts, including being a co-founder of the Disease Ontology (http:/diseaseontology.sourceforge.net) and the semantically computable BRIDG domain analysis model that is being jointly developed by members of HL7, CDISC and caBIG to represent clinical research information and the semantics necessary to conduct clinical trials.
1018513	My clinical interests include working with individuals and couples experiencing problems with communication, intimacy, sexuality, sexual functioning, and psychological or sexual aspects of reproductive health care; such as fertility, menopause, gynecological or urological disorders.  I also see couples for premarital counseling. 
1018581	Comprehensive care of adults, Peripheral vascular disease, Preventive medicine
1018597	As Director of Gynecologic Endoscopy at Northwestern since 1995, I have developed an expertise in advanced minimally invasive surgeries including laparoscopy, hysteroscopy for conditions of endometriosis, fibroids, adhesions, tubal disease and ovarian cysts.  I perform laparoscopic total and subtotal hysterectomy, myomectomy, cystectomy and hysteroscopic removal of fibroids and adhesions.
1018621	Research in the Turek laboratory is focused on the study of sleep and circadian rhythms, with special interest in identifying genes that regulate sleep and circadian rhythms. Ongoing work on sleep and circadian rhythms includes an investigation of: (1) the neurochemical, molecular, and cellular events involved in the entrainment, generation and expression of circadian rhythms arising from a central biological clock located in the suprachiasmatic nucleus (SCN) of the hypothalamus, (2) the genetics of the circadian clock system and the molecular genetic mechanisms underlying the sleep-wake cycle, (3) the feedback effects of the sleep-wake cycle on the circadian clock regulating the timing of that cycle, (4) the effects of advanced age on the expression of behavioral and endocrine rhythms, and on the expression of circadian clock genes, 5) the links between sleep, circadian rhythms and energy metabolism and, (6) the role of melatonin in modulating sleep and circadian rhythms.In addition to our work on rodents, we have established extensive collaborations with clinical researchers. Studies in humans are aimed at shifting the human clock in an attempt to alleviate mental and physical problems that are associated with disorders in circadian time-keeping, particularly in the elderly and in shift-workers. In addition, we are using both pharmacological and non-pharmacological approaches to determine if we can reverse the effects of aging on the circadian clock system in both rodents and humans. Our sleep, circadian and metabolic studies are focused on how disruption in these interactions can lead to obesity, diabetes and CVD.
1018693	My primary research interest is in perinatal epidemiology. I have an investigational interest in understanding the social determinants of racial and ethnic group disparties in birth outcome(preterm delivery, low birth weight, neonatal and post-neonatal mortality) in the United States.
1018694	As a member of the soft tissue sarcoma committee of the Children's Oncology Group (COG), my primary clinical research interest lies in the area of clinical trials for pediatric patients with soft tissue sarcomas.  I am study chair for a group-wide phase III COG clinical trial for rhabdomyosarcoma.  I also serve as Institutional Principal Investigator for COG.  My primary basic  research interest lies in understanding the regulation and function of the GLI1 oncogene, as well as understanding the role of Hedgehog-GLI1 signal transduction in pediatric solid tumors.
1018707	My primary research interest lies in clinical neuroscience in neonatology.  I have spent time looking at physiologic stability in preterm infants relating to cerebral oxygen levels.  I have also correlated cerebral oxygenation with short term neuromotor outcomes.
1018729	Our lab is interested in how the cytoskeletal protein tau is altered from its normal soluble state to oligomeric and fibrillar states.  We also are interested in aggregated tau's function in neurons and glia during the course of Alzheimer's disease and related tauopathies.
1018731	In my laboratory we study the cellular and molecular mechanisms of immunopathogenesis of T cell-mediated central nervous system (CNS) demyelinating diseases, the chemokine regulation of cell migration and host responses to mucosal bacterial infection, and the role of chemokines in the migration of B cell lymphoma.  The laboratory employs two mouse models of multiple sclerosis (MS): Theiler's virus-induced demyelinating disease (a virus-induced model of MS) and experimental autoimmune encephalomyelitis (EAE) (an autoimmune model of MS). In particular, the laboratory is examining the chemokine and chemokine receptor biology of T cell, monocyte, and dendritic cell recruitment during CNS demyelinatingdisease.  In addition, we are examining the balance between cellular and molecular mechanisms of oral tolerance induction and generation of mucosalimmunity/host defense to bacterial and viral pathogens.  Finally, the laboratory uses a model of murine B cell lymphoma to study the mechanisms of tumor cell migration to lymphoid and extra-lymphoid tissues. The approaches utilized in the laboratory are applicable to both the understanding of basic biologic mechanisms of disease progression and treatment of autoimmune diseases, enhancement of immunity to pathogens, and treatment of cancer.
1018772	Dysmorphology
1018819	Hospital-based care of the medical patient
1018820	Cosmetic Plastic Surgery with emphasis on  optimization of results in Aesthetic Plastic surgery
1018857	neurophysiology, neurocomputation, neuroanatomy, modularity, signals, information, learning, plasticity, engineering, adaptation
1018864	Circadian Rhythms, Sleep, Aging, Phase Shifting, Light, Exercise, Melatonin, Circadian Rhythm Disorders, Sleep Disorders, Delayed Sleep Phase Syndrome
1018947	clinical supervision,supervision,genetic counseling
1019040	Clinical focus on the assessment and outpatient treatment of mood and personality disorders with a special interest in the psychological sequela of disorders of attention and non-verbal learning.
1019117	My perimary clinical interests are in the area of general clinical pediatric neurology as well as neurodevelopmental disabilities.  This involves disorders affecting the developing brain and their links  with genetics and behavior.
1019129	Carl L. Backer, MD is the A.C. Buehler Professor of Surgery, Division Head of Cardiovascular-Thoracic Surgery, and Surgical Director of the Cardiac Transplant Program at Children's Memorial Hospital in Chicago.  He is a world-renowned pediatric cardiovascular-thoracic surgeon.  Dr. Backer specializes in the surgical treatment of congenital heart disease in infants and children and also performs complex re-do procedures in adults.  His primary interests are:  adults with congenital heart disease, arrhythmia surgery, heart transplantation, vascular ring surgery, tracheal reconstruction, and pacemakers.  He has authored or co-authored over 180 refereed articles, 68 book chapters, and 4 textbooks.  He is the co-editor of the 2nd and 3rd editions of the well-known textbook, Pediatric Cardiac Surgery.  His research incorporates over 40 years of database material from Children's Memorial Hospital.  Future research endeavors will focus on cardiac stem cell therapy for pediatric cardiomyopathies. 
1019185	Interventional radiology; use of real-time ultrasound for vascular and inteventional procedural guidance, transplant interventions, tumor ablation, lymphatic system interventions, percutaneous biopsy, chest interventional procedures, biliary and renal interventions, TIPS
1019312	Cervical and lumbar degenerative disc disease, Spinal cord injury, Spinal disorders, Spinal reconstruction
1019313	Back pain and chronic pain, Brain tumors, Headache, Neuro-oncology
1019370	clinical pharmacology, pharmacokinetics, pharmacodynamics, drug effect, dose-response, intravenous anesthetics, medical technology
1019437	To be completed.
1019504	Neural control of breathing, Respiratory rhythm generation, Reflex control of breathing
1019546	The overarching goals of our research program are to identify targets for novel strategies to prevent disease and disability development and progression in persons at risk for or with knee osteoarthritis.
1019567	I am very interested in minimally invasive surgery, including laparascopic hysterectomy, hysteroscopic fibroid resection, hysterscopic sterilization (Essure), and hysterscopic endometrial ablation (Novasure).
1019577	Research and clinical interests include clinical trials for Alzheimers disease and other forms of dementia, frontotemporal dementia and primary progressive aphasia, changes in cognition associated with aging, rehabilitation of memory and other cognitive disorders. 
1019636	Oral & Maxillofacial Surgery, with emphasis on orthognathic surgery,facial reconstruction, facial trauma, surgical correction of obstructive sleep apnea, implant surgery and wisdom tooth removal
1019664	Clinical Pharmacology, Colposcopy, Hysteroscopy, Laparoscopy, Medical termination of pregnancy, Medication use in pregnancy
1019731	My primary clinical interests revolve around neurosurgical anesthesia, management of the difficult airway, and the perioperative stress response.  Other focus centers on patient safety and quality improvement.
1019792	Communication in Medicine, Clinical Skills Teaching, Graduate Medical Education, general medical education
1019797	Sinus problems, chronic sinusitis, sinonasal polyps.Sinus and nasal skull base tumors.Computerized image guided sinus and skull base surgery.Intraoperative CT scanning.Research:  Better diagnosis and treatment of chronic sinusitis.Research:  Immunologic basis of chronic sinusitis.Research:  Clinical and research trials - goal: improved diagnosis and treatment of chronic sinusits.General otolaryngology.
1019856	We develop single and multi-joint intelligent rehabilitation robotics to diagnose, treat and evaluate neurologicla disorders and musculoskeletal injuries, investigate reflex/non-reflex and dynamic/static factors contributing to impaired motor control, and study injury and compensation mechanisms of pathological knee conditions.
1019882	Primary care internal medicine, Women's healthcare
1019972	My main research interest is the elucidation of molecular mechanisms uderlying cell motility with particular focus on the motile reactions of cardiovascular cells such as vascular endothelial and smooth muscle cells and cardiomyocytes. Another interest related to previous one is to discover and design substances which affect cells motile reactions and which could be applied as the novel therapies to the wide range of diseases where the motile behaviour of cells is compromised. Additionally, my lab is interested in discovery of master genes of cardiomyogenesis that could be used to govern directed differentiation of precursor cells into cardiomyocytes for the sake of therapeutic heart repair.
1020003	Adjunct Instructor in FSM Nutrition Curriculum
1020163	Mood and anxiety disorders, particularly pregnancy-emergent and postpartum disorders. Forensic psychiatry.
1020213	Stem Cell Transplantation for Pediatric diseasesMinimal residual disease in leukemiaNeuroblastoma and its treatmentStem Cell differentiationTumor vaccines.
1020281	Clinical Interests:Methicillin-Resistant Staphylococcus Aureus Infections (MRSA), Pertussis (Whooping Cough), Travel Immunizations, International Adoption, Pneumococcal Infections, Antibiotic ResistanceResearch Interest:Dr. Tans research interests focus on the epidemiology of pneumococcal infections and antibiotic resistance and is a principal investigator in the U.S. Multicenter Pneumococcal Surveillance Study Group; pertussis disease epidemiology and preventative vaccines; community-acquired methicillin resistant Staphylococcus aureus (CA-MRSA) infections and the transmission dynamics between pregnant women and their newborn infants (in collaboration with investigators in the Department of OB/GYN, Prentice Northwestern Memorial Hospital in Chicago). She has participated in both vaccine and antibiotic clinical trials as a Principal-Investigator and is also involved in several vaccine survey studies which examine the awareness, acceptance, barriers and utilization of recommended preventative vaccines among healthcare consumers and primary healthcare physicians. These studies are being conducted in collaboration with Dr. Melvin Gerbie in the Department of OB/GYN.
1020328	My work focuses on G protein coupled receptors (GPCRs).  This large family of nearly 1000 receptors is responsible for critical signaling components in normal cellular physiology responses such as differentiation, chemotaxis, and apoptosis.  In fact, nearly half the drugs an the market today are directed at members of this important family of receptors.  I study how they signal to the cognate partner, the heterotrimeric G protein using novel tools (ie US patent6,559,128) as well as other signaling partners such as arrestin.  A key part of my research is directed at allosteric modulators, compounds which can modulate GPCR signaling at a site distinct from the ligand binding site.
1020334	I am interested in the beliefs and behaviors that influence exercise and physical activity decisions of breast cancer survivors. Specifically, I am looking at fear as a barrior to activity and exercise.Lymphedema, a co-morbility of breast cancer treatment, is another area of interest. I have studied exercise as a risk factor for development of lymphedema and quantitative methods of measuring lymphedema.
1020712	My primary clinical interests are the treatment of couples and the evaluation and treatment of posttraumatic disorders
1020720	Autonomic nervous system disorders, Electroencephalography, Electromyography
1020738	neurodegeneration, Alzheimer's disease, tau protein, immunohistochemistry, neuropathology, protein structure
1020762	My long-term goal is to obtain knowledge to treat certain types of cancers that show dysregulated HH signaling activities. The first goal is to analyze the transcriptional role of GLI1 in oncogenesis and to identify potential downstream target of human oncogene GLI1 that mediates the oncogenic role of GLI1 in specific cancers. The second goal of my research is to analyze and to identify potential regulators of human oncogene GLI1 that affects the oncogenic role of GLI1 in specific cancers. The third goal of my research is to understand the regulation of GLI1 expression in specific tumors using inhibitors and activators of the SHH-GLI1 signaling pathways for potential treatment of these tumors.
1020837	High risk pregnancies, clinical trials in pregnancy, thrombophilias and pregnancy, obesity and weight gain during pregnancy
1020838	signal transduction, G protein-coupled receptors, ovary, receptor desensitization, phosphorylation,
1020875	Brain tumors / neuro-oncology, Cerebrovascular disorders, Spine diseases
1020945	Diarrheal diseases, Tropical medicine
1020947	My clinical, research and teaching interests center around the treatment of breast diseases and more specifically breast cancer.  
1021011	Preventive medicine, Primary care internal medicine, Women's healthcare
1021028	intestinal failure, liver transplantation, small bowel transplantation
1021035	Infection Control, Antimicrobial Resistance, Data Mining, Infectious diseases, Medical Microbiology, Epidemiology, Emerging Pathogens, Biodefense, Emerging Diagnostics, Molecular Epidemiology
1021074	Endoscopic surgery, Leiomyomas / laser surgery/infertility, Reproductive Surgery
1021148	I see patients in our general endocrinology and thyroid nodule fine needle biopsy clinics. My major research focus is translational breast cancer research in collaboration with my fellowship mentor Dr. Vince Cryns and Professor Sam Stupps nanotechology laboratory.
1021232	Hematology, Hematopathology<BR><BR>I am Director of Hematopathology at Feinberg Medical School of Northwestern University and Northwestern Memorial Hospital.
1021239	My primary area of research interest is clinical obstetric anesthesiology, including the effects of labor analgesia on the progress and outcome of labor, specific neuraxial techniques for labor analgesia, and post-cesarean analgesia.
1021275	Islet transplantation, engraftment, tissue engineering, imaging
1021278	Clinical outcomes in Vascular Surgery
1021319	Structural Genomics, X-ray crystallography, Protein-nucleic acid interactions
1021428	Hepatobiliary Surgery, Living Donor Transplant, Pediatric Transplant
1021446	Adult congenital heart disease, Echocardiography, Valvular heart disease
1021467	Learning, Biophysics, Neurophysiology, Eyeblink Conditioning, Aging, Hippocampus, Alzheimer's Disease, Potassium Currents, Calcium, fMRI
1021469	Hypertensive emergencies
1021653	RESEARCH TEAM. Our team of ~15 scientists works in close collaboration to tackle a wide variety of research problems in infection, immunity, endothelial biology and critical care medicine. Professors David Engman, MD, PhD, Conrad Epting, MD, and Bria Coates MD, lead the team.  TROPICAL DISEASE RESEARCH. Trypanosomes are single-celled parasites that cause human illnesses such as African sleeping sickness and Chagas disease. These illnesses cause tremendous morbidity and death among millions in the tropical world and Chagas is an emerging infection in the U.S. with an estimated half-million infected residents. We study the molecular genetics and cell biology of these organisms both to understand fundamental processes of cell function and to identify novel targets for drug discovery. AUTOIMMUNE DISEASE RESEARCH. A variety of infections and other insults to the heart can cause cardiac autoimmunity, a process by which the immune system mistakenly attacks the heart as if it were an infectious agent. We study both infectious and purely autoimmune models of autoimmune myocarditis in a global effort to understand the development of autoimmunity and mechanisms of autoimmune tissue destruction, and to use this knowledge to develop novel strategies to prevent autoimmune damage. We are also interested in the interactions of infectious agents and cells of the immune system with the endothelium, the lining of blood vessels across which both need to cross to mediate or fight disease.
1021673	Hepatobiliary Surgery, Liver Transplantation, Living Donor Liver Transplant, Pancreatic Surgery
1021688	Anaphylaxis-Clinical updates on epidemiology and pathophysiologyThe underarm as an axillary organ and the possible role of antiperspirants in hormone dependent disorders
1021694	My research is focused on ways to improve treatment and outcomes of patients with HIV on antiretroviral therapy.  In particular, I am interested in strategies of HIV eradication, broadly neutralizing HIV antibodies, and the epidemiology of HIV-associated cancers.
1021715	I am interested in human movement, particularly those that pertain to rehabilitation. Many of the projects that Im involved with focus on the biomechanics of able-bodied and pathological gait. Our goal is to better understand normal gait, and to use that knowledge to evaluate and improve the gait of persons who walk with prosthetic or orthotic devices. Results from our work may enable us to develop more functional lower-extremity prosthetic and orthotic components.
1021758	Bone density testing, Musculoskeletal radiology
1021759	Coronary bypass surgery, Pacemakers, Valve repair and replacement
1021762	The research in my lab is centered on the espins, a novel family of multifunctional actin-bundling proteins, and the elucidation of their roles in the organization and function of the actin cytoskeleton of hair cell stereocilia and sensory cell microvilli. Espins are produced in multiple isoforms from a single gene. They are present in the parallel actin bundle of hair cell stereocilia and are the target of mutations that cause deafness and vestibular dysfunction in mice and humans. For example, the jerker frameshift mutation in the espin gene of mice causes recessive hereditary deafness and vestibular dysfunction accompanied by abnormal stereociliary morphogenesis and accelerated stereociliary degeneration. In particular, the stereocilia of jerker homozygotes, which lack espin proteins, fail to increase in diameter, suggesting that espins are required for the appositional growth of the stereociliary parallel actin bundle. Espins are also present at high concentration in the microvilli of taste receptor cells, solitary chemoreceptor cells, vomeronasal sensory neurons and Merkel cells, raising the possibility that these proteins play important, general roles in the microvillar projections of vertebrate sensory cells. Unlike other actin-bundling proteins found in the microvilli and stereocilia of vertebrates, espins are potent actin-bundling proteins that are not inhibited by calcium ion. In addition, espins are unusually effective at over-twisting actin filaments in parallel actin bundles and can do so even at low stoichiometry. In cells, espins efficiently elongate parallel actin bundles and, thereby, help determine the dimensions of microvilli and stereocilia. Espins can also bind actin monomer via their Wiskott-Aldrich Syndrome protein homology 2 (WH2) domain in vitro and in vivo and can assemble actin bundles in cells. These biological activities distinguish espins from other actin-bundling proteins and may make them especially well-suited to sensory cells.
1021800	Glaucoma: surgical, laser, and medical treatment outcomes.Low-pressure Glaucoma Treatment Study (LoGTS)
1021803	My research is on the cause, treatment and prevention of glaucoma and Alzheimer's disease.  My laboratory specializes in discovering biomarkers of these disease processes.
1021859	General surgical pathology, GI / pancreatic pathology<BR><BR>Experimental: Hepatocarcinogenesis in rats and mice: nongenotoxic models peroxisome proliferator-induced hepatocarcinogenesis. AOX null mice model of spontaneous hepatocarcinogenesis. Study of liver stem cells in rat pancreas. Experimental models of nonalcoholic steatohepatitis. Clinical: Pancreatic tumors: evaluation of prognostic markers. Hepatic tumors: characterization of morphological, phenotypic and prognostic factors. Colonic tumors: characterization of carcinomas arising in inflammatory bowel disease.
1021955	My practice is limited to general obstetrics and gynecology with special interest in the menopause and premalignant conditions of the uterine cervix. 
1021958	Dr. Hammond practices General Obstetrics and Gynecology and also directs the Northwestern Center for Family Planning and Contraception. Subspecialty interests include contraception and abortion among medically compromised patients; first and second trimester medical and surgical abortion; sterilization, including Essure and Adiana Hysteroscopic Sterilizations; gynecologic care of women with HIV; contraception, sterilization and abortion among women with physical and cognitive disabilities. Dr. Hammond's current research focuses on how contraceptives modify transmission of HIV virus.
1021982	Dr. Dunlop is a health services researcher with expertise in statistical methodology.  Her applied research interests include the investigation of physical activity to prevent disability in older adults and to understand the consequences of arthritis and other musculoskeletal disorders.  She co-authored a book on statistical methodology; she has published and applied statistical methods for analyzing longitudinal data.  Dr. Dunlop is the principle investigator on an NIH-funded epidemiologic study on the relationship of physical activity to reduce disability and an NIH-funded study to evaluate the cost effectiveness of a physical activity intervention.She has served on data safety monitoring boards,  on executive committees of federally funded clinical trials, and on the editorial boards of medical journals.
1021985	sexual function, erection, ejaculation, orgasm, erectile dysfunction, prostate
1022091	Aortic surgery, Maze procedure, Minimally invasive valve surgery, Ross procedure
1022107	IMRT techniques, Gamma Knife, Hyperthermia, Radiation dosimetry, Patient safety and Quality assurance
1022350	Autopsy pathology, Liver and pancreatic pathology<BR><BR>Our current work focuses on the molecular mechanisms responsible for PPAR action. Transcription of specific genes initiated by transcription factors/nuclear receptors is a complex process and involves the participation of multiprotein complexes composed of transcription coactivators. Coactivators contain one or more highly conserved LXXLL (L, leucine; X, any amino acid) motif for direct interaction with AF-2 (activation function 2) region in nuclear receptor.  Our laboratory cloned PBP, PRIP, PIMT, PRIC285 and PRIC320 using either yeast two-hybrid screening or by isolating receptor binding proteins and their identification by MALDI-TOF analysis. We are generating gene knockout mouse models to elucidate the role of these coactivators in the regulation of specific gene transcription. Our work demonstrated that the deletion of PBP, PRIP PIMT and PRIC320  genes in the mouse results in embryonic lethality, indicating that these are vital for development and they alter the function of many nuclear receptors and other transcription factors during critical developmental stages. Recent developments in the area of conditional targeted somatic mutagenesis have opened new avenues for analyzing the physiological functions of coactivator signaling in a variety of tissues and cell types during early development and in the adult.
1022359	As a career pediatric hospitalist, I enjoy all aspects of pediatric care at both academic and community sites.  I have a strong interest in education and development of future hospitalists as the field is developing and exciting.  I have clinical interests in pediatric emergency medicine, inpatient care including ICU, and procedural sedation.
1022425	Medical publishing, Comprehensive care of the adult, Medical decision making, Preventive care
1022554	The Division of Immunotherapy and Autoimmune Diseases (DIAD) is the only center in the world devoted to a unique area of treatment and research utilizing stem cell transplantation in clinical trials for autoimmune diseases and vascular diseases. DIAD pioneered and performed Americas first hematopoietic stem cell transplants to treat: Multiple Sclerosis (MS), Diabetes, Lupus, Crohns, Rheumatoid Arthritis, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Phemphigus, Dermatomyositis, Devics, Myasthenia Gravis, Polymositis and Scleroderma
1022576	Diabetes insipidus, Fluid and electrolyte disorders, Pituitary hypothalamic disease
1022579	Vasoactive molecules in the pathobiology of adverse pregnancy outcome, Receptors
1022677	My interest is in understanding mechanism of disease. Our approach is gene discovery, animal and cell culture  modeling and therapeutic application in disorders of the nervous system. My specific emphasis is on neurodegenerative  conditions and those affecting the neuromuscular system.We have focused on amyotrophic lateral sclerosis, the spastic parapareses, primary lateral sclerosis and frontal-temporal lobe dementias as protoptypic neurodegenerative disorders. We have identified several gens that cause these disorders and have made  animal models to study their pathogenesis.In addition I collabotate with colleagues in the study of mitochondrial disorder of muscle and the peripheral neuropathies.
1022758	Diagnostic mycobacteriology, Microbiology / infectious disease
1022771	Asthma, Emphysema, Chronic Bronchitis
1022771	Our group is interested in studying the outcomes of educational strategies (including patient simulation) used for teaching critical care to medical students and interns.
1022774	Vascular health including aortic aneurysms,amputation prevention, critical limb ischemia, peripheral vascular surgery, and disorders of the veins (varicose veins and vascular malformations).
1022800	melatonin, dopamine, neuropharmacology, melatonin receptors, signaling, circadian rhythms, depression, sleep, drug discovery, 
1022881	I am interested in infantile hemangiomas, common vascular tumors seen in up to 10% of infants.  This is both a clinical and research interest.  I am involved in multicenter, collaborative clinical research regarding the epidemiology, natural history, risk factors and treatments for these lesions, with colleagues from around the U.S. and in Europe.  I also have clinical and research interests in neonatal skin maturation and development and neonatal skin disorders.  Other clinical interests are infectious skin disorders and exanthems in children.
1022955	Causes and treatment of attention-deficit-hyperactivity-disorder, learning disabilities, and related disorders in children and adolescents. Utility of the EEG in medical management of ADHD.
1023189	Health services research related to disability and chronic illness; psychosocial aspects of disability
1023190	Dr. Dyer conducts research that focuses on cardiovascular and nutritional epidemiology, particularly the role of nutritional factors in the development of high blood pressure and obesity; prevention and control of overweight and obesity in both adults and children; the development of empirically-based criteria for the diagnosis of gestational diabetes; and assessment of the impact of measurement error and regression dilution bias on associations in observational epidemiologic studies.
1023212	Relationship between employee health risks and medical conditions and direct and indirect medical, disability and productivity costs to an employer
1023232	Molecular docking, enzyme structure and function, structure-based inhibitor discovery, beta-lactamases, protein stability-function tradeoffs, enzyme evolution.
1023239	HIV infection, HIV-1 Vpr, Viral pathogenesis, Cell cycle G2/M control, Viral oncogenesis, Anti-cancer therapy
1023356	Clinical cardiac electrophysiology, Heart rhythm problems
1023528	Stroke recovery and rehabilitation especially in the area of upper limb motor control.  I am interested in the epidemiology of neurorecovery after stroke, genetic markers of recovery and cortical stimulation for motor recovery after stroke.
1023562	role, of, nuclear, lamins, in, transcription, and, DNA, replication
1023575	My clinical interests lie in developmental anomalies, prenatal counseling for fetal anomalies, minimally invasive surgery, endocrine surgery, hernias, undescended testes, inflammatory bowel disease; surgery for tumors or cancers of the neck, chest and abdomen.
1023584	Theoretical statistics, operations research, numerical optimization, behavioral medicine, health psychology
1023591	Dr. Sheehan is interested in youth development and community based injury and violence prevention.
1023744	Dr. Matsumura is a practicing vascular surgeon at Northwestern Memorial Hospital and is an Associate Professor of Surgery at the Northwestern University Feinberg School of Medicine. He is board certified in Surgery with added qualifications in Vascular Surgery.  His clinical interests are centered on endovascular treatment of all aspects of peripheral vascular disease, including carotid stenosis, thoracic aortic disease, lower extremity ischemia, deep venous thrombosis, and abdominal aortic aneurysm.  His research interests are concentrated on clinical trials of endovascular treatment of carotid stenosis and aortic aneurysm. He is involved regularly in the educational curriculum of medical students, residents, and fellows at Northwestern, but also frequently participates in continuing medical education of physicians in practice.  He organizes several educational programs each year and has been involved in the endovascular training of physicians from more than a hundred hospitals around the world. He has published over 65 peer-reviewed articles, 35 chapters, and ten books. 
1023778	My lab focuses on understanding discoordination of the upper limb after stroke, learning the involvement of brain plasticity in recovery, and developing novel neurotherapeutic training programs to enhance motor control of the upper limb even years after a stroke.  Additional research interests involve pharmacological interventions that seek to alter spinal interneuronal bias.
1023834	collagen, nidogen, dystroglycan, extracellular matrix, basement membrane, axon guidance, cell migration, development, C. elegans
1023841	Aesthetic surgery, Breast surgery, Reconstructive microsurgery
1023908	Primary clinical research efforts focus on pediatric onset systemic lupus. Active clinical research projects include development of tools to assess cognitive changes in pediatric lupus, development of best tools to assess disease flare and remission, best practices for treatment of lupus nephritis and development of biomarkers for nephritis and overall disease activity. Other clinical lupus studies have included assessment of corticosteroid therapy practices, assessment of ovarian suppression during treatment with cytotoxic agents, and multicenter studies to identify important genetic risks for pediatric lupus. I participate in studies of the genetics of pediatric arthritis as well as new therapies and phase IV drug registries. I have also participated in vasculitis registries in North America and Europe. Lastly, I have an interest in cost effectiveness and initiatives in health quality of care.
1023922	The epistemology of medicine--how physicians think--and how this affects medical education, professionalism, and patient safety.
1024002	Hepatology - liver
1024003	Dr. Maizels specializes in fetal urology, hypospadias, reflux, urine infection, enuresis, and hydronephrosis.
1024039	stress hypersensitivity, depressive disorders, genetic vulnerability, QTL, neuroendocrinology, hypothalamic-pituitary-thyroid, hypothalamic-pituitary-adrenal, emotional behavioral tests
1024043	Pain medicine
1024091	Dr. Carter's clinical interests cover a range of urologic conditions.General Urology, urologic cancers, urologic prosthetics, BPH, Stones
1024251	intercellular junctions, adhesion, desmosomes, adherens junctions, signal transduction, cell motility, skin disease, cadherins, cancer metastasis<br><br>Our laboratory is interested in the function and regulation of intercellularjunction molecules in desmosomes and adherens junctions that act to mediate cell-cell adhesion and attachment of the cytoskeleton to the cell surface. Defects in junctional components caused by mutation or post-translational modification result in a variety of pathologies ranging from skin and cardiac disease to cancer. In addition, junction-associated molecules are involved in non-junctional functions such as signaling in development and differentiation. The lab uses a multi-faceted approach to dissect the function of cadherins, armadillo and plakin family junction components including but not limited to collaborative atomic structure determinations, molecular genetics, live cell imaging and trangenic mouse approaches.
1024254	Polysomnography
1024281	Laboratory research focuses on the genetic regulation and phosphorylation of contractile proteins during cardiac development and in ishcemic and stunned heart.
1024369	Antenatal diagnostic testing, Fetal anomaly, High risk pregnancies, Obstetric and gynecologic ultrasound
1024438	Psychosomatic Medicine; Depression and heart disease; Psycho-oncology; Stroke related mood disorder; Multiple Sclerosis related mood disorder; Mood disorders; Anxiety Disorders; Evidence Based Medicine as applied in Psychopharmacology 
1024471	Attention deficit/hyperactivity disorder, child psychiatric epidemiology
1024477	Circadian rhythm disorders, Insomnia, Nocturnal seizures, Parsomnias, Restless leg, Sleep apnea, Sleep disorders, Snoring and increased upper airways
1024510	pathophysiogy, stroke, spinal cord injury, spinal circuits,biomedical engineering, neural signal processing
1024642	My research interest has been focused on pharmacology and biophysics of ion channel functions, which are either activated by voltage changes or mediated by ligand receptor binding.  Drugs of interest include, but not limited to, general anesthetics, local anesthestics, ethanol and drugs used to the treatment of Alzeheimer's diseases.
1024706	to come
1025014	Nanobiotechnology and Mantle Cell Lymphoma
1025371	Dr. Gershon is a leading expert in the application of Item Response Theory (IRT) in individualized and large scale assessments. He has developed item banks and Computerized Adaptive Testing (CAT) for educational, clinical, and health applications - including cognitive, emotional, and motor applications.  He is currently principal investigator on three projects with the NIH - Toolbox for the Assessment of Neurological Function and Behavior, the NIH Roadmap Patient  Reporting Outcomes Measurement Information System (PROMIS) Technical Center and the National Institutes on Aging Genetic Norming project.  He is also co-investigator and measurement development expert on numerous smaller projects including: NINDS sponsored project Quality of Life Outcomes in Neurological Disorders (Neuro-QoL), and the cancer-specific supplement to PROMIS.
1025562	1) Neuropsychological assessment of cognitive and memory impairment and changes in mood, behavior, and personality due to a neurologic disorder.2) Identifying Adult ADHD and psychological difficulties associated with ADHD to assist in treatment planning.3) Differential diagnosis of psychiatric disorders and identification of individual's strengths and weaknesses to tailor treatment to the needs of the individual patient.
1025760	Bleb leaks and wound revision;Intraocular pressure testing methods;Traumatic Hyphemas;Glaucoma Drainage Devices, patch grafts, and complications;Diode Cyclophotocoagulation
1025762	Clinical Interests:Congenital Infections, Fungal Infections, Kawasaki Disease, and Methicillin-Resistant Staphylococcus Aureus Infections (MRSA);Research Interest:Medical Education: I am currently involved in research on professionalism, patient safety, survey design and simulation education for Pediatric medical students
1025764	i currently direct the kidney and pancreas transplant programs at Northwestern University. My clinical interests include Kidney / pancreas transplantation, Laparoscopic surgery, Living donor kidney transplant, Vascular access, and desensitization for kidney transplant recipients. My research interests include developing cell based therapies to achieve tolerance induction in solid organ transplant recipients.
1025933	The research goal of myself, with the Schnaper lab, is to elucidate a cellular mechanism by which renal fibrosis progress and to seek for potential therapeutic/preventive approach, with focus on molecular mechanisms for function of a fibrogenic cytokine, TGF-. Due to a pleiotrophic nature of this cytokine, multiple factors other than directly downstream transcription factor, Smad, are involved in its regulation.   I have characterized several of those pathways using cultured kidney epithelial or mesangial cells as model systems. My recent work that connected those signaling events with a function of cellular receptor of the extracellular matrix, integrins, has added a new dimension to the project.  The lab is now applying our previous findings in vitro in a mice model of renal fibrosis. Our recent data (unpublished) show that the renal fibrosis in this model is dependent on both TGF- and PI3K pathways.  Interestingly, a d isoform of PI3K appears to play a role for podocyte damage, whereas up-regulation of TGF- followed by the initial podocyte damage mediates fibrotic processes.   These data are critical to further understanding of multiple steps involved to achieve final image of renal fibrosis.
1025958	Interaction of Sleep Disorders and Cardiovascular disease, CHF Disease Management
1025998	Ambulatory anesthesia, Cardiovascular anesthesia, Thoracic anesthesia
1026001	Geriatrics, Hospital-based care of the medical patient, Preventive medicine
1026204	Although I see patients with a variety of endocrine conditions (including growth and thyroid disorders, diabetes), my clinical interests specifically include pubertal disorders, adrenal disorders, PCOS
1026219	The role of PTH and thyroid hormone in cell proliferation
1026346	neonatology
1026364	Science outreach, scientific literacy
1026377	At present, my research program focuses on assessment and rehabilitation of cognitive impairment in brain injury. Current funded projects include the following.1) A clinical trial of a virtual reality treatment protocol for patients with brain injury.2) Examinations of interventions for sleep disorders in patients with brain injury.3) A study of the validity of instruments for assessment of brain injury and posttraumatic stress disorder.
1026382	Body imaging, Cardiac magnetic resonance imaging (MRI), Fast magnetic resonance imaging, Magnetic resonance angiography (MRA), Neuroradiology
1026388	Clinical interests include the care of children with growth disorders, disorders of puberty, adrenal disorders and the care of children with long-term endocrine sequelae of cancer treatment and brain tumors.
1026394	Blending an in depth psychological approach with appropriate psych meds, only as needed
1026398	Dr. Whitington's research involves the study of immune mechanisms of pediatric liver diseases.  Our lab has identified an alloimmune mechanism of fetal liver injury, a process we call gestational alloimmune liver disease, which is the cause of most or all cases of neonatal hemochromatosis and is the likely cause of most cases of liver failure in the first 3 months of life.  We also suspect it to be a major cause of intrauterine fetal demise.  We are also investigating the immune mechanisms of biliary atresia and idiopathic neonatal hepatitis, as well as mechanisms of fibrogenesis (a byproduct of immune activation) in genetic cholestasis, neonatal hepatitis, fatty liver disease, and hepatic allografts.
1026399	Interventional radiology
1026407	Research activities of our group focus on two major clinical areas: musculoskeletal pain and bone.  In the area of musculoskeletal pain, the development and characterization of analgesic agents for the management of osteoarthritis has been a major focus for over the past decade.  We have helped design and implement phase 2 studies of many of the major classes of drugs currently in use, including NSAIDs, cox-2 selective inhibitors, opioids, topical analgesic agents and novel approaches to pain including antibodies to NGF (nerve growth factor) and other agents active on the peripheral nervous system.  In the areas of chronic low back pain and osteoarthritis, our group has worked closely with Dr. A. Vania Apkarian in the Department of Physiology to describe and understand spontaneous chronic pain with a particular focus of the role of the cerebral cortex.  Current NIH-funded studies are evaluating the transition that occurs in some individuals who progress from acute to chronic pain in order to understand the changes that occur with the hope of eventually being able to modulate cortical activity to produce better clinical outcomes.Bone loss is known to be a major problem for individuals with disabilities, particularly those who are not able to ambulate or bear weight normally.  Our group has initiated studies aimed at treating patients with acute spinal cord injury to attempt to maintain bone mass during their immediate post-injury period.  In those individuals with SCI who have already lost significant bone mass, we have undertaken a second set of studies aimed at evaluating approaches to increase bone mass in these individuals, using physical and pharmacological interventions.
1026407	Research interests focus on the development and evaluation of new therapeutics for the treatment of osteoarthritis, osteoporosis and pain through clinical trials in phases I-IV.  These studies include both investigator- and industry-initiated investigations and are funded by NIH and industry sources.  
1026444	In vitro fertilization, Infertility
1026447	computational neuroscience, information processing, complex systems, neuronal code, systems neuroscience 
1026461	I am interested primarily in school health issues and those that affect children and adolescents.
1026590	Hand and upper extremity conditions (shoulder, elbow, forearm, wrist, and hand).
1026870	Primary research interests involve:  caregiver stress, psychosocial adjustment to chronic illness and disability, men's health, stroke and brain injury, agingClinical assignments include:  stroke, pulmonary rehab, brain injury
1026925	Brain tumors / neuro-oncology, Spine diseases, Stereotactic radiosurgery
1027058	Utilizing minimally invasive techniques to treat spine disease including degenerative, trauma, tumor and deformity.  Development of new techniques to facilitate minimally invasive spine access.  Treatment of spinal cord injury.
1027068	My passion is for general medical dermatology and ways to improve the patient experience through technology and education.
1027156	Clinical microbiology, General infectious disease, Transplant infectious disease
1027175	Asthma, Idiopathic pulmonary fibrosis, Pulmonary embolism, Sarcoidosis
1027175	Dr. Budinger's laboratory is interested in the mechanisms by which oxidant stress activates signaling pathways in the lung. A particular area of interest is the mechanisms by which oxidants generated in response to exposure to airborne particulate matter air pollution activates signaling pathways in the lung that might contribute to particle related morbidity and mortality.
1027212	...
1027219	Mood disorders, Psychopharmacology
1027224	Obstetric, Gynecologic and Ambulatory Anesthesia
1027227	My clinical research focuses on three areas:1.  Hospital epidemiology2.  Antimicrobial resistance, especially in    immunocompromised patients3.  Emergency preparedness for emerging pathogens and those with bioterrorism potential. 
1027227	Opportunistic infections, Transplant infectious disease
1027269	We are in the process with NCQA of starting a Patient-Centered Medical Home demonstration project within Northwestern Memorial Physicians Group at our internal medicine office site.
1027396	My research focuses on sensorimotor control of the hand and its rehabilitation following neuromuscular injury, such as stroke.  Toward this end, my research group and I are pursuing three interdependent lines of research in the Coleman Hand Rehabilitation Laboratory: description of hand neuromechanics, quantification of the mechanisms of hand impairment following stroke, and the development of mechatronic devices for hand therapy following stroke.
1027416	Blood group isoimmunization, Fetal anomaly, Hypertension in pregnancy, Prenatal diagnosis
1027425	Movement Science, Balance, Aging, Parkinson's Disease, Functional Outcomes, Cultural Competence
1027426	Bladder drop, Gynecologic surgery, Laparoscopic surgery, Minimally invasive surgery, Special female pelvic surgery, Urinary incontinence, Urogynecology, Vaginal hysterectomy, Vaginal prolapse, Vaginal repair
1027428	High Impact Education Dissemination; Palliative and End-of-life Care Research; Geriatrics and Aging Research; Patient Safety; Family Caregiver Education; Economic Resilience for Caregivers
1027443	The Bohn lab is developing gene and stem cell therapies for Parkinsons disease (PD) and amyotrophic lateral sclerosis (ALS)using experimental rodent models of these diseases. Previous studies  focused on gene therapy with the neurotrophic factor, glial cell line derived neurotrophic factor (GDNF) which the group has shown slows the progression of dopamine neuron loss in rat models of PD.  A phase I clinical trial testing GDNF gene therapy will commence soon. The lab is currently studying viral vector mediated gene silencing of alpha-synuclein, a gene linked to familiar forms of Parkinsons disease.  In addition, the lab is generating neuroprogenitor-like cells and neurospheres from rat and mouse bone marrow and determining whether this interesting source of stem cells can be developed as a novel therapy for PD.  Studies of the effects of rat bone marrow derived neurospheres are also being tested for effects on traumatic brain injury.  Viral vectors harboring neurotrophic factors are also being made for studies aimed at reversing aging of dopamine neurons in rat hypothalamus and targeting upper motoneurons in mouse models of ALS.  The experimental approaches in the lab are multi-faceted and employ techniques ranging from making viral vectors to molecular and morphometric assays  to behavioral testing.
1027447	My primary clinical interest is to use minimally invasive magnetic resonance imaging techniques to guide and monitor localized treatment of tumors, especially for liver and pancreatic cancer. I have an active laboratory that has translated a number of developments from our animal lab to the clinical arena.
1027454	Picture Archiving and Communication SystemsDisplay Systems for Medical and Image InformationImaging InformaticsIntegrating Medical Information SystemsData MiningOperational analysisImproving workflow efficiency
1027497	Autoimmune skin diseases, Non - melanoma skin cancer, Psoriasis
1027734	Diagnostic ultrasound, Fetal anomaly, High risk pregnancies
1027926	Research interests include neurodevelopmental correlates of craniosynostosis, quality of life for individuals with cleft and craniofacial conditions, and correlates of learning disabilities in children with cleft lip and palate.  I am part of a multi-disciplinary, multi-site research team that is following a cohert of children born with a single suture craniosynostosis and controls who do not have this condition.  With NIH funding, we have evaluated these children at diagnosis, 18 months, 3 years and are beginning a 7-year-old evaluation.  Differences in facial appearance affect social and emotional development in children with orofacial clefts and other craniofacial conditions.  I am investigating the impact of these conditions, stigma, and quality of life.
1027933	Dr. Cryns is an endocrinologist whose research focuses on the genes and signaling pathways that cause breast cancer. The overall goal of his research is to translate molecular insights into better therapies and prognostic markers for breast cancer patients. 
1027933	Dr. Cryns leads a multidisciplinary team of scientists who focus on understanding how cells die. His group is especially interested in elucidating how abnormalities in cell death contribute to the pathogenesis of breast cancer and in translating these insights into improved predictive markers and therapies. He is also founding Director of the SUCCEED Breast Cancer Survivorship Program at Northwestern, an innovative clinical program that provides personalized health care for breast cancer survivors.
1027947	Co-Director of Clinical Education Center:  Fostering innovative ways to improve clinical skills of our medical students and use of technology to enhance clinical skills.Clinical Practice:  Diagnositic dilemmas, health promotion
1027947	Comprehensive care of adults, Hospital-based care of the medical patient, Medical consultations and diagnostic dilemmas
1027951	I am a board certified pathologist with subspeciality certification in cytopathology. My primary intereststs are  gynecologic cytology, fine nedle aspiration of head & neck/thyroid, breast, and general cytopathology. Advocacy for cytopathology and women in medicine as well as medical education are my other interests. I am active in organized medicine and have leadership roles in many national and international cytopathology/pathology organizations. I teach at the local, national and international levels.
1028063	cytoskeleton, myosin phosphorylation, self-assembly, cell motility, signal transduction
1028321	Ancillary techniques, Cytopathology, Pulmonary pathology
1028424	Our group studies the structural basis for interactions between proteins, and between proteins and small molecules, that play important roles cell biology.  We have focused on the GTPases of the Signal Recognition Particle (SRP), Ffh and FtsY, currently seeking to understand the structural basis for regulation of the assembly of their heterodimeric targeting complex. Our lab is also initiating a proposal to determine the structures of novel members of the trypanosome surface coat proteins (VSGs).
1028426	Nucleolus, nucleus, chromatin, nuclear structure and function, cancer, growth-regulations, signal-transductions,
1028607	Care of adults with a history of childhood cancer, Preventive medicine
1028619	Genetic counseling; informed consent for genetic testing; medical decision-making, health care communication, ethics, specifically around areas of genetic testing and research. 
1028771	Current research activity is focused upon the psychological functioning of children and adolescents with HIV infection/AIDS, risk behavior in adolescents with HIV exposure/HIV infection, and individual and psychosocial factors mediating HIV medication adherence. 
1029113	Musculoskeletal imaging
1029130	epithelial cells, membrane traffic, GPCR, arrestins, epithelial polarity, mucosal biology, mucosal inflammation, apoptosis
1029134	My primary research interest is in health outcomes following pediatric liver transplantation and acute liver failure.  I lead a research group that studies all aspects of outcomes from survival to health related quality of life (HRQOL).  The largest current projects examine HRQOL and cognitive outcomes in pediatric liver transplant survivors, long term complications related to immunosuppressive medications and the causes and treatment of acute liver failure.
1029137	I have a strong interest in medical ethics, especially ethical issues in pediatrics, end-of-life care, research on human subjects, transplantation, children with disorders of sex development (DSD) and gender identify nonconformity, medical and surgical innovation, transplantation and conscientious objection to requested care by health care professionals.  My main clinical interests are in pediatric palliative and hospice care, multidisciplinary care of children with DSD/GID and parent support for difficult decisions under conditions of uncertainty.
1029164	Primary research interests are in adult and pediatric genito-urinary and CNS cancers including prostate cancer, Wilms tumor and brain tumors. The other areas of interest include development of novel therapies for recurrent tumors including prostate, brain and neuroblastoma. Radiosurgery, hyperthermia,intra-operative radiation therapy, brachytherapy, novel IMRT techniques and nanoparticle-mediated delivery of novel radiosensitizing therapy are areas of ongoing clinical and basic research.
1029324	Adolescent gynecology, Colposcopy, Menopause
1029534	Special interest in working with chronic pain and with anxiety disorders. Experienced in Mindfulness-based Psychotherapies and Acceptance and Commitment Therapy.
1029833	I am both a clinician and a researcher as well as an educator. I am interested in studying the impact of chronic illness on the adaptation and coping of children, adolescents and their families. I am also interested in the area of transitioning from pediatric to adult care among youth with chronic illness.
1029930	My current research focus is on characterizing the signaling pathways that regulate endothelial cell behavior leading to the process of blood vessel development (angiogenesis).  In particular, I am interested in characterizing the role of the a4 laminin subunit, a component of the basement membrane of endothelial cells in blood vessel development.  I have previously demonstrated that a4 laminin contributes to angiogenesis by interacting with avb3 integrin and b1 integrin containing heterodimers.  I plan to further unravel the signaling mechanisms underlying a4 laminin dependent angiogenesis, to identify the critical phosphorylation events and to determine the role of apoptosis in the endothelial cell response to a4 laminin.  I am also interested in characterizing the signaling pathways that are involved in either enhancing or blocking the differentiation process of endothelial progenitor cells to endothelial cells.  Endothelial progenitor cells have been implicated in the development of new blood vessels during normal and pathological angiogenesis.  However, the mechanism and extracellular signals that initiate and regulate this process are poorly understood.
1030012	fluorescence microscopy, live cell imaging, endothelial cell, 3D vasculature enogineering, tumor-endothelial interaction, hemodynamics.
1030041	Dr Kuikens research group is working developing bionic technologies to improve the function of artificial limbs for people with very proximal amputations.  The main research focus of the lab is developing a technique using nerve transfers to improve of myoelectric prosthesis control called targeted reinnervation.  By transferring the residual arm nerves in an upper limb amputee to spare regions of muscle it is possible to make new signals for the control of robotic arms. This allows simultaneous control of multiple joints in a natural way.  The procedure has been very successful in patients with increases in speed of 50- 500%. Similarly, hand sensation nerves can be directed to reinnervate spare skin in or near the residual limb so that when this skin is touched, the amputee feels like their missing hand is being touched including light touch, graded pressure hot/cold, sharp/dull and vibration. This is an exciting pathway to producing true sensory feedback to amputees from their prosthesis.
1030273	I work with trauma and mental illness in children's mental health, juvenile justice, child welfare and education programs.  As Clinical Director of the Illinois Childhood Trauma Coalition we are focusing on developing a statewide system of care with appropriate professional development to address child trauma.  Within research, we are looking at children in the public sector who suffer from complex trauma and attempting to understand what treatments are effective with these children.  We are also engaged in supporting a movement to include a developmental trauma disorder diagnosis in DSM-V.
1030597	Primary research interest involves identifying key molecule pathways (e.g. TLRs signaling pathways) leading to allograft rejection following organ transplantation using small animal transplant models.
1030626	Forensic NeuropsychologyTraumatic Brain InjuryPostconcussion SyndromePosttraumatic Stress DisorderViolent Behavior
1030644	Prostate cancer, angiogenesis inhibitors, PEDF, TSP
1030765	CT,MRI, Image processing, Oncologic imaging, Abdominal imaging, Cardiac imaging.
1030810	Fitness, Nutrition and Weight Management, Medical care of the obese patient, Preventive medicine
1030810	Obesity, nutrition and lifestyle clinical care; clincal research in diet, body composition and weight mangement methods; and medical education in nutrition and lifestyle medicine
1031011	My primary research is in the field of biostatistics with particular emphasis in the areas of 1) longitudinal data analysis, 2) generalized linear and nonlinear mixed-effects models and 3) outcomes research as it pertains to survival analysis and causal inference.
1031145	Dr. Smith, who is a trained prosthetist, currently serves and has served as Principle Investigator on a number of research grants relating to the delivery of rehabilitation services and technologies to war wounded populations internationally. In particular he has been involved in the development and delivery of appropriate prosthetics and rehabilitation technologies and distance learning to land mine victims in low income countries. In addition, Dr. Smith has led the development and commercialization of a number of health informatics applications including store-and-forward telemedicine, personal health record (PHR) and clinical decision support (CDSS) systems.
1031152	The focus of the work in my lab is directed towards the understanding of neuromusculoskeletal control during active movement in persons with brain injury.  In particular, studies seek to understand the control mechanisms underlying locomotor behavior in persons with post-stroke hemiplegia.  Related to this objective, the work is attempting to understand underlying mechanisms of poor control and to develop quantitative evaluation and intervention tools for the amelioration of locomotor deficits post-stroke.  The experimental approach includes measurement of electrical muscle activity, lower limb force and movement trajectories, and electro-physiological reflex testing during cyclical locomotor movements such as walking and pedaling.
1031187	Clinical interests include diagnosis and treatment of kidney diseases, hypertension, acute kidney injury and chronic kidney disease, and management of patients on dialysis.
1031217	CLINICAL NEONATOLOGY
1031304	My research focuses on spinal motor-system. I am interested in the interaction between pre-motor interneurons and motoneurons; the synaptic plasticity of motoneurons for peripheral and brainstem descending pathways; and the mechanisms of amyotrophic lateral sclerosis (ALS).  Using a root recording system I developed for mouse spinal cord study, I have demonstrated the existence of two forms of short-term plasticity in the spinal motoneurons in response to different source of synaptic inputs. Further studies in this direction will move toward the cellular level to understand their pre- and post-synaptic mechanisms.  In an animal model of ALS (mSOD1 mouse), I have found that NMDA receptors in the spinal interneurons might be an important component contributing to motoneurons' excitotoxicity. Further studies will apply intracellular recording and calcium image techniques to answer that through what ions, channels and/or receptors the interneurons interact with motoneurons in mSOD1 mouse in order to determine new therapeutic targets for this disease.
1031419	My clinical practice is focussed on treating adult and older adult individuals and couples with relational problems, depression, anxiety, and addicitions. I frequently work closely with primary care physicians to treat patients with medical disorders. My research interests are in psychotherapy and psychotherapy integration
1031423	My primary clinical interest is the field of Thoracic Imaging.  Within the field, imaging of lung cancer and imaging of pulmonary embolism are particular interests.My primary research interest at this time is lung cancer screening.  I am one of the Investigators for the National Lung Screening Trial (NLST), an ongoing multi-institutional trial funded by the National Cancer Institute (NCI) to try to determine if lung cancer screening decreases lung cancer mortality.  For more information on NLST, see www.ACRIN.org.
1031537	Medical disorders of the breast, Woman's health
1031630	Dr. Pinski practices general and cosmetic dermatology. He has a particular interest in facial rejuvenation with Botox, filler substances and liposuction. He is also a national instructor for Botox, Restylane and Juvederm.
1031667	I have just written a book on psychiatry, 'The Origin of Symptoms': cultural aspects, clinical intensive pschotherapy case studies, the brain, genetics overview ( review of journals), animal studies. My interests are pschoanalytic.
1031759	Lasik surgery, Ophthalmic plastic surgery, Refractive surgery, Refractive surgery
1031779	Implementation science and critical care outcomes.
1031800	I am currently searching for new and innovative methods for incorporation in the teaching of residents and medical students. In addition to teaching the science and the art of medicine, it is incumbent upon us, as faculty, to lead the way in providing service to community and to those who are less fortunate.    
1031839	Psychotherapy, child psychopharmacotherapy and school consultation.
1031841	Developmental Disabilities (Clinical)
1031867	I am interested in studying the experiences of families who have children hospitalized in a neonatal intensive care unit.  My focus is on medical decision-making and the interactions of families with medical providers in the process of decision-making.
1031869	Dr Reids research interests are aimed at gaining a greater understanding of the relationship between the sleep and circadian systems with health and safety. Current research areas include, understanding the basis and treatment of circadian rhythm sleep disorders, the effects of sleep loss on performance and safety, and the relationship between sleep and risk for metabolic and cardiovascular disease.  Dr Reid also has extensive experience in the study of the impact of shift work on sleep, performance and health in the workplace. 
1032015	Gynecologic infections, Menopause, Vaginal problems, Vulvar problems
1032029	Breast Imaging: mammography, ultrasound, MRIBreast Image-guided procedures
1032035	Breast imaging, Digital mammography, Radial scars
1032044	I have been deeply involved in medical decision making from the perspective of psychological and fact driven decisions.  I enjoy nearly all aspects of managing general medical problems from cholesterol to autoimmune disease to travel medicine... I try to maximize my patients health and quality of life.
1032062	My research is focused on the mechanisms underlying Parkinson's disease and schizophrenia. This pursuit employs a combination of electrophysiological, optical, genetic and behavioral approaches.
1032088	Biomedical signal processing, cardiac arrhythmias, computer modeling
1032158	Interventional Oncology offers various treatment therapies to cancer patients using minimally invasive angiographic techniques and treatment options at various stages in cancer treatment. These treatments may be used alone, in combination, or in conjunction with standard of care cancer treatments such as chemotherapy and radiation, as a palliative treatment, or may be used as a bridge to organ transplantation
1032326	magnetic resonance imaging, cardiovascular imaging, technical developments, heart, interventional, coronary artery disease, oxygenation,contrast agent, angiography,perfusion
1032446	Dr. Brian Helfand is a research assistant professor in the Department of Urology.  He completed his MD/PhD at Northwestern University and is continuing with his clinical education in urology.  His research focus is directed towards identifying the cellular and molecular mechanisms underlying prostate cancer.  Specifically, he is interested in the changes in both the cytoskeletal and nucleoskeletal intermediate filament proteins which promote metastases and disease progression.  In addition, he is focused upon elucidating the mechanisms by which intermediate filaments control the expression of DNA (transcription) and their combined influence on cell behavior.
1032461	Integrin regulation of proteases in oral keratinocytes (special focus on urokinase receptor-integrin interaction and consequent intracellular signaling events). Effects of altered expression of proteases on tumorigenecity/invasion of oral cancer.
1032738	Fetal Brain Injury, Oxidants, Neuroprotection, Cerebral Palsy, Fetal Alcohol Syndrome
1032739	Acute coronary care, Coronary angioplasty, stenting, and atherectomy, General cardiology, Peripheral vascular interventions
1032743	Abdominal aortic aneurysms, Angio / stents, Endovascular, Extracranial cerebrovascular disease
1032810	Cardiac electrophysiology
1032869	Body imaging
1032893	Cardiac rehabilitation, Echocardiography, Vascular biology
1032940	Integrated systems, Neuroanatomy, respiration, amygdala, basal ganglia, cerebellum, 
1032946	Acute renal failure, Pre and end stage renal disease care
1033130	Glycolipid and cell behavior/skin cancers.
1033185	Dr. Hirano is Associate Professor of Medicine and Director of the Gastroenterology and Hepatology Fellowship Program at Northwestern University Feinberg School of Medicine.  He attended medical school at the University of Pennsylvania and completed his medical residency and GI fellowship at Beth Israel Hospital in Boston. He took a faculty position at Harvard Medical School working in esophageal physiology before coming to Northwestern in 1998. His academic interests focus on eosinophilic esophagitis and swallowing, motility,  and esophageal disorders.
1033185	Eosinophilic Esophagitis, Eosinophilic Gastroenteritis, Esophageal motility disorders, Gastroesophageal reflux disease, Swallowing disorders
1033220	Clinical researchDevelopment of devices facilitating the plastic surgery field
1033261	From 1987-1997, I built a clinical service and research program at Rush University with an emphasis on quality of life and outcome evaluation in cancer treatment research.  I developed and am continually refining the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System for outcome evaluation in patients with chronic medical conditions.I have focused my career studying questions regarding quality of life measurement in clinical trials, cross-cultural equivalence of quality of life measurement, efficacy of psychosocial interventions in oncology, and medical outcomes research. I am the principal investigator of the statistical coordinating center for the NIH Roadmap Initiative to build a Patient Reported Outcome Measurement Information System (PROMIS). I am also the principal investigator of a contract to develop item banks for the clinical trials supported by the National Institute of Neurological Disorders and Stroke.
1033359	informed consent in the clinical arena, health policy development, classificatory theory, medical education and patient safety research
1033423	Building And Re-Building Of Limbs And Hearts. The Simon Laboratory has identified regulartory genes that play key roles in limb development in virtually all vertebrates, including humans. Surprisingly, these genes are also critical for the shaping of the heart during embryogenesis and when mutated in humans, they lead to birth defects of the arms and heart. Using zebrafish and mouse models, the lab tries to gain a deeper understanding of common genetic pathways in limb and heart development and disease. In addition to these developmental studies, the lab is interested in discovering the genes that are involved in regenerative processes. As models for these investigations, zebrafish and newts are employed, which can regenerate limbs and heart ventricles throughout their life times. The identification of genetic pathways that are operational in these regenerating species but not in mammals, will provide new insights how to restore regenerative abilities in non-regenerating species including humans.
1033524	My primary interest is the diagnosis and treatment of pain disorders pertaining to the spine.
1033629	Chronic inflammatory demyelinating neuropathy (CIDP); Guillain-Barre syndrome (GBS; Chemotherapy induced neuropathy; Myasthenia gravis; Muscular dystrophy; Electrophysiology in peripheral nervous system diseases
1033859	Dr. Rudicks research focuses on characterizing the peripheral and central (spinal cord and brain) neuronal mechanisms of acute and chronic pain in interstitial cystitis, chronic prostatitis/chronic pelvic pain syndrome and urinary tract infection.  Dr. Rudick is currently investigating the transition from acute pain to chronic pain and developing novel therapies to treat both acute and chronic pain associated with the urinary tract.
1034093	Current clinical practice utilizes a multidisciplinary team approach to the diagnosis and treatment of pediatric epilepsy and comorbidities.  Dr. Millichap has over 20 peer-reviewed medical publications and serves as the Deputy Editor of the Resident and Fellow Section of the journal Neurology.  As a member of the academic faculty of Northwestern University, he is involved in the education of trainees and grant-funded clinical research concerning epileptic encephalopathies.
1034109	biomedical communications, biomedical policy, biomedical literacy, health literacy, scientific literacy, cancer communications, public health communications, information technologies, multivariate analysis
1034453	Our group seeks to elucidate the molecular mechanisms by which human prostate cancer cells regulate motility (and thus ultimately metastasis), to identify new drugs which target regulatory elements, and to evaluate their efficacy in humans.  Studies employ basic cell and molecular biology based investigations, animal models of metastasis, and early phase clinical trials involving cell and molecular based endpoints.  A central focus is upon the role of transforming growth factor beta (TGFb) associated signaling members.  Through these studies we have been able to link TGFb super family receptors, Smad proteins, members of the p38 MAP kinase signaling pathway, small heat shock proteins (in particular, HSP27), and matrix metalloproteinases (MMPs), into an inter-linked regulatory network within the cell, which together regulates cell motility, invasion, and metastasis.  We have identified a lead compound that effectively blocks activation of the key regulatory elements.  Our lead compound inhibits metastasis in murine orthotopic models, was well tolerated in human phase I trials, and demonstrates mechanistically relevant cell and molecular efficacy in phase II human trials.  
1034453	Phase 1 & 2 clinical trials, Prostate cancer
1034459	Development and validation of instruments to measure quality of life and rehabilitation outcomes
1034616	Dr De Plaens research focuses on the developmental aspects of the inflammatory mechanisms contributing to necrotizing enterocolitis, a devastating disease of the premature infant, causing sudden bowel inflammation and necrosis.  
1034656	A major pediatric research priority and the long-term goal of my laboratory is the identification of the etiology and pathogenesis of Kawasaki Disease (KD), the leading cause of acquired heart disease in children in developed nations. KD can result in coronary artery aneurysm (CAA) formation with resultant myocardial infarction and/or sudden death. Clinical and epidemiologic data are consistent with an infectious cause of KD, but conventional methods have not yielded the etiologic agent. We discovered that oligoclonal IgA plasma cells, CD8 T lymphocytes, and macrophages infiltrate CAA and other tissues in acute KD, indicating an antigen-driven response to an intracellular pathogen, such as a virus, with a mucosal portal of entry. We made oligoclonal KD antibodies in vitro and used them as tools to identify their target antigens. Immunohistochemistry revealed that KD synthetic antibodies detected antigen in acute KD but not control bronchial epithelium and in a subset of macrophages in acute inflamed KD tissues. In acute KD ciliated bronchial epithelium, antigen localized to distinctive perinuclear intracytoplasmic spheroids. Light and electron microscopy revealed that the spheroids in ciliated bronchial epithelium were cytoplasmic inclusion bodies (CIB). The CIB were most consistent with aggregates of protein and associated nucleic acid and likely derive from the KD etiologic agent. These data support the hypothesis that the KD agent enters via the respiratory tract, infects bronchial epithelium, and travels in macrophages to targeted tissues including coronary arteries, with antigen-specific IgA plasma cells and other inflammatory cells entering the tissues to combat the pathogen and resulting in tissue damage. The presence of CIB consistent with aggregates of microbial, likely viral, proteins and nucleic acids in acute KD lung provides a structural and molecular footprint that could lead to identification of the KD etiologic agent.
1034762	<BR><BR>My research work is focused on studying the mechanisms that regulate the transcriptional activities of nuclear receptors. Nuclear receptors constitute a large superfamily of transcription factors that regulate a diverse array of biological processes, including development and neoplasia, as well as energy and xenobiotic metabolism. In order to initiate transcription, some more factors are required to interact with nuclear receptors and to regulate their activities. These factors are collectively called 'nuclear receptor co-factors'. Several co-factors have been identified by our studies. Generating mouse models using gene targeting technology to investigate the functions of these genes is in process.
1035505	retrovirus replication, reverse transcription, integration, virus assembly mechanisms, molecular genetics
1035506	Primary Research Interest: Gene Regulatory and microRNA networks during neural tube developmentClinical Research Interest: Biomarker discovery and validation in Spina Bifida.
1035648	Dr. Holly Falk-Krzesinski is the Director of the Office for Research Development.  In this position, Dr. Falk-Krzesinski and her team support and advance faculty research and the Northwestern's collective research enterprise through strategic alignment of vision, priorities, capabilities, and opportunities to enable pursuit of large, multi- and interdisciplinary research initiatives that garner national and international recognition.  Dr. Falk-Krzesinski specifically focuses on life and biomedical sciences initiatives and works closely with five of the research schools: arts & sciences, engineering, communication, education & social policy, and medicine.  As Director, Office for Research Development, Dr. Falk-Krzesinski has successfully catalyzed and fostered a number of major multi- and interdisciplinary research projects: The NIAID-funded contract award for a large-scale Structural Genomics Center of Infectious Diseases is a Center that applies state-of-the-art high-throughput structural biology technologies to experimentally characterize the three-dimensional atomic structure of targeted proteins from pathogens in the NIAID Category A-C priority lists and organisms causing emerging and re-emerging infectious diseases.  The Center provides a high throughput pipeline for structure determination that will carry out all steps of the process from target selection through structure deposition and will determine over 375 structures during the five-year period of the contract.  This initiative strengthened the partnership with the Advanced Photon Source and structural biologists at Argonne National Laboratory. The NCI-funded Nanomaterials for Cancer Diagnostics and Therapeutics Center for Cancer Nanotechnology Excellence (CCNE) that advances nanotechnology as a critical driver of advances in oncology and cancer research leading to near-term benefits for patients. The new Center capitalizes on the very strong partnership between the University's International Institute for Nanotechnology and the medical school's Robert H. Lurie Comprehensive Cancer Center.  The Oncofertility Consortium: Fertility Preservation for Women, a program through the NIH Roadmap for Medical Research Interdisciplinary Research Consortium initiative.  The inter-institutional consortium is a framework into which new discipline of oncofertility will be fostered  to create new knowledge about the process of ovarian follicle development and provide the medical solution to fertility preservation for women with a fertility-altering cancer diagnosis. The Regenerative Medicine Training Program, an interdisciplinary research training program of the NIH Roadmap for Medical Research Training for a New Interdisciplinary Workforce initiative.  The training program is for pre- and postdoctoral trainees and provides integrated training in the physical sciences, life sciences, and engineering with the goal of creating a new generation of scientists in regenerative medicine who can focus on overcoming the obstacles to developing techniques for repairing or regenerating damaged tissues and organs.  Participated as a co-organizer and engaging Northwestern faculty to participate in the regional partnership to bring university and industry research together: Catalyzing Collaboration between Industry and Academia in the Life SciencesNeurodegenerative Medicine, Regenerative Medicine/Stem Cell Biology, and Women's Health Research. The NIDDK-funded NIH Islet Cell Resource as the lynchpin activity of the Chicago Islet Consortium, which Northwestern University, the University of Chicago, and the University of Illinois at Chicago comprise.  The overall goal of the Resource is to advance the field of human islet isolation for basic research and clinical transplantation.&.TRUNCATED
1035648	Holly Falk-Krzesinski, PhD, is Research Assistant Professor and Director, Research Team Support & Development at the NIH CTSA-supported Northwestern University Clinical and Translational Science (NUCATS) Institute.  My research activities involve collaboration enhancement and research development and grantsmanship for clinical and translational team-based, cross-disciplinary research.  Connecting the science of team science (research on scientific teams) with the praxis of team science (the practical aspects of science performed in teams), I translate empirical research findings about team science into evidence-based effective practices for scientific teams, institutions, and funders of collaborative team science.  Two areas of application on which I focus are tools and training.  I have been working on the development and implementation of research networking tools, knowledge management systems for the research enterprise, to support the efforts of researchers and research development professionals to initiate and nurture new interdisciplinary partnerships and secure collaborative extramural research funding.  And, in an effort to prepare trainees and investigators to engage effectively in collaborative research and team science, I have recently developed two interdisciplinary, team science training resources: a graduate-level Team Science course and TeamScience.net, an online learning tool.  I am now developing a workshop series focused on leadership and team science.  Finally, I chair the Annual International Science of Team Science (SciTS) Conference, through which I am working to develop a strong, interdisciplinary community of practice for team science, SciTS, and interdisciplinary research training.
1035819	I am committed to a career in patient-oriented research related to pulmonary vascular disease. Exploring the clinical impact and the mechanisms of pulmonary hypertension (PH) in patients with underlying lung disease is my primary research interest. This interest stems from my clinical experience over the last several years developing and building the Northwestern Pulmonary Hypertension Program. Pulmonary hypertension is a common complication seen in patients with lung disease, specifically chronic obstructive pulmonary disease (COPD). Although the association between the presence of PH in COPD and increased mortality has been well described, we have recently explored the impact of PH on patient-centered outcomes. I am interested in exploring the mechanisms of PH and identifying the disease as it presents early in the course of lung disease when interventions could potentially alter disease progression.
1035946	Samuel Stupp's research is focused on self-assembly and supramolecular materials with special emphasis in regenerative medicine, organic electronics, solar energy, and cancer therapies.
1035953	Neuromuscular Disorders:Amyotrophic Lateral SclerosisMuscular DystropyPeripheral Neuropathy
1036098	Traumatic Brain Injury, Outcomes, Measurement, Assistive Technology
1036119	Our laboratory investigates the pathogenesis of the gram-negative bacterium Pseudomonas aeruginosa.  We focus on this organism's type III secretion system, an apparatus that injects toxins directly into host cells.  A second interest is the identification of novel virulence determinants.  Our studies utilize a broad range of approaches, including molecular and cellular techniques as well as animal models and epidemiologic studies on human populations.
1036135	The major focus of my academic interest has been the study of newborn vascular biology. I spent my fellowship and early faculty years studying extracorporeal life support (ECMO) in newborn infants under the direction of Dr. Thomas P. Green. I entered the laboratory of Dr. James Russell in 1990 and learned techniques to investigate basic mechanisms regulating vascular tone. I have gone on to apply this knowledge to better understand the normal development of the perinatal pulmonary circulation, and to determine specific abnormalities that result in persistent pulmonary hypertension. My recent work has utilized intact animal and bench approaches to investigate the role of oxidant stress in the vascular dysfunction and remodeling that characterizes PPHN. We have not only identified enzymatic sources of reactive oxygen species, but have also shown that antioxidant strategies reverse the physiologic and enzymatic abnormalities of PPHN. In collaboration with Dr. Paul Schumacker, my laboratory group has recently incorporated novel in vitro techniques to better understand specific cellular sources of oxidant stress during hyperoxic ventilation, which paradoxically is the most commonly used clinical treatment for respiratory failure and PPHN. Our work provides the scientific foundation for revising the current AHA recommendations to resuscitate critically ill newborns with 100% O2. I recently served as a lead investigator for a Phase I/II trial of intravenous sildenafil for the treatment of PPHN, and plan to proceed to a randomized multicenter clinical trial of intravenous sildenafil for infants with PPHN, beginning late in 2010.
1036144	My primary clinical and research interests lie in pediatric body imaging, especially CT and MRI with a specialty interest in cardiovascular imaging.
1036213	Rheumatoid arthritis, Scleroderma, Systemic lupus, Vasculitis, Wegener's Granulomatosis
1036243	Diagnostic ultrasound (obstetrics and gynecology), Fetal anomaly, High risk pregnancies
1036357	Primary research interests include critical evaluation of clinical research, post-graduate education, adverse drug reactions,and safety outcome measures.
1036557	Dr. Epsteins laboratory is engaged in the study of the impact of viral infections on the developing nervous system.  Currently we are investigating the role of Human Herpesvirus 6, and 7 (HHV-6 and HHV-7) as potential causes of hippocampal injury during febrile status epilpepticus (FSE).  Dr. Epstein is a co-investigator and the study neurovirologist for the ten year NINDS funded multicenter longitudinal FEBSTAT study of  200 children with FSE.   To date we have found that HHV-6B is the most common cause of FSE in children accounting for nearly 30% of the infants that present with FSE.  This longitudinal study will allow us to determine if FSE caused by HHV-6B or HHV-7 is more likely to result in mesial temporal sclerosis and temporal lobe seizures.  Intractable temporal lobe seizures are the most common reason for epilepsy surgery in adolescents and young adults.   If  HHV-6B or HHV-7 prove to be responsible for hippocampal damage it is possible that the injury could be prevented by treatment with anti-viral or anti-infammatory medications at the time of presentation with FSE.
1036558	Acute lung injury and the impact of mechanical ventilation on the injured lung have been a central focus of my laboratory work.  Particular attention to free radical production and inflammation are important are of interest.  The impact of critical illness on the metabolic response of young children has been a persistent interest of mine.
1036566	Current main research interests include: (1) patient safety, primarily risk assessment and in-situ simulation to improve team work and communication in pediatrics, obstetrics, transplant surgery, and family planning; (2) National Children's Study: child health outcomes; (3) healthcare quality indicators pediatric); (4) role of chronic stress in premature labor; (4) contribution of clinician and system factors to clinician-initiated deliveries; (5) prevalence and severity of food allergy and health services.
1036593	Complex dermatological cases, Cutaneous infectious disorders, General dermatology
1036661	Chemical pathology<BR><BR>Plasma lipoprotein metabolism and the pathogenesis of atherosclerosis.
1036691	Breast cancer, General Oncology
1036692	Placenta, Perinatal outcomes, Hypoxia, Angiogenesis
1036702	Benign hematology, Disorders of thrombosis and hemostasis
1036707	Cell signaling and breast cancer progression;Molecular staging of breast cancer;Fertility preservation for young patients with cancer;Impact of fertility treatment on mammary gland 
1036743	Colon cancer, Esophagus cancer, Gastric cancer, Hepatocellular cancer, Pancreas cancer, Rectal cancer
1036746	Specializing in the non-operative management of musculoskeletal conditions, joint injections, spinal injection.  Research interests include outcomes of spinal injections 
1036771	Hepatitis, HIV
1036775	Swallowing Disorders, GERD, Surgical complications and General GI
1036779	High Fidelity Simulation, Virtual reality, Advanced Technologies in Medical Education
1036796	Cardiac imaging, Diabetes mellitus, Kidney failure
1036807	Research and clinical interests of the role of non-invasive cardiovascular imaging in acute coronary syndromes, coronary artery disease, ischemic and structural heart disease, and pre-operative cardiac evaluation. Specific focus on nuclear cardiology and cardiac magnetic resonance imaging.
1036807	Research in the noninvasive clinical utility of cardiac magnetic resonance and nuclear cardiology in the treatment, diagnosis and management of patients with cardiovascular disease.
1036812	Incontinence, Neurogenic bladder, Complex voiding dysfunction, Pelvic reconstruction
1036816	We are involved in a variety of bimomechanical research projects in order to compare and optimize the biomechanics of fracture fixation. I am also collaborating with Sam Stupp at IBNAM looking at ways to enhance bone regeneration in a traumatic defect animal model using nanotechnology.
1036821	1 Failure to extubate / re-intubation rate in our institution (incidence, risk factors, complications, outcomes).   2 Special interest in ARDS (Adult Respiratory Distress Syndrome). 3 Gender difference in propofol-induced pain.4 Developing teaching videos (in English and French) on hot topics of Neuro-Anesthesia and Neuro-critical care. 5 Electrolyte abnormalities seen after bladder reconstruction surgery6 Surgical airways in our institution (incidence, risk factors, complications, outcomes).7 Private and institutional Investors: Please note that your contributions are welcome to support our research efforts.
1036822	My  interests include defining the non-medical factors associated with clinician-initiated obstetric deliveries, specifically as it applies to birth prior to 39 weeks' gestation.  Our group has recently focused on racial disparities and the trends in these disparities for women who received induction of labor at both early-term (37-38) and late preterm (34-36) gestations.  Additionally, we have studied the associated between medico-legal pressures and regional rates of clinician initiated delivery including primary cesarean delivery and late preterm induction of labor in Illinois.  Another set of projects are within the Children's Hospital Neonatal Consortium (CHNC), an organization dedicated to improving care and outcomes for infants in Childrens Hospital NICUs through sharing of data, information  and ideas for benchmarking, research, and development of safety and quality improvement initiatives.  With the close collaboration of the Child Health Corporation of America, the CHNC has developed and deployed a database focusing on the population ill infants requiring medical/surgical subspecialty care due to congenital anomalies, preterm-associated consequences that were admitted to 22 US children's hospitals' NICUs since 2010.   Over 17,000 infants have been captured, and we aim to describe the care and outcomes for a population of infants that has not been focused on in traditional neonatal databases.  These include, for example, children requiring surgical care, those with congenital anomalies, and/or those with uncommon medical problems that are not necessarily associated with preterm birth.
1036826	Allergic rhinitis, Angioedema, Asthma, Drug allergy, Idiopathic anaphylaxis, sinusitis, Urticaria
1036826	My main research interest is in the subject of chronic rhinosinusitis.  Chronic rhinosinusitis is one of the most common medical condition seen in the U.S.  We are currently investigating the role of Staphylococcus aureus in the pathogenesis of chronic rhinosinusitis.  We have demonstrated the presence of IgE allergic antibody in the serum of patients' with chronic rhinosinusitis.  We have also implied a superantigen  effect in the pathogenesis of nasal polyps by demonstrating clonal expansion of staphylococcal toxin specific T cell receptor (TCR) V-b domains in the polyp lymphocytes of individuals with chronic rhinosinusitis and nasal polyps.
1036835	Dr. Costellos research interests focus on clinical investigations in critically ill children with congenital and acquired cardiac disease. He is currently involved in perioperative clinical trials investigating natriuretic hormone infusions and strict glycemic control following pediatric cardiac surgery. He is also interested in the epidemiology and prevention of healthcare associated infections in critically ill children, and outcomes studies in neonates with critical congenital heart disease.
1036839	My primary research interests are in translational efforts in GI oncology.
1036841	Please visit our Sinus & Allergy Center website.www.northwestern-sinus.com
1036853	1. Targetting frail elderly in acute care setting using EMR and developing interventions to improve hospital and posthospitalization outcomes2. Hospital wide QI project of recognition of cognitively impaired patients, and recognition and prevention of delirium
1036859	Electroencephalography, Epilepsy, Seizure disorders
1036916	Dr. Gonzalez's clinical interests include male reconstructive surgery and health policy.  He was awarded an NIH SPORE project pilot grant to study prostate cancer screening trends in Chicagos Hispanic community. He has also received funding from the Grant Healthcare Foundation for the development of electronic pre-visit software in order to improve the quality of patient care, reduce errors, control costs, and facilitate patient flow. Dr. Gonzalez is the Vice Chairman of Health Policy for the Americna Urological Association.
1036943	My laboratory focuses on understanding pathways relevant to the recruitment and trafficking of leukocytes within the intestines. Our goal is to understand how altering this recruitment can influence states of intestinal inflammation, specifically Inflammatory Bowel Disease (IBD).  My primary clinical interest is IBD (Crohn's disease and ulcerative colitis). I am also interested in understanding the relationship of the intestinal immune system to GI symptoms in rheumatologic disorders, specifically Juvenile Dermatomyositis.
1036974	Management of thyroid cancer, its recurrence process and associated neck dissections and advanced thyroid cancer with special interest in young adults.
1036989	My primary interest is in the career advising of medical students.
1037005	The diagnosis and treatment of bleeding disorders and their complications. Evaluation of causes of thrombosis and education regarding treatment and prevention of thrombosis.
1037017	As a pediatric electrophysiologist, I follow pediatric and adult congenital patients with all types of arrhythmias.  In addition, I have a complex cardiomyopathy clinic to address the electrophysiologic issues in patients with heart failure and cardiomyopathy.  I am interested in the prevention of sudden cardiac death in the pediatric population, pediatric ECG screening (newborn, sports and ADHD ECG screening), and public use of AEDs.  In addition, I am interested in the cardiac changes from intense sports training and in cardiac rehabilitation in the pediatric population.
1037039	Dr. Mary Beth Madonna is a pediatric surgeon with expertise in minimally invasive surgery, hernias, undescended testes, gynecologic diseases, neonatal surgery, neck masses, cancer surgery and emergency consultations. Special interest in diseases of the intestines, specifically anorectal malformations and Hirschsprungs disease. Founded a special bowel management clinic for patients with these diseases  the second of its kind in the country.
1037049	I am a general Pediatrician who sees children from birth through college.  I have a clinical interest in breastfeeding and also in allergies, eczema, and asthma.  I speak Polish.  
1037051	Asthma and allergic diseases in the elderyly-project studied how to empower low income elderly patients to obtain appropriate asthma care.Role of innate immunity in asthma exacerbations: project involves measuring innate immune markers in asthmatics with high and low frequency of exacerbations.
1037051	Asthma, Hypersensitivity pneumonitis, Urticaria
1037113	Stem cell regulation in diabetic nephropathy
1037136	Dr. Hairstons clinical interests include male and female incontinence, voiding dysfunction and pelvic reconstruction. He holds a particular interest in voiding dysfunction from neurologic causes such as spinal cord injury, multiple sclerosis, stroke, etc. His research efforts have included trials encompassing the prevention of UTIs in spinal cord injury patients, a placebo-controlled trial for treating Interstitial Cystitis, and investigation on the safety and efficacy of the urethral bulking agent Macroplastique for the treatment of female urinary stress incontinence.
1037160	Patient Safety, Interdisciplinary Teamwork, Hospital-based Care of the Medical Patient
1037160	Using enhancements in interdisciplinary teamwork to reduce adverse events in the hospital. 
1037226	Endoscopic Ultrasound (EUS), ERCP
1037232	Aestetic-cosmetic, Breast surgery, Eyelid, Oculoplastic, Orbit reconstrunction
1037259	Dr. Story is intersted in asthma and food allergy.  In the area of asthma she is particularly interested in the relationship between asthma and obesity.  In the area of food allergy she is interested in prevention and treatment of food allergy as well as eosinophilic esophagitis.
1037261	My clinical interest is the diagnosis and management of patients with hypertrophic cardiomyopathy and my research interest is the application of noninvasive imaging techniques such as cardiac MRI to HCM and the evaluation of their utility in risk stratification for sudden death/ adverse outcomes in HCM.
1037261	My research interest is in the relationship of clinical outcomes in Hypertrophic cardiomyopathy patients with their cardiac imaging findings. My clinical interests include, the care of patients with hypertrophic cardiomyopathy, family history of sudden cardiac death, left ventricular hypertrophy, valvular heart disease, coronary artery disease and preoperative cardiac evaluation.
1037262	Clinical Interests: Cerebrovascular surgery; skull base surgery; interventional neurosurgery.Research Interests: Outcome studies in vascular neurosurgery and stroke; simulation in neurosurgical education; advanced imaging of neurovascular diseases and brain ischemia.
1037264	General gastroenterology
1037282	The majority of my clinical research spans the areas of type 2 diabetes in youth, insulin resistance, metabolic syndrome and polycystic ovary syndrome.  My research explores both pathophysiology as well as treatment options. I am also involved in TrialNet, a national consortium exploring avenues to prevent type 1 diabetes.
1037285	Anesthesia for High Risk Spine SurgeryAnesthesia for Urological Surgery
1037296	Rheumatoid arthritis pathophysiology, cytokine biology,inflammatory arthritis, general rheumatology
1037305	My primary clinical interests relate to hemoglobin disorders, specifically pediatric and adult sickle cell disease and thalassemia.  I also engage in clinical investigation in these areas.  I am currently the principal investigator of an NHLBI K23 award (K23HL094376), entitled, 'The Physiologic Assessment of Exercise Capacity in Pediatric Sickle Cell Anemia'.  This study aims to examine the cardiopulmonary determinants of exercise limitation, the acute inflammatory response to exercise and longitudinal changes in fitness in children and young adults with sickle cell anemia.  I am the principal investigator of several other protocols at Children's Memorial Hospital related to the detection of early cardiopulmonary disease and the assessment of free-living physical activity in this population.  I am also interested in the use of qualitative methods to study parental decision making as it relates to pediatric research participation as well as the socio-cultural barriers that face Asian and Asian Indian families affected by thalassemia.
1037308	Abnormal uterine bleeding, Adolescent health, Annual gynecological examinations, Menopause and menopausal symptoms, Minimally invasive treatment options, Osteoporosis and bone health, Uterine fibroids
1037345	Neuroradiology
1037363	My clinical interests encompass the Genitourinary malignancies including kidney cancer, bladder cancer, prostate cancer, penile and testis cancer with special interest in kidney cancer. My primary research interests involve translational applications of novel nanotechnology in the genitourinary cancers.
1037372	Dr. Perry is Co-Director of the Minimally Invasive Surgery Program and is a nationally recognized expert in minimally invasive approaches to kidney cancers and other malignancies.  He has focused on treating renal and prostate tumors via robotic, laparoscopic and percutaneous approaches in order to reduce bleeding, complications, post-operative pain and recovery time.
1037374	regional: peripheral nerve blocks, transverse abdominus plane block, continuous peripheral nerve cathetersobstetrics: epidural anesthesia, risk factors for postpartum hemorrhage
1037428	General neurosurgery, Neuro-oncology, Spine disease
1037482	Interventional Cardiology
1037512	Dr. Rinella's research interests primarily include non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).  She is engaged in both laboratory and clinical investigation of the pathophysiology of these diseases.  Her patient oriented research focuses on new treatments and understanding the factors responsible for the progression of NASH.
1037526	hematopoietic stem cell transplantation for autoimmune diseases. stem cell based therapy for incurable diseases. gene and immune therapy for malignancies.
1037526	stem cell based therapy and stem cell transplantation for non-malignancies.
1037532	Critical Care Medicine
1037537	Benign breast disease, Breast cancer surgery
1037549	We are interested in understanding the mechanisms leading to newborn brain injury, especially preterm brain injury. Our research focuses on the impact of hypoxia-ischemia on the development of cells of the oligodendroglial lineage. Our strategy is to genetically manipulate BMP signaling in an attempt to regenerate white matter lost to perinatal hypoxic-ischemic brain injury. Currently, we are exploring the role of microRNAs in modulating BMP signaling.
1037573	1.  Evaluation of Resident Physicians in their  performance of Internal Medicine Procedures using simulation2. Congestive Heart FailureOutcomes at discharge and congestion relief
1037573	Hospital Medicine, Medical Procedures, Simulation, Heart Failure, Medical Ethics / Religion, Patient-Physician Relationship
1037583	Clinical Interests:  Interventional Cardiology, Valvular Heart Disease, Radial Artery Angiography, Peripheral Artery DiseaseResearch Interests:  Ischemic Cardiomyopathy, Diabetes and Coronary Artery Disease
1037583	Dr. Flaherty is an Assistant Professor of Medicine in Interventional Cardiology.  His clinical interests include coronary and peripheral intervention, PFO and ASD closure, heart failure, valvular heart disease, cardiac CT angiography and critical care.  His research interests include coronary revascularization in patients with heart failure and diabetic patients with coronary artery disease.  In 2008, he was recognized as the Teacher of the Year in the Division of Cardiology.Dr. Flaherty is board certified in Internal Medicine, Cardiovascular Disease and Interventional Cardiology.  Prior to joining the faculty in 2006, he completed residency and fellowship training at Northwestern Memorial Hospital.  He received additional training in Left Main Coronary Artery Stenting in Seoul, Korea.  He was graduated with honors from the State University of New York at Buffalo School of Medicine and Biomedical Sciences in 1999.   
1037585	Eosinophilic esophagitis, eosinophilic gastrointestinal disease, gastroesophageal reflux disease, esophageal disorders, food allergy and gastrointestinal disease, celiac disease, general gastroenterology
1037662	Perioperative Pulmonary Disease Management, Aneurysmal Subarachnoid Hemorrhage, Mechanical Ventilatory SupportEnd of Life, Do Not Resuscitate
1037673	I am interested in Neonatal-Perinatal Medicine, especially congenital cardiac defects and their management. I am also interested in the use of computers in medicine related to improving efficiency and quality in clinical medicine. 
1037769	Airway Stenosis, Chest Wall and Mediastinal Tumors, Esophageal Cancer, Lung Cancer, Minimally Invasive Thoracic Surgery
1037813	I have a busy clinical cardiology practice in Glenview and Evanston as well as teaching responsibilities at Evanston and Glenbrook Hospitals.
1037814	Abdominal and thoracic aneurysm repair, Carotid angioplasty and stenting, Endovascular surgery
1037814	Dr. Eskandari is a vascular surgeon at the Bluhm Cardiovascular Institute of Northwestern Memorial Hospital with a special interest in endovascular surgery and stent technology. He is also an associate professor of Surgery and Radiology, co-director of the Northwestern Endovascular Center, director of Carotid and Peripheral Artery Interventions, assistant director of the Blood Flow Laboratory and is on staff at Evanston Hospital. Dr. Eskandari has a special interest in carotid stenting. He developed the Carotid Stent Program at Northwestern Memorial and is the site principal investigator for the National Institutes of Health-sponsored CREST trial comparing carotid stenting with endarterectomy. He also specializes in abdominal and thoracic aneurysm repair. An associate professor at Northwestern University's Feinberg School of Medicine, Dr. Eskandari has educational experience as an instructor for both the Resident Core Curriculum and the Scientific Basis of Medicine course. He has served on the faculty of Northwestern University's annual Vascular Surgery Symposium, the Midwestern Vascular Surgical Society's endovascular training course, and the Vascular Interventional Advances peripheral vascular interventions course. He is also course director for several national carotid stent and thoracic stent graft training programs. Dr. Eskandari currently serves as Northwestern's primary investigator for four trials investigating the use of stent grafts in the treatment of thoracic and abdominal aortic aneurysms. He is the Northwestern Vascular Surgery Fellowship Program Director and serves as the director of the Department of Surgery Morbidity and Mortality Conference. His bibliography includes 55 peer-reviewed manuscripts, 17 book chapters, and over 60 international presentations. In addition, he has received three awards for excellence in research endeavors and is the recipient of the Lifeline Foundation's Wylie Traveling Fellowship. Dr. Eskandari serves as reviewer for Journal of Endovascular Therapy, Journal of Vascular Surgery, Journal of Vascular and Interventional Radiology, Journal of the American Medical Association, Expert Opinion on Therapeutic Targets and Future Cardiology. He is associate editor for the Yearbook of Vascular Surgery and on the editorial board the Journal of Endovascular Therapy. He currently sits on the Society for Vascular Surgery Practice Guidelines Committee, and is a representative to the Intersocietal Commission for the Accreditation of Computed Tomography Laboratories for the Society for Vascular Surgery. Dr. Eskandari also serves on several quality management and leadership committees for Northwestern Memorial Hospital. Dr. Eskandari completed his undergraduate and medical schooling at the University of Michigan. He completed his general surgery residency at the University of Pittsburgh Medical Center and his vascular fellowship at Northwestern University Medical School in 1999. He is board certified in general surgery and vascular surgery. 
1037905	Skin Cancer, Facial Aging
1037926	Research is primarily concerning food allergy, but clinical interests also include asthma, atopic dermatitis (eczema), and allergic rhinosinusitis.
1037928	My primary areas of research interests and clinical expertise are psychiatric and cognitive problems of children with epilepsy and other neurological disorders, as well as diagnosis and treatment of psychogenic non-epileptic seizures.  I have developed multidisciplinary clinical service model to provide effective comprehensive treatment for children suffering from comorbid neurological and psychiatric illnesses.  This clinical program provides guidance and assistance in their transition to adulthood. It also offers a unique training environment for fellows in child psychiatry and neurology. 
1037962	Cardiac magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), Coronary CT angiography, Cardiac CT, CT angiography, Vascular and interventional radiology
1038130	Otolaryngology, Surgery, sinus, Surgery, voice, Voice disorders
1038180	My clinical interests are pulmonary vascular disease and cardiovascular disease. I am specifically interested in the evaluation and treatment of children with pulmonary vascular disease, and infants with anatomic or functional cardiovascular disease.My research interests include clinical characterization and management strategies of children with pulmonary vascular disease, and basic evaluation of cardiac remodeling in response to pulmonary vascular pressure overload.
1038351	Advanced laparoscopic procedures, Gastroesophageal reflux disease, Inguinal hernias, Laparoscopic Anti-Reflux Surgery, Laparoscopic Bariatric Surgery, Laparoscopic Heller Myotomy
1038505	Asthma, Chronic obstructive pulmonary disease (COPD), Interstitial lung disease
1038702	Dr. Robert E. Brannigan's clinical concentration is male reproductive medicine and surgery. His surgical interests included performing: microsurgical vasectomy reversal; microsurgical varicocelectomy; micro-TESE for sperm extraction; and vasectomy. He treats hypogonadism (low testosterone) in males, including hypogonadism associated with aging and congenital causes such as Klinefelter's syndrome. His primary research focuses on fertility preservation (oncofertility) in adolescent and adult male patients with cancer.
1038726	Currently my research focuses on the development and validation of magnetic resonance imaging techniques for optimal delivery and functional guidance of minimally invasive therapies, early prediction of therapy response, and non-invasive staging of carcinogenesis. My most recent efforts are focused on the development of imaging methods for primary and metastatic tumors of the liver. Our group deliberately emphasizes a bench-to-bedside translational approach to research. Working closely with a multi-disciplinary group of clinical collaborators, methods first developed and validated in phantoms and animal models are rapidly translated to the clinical setting at Northwestern Memorial Hospital.
1038918	Research expertise and area of interest is the measurement and promotion of lifestyle physical activity among persons with arthritis, to alleviate symptoms of arthritis and delay the onset and progression of arthritis-related disability.
1039131	Cardiac arrhythimias, General cardiology
1039265	mood disorders, including depression and bipolar disorder; treatment of psychiatric illness in patients with coexisting medical and neurologic disease
1039271	Transplant Nephrology, Role of immunosuppressive medications in modulating the immune system, Genomic of chronic renal allograft rejection, Chronic kidney disease after liver transplant, Prednisone-free and Calcineurin inhibitors free immunosuppressive protocols, new immunosuppressive strategies
1039271	Unos Medical Director Renal Transplant Program.Unos Medical Director Pancreas Transplant Program.Director and Course developer for Renal Transplant Fellowship.Director, Transplant Nephrology.Research: Impact of different immunosuppressive protocols on kidney function. Immunobiology of kidney allograft rejection.NIH sponsored trials: Genomics of chronic renal allograft rejection. Impact of Folic acid supplementation on cardiovascular disease of renal transplant patients (Favorit Trial). Immunophenotypig and functional profiles of peripheral lymphocytes in renal transplant recipients after T-cell depletion. Course Director for Monthly Clinical Transplant Conference
1039301	Congestive heart failure, Heart transplantation
1039330	Clinical interests: Glaucoma and cataract.  Normal-Tension Glaucoma, Pigmentary Glaucoma, Pseudoexfoliation Glaucoma.  Early Diagnosis of Glaucoma.Research interets: Selective Perimetry for the Early Diagnosis of Glaucoma, Optic Nerve and Retinal Nerve Fiber Layer Imaging, Tonometry, Efficacy and Safety of Glaucoma Medications, Epidemiology of Glaucoma.
1039411	Chronic viral hepatitis, Post liver transplant medical issues
1039479	Lasik surgery, Ophthalmic pathology, Refractive surgery, Refractive surgery
1039486	I have had a long-standing interest in studying RNA regulatory mechanisms in development.  My lab has focused on studying the mechanism of action of Evfs, novel long non-coding RNAs that regulate transcription factors essential for proper GABAergic interneuron development.  Although a critical role for developmentally regulated transcription factors in patterning and differentiation has been established for some time, the role of long, polyadenylated non-coding RNAs (lpncRNAs) is only beginning to be understood.  A handful of lpncRNAs play roles in X-inactivation, imprinting, and germ cell development, raising the question of whether lpncRNAs constitute a common or rare gene regulatory mechanism in the developing embryo.  We recently showed that the novel lpncRNA, Evf2 is conserved across vertebrates (ultraconserved), and is a sonic hedgehog target in the developing forebrain.  We also showed for the first time that the lpncRNA Evf2 complexes with the Dlx2 homeodomain transcription factor and regulates Dlx 5/6 enhancer activity in vitro (Feng et al. 2006).  Through analysis of an Evf2 loss-of-function mouse model developed in my lab, we now find that the Evf2ncRNA is not only required for proper regulation of genes in the Dlx 5/6 region, but also for proper GABAergic interneuron development in the embryonic brain and adult hippocampal circuitry (Bond et al. 2009).  This provides a novel mechanism in which a DNA regulatory element is regulated by a complementary lpncRNA critical for proper interneuron development. Future work focuses on the mechanism of Evf2-dependent interneuron loss and mechanisms involved in long ncRNA transcriptional control. In addition, the importance of GABA in orchestrating multiple developmental events and maintaining homeostasis in adult brain circuitry is leading us to test whether Evf2-mutants exhibit specific behavioral phenotypes.  Results support the idea that a single ncRNA controls a  complex behavior.
1039527	My research interests are ecclectic and varied. 
1039528	Dyspnea / exercise physiology, Interstitial lung disease, Lung cancer
1039530	Pathogenesis of Legionella pneumophila, intracellular parasitism and protein secretion.
1039566	Leukemia (CLL), Lymphoma
1039668	Body imaging, Cross sectional imaging of the body, Genitourinary radiology, Ultrasound, Ultrasound evaluation in organ transplantation, Ultrasound evaluation in prostate imaging
1039670	General gastroenterology, acid-peptic disease, functional gastrointestinal disorders, Helicobacter pylori infection
1039670	Pharmacology of gastrointestinal disorders, Upper gastrointestinal tract disorders, functional gastrointestinal disorders, Helicobacter pylori infection, colorectal cancer screening and educaiton
1039677	General gastroenterology.
1039815	I am a consulting biostatistician, with focus on clinical trials, basic science and epidemiology.
1039923	Developmental nephrology, endothelial cells, mesangial cells, gene regulation
1040000	Improving both the short and long-term outcomes for critically ill and premature infants, tracking the neurodevelopmental outcomes in these patients throughout the developemental period, ensuring that the same level of quality is provided to each patient in both of the neonatal intensive care units at Children's Memorial Hospital and Prentice Women's Hospital from the moment of birth throughout their hospital course
1040160	We study the regulation of alveolar fluid clearance under hypoxia. In particular we study the signal transduction mechanisms that regulate the activity of the Na,K-ATPase in alveolar epithelial cells
1040637	Anatomic Pathology, Neuropathology, Neuromuscular pathology<BR><BR>The early growth response (Egr) family of transcription factors are involved in cellular growth and differentiation and may play a role as initiation and propagation factors in some cancers. A major focus of our research is to understand the role of Egr transcription factors during development of the mammalian nervous system. We and others have discovered that these transcription factors regulate a variety of developmental processes including hindbrain organization, peripheral nerve myelination, sympathetic nervous system development, male and female fertility, induction of late phase long term potentiation (a form of synaptic plasticity) and muscle mechanoreceptor development. In the nervous system, Egr transcription factors are downstream signaling mediators of neuronal activity and growth factor molecules known as neurotrophins. We are actively exploring their role in mediating a variety of neurotrophin actions that include neurite outgrowth, synaptic vesicle protein regulation and muscle stretch receptor development. As plasticity related transcription factors, Egr genes are important for mediating nervous system adaptation to a variety of developmental and environmental stimuli. Egr transcription factors are also essential for some non-nervous system related developmental processes. For example, they are involved in monocyte and thymocyte development, and they are involved in growth and differentiation of pheochromocytoma and neuroblastoma tumors. Using these model systems of differentiation, we are exploring the varied developmental pathways and target genes regulated by Egr transcription factors to elucidate their roles in cancer and developmental biology.
1040956	Cancer pain, chemotherapy-induced peripheral neuropathy, neuropathic pain syndromes and their prevention or management, analgesic agents for relief of pain, international efforts to relieve pain and improve end-of-life care
1040956	Dr. Paice's clinical work is in the management of cancer-related pain. Current research is in the study of chemotherapy-induced peripheral neuropathy associated with paclitaxel.
1041070	Epstein-Barr virus, viral genome replication, viral genome maintenance, latency, transformation
1041107	Clinical interests: include all of anesthesiology with a particular interest in securing airway management and anesthesia in the most difficult airway patients as well as providing anesthesia and monitoring for patients needing brain or spinal column surgery.  Primary research interests: involve improving education of airway management among anesthesiology trainees.  This has encompassed various facets, including the following:  development of an assessment tool for determination of baseline knowledge in trainees, production of checklists for different airway management techniques, construction of computer-based modules for teaching airway management, organization of simulation sessions in the specific area of endotracheal extubation, and a continuing study to improve American Society of Anesthesiologists attendees skill and self-confidence in adult flexible fiberoptic intubation.
1041128	Patient-reported outcomes and patient-provider communication in chronic illnesses, with a focus on underserved populations and health disparities.
1041130	Psychometrics, Informatics, Clinical Infometrics, Quality of Care, Patient Safety, Quality Improvement, Patient Satisfaction, Aging, Palliative and End-of-Life Care Research, Patient-Reported Outcomes (PRO), Health-Related Quality of Life (HRQOL), Caregiver Health, Clinical Decision Making, Health Literacy, Item Response Theory (IRT), Rasch Measurement Models, Item Banking and Computerized Adaptive Testing (CAT)
1041142	Research areas of interest include: public health genomics, ethical/legal/social issues in genetics/genomics, translational genomics, community-based participatory research interventions and education models, community consultation methods, client-derived outcome measures, and cross-cultural issues with underserved populations in health care. 
1041268	Medical Physics, Digital Imaging, Cancer Detection,Clinical Image Quality
1041308	Healthy lifestyles, Medical care of the obese patient, Preventive medicine
1041441	My research agenda lies in the area of Experimental and Clinical Neuroscience, and involves mainly the study of spinal neuronal mechanisms/circuits coupled with motor control and locomotion. The main driven force for my studies is to better understand the functional units of motor control in humans so to develop rehabilitation protocols that promote sensorimotor recovery in people with a spinal cord injury (SCI). I employ non-invasive electrophysiological techniques incorporating also engineering elements to fully describe the above concepts. Currently, my research studies are concentrated on examining the reorganization of spinal reflex circuits after intensive locomotor training in people with SCI. 
1041463	My research interests are to understand how cells in the body can contribute to the heart and lungs during our lives. This process starts during fetal development and is often inhibited by disease. So I am studying cells that make blood vessels in the fetus and how this is controlled by signaling pathways. Then I would like to figure out how to activate these fetal programs in adults with heart and lung disease.
1041493	Hematopathology <BR><BR>Cytogenetics, hematologic malignancies
1041494	Migration of subventricular zone cells.
1041544	We investigate the roles of reactive oxygen species (ROS) in the pathogenesis of pulmonary hypertension. ROS alter gene expression, enzyme activity and vascular cell growth, leading to impaired vasorelaxation and vascular remodeling. Our goals are to identify the sources of ROS and their downstream targets, thus identifying potential therapeutic targets for the treatment of pulmonary hypertension.
1041556	Pediatric Nephrology, Lupus Nephritis and Vasculitis, Nephrotic Syndrome, FSGS (Focal Segmental Glomerulosclerosis), Hypertension, Dialysis and Continuous Renal Replacement Therapy, Prenatal Counseling regarding congenital kidney conditions, Polycystic Kidney Disease
1041624	Our research closely links to the clinical problem of pressure induced soft tissue injury, commonly seen as the pressure sore in SCI individuals. To test our hypotheses that the mechanical properties are altered in wounded and denervated tissues, soft tissue samples (skin, fat, muscle) freshly collected from able-bodied, SCI individuals, and wounded tissues are being tested for compressive mechanical properties. Rat models of chronic SCI and pressure sore are being used to characterize the mechanical property change in vivo and ex vivo. A finite-element model for buttock-thigh has been developed specifically for the condition of sitting, is used as a tool to bridge the lab-acquired basic knowledge of the soft tissues and the clinical problems in reality. The effect of different sitting configuration on the buttock-thigh tissue loading, tissue perfusion, and skin temperature elevation are evaluated. We found that sitting greatly impeded tissue perfusion in buttock tissue and the pressure relief push-ups did not provide adequate recovery for tissue perfusion. Also, SCI individuals needed longer time for buttock tissue perfusion to recover after a long time sitting. We developed an Intelligent Automated Pressure Relief Seat  IAPRS which detects the seat-buttock contact and automatically relieves the buttock loading by lowering down the back part of the seat. IAPRS is being tested in clinical setting on SCI individuals and sitting related pressure sore. Preliminary results show that IAPRS promotes the pressure ulcer healing in sitting area, while maintaining the mobility for wheelchair users during the treatment of pressure ulcers. To test the feasibility of early detecting of pressure induced deep tissue injury under intact skin; an ultrasound tissue palpating probe (TUPS) has been adapted for in vivo testing of soft tissue gross stiffness on human subjects and on our animal models to differentiate injured from healthy tissue by detecting their stiffness difference
1041683	Ambulatory anesthesia, Regional anesthesia
1041733	I am primarily interested in the diagnosis and treatment of patients with inherited metabolic disorders and in clinical trials of new therapies for rare disorders. I have particular interest and expertise in disorders daignosed through newborn screening (phenylketonuria and others) and in lysosomal storage disorders.
1041762	Alveolar epithelial cell function, Gene transfer, epithelial beta-adrenergic receptors
1041909	Pediatric oculoplastic disease, ocular involvement in cGVHD, adult strabismus
1041920	hypoxia
1042081	My work focuses on cancer stem cells (CSCs) found in patients with primary brain tumors, in particular, Glioblastoma multiforme (GBM). Despite aggressive treatment including surgery, radiation and chemotherapy, the average survival of patients with GBM is just over one year.  I believe that tumor progression in driven by glioma stem cells that are intrinsically resistant to cell death secondary to radiation- and chemotherapy-induced DNA damage. In collaboration with Drs John Kessler and Sam Stupp, I am working on a self-assembling nanogel conjugated to a biologically active molecule that can diminish the stem-ness of these cells, and render them more susceptible to current treatments.
1042149	I am interested in the treatment of spinal column and cord disease, specifically traumatic, degenerative, and neoplastic processes. I am currently investigating the outcomes of people with post-traumatic syringomyelia. In addition, I am studying the effect of surgical treatment on basal energy expenditure in those with lumbar spondylolisthesis. I am a member of the Spine Oncology Study Group, an international multidisciplinary group dedicated to the furthering of our understanding reagrding the care of people with tumors of the spinal column. Lastly, I have a number of studies at present regarding both undergraduate and gradute medical education.
1042263	Crohn's disease, IBD - Inflammatory Bowel Disease, Ulcerative colitis
1042273	Dr Meiers research interests lie in the fields of functional evaluation of prosthetic components, the development of appropriate prosthetic/orthotic components and technology for economically disadvantaged countries, and the successful dissemination of such technology through the development of appropriate education materials (knowledge transfer). She is further interested in the development of alternative and intelligent materials and their application in the field of prosthetics and orthotics. Dr Meier also has an interest in motor control and the adaptations that occur during the rehabilitation process.
1042296	Dr. Andrew Evens is Assistant Professor of Medicine at the Feinberg School of Medicine, Northwestern University and member of the Robert H. Lurie Comprehensive Cancer Center. Following graduation with honors from Chicago College of Osteopathic Medicine, Dr. Evens completed an Internal Medicine residency at Lutheran General Hospital and he served an additional year as Chief Resident.  Dr. Evens subsequently completed his Hematology/Oncology fellowship at Northwestern University and is board certified in Hematology and Medical Oncology.  During fellowship, Dr. Evens also completed a Masters of Science in Clinical Investigation at Northwestern University.Dr. Evens' clinical and research interests are in lymphoma: non-Hodgkin lymphoma and Hodgkin disease, including stem cell transplantation (SCT).  Dr. Evens is also involved in a translational lymphoma laboratory to develop and study novel treatment agents for the treatment of lymphoma. His translational investigations have included research of free radical-mediated biology and the study of apoptotic pathways in hematologic malignancies.  Dr. Evens was awarded a 5-year NIH/NCI K23 grant towards the study of targeting the mitochondria for the treatment of lymphoma.  Dr. Evens is Principal Investigator for several investigator-initiated clinical trials including the combination of motexafin gadolinium with zevalin radioimmunotherapy for relapsed lymphoma, proteasome inhibitor/rituximab therapy for untreated indolent lymphoma, gemcitabine/bortezomib for T-cell lymphoma, chemoimmunotherapy for Burkitt's lymphoma, and a novel therapeutic regimen for the treatment of primary CNS lymphoma.  He has also published data regarding the prognosis and treatment of mantle-cell lymphoma and treatment of newly diagnosed and relapsed/refractory Hodgkin disease.Dr. Evens is a member of the Core lymphoma committee of the Eastern Cooperative Oncology Group (ECOG) and he is Principal Investigator for national ECOG clinical trials. Dr. Evens is involved in collaborations with investigators at Northwestern and throughout the region regarding post-transplant related lymphoma, drug safety, and epidemiologic lymphoma research.  He also co-chairs an annual Chicago Lymphoma Symposium along with the University of Chicago.Dr. Evens was recipient of the 2002 ECOG Translational Research Award and received the Compassionate Care award from the Women's Board of Northwestern Memorial Hospital in 2005.  Dr. Evens is also highly interested in mentoring residents and fellows at Northwestern University for translational and clinical research. 
1042296	Dr. Evens' clinical and research interests are in lymphoma: non-Hodgkin lymphoma and Hodgkin disease, including stem cell transplantation (SCT). Dr. Evens is also involved in a translational lymphoma laboratory to develop and study novel treatment agents for the treatment of lymphoma. His translational investigations have included research of free radical-mediated biology and the study of apoptotic pathways in hematologic malignancies. Dr. Evens is Principal Investigator for a multitude of investigator-initiated and industry-sponsored clinical trials studying new exciting treatments agents for lymphoma. Dr. Evens is a member of the Core lymphoma committee of the Eastern Cooperative Oncology Group (ECOG) and he is Principal Investigator for several national ECOG clinical trials. He is also involved in collaborations with investigators at Northwestern and throughout the world regarding post-transplant related lymphoma, drug safety, and epidemiologic lymphoma research.
1042297	Dr Kaklamani has been working on the role of TGF-&#946; and its polymorphisms in breast and colon cancer risk. She is currently conduction two clinical trials enrolling patients with a person and/or family history of breast and colon cancer. The objectives of these trials are to identify genetic markers which will lead to earlier detection and prevention of breast and colon cancer. Dr Kaklamani is also conduction clinical trials with a focus of treatment of breast cancer. More specifically she is the principal investigator of a trial evaluating an investigational agent, RSR-13, in patients receiving brain radiation for breast cancer. 
1042297	Dr Kaklamani's research interest is novel genes related to breast, colon and prostate cancer
1042299	General GastroenterologyColon cancer screeningBiliary disease--ERCPViral hepatitis B and C
1042299	My interests include colon cancer sceening, GERD, inflammatory bowel disease, viral hepatitis, autoimmune liver disease, hemochromotosis, complications of cirrhosis including and liver cancer.
1042402	Child health within the context of the family, with particular emphasis on the role of fathers and special attention to the ability of techonology to support parenting.
1042418	Preventive medicine, Primary care internal medicine
1042558	Obstetric Anesthesiology
1042563	Dr. Kyriacou is Professor of Emergency Medicine and Preventive Medicine at the Northwestern University Feinberg School of Medicine.  His medical degree is from the University of Michigan and his residency training was in emergency medicine at the Los Angeles County + University of Southern California Medical Center.  He also has a Master of Public Health degree from the University of Michigan and a Doctor of Philosophy degree in epidemiology from the UCLA School of Public Health where his dissertation project was on risk factors for injury from domestic violence.  In addition, Dr. Kyriacou has a Diploma in Tropical Medicine and Hygiene from the London School of Hygiene and Tropical Medicine.  Dr. Kyriacous research interests also include injury prevention, clinical infectious diseases, and health services.  Dr. Kyriacou has mentored numerous medical students, residents, and junior faculty on clinical and epidemiological research methods, resulting in several publications and the awarding of numerous masters degrees.  Dr. Kyriacous research endeavors have been recognized with awards from the Emergency Medicine Foundation and the University of California/California Wellness Foundation.  Dr. Kyriacou has also international experience, having worked in Ghana and Ethiopia.  He was recently appointed to the Fulbright Specialist Roster.
1042630	My clinical and research areas of interest include RETINOBLASTOMA, LYMPHOMAS(both Non-Hodgkin and Hodgkin subtypes) and post-transplantation lymphomas, and the HISTIOCYTOSES.  Our retinoblastoma team includes oncologists, ophthalmologists, a social worker, a genetics counselor, clinical research specialists, as well as researchers in the laboratory.  We are currently working on novel approaches to treating retinoblastoma, the most common intraocular tumor of childhood.
1042631	Radiofrequency Ablation - Tumors, Sympathectomy/ Hyperhidrosis, Thoracic Oncology, Bronchoscopy, Brachytherapy, Robotic Thoracic Surgery, Lobectomy, Esophagectomy, Airway/Esophageal Stenting, Medistinal Tumors, Gastroesophageal Reflux Disease (GERD), Esophageal Cancer, Esophageal Disorders, Minimally Invasive Surgery, Mesothelioma, Lung Cancer, Chest Wall/Mediastinal Tumors, Tracheal Surgery, Video-Assisted Thoracoscopic Surgery
1042734	Advanced minimally invasive surgery in infants and children, neonatal surgery, tumorsand developmental anomalies, surgery for hernias and undescended testes, thyroid disease,chest wall deformities, anorectal malformation, hirschsprung's disease, ovarian and breast diseases, surgical ultrasound, and healthcare quality and patient safety.
1042758	Hematopathology <BR><BR>Diagnostic and prognostic markers for lymphoma and leukemia.
1042765	Dr. Koski has a strong interest in adult spinal deformity, spine tumors, and complex revision surgeries. He is actively involved in research focused on patient outcomes, spinal sagittal alignment, and quality of life in adults with spine deoformity.
1042768	My research focuses on the migratory/invasive behavior of brain tumor cells that results in increased resistance of these cells to chemotherapy and radiation therapy.  I am addressing this question through molecular biology and genetic techniques with the aim of finding ways to reverse resistance to these therapies and thus improving patient outcomes.  My clinical interest is synergistic with that of my research, in the surgical care of patients diagnosed with brain tumors.
1042791	Primary interests include ambulatory regional anesthesia and obstetric anesthesia.
1042806	My primary research interest surrounds the physiologic and pathophysiologic regulation of the fetoplacental vasculature and its contribution to short- and long-term pregnancy outcome.
1042840	My clinical and research career has focused on diseases of the pancreas. In recent years, I have focused on medical education, and led a multi-organizational program to develop a national curriculum for general surgery training in the U.S. For the past year, I have worked with the Patient Safety Education Program, centered in the Buehler Center on Aging, Health, and Society at Northwestern.
1042973	My research interests include rehabilitation outcomes and health policy research. In particular, I have expertise in the design, development, selection, and enhancement of rehabilitation outcomes measures using contemporary psychometric approaches. My research compares access and outcomes of across post-acute care rehabilitation settings. My health policy research involves examining the impact of Medicare post-acute care policy on service utilization, costs, and patient outcomes.  I have been a licensed occupational therapist for over 20 years working in the areas of both older adults and pediatrics. My particular clinical interest is behavior change and human motivation.  I am certified as a trainer in Motivational Interviewing. I am a charter member of the AOTA Research Advisory Panel and serves as an AOTA representative to the Preventive Care and Screening workgroup of the American Medical Associations (AMA) Physician Consortium on Performance Improvement (PCPI) which is responsible for developing quality indicators in health promotion and prevention.
1042976	Pancreatic ductal adenocarcinoma is currently the fourth leading cause of cancer-related death in the US, with a median survival time after diagnosis of less than 6 months and a 5-year disease-free survival of less than 5%. Pancreatic cancer is commonly associated with pronounced collagen-rich fibrotic reaction. We have found that there is significant cross-talk between type I collagen and the key proteinase membrane type 1-matrix metalloproteinase (MT1-MMP, MMP-14) in regulating pancreatic cancer invasion. MT1-MMP is overexpressed in human pancreatic tumors particularly in areas of pronounced fibrosis. To better understand the role of MT1-MMP in vivo, we have created transgenic mice that can be targeted to express MT1-MMP in the pancreas, and have crossed these mice with mice expressing mutant KrasG12D. Excitingly, co-expression of human MMP-14 and K-rasG12D in the pancreas results in large, cystic, papillary lesions consistent with human intraductal papillary mucinous neoplasms. Surprisingly, these lesions have very pronounced fibrotic reaction and are associated with increased TGF- signaling and activation of stellate cells. We have also been examining whether the interplay between collagen and MT1-MMP is involved in resistance of pancreatic cancer cells to gemcitabine chemotherapy. Recent reports have suggested that the fibrotic reaction limits the delivery and effectiveness of current therapies in pancreatic cancer. Consequently, my research group has been examining the extent to which type I collagen contributes to gemcitabine resistance. We have found that cells grown in 3D type I collagen are less likely to respond to gemcitabine compared to cells grown atop 3D collagen or on tissue culture plastic. Significantly, we have found that the effect is mediated in part via MT1-MMP. We are currently in the process of characterizing the detailed signaling pathways downstream of MT1-MMP that are involved in chemotherapy resistance in the 3D microenvironment.
1042976	The major focus of my lab is to understand the mechanisms utilized by invading and metastasizing tumor cells to promote expression and activity of extracellular matrix-degrading matrix metalloproteinases (MMPs). The lab currently has two projects. In our oral cancer project, we are interested in understanding how TGF-b1 signaling through Snail family of transcription factors increases MMPs and promotes invasion of oral cancer cells in 2D and 3D organotypic models of oral cancer. We have also established an orthotopic model for oral cancer wherein OSCC cells expressing GFP-tagged Snail or Slug are injected directly into the tongue to examine the role of these key proteins in promoting tumor growth and invasion in the in vivo microenvironment.  In addition to our work in oral cancer, we have also been examining the contribution of fibrosis to pancreatic cancer progression. Fibrosis, also known as desmoplastic reaction, is a very prominent feature of almost all human pancreatic tumors, and earlier reports suggested that this desmoplasia in fact contributed to pancreatic cancer progression. We recently published that the pancreatic cancer cells adjacent to areas of fibrosis exhibit increased expression of membrane type 1-MMP (MT1-MMP). We are particularly interested in understanding how the desmoplastic reaction increases the expression of MT1-MMP in the cancer cells, thus enabling the pancreatic cancer cells to invade through a collagen-rich extracellular matrix. In addition to utilizing in vitro models to examine the cross-talk between type I collagen and MT1-MMP, we have also established a transgenic mouse model in which MT1-MMP is selectively and under regulated conditions expressed in the pancreas to examine the effect of MT1-MMP on tumor growth and on the generation of desmoplastic reaction.
1043077	We are interested in understanding how the lung responds to injury and the process of normal healing, in order to develop novel therapies for treating patients with pulmonary fibrosis and similar types of lung disease.
1043078	Geriatric Medicine, Geriatric Education, Discharge Processes/ Transitional Care, Paid Caregivers of Seniors, Patient Safety, Medical Education
1043078	Lee Lindquist, MD, MPH is an Assistant Professor of Medicine at Northwestern University Feinberg School of Medicine.  She is a member of the Division of Geriatrics and her clinical practice primarily revolves around care of those aged 65 yrs and older.  Dr. Lindquist is a graduate of Northwestern University Feinberg School of Medicine and completed her internal medicine residency and her fellowship training in geriatrics at Northwestern University. She is board certified in internal medicine and geriatrics.  She also completed her Masters in Public Health during her participation in the NRSA fellowship program.Her research has focused on issues of transitional care among the elderly, particularly in improving the safety between the hospital discharge to outpatient care settings. She has also performed work on assisted living and alternatives to assisted living for the elderly as well as improving geriatric education for medical students. 
1043177	Surgical Pathology <BR><BR>
1043288	Breast imaging
1043300	Clinical cancer/cancer health disparities research with focus on improving patient safety for older individuals with cancer. I am primarily engaged in active pharmacovigilance, including the detection and assessment of safety signals related to drugs and devices and the timely dissemination of findings to relevant stakeholders. A related research focus is comparative and cost effectiveness analyses of cancer related therapies targeted at older cancer patients and safe and cost-effective transitions of care for this cohort. I am also engaged in a collaborative NCI sponsored minority biobanking/biospecimen collection initiative with colleagues at several comprehensive cancer centers across the country. Future studies in pharmacogenomics are expected to aid in prescribing decisions and will likely predict older cancer patients who will respond appropriately to a given cancer-related medication or experience severe adverse drug reactions.
1043300	Serious adverse drug reactions in elderly cancer patients in the oncology setting are not being regularly identified, evaluated and reported. When adverse events are reported for older cancer patients, the reports are often incomplete and hence causality assignment is delayed, leading to increased morbidity and mortality.A  clinically-based, hypothesis-driven approach to pharmacovigilance will improve the completeness of reporting and the assignment of causality, resulting in improved health outcomes for older cancer patients.In summary, I aim to 1) Identify, evaluate, and report on serious adverse reactions to drugs used in cancer patients age 65 and older;  2) Assess the completeness of adverse event reports for patients 65 years and older and  3) Assess both causality assignment and the timeliness of causality assignment in  patients <65 years with those >65 years
1043341	The Li laboratory is interested in dissection of molecular mechanisms that regulate cellular stress response and cell death signaling.  We have recently identified Cdk5 activator binding protein C53 as a novel regulator of cell cycle and DNA damage response.  We are currently investigating how C53 regulates normal cell cycle progression and DNA damage response. 
1043419	Dr. Green's research employs murine models of cholestatic liver disease and fatty liver disorders in order to determine the pathogenesis of liver injury, and  thus devise rational therapies for these common liver diseases.  In addition, he participates in clinical trials on the treatment of hepatic disorders with other members in the Division of Hepatology. 
1043419	Hepatology (liver)
1043443	Perinatal brain injury including hypoxic-ischemic encephalopathy and neonatal stroke
1043458	Body imaging, Ultrasound (US)
1043560	Ethics, professionalism and communication in the healthcare setting.Achieving measurable efficacy, safety, efficiency and satisfaction in a complex healthcare delivery system.
1043570	1.  The role of EEG in the evaluation of children with febrile status epilepticus.  2.  The classification and characterization of infantile epilepsies.3.  The correlation between EEG findings and cognition.4.  Epilepsy surgery in children.
1043582	Master of Science: Healthcare Quality and Patient Safety 2011
1043621	Neuroradiology
1043672	Neuroanesthesia
1043708	Menopause, Minimally invasive surgery, Perimenopause management, Vaginal pain, Vaginal plastic repairs
1043952	General pediatric endocrinology and diabetes patients with a specific interest in disorders of sexual development and puberty.
1044194	Thyroid disease, Fine needle aspiration thyroid nodules, pituitary disease
1044200	Our laboratory investigates stem cell biology and approaches to regeneration of the damaged or diseased nervous system.   I have had two R01 grants for more than 25 years that are focused on the biology of stem cells and growth factors, and on potential clinical applications.   I direct the Northwestern University Stem Cell Institute and have established a hESC and iPS cell core laboratory for the University. I am also the Chairman of the Neurology Department at Northwestern University and an active clinician.  Our research has focused extensively on the regulation of gene expression by neural stem/progenitor cells and their differentiated progeny. We have defined signaling pathways that direct glial and neuronal lineage commitment and characterized patterns of gene expression that coordinate these processes in both the developing and adult nervous system.I am also running clinical gene therapy trials in neuropathy.
1044214	My focus and expertise as a clinical psychologist is in the practice of cognitive-behavioral therapy (as clinician, instructor, and supervisor). Within that paradigm, my research and clinical interests are in the treatment of anxiety and mood disorders, particularly obsessive-compulsive disorder.  Also, I am interested in the use of technology for self-help and the treatment of mental health problems.
1044272	Susan Yount, Ph.D., is a licensed clinical health psychologist and associate professor in the Department of Medical Social Sciences (MSS), Northwestern University Feinberg School of Medicine. Her research interests include the development and application of measures of quality of life, symptoms, and health status in chronic illness; and adjustment to and coping with chronic illness. Her clinical research interests include chronic pulmonary diseases, oncology and organ transplant as well as a range of other chronic illnesses.
1044275	Hematopathology<BR><BR>Lymphoproliferative disorders
1044490	I am a surgeon; my main professional goal is to provide surgical treatment for women with breast cancer, those at high risk for it, and those with benign breast problems. To deliver the best surgical care, I strive to help women with breast cancer and those with benign breast conditions understand their disease so that they will make informed treatment decisions that give them the best chance of cure with the best quality of life.  In addition to treatment of breast diseases, I have a major clinical and research interest in understanding breast cancer risk and finding safe ways of preventing breast cancer so that I can accurately identify high risk women and help them make the decisions that will leave them with the lowest risk of breast cancer with the best quality of life.
1044494	Dr. Lin has special interest in the mangement of prostate, kidney, and bladder cancers with an emphasis on robotic surgery.
1044533	Emergency Ultrasound &Resident Education
1044534	Medical disorders of the breast, Primary care internal medicine, Women's health care
1044537	Advanced Laparoscopic Procedures, Gallstones, Hernia, Obesity Surgery, Pancreas
1044550	Human brain imaging of chronic pain conditions. Animal studies of crtical dynamics of pain.
1044559	clinical trial design, vaccines, epidemiological methods
1044682	Regional Anesthesia
1044711	Adrenal tumors, Female hernias, Galbladder disease, Gallstones, Incisional hernias, Laparoscopy, Minimally invasive endocrine surgery, Parathyroid Disease, Thyroid tumors, Ventral hernias
1044739	Hematopathology, leukemia, nucleoporins, NUP98
1044955	Calcium Disorders, Hyperparathyroidism, Metabolic Bone Diseases, Osteoporosis
1044980	Cancer genetics, Colon cancer
1045018	Genitourinary Imaging, Gynecologic Imaging, Gastrointestinal Imaging, Pelvic MRI, Body MRI, Hepatobiliary MRI, Computed Tomography
1045019	Cancer early detection, Colposcopy, Ovarian cancer
1045030	Articular cartilage repair, General orthopaedics, Shoulder problems / injuries, Sports medicine
1045124	My clinical interests are in pediatric neurocritical care including stroke, traumatic brain injury, refractory status epilepticus and the neurologic complications of critical illness. The activity of my research group is focused on the glial responses to traumatic brain injury and the role of activated glia in the mechanisms of epileptogenesis and blood brain barrier dysregulation following acute brain injury. Our clincal research is focused on the application of bioinformatics to pediatric critical care with the goal of developing fully integrated  real-time physiologic and laboratory data collection and analysis in the pediatric intensive care unit.
1045145	Atrial fibrillation, Biventricular pacing, Cardiac arrhythmias, Catheter ablation, Implantable defibrillators
1045159	Early detection, biomarkers, epigenetics, drug resistance, DNA methylation
1045163	Head & neck cancer, Lung cancer
1045197	Movement disorders including chorea, Dystonia, Essential tremor, Multiple systems atrophy (MSA), Myoclonus, Parkinson's disease, Progressive supranuclear palsy (PSP), Tics. Interest is focused on clinica management, clinical pharmacology, clinical trials desifn, experimental pharmacology
1045213	Mechanisms of action of the naturally occurring inhibitors of angiogenesis;endocrine therapy for breast cancer
1045293	Current research is focused on Interventional Spine Care.  Clinical interests include diagnosis and treatment of spine disorders, including cervical and lumbar degenerative disc disease, radicular pain/sciatica, facet joint mediated pain, and other causes.  Treatment is focused on rehabilitation, including physical therapy and occupational therapy. Complementary treatments offered include acupuncture and chiropractic.  All treatments are offered on site at the Rehabilitation Institute of Chicago.  Interventional spine procedures include cervical and lumbar epidural steroid injections/selective nerve root blocks, facet injections and radiofrequency neurotomy(rhizotomy), facet cyst aspiration/rupture, sacroiliac joint injections, discography, percutaneous disc decompression, and sympathetic blocks
1045433	Outcome based researches on educational interventions to create better physicians of the future.
1045466	Our laboratory investigates the role of the nuclear factor Ikaros in T cell development and leukemogenesis. Ikaros is a nuclear factor that is a component of two chromatin remodeling complexes associated with gene activation as well as gene repression.  Genetically engineered Ikaros null mice develop T cell leukemia with 100% penetrance suggesting that Ikaros is a tumor suppressor.  In addition, lack of Ikaros results in multiple defects in T cell development that include a decrease in the number of T cells, an increased potential to differentiate into the CD4 lineage and a complete lack of fetal T cell development. In addition, they are unable to undergo negative selection, a checkpoint that is required to prevent the inappropriate maturation of autoreactive T cells.  In order to determine mechanisms for Ikaros role in T cell biology, we are studying the role of Ikaros in regulating Notch and TCR signaling pathways, as well as in regulating early developmental decisions from the level of early lymphoid progenitors.  We are also interested in investigating the role of Ikaros in regulation of T helper fate decisions during an immune response. 
1045574	I am interested in how early events and environments shape later outcomes of preterm births.  For example, babies who were small at birth seem to be at high risk for complications such as high blood pressure, diabetes and obesity in adulthood.  Why?  There are many theories, but a biological explanation is still missing.  I study prenatal environments such as maternal health, biological markers such as cord blood and placenta, and early neonatal experiences for clues as to and how they relate to later outcomes, especially obesity.  At present, I focus on outcomes during the neonatal period, but eventually I would like to follow growth and health of these babies into adulthood.
1046251	Major focus of my research program is a translational approach to study of valvular heart disease basic and clinical research.
1046467	Diseases of ear, Ear surgery, Otology
1046492	Ablations, Arrhythmias, Defibrillators, EP studies, Pacemakers, Syncope
1046519	Gene delivery, nuclear transport, intracellular trafficking of DNA, gene therapy
1046717	Dr. Trainor is a board certified in Pediatrics and Pediatric Emergency Medicine.  She is director of the M4 Pediatric Sub-internship for the Feinberg School of Medicine, and is in charge of the M4 electives in Pediatric medicine at Children's Memorial Hospital.  In addition, she is the Associate Fellowship Director in Pediatric Emergency Medicine.  Her primary research interests involve medical education and the use of simulation to teach medical students, residents, and fellows clinical pediatrics and pediatric emergency medicine.
1046718	My primary interest is family therapy and family-based treatments for a variety of disorders.
1046736	Application of Hematopoietic Stem Cell Transplantation to treat pediatric diseases--cancers, hematologic and immunologic diseases. Expand the indications for Stem Cell transplantation as cellular therapy for other diseases/organ dysfunction.
1046741	Rheumatoid Arthritis, Psoriatic Arhritis (combined program with Dermatology), Spondyloarthopathies
1046744	My research examines the effects of prostheses and orthoses on human locomotion in order to increase understanding, establish efficacy, and improve effectiveness of prosthetic and orthotic interventions for people with disability.
1046905	My research focuses on the role of secreted protein toxins on bacterial pathogenesis.  The toxins we study are  members of the MARTX family and are produced by Vibrio cholerae, a pathogen important for the diarrheal disease cholera, and Vibrio vulnificus, a pathogen that causes septicemia and necrotizing fasciitis from seafood consumption.  Our group studies both the role of these toxins in evasion of the innate immune response using mouse models and the mechanism of action of these toxins using a combination of cell biology, biochemistry, and structural biology.
1047087	Resident education, Student education
1047088	Neuroradiology
1047091	Hepatology
1047131	MaryBeth Lake, MD, a former chief resident at Western Psychiatric Institute and Clinic (WPIC) at the University of Pittsburgh, is associate professor and the director of education in the Division of Child and Adolescent Psychiatry, which is housed at Childrens Memorial Hospital. Prior to joining Northwestern and Children's Memorial in 2000, Dr. Lake worked briefly in the private sector providing inpatient, outpatient and partial hospitalization program services. She is a member of several regional and national professional organizations and was previously a member of the American Academy of Child and Adolescent Psychiatry (AACAP) Committee for Liaison with Primary Care. Dr. Lake is a co-author of the Concise Guide to Child and Adolescent Psychiatry, as well as other publications. In addition to her focus on graduate medical education, Dr. Lake has a special interest in family therapy and cognitive behavioral therapy. 
1047160	For several years, I have been interested in the professional development of physical therapists working in different roles. This led to an interest in physical therapists' development of cultural competence and provision of patient-centered care. Currently, my work is examining physical therapists' knowledge, attitudes, and practices regarding patients' health literacy.
1047214	Laboratory investigations of the molecular basis of disease progression in myeloid malignancies.
1047214	Leukemia, Lymphoma, Myeloma
1047272	General gastroenterology
1047289	Coronary disease, Lipid management, Prevention of heart disease, Preventive cardiology
1047291	Cellular immunology, macrophage-virus interactions, apoptosis induction
1047292	Dr. Weiss is Director of the medical school's Institute for Healthcare Studies.  The Institute conducts research and education in the area of health care quality, patient safety, healthcare equity, and policy.  Dr. Weiss' research includes more than 100 publications in the area with a focus no chronic respiratory disease and clinical guidlines.  Dr. Weiss is involved in the development of national healthcare policy related to measurement of physician quality of care.
1047321	Primary Research Interests Focus Upon Pediatric Kidney Disease Specific to:(1) Methylated arginine derivatives and kidney disease progression;(2) Methylated arginine derivatives and cardiovascular remodeling;  (3) Proteomic markers for prediction of kidney disease progression;(4) Use of ambulatory blood pressure monitoring (ABPM) for undiagnosed hypertension and progressive loss of nocturnal BP dip;(5) Hemodynamic and rheologic responses during hemodialysis, including use of conventional and non-conventional markers in evaluation of hypervolemic states in end stage kidney disease.
1047445	We are interested in the universal patterns of organization of complex systems in nature.  Previous work includes the  mathematical modeling of cardiac arrhythmias, the study of molecular motors and ion channels as  stochastic ratchets, cooperative role of nonlinearities and noise in neural coding, self-organization and collective phenomena in ants swarms, brains and communities of natural and artificial agents.
1047485	Headaches, Primary care internal medicine
1047485	Health care policyHealth care operational and financial administration
1047547	Pediatric liver disease
1047657	I am a pediatric neuropsychologist and conduct clinical neuropsychological evaluations on school age children and adolescents.  My clinical interests include brain tumor and other cancers, brain injury, solid organ transplant, lupus, encephalitis, epilepsy, sickle cell, stroke, genetic disorders, as well as learning disability and attention deficit hyperactivity disorder (ADHD).  My research is primarily on neurocognitive outcomes in patients with liver disease and liver transplant.
1047664	Dr. Cartland is the Director of Child Health Data Lab at Children's Memorial Research Center, where her time is split between epidemiological and evaluation research. Dr. Cartland is a public policy analyst with twenty years of experience working on child and adolescent health and welfare issues. Her areas of expertise include health care financing, community-based interventions, and child and adolescent injury. Much of her current work involves expanding the capacity of the State of Illinois to conduct public health surveillance for children and adolescents.  ------    Monthly CHDL Data Briefs can be found at http://www.childrensmrc.org/chdl/Publications/.
1047667	Characterization by x-ray computed tomography (microtomography), x-ray phase contrast imaging, x-ray microbeam diffraction, synchrotron x-radiation of mineralized tissue in mammals and echinoderms.
1047682	Myeloma, Transplantation
1047683	Myeloma, Transplantation
1047866	Obstetric anesthesiology
1047935	Cytotoxic killing mechanisms, Apoptosis, Tumor Immunology, Neuroimmunoendocrinology.
1047949	RNA interference - Molecular biology and Therapeutics
1047986	Pregnancy outcomes, infectious disease in pregnancy
1047987	Pathogenesis of preterm labor, infection in pregnancy, prenatal genetic diagnosis
1048034	My lab studies the structure and function of ion channels, a family of membrane proteins that play many key roles in neuroscience and which are a major target of essential drugs used in clinical medicine. About a third of all genes in a typical genome code for membrane proteins, yet we know very little about their structure and function. Because ion movement across membranes can be measured with exquisite sensitivity, ion channels have always been at the vanguard of functional studies of membrane proteins, and as a consequence we have learned a great deal about how they function. Until recently, however, ion channels, like so many other membrane proteins, had proven very difficult to study at the structural level. The recent high-resolution description of several ion channels has opened up the field of structure-function in ion channels, and we are now in a position to ask detailed questions about how function is achieved through structure in this essential class of proteins.How do voltage-dependent ion channels sense the membrane potential? Through what structural rearrangements do these channels achieve voltage-dependent ion flow across the membrane? How can highly dynamic proteins maintain such outstanding control of what sorts of ions are allowed to pass? These are some of the questions that we attempt to answer.
1048036	Our research focuses on molecular and cellular mechanisms of Alzheimer's disease. In particular, we investigate the beta-secretase enzyme BACE1, which initiates the production of the beta-amyloid peptide that plays a central early role in the pathogenesis of Alzheimer's. We use a combination of biochemical, cell culture and animal model approaches to investigate the role of BACE1 in health and disease.  
1048050	Sleep disorders, epilepsy, narcolepsy, sleep apnea, restless legs, clinical pharmacology
1048055	Arterial dissections, Carotid artery disease, Cerebral hemorrhage, Familial strokes, Inherited strokes, Mini-strokes, Stroke, Subarachnoid hemorrhage, Vascular dementia
1048162	Contraception and Family Planning
1048277	Female bladder problems, Female pelvic floor disorders and pain, Female pelvic surgery, Gynecologic surgery, Recurrent bladder infections, Urinary incontinence, Urogynecology, Vaginal prolapse, Minimally invasive surgery
1048362	Magnetic resonance imaging, kidney, renal medulla, blood flow, oxygenation, acute renal failure, hypertension, endothelial dysfunction
1048363	Magnetic Resonance Imaging
1048496	Interventional Cardiology, angioplasty, stents, treatment of acute myocardial infarction, angiogenesis, valvular heart disease
1048574	The laboratory is interested in determining the role of intermediate filament proteins (IF) in prostate cancer. There are two main goals. First, can the development and progression of prostate cancer and patient outcome be determined be determined by the IF expression profile. This hypothesis is based on the observations that expression patterns of IF change when cells differentiate. Second, does the organization of nuclear lamins in prostate cancer cells affect DNA replication and transcription. We have previously determined that lamins directly bind proliferating cell nuclear antigen and expression of dominant negative mutant lamins affects DNA replication. Furthermore, we have shown that lamin expression affects RNA Pol II transcription. Nuclear microdomains can also influence the transcription potential of chromosomes in the region.
1048590	PCOS (poly cystic ovary syndrome)
1048590	Phenotyp-genotype studies in PCOS, mapping PCOS susceptibility genes, Specialized Center of Research (SCOR) on sex and gender factors affecting women's health, fetal origins of PCOS
1048758	Sepsis, macrophage, endotoxin tolerance, lipopolysaccharide, cell biology, signal transduction, MODS, surgical infections, critical illness 
1048762	Cells contact and communicate with their neighbors via specialized cell surface receptors.  This intimate exchange of information controls morphogenetic events during embryonic development and maintains tissue organization in adults.  Birth defects and cancer commonly result when cells fail to recognize and respond appropriately to their environment.  The work in my laboratory is guided by the hypothesis that epithelial cells receive and interpret contextual information through the coordination of adhesion and signaling receptor systems present on the cell surface.  To test this idea, we manipulate the ability of epithelial cells to interact with one another and measure their capacity to transduce intracellular signals that regulate cell fate and behavior.  In parallel, we assess the potential of cell surface signaling receptors to alter the manner in which epithelial cells adhere to their partners.  A three-dimensional in vitro model of the human epidermis is used to help define these adhesion-signaling networks during epithelial tissue morphogenesis. 
1048927	Comprehensive Ophthalmology, Meidcal Ethics
1049188	Advanced laparoscopic surgery, In vitro fertilization, Infertility, Polycystic ovary syndrome
1049211	Primary interests are looking at the use of mindfulness meditation within an intensive chronic pain management program.
1049219	n/a
1049330	Gastrointestinal Cancer Surgery, Melanoma / Sarcoma, Pancreatic / Liver cancer surgery, Surgical Oncology
1049332	Primary interests include:  pediatric radiology, cross sectional imaging, education, digital teaching files and website design and management
1049389	Pain medicine
1049440	Interventional spine procedures, Spine Pain Management, Neuroradiology, CT Angiography, CT/MR Perfusion, MR Spectroscopy, 3D Imaging
1049457	Facial plastic, Facial reconstruction, Facial surgery
1049458	Patient safety, Health Services, Operations, Quality
1049461	Anal incontinence, Benign anorectal disorders, Colon and rectal cancer, Colon and rectal surgery, Hereditary colon cancer syndromes, Ileal pouch surgery, Inflammatory bowel disease, Laparoscopy
1049467	Retina, synaptic transmission, glutamate, vision
1049549	Pancreatic cancer, cancer biology, growth factors, novel therapeutics, cachexia, eicosanoid metabolism
1049606	Dr. Kumar is interested in asthma health disparities. He is particularly interested in the effects of ther interaction of genetic factors and early life exposures on the development of asthma and allergies.
1049626	Difficult Airway Predication, Obstetric Anesthesia, Intravascular Volume Monitoring and Management
1049668	My overall research and clinical goals have been focused on the development of NICU graduates, particularly during the first three years of life.  The overarching theme of my research has been to improve understanding about how high risk conditions affect brain development and function in newborn infants.  Since brain development is also affected by nutrition and the environment, I have been particularly interested in those topics and the relationship between infant brain development and tests of development, including event-related potentials (a neurophysiologic technique), conventional infant testing, and now computerized evaluation of infant movement patterns.
1049685	sickle cell pain management, hypertension screening in the emergency department, pain management, triage systems
1049703	Dr. Yan is a cardiovascular epidemiologist with a background in demography and health economics. Her main research interests are prevention and control of cardiovascular diseases (including diabetes).  She has been involved in investigating associations of major modifiable risk factors and psychosocial factors with long-term coronary and cardiovascular morbidity and mortality. She is highly interested in and committed to translating best evidence into policy and practice globally, especially in China. She is currently the head of the Research and Development Division at the George Institute for International Health, China (www.george.org.cn) and the director of the NHLBI/UHG Center of Excellence for Chronic Disease Prevention and Control in China.
1049780	Mucosal immunology; Intestinal epithelial biology; Pathogenesis of intestinal injury; Probiotics and immunity.
1049781	My research interests lie in the area of neurodegenerative disease, particularly Alzheimer's disease and related disorders such as the frontotemporal lobar degenerations and motor neuron disease. My focus is on the role of genetics and morphologic abnormalities such as parenchymal vacuolation and ubiquitin, TDP-43, and tau positive inclusions in frontotemporal lobar degenerations and related disorders such as primary progressive aphasia, progressive supranuclear palsy, corticobasal degeneration, and motor neuron disease-associated dementia. In addition, I continue my role of Neuropathology Core leader in the NIH-supported Cognitive Neurology and Alzheimer Disease Center at Northwestern University Feinberg School of Medicine. Within the framework of the Core-related Laboratory for Cognitive and Molecular Morphometry, the Neuropathology Core is actively involved in assisting basic science researchers investigate the applicability of their findings to human tissue.
1049798	Electroencephalography, Epilepsy, Seizure disorders
1049802	Limb Reconstruction, Metastic Disease, Musculoskeletal Oncology, Soft Tissue Sarcoma
1049813	Adult and Pediatric Spine Disorders, Cervical and Degenerative, Minimally Invasive Procedures, Scolosis and Deformity
1049887	Functional outcomes in patients with amputation and cancer
1049949	I am interested most in the optimal acute diagnosis and therapy of venous thromboembolic disease.
1049950	Cardiac Transplantation, Heart Failure, Signal Transduction (research)
1050035	Auditory nociception, brain evolution and development, mechanosensory transduction, sensory organ development, function and degeneration.
1050041	Interventional Radiology including oncologic management and venous access.
1050056	Interventional Radiology
1050075	My primary clinical and research activities relate to the care of marginalized youth populations including HIV+ and LGBT young people. Our research is largely HIV prevention in nature, mostly targeting either young men who have sex with men or transgender individuals. A new area of research and clinical interest involves working with young gender variant children and families
1050146	Ms. Trivedi has a special research interest in how hereditary cancer may affect the social and reproductive options of young women at high risk for cancer.
1050169	My interests are in clinical outcomes following anesthesia and surgery.
1050189	Air pollution, ischemic cardiovascular events, acute lung injury, adipokines
1050264	Neuroanesthesiology, Pain Medicine
1050302	Our laboratory studies the neuroinvasive herpesviruses with a focus on the molecular mechanisms by which these pathogens propagate and disseminate within the nervous system. The outcome of infection is closely tied to the route the viruses spread within the nervous system, with outcomes typically relative benign but sometimes producing blindness and lethal encephalitis. We use a combination of live-cell fluorescence microscopy, molecular genetics and neuronal cell biology to examine the dynamics of viral particle assembly and intracellular axon transport. These molecular mechanisms are then examined in the larger context of neuroinvasion and pathogenesis. Two long-term goals of our research are to identify novel targets in the viral infectious cycle for development of antivirals, and engineering recombinant viral particles as effective gene delivery vehicles.(Keywords: neuron, axon, microtubule, cytoskeleton, dynein, kinesin, transport, virus, virion, herpesvirus, herpes, capsid, tegument, egress, nucleus, GFP, BAC, bacmid, recombination, GS1783)
1050367	Interested in the use of high-fidelity medical simulation to improve individual and team performance in acute emergencies, in particular, the amount and frequency of training needed.
1050433	Dr. Urbanek's research focuses on the identification of susceptibility genes for complex diseases.  Her approach to this research is to use family based gene-mapping techniques and population based association studies in conjunction with molecular techniques to identify and verify genes and pathways contributing to the pathogenesis of genetically complex diseases. Specifically she is carrying out studies to identify susceptibility genes for polycystic ovary syndrome (PCOS) that map to Chr19p3.13.  She has previously shown that this region shows linkage and association with PCOS in a large set of families.   Other projects focus on identifying candidate genes for gestational diabetes and  glycemic control during pregnancy,  and identifying genetic variation contributing to extreme obesity
1050433	Genetics of complex diseases, PCOS, Obesity, Metabolic syndrome, diabetes
1050501	HIV infection, Orthopedic-related Infections, Travel-related infections
1050564	My research focuses on molecular evolutionary mechanisms of HIV/SIV in host defense, antiretroviral drug resistance and genetic variation in HIV, HIV susceptibility to HIV infection and disease progression, and how host genetics and immunity affects HIV infection and dynamics. Researches include next generation sequencing of HIV and host genes and transcriptome to pursue a detailed genetic interrogation of the human extended Major Histocompatibility Complex (xMHC) and host genes involved in multiprotein virus-host interactions that regulate HIV infection.
1050565	Adolescent depression and suicide, Adult depression, Anxiety disorders, Obsessive Compulsive disorder, Panic disorders
1050642	My research interests center on better understanding the cellular and molecular building blocks that make up the basal ganglia macrocircuit as well as their implications on neural activity level, pattern and plasticity in the basal ganglia in health and disease. My long-term research goal is to elucidate cellular components involved in the pathophysiology and motor symptoms of Parkinson's disease and other related disorders. We hope to translate our insight into developing novel treatments for neurological disorders of the basal ganglia such as Parkinson's disease.
1050663	The mission of the Center for Global Initiatives is to create self-sustaining programs that improve access to healthcare in underserved communities throughout the world. 
1050725	Head and Neck Radiology
1050787	The principal focus of this laboratory is the examination of the spatial and temporal patterns of motor cortical activity preceding voluntary movement and the function of this activity in shaping and controlling movement initiation.  In particular we are interested in the function of the primary and supplementary motor areas and their interactions with the basal-ganglia in the feedforward and feedback control of movement.  We use a variety of non-invasive techniques to assess these systems in humans such as:  high-resolution EEG recordings and MRI-based source reconstruction techniques, transcranial magnetic stimulation, peripheral nerve stimulation, multi-channel EMG, and measures of movement kinematics and kinetics.  Experiments are currently being conducted to examine the role of the primary and supplementary motor areas and brainstem in the preparation and release of voluntary movements.Neurological diseases that affect the basal ganglia have a significant impact upon the function of the primary and supplementary motor areas.  For this reason, our research is also focused on the assessment of motor cortical function in neurological disorders such as Parkinsons disease and dystonia.  This work is conducted in collaboration with The Parkinsons Disease and Movement Disorders Center at Northwestern.  We are currently examining the control of repetitive movements in patients with Parkinsons disease and the effects of dopaminergic replacement therapy and deep brain stimulation of the subthalamic nucleus (a neurosurgical treatment for advanced Parkinsons disease) on the control of these movements.
1050821	I am interested in investigating the role of musculoskeletal biomechanics on the upper extremity movement deficits following stroke based on experimental methods and computer modeling.I am also interested in the design of robotic devices for therapeutic applications in stroke.
1050876	I am interested in designing new experimental methods to understand basic neuromechanisms underlying movement disorder following injuries to the nervous system; and in developing new rehabilitation methods based on the improved understandings of neuromechanisms. More specifically, I am interested in using multi-modality functional brain imaging and modeling based signal processing to further explore the neuromechanisms underlying movement disorder following injuries to the nervous system. By combining these understandings with advanced biomedical engineering techniques, such as neural machine interface, I hope to regain the functional control of the impaired hand in moderately to severely impaired stroke survivors.
1050919	Major Psychotic Disorders, Women's Mental Health
1050964	Pediatric Cardiology, Electrophysiology, Education, Syncope, arrhythmias, sudden cardiac death, ventricular fibrillation
1051094	I am interested in child and adolescent well-being as fostered by community conditions.  As a sociologist I work to understand environmental, cultural, institutional and social influences on child and adolescent well being in low resourced and minority communities.  I have experience and interest in community engaged scholarship.
1051123	skin inflammation research, melanoma immunotherapy research, skin neuroinflammation research, clinical treatment of general dermatology
1051160	Cardiovascular outcomes, Quality of Care, atrial fibrillation, ablation, defibrillators, anticoagulants, pacing
1051160	Cardiovascular outcomes, atrial fibrillation, implantable devices, quality of care, ablation, anticoagulants, antiarrhythmic drugs
1051248	Pediatric Pathology<BR><BR>Wilms tumors, germ cell tumors, genitourinary development
1051269	Brain functions are the result of the coordinated activity of large networks of neurons, which are composed by many different cell types. As a consequence, the specific properties of synaptic communication between different types of neurons play a pivotal role in shaping the computational power and network activity of specific brain regions. Research in my laboratory is focused on the hippocampus, which is an area of the brain involved in higher cognitive functions, such as learning and memory, and is often affected by important neurological illnesses like epilepsy, schizophrenia and Alzheimers disease. In particular, we are interested in the synaptic properties of GABAergic inhibitory interneurons, which are a very heterogeneous cellular population, with wide anatomical and functional diversity. Additionally we are trying to unravel the network properties of Cajal-Retzius cells, which are a neuronal population involved in guiding cortical development, whose computational functions remain poorly understood.Methodologically, we use state-of-the-art electrophysiological techniques in vitro such as paired recordings from anatomically identified connected neurons and optogenetic control of specific cellular populations.We hope that relating different neuronal types to clear network functions may lead to a better understanding of the cellular and molecular basis of hippocampal activity, and generate important insight into the organizing principles of cortical networks in the normal brain and during disease.
1051280	MRI, stroke, perfusion, angiography, 
1051283	My research is focused on two general areas: radiobiology and bionanotechnology. Work in radiobiology includes studies of the molecular biology of radiation responses, particularly radiation toxicities, radiation effects, dose-, dose-rate, and radiation quality issues and other general areas of radiobiology. In addition, my laboratory houses the tissues and data from mojority of  the radiobilogical experiments conducted in US between 1950-1990's (http://janus.northwestern.edu). In addition to sharing these data and materials with the radiobiological community, my group is investigating the archive as well; we are applying new statistical approaches on old datasets and new experimental approaches for investigation of formalin fixed and paraffin embedded materials. Work with micro-RNA microarrays, and use of X-ray fluorescence microscopy for histopathological analysis fall into this research.Work in bionanotechnology includes development and investigation of multifunctional nanoconstructs, increasing contrast for biomedical imaging (MRI and CT), enabling delivery of small molecules (such as chemotherapeutic drugs, flavonoids etc.) and producing cytotoxic reactive oxygen species to fortify effect of radiotherapy.
1051295	Why do some premature infants experience adverse outcomes, while others do not? Dr. Mestan is an attending neonatologist at Children's Memorial and Northwestern's Prentice Women's Hospital, whose research focuses on identifying biochemical, environmental, and genetic markers for preterm birth and its complications. Understanding these markers could allow clinicians to predict which babies are most at risk for preterm birth and its complications, such as chronic lung disease, poor growth, and developmental problems in children.
1051375	prevention / reduction of postoperative nausea/vomiting and pain, Sports medicine principles applied to musical performance and training
1051378	Research interest is focused on the evaluation of electronic systems and their abilities to support safe and efficient clinical care and in the design of new electronic systems.
1051378	The impact of focused clinical decision support at the point of care.
1051485	Our laboratory studies the regulation of DNA Replication during the cell cycle. 
1051485	We study how stem cell division and differentiation are coordinated.  Cell division and differentiation are in many ways mutually exclusive. Most cells stop dividing as they adopt a specific fate, while relatively undifferentiated stem cells are able to divide throughout the lifetime of the organism. Cancer cells are characterized by both poorly controlled proliferation and a loss of the differentiated phenotype. During regeneration, quiescent differentiated cells revert to a stem cell phenotype and begin dividing anew.  Our research focuses on hematopoietic stem cells, germline stem cells, and myocardial stem cells.  Our central approach is to construct knockout mouse models to study proteins that regulate stem cell division and differentiation patterns.  We also study the mechanism of nuclear reprogramming using Xenopus eggs.
1051542	pancreas, cancer, transgenic, mice, models, detection, chemoprevention, diet, immunology, therapy
1051571	Dr. Boberg has spent 12 years studying the development and evaluation of computer-based systems for patient education and support.  His research career spans basic, clinical, and health services/outcomes research.  He is author of over 25 peer-reviewed publications and book chapters, and has made dozens of presentations across the United States, Canada, and Europe.  Since 1999, he has been a member of NIH Small Business Innovation Research (SBIR), NCI, and NIDA study sections.  Dr. Bobergs research interests focus on needs assessment and design of web-based interventions to meet patient and caregiver needs.
1051571	patient needs assessment, web-based patient information and support
1051610	The research interests of my group are in the field of cytokine-signaling in malignant cells.  We have previously identified and characterized several novel signaling cascades activated by the Type I interferon receptor downstream of Jak-kinases in leukemia and other neoplastic cells, including the insulin receptor substrate (IRS)-pathway, the Crk-pathway and the p38 Map kinase signaling cascade.  These studies have been expanded in efforts to determine the mechanisms by which chronic myelogenous leukemia (CML) cells become refractory to the antiproliferative effect of interferons and the mechanisms of synergy between interferon and STI571 (Gleevec) in CML cells.  We have also recently identified the kinase that mediates phosphorylation of Stat1 on serine 727 as the protein kinase C-delta (PKC&#61540;).  Other research areas in which our laboratory is actively engaged are the mechanisms of signal transduction of all-trans-retinoic acid (ATRA) and arsenic trioxide in acute promyelocytic leukemia.  We have recently shown that ATRA activates the Rac1/p38 Map kinase pathway and that pharmacological inhibition of this pathway enhances its effects on leukemia cells, raising the prospect of development of translational studies combining ATRA with pharmacological inhibitors of Map kinases for the treatment of acute promyelocytic leukemia.  Finally, our group also studies the signaling mechanisms of regulation of normal hematopoiesis by myelosuppressive cytokines, including interferons, tumor necrosis factor-alfa and transforming growth factor-beta. 
1051610	chronic leukemias, multiple myeloma, non-hodgkin's lymphoma
1051628	My research interests include surgical simulation in undergraduate and graduate medical education specifically, skill development and assessment. Clinically, early diagnosis of retinal disorders as well as optic neuropathy are the focus of my practice.
1051734	The laboratory has a long standing interest in the biology of epithelial stem cells. To this end, in collaboration with Tung-Tien Sun (NYU Medical School) we have identified and characterized epithelial stem cells of the epidermis, corneal epithelium and hair follicle      Another research focus of the laboratory is the characterization of epithelial-enriched  microRNAs (miRNAs) to understand how these miRNAs regulate epithelial stem cell behavior and epithelial differentiation. We have demonstrated the presence of several miRNAs that are specifically localized in the corneal epithelium of adult mice; other miRNAs are found in many stratified squamous epithelia including the epidermis. Recently we have found that the lipid phosphatase SHIP2 is a target for miRNA- 205 (miR-205), which is expressed in many stratified squamous epithelia. We have also found that miR-184, which is exclusively found in the corneal epithelium, antagonizes miR-205 to help maintain the levels of SHIP2. This is the first example of a miRNA negatively regulating another to maintain levels of a target protein. 
1051743	My current research interests include radiation biology and nanotechnology and development of a new instrument for high resolution microscopy--Bionanoprobe. In the field of radiation biology, my primary focus is on mechanisms underlying development of genomic instability caused by ionizing  irradiation. This investigation includes work with cells in culture and animal models as well as exploration of archival animal tissues collected from large scale animal experiments, currently located in Woloschak laboratory.My efforts in the field of biomedical nanotechnology include development and investigation of nanoconstructs suitable for biomedical imaging and cancer therapy. Different metals and metal oxides are combined to form the compact center of nanocomposites; their outer layer(s) are made by conjugation of biomolecules and small molecules which enable nanoconstruct targeting and use in vitro and in vivo. Study of interactions between nanoconstructs and cells and tissues requires high throughput and high resolution imaging that co-registers both biological material and nanoconstructs. Only technique that can fulfill all of these requirements is X-ray fluorescence microscopy. A grant awarded to our laboratory was used for custom construction of unique new instrument--Bionanoprobe. This instrument is now installed at the Advanced Photon Source synchrotron and will be used for imaging for bio-nanotechnology.
1051757	Neuropsychological Testing, Geriatrics, Medical Rehabilitation Populations, LD/ADHD, Nervous System Diseases, Alcohol/Substance Abuse, Bariatrics
1051857	My overall interests lie in the translation of evidence-based practices into integrated clinical care. More specifically, I am involved in clinical, training, and programmatic activities designed to extend the access of cognitive-behavioral therapies to individuals with psychotic and bipolar disorders.
1051986	Criminal Competency, Disability, Fitness for Duty, Race Discrimination, Sexual Harassment, Violence and Risk Assessment
1052027	Breast Imaging including ultrasound, magnetic resonance imaging and breast intervention.
1052037	Dr. Kibbe is an Associate Professor of Surgery at the Northwestern University Feinberg School of Medicine, Division of Vascular Surgery as well as Staff Physician and Director of the Vascular Laboratory at the Jesse Brown VA Medical Center.  She received her MD degree from the University of Chicago in 1994, completed her general surgery residency at the University of Pittsburgh in 2002, and vascular surgery fellowship at Northwestern University in 2003.  She is board certified in both General Surgery and Vascular Surgery.  She received her RVT certification in 2003.Dr. Kibbes clinical efforts focus on open and endovascular surgery, with a particular interest on carotid and peripheral arterial endovascular interventions.  Her research interests focus on nitric oxide vascular biology.  Specifically, she is studying how nitric oxide inhibits vascular smooth muscle cell proliferation by focusing on the role of nitric oxide in regulating the cell cycle, the ubiquitin-proteasome pathway, and apoptosis.  She is also developing and testing nitric oxide-based pharmacological approaches to inhibit neointimal hyperplasia following vascular bypass grafting.  Her hope is to have a positive effect on patency rates of both vein and prosthetic bypass conduits, thereby effecting millions of patients that undergo coronary artery or peripheral artery bypass procedures.
1052057	Interested in understanding the informed consent process around genetic research and predictive genetic testing. Additionally, I am interested in how patients choose to use information from predictive testing to manage their health.  Also, interested in understanding what the general patient population understands about genetic testing, genetic research, and personalized genetic medicine and how best this information can be communicated.
1052125	Emergency Medicine, Medical Toxicology, Innovative Scholarship
1052190	Dr. Chetkovich practices general neurology at Northwestern Memorial Hospital and at the Northwestern Medical Faculty Foundation Neurology Clinic.  Dr. Chetkovichs current research focuses on the molecular mechanisms that underlie the targeting of ion channels to synapses and other specialized areas of the dendrites of neurons.  In particular, the lab is interested in the synaptic targeting of ligand and voltage-gated ion channels, molecules responsible for controlling communication in the brain of mammals.  The laboratorys approach utilizes a variety of cellular, molecular and electrophysiological tools to address the mechanisms by which ion channels are targeted to dendrites, as well as the role that this targeting plays in synaptic structure and function as it pertains to epilepsy and brain injury, as well as in disorders of learning and memory such as Autism and Alzheimers disease.  Dr. Chetkovich is also the Director of the Northwestern University Feinberg School of Medicine Medical Scientist Training Program (MSTP).
1052193	Treatment of leukemias, myelodsyplastic syndromes and myeloproliferative disorders.  Management of non-Hodgkin and Hodgkin lymphomas.
1052202	Neurovascular Critical CAre, Stroke
1052228	College Mental Health, General Adult Psychiatry
1052334	Both my clinical and research interests are in nutrition of critically ill neonates, including early institution of parenteral nutrition, use of human milk, and the effect of early growth patterns on subsequent health and neurodevelopment.
1052335	Dr. Farrow's research focuses on the tissue-specific and developmental regulation of phosphodiesterases (PDEs) in the pulmonary vasculature, both in normal transition after birth, as well as in the context of persistent pulmonary hypertension of the newborn (PPHN) and bronchopulmonary dysplasia (BPD). Dr. Farrows laboratory has demonstrated that exposure to high levels of oxygen, which is a common treatment for both PPHN and BPD, leads to increased PDE5 expression and activity in the pulmonary vascular smooth muscle of neonatal sheep and mice. This increased PDE5 expression and activity leads to decreased pulmonary vascular relaxation in response to nitric oxide, a common pulmonary vasodilator.  In the future, new drugs such as PDE5 inhibitors or anti-oxidants may play an important role in the treatment of infants with PPHN or BPD.
1052350	Dr. Bakers research has focused on access to health care, racial and ethnic disparities in care, health communication, and interventions to improve quality of care for chronic diseases.  In the area of access to care and health care delivery for vulnerable populations, his interests include health literacy, language barriers, the effect of lack of insurance on health care use and health outcomes, and racial and ethnic differences in health care use and outcomes.  He has led studies examining many aspects of quality, including whether hospital mortality report cards lead to changes in market share for hospitals and improvements in outcomes, the effect of disease management programs for patients with heart failure, and the effectiveness of learning collaboratives.  His current work is examining quality measurement and quality improvement using electronic health record systems.
1052350	My research has focused on access to health care, racial and ethnic disparities in care, health communication (including health literacy and language as barriers to care), and quality of care for chronic diseases.  I was Principal Investigator for the Literacy in Health Care Study, the first study of the prevalence of inadequate health literacy, and Principal Investigator for the Prudential Health Literacy Study, the largest study ever conducted of the relationship between literacy, health status, and use of health care services.  I was also the Principal Investigator for a study examining health outcomes for the uninsured among a national sample of adults in late middle-age.  In the area of quality of care, I served as the Associate Project Director for the AHCPR-funded Heart Failure guideline and was lead author for a series of manuscripts in JAMA on quality of care for patients with heart failure. I was Principal Investigator for the largest study conducted to date to determine whether publicly reporting hospital mortality rates led to improvements in outcomes My current projects are examining 1) the relationship between reading comprehension, cognitive function, and mortality among the elderly, 2) methods to improve health communication through multimedia, 3) the relationship between race, ethnicity, and language and quality of care for patients hospitalized with myocardial infarction, heart failure, and pneumonia, 4) racial/ethnic differences in subjective versus objective health status (i.e., physical functioning) measures, and 5) use of electronic health records to measure quality of care and to improve healthcare quality and safety.
1052351	My current research efforts employ several innovative methods for quantifying multi-joint upper extremity movement control during both postural and movement tasks in individuals with stroke. I utilize the same quantitative methods to instrument direct impairment-targeted interventions in an effort to elucidate neural mechanisms underlying impaired movement and subsequent restoration of normal movement in individuals with stroke. This research is in collaboration with Julius P.A. Dewald, PT, PhD and is further augmented by collaborations with colleagues with expertise in neural imaging techniques such as magnetic resonance imaging, electroencephalography, and transcranial magnetic stimulation. I also specialize in the training of Physical and Occupational Therapists in the administration of impairment, activity, and participation limitation assessments for individuals with stroke and the subsequent processes necessary for standardized delivery of assessments in clinical trials. Through my clinical research efforts I hope to contribute to the evolution of rehabilitation medicine and science by advancing neurological rehabilitation principles and techniques. The key component most likely to impact rehabilitation in this magnitude is the elucidation of the neurological underpinnings responsible for movement discoordination and through the subsequent development of more effective rehabilitation therapies for individuals with functionally debilitating movement impairments.
1052368	Blood Bank   Hemostasis-Coagulation<BR><BR>Our laboratory focuses on the mechanisms by which prostate cancer cells invade surrounding tissues and spread to distant sites in the body, leading to prostate cancer morbidity and death. We have characterized prostate cancer cell lines and found that the ras homolog RhoA and the nuclear transcription factor NF-kappaB are active and necessary for highly invasive prostate cancer cell behavior. Tumor-associated macrophages (TAMs) may promote tumor progression and stimulate tumor growth and angiogenesis. We have found that co-cultures with monocyte-derived THP-1 and U-937 cells or peripheral blood monocytes stimulated PC-3, DU145 and LNCaP prostate cancer cell basement membrane invasion. The monocyte-derived cells also stimulate prostate cancer cell NF-kappaB activity.  Prostate cancer cell invasion and NF-kappaB activity in the co-cultures is inhibited by dominant negative I-kappaBalpha transfection or treatment with biochemical NF-kappaB inhibitors. These studies provide evidence that human monocyte-derived cells cross-communicate with prostate cancer cells and stimulate cancer cell invasion requiring cancer cell NF-kappaB activity. This model has the potential to identify treatments that may target the effect of monocyte-derived cells on cancer cell invasion and progression.  By identifying the mediators of prostate cancer cell invasion and metastasis, we hope to discover critical steps of cancer cell invasion and metastasis and find targeted strategies to block malignant prostate cancer progression.
1052521	General Gastroenterology
1052551	Botox, Chemical Peels, Collagen, Cosmetics Surgery, Excisional Surgery for atypical moles, Fat Transplantation, Laser Surgery, Liposuction, Melanoma Surgery, MOHS Surgery for the removal of basal and squamous cell cancers
1052573	Medical education, faculty development, effective teaching and learning, education measurement and evaluation
1052623	Dr. Kielb's clinical interests include female urology, pelvic floor dysfunction, vaginal prolpase, male and female urinary incontinence, and neurourology/urodynamics. She also has interests in minimally invasive/laparoscopic surgery, robotic surgery, sacral nerve stimulator therapy, and orthotopic neobladder construction.
1052633	Botox, Collagen, Cosmetic Surgery, Excision of atypical moles, Fat transplantation, Glycolic Peels, Laser Surgery, Liposuction, Melanoma Surgery, MOHS Surgery
1052665	consultative cardiology, echocardiography, women's cardiovascular health
1052726	Epidemiologic studies of diabetes, obesity, cardiovascular disease, fitness, and autonomic function.
1052740	Prion proteins are capable of existing in multiple stable conformations, at least one of which is infectious. It is generally accepted that prion (PrPSc) is the responsible agent for the devastating neurodegenerative disorders known as transmissible spongiform encephalopathies or prion diseases. Our laboratory is interested in using yeast and other model organisms to understand how a prion protein acquires its infectious prion conformations and how such conformations are maintained in vivo. Our ultimate goal is to dissect the initiation and propagation processes of prionogenesis, and to identify important cellular factors required in each of these processes
1052793	I currently have three primary lines of research interests.  Gymnastics:Development and analysis of the Gymnastics Functional Measurement Tool (GFMT). The GFMT is a reliable and valid field test for assessing the physical fitness levels of high level gymnasts.  I am currently researching its ability to be a predictor of gymnastics injury.Development of a Men's Gymnastics Functional Measurement ToolAnalysis of injury occurrence in women's Division 1 college gymnasticsPerforming Arts:  I am currently looking at the jump landing mechanics in professional dances in an effort to decrease knee injuries.Orthopedic Rehabilitation:I am doing an outcomes analysis of 3 common rehabilitation treatments for Achilles Tendonopathy
1052813	developmental neurobiologymolecular diagnosticsclinical pathologyResearch Interests <BR> <BR>Our major research interest is understanding the factors that control cell proliferation and differentiation in the developing mammalian central nervous system. Although the mechanisms that regulate cell proliferation during neural development are poorly understood, studies in other tissues suggest that loss of normal cell polarity and tissue architecture play crucial regulatory roles in cell proliferation and cancer. Our most recent work suggests that beta catenin, an integral component of the adherens junction, can regulate cell cycle re-entry and differentiation in the developing mammalian brain. Transgenic mice expressing a truncated, stabilized form of beta catenin develop massively enlarged brains with increased cerebral cortical surface area and folds resembling sulci and gyri of higher mammals. Understanding the biology of epithelial organization can lend insight onto the regulation of proliferation during neural development and ultimately reveal mechanisms underlying developmental brain disorders and tumors in the central nervous system.
1052862	Dr. Jacobsohn is an attending in the Stem Cell Transplant Program at Children's Memorial Hospital.  He is actively involved in clinical research in the area of stem cell transplantation.  His main interests are graft-versus-host disease (GVHD) and reduced intensity transplantation.  He is involved in the conduct and design of novel clinical trials to prevent and treat graft-versus-host disease.  For example, he currently heads a national, multi-institutional trial, through the Pediatric Blood and Marrow Transplant Consortium, to treat children with chronic GVHD with pentostatin.  Dr. Jacobsohn is also leading a novel transplant protocol at Children's Memorial Hospital that utilizes photopheresis post-transplant to prevent graft-versus-host disease.  In addition, he is involved with the NIH Consortium for Chronic GVHD, specifically leading an effort to design and validate grading criteria for pediatric patients on chronic GVHD clinical trials.  He has numerous publications in the field of stem cell transplantation and GVHD.
1052876	Airway Management, Cardiothoracic Anesthesiology, Regional Anesthesiology
1052935	I am interested in the larger topic of social justice in health care, and in the ethical issues in how we conceive, direct and regulate the teaching of medicine and science, the research praxis, and the policy that shapes and funds research. I primarily am interested in basic and translational research. While I have focussed my attention on issues in stem cell research, AIDs, synthetic biology and neuroscience, I am also interested in the issue of foster care. I study at the intersection of religious studies, theology and moral philosophy.
1053088	As many as 20% of breast cancer patients have brain metastases, with women surviving only 2-16 months after diagnosis of this metastasis. Thus, resolving the mechanisms of metastasis to the brain is clinically important. In invasive breast carcinomas, Syndecan (Sdc) 1 is observed in stromal fibroblasts and endothelial cells where it is involved in tumor growth and angiogenesis. Staining for Sdc1 in both the tumor and stromal cells has been reported to be a negative predictor of disease free and overall survival in estrogen receptor (ER) negative breast tumors, and expression of Sdc1 and 4 is associated with increased proliferation index in breast tumors. A direct connection between these receptors and breast cancer metastasis has not been shown. The reduced expression of Sdc1 or 4 in MDA-231 breast cancer cells and reduced expression of Sdc4 in CN34Brm breast cancer cells significantly decreased metastases to only the brain but had no effect on bone, lung, or ovarian metastases when the cells were injected into the left ventricle of the mouse heart (nude mice). Additionally, metastases to the brain was reduced when these cells were injected in the orthotopic site of NSG mice, however, primary tumor growth and metastases to the lung, liver, ovaries, and lymph nodes were not affected in this model. These results suggest Sdc1 and 4 facilitate breast cancer organotropism to the brain. We are currently examining the mechanism of how Sdc1 and 4 affects breast cancer organotorpism to the brain. These results may explain the correlative observations of Sdc expression with poor clinical outcome. These studies may lead to development of new biomarkers and/or treatment for breast cancer metastasis to the brain.
1053089	Microbiology/Virology <BR><BR>Molecular diagnostics, mechanisms of bacterial antibiotic resistance
1053099	.
1053305	I am interested in signal transduction in cancer biology, development of new strategies for cancer prevention and identification of novel targets for better treatment. Currently my studies are focused on different pathways inresponse of keratinocytes to ultraviolet (UV) irradiation and development of novel chemopreventive agents against UV-induced skin cancer.
1053369	Our research is focused on issues of immune regulation. A long-standing effort has been to understand the how IL-4 is regulated in T and mast cells. We have identified that Ikaros, a transcription factor that regulates chromatin conformation, has distinct cell-type specific effects on the IL-4 gene locus in these cells. We are trying to understand the underlying mechanism of this unique repression of transcription in mast cells and activation of transcription in T cells.Another major project involves the study of mast cells in the autoimmune diseases MS and type 1 diabetes. Althoug well-established mediators of allergic responses, mast cells are potent sources of many immunomodulatory molecules cells that can modulate disease course. Using mast cell-deficient mice, we have established that mast cells are required for fulminant EAE (MS) and NOD mouse diabetes. We are investigating the mechanism of action of these cells in disease pathogenesis.
1053382	I work on modeling complex systems with an emphasis on biological and social systems. I am interested in understanding the relationship between the network of interactions between the units of the system and the function the system wants to perform. In the case of biological systems, I am interested in developing systems level phenomenological theories for cellular processes that are generalizable and have predictive power. In the case of social systems, I am interested in understanding the scientific process, how high quality research arises and how to locate and evaluate high quality research. 
1053420	Clinical: General psychiatry including psychotherapy and psychopharmacology. Medical psychiatry including consultation for and treatment of psychiatric conditions in the setting of co-occurring medical conditions. Forensic psychiatry, both civil and criminal issues, including malpractice, disability, competency, and mitigation.
1053631	Women's Health, primary care, osteoporosis.
1053660	General Surgical Pathology and Urological Surgical PathologyDiagnosis of genital urinary cancers including prostate, bladder, kidney, testis and other GU organsImmunohistochemistry<BR><BR>Pathogenesis of prostate cancer, kidney cancer and bladder cancerIdentification of new molecular markers of GU cancersSolid tumor banking for biological studies
1053762	Mood Disorders, Depression, Treatment and Outcome, Remission, Treatment of Depression Subtypes.
1053859	My area of academic interest focuses on pediatric neurocritical care especially as it pertains to epilepsy, status epilepticus, coma, brain injury, and neurophysiology.
1053905	Dr. Catalona is currently conducting research into the genetics of prostate cancer which could lead to new tests for the disease as well as possible new means of treating or preventing prostate cancer. He specializes in prostate cancer surgery and is recognized as an expert in performing the 'nerve-sparing' radical prostatectomy that can preserve sexual potency.
1053924	Disability Research
1053926	1. Long-term cellular and molecular consequences of early-life seizures2. Inflammation and immunity in epileptic brain3. Novel therapies to block epileptogenesis in genetic models of childhood epilepsy
1053946	My lab has two main research lines: one is cellular neurophysiology, with particular emphasis on the mechanisms of action potential generation and propagation and on the role of dendrites in post synaptic signal integration.The second research line of the lab focuses on the role of ion channels in neurological disease, and in particular on the central (brain) mechanisms mediating chronic pain. 
1053957	My research efforts focus on identification of risk factors for injury in youth sports and investigating strategies for prevention.  My 2006 research demonstrating that a coach-led neuromuscular warm-up can significantly reduce knee injuries in girls soccer and basketball players at Chicago Public High Schools won two awards.  In conjunction with the CMH Motion Analysis Center, we are using 3D motion analysis to investigate the role of pitching technique on the risk of overuse injuries in youth pitchers. I am also involved in research investigating the risks of early sports specialization in young athletes and establishing age-appropriate clinical evaluation tools for sports-related concussions.
1053987	I am a scientific annotator working mainly on the dictyBase database, whose goal  is to provide the scientific community with a centralized resource containing all the information available about Dictyostelium discoideum. I analyze and annotate genes of the Dictyostelium genome, which includes: verifying and modifying gene models, descriptions and classifications of the biological roles, molecular functions, and subcellular localizations of predicted and known gene products using the Gene Ontology (GO) controlled vocabulary, adding links to literature information, classifying phenotypes, and cataloging Dictyostelium strains.  I also work on biomedical ontologies: I work on the Gene Ontology and have developed the Dictyostelium Anatomy Ontology (Gaudet et al, 2008, BMC Genomics. 18;9:130. PMID: 18366659), and I manage a project of the Gene Ontology group called the GO Reference Genome where we annotate in parallel the orthologs from multiple species (Gaudet et al 2009 PLoS Computational Biology).
1054108	non-Hodgkin lymphoma, etiology, diet, obesity, pesticides, lifestyle factors, chromosomal abnormalities, molecular epidemiology, gene-environment interactions
1054111	I am interested in ethical issues associated with conducting large-scale genetic research including consenting, data sharing, privacy, return of results, recontact and education of research participants.
1054143	Interferon signal transduction, MAPK signaling, CML, MDS, myeloproliferative disorders, cellular proliferation and apoptosis signaling, cytokine signaling  
1054153	I have had the opportunity to study problems in a number of areas of endocrinology and metabolism. Recent efforts have included studies of the evolution of the metabolic syndrome led by Dr. Xiaobin Wang.  I have been continuing work on thyroid disease including thyroid cancers.
1054166	I specialize in Neonatal-Perinatal medicine with particular interest in persistent pulmonary hypertension of the newborn. I helped establish the head-cooling program for hypoxic ischemic encephalopathy at Central DuPage Hospital.  I also have special interest in the nutritional needs of the term and preterm newborn.
1054182	Spinal cord stimulation is a fascinating modality for treatment of chronic pain which is finding new applications in medicine, yet the physiology of the spinal cord and dorsal root ganglion is not comletely elucidated in this milieu. Chronic abdominal pain and other intestinal disorders are being treated with spinal cord stimulation with increasing success. Current clinical research is in the field of injection related anxiety, cervical epidural injection safety, hormonal changes with epidural steroid injections, and novel use of stellate ganglion injections for non-pain related syndromes.
1054188	Co-P.I. for SHAPE study evaluating use of gastric pacemaker for obesity (21 patients implanted at NMH)- Transneuronix is sponsor
1054188	obesity/weight management, nutrition in chronic diseases, diabetes
1054303	Clinical and Research interests include Eosinophilic Esophagitis (EoE) in pediatric populations including studying the mechanisms of fibrosis and remodeling,identifying non invasive biomarkers to assess recurrence of esophageal inflammation. Also interested and I am studying the impact of elimination diets in inducing and maintaining clinical and histological remission in children with EoE.
1054309	Hospital based treatment of children and adolescents
1054320	leukemogenesis, NUP98-HOXA9, AML, MDS, CD45-AP, CD45, PTP, signal transduction, hematopoiesis, nucleoporins
1054387	Primary interests in dysmorphology and chromosome abnormalities (specifically 22q11 deletion syndrome)
1054404	Psychiatry, genetics, schizophrenia
1054412	T cells, immunology, skin, NKT cells, signal transduction, tyrosine kinases
1054508	Mass event management. issues and circumstances with Sudden Cardiac Death in the Community
1054599	My laboratory research has focused on noninvasive prenatal genetic diagnosis using fetal cells and nucleic acids in maternal blood.I also have an interest in medical ethics as related to prenatal genetic screening and diagnosis and reproduction.
1054782	My interests include mental health treatment and evaluation of children and adolescents. I am also interested in the development of antisocial behaviors and substance abuse, pediatric bipolar disorder, non-suicidal self-injury, and racial/ethnic disparities among youth in the juvenile justice system.
1054853	I am a health services researcher and primary care internist. My research involves the design, implementation and evaluation of electronic health records-based quality improvement tools, practice redesign techniques and methods for clinician performance measurement. I have performed multiple studies using data from clinical information systems to assess various aspects of cardiovascular disease, hypertension and preventive care. I have an AHRQ career development award examining how to improve the practice of preventive cardiology by predicting patients cardiovascular risk using electronic health record data and integrating this information into clinical use for both clinicians and patients. I am co-investigator and playing a leading role in the UPQUAL Study, Using Precision Performance Measurement to Conduct Focused Quality Improvement, from AHRQ. This multi-site study uses precision quality measurement embedded within clinical information systems to deliver focused quality improvement for multiple chronic disease and prevention targets.
1054853	My research focuses on several related areas: 1) quality improvement for outpatient care of cardiovascular disease and diabetes mellitus including changing the healthcare delivery system and patient communication,2) the way patient knowledge and attitudes influence health behaviors in chronic illnesses such as diabetes and cardiovascular disease, and3) issues surrounding the measurement of healthcare provider performance for public accountability.
1054857	My primary research interests include medical education, curriculum design and career development with residency and faculty learners. I am also interested in education and research driven practice improvement in the care of emergency department patients with palliative and end-of-life care needs.
1054860	The laboratory research of Serdar E. Bulun, MD, focuses on studying estrogen biosynthesis and metabolism, in particular aromatase expression, in hormone-dependent human diseases such as breast cancer, endometriosis and uterine fibroids. A team of investigators works on understanding the epitheial-stromal interactions and aromotase overexpression in breast cancer tissue. Since aromatase inhibitors treat breast tumors primarily via suppressing intratumoral estrogen biosynthesis, these efforts are important for discovering new targets of treatment. Another team studies endometriosis. Basic data from this laboratory led to the introduction of aromatase inhibitors into endometriosis treatment. Human tissues and a primate model are used to elucidate cellular and molecular mechanisms responsible for the development of endometriosis. Regulation of aromatase expression is also studied in uterine fibroids, benign tumors that are dependent on estrogen for growth, by a third team. A fourth team is investigating the link between progesterone action and estrogen inactivation in normal endometrium and endometriosis. Lastly, a fifth team has identified novel mutations that cause familial excessive estrogen formation syndrome. This syndrome is characterized by short stature, gynecomastia, and hypogandism in males and early breast development and irregular menses in females. In this syndrome, heterozygous inversions in chromosome 15q21, which cause the coding region of the aromatase gene to lie adjacent to constitutively active cryptic promoters that normally transcribe other genes, result in estrogen excess owing to the overexpression of aromatase in many tissues.
1054986	Autopsy   Sub-specialty Hematology, Sub-specialty Transfusion Medicine  <BR><BR>Hematology, Transfusion Medicine
1055017	Alcohol and prescription drug abuse among college students; Sexual assault
1055047	Schizophrenia is a devastating neurodevelopmental illness, which affects 1% of the population and is associated with high rates of morbidity and mortality.  We focus our research on the cellular mechanisms by which DISC1, a schizophrenia susceptibility gene, affects neurodevelopment. DISC1 was initially identified in a large Scottish family with members who suffered from schizophrenia, bipolar disorder and recurrent major depression. DISC1s association with schizophrenia has been confirmed in other population and family studies. Genetic studies have also indicated a DISC1 association with bipolar affective disorder and with autism and Asperger syndrome. Understanding the genetic and developmental basis of schizophrenia is critical for discovering treatments.  Two recent publications by the Morris laboratory focus on the role of Disc1 in development, particularly the migration of cells to their proper location in the brain and subsequent differentiation into their intended fate.
1055048	My lab studies the processes that regulate the early development of the embryo, including cell movements, survival, proliferation, and differentiation.  We focus on a number of proteins which are linked to human birth defects, to try to understand these abnormalities.  In order to observe changes in cells and gene expression, we model human birth defects in both chicken and zebrafish embryos.  This combination of systems allows us to have rapid interrogation of developing embryos as well as large supplies of tissues for comparative studies.  We focus on the Sonic Hedgehog signaling pathway, which plays multiple roles in establishing cell fates, as well as regulating cell numbers by controlling both proliferation and survival.Current studies in my lab include exploring the gene expression changes produced by embryonic exposure to ethanol, and developing novel therapeutics that can restore normal development without causing harm to non-affected embryos.
1055051	zebrafish, glypican, Wnt, morphogenesis, developmental biology, heparan sulfate proteoglycans
1055119	Dr. Xu's primary research work focus on therapeutically prevention of prostate cancer metastasis.
1055143	Hypertension, diabetes, migraine, women's health, medical education
1055145	My research focuses on the basal ganglia, a group of subcortical brain nuclei that are critical for voluntary movement and associative learning and are the primary sites of dysfunction in Parkinsons disease, Huntingtons disease, obsessive-compulsive disorder and addiction. My objectives are to define the principles underlying the normal and pathological operation of the basal ganglia.  My hope is that this information will provide the foundation for the rational development of corrective or neuroprotective therapies.
1055146	My primary clinical interests are in the care of the frail elderly. I am particularly interested in memory disorders, dementia, gait disorders and falls, failure to thrive, Parkinson's Disease, and medication management in the older adult.
1055267	Dr. Rosenow is the Director of Functional Neurosurgery in the Northwestern University Feinberg School of Medicine Department of Neurosurgery and at Northwestern Memorial Hospital. He specializes in the treatment of movement disorders such as Parkinsons disease, tremor, and dystonia, as well as the surgical treatment of epilepsy and chronic pain. He works as part of a coordinated multidisciplinary team that includes physicians in neurology, neurophysiology, neuropsychology, neuroradiology, physical therapy, speech pathology, and social work.My research revolves around restorative neurosurgery. This includes neurostimulation (deep brain, cortical, transcranial magnetic), brain-machine interface (both cortical chip and EEG-based), and gene therapy methods. Our group currently has active projects investigating cortical-basal ganglia interactions in Parkinson's disease patients with externalized deep brain stimulating electrodes as well as computer modeling of both cortical-basal ganglia interactions and novel paradigms of deep brain stimulation.  We are also involved in a project using an animal model of neuropathic facial pain to discern and refine motor cortical stimulation for facial pain. We have an active protocol for transcranial magetic stimulation for recovery for brain injury. Another area of interest is image-guided surgery. We pioneered frameless deep brain stimulation surgery and have several projects investigating new methods of intraoperative localization and navigation.
1055282	Family health and mental health, impact of chronic illness on the family, biological and psychological measures of stress, health disparities
1055316	As the tracheostomy specialist for the medical center, tracheostomy management is a key research interest.  Other research interests include exercise programs to prevent venous thrombosis and other sequelae related to critical illness, and a new method of training for critical care nurses.
1055329	Risk factors and outcomes of traumatic illness, racial disparities in trauma, intimate partner violence
1055338	Brain Tumors, Spinal Cord Tumors, Neurologic Complications of Cancer
1055338	Development of clinical trials for primary brain tumors, brain metastases, leptomeningeal metastases.
1055434	Study of the mechanisms underlying atrial fibrillation. We are currently investigating the autonomic profile of the the pulmonary veins and the rest of the left atrium in a canine model, especially as it relates to the genesis of atrial fibrillation. Our laboratory is also investigating the mechanisms underlying atrial fibrosis (and resulting substrate for atrial fibrillation). 
1055441	Osteoporosis, Systemic Lupus Erythematosus, Inflammatory myositis, Clinical Outcomes
1055487	My primary research interest is the interface between cognition and emotion. This includes the relationship between mental illness and memory, attention, and other cognitive processes. I am also interested in applied statistics and the application of psychometric theories to the development of better measurement tools for use in health research.
1055505	Dr. Huang's research interests lie in functional genomics. A main focus of his research has been on identifying novel biomarkers for disease disgnosis and prognosis. He is also interested in integrating bioinformatic and epidemiological/clinical data resources to accelerate translational discovery.
1055535	nutrients, diet, trace elements, lifestyle factors, cardiovascular diseases, stroke, obesity, metabolic syndrome, nutrition, epidemiology.
1055581	Synapses, plasticity, learning
1055592	My broad research interest lies in understanding the molecular basis of human genetic diseases and developing therapeutics for their treatment. Specifically, my research primarily focuses on neuromuscular diseases, which are those that affect muscle, the nerves that innervate muscle or the neuromuscular junction, which is the connection between the two. One way to approach this problem is to study mutations that disrupt normal neural development. Proximal spinal muscular atrophy (SMA) is a prime example. After cystic fibrosis, SMA is the most common autosomal recessive childhood disease. The disease affects 1/10,000 live born children. It is characterized by degeneration of the a-motor neurons in the spinal cord, which causes proximal, symmetrical limb and trunk muscle weakness that progresses to paralysis and ultimately death. Currently, there is no available treatment for SMA patients. Mutations in survival motor neuron 1 (SMN1) gene are responsible for SMA. In humans, two virtually identical copies of SMN are present, SMN1 and SMN2. SMN1 produces only full-length transcripts (FL-SMN) and is therefore the SMA-determining gene, whereas the predominant transcript from SMN2 is an exon 7 alternatively spliced form. The SMN2 gene also produces a low level of FL-SMN transcript, which explains why SMA is not embryonic lethal in humans. Nevertheless, lower motor neurons eventually succumb to the reduced SMN dosage and degenerate. Why motor neurons are specifically affected is not clear but it has been proposed that this may be due to a distinct role for SMN in this cell type. We have developed a translational research program for SMA. The research is multi-faceted and uses biochemistry, cell biology, molecular biology, and animal modeling. We use these approaches to decipher SMN function within nerve and muscle, the two tissues affected in SMA. We have also generated a hypomorphic allelic series of Smn mutations in mice that mimic human SMN2 splicing.
1055613	Kinesin motors drive intracellular transport of many different cargoes along microtubules, and they are critical to trafficking in the nervous system as well as cell division.  Antimitotic drugs that act on two kinesin motors, Eg5 and CENP-E, are currently in phase I and II clinical trials.  Several kinesin motors, including Eg5 and CENP-E, are intrinsically regulated in the cell by their C-terminal tail domains. Our laboratory's work is inspired by the fact that there appear to be multiple, highly effective mechanisms that nature has developed for regulating kinesin kinesin motors. Our hope is that once we understand these natural regulation mechanisms, they can be mimicked to develop new and better antimitotic drugs, resulting ultimately in a larger number of treatment options.
1055648	SYNAPTIC STRUCTURAL PLASTICITY: FROM MOLECULES TO COGNITIVE FUNCTIONS AND DISEASEResearch in my lab centers on signal transduction networks that regulate the structural and functional plasticity of excitatory synapses. Synaptic communication between neurons within brain circuits underlies cognitive functions, and is disrupted in numerous neurodevelopmental and neuropsychiatric disorders. Most central excitatory synapses are located on dendritic spines, and spine structure is essential for normal and pathological brain function. Spine dynamics is crucial for the establishment, maintenance, and experience dependent modification of connectivity in neural circuits. Conversely, abnormal dendritic spine morphology occurs in patients with neurodegenerative, psychiatric, and neurodevelopmental disorders, including schizophrenia, autism, and Alzheimers disease.As spine morphology is closely associated with cognitive functions, understanding the mechanisms of regulation and dysregulation of spine plasticity is necessary to elucidate the neural bases of cognitive functions and disorders. The long-term goals of my research are:1) to identify and characterize the molecular mechanisms that control synaptic structural plasticity. 2) to determine how they influence the development, functioning, and plasticity of brain circuits underlying cognition. 3) to uncover the molecular mechanisms underlying synaptic pathology and determine their impact on disease endophenotypes. To to achieve these objectives, we employ a multidisciplinary array of molecular, cellular, imaging, transgenic, electrophysiological, and behavioral approaches, and have assembled an outstanding team of collaborators.
1055794	Antimicrobial Resistance, Antimicrobial Utilization, Nosocomial Infections, Geriatric Infections, MRSA
1055794	Clinical responsibilities include inpatient general infectious diseases consultation and outpatient HIV and general infectious diseases care.  Research projects include:  MRSA colonization in HIV-infected individuals; Antimicrobial utilization in hospitalized elderly population; Evaluation of surveillance methods to identify surgical site infections following total hip arthroplasty.
1055878	My research interests lie in the epidemiology of heart failure and sudden cardiac death in patients with heart failure. My research is funded by grants from the National Institutes of Health and the American Heart Association.
1055878	My research is aimed at understanding heart failure, atrial fibrillation and sudden cardiac death in women. In addition, I am interested in pharmacogenomics in relation to heart failure medications. My research is funded through grants from the National Institutes of Health and the American Heart Association.
1055931	Breast cancer, oncogenes, tumor suppressors, p16, pRB, p53
1055970	My clinical expertise is in Rheumatology and I treat all types of rheumatologic problems.  My research focuses on the epidemiology of rheumatoid arthritis and the relationship between autoimmune rheumatic diseases and cardiovascular disease. I have conducted studies identifying preclinical rheumatoid arthritis-related autoantibodies measured in stored serum from asymptomatic individuals prior to their subsequent rheumatoid arthritis development.  Currently, I am conducting two large ancillary studies sponsored by the National Heart, Lung, and Blood Institute and the Arthritis Foundation.  In those studies, I am examining autoantibodies as risk factors for subclinical atherosclerosis and clinical cardiovascular outcomes in two large general population cohorts, the Coronary Artery Risk Development in Young Adults (CARDIA) Study  and the Multi-Ethnic Study of Atherosclerosis (MESA).  I am interested in this area of research because there is a well-established association between coronary heart disease and autoimmune rheumatic diseases including rheumatoid arthritis and lupus, but the exact cause is not known. In addition, I am also examining the influence of race and gender on rheumatic disease related autoantibodies in the CARDIA and MESA participants in order to better understand risk factors for rheumatic disease development.
1055971	My research has focused on the application of pharmacokinetics and drug metabolism to problems in clinical pharmacology.  When at NIH I also established an interest in the development and proper use of biomarkers in drug development.
1056003	Obesity in childrenHealth Care in Underserved Populations
1056004	My basic research interest is on the delineation of the mechanism of cell fate determination in blood and marrow stem cells and the development of novel cell-based therapy based on this knowledge. We recently discovered that blood stem cells maintain a balance between self-renewal and maturation through asymmetric cell division and we are develop methods to manipulate this process and expand blood stem cells. My clinical research interest is on the application of an effective but less toxic method of stem cell transplant to treat children with severe inborn immunological defects. Using this method, we have achieved a cure rate of 100% in these patients, if they are diagnosed and treated early.
1056039	Our laboratory is interested in a range of issues related to the development, physiology and pathology of the 'neurovascular unit' (NVU) (neurons, vessels, pericytes, astrocytes). We also devise new approaches to study at high spatio-temporal resolution, cellular interactions within the NVU, using optical imaging techniques such as two photon microscopy, genetic tools and experimental disease models
1056043	In my lab we are interested in delineating the molecular mechanisms of progesterone action through its receptor, PR in the uterus.  This is done in the context of normal endometrial differentiation, specifically, decidualization, as well as in uterine pathologies, such as endometriosis, endometrial cancer and uterine fibroids.  Specifically, we are interested in studying PR function in relation to other signaling pathways and transcription factors.  
1056074	Dr Carla Pugh is currently Associate Professor of Surgery and Director of the Center for Advanced Surgical Education at Northwestern University. She also holds an appointment in the School of Education at Northwestern.  Dr. Pugh has a broad interest in the use of technology for medical and surgical education.http://www.npr.org/templates/story/story.php?storyId=18939055
1056108	I have a general interest in medical informatics and am interested in applications of informatics and information systems to the care of critically ill children.
1056109	My area of expertise is Pediatric Cardiology with a focus on non-invasive imaging (transthoracic, transesophageal, and fetal echocardiography) and connective tissue disorders.  I am the principal investigator at Children's Memorial Hospital for the Marfan Trial, which is a multi-center study sponsored by the Pediatric Heart Network and NIH/NHLBI assessing the long-term effects of atenolol versus losartan in patients with Marfan syndrome.
1056118	My primary interests are in the minimally-invasive repair of abdominal and thoracic aortic aneurysms as well as the minimally-invasive reconstruction of lower extremity arterial occlusive disease. I am also an investigator for the ATTRACT trial looking at early thrombolytic therapy of DVT to precvent the development of post-thrombotic syndrome. In addition, I have considerable experience in the use of electronic health records in clinical practice.
1056153	John A. Martin, MD, is Associate Professor of Medicine and Surgery, Director of Endoscopy, and Medical Director of the Gastroenterology Laboratory and Endoscopy Unit in the Division of Gastroenterology at the Northwestern University Feinberg School of Medicine and Northwestern Memorial Hospital. His clinical, research, and medical education efforts and interests are focused in endoscopic retrograde cholangiopancreatography (ERCP), advanced interventional endoscopy, surgical endoscopy, hepato-biliary disorders, pancreatico-biliary diseases, transplantation surgery, natural-orifice transluminal endoscopic surgery (NOTES), and the development of novel endoscopic devices for advanced therapeutic endoscopy, as well as interdisciplinary investigation of new advanced multimodal molecular imaging technologies in the laboratories of Drs. Khashayarsha Khazaie and Elias Gounaris. He is also involved in interdisciplinary study, application, and validation of new simulation models and devices for use in endoscopic training and education. With Drs. Nathaniel Soper and Eric Hungness in the Department of Surgery, he is co-founder of the Northwestern NOTES Investigation Group commenced in 2006. In 2007, he initiated the third-tier, fourth year fellowship program in Advanced Therapeutic Endoscopy at Northwestern.Dr. Martin is a graduate of the University of Virginia College of Arts and Sciences and of the University of Virginia School of Medicine. He served his internship and residency at the University Hospitals of Cleveland, Case Western Reserve University. He received his fellowship training in Gastroenterology and Hepatology at the University of Pittsburgh, where he concentrated in pancreatico-biliary disorders, hepatobiliary disorders, and therapeutic endoscopy. He then undertook third-tier fellowship training in advanced interventional endoscopy under the direction of Dr. Gregory Haber and Dr. Norman Marcon at The Wellesley Hospital, University of Toronto, Ontario, Canada. Dr. Martin was appointed to the faculty at the University of Pittsburgh School of Medicine in July, 1997. He joined the faculty of the Division of Gastroenterology at the Northwestern University Feinberg School of Medicine in 2003.
1056183	Transplant rejection and tolerance
1056185	Our primary research interests are in epigenetics, or how changes in gene expression can impact neurodevelopmental disorders such as autism, epilepsy, Rett and Angelman syndromes; and in how general or specific environmental factors such as fetal alcohol exposure can work through epigenetics to impact outcome.
1056241	My research interests revolve around understanding the risk factors and improving outcomes of critically ill patients with serious infections. This includes severe community-acquired pneumonia, sepsis of all causes, and nosocomial infections, particularly ventilator-associated pneumonia.
1056270	Dr. Lloyd-Jones research interests lie in cardiovascular disease epidemiology, risk estimation, and prevention. A main focus of his research has been investigation of the lifetime risks for various cardiovascular diseases, and factors which modify those risks. Other areas of interest include CVD risk estimation using novel biomarkers, imaging of subclinical atherosclerosis, and the epidemiology of hypertension. His clinical and teaching interests lie in general cardiology, with a focus on prevention.
1056292	The use of simulation technology to improve team training and resident education in neonatal resuscitation.  Other interests include neonatal brain injury and neuroprotection.Neonatal Infectious Diseases.
1056312	Dr. Soper's research interests have revolved around the applications of minimally invasive surgery for gastrointestinal disease, laparoscopic ultrasound, alternative treatments for gallstones and motility of the gastrointestinal tract. More recently he has been involved in the early clinical experience with Natural Orifice Transluminal Endoscopic Surgery (NOTES) and Per Oral Endoscopic Myotomy(POEM) surgery.
1056397	The scientific objectives of our laboratory include identifying genes that contribute to cancer metastasis. The major goal of this research is to define important structure/function relationships and provide the biological basis for new therapeutic strategies. Recent studies have generated molecular classification(s) of specific tumors, and have provided new prognostic markers and novel targets for therapeutic intervention based on the convergence of embryonic and tumorigenic signaling pathways. Current research activities focus on elucidating how regulatory molecules and phenotype control genes govern cell-to-cell and cell-to-matrix interactions, epithelial/mesenchymal transitions, and motility. Specific projects include signal transduction events initiated by cell adhesion molecules and growth factors; factors regulating interconversion of the tumor cell phenotype; novel three-dimensional analysis of cellular invasion through extracellular matrices; regulation of matrix metalloproteinases by tumor and stromal cell interactions; tumor angiogenesis and vasculogenesis; and role of the microenvironment in epigenetic reprogramming of cellular phenotypes.
1056406	Dr. Wang is a board certified pediatrician and a molecular epidemiologist whose work unites molecular biology, population genetics, clinical medicine, and epidemiology and brings together investigators and health professionals from multiple disciplines. Her research has covered a broad scope of health issues ranging from adverse reproductive outcomes, child growth and development, allergy and respiratory health, and childhood precursors of adult diseases, including obesity and metabolic syndrome. Dr. Wang has authored and co-authored over 100 publications in peer-reviewed scientific journals, and many of them appear in prestigious journals, including New England Journal of Medicine, Journal of American Medical Association, and Lancet. At present, Dr. Wang is the principal investigator of multiple large-scale molecular epidemiological studies funded by the National Institute of Health, with a particular focus on environmental factors, genetic variants, epigenomic alterations, and their interactions in adverse reproductive outcomes, food allergy and related conditions, and obesity and metabolic syndrome.Dr. Wang received her MD from Beijing Medical University in Beijing, China, and a master of public health from the School of Public Health and Tropical Medicine at Tulane University in New Orleans. She also received a doctor of science degree from the Department of Maternal and Child Health at the Johns Hopkins University School of Hygiene and Public Health in Baltimore. Dr. Wang completed a three-year research fellowship in Environmental Epidemiology at the Harvard University School of Public Health and a residency in pediatrics at Boston Medical Center.
1056422	My research is focused on studying the role of glial cells in the response to brain injury and blood brain-brain barrier dysfunction.
1056446	Preschool children with behavioral and emotional problems, anxiety disorders, parent training, developmental assessments for educational and treatment planning
1056465	Primary interests center around investigations into immunologic correlates of fatigue in individuals with multiple sclerosis and chronic fatigue states. Also interested in immunologic correlates of disease in individuals with MS.
1056593	The major focus of our laboratory is to elucidate the mechanism of signal transduction by which nuclear receptor and associated coactivators regulate gene expression in tissue/cell specific manner. To understand the biological role of nuclear receptors and coactivators, our lab is using genetically modified (transgenic and gene knock-out) mouse models of novel coactivators which are identified and characterized in our lab and study their biological significance in mammalian development and various diseases like obesity, diabetes and cancer.
1056682	muscle, contractility, cardiac function, troponin, calponin, transgenesis, gene targeting, protein structure-function relationship
1056693	Dr. Scandrett works primarily at a subacute and long-term care nursing facility near Northwestern Memorial Hospital.  Her clinical and research interests include care quality and improvement, and helping individuals maintain their quality of life in long-term care.  
1056693	My primary research and clinical interest is improving the healthcare-related quality of life for elderly patients residing in nursing facilities toward the end of life. My research examines the factors associated with high quality nursing home care, with the goal to improve the skills of the interdisciplinary team working in the long-term care setting.
1056697	Dr. Schleimer has a longstanding interest in the mechanisms of action of glucocorticoids in allergic diseases.  Past studies have ranged from translational investigations in human subjects to molecular biological assessment of glucocorticoid action.  Mechanisms of the pathogenesis of allergic diseases including asthma, rhinosinusitis, dermatitis and others have also been an area of investigation.  Recent studies have focused on the role of airway epithelial cells as integrators of responses in the airways, including inflammation, innate immunity and adaptive immunity.
1056697	I am interested in the mechanisms of pathogenesis and treatment of a variety of allergic and inflammatory diseases associated with allergy.   These include chronic rhinosinusitis, asthma, hay fever, rhinitis, food allergy and others.   We also study the mechanisms of action of antiinflammatory glucocorticoids.   Our studies focus on the molecular and cellular mechanisms underlying disease and steroid action as well as developing strategies to for new treatments.
1056714	Multiphoton Microscopy of living cells and tissues.  See NINDS P-30 grant.
1056726	I am developing non-invasive transcranial brain stimulation as an adjuvant to lower and upper limb movement therapy following stroke. Adjuvants include transcranial magnetic stimulation, transcranial direct current stimulation, and spike-timing dependent plasticity which uses transcranial magnetic stimulation paired with electrical stimulation of a peripheral nerve.
1056845	My lab is interested in how cell-cell adhesion and differentiation are controlled and coordinated by the multifunctional protein, beta catenin. In particular, we are interested in how the signaling form of beta catenin becomes activated, and how phosphorylation modulates beta catenin's various functions.  Molecular insights into the fine regulation of beta catenin signaling and adhesion will be relevant to pulmonary fibrosis and cancers.
1056845	My research centers on understanding mechanisms of cell-cell adhesion, and how adhesive information is conveyed to the cell's interior.  We focus on the cytoplasmic protein, b-catenin, which plays essential roles in both intercellular adhesion and nuclear signaling.  At the cell surface, b-catenin binds the cytoplasmic domain of cadherin-type adhesion receptors, which allows cells to engage their neighbors through robust intercellular adhering junctions.   In the cytoplasm and nucleus, a cadherin-independent pool of b-catenin transduces extracellular Wnt signals by interacting with TCF-type transcription factors to activate target genes. The Wnt/b-catenin signaling cascade activates genes that allow cells to adopt particular identities throughout development.  In adult tissues, activation of this pathway maintains the 'progenitor' phenotype, while inhibition of this pathway promotes differentiation.  In the lung alveolus, type 2 epithelial cells are thought to give rise to type 1 cells, but the signaling mechanisms which drive this process remain poorly defined.  We reason that modulation of Wnt/b-catenin signaling controls type 2 differentiation into type 1 cells, and experiments are currently underway to address this hypothesis.  Defining the signaling pathways that control AT2 maintenance and differentiation may aid our understanding of the pathophysiology of pulmonary fibrosis and COPD.
1056853	Richard C. Meagher, Ph.D. is Associate Research Professor in the Division of Hematology/Onocology and Director of the Cell Therapy Processing Facility at the Feinberg School of Medicine.  Dr. Meagher's primary research interests include the role of the hematopoietic microenvironment (stroma) on the regulation of proliferation and differentiation of stem cell progenitors and precursors, especially the role it plays in directing the immune arm of the hematopoeitic system.  In addition, Dr. Meagher has studied the mechanisms of action of hematopoietic growth factors and cytokines and the control they exert on stem cell precursors.  These interests have led him to develop novel translational methods and procedures for the collection and long-term cryopreservation of human stem cell sources including bone marrow, peripheral blood progenitors and umbilical cord blood cells.  He is currently investigating novel replacement agents for dimethyl sulfoxide (DMSO) that is considered the gold standard for cryopreservation of human blood products intended for clinical transplantation.  
1056890	Valve Repair/Replacement, Mitral Valve Repair, Atrial Fibrillation Surgery, Maze Procedure, Aortic Aneurysm, Coronary Bypass Surgery, Hypertrophic Cardiomyopathy / Myectomy, Minimally Invasive Surgery 
1057015	Cancer Survivorship
1057063	The innovation of pediatric specialty clinicians has extended the lives of children with complex medical needs, neurological impairment, and technology dependence.  However, our systems of care have difficulty meeting the complex needs of this emerging population.  Challenges lie in coordination of care through a vast continuum that includes hospital systems, primary care, home health, etc.  My interests lie in defining this population of patients; studying their needs on a clinical and systems level, and advocating for quality improvement.  A new area of focus is the potential for electronic health information exchange, now a national priority, to facilitate the coordination of care for these patients.
1057152	Clinical interests included Mood and Anxiety disorders in adults and older adults, as well as the evaluation and treatment of the behavioral and psychological symptoms of Dementia.
1057261	Dr. Podojils work has focused on the role of costimulatory molecule expression and function on both CD4+ T cells and APC populations during autoimmune diseases, such as multiple sclerosis, and he has a particular interest in neuroimmunology.  His primary research focus is to determine the cellular and molecular mechanisms underlying the differential effect of structurally modified forms of anti-CD80 monoclonal antibody (mAb) in the CD4+ Th1 cell mediated disease model of PLP139-151-induced EAE. His current findings suggest that stimulation of CD80 on a CD4+ T cell activated in Th1-promoting conditions induces an increase in the amount of IFN- produced per cell and increases Th1 cell survival within the CNS.  These findings suggesting a mechanism by which anti-CD80 mAb treatment of PLP139-151-primed mice exacerbates disease, while treatment with anti-CD80 Fab fragments decrease disease severity.  In line with his research studying the role of CD80 expression and reverse signaling to the cell expressing CD80, he has also been studying the role of B7-H4 in CD4+ T cell function.  B7-H4 is a recently discovered B7-family member molecule hypothesized to inhibit effector CD4+ T cell responses.  Since current approaches for regulation of human autoimmune diseases are largely broad-based immunosuppressive strategies necessitating the physical deletion/inhibition of entire subsets of T cells or non-specific inhibition of antigen presentation or pro-inflammatory cytokine production which could compromise the hosts ability to combat opportunistic pathogens and/or increase risk of neoplasia, therefore we are currently investing the ability of short-term therapy with B7-H4 Ig may prove to be clinically viable.
1057352	I am interested in clinical research centered on cardiac imaging and valve disease.
1057436	Clinical outcomes for thyroid cancer, hyperparathyroidism, and adrenal tumors including pheochromocytoma and adrenal cancers.Decision analysis.Cost-effectiveness analysis.Database analysis.
1057622	Dr Naidech's primary research and clinical interests include life threatening neurologic diseases such as intracerebral (brain) hemorrhage, subarachnoid hemorrhage, status epilepticus (continual seizures) and traumatic brain injury. Dr. Naidech manages several prospective outcomes databases; these data may be linked with the Enterprise Data Warehouse for quality and academic purposes. Administratively, he is a Medical Director of the Neuro/Spine ICU at Northwestern Memorial Hospital. Dr. Naidech is a frequent peer-reviewer for academic journals.
1057695	Outcomes of novel techniques in breast cancer reconstruction, aesthetic surgery, general reconstruction.Medical device innovation and biodesign.
1057699	The focus of research in my laboratory is to understand the immune basis of prostate disease in humans. We have a particular emphasis on chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), a debilitating medical condition characterized by dysuria and pelvic pain.  My laboratory is very interested in understanding the mechanism underlying inflammation of the human prostate and it's impact on prostate diseases. The laboratory utilizes comparative animal models that closely track human prostate disease to examine prostate disease mechanisms and also as tools for translational research. Some specific areas of research interest are as follows -1. Th1/Th17 mechanisms in chronic pelvic pain: We are interested in understanding the mechanism of T cell mediated pain, the effectors of the pain pathway and measures to modulate Th1/Th17 immune response in animal models and ultimately in humans.2. Chemokine mechanisms in chronic pelvic pain:We are in the process of identifying the mechanisms that appear to mediate chemokine mediated pelvic pain by focusing both on the prostate as well as on neuronal mechanisms of central sensitization. A further focus of this project is the role of mast cells and mast cell-released intermediates in the pathogenesis of chronic pelvic pain. Identification of biomarkers for CP/CPPS in humans is also an emphasis of this project.3. Pattern recognition receptors in prostate inflammation: Deficiencies in TLR4 signaling pathways result in increased susceptibility to bacterial infection, and profound defects in innate and adaptive immunity. We are  in the process of studying the microbial pathogenesis of prostatic bacterial isolates and dissecting TLR signaling pathways in prostate cells.
1057718	I am interested in Pediatric pulmonology, specifially looking at cystic fibrosis and interstitial lung disease. I am also interested in lung function testing from birth to adulthood. I also have an interest in Healthcare Quality and outcomes research.
1057749	I am a general internist with advanced training in epidemiology, public health, and health communication. After completing my residency in Primary Care/Internal Medicine at New York University/Bellevue Hospital, I was a Robert Wood Johnson Foundation Clinical Scholar at the University of Chicago.  My expertise is in cross-cultural communication and health promotion for minority communities. I am a recipient of a Mentored Patient-Oriented Research Career Development Award (5K23HL084177-04) from the National Heart, Lung, and Blood Institute to develop and evaluate culturaly targeted heart disease prevenetion messages for South Asians. I currently direct an ongoing research program to develop, implement, and evaluate literacy and culturally appropriate health education materials on heart disease and diabetes.
1057754	health-related quality of life, symptom evaluation, functional status, primary care
1057770	Of the one million hospitalizations for acute heart failure (AHF) that occur every year, 80% are initially managed in the Emergency Department.  Despite tremendous advances in cardiovascular management, these patients have a very high post-discharge mortality and re-hospitalization rate, approaching 35% within 90 days.  The financial costs are also enormous, consuming more than half of the 40 billion spent annually on HF care.  Attempts to improve post-discharge outcomes with novel therapies have all failed, in  spite of 10 years of efforts.  Current therapeutic management in the ED is the same today as 40 years ago.   I firmly believe we can improve these dismal outcomes.   At Northwestern, it has been a tremendous privilege to have mentors/partners/and collaborators who are experts in Cardiology and Medicine both locally, nationally, and internationally to improve the care of AHF patients.  We are actively working to better understand the pathophysiology of early AHF in order to improve post-discharge outcomes for all AHF patients.  Through public/private partnerships, we are actively engaged in the discovery of novel therapies to help patients feel better and live longer.  Through both clinical research as well as quality improvement efforts, we hope to achieve our goal of reducing the morbidity and mortality associated with AHF.
1057792	Dr. Rahul Khare has recently received a K08 grant 'Improving Emergency Department (ED) Quality and Safety by Enhancing Operations and Quality Management' from the Agency for Healthcare Research and Quality.  For this five-year project Dr. Khare will focus on one key quality indicator score in the ED:  time-to-percutaneous intervention (PCI) quality indicator score for acute ST-elevation myocardial infarction (STEMI) patients. Patients with STEMI have increased mortality if reperfusion or PCI is not achieved within 90 minutes.   Although there is an extensive literature about implementation of this process, the time-to-PCI quality indicator is achieved only 70% of the time.  Dr. Khare will develop and implement process improvements to address the most serious time-to PCI process concerns and  develop a toolkit, based on the findings that will assist hospitals and EDs in assessing opportunities for operational improvement and offer an approach for assessing and resolving quality management issues for time-to-PCI.
1057805	Ruchi Gupta, M.D., M.P.H, is Assistant Professor of Pediatrics and a health services researcher at Northwestern University and Childrens Memorial Hospital.  Dr. Gupta has significant interest and experience with community-based research.  Her research and clinical interests include childhood food allergy and childhood asthma.  Dr. Gupta has more than 25 first-authored peer-reviewed publications and grant support through the Food Allergy Initiative, the National Children's Study and the Robert Wood Johnson Physician Faculty Scholars award.
1057813	We study the molecular and cellular mechanisms by which memories of stressful events contribute to anxiety- and depression-like behavior.  Specifically, our interest lies in neuronal receptors, signal transduction pathways and gene responses mediating: (i)  formation and extinction of aversive memory; (ii)  delayed enhancement of fear memory in the aftermath of stressful experiences; (iii) social modeling of fear; and (iv) the relationship between aversive memories and depression.  Our long-term goal is to elucidate the key brain mechanisms linking cognitive and emotional processes and identify novel targets for treatment of anxiety and depression.
1057824	Dedicated to the care of hospitalized patients.  Additionally works as the Assistant Medical Director of Clinical Information Services for Northwestern Memorial Hospital.
1057832	TRANSPLANT IMMUNOLOGY, ANTIGEN PROCESSING AND PRESENTATION, HUMORAL IMMUNOTY, HLA ANTIBODEIS, NON-HLA ANTIBODIES
1057873	Primary interests: Education of medical students and residents, Otitis Media
1057874	Denys T. Lau, Ph.D., joins the Buehler Center on Aging, Health & Society as Assistant Professor and Director of Health Services Evaluation and Policy Research Section. As a health services and outcomes researcher, Dr. Lau applies various types of quantitative and qualitative research methods to study the quality and safety of health services provided to older populations.
1057874	quality and safety of medication use among older adults
1057883	I am a cardiovascular epidemiologist with particular interest in obesity-specifically associations of physical activity with weight gain and cardiovascular consequences of obesity.
1057890	-Strain imaging in coronary heart disease-Stress echo in valvular heart disease-Patient Prosthesis mismatch.-Advanced heart failure supportive therapies
1057897	<BR><BR>Our laboratory is investigating the response of keratinocytes to ultraviolet (UV) irradiation. We are investigating the role of JNK, p38 and ERK signal transduction pathways in response of cells to UV light and have recently demonstrated that JNK enzyme co-associates with p53 protein and p21Waf cyclin inhibitor. Other studies in the laboratory focus on development of novel chemopreventive agents against UV-induced skin cancer. Apigenin is a plant flavonoid which has been shown to inhibit UV- and chemically-induced mouse skin tumorigenesis and we believe it shows promise for development as a protective agent against human skin cancer. We have demonstrated that apigenin induces G1 and G2/M cell cycle arrest in keratinocytes and other cell lines by inhibiting both accumulation of cyclins and the cyclin dependent kinase activities of cdc2p34 and cdk2. We have also demonstrated that apigenin induces expression of the cell cycle inhibitor WAFp21 in a p53-dependent manner, and that the half-life of p53 protein is extended, due to stabilization via site-specific phosphorylation. Experiments are underway to characterize the kinase(s) involved in p53 phosphorylation. Our laboratory is also investigating the mechanisms by which apigenin inhibits UV-induction of the cyclooxygenase-2 (COX-2) pathway, an enzyme important for prostaglandin production and cell transformation. Experiments are underway to characterize transcription factors which are involved in UV-induction of COX-2 and which may be modulated by apigenin treatment.
1057915	Pediatric Urgent Care
1057921	pediatric emergency medicine ultrasound to reduce radiation exposure, improve patient safety, expedite care, and decrease waiting time
1057996	Dr. Chin is a pediatric surgeon with interests in minimally invasive surgery, critical care, neonatal surgery, congenital anomalies, tumors of the chest and abdomen, endocrine surgery, hernias, undescended tests and ovarian disease.
1058027	Clinical interests: 1- Outcomes after Solid organ transplantation in Hispanics 2- Health communication and literacy in Solid Organ transplantation 3- Quality of Life in Solid Organ transplantation
1058057	Preventive health, health care disparities, immigrant health, cancer care, communications
1058111	Our research focuses on fibrosis and tissue repair. Fibrosis and aberrant tissue repair are prominent in autoimmune diseases (scleroderma, myositis, lupus) and in organ-based disorders (pulmonary fibrosis, glomerulosclerosis, hypertrophic scar), and are considered intractable. Aberrant tissue regeneration also underlie aging and obesity. Fibrosis contributes to 30% of all death worldwide, and thus represents a compelling and urgent scientific challegen.We believe that fibrosis is in fact potentially reversible. Our research takes a 'systems-biology' multi-disciplinary approach to fibrosis, utilizing human tissue, DNA, serum, and animal models and cell biology studies to identify and validate novel targets for therapy, discover genetic risk factors and useful biomarkers. we then attempt to translate these discoveries into clinically relevant approaches.
1058111	Our research focuses on the pathogenesis and treatment of fibrosis. We focus on the  interplay between vascular and autoimmune/inflammatory events in pathological fibrosis.  Our clinical research is focused on the development and evaluation of novel treatments for scleroderma, in using functional genomics to identifying novel biomarkers, and in identifying the genetic bases for fibrosis and systemic sclerosis.
1058170	Areas of interest include heart failure, heart transplantation, ventricular assist devices, disease management programs, health-related quality of life, psychosocial outcomes, patient adherence with therapeutic regimens, patient decision-making, caregiver burden, health literacy, nutrition, palliative care, and transition from pediatric to adult care.
1058191	Dr. Jordans work spans several areas, including quality and cost of care for persons with chronic illnesses, financing and outcomes of mental health and child welfare services, and health economics.
1058264	I enjoy caring for children with disorders of growth, puberty and the adrenal, pituitary and thyroid gland.  I also enjoy care of children with diabetes
1058270	My primary interests involve parental education on health maintenance for their children, preventative medicine, and child safety/injury prevention.  Also, due to the prevalence of childhood obesity in our community, education on proper nutrition and exercise has become another focus of interest in my practice.
1058291	Dr. Michelsons research interests include end-of-life decision making, palliative care, and ethics. Currently, her research focuses on communication and decision making in end-of-life care among patients, family caregivers, and professional caregivers in the pediatric intensive care unit.
1058311	My research focuses on understanding how the human brain transforms odor inputs into olfactory percepts (such as the smell of mint, banana, or wet dog), and how learning, memory, and experience modulate odor perception at the neural and behavioral levels. To address these questions we use a combination of techniques including high-resolution olfactory functional magnetic resonance imaging (fMRI), multivariate statistical analyses, psychophysical paradigms, and physiological recordings.  Given that patients with Alzheimers disease (AD) exhibit profound impairments in the sense of smell, I am also investigating whether olfactory fMRI techniques can be effectively used as a non-invasive diagnostic biomarker to identify asymptomatic individuals at risk for developing AD.
1058513	Our lab is interested in the effects of oxygen on cell metabolism, and in the molecular mechanisms underlying cellular oxygen sensing.  The signaling pathways activated by hypoxia, and their regulation of transcriptional and post-translational responses in diverse cell types are also of major interest.
1058524	neuroscience
1058559	Functional gastrointestinal disorders including abdominal pain, nausea, vomiting and constipation in children. Gastrointestinal motility.
1058585	Coinvestigator. A study looking at strain, strain rate, and changes in left ventricular volumes and geometry with 3D echocardiography in patients with chronic valvular regurgitation and in patients with valvular regurgitation before and after surgery.Coinvestigator. A study looking at strain, strain rate, and myocardial viability with dobutamine stress echo in patients with congestive heart failure before and after placement of biventricular pacemaker for resynchronization therapy.MADIT-CRT, coinvestigator. Will be overseeing and directing the acquisition of echocardiogram studies for all recruited patients in our center.
1058594	As a certified sex therapist, I treat a wide range of sexual disorders, including problems with desire, arousal and orgasm, as well as pain disorders, sexual compulsivity and paraphilias. As a clinical psychologist I also treat individuals and couples with relationship problems, depression and anxiety.
1058614	My research interest focuses on the role of acetyltransferase p300 in collagen synthesis and tissue fibrosis. Excessive synthesis and deposition of extracellular matrix proteins especially Type I collagen in the tissues causes fibrosis. TGF-beta stimulates collagen synthesis and has been implicated in fibrosis. We recently demonstrated that i) acetyltransferase p300 is essential for TGF-beta-induced collagen synthesis, ii) TGF-beta induces the levels of p300 in fibroblasts, and iv) most importantly, p300 level is significantly elevated in fibrotic tissues. We are interested i) to determine the molecular basis of elevation of p300 in fibrotic tissues, ii) to determine the contribution of elevated level of p300 in the development of fibrosis, and iii) to develop novel therapeutic approaches to control tissue fibrosis  
1058614	My research interest focuses on the role of acetyltransferase p300 in collagen synthesis and tissue fibrosis. Excessive synthesis and deposition of extracellular matrix proteins especially Type I collagen in the tissues causes fibrosis. TGF-beta stimulates collagen synthesis and has been implicated in fibrosis. We recently demonstrated that i) acetyltransferase p300 is essential for TGF-beta-induced collagen synthesis, ii) TGF-beta induces the levels of p300 in fibroblasts, and iv) most importantly, p300 level is significantly elevated in fibrotic tissues. We are interested i) to determine the molecular basis of elevation of p300 in fibrotic tissues, ii) to determine the contribution of elevated level of p300 in the development of fibrosis, and iii) to develop novel therapeutic approaches to control tissue fibrosis. We are also interested to delineate the role Plasminogen Activator Inhibitor-1 (PAI-1) in tissue fibrosis. PAI-1 inhibits uPA/tPA and plasmin-mediated activation of MMP activities. PAI-1 level is elevated in different fibrotic tissues and implicated in fibrosis. Paradoxically, PAI-1 deficiency is associated with cardiac fibrosis in aged mice. We are investigating the molecular basis of cardiac fibrosis in PAI-1 deficient mice.
1058641	Clinical research: focus on new drug and device development in dermatology, skin oncology, and cosmetic surgery.Technology & educational interests: clinical imaging and surgical simulation in graduate and postgraduate medical education.  Volunteer interests: free clinics for the underserved, skin cancer screenings, skin cancer detection and prevention education, and sports dermatology for professional and amateur leagues.
1058663	Dr. Schink has been a principal investigator on several clinical trials related to ovarian cancer, specifically on chemotherapy for the treatment of ovarian cancer.  Currently, Dr. Schink is working on a number of gynecologic oncology projects, including a clinical trial involving treatment for patients with stage III or stage IV ovarian epithelial cancer.  This particular study is a multi-center clinical trial to test the capabilities of three different combinations of chemotherapy drugs.  The three combinations will be compared based primarily on the survival of patients, but also on the incidence of toxicity and the quality of life of the patients.  The goal of Dr. Schink's project is to find the most effective treatment for women with late-stage ovarian cancer.  
1058670	Mitochondrial transport, preconditioning, ion transport
1058681	Neuropathology <BR><BR>Molecular genetics of brain tumor (by FISH)
1058758	Our research focuses on pathologic mechanisms of asthma. We use in vivo mouse models involving allergen sensitization of wildtype, transgenic and gene knockout mice. We also focus on mucosal immunity, specifically the role of secretory IgA, 12/15-lipoxygenase and intelectin in asthma. We augment these in vivo studies by studying the responses of cultured normal human primary airway epithelial cells to the effects of allergic mediators. Experimental measurements include in vivo airway physiology (the development of airway hyperresponsiveness to bronchoconstrictors), lung inflammation, airway goblet cell hyperplasia (excessive mucus production), sub-epithelial fibrosis (excessive collagen), and airway smooth muscle increases in mass or contractility. We use quantitative RT-PCR (Taqman) to measure expression of genes. We use computer-assisted stereology to quantify pathologic changes observed in sections of mouse lungs. We use ELISA to measure protein levels of specific mediators in mouse lung lavage samples and serum.
1058758	Our research focuses on pathologic mechanisms of asthma. We use in vivo mouse models involving allergen sensitization of wildtype, transgenic and gene knockout mice. We also use classical genetic studies to identify asthma susceptibility genes in mice and we focus on mucosal immunity, specifically the role of secretory IgA in asthma. We augment these in vivo studies by studying the responses of cultured normal human primary airway epithelial cells to the effects of allergic mediators. Experimental measurements include in vivo airway physiology (the development of airway hyperresponsiveness to bronchoconstrictors), lung inflammation, airway goblet cell hyperplasia (excessive mucus production), sub-epithelial fibrosis (excessive collagen), and airway smooth muscle increases in mass or contractility. We use quantitative RT-PCR (Taqman) to measure expression of genes. We use computer-assisted stereology to quantify pathologic changes observed in sections of mouse lungs. We use ELISA to measure protein levels of specific mediators in mouse lung lavage samples and serum. We perform gene expression studies in cultured normal human primary airway epithelial cells.
1058781	My primary research interest is centered on tumor cell and extracellular matrix (ECM) interactions associated with cancer progression. These studies involve analyzing how tumor cells affect/alter their ECM, as well as respond to their changing environment using in vitro model systems based on an underlying concept of dynamic reciprocity. 
1058800	metabolic syndrome, cholesterol, lipids, menopause, CVD
1058949	Major Research Interests:Global Mental Health,Psychology of Justice,Transmission of Post-Traumatic Stress Disorder,Psychology of Diversity,Cultural Issues in Clinical Psychology,Predictors of Psychotherapy Outcome,
1058962	Research in our laboratory is focused on the molecular and cellular mechanisms of intracellular calcium (Ca2+) signaling. Ca2+ is a ubiquitous intracellular signaling messenger, mediating many essential functions including gene expression, chemotaxis, and neurotransmitter release. Cellular Ca2+ signals generally arise from the opening of Ca2+ permeable ion channels, a diverse family of membrane proteins. We are studying Ca2+ signals arising from the opening of Store-Operated channels (SOCs), a family of plasma membrane Ca2+ channels activated by a decrease in the calcium content of the endoplasmic reticulum (ER). Human patients with mutations in SOCs suffer from a devastating immunodeficiency, underscoring their vital importance for human immunity. We are studying the molecular and cellular mechanisms by which SOCs are activated and the mechanisms by which they regulate gene expression, immune cell function, and the development of neural stem cells.
1058964	cytoskeleton, motor proteins, cell movement, microtubules, actin, kinesin, dynein, myosin, neurodegenerative diseases
1058994	Dr. Laumann's clinical interests include the diagnosis and treatment of complex  medical dermatologic disorders including collagen vascular, psychocutaneous, and genital diseases. She has a particular interest in fibrosing, pruritic and other disorders related to renal dysfunction, as well as Raynaud's syndrome. She has an ongoing interest in the various aspects of the application of body art and how this may be used to help functioning. Currently, she is involved with other research studies related to psoriasis, atopic dermatitis, nephrogenic systemic fibrosis, and lupus erythematosus, as well a study using a magnetic tongue stud to activate the tongue drive system to help those with neurological disorders access their environments.
1059008	Immunosuppression Withdrawal for Pediatric Living-donor Liver Transplant Recipients.Currently a Co Investigator in a study sponsored by the National Institute of Allergy and Infectious Diseases, National Institutes of Health.                            The primary objective of this study is to determine the proportion of participants successfully withdrawn from immunosuppression and to measure the outcome of immunosuppression withdrawal.Interest also in immune pathogenesis of late allograft dysfunction post liver transplantation.  Currently PI in a study evaluating immune pathogenesis of post transplant allograft hepatitis.Center PI on an NIH sponsored study (U01 NIAID) - Immunosuppression Withdrawal for stable pediatric liver transplant recipients.The primary objective of this study is to assess the efficacy of immunosuppression withdrawal (ISW) in pediatric liver transplant (tx) recipients.
1059041	Comparative medicine and pathogenesis, preclinical testing and toxicology, nanotoxicology
1059090	Epithelial cells, which are positioned at the line of first exposure to many pathogens, regulate both innate and adaptive immunity through production of functional molecules and via physical interactions with cells of the immune system. We are currently investigated on the epithelial factors which activate and/or regulate immune cells. We are also focusing on the pathogenesis of chronic rhinosinusitis.
1059090	Local immunity in the airway; airway epithelial cell biology; mast cell biology; the pathogenesis of chronic rhinosinusitis.    A long-recognized property of airway epithelial cells is their function as a complex physical barrier that defends against exposure to potentially harmful inhaled substances and microbial pathogens. It is now clear that airway epithelial cells also regulate both innate and adaptive immunity through production of functional molecules and via physical interactions with immune cells. Our laboratory is focused on the role of epithelial cytokines including BAFF, TSLP and IL-1 family cytokines in the initiation and activation of airway inflammation.                 Chronic rhinosinusitis (CRS) is a chronic inflammatory disease of the sinuses and upper airways that affects over 30 million Americans. Current medications have variable efficacy and over 250,000 surgical procedures are performed annually in the United States on patients who failed maximal medical therapy. Our laboratory investigates the pathogenesis of CRS. We are currently focused on the role of epithelial cells and inflammatory cells including B cells, T cells, macrophages, eosinophils and mast cells in patients with CRS.
1059114	Functional and molecular imaging application on radiation treatment planning
1059133	My research interest is primarily on the structural mechanisms of activation of the cell-surface receptors in cancer and neural development. We try to obtain atomic-resolution views, using X-ray crystallography and biochemical/biophysical tools, on how the transmembrane receptors recognize their ligands, and how these recognition/activation processes can be modulated for clinical purposes.
1059140	My research interest lies in identification and characterization of cell surface carbohydrates and proteins required for herpes simplex virus (HSV) viral entry and cell fusion. I have been focusing on glycoprotein B (gB) and gL, two of four glycoproteins essential for HSV entry and cell fusion. I have been studying the interaction between gB and gB entry receptor, paired immunoglobulin like-type 2 receptor (PILRa). I am also interested in the interactions among gB, gD, gH and gL.
1059149	Gastroesophgeal reflux disease;Esophageal motility;Mathematical modeling;
1059178	1. Genomics for Kidney Transplantation - a collaboration to find genetic predispositions to various clinical outcomes in transplantation.2. Non-invasive diagnosis of renal allograft rejection - Urine based assays for mRNA to diagnose rejection and predict outcomes.3. A randomized controlled trial of Rituximab vs. Placebo for treatment of de novo donor specific antibodies detected post renal transplant.
1059178	Living Kidney Donation, Kidney allocation, Highly Sensitized and incompatible patients, Kidney Paired Donation, Transplant Genomics and Biomarker Development, acute renal failure, humoral allograft rejection
1059251	My primary clinical interests are in the cognitive-behavioral treatment of anxiety and mood disorders.  I am a certified affiliate with the Academy of Cognitive Therapy (ACT).
1059267	Gregory B. Waypa, Ph.D. received his B.S. in Biomedical Engineering Sciences from the University of California, San Diego in 1991.   He then enrolled as a graduate student at Albany Medical College in Albany, New York, where, under Fred L. Minnear, Ph.D., he studied increased pulmonary vascular permeability associated acute respiratory distress syndrome (ARDS) and explored the possibility of using cAMP-enhancing agents as a possible therapy for the disease.  Dr. Waypa received his M.S., and later his Ph.D., in Physiology and Cell Biology from Albany Medical College in 1997 and 1998, respectively. From 1998 to 2002, Dr. Waypa was a postdoctoral fellow with Paul T. Schumacker, Ph.D. at The University of Chicago.  In 2002, Dr. Waypa received an appointment from The University of Chicago as a Research Associate (Assistant Professor) where he continued to work with Dr. Schumacker.  In 2004, Dr. Waypa received an appointment from Northwestern University as a Research Assistant Professor where he is continuing his collaboration with Dr. Schumacker.  Currently, Dr. Waypa is studying hypoxic pulmonary vasoconstriction (HPV), which is a physiological response to low alveolar oxygen tension and, in cases where a small percentage of the lung alveoli are hypoxic, HPV improves lung gas exchange by redistributing blood flow away from those areas toward regions with better oxygenation.  Key to this research is understanding the mechanism of O2 sensing by the pulmonary vasculature and how this results in the generation of the HPV response.
1059270	cell cycle, knockout mice, breast cancer, cyclin, diabetes, pituitary, development, reproductive biology
1059361	Research interests include: Efforts include (1) basic biophysical mechanisms contributing to oxygen-sensitive contrast in MRI; (2) fast imaging methods to detect and stage coronary artery disease; (3) development of MR-based methods to understand and evaluate the mechanisms governing ischemic heart failure; (4) utilization of interventional MRI methods for delivering therapeutic substrates (stem cells, growth factors, etc.) following myocardial infarctions; and (5) development of MR molecular imaging methods in the assessment of cardiovascular disease.
1059384	Clinical and Translational Bioinformatics
1059611	Dr. Lebowitz is the founder and director of Cardiac Behavioral Medicine at the Bluhm Cardiovascular Institute at Northwestern. She is a licensed clinical health psychologist specializing in the heart-mind connection. She works exclusively with cardiac patients and helps them prepare for surgery, adjust to a new diagnosis, and cope with common emotional consequences of cardiac disease or cardiac surgery, including stress, depression, and anxiety. She teaches stress managment techniques, treats cardiac-related depression and anxiety and helps individuals initiate and maintain lifestyle changes to reduce their risk of heart disease.  Her research interests focus on the interplay between depression, stress, and cardiac health.   
1059636	My research activities focus mainly on asthma. Asthma exacerbations are mostly precipitated by common cold viruses. I am interested in elucidating the early mechanisms of respiratory viral infections that determine the severity of exacerbations in people with asthma. In addition, in collaboration with Dr. Esteban G. Burchard, M.D. from the University of California San Francisco and other investigators accross the US and abroad, we participate in a network of centers studying the genetic and environmental factors that influence the development and the severity of asthma in minority groups. Other research interests include pathogenesis of airway inflammation in allergic rhinitis and in asthma, and research in primary immunodeficiencies.
1059636	My research interests include investigations on how respiratory viruses cause asthma exacerbations, influenza virus infection, airway epithelial cells, asthma management and genetics of asthma. My clinical interests include allergic conditions such as allergic rhinitis, asthma, sinusitis, urticaria, skin allergic diseases, food allergy, insect allergy, as well as primary immunodeficiencies.
1059640	Dr. Weltys research interests are in the application of biostatistics to psychiatric epidemiology and environmental research.  She is the lead statistician for the Northwestern Juvenile Project, a large-scale longitudinal study of psychiatric disorders and risky behaviors in delinquent youth.   Her work on the on the National Morbidity Mortality and Air Pollution Study (NMMAPS) used Bayesian methods to estimate generalized linear models with distributed lags to capture short term effects of air pollution on mortality.  She has also worked on formulating covariance models for random fields and estimating likelihoods for very large data sets, using algae levels in Lake Michigan.
1059658	Clinical interests are in General Internal Medicine/Primary Care, Community Health and Hospital Medicine.  Research Interests are in Medical Education, Medical Decision Making, Simulation, Quality Improvement and Patient Safety.
1059672	test
1059840	Diabetic Nephropathy, Albuminuria, VEGF, TGF-beta, mouse models, MCP-1, podocyte motility, multiphoton microscopy
1059840	I work in the field of diabetic kidney disease, specifically looking at the role of vascular endothelial growth factor (VEGF) and podocytes in the pathogenesis of albuminuria. We have made some exciting discoveries that are being pursued with genetic mouse models.
1059841	My laboratory is interested in understanding the mechanisms behind allergic diseases...<p><b>Why do they develop? <p>What controls them? <p>How can we stop them?</b><p>We are interested in understanding this from the point of view of the immune system and have several projects that focus on the mast cell. This tissue-resident cell is best known for being able to release histamine but we believe it plays a much more complex role that just this final part in an allergic reaction.<p><center><img src='http://www.brycelab.com/Science_files/Mast%20Cells.jpg' alt='mast cell degranulation'/><p><i><font color='0066cc'>A mast cell releasing its preformed granules.</i></font color></center><p>We employ both preclinical studies and clinical work in our studies. One of our main goals is to better understand food allergy and we use animals models of anaphylaxis, as well as clinical studies on patient biopsy material to explore this.<p>More information about us and our research is available at our personal webpage above.
1059841	We are interested in the mechanisms that regulate allergic sensitization. Using mouse models of allergic diseases, such as asthma, eczema and allergy to food, our research is focusing on how histamine and histamine receptors might influence the progression of allergic sensitization.
1059844	Local synaptic circuits in motor-frontal cortex engage in neural operations underlying many aspects of cognition and behavior  motor control, executive functions, working memory, and more  yet circuit organization at the synaptic, cellular, and molecular levels remains poorly understood in this agranular cortex. What is the functional organization of these synaptic pathways? What cellular and circuit-level operations do neurons in these perform? How do these local circuits communicate with each other and how do they interact with subcortical systems in the basal ganglia and thalamus? The focus of our laboratory is to apply multiple tools of quantitative synaptic circuit analysis to elucidate the functional wiring diagrams of neocortical neurons in motor-frontal cortex. We use laser scanning photostimulation (LSPS) microscopy, based on glutamate uncaging and channelrhodopsin-2 excitation, for rapid functional mapping of synaptic pathways onto single neurons in brain slices of motor-frontal cortex. We are also applying a variety of circuit analysis tools in efforts to identify circuit-level mechanisms in mouse models of disease, including autism, Rett syndrome, epilepsy, and motor neuron diseases. Our lab is also involved in the development and maintenance of software tools for imaging and electrophysiology applications: www.scanimage.org, www.ephus.org.
1059857	Research on motor control and learning with the use of computational tools, virtual reality, whole body machine interfaces and dance for physical rehabilitation of cerebral palsy and movement disorders.
1059894	Skin toxicities, chemotherapy, targeted agents, rash, paronychia, EGFR, side effects
1059904	Surgical Pathology<BR><BR>The long-term objective of our research is to study molecular mechanism and chemoprevention of chronic inflammation-driven carcinogenesis. The specific areas of interest are 1) to develop a molecular mimicking model of ulcerative colitis-associated carcinogenesis in rodents, and further to elucidate the role of inflammation-caused and dietary iron-enhanced nitro-oxidative stress and inflammatory mediators in DNA damage, cell proliferation and inflammation-driven carcinogenesis; 2) to study the pathogenesis and molecular biomarkers of pancreatic carcinoma in genetically engineered mouse model and in human; and 3) to develop an efficient strategy on the prevention of chronic inflammation-driven carcinogenesis, particularly interested in dietary nutrients, antioxidants, green tea and inositol compounds and specifically targeted on colorectal, pancreatic, and liver carcinogenesis.
1059913	Synaptic plasticity is the process by which the strength of communication between neurons is modulated in response to stimuli. This process has emerged as the strongest candidate mechanism underlying information storage and processing. In the cerebral cortex, the majority of excitatory synapses found on pyramidal neurons occur on dendritic spines. Dendritic spines are highly dynamic structures and undergo many forms of structural modification. Spine remodelling occurs in concert with changes in post-synaptic function, driven by the trafficking of synaptic glutamate receptors. Thus, structural plasticity is thought to control neural circuit refinement and information storage. Neuromodulators, including dopamine, noradrenaline and neurosteroids, can dramatically influence synaptic plasticity, but much less is known about mechanisms by which these modulators control structural plasticity. Aberrant structural plasticity and neuromodulatory signalling have been extensively associated with neuropsychiatric disorders, including schizophrenia, autism spectrum disorders and mental retardation. Conversely, increased structural plasticity, and regulation of neuromodulatory signals, can promote functional recovery from neurological disorders. Thus, one of the most important challenges in neuroscience is to uncover the mechanisms underlying structural plasticity during brain development. My work is centered on understanding how neuromodulators and neurosteroids control structural plasticity and the mechanisms that underlie these effects.
1060183	The overarching objective of the research ongoing in my laboratory is the identification of protein networks and signaling pathways that are functionally compromised in pediatric brain tumors to enable development of effective and safe individualized targeted therapies. Toward this goal, we are conducting a comprehensive integrative analysis of the genome, epigenome and transcriptome of these tumors and mapping all identified structural/functional alterations to protein networks and cellular processes with the aid of system's biology databases.
1060189	i am particularly interested in family and marital therapy and clinically am interested in childhood anxiety disorders and the autistic spectrum disorders.
1060317	My interests include osteoarthritis of the knee and hip and how dynamic loading (such as gait) can effect progression of the disease.  
1060325	<BR><BR>My research interests are in the relationship between diet and cancer, particularly focusing on elucidating the role of dietary iron on inflammation-driven carcinogenesis in a molecular mimicking model of ulcerative colitis associated carcinogenesis in IL-2 deficient mice. I am also working on developing efficient chemopreventive agents in the inhibition of ulcerative colitis associated carcinogenesis. I am particularly interested in dietary nutrients, antioxidants, and green tea.
1060327	Mucosal Innate and adaptive immunity 
1060327	My research interests center on the immunological mechanisms involved in infectious and allergic diseases. My previous studies have ranged from investigations of infectious diseases in tropical endemic areas to molecular diagnosis and translational science. The shared mechanisms of pathogenesis between allergic and infectious diseases have been an active area of investigation. Recently, I have focused on epithelial cells biology and their role in inflammation, innate immunity and adaptive immunity.
1060342	Primary Clinical Interest:Provide clinical care to Pediatric Oncology patients at Lurie Children's and to Pediatric Hematology patients at the New Lenox Outreach Clinic.
1060364	Recently, Dr. Buttin received a two-year award from the Sidney Kimmel Foundation for Cancer Research for her work studying molecular mechanisms that influence cell growth and metastasis in an aggressive subtype of endometrial cancer, uterine papillary serous carcinoma (UPSC). This work has since led to an additional grant from the National Cancer Institute as well as several smaller, foundation grants. She has authored several research articles on a novel biomarker to predict chemosensitivity and prognosis in UPSC as well as the role of defective DNA mismatch repair and hereditary cancer susceptibility in endometrial cancer focusing specifically on the MSH6 DNA mismatch repair gene.  Her current basic research includes the elucidation of pathways of carcinogenesis in uterine papillary serous carcinoma, its association with inherited cancer syndromes, as well as the prevalence of defective DNA mismatch repair in type II endometrial cancer.  Her clinical research focuses on the development of synuclein-gamma (SNCG) as a novel prognostic biomarker for high risk endometrial cancer and its association with chemoresistance.  Dr. Buttin is collaborating with the Gynecologic Oncology Group (GOG) and has a special interest in novel chemotherapy and targeted agents for endometrial, cervical and ovarian cancer, treatment strategies for uterine sarcomas, as well as the role of radical surgery and minimally invasive surgery in the management of gynecologic malignancies.
1060466	My interests include: - Adults with congenital heart disease with arrhythmias, particularly, which type of device (pacemakers/defibrillators) is indicated in patients to prevent sudden cardiac death.- Management of arrhythmia in patients of all ages, from fetal arrhythmias to adult congenital patients.- Catheter ablation.- Utilization of resynchronization in single ventricle patients and in patients with cardiomyopathy.- Screening athletes and patients on ADHD medications.- Prevention of sudden death in congenital central hypoventilation patients.
1060531	My primary clinical and research area focuses on infections in transplant recipients.  My research is futher focused on viral infections, specifically respiratory viral infections (influenza, adenovirus) in transplant recipients.
1060553	My primary research interest is in promotion of healthy lifestyle (physical activity and nutrition) in persons with arthritis utilizing motivational interviewing.
1060566	I am currently a hepatologist with a strong interest in liver transplantation & complications. My main research interests are minimization or withdrawal (tolerance) of immunosupression and infection complications
1060566	Infectious disease, liver transplantation, immunosuppression, cirrhosis, bacterial infections, intestinal permeability
1060579	Clinical interests include pediatric pancreatic disorders and pediatric feeding/swallowing dysfunction
1060618	My laboratory conducts research on behavioral risk factors (obesity, poor quality diet, physical inactivity, tobacco use). We also develop cutting-edge handheld technologies that support self-regulation and healthy behavior change.  Finally, we create on-line learning tools to support skill mastery in evidence-based practice and team science.
1060619	The overall goal of my research program is to understand the mechanisms of mammalian reproduction, in particular, how germline stem cells, meiosis and gamete differentiation, are regulated in mammals, using combined genetic, development and evolutionary approaches. We work with both mouse and Drosophila systems as well as cell culture to characterize the roles of highly conserved components of regulatory machinery for stem cell and reproductive development. We are also interested in translational research which extends our findings from animal models into reproductive medicine, in particular in our battles against reproductive cancers and infertility.
1060635	In additional to his clinical practice as a pediatric emergency medicine physician, Walter is Core Faculty at the Feinberg School of Medicine and Northwestern Simulation and leads a university-wide faculty development program on improving medical faculty feedback skills. He has been a co-investigator on simulation-related research grants dealing with curriculum development in pediatric emergency medicine, risk-informed in situ simulations and the effect of scripted debriefing on learning outcomes. He has taught on many basic and advanced simulation instructor courses as an international partner of EuSim, a European Simulation Collaborative led by Dr. Peter Dieckmann, and through strong collaborations with the Harvard-affiliated Center for Medical Simulation, as well as PAEDSIM, a German-speaking Paediatric Simulation Working Group. He currently serves on the Board of Directors for the Society for Simulation in Healthcare.
1060674	Cognitive-Behavioral and Mindfulness- and Acceptance based Behavioral therapies for depression and anxiety disorders in adolescents and adults. Cognitive-behavioral stress management for multiple sclerosis and pain.
1060686	Exercise and Fitness in WomenPreventive CardiologyMetabolic Syndrome
1060686	Principal Investigator of the St. James Women Take Heart ProjectPrincipal Investigator of STILETTO (Syndrome X Trial: Identifying underLying Endothelial dysfunction and Testing Treatment Outcomes in women) Study
1060688	CT and MR imaging of the central nervous system including the brain and spinal cord.Advanced neuroimaging techniques including CT and MR perfusion, time-resolved MR angiography, CT angiography, CSF flow imaging, and functional MRI.Spine procedures including myelography, vertebroplasty, diskography, image-guided biopsy, and steroid injections.Cerebral angiography
1060697	I am primarily interested in loco-regional therapies to treat primary and secondary liver cancers. I am involved in both pre-clinical and clinical studies along these lines. I am also very interested in the use of IVC filters in patients with venous thromboembolic disease.
1060922	My clinical areas of interest is peri-operative quality of care of the cardiac and thoracic surgical patients.My primary areas of research interest are the control of breathing, peri-operative metabolic disorders, critical care outcomes, and resuscitation.My primary areas of education include curriculum design and problem-based learning discussions.
1060934	Dr. Sheeans research goals are to combine clinical nutrition and epidemiology. Her general interests include evaluating nutrition therapies during illness, treatment and recovery, where she has specifically focused on the impact of parenteral nutrition on stem cell transplant outcomes and on enteral nutrition during critical illness. She is especially interested in translation research; exploring the impact of hospitalization on nutritional status and nutrition behaviors and increasing the recognition of these acute declines across disciplines. Dr. Sheean is also a Research Editor for the Journal of the American Dietetic Association and assists with the coordination and implementation of medical nutrition education at the Feinberg School of Medicine.
1061090	ENDOTHELIAL CELL FUNCTION DURING ALLERGIC DISEASE.Leukocyte migration from the blood into tissues is vital for immune surveillance and inflammation.   Specificity for the site of leukocyte migration is determined by the combination of adhesion molecules, cytokines and chemokines in the microenvironment. We have focused on the function of the endothelial cell adhesion molecule VCAM-1.  VCAM-1 is expressed on endothelial cells during atherosclerosis, allograft rejection, infection, and asthmatic responses. Furthermore, disruption of the mouse VCAM-1 gene impairs placentation and cardiac development resulting in embryo death.  Thus, VCAM-1 has important functions in development and disease.  As little was known regarding VCAM-1 signaling, we studied the molecular mechanisms for VCAM-1 signal transduction in endothelial cells in vitro and in vivo.Although it has traditionally been thought that VCAM-1 simply serves as a scaffold for leukocyte binding to endothelium, we have reported that it activates endothelial cell intracellular signal transduction pathways which result in endothelial cell shape changes and leukocyte passage. VCAM-1 activates endothelial cell NADPH oxidase resulting in the generation of low non-toxic levels of reactive oxygen species (ROS).  These ROS rapidly stimulate endothelial cell-associated  matrix metalloproteinases (MMP) which are required for VCAM-1-dependent lymphocyte migration. We have also demonstrated that in vivo administration of the antioxidant bilirubin blocks VCAM-1-dependent leukocyte migration into the lung in experimental asthma. Currently, there are two main research directions.  1. We are examining mechanisms for VCAM-1-stimulated activation of endothelial cell NADPH oxidase, including studies of the structure/function of the cytoplasmic tail of VCAM-1.  We are also examining the mechanisms for ROS function in regulating endothelial cell intracellular signals.2.  To further determine whether these VCAM-1 signals function in vivo, we are utilizing knockout and transgenic mouse models to examine VCAM-1-dependent infiltration of eosinophils in experimental asthma.  Pulmonary eosinophilia is one of the most consistent hallmarks of asthma. Information about the mechanisms that control leukocyte infiltration will provide a basis towards proposing interventions in VCAM-1-mediated processes in disease.    Moreover, limiting VCAM-1 dependent inflammation in chronic disease may be an advantageous target as it could spare VCAM-1-independent inflammation such as neutrophil clearance of infections.
1061090	LEUKOCYTE RECRUITMENT DURING ALLERGIC DISEASE. White blood cell (leukocyte) migration from the blood into tissues is vital for immune surveillance and inflammation.   Specificity for the site of leukocyte migration is determined by the combination of adhesion molecules, cytokines and chemokines in the microenvironment. We have focused on regulation of allergic inflammation by vascular cell adhesion molecule (VCAM-1).  VCAM-1 is expressed on blood vessel endothelial cells during atherosclerosis, allograft rejection, infection, and asthmatic responses. Furthermore, disruption of the mouse VCAM-1 gene impairs heart development resulting in embryo death.  Thus, VCAM-1 has important functions in development and disease.  We are examining the molecular mechanisms for VCAM-1 signal transduction in endothelial cells in vitro and in vivo.  We have reported that VCAM-1 signals through reactive oxygen species such as hydrogen peroxide.  These reactive oxygen rapidly stimulate endothelial cell-associated  matrix metalloproteinases (MMP) and protein kinase Ca, resulting in endothelial cell contraction for the opening of passageways through which leukocytes migrate.  Blocking this signaling pathway in vivo inhibits allergic inflammation.Currently, there are three main research directions regarding regulation of allergic inflammation. 1. Mechanisms for VCAM-1 signaling.  2. Vitamin E regulation of leukocyte recruitment in allergen responses.3. Amino Acid (5HTP)/Neurotransmitter regulation of inflammation.
1061208	My research interests are in 2 areas: 1. Tissue-specific regulation of gene expression, chromatin structure and modification in the context of the CFTR gene, that when mutated causes the common inherited disease Cystic Fibrosis. We identified and are characterizing intronic and extragenic elements that control CFTR gene expression, modulate the 3D structure of the locus and mediate tissue specificity. 2. Pancreas Cancer. We are investigating the role of secreted proteoglycans (collagen XV and the MUC6 mucin) in initiation, invasion and metastasis of human pancreatic adenocarcinoma.
1061219	Russell G. Robertson, MD, is professor and chair of the Department of Family and Community Medicine at Northwestern University Feinberg School of Medicine.  He joined the Feinberg Schools leadership in October 2005.  He holds a B.A. in elementary education from Michigan State University and an MD from Wayne State University.  He completed his family medicine residency in Grand Rapids, Michigan before joining the Medical College of Wisconsin (MCW) in Milwaukee.  He was recruited from MCW, where he had served as interim chair of the Department of Family and Community Medicine and most recently as the associate dean for faculty affairs.  He began his professional career as an elementary and junior high school teacher in suburban Detroit.Dr. Robertson was one of 17 physicians nationwide appointed to the Council on Graduate Medical Education by the U.S. Secretary of Health and Human Services in 2003.  Now chair of the Council since 2008, Dr. Robertson and his fellow members advise Congress and the Department of Health and Human Services on issues related to physician supply and distribution.  In this capacity he has been invited to serve on a number of national and international workforce bodies.Dr. Robertsons interest in medical education has evolved to an international level.  He is the Associate Director for Global Education for Northwesterns Center for Global Health.  He also serves as president of the board of Hillside Healthcare International, which supports a clinic in Punta Gorda, Belize, Central America.Dr. Robertson also holds a certificate of added qualification in geriatrics.
1061234	My central clinical interests are trauma-related disorders (acute stress disorder, post-traumatic stress disorder, complex trauma), mood disorders, and physician health and wellness.  I am very involved in graduate medical education and educational research in medical education, especially clinical skills training and evaluation and the development of professionalism during residency.
1061449	I have done numerous vaccine studies and have a continued interest in vaccine preventable disease
1061501	Dr. Yerkes primary concentrations are reconstruction of complex genitourinary anomalies, medical and surgical management of neurogenic bladder, disorders of sex development,  hypospadias, and congenital vaginal anomalies and urogynecology.
1061503	Dr. Chaviano's clinical concentrations include pediatric urologic reconstruction, hypospadias, hydronephrosis and fetal urology.
1061575	Psychosomatic medicine: psychiatric issues in those with co-occurring medical illnesses
1061598	Dr. Rothrocks research interests include psychosocial aspects of chronic illness, psychosocial oncology, quality of life, patient-provider communication, and distress and symptom management.
1061609	Dr. Pellegrini is an exercise physiologist with research interests in behavioral weight loss, physical activity, and sedentary behaviors.  Dr. Pellegrini's research has compared the use of a technology-based system and standard behavioral weight loss program on weight loss and physical activity.  Dr. Pellegrini is the Project Coordinator for the ENGAGED (E-Networks Guiding Adherence to Goals in Exercise and Diet) clinical trial (PI: Bonnie Spring, Ph.D.).
1061645	Reproductive genetics; graduate training and education, finance and reimbursement, genetic service delivery models, psychosocial issues and decision making in genetic counseling.
1061682	Understanding the group dynamics and interpersonal processes in group decision-making as it relates to IRB and IACUC review and approval processes.  Development of effective programs for the protection of human subjects.  Research on attitudes about spirituality and religiosity in psychology graduate students as well as graduate students in other health sciences, and research on training programs in multi-culturalism as they relate to spirituality in the clinical domain.
1061719	Dr. Keefer is an NIH-funded investigator with a research interest in the application of behavioral interventions to chronic gastrointestinal diseases including Ulcerative Colitis, Crohns Disease and Irritable Bowel Syndrome.  
1061719	I am funded by the NIH to design and test behavioral interventions for chronic gastrointestinal disorders, including Inflammatory Bowel Disease (Ulcerative Colitis, Crohns Disease) and Irritable Bowel Syndrome.  My most recent interests include the effects of a brief self-management program for patients with Crohns Disease and the behavioral phenotyping of esophageal disorders.
1061813	Primary research interests include any rehabilitation topics involving brain injury and stroke survivors.
1061814	My clinical and research pursuits have focused on improving health-related quality of life (HRQL) in people with cancer, neurological disorders and other chronic medical conditions (e.g., Spinal Cord Injury, Traumatic Brain Injury, Burn/Orthopedic Injury, COPD, Sarcoidosis, HIV, Coronary Heart Disease). Specific interests include stress reduction and CAM-based interventions in oncology, self management support interventions using health information technology, and developing patient reported outcomes measures in HRQL, disease symptoms, coping/adjustment and resilience. I was the Principal Investigator on a 1-year hospital funded Pilot Grant to examine HRQL and self management support preferences in a prostate cancer sample and am currently the Principal Investigator of a hospital-funded RCT examining the effects of a mindfulness-based stress reduction intervention for men diagnosed with prostate cancer who are on active surveillance. I am the site Principal Investigator on two NIH-funded grants (NCI: Reflexology for Women with Advanced Breast Cancer; NCMRR: Quality of Life for SCI Clinical Trails: Development of the SCI-QOL;). In addition, I serve as a Co-Investigator on an NINDS-funded study (Neuro-QOL; PI: D Cella) to develop patient reported outcomes measures for neurology clinical trials research. Since 2003 I have led a mindfulness-based stress management class at Evanston Hospital for people with chronic medical conditions and their caregivers.
1061842	PI in Fetal data base
1061843	The primary thrust of our research team has focused on studies to identify the basic biological processes that regulate adaptation of malignant tumor cells to stressful environments, such as those produced by anti-cancer drugs, and thereby permit their survival in the presence of agents that would normally kill them. Understanding these processes will help cancer researchers develop novel chemotherapeutic strategies. Our group has directed our recent attention to the understanding of cancer cell behavior and in particular on the molecular basis underlying resistance of neuroblastoma cells to chemotherapy.
1061875	The Molecular Basis of Wilms' TumorThe Sprouty  ProteinsThe Molecular Biology of Acute Promyelocytic LeukemiaThe Molecular Basis of Multiple MyelomaMolecular Basis of Myeloproliferative Disease
1061890	I currently serve as the Medical Director of Sports Medicine for the United States Navy Recruit Training Command/CAPT James A. Lovell Federal Health Care Center.  I am Board Certified in Family Medicine and hold a Certificate of Added Qualifications in Sports Medicine.
1061894	Onset of pediatric brain tumor formation; generation of human induced Pluripotent Stem cells (hiPSCs), neuronal differentiation of hiPSCs, particularly into radial glia; in-vivo brain tumor modeling; molecular characterization of the onset of early neuronal differentiation in hiPSCs as well as in human Embryonic Stem cells.
1061897	Pediatric solid tumorsFertility preservation
1061909	I am a Research Assistant Professor in Feinberg School of Medicine, Northwestern University, with the research focuses on age-related eye disease, such as age-related macular degeneration, diabetic retinopathy.   I am an advanced degree professional in this field by virtue of the M.S. and Ph.D. degrees in Ophthalmology from Weifang Medical College and Peking University, respectively. Recent growth in clinical and translational research has heightened the need for a competent clinical research workforce in industry and academia. I am currently in the Graduate Certificate Program in the School of Continuing Studies-Clinical Research and Regulatory Administration. 
1061921	Neural degeneration, glial responses, signal transduction, gene expression profiling, genetic susceptibility, optic neuropathy,transcriptional regulation. 
1062000	Elizabeth R. Ryan, Ed.D. graduated from Loyola University of Chicago with a doctorate degree in Education in May 2006.  She has worked in both family medicine and surgical education, holding administrative staff positions in both graduate and undergraduate programs, from April 1995  February 2006.   Dr. Ryan contributed to the Department of Surgerys redesign of the undergraduate and graduate program curriculum; was an invited member of the Department of Surgerys Think Tank Consortium; is a Co-Leader for Northwestern University Feinberg School of Medicines Community Engagement and Service Competency; is the Teaching Selective Course Director; and the Co-Course Director for Patient Physician and Society IV.  Dr. Ryan joined the Department of Family and Community Medicine faculty as an Assistant Professor and the Vice Chair of Education in March 2006.
1062051	End of Life care; medication compliance, depression, clinical and economic evaluation, patient report outcome
1062103	Surgical Pathology
1062105	Epigenetic regulation of Cytomegalovirus(CMV) gene transcription during establishment of latency and reactivation from latency.
1062189	The primary research is in the field of neurophysiologic monitoring during cerebral aneurysm surgery in particular and neurophysiologic monitoring in head and spine surgeries in general.
1062254	I currently work as an internist in Preventive Medicine and have many other interests within the health care field including technology development (including electronic health records), health care quality, health literacy and communication in patient encounters
1062414	My area of interest is in health care disparities research and assessment of policy and pratice to advance equity. I serve as the principal investigator for a number of national studies examining quality of care for diverse populations. I am currently an investigator for the Robert Wood Johnson Foundations national initiative, Aligning Forces for Quality, and  lead the disparities/equity component of this project. My research also focuses on quality of care in the health care safety net and integrating equity into performance measurement and reporting.
1062458	I serve as Director of Chicago Cardiac Arrest Resuscitation Education Service. We are a not-for-profit organization housed within NUFSM Department of Emergency Medicine dedicated to improving survival from sudden cardiac arrest through community education about CPR and AEDs. Please visit our website at www.ccares.northwestern.edu.
1062841	Primary clinical interests involve hospital-based medicine in pediatrics. In particular, the application of evidence-based medicine to changes in disease management is a major focus. The role of the hospitalist in medical education, both undergraduate and graduate, is a secondary area of focus.
1062847	To provide quality patient care, contribute to pediatric emergency medicine literature and participate in the education of medical students, residents and fellows.
1062886	My research is focused on the mechanisms and prevention of sudden unexplained death in epilepsy (SUDEP). I am also interested in cortical plasticity and functional mapping in patient undergoing epilepsy surgery. Outside of epilepsy, I am involved in clincal care and research of musicians with medical problems related to their instrument, in particular focal task specific dystonia. 
1062956	I am interested in research involving novel technologies in neurosurgery.
1062975	neural-machine engineering, myoelectric control, EMG modeling, biomedical signal processing, Bioelectromagnetism
1063005	Dr. Simon's primary research interests are aimed at eliminating health disparities among low income, medically underserved women across the lifespan.  Integrating health services research with social epidemiologic models, Dr. Simon's research focuses on interventions (such as patient navigation and community health outreach workers) that aim to reduce and eliminate such disparities.  Within this context, Dr. Simon prefers to leverage culture and community to achieve these goals and thereby integrates community based participatory research framework into her work.
1063045	My primary academic/clinical interest is in quality, information systems, patient safety, care-pathways and administrative medicine relating to; creating/supporting evidence-based approaches to patient care, establishing standards, developing process/protocols to support the standards and globally reducing multidisciplinary practice variance.
1063052	I have been interested in both clinical and basic research. My clinical research interest includes Echocardiography especially in the field of 3D Echocardiography; valvular heart disease, woman's heart disease, coronary artery disease and cardiomyopathy. My basic research interest is in hypertension and heart failure.
1063096	Jason Kane is an Attending Physician in the division of Pediatric Critical Care Medicine at Childrens Memorial Hospital and an Assistant Professor of Pediatrics at Northwestern Universitys Feinberg School of Medicine.  He graduated from the Medical College of Rush University in Chicago, completed his training in Pediatrics at Indiana University and Riley Hospital for Children in Indianapolis, and attended the Medical College of Wisconsin and the Childrens Hospital of Wisconsin in Milwaukee where he completed his Fellowship in Pediatric Critical Care.  In 2009, Doctor Kane obtained his Masters of Science Degree in Patient Safety and Healthcare Quality from Northwestern University.  Doctor Kanes primary clinical focus is cardiac intensive care where he is responsible for directing the recovery and ICU management of children who have undergone open-heart surgery to repair congenital heart defects.  His research interests include pediatric patient safety, healthcare quality, and near-infrared spectroscopy monitoring in the intensive care unit.
1063131	Dr. Kho's research involves the creation of electronic networks spanning multiple institutions.  He developed an electronic network to enable infection control providers to share infection data across the major healthcare providers within Indianapolis.  The system currently tracks thousands of patients with drug-resistant infections in the region and provides secure real-time admission alerts to infection control providers.   He continues this AHRQ funded research as a Regenstrief Affiliated Scientist.  His research interests also include the application of geographic information systems, and large dataset driven decision support to improving infection control processes.  He is actively involved in project linking Electronic Medical Record data with genomic data across multiple institutions.
1063149	My research interests revolve around the neural mechanisms supporting selective attention and cognitive control, and their interaction with motivational/emotional factors.
1063190	My primary clinical and research interests are in HIV and HBV and HCV viral co-infections in both domestic and international settings. I am currently collaborating on research projects in the US, Tanzania and Nigeria in the following focus areas: HIV/Hepatitis co-infection, HIV drug resistance, antiretroviral treatment outcomes, non-communicable diseases (NCD's), and qualitative studies of patient and healthcare worker satisfaction.
1063212	Dr. Fangusaro has an expertise and specialty training in treating children with central nervous system malignancies, including brain and spinal cord tumors.  His primary area of research interest is in the development of clincal trials, novel therapeutics and relevant biologic correlates in pediatric brain tumors in an effort to improve survival outcomes and minimize toxicities.  He devotes much of his time to clinical trial research and has developed numerous collaborations with basic scientists in an effort to advance translational and clinical initiatives.
1063230	The research of the Economics of Movement group shows that movement and movement learning are similar in many respects. Our Sensors (Eyes, Ears, Skin etc) are not perfect but are noisy. Moreover, our muscles are noisy and if we try to do the same movement over and over it will be different each time. This means that if we make a movement, say swing a golf club, we will have uncertainty in the potential movement outcomes. Our group studies how people make movement decisions in the presence of such uncertainty. Our research has three main thrusts. (1)We study experimentally how people move and how their movements are affected by uncertainty. (2) We build computational models using Bayesian statistics to calculate how people could move optimally or learn to move optimally. (3) We build Bayesian Algorithms to solve problems that we find interesting. For example we analyze how neurons are connected in the nervous system. (4) We use mobile phone and gaming technology to improve rehabilitation and to improve diagnoses.The main thrust of our current research is to allow for better rehabilitation procedures through an understanding of motor learning.
1063244	Dr. Mauvais-Jarvis is internationally recognized for the discovery of estrogen receptors activation in protecting insulin-producing pancreatic beta-cells in type 1 and type 2 diabetes using pre-clinical models. He has authored over 50 publications and book chapters dealing with novel mechanisms and therapeutic perspectives for diabetes and obesity. He is the principal investigator of federal research grants from the National Institutes of Health and has received national and international awards from organizations including the Juvenile Diabetes Research Foundation, the American Heart Association, the March of Dimes and Birth Defects Foundation and the French Diabetes Association. He is an elected member of the American Society for Clinical Investigation.
1063244	Our laboratory is interested in understanding the mechanisms by which energy homeostasis is differencially regulated in males and females and how does this influence the risks of obesity and diabetes. We currently focus on identifying the cellular and molecular mechanisms by which estrogens and androgens program and regulate energy metabolism in a gender-specific manner. We use genetic, physiological, molecular, and pharmacological tools to study mice with conditional knockouts of the sex steroid receptors as well as cell culture models in highly controlled environments.  Our goal is 1) to obtain a better understanding of the biological processes at the root of diabetes and obesity and the role of gender in this process 2) to determine whether modulating estrogen/androgen actions in a tissue-specific manner can have a therapeutic impact on diabetes and obesity.
1063304	Over the last 10 years, I have gained considerable experience with both MRI and MRS in clinical practice and research; in research settings my primary interest has been the development of molecular and cellular imaging methods. I am also very familiar with small animal tumor models and have conducted extensive molecular and cell biology research; I am highly proficient in the use of optical imaging, cell culture, gene expression techniques and FACS analysis. I was appointed to my current faculty position at NWU after a short time working for VirtualScopics where my role was to direct the imaging component of clinical trials. Given my multi-disciplinary background (and the broad range of skill-sets provided by my close collaborators) I am ideally suited to develop MRI-monitored cellular therapies for the treatment of pancreatic cancer.
1063334	I am examining issues relating to neuromusclular control of voice pitch and volume. I am also examining the use of novel carbon dioxide laser technologies in the surgical management of laryngeal and trachel pathologies
1063382	My clinical interests encompass all of general obstetrics and gynecology, including well-woman care, obstetric care, office procedures, contraception, and women's mental health issues, to name a few.My research projects focus on delivery of health care and patient outcomes. The large obstetric volume at Prentice Women's Hospital allows us to perform large, high-quality studies to answer important questions about pregnancy and delivery care.  We recently completed a large study looking at epistaxis (nose-bleeds) during pregnancy, and found that women with more nose bleeds were more likely to suffer excessive bleeding at delivery. n another project, we examined women with infections during labor (chorioamnionitis) to create a scoring system that allows us to predict which women will become septic. I am also interested in the social and psychological aspects of reproduction and childbearing,and just completed another project looking prospectively at obsessive-compulsive disorder in pregnancy and postpartum, which turns out to be unexpectedly common. I will next be creating a 'Global Assessment of the Postpartum Woman' to get a more comprehensive picture of the mental health challenges women face postpartum.
1063384	As a clinical psychologist, I direct NMFF's Women's Behavioral Health Clinic, which offers pharmacotherapy and psychotherapy for women during pregnancy and postpartum phases. Also, I direct a clinical research lab with five Ph.D. students. Our current research projects include (a) identifying predictors of response to Behavioral Activation using HLM analyses (NIMH-funded project), and (b) identifying differences in emotional responses using functional magnetic resonance imaging (fMRI) among women with and without major depression.
1063448	Developing, implementing and evaluating patient-centered primary care as an integrated and evidence-based system in underserved settings, with the goal to improve outcomes while reducing or eliminating disparities, with an emphasis on maternal child health and chronic conditions. Clinical and research interests in these areas are focused around performance improvement, health care reform, and community-based training for tomorrows health workforce.
1063452	My primary interests are in Community Medicine and Health Disparities, from a public and global health perspective. As the Vice Chair of Community Medicine and Director of the Chicago Community Engagement Program at the Department of Family and Community Medicine, I advise and mentor students interested in developing local and global community-engaged projects, with a dual focus on education and community service.
1063472	Lynette Craft, PhD is a Kinesiologist and her research interests focus on the relationships among physical activity and mental and physical health.  Specifically, Dr. Craft examines the use of structured exercise interventions to reduce symptoms of depression and improve quality of life.  In addition, she investigates the potential mechanisms underlying these relationships.   She has examined these associations in several patient populations such as individuals with clinical depression, cancer survivors, and smokers attempting smoking cessation. A secondary interest in her current work is identifying the psychosocial factors that predict exercise adherence in these various groups.
1063490	Sonya Rasminsky is the Director of Medical Student Education in psychiatry at Northwestern Feinberg School of Medicine. She sees patients for psychotherapy and medication management.  Her clinical interests include women's mental health and student mental health.
1063502	My graduate work so far has been directed at health professional epistemology in context - the relationship among clinicians, academics and political actors and its effects on clinical decision making. I hope to continue this in my dissertation (in disability studies) in relation to understandings of disability within curriculum development in healthcare professions and medicine.
1063635	Medical Director of Consultation-Liason and Emergency ServicesDept of Child and Adolescent PsychiatryClinical interests include the recognition and treatment of delirium in medically hospitalized patients. 
1063665	Glucocorticoids are the most frequently prescribed medicine today and they are indispensable in the treatment of asthma, inflammation, and cancer.  However, two concerns regarding glucocorticoid use remain unresolved.  One is that high-dose or long-term glucocorticoids result in troublesome side effects such as metabolic syndrome and osteoporosis; the other is that some patients do not respond to glucocorticoids.  We tackle both questions by examining the glucocorticoid receptor.  Translational isoforms of glucocorticoid receptors were recently discovered in our lab and they provide insights into the mechanisms of action of glucocorticoids.  Ribosomal shunting and leaky scanning processes generate translational glucocorticoid receptor isoforms. These receptor isoforms have distinct cell-killing and cytokine-suppression capabilities in a bone cancer cell model system.  Currently, we are identifying and characterizing the receptor isoforms in different populations of immune cells in diseases such as asthma and cancer.This line of research has implications in several other fields in addition to immunology and oncology.  For instance, our findings in glucocorticoid receptor biology have significant impact on research in endocrinology as well.
1063665	Glucocorticoids are the most frequently prescribed medicine today and they are indispensable in the treatment of asthma, inflammation, and cancer. However, two concerns regarding glucocorticoid use remain unresolved. One is that high-dose or long-term glucocorticoids result in troublesome side effects such as metabolic syndrome and osteoporosis; the other is that some patients do not respond to glucocorticoids. We tackle both questions by examining the glucocorticoid receptor. Translational isoforms of glucocorticoid receptors were recently discovered in our lab and they provide insights into the mechanisms of action of glucocorticoids. Ribosomal shunting and leaky scanning processes generate translational glucocorticoid receptor isoforms. These receptor isoforms have distinct cell-killing and cytokine-suppression capabilities in a bone cancer cell model system. Currently, we are identifying and characterizing the receptor isoforms in different populations of immune cells in diseases such as asthma and cancer. This line of research has implications in several other fields in addition to immunology and oncology. For instance, our findings in glucocorticoid receptor biology have significant impact on research in endocrinology as well.
1063685	Cancer and blood diseases; sickle cell disease (with research focus on pain); blood donations for patients with sickle cell disease; immune thrombocytopenic purpura, iron deficiency anemia, hemolytic anemias
1063818	Special interests include respiratory and autonomic disorders in Pediatrics with attention to cardio-respiratory monitoring and physiology, specifically, Congenital Central Hypoventilation Syndrome (CCHS) and Rapid-onset Obesity with Hypothalamic dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD); Alterations in sleep physiology in Pediatric disease; Response of the autonomic nervous system in children to environment.
1063829	My research focuses on the utilization of agent-based modeling for multi-scale modeling of acute inflammation. Agent levels include cells and molecules, with the goal of simulating organ- and organism-level behaviors from these generative mechanisms. While the focus of my models have primarily been on the pathophysiology of sepsis and multiple organ failure, in a more general sense I am interested in using agent-based modeling as a means of dynamic knowledge representation to augment the biomedical research process. With respect to acute inflammation, the ubiquitousness of the underlying cellular and molecular mechanisms suggest the application of this methodology to such area as oncogenesis, transplant immunology/rejection, autoimmune disease, wound healing/scarring, atherosclerosis and aging. I am currently using NetLogo as my primary agent-based modeling platform, but am involved with the development of SPARK (Simple Platform for Agent-based Representation of Knowledge http://www.pitt.edu/~cirm/spark/ ) currently being done at the University of Pittsburgh. I am also interested in automated text analysis/information extraction from biomedical texts, formal knowledge representation in biomedicine and the development of methods for evolving biomedical ontologies. These goals form a 'front-end' to high-level modeling tools (such as MetaABM http://www.metascapeabm.com/ ) and are intended to facilitate the ability for biomedical knowledge to be represented, communicated and evaluated via executable models. I am also involved in projects directed at developing methods to execute ABMs on massively parallel computing platforms. I believe this is a vital development necessary for true, multi-scale, biologically relevant simulation.
1063851	neurocritical care, status epilepticus, subarachnoid hemorrhage, neurogenic respiratory failure, intracerebral hemorrhage, Guillain-Barre syndrome, central nervous system infections, clostridial diseases, bioterrorism
1063926	My primary interests lie in the assessment, diagnosis and treatment of trauma in the lives of children and women, with an emphasis on serving traditionally under served populations.  I have a particular interest in efforts to make services maximally culturally sensitive and relevant for various (sub)cultures.
1063999	My primary research/clinical interests are children's mental health, issues related to gender and health disparities and public policy.
1064003	Dr. Kwiatek's research interests are in the area of the gastrointestinal motility with special focus on the clinical physiology of the esophagus and stomach, monitoring of gastroesophageal reflux, use of manometry and novel technologies to define the extent of gastrointestinal disorders and potential future diagnostic parameters.
1064120	My primary interest is developing and evaluating technology-assisted behavioral and psychological interventions.  I am also interested in the relationship between stress, depression and inflammation, particularly in multiple sclerosis.
1064162	Early intervention and prevention of kidney disease
1064178	Interests in clinical quality improvement
1064217	Interesting in identifying and developing novel therapeutics in patients with advanced cardiac and vascular diseases.
1064232	Primary research interest include the quality of life related to families of children with feeding disorders, clinical imaging related to non-alcoholic fatty liver disease in children, and lifestyle interventions used to treat childhood and familial obesity.
1064279	Mechanisms of normal and malignant blood cell development
1064279	Research in the Crispino lab is focused on investigating the regulatory mechanisms governing normal and malignant blood cell development, with an emphasis on understanding the growth of erythroid cells (red blood cells) and megakaryocytes (platelet-producing cells). In addition, we are greatly interested in learning how changes in normal essential regulatory molecules lead to human blood diseases, including leukemias, myelodysplastic syndromes (MDS) and myeloproliferative diseases (MPD). 
1064350	* Promotion of collaborative studies in stem cell biology    * Focus on genetic regulations of stem cell lineages, directed differentiation and utilization for therapy    * Study of human diseases using hESCs and iPSCs with genetic genetic mutations    * Development of repository of hESCs and iPSCs
1064357	I am interested in the mechanisms of neuronal and glial lineage specification from neural progenitor cells during normal development and after injury.
1064405	Our research is dedicated to bring molecular advances in the pathogenesis and therapy of human brain tumors to clinical application. Our laboratory aims to identify new therapeutic leads for patients with high-grade gliomas and to develop tools that allow predicting an individual patients likelihood to benefit from a certain treatment regimen. Our work integrates complex molecular tumor data generated by the complementary and iterative application of data-driven (genome-wide analysis) and hypothesis-driven research approaches and corresponding clinical patient profiles.
1064439	I am a licensed clinical psychologist and Research Assistant Professor in the Department of Medical Social Sciences, Department of Surgery, and the Institute for Healthcare Studies at Northwestern University. In this position, my research focuses on the development and application of patient reported outcomes (PROs) in the postsurgical context, with specific emphasis on organ donation and transplantation.I lead the Quality of Life Workgroup of the Northwestern University Transplant Outcomes Research Collaborative (NUTORC) to foster multidisciplinary research and to provide research mentorship to postdoctoral fellows in this area.  In addition, I am Co-Chair of the Health-Related Quality of Life Group of the NIH A2ALL study, providing leadership in the assessment of living liver donors well-being across 9 transplant centers. Earlier this year, I was selected to be co-PI of a contract from the Patient-Centered Outcomes Research Institute (PCORI) to establish minimal guidelines for the design and selection of patient-reported outcomes in patient-centered outcomes research.In addition to my work on NIH- and industry-funded grants and contracts, I am on the editorial board of the journal Assessment and section editor of the American Psychological Association (APA) Division 12s The Clinical Psychologist. I serve as the first Chair of the Early Career Professionals Council of APA Division 38 (Health Psychology) and was elected to the Executive Committee of the Allied Health Community of Practice of the American Society of Transplantation. I also serve as an ad hoc reviewer for a number of journals, conferences, and grant task forces to provide expertise in health psychology and psychometrics.
1064445	My research interest is to evaluate the effects of genetic, epigenetic, and environmental factors as well as gene-environment (GxE) interactions on complex human diseases, with a particular focus on allergic diseases, preterm birth, and obesity-related phenotypes.
1064467	My main clinical interest is the diagnosis and treatment of primary immunodeficiency diseases and my research interest is focused on elucidating the pathogenesis of primary immune deficiency diseases, understanding the natural history of these diseases and developing novel approaches to their therapy. Lymphocyte development is another area of interest, which ties in closely with primary immunodeficiency disease as many of these diseases results from failure of lymphocyte development.  In addition, I am also interested in the immunopathogenesis of allergic diseases especially food allergy and the mechanisms involved in the development of tolerance to allergens.
1064580	The main focus of my research program is to study roles of tumor suppressors in normal development and in breast and prostate cancer progression, focusing on Maspin and an Ets transcription factor PDEF. Maspin is a unique member of SERPIN family that plays roles in normal tissue development, tumor metastasis, and angiogenesis. Genetic studies by my laboratory using maspin transgenic and knockout mice demonstrated an important role of maspin in normal mammary, prostate, and embryonic development. Recently, we have identified several new properties of maspin. As a protein that is present on cell surface, maspin controls cell-ECM adhesion. This function is responsible for maspin-mediated suppression of tumor cell motility and invasion. We have also discovered that maspin is involved in the induction of tumor cell apoptosis through a mitochondrial death pathway. The long-term goals of these projects are to elucidate the molecular mechanisms by which maspin and PDEF control tumor metastasis and to identify their physiological functions in development. Another focus of research in Zhang lab is to identify immune components that control breast cancer metastasis. Chronic inflammation not only increases neoplastic transformation but also drives the inhibition of the immune response in a protective negative-feedback mechanism. Suppressive immune cells are recruited to the sites of inflammation and function to inhibit both innate and adaptive immune responses, enabling tumor tolerance and unmitigated tumor progression. To study the interplay between tumor and immune cells, Zhang lab has developed a unique animal model of breast cancer that reproduces different stages of breast cancer bone metastasis. Molecules that control tumor-immune cell interaction and immunosuppression have been identified. We are currently studying roles of these genes in tumor-driven evolution that control chronic inflammation and immunosuppression.
1064642	Research interests Dr. Hou was trained as a physician in China with several years of clinical experience in internal medicine.  Dr. Hous graduate training includes a Master of Medical Science degree in epidemiology and community medicine and a MD & PhD combined degree in molecular genetics in Japan. Dr. Hou further received her postdoctoral training in molecular cancer epidemiology in the Division of Cancer Epidemiology and Genetics (DCEG) at the National Cancer Institute (NCI).  With a multidisciplinary background in medicine, basic science, and epidemiology, Dr. Hous research interest lies in integrating traditional epidemiologic methods with the ever-advancing molecular techniques in multi-disciplinary research focusing on identifying key molecular markers and understanding their potential impact on disease etiology, detection, and prevention.  Dr. Hous major research efforts to date have focused on two areas: 1) identification of risk factors that may cause chronic diseases; and 2) identification of biomarkers that serve as indicators of an individuals past exposure to disease risk factors and/or predict future disease risks and/or prognosis. The environmental/lifestyle risk factors that Dr. Hou has studied include air pollution, pesticides, overweight, physical inactivity, and reproductive factors in relation to chronic diseases.  The biomarkers that Dr. Hou has investigated include genetic factors (i.e., polymorphisms, telomere length shortening, mitochondria DNA copy number variations); and epigenetic factors (i.e., DNA methylation, histone modifications, and microRNA profiling).  Her over-arching research goal is to understand the biological mechanisms linking environmental risk factors with subclinical or clinical disease development, which ultimately lead to development of effective strategies for prevention of chronic diseases.
1064657	1. Mechanisms and physiology of Interleukin-10 mediated attenuation of cardiovascular injury and inflammation. These studies have an overall focus to understand the role of inflammation in exacerbating post-injury myocardial functions and tissue repair. The strategy involves utilizing IL-10, a potent anti-inflammatory cytokine, to inhibit the expression of pro-inflammatory mediators. Past studies delineated the mechanisms by which IL-10 imparts its inhibitory action and showed that on molecular level, IL-10 acts mainly via post-transcriptional de-stabilization of mRNA half-life by suppressing mRNA stabilizing protein HuR which binds to mRNAs harboring specific A+U rich sequences in their 3 untranslated regions.  Current studies are expanded utilize IL-10 and its direct downstream target HuR, as potential therapeutic approaches to inhibit inflammation in post-myocardial infarction in animal models and to elucidate signaling pathways that govern IL-10 actions both in vitro and in vivo (Rajasingh et al, FASEB J, 2006; Krishnamurthy et al, Circ Res., 2009, Krishnamurthy et al., FASEB J, 2010). 2. Epigenetic reprogramming of somatic cells to generate induced pluripotent cells and mechanisms of embryonic stem cell differentiation into cardiovascular linage cells. One component of this research focuses on to understand the molecular and signaling mechanisms governing directed differentiation of mouse embryonic stem cells into cardiomyocytes (Rajasingh J et al, Circ. Res., 2007).  The second project in regenerative and stem cell biology that we have developed is to epigenetically reprogram adult somatic cells into ES-like cells (iPS cells) by utilizing cell-free ES cell protein extracts thereby bypassing the use of retroviral mediated forced expression of exogeneous transgenes (Rajasingh J et al, Circ Res., 2008). Studies are ongoing to address the mechanisms of somatic cell reprogramming and to define the role of critical epigenetic factors required for this transition.
1064657	CURRENT RESEARCH INTERESTS1 )  To understand molecular mechanisms and signal transduction involved in the inflammatory cytokines (e.g. TNF-alpha)-induced dysfunction of endothelial cells (EC) in cell culture model system and the mechanisms of cytokine regulation on the healing of endothelium in vivo in moue models of carotid artery denudation (equivalent to balloon angioplasty in patients). We have established that locally secreted TNF acts to inhibit endothelial recovery leading to restenosis, partly via inducing cell cycle arrest in ECs (Kishore, Circulation Research 2002, 2003; JCI, 2005),although complete molecular mechanisms and signal transduction pathways involved therein are yet to be deciphered. Understanding of EC gene regulation may potentially help finding target molecules whose modulation can nullify deleterious effects of TNF. Another component of this project involves elucidating trans-factors involved in posttranscriptional (mRNA stability) regulation of TNF by anti-inflammatory cytokine IL-10 (Rajasingh, Kishore, FASEB J, 2006).2)  To understand the molecular and signaling mechanisms governing directed differentiation of mouse embryonic (Rajasingh, Circulation Research; 2007) and adult stem cells and oocyte-independent means for the de-differentiation of adult somatic cells to generate stem-like cells and to assess the therapeutic efficacy of these cells towards tissue repair in mouse models of surgically induced myocardial infarction and other ischemic injuries.3) To study and understand the role of long-term alcohol consumption (chronic alcoholism) on cardiovascular system. Chronic ethanol inhibits cell survival signaling by various mechanisms, including but not limited to the enhanced release of TNF and other pro-inflammatory cytokines. Our studies indicate that in vitro chronic ethanol exposure exerts inhibitory effects on EC proliferation and survival (Luedemann, Kishore, Alco Clin Exp Res, 2005; Rajasingh, Kishore, Endocrinology, 2007). Chronic ethanol not only elevates agonist-induced TNF expression in EC but also exacerbates TNF-mediated EC dysfunction, synergistically. Our current studies are focused toward understanding the biology of ethanol-induced EC dysfunction in ethanol-fed rodent models as wells as towards understanding the underlying molecular mechanisms in cell culture model system.
1064699	Working with children suffering from diminished daily school and social performance as evidenced, perhaps in ADD/ADHD, perhaps relating to allergy, or both, by attempting to objectively quantify clinical findings through computerized continuous performance testing (MMAT/Quotient ADHD System) approved by the Food and Drug Administration in 2002, and invented by Dr. Martin Teicher at McLean Hospital in Belmont, MA (McLean is a psychiatric hospital affiliated with Harvard Medical School).
1064705	My primary research and academic interests are in the development of young scientists. My work in this arena spans the continuum including: the 'basic science' of how undergraduate and PhD student fine tune career decision with a longitudinal study of 500 students; application and study of new coaching-based models to support early PhD students; use of group-based modesls to assist junior faculty develop as scientists; a randomized controlled trial of a totaly different approach to fostering diversity in academia.
1064835	My primary research interests include HIV treatment outcomes in resource-limited settings, as well as antiretroviral clinical pharmacology research, particularly in special patient populations, such as pregnant women. I am also interested in pharmacist-initiated program implementation, including community pharmacy-based rapid HIV testing models and HIV-related pharmacovigilance activities.
1064839	Within the field of Otolaryngology, my area of interest and expertise is in head and neck surgery specifically for cancer.  I am particularly interested in trans-oral endoscopic removal of tumors, as well as reconstructive surgery following tumor removal including free tissue transfer.  I have also recently expanded surgical services to include trans-oral robotic surgery (TORS) at Northwestern, by which tumors can be removed through the mouth with robotic assistance.
1064942	My primary interest is pediatric airway obstruction and pediatric upper airway reconstruction specifically laryngomalacia and its surgical treatment - supraglottoplasty. I am also interested in the Diagnosis and Medical and Surgical Treatment of Pediatric Dysphagia.  Specifically, I am interested in how congenital and acquired airway lesions affect a childs ability to eat and swallow.       My interest also include the medical and surgical treatment of pediatric obstructive sleep apnea and sinusitis.
1064948	Educational Research, Curriculum Development, Technology Enhanced Instruction, Faculty Development, Program Evaluation;  Public Health, Food Access, Nutritional Environment, Workforce Development
1064963	I have a primary interest in the evaluation of assessment and reduction of risk for harm to self or others; psychic harm; boundary issues; disability; fitness for duty; closed head injury; competence to stand trial; sanity/mitigation in criminal cases; and correctional mental health.
1064977	I provide inpatient pediatric care and term infant nursery care at a community hospital.
1064985	Research interest: Examining the potential benefits of integrative medicine therapies (complementary and alternative medicine) for a range of conditions.
1065018	Integrative medicine (complementary/alternative medicine) in pediatrics.I have training in medical acupuncture, medical hypnosis and homeopathy and am interested in the use of integrative medicine.
1065021	Measuring health outcomes using modern psychometrics including item response theory and computerized adaptive testing
1065026	Genetics, Hereditary breast and ovarian cancer, Minimally invasive surgery (Robotics, laparoscopy, management of pelvic masses, endometrial ablation, tubal ligation/sterilization), In-office procedures (Essure, Novasure), Management of abnormal pap smears, Menopause, Fibroids, Contraeption, Normal and complicated pregnancies (twins, advanced maternal age)
1065034	Developmental biology of urogenital organs.
1065059	Hypochondriasis as psychiatric diagnosis; hypochondria/disease anxiety as a problem for primary care; cultural narratives regarding health/disease and their role in fostering anxiety about disease and about health care. The role of narrative in patients', physicians', and biomedical scientists' thinking about the inside of the living human body. The place of fear and uncertainty in medical epistemology.
1065060	My clinical and research interests pertain to the nutritional support of newborns.  I am currently collecting fatty acid levels of premature neonates with long exposures to intravenous lipid emulsions.  My long term goal is to improve the quality of the constituents of parenteral nutrition that we provide to neonates, both preterm and term populations.  I also work to promote the provision of breast milk as a newborns primary form of nutrition.
1065061	Dr. Richard Lee practices the full spectrum of adult cardiac surgery and has special interests in surgical treatments of atrial fibrillation, mitral valve repair, tricuspid valve repair, and surgical alternatives to heart transplantation.
1065062	Dr. Andrew J. Fishman is an Otologist/Neurotologist, Skull Base Surgeon, and Cochlear Implant specialist at Northwestern Memorial Hospital. Dr. Fishman holds an appointment to the departments of Otolaryngology and Neurosurgery at Northwestern Memorial Hospital.         He has performed pivotal research with Dr. Claus-Peter Richter M.D. Ph.D. -Director of the Otolaryngology Laser Research Laboratory on laser nerve stimulation for hearing, and clinical research, which ultimately lead to the development of one of the cochlear implant electrodes currently in use today.    In 2005, he went on a yearlong medical mission to South India, where he developed a Transtemporal Cranial Base Surgery Program at the Amrita Institute of Medical Sciences (AIMS) in the city of Cochin, Kerala. He was appointed as Consultant in the disciplines of Otolaryngology, Head & Neck Surgery and Skull Base Neurosurgery.  During that time, he also worked as a surgical consultant for one of the major cochlear implant companies, training doctors in surgical implantation techniques.          In 2007 Dr. Fishman was granted the honorary appointment of International Professor at the Nicolas Copernicus University in Poland for his work in that country over the past 10 years.  Today, he continues to be an active participant in the development of acoustic neuroma, neurofibromatosis II, and skull base tumor surgery in a center which he developed at the University Hospital of Dr Jurasz in Bydgoszcz, making invited visits to lend surgical support and training to the physicians of the Neurosurgery and Otolaryngology Departments.  In 2007 Dr. Fishman organized a joint international surgical mission where he and the members of the Indian Cranial Base Surgery Team from the Amrita Institute came to perform a series of challenging surgeries on patients in Poland with rare and unusual tumors.  Observers were invited from the local area hospitals including the regional NATO medical center.
1065069	As Associate Director of Surgical Clerkship, interests and research are focused on Curriculum Development and Case-based learning. Thesis research focused on cultural diversity within a community college health career program.  Clinical background is in Trauma and Emergency Medical Services.
1065133	1. The use of clinical use of echocardiography in pediatric cardiovascular disease. 2. The use of exercise testing in pediatric cardiovascular disease and the development of a wellness center. 
1065171	MRI, Functional Neuroimaging, Head & Neck
1065185	Glaucoma Research Coordinator
1065196	As the Associate Director of the Pediatrics Clerkship for NUFSM, Dr. Greenberg's interests in medical education include medical simulation, innovative curriculum design, and hand-off communication skills.  Dr. Greenberg also directs the Medical Observation Unit (MOU) in the Ann and Robert H. Lurie Children's Hospital of Chicago.  His clinical and research interests include observation care in pediatric populations, quality improvement, and medical informatics.
1065215	Dr. Lowe is a nationally and internationally recognized expert in robotic and minimally invasive surgery for gynecologic cancers. He has been honored at the national/international level with numerous presentations on minimally invasive surgery. For several years, Dr. Lowe has taught laparoscopy and robotics throughout the United States and recently Italy to gynecologic surgeons and oncologists.  His surgical videos (on YouTube) have been selected for presentation at national/international meetings for the American Association of Gynecologic Laparoscopists, Society of Gynecologic Oncologists, and the American College of Surgeons. Additionally, he was one of the first gynecologic oncologists to receive certification on the da Vinci Surgical System in the United States in 2006 and performed the first robotic surgery for endometrial cancer in the Mid-South region of the United States.
1065270	Dr. Hos primary interests involve improving the accessibility to mental health services and prevention programs in ethnic minority populations. She is especially interested in exploring new ways to achieve these goals, including how communications technology may be used to promote health and prevent mental illness.
1065283	I am a hospitalist working in General Medicine (inpatient service),Medical Observation Unit, Pediatric Intensive Care Unit and Sedation for Medical Imaging.  I am involved in resident and medical student education during service time on General Medicine and Sedation.
1065385	My clinical interests involve the inpatient care of Hematology and Oncology patients as a Hospital Medicine and Infectious Diseases specialist.
1065474	I work as a pediatric hospitalist in a community hospital, and asthma is one of my primary clinical interests.
1065656	My research involves the substantiation that bone marrow derived cells have an immunoregulatory capacity that can influence the induction of clinical tolerance (the elimination of maintenance immunosuppressive drugs).  This includes the development of sophisticated monitoring techniques to detect the immune status of the recipient and the appearance of these regulatory cells in the bone marrow, peripheral blood, and transplanted organ in the recipient.  I am currently conducting a clinical trial at Northwestern in 20 such HLA-identical living donor kidney transplant recipients of donor stem cells, along with the transplanted organ, and following the recipient for the detection of these immune regulatory functions.
1065729	My lab studies the inflammatory response at the cellular and molecular level.  We are focused on the process of diapedesis, the 'point of no return' in inflammation where leukocytes squeeze between tightly apposed endothelial cells to enter the site of inflammation.  We have identified and cloned several molecules that are critical to the process of diapedesis (PECAM (CD31), CD99, and VE-cadherin) and are studying how they regulate the inflammatory response using in vitro and in vivo models.  We have recently described the Lateral Border Recycling Compartment, a novel para-junctional organelle that contains PECAM and CD99 and is critical for diapedesis to occur. We are currently investigating how this compartment regulates diapedesis in the hope of finding novel targets for anti-inflammatory therapy.
1065744	My clinical and research interests involve my primary specialty, Pediatric Emergency Medicine.  I am interested in youth firearm injury epidemiology and prevention and am currently involved in database research examining firearm injury among youth in Cook County.  I am also actively involved in the medical education of residents and medical students in the emergency department, PBL, and resident lectures.
1065776	Clinical Interests: Musculoskeletal injuries, Sporting Event coverage, mass participation events.Research Interests: Clinical Operations in the Emergency Department, Patient Satisfaction, Mass participation events, Sports Injuries, Procedural teaching.
1065793	Clinical interests include percutaneous aortic valve replacement, minimally-invasive aortic valve replacement, aortic valve repair, valve-sparing aortic root replacement, aortic arch repair, endovascular stent-grafts, thoracoabdominal aortic aneurysm repair. Research interests include Marfan syndrome, bicuspid aortic valve, thoracic aortic aneurysm.
1065795	Pediatrics and Urgent Care
1065796	Fetal echocardiography
1065799	My laboratory has two main research interests. The first is to understand how retinal ganglion cells (RGCs) acquire their dendritic morphology during postnatal development. We focus on understanding how neurotrophins, specifically, Brain-derived neurotrophic factor (BDNF) and Neurotrophin 3 (NT-3),  affect RGC dendritic development and function. The second is to determine how neurotrophins can be used to protect RGCs in glaucoma, a group of neurodegenerative diseases characterized by RGC death.
1065833	<BR><BR>Cytopathology
1065940	My primary interest is in pathogenesis of herpes simplex (HSV) disease, focusing on development of vaccine candidates.  I also study herpes simplex disease in newborns, specifically focusing on the role of the different entry receptors in disease pathogenesis.  Additionally, I have projects related to use of HSV an oncolytic virotherapy and projects intended to increase our understanding of immune responses to skin and mucosal infections.
1065960	Clinically, my interests encompass all classical hematology, including thrombosis/clotting disorders, thrombophilia/inherited clotting disorders.  Bleeding disorders.  Platelet disorders including ITP/autoimmune thrombocytopenia.  Anemias (including sickle cell anemia, autoimmune hemolytic anemia, pure red blood cell aplasia, etc). Aplastic anemia.  Chronic myeloproliferative disorders including polycythemia vera, essential thrombocythemia, eosinophilia, & myelofibrosis.  Hematologic issues in unique patient populations, including solid organ transplant and autoimmune/rheumatologic diseases. Research interests include evaluating mechanisms of thrombosis particularly in malignancy, investigating new ways to evaluate the clotting system/platelet function, identification of those patients at high risk for thrombosis & thrombosis recurrence.
1065989	Research interests include hair loss and its impact on quality of life, immunobiology of inflammatory hair loss conditions, impact of diet and nutrition on hair loss.  Clinical and administrative interests in medical student education, establishing uniform education and testing in dermatology among medical students. 
1066028	Clinical trials in early lung cancer diagnosis and minimally invasive surgical techniques for lung cancer treatment.
1066072	1.Patients with diabetes and obesity have increased risk for cardiovascular disease. These metabolic conditions are associated with chronic inflammation, oxidative stress, and insulin resistance leading to severe coronary events and worse clinical outcomes. The long-term goal of our research is to determine mechanisms by which diabetes/obesity increase risk for coronary artery disease and the resulting pathophysiological consequences. In this context, macrophages (part of the innate immune system) have emerged as a key pathogenic link between diabetes/obesity and the resulting coronary artery disease. Macrophages play critical role in regulating the body's inflammatory response to environmental stimuli, pathogen recognition, clearing cellular debris and inflammatory cytokine secretion. However, their chronic activation in diabetes/obesity might induce endothelial dysfunction, cardiac cell death, extracellular matrix remodeling and contractile dysfunction leading to heart failure. Our research efforts are focused on understanding the cellular and molecular connections between macrophage biology, chronic inflammation, oxidative stress and insulin resistance, and diabetes/obesity-induced cardiovascular disease. These studies will facilitate development of novel therapies that specifically target recruited macrophages to treat the underlying inflammation and insulin resistance in patients with type 2 diabetes/obesity.2. Acute ischemic injury and chronic cardiomyopathies lead to permanent loss of cardiac tissue. Transplantation of bonemarrow (BM)-derived progenitor cells has the potential to improve cardiac function after ischemic injury. However, number and functional capacity of these cells are impaired in diabetes. Our objectives are to determine the impact of the diabetic milieu (high glucose and fatty acids) on progenitor cell biology and function and their contribution to myocardial repair in response to ischemic injury.
1066075	My research for the past 20 years has been in the areas of immune responsiveness and tolerance induction in clinical organ transplantation.  These studies have resulted in more than 200 publications including book chapters, review articles and editorials, original papers and presentations.  The major thrust of these has been on the immunological effects of donor bone marrow cell (DBMC) and donor hematopoetic stem cell (DHSC) infusions in organ transplant patients using in vitro and ex vivo culture systems. It has been observed that using multiple assays for donor specific unresponsiveness may identify potentially tolerant recipients who may be candidates for immunosuppressive drug (IS) withdrawal. Recent studies have also assessed the role of CD4+CD25High FoxP3+ regulatory T cells as potential tolerance inducers in kidney and liver transplant patients, as well as the differential susceptibility these cells to various immunosuppressive drugs used in clinical transplantation.
1066091	My clinical interests include neonatal stroke, congenital brain malformations, perinatal hypoxic ischemic injury and the neurological complications that arise from these insults.  My research focuses on mechanisms regulating glial progenitor cell response to perinatal injury.
1066093	Primary research interest focuses on optimizing value in health care delivery through evaluating quality of care delivery and costs. Additional interests include health literacy, patient centered care, and relevant medical education.
1066134	My research interests exist in the interaction between the epidemiology of pediatric and adult infectious diseases.  Many infectious pathogens pass between the two populations and can be impacted by vaccination or other infection control strategies.  In particular, I have been interested in the burden of gastroenteritis in adults that is due to rotavirus and norovirus.  Additionally, I am currently part of a multicenter study of community-acquired pneumonia in children and adults.
1066173	Incoorporating prevention services to hospitalized patients
1066178	I am interested in clinical research that focuses on echocardiography and valvular heart disease, as well as prevention of coronary artery disease. I am currently developing a study to evaluate the effects of a comprehensive lifestyle behavioral program in women with the metabolic syndrome.
1066198	Sports Medicine
1066200	I have three main intersts: Surgical education (curriculum design) and Faculty developmentCritical Care and Trauma outcomes research
1066201	Clinical and research interests include thyroid cancer, thyroid nodules and other benign disorders of the thyroid gland, hyperparathyroidism, functional and nonfunctional adrenal tumors, inherited endocrine disorders, and minimally invasive methods of treatment including minimally invasive thyroidectomy and parathyroidectomy as well as laparoscopic adrenalectomy.
1066214	Dr. Devries specializes in preventive cardiology and noninvasive cardiac testing with echocardiography. Prevention interests focus on an integrative approach to treatment emphasizing nutrition and innovative uses of non-pharmacologic therapies-in addition to conventional treatment.
1066217	Dr. Kim's research interests involve statistical problems that arise in genetics and genomics research. He is particularly interested in developing statistical methods and computational tools to identify genes involved in Mendelian and complex genetic disorders. His work emphasizes the importance of characterizing gene-gene and gene-environment interactions in successfully identifying disease genes. Dr. Kim's research can be applied to various types of experiments, including genomic studies with high-throughput microarray data. His recent work has contributed in understanding the regulation of gene expression in the mammalian eye.
1066226	Dr. Schlossers areas of interest include acne, rosacea, polycystic ovary syndrome, excess hair disorders in women, skin disorders in pregnancy, female genital mucosal disorders and adolescent dermatology.  As the Director of the Womens Skin Health Initiative, Dr. Schlosser leads a team of expert physicians in providing outstanding and comprehensive care in medical, surgical and cosmetic dermatology to women of all ages and stages of life.  In addition, Dr. Schlosser directs the Vulvar Mucosal Specialty Clinic, a multidisciplinary clinic dedicated to the expert care of women with genital (vulvar) disorders including inflammatory skin diseases (lichen planus, lichen sclerosus, pemphigus, Hailey-Hailey disease, lichen simplex chronius, eczema and others), infections, and chronic irritation, pain and/or itching. She currently sees patients at the Northwestern Medical Faculty Foundation outpatient dermatology clinic and performs inpatient consultations at Prentice Womens Hospital.
1066253	My laboratory's research focuses on understanding how dysregulated cell cycle controls promote tumorigenesis and alter normal, lineage-specific transcriptional programs in hematopoietic stem and progenitor cells as well as in epithelial cells. We also study basic mechanisms of cyclin regulation. In my laboratory, we utilize primary and organotypic cell culture, mouse models, and live cell imaging. Discovery projects underway involve the use and study of small regulatory RNAs and synthetic lethality screens.
1066274	flourescence endoscopy (Imaging proteolytic activity in cancer)cancer vaccinesimmunetherapy
1066309	1. Echocardiographic diagnosis of Diastolic dysfunction.2. Prognosis associated with asymptomatic diastolic dysfunction. Evaluation of the CARDIA study3. Echocardiographic determinants of Heart transplant rejection4.Right ventricular area normative data from CARDIA study5. Prognostic value of Right ventricular area6. Echocardiographic core lab for MARVEL study
1066309	Diastology, Hypertension, Tissue Doppler Imaging, Echocardiography
1066351	Traumatic Brain injury
1066379	We are interested in the functional roles of chondroitin sulfates and chondroitin sulfotransferase genes in mammalian development, disease, and cellular signaling pathways. Specifically, we are currently investigating the roles of the sulfotransferase C4ST-1  and its chondroitin sulfate products in breast cancer progression, in the pediatric disease Costello syndrome, in developmental processes including ES cell differentiation and cell lineage determination, and in the control of Wnt signaling. Our long-term goal is the development of carbohydrate-based pharmacological interventions for the treatment of cancer and cardiovascular disease.
1066385	I am interested in diabetes, thyroid, growth, and pubertal disorders. I have an interest in the planning for transition between pediatric and adult medical care. I am also interested in integrative diabetes therapies. I am also insterested in disorders of sexual development.
1066395	Dr. Duffecys research background is in behavioral medicine. Her specific interests include methods to improve weight loss as well as using technology to reduce barriers to receiving behavioral and mental health care.
1066403	My primary clinical and research interests are in the early diagnosis of autism spectrum disorders in young children.
1066404	Leukemia, Lymphoma, new agents and survivorship in children
1066435	Bone Health in Children and Adolescents - using fractures to predict low bone densityFracture managementHip dysplasiaHip preservation techniques
1066440	Clinical and genomic modifiers of cardiac conduction
1066440	I am interested in caring for and treating patients with acquired and inherited arrhythmias and understanding the underlying reasons for this susceptibility.  In addition, I treat patients with these arrhythmias either through ablation, or with devices, such as pacemakers and defibrillators.
1066455	Clinical educator in the Division of Endocrinology, Metabolism and Molecular Medicine
1066455	Dr. Hahr is interested in endocrinologic disorders.  She specializes in disorder of calcium and bone, including osteoporosis, hyperparathyroidism and vitamin D deficiency.  She also cares for patients with thyroid disorders and Polycystic Ovary Syndroma.
1066458	Regulatory mechanisms of inflammatory and apoptotic responses during pathogen infection and inflammatory disease
1066503	Clinical interest in surgical and non-surgical treatment of Female Pelvic Floor Disorders including pelvic organ prolapse, urinary and fecal incontinence, genitourinary and rectovaginal fistulas, complicated obstetrical lacerations.
1066654	I am interested in the process of communication that occurs between patients, families and providers in the acute care setting. In particular, my focus is on the impact of communication and information exchange on patient satisfaction, comprehension and outcomes following an ED visit. I am committed enhancing the discharge process for patients when they leave the ED. In addition, I am very interested in the intersection between emergency medicine and palliative care. I feel that education and training in EM must include an emphasis on quality of life and end of life issues which have traditionally be underrepresented.
1066664	Primary research interests are in the applications of minimally invasive surgery to spine.  Secondary research interest is in stem cell transplantation for spinal cord injury.
1066665	My laboratory explores the cell surface as a dynamic platform regulating cell behavior.  Specifically, we seek to understand how surface glycoproteins regulate cell-cell fusion in muscle cells, and to determine how pathogens target cardiac muscle.  Using surface modification, we then hope to re-engineer stem cells to improve tissue targeting and tissue integration.  To accomplish these broad aims, our current research projects are exploring the following research issues:  (1) Tissue tropism of Trypanosoma cruzi.  T. cruzi demonstrates tissue tropism during both the acute and chronic phases of infection, targeting cardiac, skeletal, and smooth muscle.  Patients with chronic T. cruzi infection may develop clinical symptoms related to target tissue infection, notably myositis, dilated cardiomyopathy, and megasyndromes.  The molecular basis for these clinical observations is incompletely understood.  My research hopes to define and characterize the cell surface proteins important during the initial host-parasite interaction enabling myogenic specificity.  (2) Drug discovery for African Trypanosomiasis. T. brucei behaves as an eukaryotic tumor in the host. We are exploring the use of traditional cytotoxic chemotherapy, as well as targeting bioactive lipid pathways, to discover potential inhibitors. (3) Cell-cell fusion and GPI-anchored proteins during skeletal myogenesis.  Secondary skeletal myogenesis, the process of differentiation of dividing, mononuclear myoblast into quiescent, multinucleate myotubes is critical for maintenance of skeletal muscle during aging and after injury.  GPI-anchored cell surface proteins appear to be critical for these regulated membrane-membrane fusion events.  Our research hopes to dissect the molecular choreography occurring at the site of opposing membranes which enables cell fusion.
1066671	Urgent Care pediatrics/general pediatrics
1066766	My primary research interest focuses on the mechanisms of actin cytoskeletal remodeling.
1066898	All clinical supports in diagnostic radiological physics at Northwestern campus; Applied research in medical imaging, mainly in CT, X-ray, mammographic, ultrasound, MR and PET imaging, and radiation shielding/protection.
1066951	Dr Berkelhamer researches oxidative lung injury with an interest in the metabolic consequences of hyperoxia on the developing lung. In addition, she is interested in gender differences in pulmonary morbidity and the potential role of estradiol in protecting against oxidative lung injury.
1066962	Tumor recurrence and metastasis represent the major causes of cancer related deaths. Studies aimed at understanding how cancer cells grow and spread can help identify novel anti-cancer targets. Dr. Strizzi's research involves the study of how the extracellular microenvironment is capable of regulating cancer related mechanisms including matrix remodeling, cellular invasion and angiogenesis known to play important roles during cancer spread. More recently his work has focused on the role of embryonic morphogens, Cripto-1 and Nodal during tumorigenesis. Both Cripto-1 and Nodal are involved in early development and have been shown to be re-expressed in human cancers like breast cancer and melanoma. Dr. Strizzi is currently studying how Cripto-1 and Nodal signaling can affect differentiation, migration and invasion of cancer cells and identify molecules and molecular pathways capable of regulating these Cripto-1/Nodal-dependent activities in cancer.
1067116	Dr. Evans has expertise in epidemiologic methods, health outcomes, and infectious disease related research. Her past and current research has focused on the secondary complications of persons with spinal cord injury and disorder (SCI&D) and women with HIV. Her major research interests include the epidemiology of infectious diseases (particulary healthcare associated infections) and outcomes as related to these infections, antimicrobial prescribing and its effects on patient outcomes, and uptake of influenza and pneumococcal pneumonia vaccinations.
1067124	Epilepsy in children and adults, the pharmacology of anticonvulsant medications, vagus nerve stimulation in epilepsy, epilepsy surgery, the neurophysiology of epilepsy. Intra-operative neurophysiological monitoring.
1067182	Yersinia pestis and Yersinia pseudotuberculosis are two bacterial pathogens that are very closely related, yet cause vastly different diseases in the mammalian host. Y. pestis is infamous for causing the devastating disease plague, while Y. pseudotuberculosis infection often results in a mild, self-limiting gastrointestinal illness. While genetically similar, the distinct mechanisms by which these two bacterial species interact with the host is of great interest to our group.Shared amongst both pathogens is a protein called Hfq, which serves as a chaperone for small, non-coding regulatory RNAs (sRNAs). One set of projects in the lab centers on understanding the post-transcriptional regulatory networks controlled by Hfq and sRNAs in both Yersinia species, particularly as they relate to virulence. We anticipate that the similarities and differences we identify between Y. pestis and Y. pseudotuberculosis in this regard will provide keen insight into how a relatively mild pathogen evolved into one of the most deadly known to mankind.We are also interested in determining the mechanisms by which Y. pestis specifically causes primary pneumonic plague, a respiratory form of disease that Y. pseudotuberculosis does not produce. Another set of projects in the lab focuses on dissecting the mechanisms by which the Y. pestis virulence factor Pla controls the development of pneumonic plague. These include understanding the interaction of Y. pestis and Pla with the mammalian fibrinolytic and coagulation cascades, the identification of additional host substrates cleaved by Pla that lead to the development of a severe pneumonia, and the mechanisms by which Pla specifically induces an overwhelming inflammatory response in the lungs during infection.
1067233	Acute liver failure predictors of recovery and need for liver transplantation
1067233	Principal Investigator NMH siteAcute Liver Failure NIH sponsored grant. Principal Investigator NMH site study name:SANVAR . Completed July 2008sponsored by DEBIO  
1067235	Interested in diagnosis and treatment of ectopic pregnancy' gynecologic surgical techniques and preinvasive neoplasia if cervix, vagina and vulva
1067245	Debra E. Weese-Mayer, M.D. is a Professor of Pediatrics at Northwestern University Feinberg School of Medicine and Director of the first Center for Autonomic Medicine in Pediatrics (CAMP) at Childrens Memorial Hospital. She is recognized internationally for her expertise as a leader in clinical and research advances in respiratory and autonomic disorders of infancy, childhood, and adulthood (RADICA)--including Sudden Infant Death Syndrome (SIDS), Congenital Central Hypoventilation Syndrome (CCHS), Rapid-onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD), Rett Syndrome and Familial Dysautonomia. She has authored more than 250 peer-reviewed articles, reviews, chapters, and abstracts. Her clinical and research programs have grown to include a wide-ranging referral base (48 states; 49 foreign countries). Dr. Weese-Mayer was awarded the March of Dimes Jonas Salk Health Leadership Award in Research for 2005. She patented a genetic test to diagnose CCHS, allowing early confirmation of diagnosis, and prenatal testing (patent proceeds support CCHS research). Dr. Weese-Mayer's long term career objectives are to 1)build the model Autonomic Medicine program in Pediatrics---with wholly innovative protocols and technology for in and out-patient application; 2)develop norms for all age groups, ethnicities, and by gender for pediatric-friendly autonomic testing protocols; 3)continue to characterize CCHS and ROHHAD; 4)identify the genetic or epigenetic basis of ROHHAD, SIDS, and stillbirth; 5)develop a Neurocristopathy Consortium to expand knowledge of rare disorders in the context of related disorders (ex. Hirschsprung disease, neural crest tumors, CCHS, MEN2A, pheochromocytoma, ROHHAD, and more)--to improve visibility of Rare Disease Medicine and value of study of rare diseases to understand basic systems in health; and 6)train the next generation of experts in respiratory and autonomic control.
1067322	Research focuses on: 1) evaluating combination psychological and pharmacological treatments for tobacco dependence; 2) characterizing smoker- and treatment-related factors that influence smokers adherence to treatment and likelihood of quitting; and 3) developing an understanding though human laboratory and genetic epidemiologic studies of psychological, biological, and genetic factors that convey risk for smoking persistence. Primary end-point is to decrease risk of tobacco attributable disease through long-term smoking cessation.
1067418	Our lab is interested in studying signaling pathways that regulate cancer progression. One of our current projects looks at the role of the extracellular matrix protein, collagen, a major component of the fibrosis associated with pancreatic cancer, in promoting chemotherapy resistance. We have recently found that collagen up regulates expression of the matrix metalloproteinase MT1-MMP (MMP14), which in turn induces expression of the chromatin modeling protein HMGA2. This results in pancreatic cancer cells escaping the proliferation arrest on gemcitabine treatment.
1067420	Renal and transplant pathology.
1067449	My research focuses on the immune function of major histocompatibility complex (MHC) class Ib molecules in normal and diseased states. My lab is interested in understanding how MHC class Ib-restricted T cells are selected and regulated during development and how they contribute to the control of autoimmunity, anti-tumor immunity and infectious diseases.  My lab is also interested in identifying microbial antigens recognized by MHC class Ib-restricted T cells with the goal of developing new T cell-based vaccines for microbial infection.
1067451	Microbiology/Virology  <BR><BR> am interested in the ecology of infectious diseases, especially those that are zoonotic (transmitted from animals to humans) or involve pathogens that have transmission dynamics strongly influenced by environmental conditions. This type of research requires a wide variety of techniques ranging from basic field studies to molecular epidemiology. Ecologic modeling of these diseases is aided by computerized mapping with geographic information systems (GIS) and much of the data we analyze is acquired by remote sensors on earth-orbiting satellites.
1067515	My laboratory is interested in identifying new biomarkers for psychosis and dementia, using biomarkers to develop new treatment approaches for the disorders, and developing more informative animal models of neuropsychiatric disorders.
1067525	My laboratory has a longstanding interest in mast cell and eosinophil biology. We have developed specific and novel in vivo approaches for the analysis of mast cell function in experimental gastrointestinal inflammatory and allergic reactions. We can apply this model to determine the precise influence of mast cells and mast cell-derived cytokines/chemokines in gastrointestinal inflammation.
1067560	I am mainly involved in uncovering the mechanisms of endoplasmic reticulum stress in regulation of metabolic disorder and hepatocarcinogenesis based on the acyl-CoA oxidase 1 deficient (Acox1-/-), leptin and Acox1 double deficient (ob-/-Acox1-/-), and Promethin deficient (Prom-/-) mice.
1067632	Dr. Hagerty is a pediatric urologist.
1067664	My current works focus on cancer related translational studies (from bench to bed) by means of developing algorithm and analyzing high-thoughput genomic and transcriptomic data, such as next-generation sequencing and microarrays, as well as pipeline construction for drug discovery and repositioning by integration of varies of tools (developed by others and us) and datasets including clinical data, genomic data, etc, with annotations, like functions, pathways, diseases, compounds, etc. I am also interested in molecular modeling, such as molecular dynamics simulation, coarse grain simulation, etc, which is also widely applied for compounds screening at atomic level.
1067808	Primary interest is health psychology/behavioral medicine with specific interest in psycho-oncology. 
1067860	Adjunct Instructor in FSM Nutrition Curriculum
1067861	Adjunct Instructor in FSM Nutrition CurriculumInterests include Cystic Fibrosis (CF) nutruton
1067862	Adjunct Instructor in FSM Nutrition CurriculumInterests include neonatal nutrition
1067863	Cancer of the Skin
1067914	Adjunct Instructor in FSM Nutrition Curriculum
1067916	Adjunct Instructor in FSM Nutrition Curriculum 
1067917	Adjunct Instructor in FSM Nutrition Curriculum
1067927	My major research interests are on identification of molecular biomarkers that are associated with tumor growth and progression in benign and malignant uterine smooth muscle tumors. In addition, I am interested incharacterization of the role of microRNAs in the pathogenesis of benign and malignant tumors in women's reproductive organs through regulation of the target gene expression.
1067953	My research interests involve resident education and development utilizing medical simulation.  I am involved with simulation at a national level.  I also instruct simulation courses for Maintenance of Certification in Anesthesiology (MOCA); such courses are required by the American Board of Anesthesiology.  The over-arching theme is increased patient safety with the goal of enhanced/improved resident education.  To that end, I also participate in anesthesiology Resident Recruitment for Northwestern, as well as our department's Clinical Competence Committee.
1068004	Dynamics of lateral Border recycling compartment during leukocyte transmigration
1068072	Dr. Vaughan directs a multidisciplinary research group focused on investigating the role of the plasminogen activator system in cardiovascular disease. Active experimental programs are underway at the molecular and cellular level in animals and in humans. Transgenic and knockout mice are used in a variety of studies designed to explore the tissue-specific expression of PAI-1 in vivo and the role of the fibrinolytic system in vascular disease and tissue remodeling. 
1068072	My primary clincial interest is in adult cardiovascular disease.  My practice has focused on the management and treatment of patients with coronary artery disease.  I am also interested in the diagnosis and management of arterial thrombosis.  My research interests align with these clinical interests.  My primary investigative focus is and has been on the mammalian plasminogen activator system and the role this system plays in cardiovascular disease.  We apply a multidisciplinary approach in this effort, and utilize molecular and cellular approaches, as well as animal and human studies.
1068073	Barrett's Esophagus; Biliary Tract Disease; ERCP; Endoscopic Mucosal Resection; Endoscopic Surgery; Endoscopic Ultrasound; Gastrointestinal Cancer; Pancreatitis; Radiofrequency Ablation
1068073	Dr. Komanduri is an Interventional Gastroenterologist. His interests include pancreaticobiliary disease, Barrett's esophagus, and gastrointestinal oncology. His expertise includes: Endoscopic Retrograde Cholangiopancreatography, ERCP, Endoscopic Ultrasound (EUS), Endoscopic Mucosal Resection (EMR), and Radio Frequency Ablation for Barrett's Esophagus (RFA). Dr. Komanduri serves as an integral part of the comprehensive GI cancer team.
1068089	Dr. Keswani is an interventional gastroenterologist who focuses on minimally invasive procedures. Clinical interests include the use of endoscopic ultrasound in tumor diagnosis and staging, palliation of gastrointestinal malignancy, pancreaticobiliary endoscopy (ERCP), endoscopic mucosal resection for early gastrointestinal malignancy, and small bowel endoscopy including single balloon enteroscopy. Research interests focus on clinical outcomes of interventional endoscopic procedures including EUS, ERCP, and stent placement.
1068120	While I practice general Gastroenterology, my primary clinical and research interests focus on gastrointestinal pelvic floor disorders (e.g. constipation/fecal incontinence)and irritable bowel syndrome. I also specialize in treating gastrointestinal disorders associated with Scleroderma.
1068128	Clinical interests include treatment and diagnosis of food allergy, childhood wheezing and asthma, eczema and drug allergies.Current research interests include involvement in food allergy and asthma clinical trials. Prior research focused on the epidemiology of early childhood wheezing.
1068131	Dr. Smith's primary research interests are the neurobiology and treatment of social cognitive deficits in schizophrenia and other psychiatric disorders.
1068135	Gamma Knife Radiosurgery, Intensity Modulated Radiation Therapy, High Dose Rate Brachytherapy
1068180	Surgical Oncology. Liver/hepatic surgery. Pancreatic surgery. Biliary surgery. Pancreatic cancer, liver cancer, gastric cancer, gastrointestinal cancer.
1068246	My clinical and laboratory-based research centers on why white blood cells fail to proliferate or differentiate normally. When these fundamental processes go awry, there is either bone marrow failure or leukemia. I have established a multi-disciplinary clinic at Children's Memorial Hospital for Bone Marrow Failure and Myelodysplastic Syndromes. In my lab, we are studying the roles of protein tyrosine kinases and PI 3-kinase in acute myeloid leukemia, myelodysplasia, and granulopoiesis. In particular, we are investigating the signal transduction biochemistry of the granulocyte colony-stimulating factor receptor. While studying Src kinases, we discovered a cytoskeletal protein, Cdc42 Interacting Protein 4 (CIP4). We made the CIP4 knockout mouse and discovered that the mouse strain displays thrombocytopenia. We have made other unique knockout mouse strains to study the role of CIP4 in normal physiology and disease.  Understanding the roles and components of kinases will translate to improve drug therapies for a variety of human cancers.  Cancer biology and therapeutics is complex, thus I have been developing a program in systems biology so to reveal new insights. Bone Marrow Failure syndromes, acquired or inherited; Neutrophil Defects; Myeloid leukemias (acute or chronic); Myelodysplastic Syndromes; Myeloproliferative Syndromes; Juvenile Myelomonocytic Leukemia (JMML);Ataxia Telangiectasia; Neutropenia; Thrombocytopenia;Systems BiologyMolecular Targeted Therapy
1068247	I have a wide range of clinical interests including ADHD, mood, and anxiety disorders in children and adolescents.  In addition, I am particularly interested in psychiatric education and training. 
1068287	<B>CLINICAL:</B>  Dr. Mandelin provides general rheumatology care, and has an interest in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. His practice philosophy is: <I>'Patients do better if they can participate in their own care, and to do that they need to be given an understanding of their disease.'</I> <P><B>RESEARCH:</B>  Dr. Mandelin conducts basic science research into the disease mechanisms of rheumatoid arthritis, and he participates in clinical trials of new and existing medications for the treatment of rheumatoid arthritis and ankylosing spondylitis.<P>Dr. Mandelin also serves as the editor of Division's website and as the liason for our electronic medical records system.
1068287	My 'bench' research interests include the control of apoptosis in rheumatoid arthritis (RA) fibroblasts via a the mitochondrial pathway.My clinical research interests are in the field of medical informatics / electronic medical records / data mining.
1068431	I am a clinical instructor within the Division of Hospital Medicine. I work primarily on the heme-onc floors as an oncology hospitalist. I serve as the Director of Hospital Medicine for Oncology Services. Additionally, my clinical and non-clinical interests include women's health, global health, physician work force issues, and health and provider disparities.
1068433	My clinical practice is focused on inpatient care of oncology patients and attending on our palliative care services.  I'm working with my colleagues in palliative care to develop improved techniques for teaching medical students and residents how to effectively use opioids for pain control.
1068435	My primary clinical interests include sleep disorders in children and adults, insomnia in children and adolescents, and patients with control of breathing deficits.
1068449	I specialize in neuropsychiatry, the mental and behavioral disorders due to brain diseases such as epilepsy, movement disorders, dementias, or autoimmune diseases.
1068455	Dongs lab research interesting focuses on the mechanisms of neurodegeneraton and related disorders. Two on going NIH funded projects are: using a combination of human and mouse genetics to identify novel genes and pathways that give rise to schizophrenia; also using a transgenic mouse model of Alzheimers disease to investigate the relationship and mechanisms between stress and Alzheimers pathogenesis.
1068527	Neurovascular diseases; neurointerventional surgery; development of new devices
1068541	Interested in clinical research on polycystic kidney disease.
1068542	Dr. Uchida is experienced at caring for patients with complex medical illnesses. She practices evidence-based medicine which includes treating each patient as a unique individual. She also focuses on health promotion and the care of the whole person.
1068542	Toshi Uchida is a clinician-educator in the Division of General Internal Medicine.  Her clinical work in primary care focuses on promoting wellness and outpatient care of patients with complex medical illness.  Her educational work includes clinical skills education, assessment and dissemination.  She is a member of the Research and Education for Academic Achievement (REACH) Team which is developing a practice-based research network through the Northwestern University Clinical and Translational Science (NU-CATS) Institute.
1068543	Hematopathology
1068545	My primary focus is in maternal/child health including high risk obstetrics. My background in public health provides me opportunity to use my statistical knowledge in data analysis and review. I have published and presented papers relating to women's health, pediatrics and obstestrics.
1068571	<BR><BR>Surgical Pathology
1068572	Clinically, I am interested in early detection and early treatment of emerging psychotic disorders to protect cognition and prevent disability.  My primary research interest interest is in biological markers of neuropsychiatric conditions, especially anatomical and neurocognitive endophenotypes of severe mental illnesses such as schizophrenia. Recent projects have used structural magnetic resonance imaging to correlate cognitive performance and symptoms with anatomical changes. Ongoing projects include longitudinal studies of subjects at risk for developing schizophrenia and clinical research into strategies for enhancing cognition in schizophrenia.
1068577	Our lab's research is focused on the development of multidimensional and multimodal neuroimaging biomarkers using the tools of computational anatomy. Working with collaborators from engineering, mathematics, psychology and clinical specialties, we focus on the following major areas:<br />Mapping of Brain Structures using MRI: We develop automated pipelines to delineate brain structures based on simultaneous mappings of multiple structures from multiple atlases. This includes deep brain structures (such as the hippocampus, amygdala, thalamus, and basal ganglia) and cortical structures. <br /><br /><b>Complex Neuroimaging Biomarkers:</b> We develop modeling and statistical approaches for the analysis of these maps. We develop frameworks for joint, integrated analyses of multidimensional, multimodal information based on the structural mapping of the brain. These include:<br /> ' Multimodal MRI analysis: structural MRI, functional MRI, diffusion MRI, perfusion MRI, PET <br /> ' Network analysis<br /> ' Structure-function relationship<br /> ' Subtyping and dimensional analysis<br /> ' Prediction and longitudinal analysis<br /><br /><b>Clinical Applications:</b> We are interested in developing neuroimaging markers to characterize neuropsychiatric disorders, disease progression and prediction, and monitoring of treatment:<br /> ' Mild cognitive impairment (MCI), dementia<br /> ' Breast cancer-related MCI<br /> ' Psychosis/Schizophrenia/Mood Disorders<br /> ' Imaging Genetics<br /><br /><b>Neuroinformatics:</b><br /> ' Data sharing<br /> ' Data mediation<br /><br /><b>Preclinical Applications:</b> Neuroimaging of Animal Models<br /> ' Schizophrenia, Dementia, Mood Disorders, Memory<br /> ' Mouse, rat, rabbit<br />
1068651	In efforts to understand how to prevent sexual transmission of HIV-1, our lab is studying how mucosal transmission occurs in both the male and female genital tracts. Using ex vivo tissue explant cultures, we are able to identify viral particles that have breached the protective layers of the squamous epithelium to reach potential underlying target cells. 
1068651	Sexual Transmission of HIV (female-to-male and male-to-female).
1068678	My research interests are in utilizing various neuroimaging techniques to study relationships between cognitive functioning and brain structure in schizophrenia populations. I also investigate cortical changes in primary progressive aphasia, a language-based dementia.As a clinical neuropsychologist, I evaluate the cognitive functioning of various brain injuries and illnesses, including adult ADHD, autoimmune disorders, hepatic encephalopathy, traumatic brain injury, epilepsy, tumors, as well as the influence of psychiatric illness on cognition.
1068691	Dr. Sarah Kinsingers background and training is in health psychology and she has experience providing cognitive-behavioral therapy (CBT) interventions to a variety of medical populations, including cancer, obesity, acute rehabilitation, and gastroenterology.  Her research interests include the influence of partner support on adjustment to illness, sexual functioning following cancer treatment, and coping with chronic illness.  Dr. Kinsinger is also experienced in using CBT to treat depression and is approved by the Beck Institute of Cognitive Therapy and Research to provide CBT.
1068720	The overarching goal of our research is to improve upon current methods of bone healing.  In particular, we hope to develop more efficient and cost-effective methods of spine fusion that are associated with fewer adverse effects.  We utilize several different approaches to accomplish these goals.One research arm involves the use of mesenchymal stem cells isolated from human adipose tissue to elicit spine fusion in a point-of-care protocol.  In this research, we isolate mesenchymal stem cells from human liposuction aspirates and evaluate their capacityin conjunction with both standard and novel, nanotechnology-based carriersto elicit bone formation.  A second arm of our research utilizes a novel nanotechnology developed by our collaborator, Dr. Samuel Stupp, Director of the NU Institute for Bionanotechnology in Medicine (IBNAM).  Here, we employ a self-assembling, biodegradable nanogel composed of cylindrical nanofibers which contain an epitope directed at bone morphogenic protein-2 (BMP-2) in an attempt to facilitate spine fusion in our rat posterolateral spinal arthrodesis model.  Our research also focuses more broadly on mechanisms of bone healing.  In these studies, we investigate the molecular pathways by which normal bone healing occurs, as well as mechanisms by which these processes are disrupted, such as under osteoporotic conditions and after exposure to smoke and other environmental contaminants. Our goals are to elucidate these mechanisms of bone healing inhibition and develop novel methods to prevent such effects.
1068930	Cilia Polarity.The ability of ciliated epithelia to generate directed fluid flow is an important aspect of diverse developmental and physiological processes including proper respiratory function.  To achieve directed flow, ciliated cells must generate 100-200 cilia that are polarized along a common axis both within and between cells.  My lab is currently working towards understanding the molecular mechanisms for how cell polarity is coordinated as well as how individual cilia interpret the cells polarity.  Centriole Duplication.Centrioles are microtubule based structures with nine fold symmetry that are involved in both centrosome organization and aster formation during cell division.  During the normal cell cycle centrioles duplicate once, generating a mother / daughter pair, and in most post-mitotic vertebrate cells the mother centriole then goes on to form the basal body of a sensory cilium.  Abnormalities in the duplication of centrioles (and centrosomes) are prevalent in many cancers suggesting a link between centriole duplication and cancer progression.  My laboratory is addressing this fundamental question in cell biology from a novel direction with the use of Xenopus motile ciliated cells.  Ciliated cells are unique among vertebrate cells in that they naturally generate hundreds of centrioles therefore providing a great system for studying the regulation of centriole duplication.  Understanding how nature has overcome the typically tight regulation of centriole duplication will lend insight into the molecular mechanisms of cancer progression.
1068940	My research is focused on the evaluation of health information technology-enabled methods to assess and address disparities in the quality of chronic disease and preventive care.
1068950	Global Health/International Health, Tropical Medicine, Bacterial Infections, Parasitic Infections, Viral Infections, Diabetic Foot Infections, Osteomyelitis, Sexually Transmitted Diseases,  Tuberculosis, Travel Medicine
1068957	General neurology disorders, multiple sclerosis, transverse myelitis and other demyelinating diseases
1068982	Oral and Maxillofacial Surgery including orthognathic surgery, microneurosurgical reconstruction of trigeminal nerve injuries, temporomandibular joint surgery, distraction osteogenesis, alveolar cleft repair, neonatal distraction osteogenesis for airway management (e.g. Pierre-Robin sequence), endoscopic-assisted maxillofacial surgery, maxillofacial trauma, dental implants and reconstruction of alveolar ridge defects and sinus augmentation, and extraction of wisdom teeth.
1068983	To investigate the role of soluble epoxide hydrolase in the development of type 2 diabetes.To investigate the interaction between the plasminogen activation system and the arachidonic acid pathway in the context of fibrinolysis/thrombosis and this in normal and obese subjects.
1068995	I am primarily interested in treating benign and malignant diseases of the colon and rectum.  I have a particular interest in pelvic floor disorders and surgery for these problems.  I utilize laparoscopic and advanced endoscopic techniques in the treatment of the entire spectrum of colon and rectal problems, including cancer.  
1069004	My clinical interests are in the physical therapy management of adults with neurological conditions (particularly stroke, MS, and Parkinson's) and elders with imbalance and falls.  My research interests are in identification and treatment of imbalance and falls in elders and individuals with neurological conditions, and outcome measurement in neurological physical therapist practice.
1069041	My clinical interests include pregnancy care, routine gynecologic care, contraceptive management and the evaluation/management of abnormal Pap smears. I am actively involved in medical student education as the third year medical student clerkship director for Obstetrics and Gynecology. Additionally, I am one of two staff gynecologists for the HIV clinic.
1069043	My research is to understand molecular mechanisms that govern the biological functions of the intracellular signaling network in both physiological and pathological events.  We focus on regulation of JNK, which is member of the mitogen-activated protein kinase (MAPK) superfamily.  JNK is activated by a MAP kinase module through sequential protein phosphorylation in response to a variety of extracellular stimuli, including proto-oncogens, growth factors, inflammatory cytokines, and physical stresses.  Once activated, JNK phosphorylates its cytoplasmic target proteins such as members of the Bcl-2 family proteins, Itch, tau, IRS-1, or its nuclear target proteins such as the transcription factors c-Jun, ATF2, Elk-1, Stat3 and p53, thereby controlling proliferation, differentiation, programmed death and transformation.  Not surprisingly, JNK is involved in the process of many human diseases including lung diseases and lung cancer.   Through its involvement in regulation of airway smooth muscle cell proliferation, cell death, myofibroblasts proliferation, cytokine synthesis and transformation, JNK is likely to play a critical role in asthma, ischemia/reperfusion damage, pulmonary fibrosis, allergic inflammation in lung and NSCLC.  However, the challenge is how to selectively modulate JNK activity in vivo.  We have evidence that JNK functions as a protein complex, i.e., the JNK signalsome that is composed of both known JNK activators and novel stimulus-dependent modulators or regulators (SMOR).  SMORs are selectively recruited to or dissociated from the JNK signalsome in a stimulus-dependent manner, thereby specifying the activation of JNK by various extracellular stimuli.  It is possible that one can target a unique SMOR to selectively regulate JNK activation by a specific stimulus without affecting JNK activation by other stimuli or affecting activation of other singling pathways by that stimulus.  Our study on the JNK signalsome should shed light on our understanding of the molecular mechanism of pulmonary diseases including lung cancer and provide potential therapeutic targets.
1069054	I am investigating the impact of perioperative lidocaine infusion on the incidence of post-mastectomy pain syndrome.
1069067	Current research projects involve developing a clinical decision tool to differentiate abusive fractures from accidental fractures in infants and studying the natural history of scalp swelling following accidental head trauma.
1069068	Retinoblastoma, the most common pediatric cancer of the eye, is a devastating and sometimes fatal pediatric cancer. Within the United States, the majority of retinoblastoma patients are diagnosed before their 2nd birthday, and many lose their sight due to this disease. Outside of the United States, advanced retinoblastoma is an even greater clinical challenge in developing countries, where the mortality rate among children diagnosed with advanced metastatic retinoblastoma is as high as 80%.    Our laboratory mission is to understand the molecular mechanisms associated with retinoblastoma progression in order to facilitate the identification of novel therapeutic targets.  We are accomplishing our mission by studying both genetic and epigenetic changes that occur during retinoblastoma progression in human retinoblastoma tumors, and in retinoblastoma model systems.  Defining these changes is particularly valuable for the purposes of identifying novel targets for chemotherapeutic interventions.
1069069	Pediatric Orthopaedic Surgery
1069071	Clinical and research interests include sports concussion management, treatment of congenital clubfoot deformity, preparticipation evaluation for sports.
1069073	Dr. Gordon is Research Associate Professor in the Institute for Healthcare Studies and Department of Surgery, Division of Organ Transplantation at the Feinberg School of Medicine at NorthwesternUniversity. Dr. Gordon completed her doctorate in Medical Anthropology at Case Western ReserveUniversity. Thereafter, she completed a Fellowship in Clinical Medical Ethics at the University of Chicago. Dr. Gordon obtained her Masters in Public Health from University of Illinois, Chicago, specializing in Community Health Sciences. Dr. Gordons research interests include: ethics of organ transplantation and donation, determinants of disparities in access to health care and health outcomes, health literacy, human subjects research ethics, self-care & chronic illness management, and qualitative research & mixed methods. Dr. Gordon received a Career Development Award from the NIDDK to examine self-care and outcomes among kidney transplant recipients. Dr. Gordon currently serves on the Ethics Committee of UNOS and has been actively involved in the American Society for Bioethics and Humanities.
1069089	My clinical interests lie within the field of neuroradiology, including head and neck radiology, pediatric neuroradiology, functional MRI, MR spectroscopy and perfusion imaging.
1069105	Interventional Radiology
1069212	Stem cell dysfunction likely plays a central role in the pathogenesis of certain human diseases, particularly aging and cancer.  The use of simple eukaryotic model organisms in aging research has led to the identification and characterization of many genetic and environmental factors that modulate longevity.  The classic invertebrate model organisms, such as nematodes and fruit flies , however, are not ideal models for investigating the role of stem cells in human disease because of the relative absence of adult stem cells in these species.  My research program combines interests from my graduate research (stem cell biology) and postdoctoral work (basic biology of aging) using the freshwater planarian, Schmidtea mediterranea, as a model system. Our goal is to establish S. mediterranea as a model for the study of aging and age-related disease, with emphasis on the role of stem cells in longevity. S. mediterranea represents an excellent model for investigating mechanisms of longevity because of their apparent immortality and remarkable capacity to repair and regenerate tissues .  Regeneration in planarians is due to the presence of neoblasts, a pluripotent stem cell population in the adult.   To investigate the relationship between stem cells and longevity, we are using known longevity determinants to characterize age-related phenotypes in planaria, paying particular attention to regeneration and tissue homeostasis. We are also investigating telomere homeostasis and it's role in stem cell function in planaria.  Together, these efforts will establish S. mediterranea as a powerful model for the study of aging and age-related disease, and bring new understanding into the role of stem cells in longevity.
1069358	My main clinical interests/responsibilities are in perinatal pathology which includes placental pathology and perinatal autopsy pathology. My research interests are in correlating placental pathology with neonatal outcomes and investigating the causes of stillbirth.
1069409	Calvin R. Brown Jr., M.D. is Professor of Medicine in the Division  of Rheumatology of The Feinberg School of Medicine of Northwestern University.  He also serves as director of the rheumatology training program there.Dr. Brown is a member of a number of professional organizations, including the American College of Rheumatology, the American College of Physicians, and is past president of the Chicago Rheumatisim Society.  His research has been published in such journals as Arthritis and Rheumatisim and The Journal of Rheumatology.  He is author of several textbook chapters dealing with arthritis and allied conditions.His areas of focus include education in the rheumatic diseases, sports medicine, and disability evaluation.Dr. Brown received his medical degree from Wayne State University.  He completed his internship and residency at Northwestern Memorial Hospital.  He also completed fellowships in rheumatology at the University of Michigan and in sports medicine at Rush University Medical Center.
1069409	Calvin R. Brown Jr., M.D. is Professor of Medicine in the Division  of Rheumatology of The Feinberg School of Medicine of Northwestern University.  He also serves as director of the rheumatology training program there.Dr. Brown is a member of a number of professional organizations, including the American College of Rheumatology, the American College of Physicians, and is past president of the Chicago Rheumatisim Society.  His research has been published in such journals as Arthritis and Rheumatisim and The Journal of Rheumatology.  He is author of several textbook chapters dealing with arthritis and allied conditions.His areas of focus include education in the rheumatic diseases, sports medicine, and disability evaluation.Dr. Brown received his medical degree from Wayne State University.  He completed his internship and residency at Northwestern Memorial Hospital.  He also completed fellowships in rheumatology at the University of Michigan and in orthopaedics at Rush University Medical Center.
1069420	I am interested in understanding the cellular and molecular mechanisms for cell-type specific degeneration in neurodegenerative diseases. I am mainly focused on corticospinal motor neurons that degenerate in ALS, and HSP.
1069448	My primary clinical and educational efforts have been devoted to promoting the subspecialty of Pediatric Emergency Medicine in the Community Hospital setting through the development of partnerships between community hospitals and academic Pediatric centers.
1069481	My laboratory studies the regulation of spinal motor neuron and ventral midbrain dopaminergic neuron differentiation in development and disease. We want to understand what genetic and epigenetic mechanisms are utilized to regulate motor neuron and dopaminergic neuron differentiation and why these specific type of neurons degenerate in spinal muscular atrophy (SMA) and Parkinson's disease. To address these questions, we use a combination of biochemical, genetic and cell biological approaches, and utilize induced pluripotent stem (iPS) cells reprogrammed from fibroblasts, genetically modified mice, and zebrafish as model systems. Based on our findings, we hope to develop new therapeutic strategies for treating SMA and Parkinson's disease.
1069524	Palliative Care is a subspecialty that focuses on the relief or prevention of suffering -- physical, psychological, or spiritual -- in patients or families facing a life-threatening illness.  My interests lie in advanced symptom management and the role palliative care can play in an intergrated healthcare system.
1069530	Dr. Thompson has strong interests in the areas of quality improvement, patient satisfaction, medical documentation/coding, and telephone triage.  He has served as both chair and/or member of hospital-based and national quality assurance committees. He has developed databases and educational tools to promote benchmarking and quality improvement for emergency departments and medical call centers. Working in collaboration with nationally-known pediatrician Dr. Barton Schmitt, Dr. Thompson has authored a comprehensive set of telephone triage protocols for use in medical call centers and physician offices.
1069629	I am primarily interested in family and community medicine, with an interest in community assessment and clinical program development.  I have also done research in the area of physician stress and burnout.
1069689	My current research involves a variety of statistical issues arising in non-randomized observational studies, with particular emphasis on the causal inference of the effects of naturalistic lifestyles such as diet behaviors and physical activities on various cardiovascular diseases outcomes. One area of interest in statistical methods is combining parsimonious classification model of naturalistic behaviors and the lifetime outcome model of cardiovascular diseases. I am also interested in developing a methodological framework to infer causal links between gene expression, lifestyle behaviors and incidence of cardiovascular disease.
1069709	My primary research presently focuses on the examination of safety vulnerabilities in kidney and liver transplantation. I have received a Dixon Innovation Award to study safety in kidney transplantation and am R01 funded to examine safety in living donor liver transplantation.  Furthermore, I study geographic inequity in kidney organ allocation in close collaboration with NU Industrial Engineers.  I serve as the Director of the Northwestern University Transplant Outcomes Research Collaborative (NUTORC) which reaches across campus to bring together disparate expertise in order to address pertinent questions in transplantation.
1069730	My main interest is in spatial perception and control of movements in both healthy individuals and in stroke and traumatic brain injury survivors. Specially, Im interested in perception and action in spatial neglect following stroke. Im also interested in using virtual reality and robotics technologies for treatment and rehabilitation of individuals with cognitive and physical disabilities following brain injuries.
1069775	Dr. Siddiques methodological research interests are in the area of incomplete and latent data. His recent work has focused on multiple imputation for missing data and latent variable modeling in comparative effectiveness research. His collaborative work is in the areas of behavioral medicine and health services research.
1069836	My primary area of clinical interest is pediatric cardiac anesthesia and pediatric fellow education. My main area of research interest revolve around safety in pediatric cardiac anesthesia
1069882	Most of the research that I have been involved with through Northwestern University has been in the arena of lower limb prosthetics; utilizing motion analysis to determine differences in component usage.  Currently I am working with the Nueral Engineering Center for Artificial Limbs at the Rehabilitation Institute of Chicago in the 'Revolutionizing Prosthetics' project which has been primarily focussed on creating new upper extremity prosthetics components and controls.  Similarly, we are also investigating the capabilities of controlling lower limb prostheses with the use of residual limb EMG.
1069886	One of the focuses of my laboratory is to elucidate inflammatory signals induced in mucosal innate and T cells by bacterial products (e.g., peptidoglycan, lipoteichoic acid, surface layer proteins) leading to intestinal colitis. Using gene targeting in probiotic bacteria we clearly show the mitigation of colitis progression. Additionally, to mobilize mucosal and systemic immunity against microbial challenge we further optimize various aspects of our mucosal multivalent-vaccine platform against a broad range of pathogens such as HIV, H1-N1, and Biodefense. This goal is achieved by directly targeting immunogens to small peptides derived from a phage display peptide library leading to efficiently capture by dendritic cells when expressed by probiotic bacteria at the mucosal side.
1070050	Dr. Rowell is a pediatric surgeon with expertise in minimally invasive surgery; congenitalanomalies; anorectal malformations; prenatal counseling for fetal anomalies; herniasand undescended testes; tumors of the chest, abdomen and pelvis; thyroid disease; andovarian and breast disease
1070120	My major research interest has been to identify the pathophysiology of clinical features of severe psychiatric illness. I have focused most of my career on linking the water imbalance that is found in about 25% of schizophrenic patients to structural and functional deficits in the central nervous system. Our current efforts are focused on establishing whether  neuroendocrine deficits, particularly oxytocin, are responsible for increased vulnerability to psychological stress and impaired emotion recognition and social functioning in this patient population, and may be reversible with neuropeptide therapy.
1070355	Our research program is aimed at understanding the genetic program that underlies the pathogenesis of Glioblastoma multiforme (GBM), the most prevalent and malignant form of brain cancer. Applying a combination of cell/molecular biology, oncogenomic and mouse engineering approaches, we are dedicated to systematically characterize novel gliomagenic oncogenes and tumor suppressors. We will functionally delineate and validate these pathways towards pharmaceutical opportunities using sophisticated cell culture and animal models.
1070358	(1) Research how to better apply the EEG in the diagnosis and treatment of children with epilepsy.(2) Learn and develop better ways to provide comprehensive, compassionate, and technically superior care for children with epilepsy.
1070381	I currently specialize in genetic counseling regarding Neurofibromatosis and Jewish genetic disorders, including hereditary cancers.
1070382	Dr. Lee's research interests include statistical methods in epidemiology, longitudinal data analysis, and multilevel analysis. Her recent work on partial population attributable fraction has focused on estimating variance and computing confidence intervals to make inference on competing risk factors. She is currently interested in methodological issues relevant to the development and evaluation of risk prediction models for various study designs and data for model building, including cohort, nested case-control, case-control data combined with registry data, and kin-cohort data.
1070472	Transcranial Magnetic Stimulation, Electroconvulsive Therapy, Cancer Psychiatry, Psychosomatic Medicine.
1070473	Breast imaging and interventional proceduresBreast disease
1070490	Dr. Hargroves research interests include signal processing, pattern recognition and myoelectric control of powered prostheses.  Dr. Hargrove focuses on research and development of clinically realizable myoelectric control systems in hopes that the systems can be made available to amputees in the near-term.
1070492	Dr. Saroli's clinical interests include echocardiography in congenital heart disease, both by transthoracic and transesophageal echocardiography. She is the Associate Director of the Echocardiography Laboratory at Children's Memorial Hospital. She has additional training in Fetal Cardiology and performs and interprets fetal echocardiograms. In addition to her imaging committment, she runs a weekly general outpatient pediatric cardiology clinic, and provides attending service coverage in the pediatric Cardiac Intensive Care Unit. She is particularly interested in patients with single ventricle physiology and attends in the Transitional Clinic that allows transition of complex cardiac patients from the ICU to care by their own cardiologist.Her research interests currently include projects investigating the association between biochemical markers and post-Fontan cardiac index, as well as quality of life assessment in the pediatric cardiac population. She is also interested in research involving fetal cardiology patients and is involved in maintaining the fetal cardiac patient database.
1070520	' Auditory and vestibular neural prostheses and therapeutics' Auditory processing in the inferior colliculus and its significance in multisensory perception' Optical stimulation of neurons and cardiomyocytes' Biomechanical and biophysical underpinnings of vestibular disorders
1070746	Primary clinical interests include cardiac intensive care, single ventricle physiology, and neurodevelopment in children with severe congenital heart disease.
1070859	My primary clinical interest is grounded in primary care sports medicine.  My clinical interests include caring for endurance athletes, athletes who suffer from concussions, and athletes affected by the female athlete triad.  I also actively practice osteopathic manipulative techniques to aid in the recovery and rehabilitation of musculoskeletal injuries and dysfunction.
1070862	In Dr. Bohns laboratory, I  lead the research project focused on potential therapeutic effects of bone marrow-derived neuroprogenitor-like cells in a rat model of Parkinsons disease (PD). In our experiments we use human and rat mesenchymal stem cells (MSC) genetically modified with the intracellular domain of the Notch1 (NICD) gene, a modification that up-regulates expression of certain neuroprogenitor phenotypic markers. We are studying the neuroprotective potential of these bone marrow-derived neuroprogenitor-like cells (MSC-NICD) in a rat model of PD. In addition, we are exploring the potential of MSC-NICD cells to deliver glial cell line-derived neurotrophic factor (GDNF), a well known dopaminergic neurons trophic factor, to the lesioned rat striatum.
1071074	Dr. Kumes research interests focus on cardiovascular development, cardiovascular stem/progenitor cells, and angiogenesis.  Current studies include the role of Foxc transcription factors in cardiovascular development and disease.
1071116	My primary research interests are in the fields of emergency medicine and health services research with a goal of improving healthcare quality and patient safety.  I have a background in operations research as well as health services research and have completed a Masters in Business Administration and a formal health services research fellowship.  My work uses innovative methodologies, such as in situ simulation and failure mode effects analysis, to assess and improve care delivery.  I also have experience with large database analysis.   I am particularly interested in improving the delivery of severe sepsis and septic shock resuscitation in the emergency department.
1071132	My primary area of research is in women's reproductive and sexual health, from 1900 to the present.I am also a thesis advisor for Medical Humanities and Human Sexuality research for the Area of Scholarly Concentration at FSM.
1071143	I am interested in medical education and quality improvement as it relates to the inpatient management of pediatric patients.I am interested in the quality improvement of inpatient asthma management.
1071151	My research interests lie in elucidating the pathophysiological and clinical consequences of lung dysfunction in patients with diabetes.
1071327	Dr. Salsman is a Principal Investigator on an ACS-Illinois Division grant titled No Worries? Adaptation and Health Behaviors among Young Adult Survivors. This project explores the positive effects and special needs of young adult cancer survivors during the transition from active treatment to survivorship. He is also a Co-Investigator on an NIH-funded contract titled The Toolbox of the Assessment of Neurological and Behavioral Function.' The goal of the Toolbox is to assemble a brief battery of measures for the assessment of cognitive, emotional, sensory, and motor health and function across the lifespan (ages 3-85) for use in longitudinal studies and clinical trials. Dr. Salsman  is the emotional health domain manager for Toolbox, liaising with senior project personnel and facilitating the instrument and item selection process for the emotional health subdomains of negative affect, positive affect, stress & self-efficacy, and social relationships. Dr. Salsman also serves as a Co-Investigator on an NIH-funded project developing a Patient Reported Outcomes Measurement Information System (PROMIS), providing input on existing item banks for cancer patients and reviewing negative and positive Illness Impact items. Other areas of research interest include positive-psychological functioning, religious and spiritual well-being, and patient-physician communication.
1071375	The focus of research is the role of plasmin activator inhibitor-1 (PAI-1) in the pathogenesis of airway remodeling in asthma. In this aspect, I am clinically interested in steroid-resistant asthma, asthmatic smokers and asthmatic patients with obesity. As a board certified otolaryngologist (Korean Board) and allergist (American Board), my another clinical interest is in chronic rhinosinusitis (CRS), especially the pathogenesis of CRS in elderly population.
1071421	Methodologic research interests include issues related to data misclassifiction or mismeasurement especially in regards to anthropometric measures, and changes in those measures over time.  Current research also includes research in Gastroenterology, Dermatology, and Congestive Heart Failure.
1071429	Non-invasive evaluation of heart transplant rejection.
1071433	My primary research interest focuses on elucidating mechanisms by which genetic variations in the zinc transporter gene ZnT8 influences beta cell function.
1071451	Dr. Allen specializes in cardiovascular epidemiology with a focus on health services research.  Her research interests include the effect of neighborhood and environment on cardiovascular disease, disparities in quality of care and outcomes as well as the use of large databases to examine these questions.
1071472	My research focuses on understanding the principles governing neuromechanical control of human locomotion and applying this knowledge to promote walking recovery following neurological injury. I employ an interdisciplinary experimental approach using robotic tools to examine whole-body human movement from a biomechanics and motor control perspective. I also do research on bone health following spinal cord injury with an emphasis on the role of mechanical loading on the prevention and treatment of bone loss.
1071490	Dr. Maxwell has special interest in the management of prostate, kidney, and bladder cancers with an emphasis on robotic surgery.
1071500	Problem-based learning
1071516	I have a special clinical interest in juvenile dermatomyositis, but also enjoy seeing patients with all types of autoimmune conditions including systemic lupus erythematosus, juvenile idiopathic arthritis, vasculitis, scleroderma, and periodic fever syndromes.  My research interests in pediatric rheumatology reside in the field of medical education.  My goal is to improve medical student, resident, and fellow education about pediatric rheumatology.  I am presently undertaking a research project to define rheumatology educational goals and objectives for pediatric residents.  I am also surveying pediatric residency program directors about their current practices in rheumatology education and their perceived needs.  With this information and through funding through the American College of Rheumatology Research and Education Fund Clinician Scholar Educator Award, I plan to develop and collect educational materials that can be taught within existing lecture time and rotations.   The materials will be taught by non-rheumatologist physicians in programs where no pediatric rheumatologist is available for teaching, approximately 40% of all pediatric training programs.
1071527	Research interests:1.The long term effects of critical illness on children including any impact on functional ability, quality of life and neurocognition.2. The causes and effects of delirium on patients in the pediatric intensive care unit.
1071552	Heart rhythm disorders mechanisms and therapy, atrial fibrillation, cardiac autonomic nervous system, cardiac sarcoidosis, complex arrhythmia, radiofrequency ablation
1071571	My research thus far has focused on the following issues: 1) clinical trials of computerized, Internet, and mobile phone treatments for anxiety and depression; 2) the relationship of mental health with minority stress and related cognitions; 3) cognitive processes involved in anxiety disorders; and 4) co-occurring psychiatric disorders and outcomes for underserved populations in randomized controlled psychotherapy trials. I am particularly excited about the potential of mobile mental health interventions to provide real-time outreach and feedback to patients in their unique environments, and overcome barriers to traditional psychotherapy in hidden, underserved communities.
1071582	My broader research interest is in collaborative care.  I hope to better understand coordination among providers from various disciplines that converge on the care of a hospitalized patient.  Specifically, I am currently examining the role of internal medicine physicians in the care of medically complex surgical patients.
1071751	Sinusitis, chronic sinusitis, nasal polyps, nasal tumors, smell and taste disturbances, minimally invasive approaches to the skull base, inflammation, mechanisms of smell loss from inflammation, therapeutics and diagnostic approaches for sinus disease
1071785	The human immune system must be kept in a state of constant balance to remain healthy.  Elevated immune responses are needed to fight harmful pathogens, yet those responses have to be kept from overreacting and attacking the bodys normal tissues.  A complex mix of immune cells is known to influence this balance.  My research interest is to understand the crosstalk among different cell types, especially focusing on two types of immune cells, Th17 cells and Treg cells, in the maintenance of immune homeostasis.  Our laboratory is studying the molecular mechanisms by which different transcription factors influence the differentiation of Th17 and Treg cells, and examine the Th17-Treg balance in immunity and autoimmune diseases using a combination of molecular, cellular and mouse genetic approaches.
1071795	Inflammatory bowel disease, Crohn's disease and Ulcerative colitisWomen's Health issues in Gastroenterology
1071803	Dr. Hemmer's primary clinical and research interests include neurosurgical anesthesiology, intraoperative neuromonitoring, and perioperative patient safety.
1071822	Dr. Matthew D. Saltzman is an Orthopaedic Surgeon at Northwestern Memorial Hospital and an Assistant Professor on faculty at Northwestern University Feinberg School of Medicine. He specializes in shoulder and elbow surgery. His clinical interests include biomechanical evaluation of rotator cuff repair techniques, reverse shoulder arthroplasty, and sports related injuries.
1071859	Parkinson's disease results from the degeneration and frank loss of dopamine-releasing neurons in the substantia nigra. Interestingly, a nearby population of dopamine-releasing neurons in the ventral tegmental area remains unaffected by this degenerative process.  Recent studies have suggested that this degenerative process, and the onset of Parkinson's disease, are preceded by a similar process that takes place in other brain regions, wherein only a particular class of neurons is affected while others are spared.I am interested in understanding whether there is a common mechanism underlying the selective nature of these neurodegenerative processes. A hypothesis put forward by Dr. D. James Surmeier points to a common property shared by the various neurons that degenerate. They are all perpetually active neurons whose output is necessary for basic physiological functions carried out by such systems as the cardiovascular system or the gastrointestinal tract. According to this hypothesis the ongoing activity of these cells comes at a metabolic cost leading to their premature 'aging' and death.In particular I am studying the machinery that enables neurons in the dorsal motor nucleus of the vagus, that innervate the heart and the GI tract, to maintain their perpetual activity, and how this may cause them to be particularly vulnerable to neurodegeneration. My research combines neurophysiological techniques, live cell imaging, molecular biological tools and computational modeling.Additional interests:1. the cellular basis for the role played by cholinergic interneurons of the striatum, in health where their activity comprises a neural correlate of classical conditioning, and in the pathophysiology of Parkinson's disease where their release of acetylcholine is upregulated.2. The biophysics underlying collective dynamics of perpetually active neurons.3. Design and development of electrodes for functional electrostimulation.4. Deep brain stimulation.
1071912	My clnical and research interests overlap in the areas of hereditary cancer genetics and preimplantation/prenatal genetic diagnosis.
1071921	Head and Neck and Skin Cancers, Genitourinary Malignancies (Prostate Cancer, Testicular Cancer, Bladder Cancer), Lung Cancer, Proton Therapy, SBRT
1071945	My major research interests are collaborative research with biomedical investigators in areas of clinical trials, microarray data analysis, imaging analysis, non-linear fitting, and genomics studies such as methylation. I am also interested in statistical methodology research. I have published methodology research papers in peer-reviewed journals, including JASA, BMC Bioinformatics, Journal of Biopharmaceutical Statistics, and Annals of Human Genetics. I am also a co-author of a wide range of collaborative papers published in peer reviewed journals. I served as the primary statistician for NIH funded grants, including R21, R34, R01, U19, UO1 and some foundation grants.
1072008	Dr. Roehrig is a clinical health psychologist with a specialization in obesity and disordered eating.  Her research aims to (1) examine behavioral risk factors associated with obesity (i.e., poor diet, inactivity, binge eating), (2) develop and test novel treatment approaches to produce sustained weight loss and health behavior change, and (3) understand the links between behavior and health outcomes.
1072048	My primary clinical interest is in the care of individuals infected with HIV and the complications of HIV infection, including oppurtunistic infections, cancers and metabolic disease.  I also specialize in the care of infections seen in recipients of solid organ and stem cell transplants and teh evaluation of persons prior to transplantation.  Other specific interests that I have are sexually transmitted infections and fungal infections.
1072101	I see patients in with General Pediatric Neurology concerns, including epilepsy, headaches, abnormal movements, muscle weakness, and neuropathies.
1072116	As a member of a work group, funded by the National Coalition for Health Professional Education in Genetics, Ms. Healy is an author of a web-based, interactive genetics curriculum for physician assistants. It is available at: http://pa.nchpeg.org/
1072154	My lab focuses on how genetic and epigenetic modulators promote the development and maintenance of adult stem cells. Microenvironments, or niches, support the maintenance of stem cells and facilitate the development of tumors through largely unknown mechanisms. Cell-autonomous genetic pathways and epigenetic networks have emerged as important determinants for the self-renewal and differentiation of stem cells in embryonic, juvenile, and adult issues. The importance of non-cell autonomous genetic and epigenetic factors is less well established. Our goal is to identify and characterize the genetic and epigenetic mechanisms utilized by both stem cells and their surrounding niche in supporting the stem cell program. For these studies, the developing mouse testis is used to examine interactions between male germline stem cells (GSCs) and their somatic niche.
1072174	Dr. Krichavsky is board certified in Interventional Cardiology, Endovascular Peripheral Interventions, Cardiovascular Disease, Nuclear Cardiology, and Internal Medicine.  His clinical interests include coronary, carotid, renal, upper extremity, and lower extremity angioplasty and stenting, vascular medicine, percutaneous valve therapy, closure of patent foramen ovale and atrial septal defects, percutaneous ventricular assist devices, catheter directed arterial and venous thrombolysis, and inferior vena cava filters.  In addition to performing procedures in the Cardiac Catheterization Laboratory, he serves as an attending physician on the Coronary Care Unit (CCU), In-patient Cardiology, and Cardiology Consultation services at Northwestern Memorial Hospital.His research interests include investigation of novel devices and therapies, including stem cell, and cell-based therapies for cardiac and vascular disease.
1072212	Neurological Clinical Specialist (NCS), primary interest in recovery of locomotion following spinal cord injury and stroke
1072275	Regional anesthesia, ultrasound guided procedures in anesthesia, acute postoperative pain, opioid free analgesia
1072546	My Clinical expertise and research primarily occurc in the Prosthetics-Orthotics field.  I am a Prosthetist and Orthotisr and I have spent the majority of my career in clinical practice. I have come to Northwestern to pursue a vairety of goals.
1072619	Dr. Siziopikou's subspecialty focus is on breast tumor markers and molecular diagnostics in breast cancer. Her research interests center around molecular markers of prognostic and predictive significance in breast cancer.
1072644	As the Medical Director of Cardiac Electrophysiology at Northwestern Memorial Hospital since November 2009, Dr. Knight remains clinically acitive with a broad range of clinical and research interests in the field of Heart Rhythm Disorders. These interests range from catheter ablation for complex arrhythmias, such as atrial fibrillation, to fundamental issues related to the basic mechanisms of various types of heart rhythm disorders, and the use of imaging in the electrophysiology laboratory to guide ablation procedures and device implantation. He is involved in several multicenter clinical trials that are evaluating novel ablation tools and implantable devices, including a totally subcutanous implantable defibrillator. He has coauthored over 200 scientific papers and is on the editorial board of several high-impact medical journals.
1072806	Emphysema (COPD), Esophageal Cancer, Minimally Invasive Thoracic Surgery, Thymoma, Lung Volume Reduction Surgery (LVRS), Chest Wall Tumors, Tracheal Surgery, Pleural Disease, Video-Assisted Thoracic Surgery, Mediastinal Tumors, Lung Cancer, Lung Transplantation
1072813	My primary interest is in the evaluation and treatment of children with intractable epilepsy. I have done research on the ketogenic diet. I am particularly interested in treating children with Tuberous Sclerosis.
1072872	Cardiac Assessment; Congestive Heart Failure; Echocardiography; Exercise Training/Sports Fitness; General Cardiology; Ischemic Heart Disease; Pre-Operative Evaluation; Prosthetic Valve Dysfunction; Trans-Esophageal Echocardiography; Valvular Heart Disease
1072922	I am interested in understanding the initiation of childhood atopic disorders, such as food allergies, eczema and asthma.  Early life events play an important role in the maturation of the immune system.  I am interested in understanding the role of environmental factors and exposures that play a role in the development of allergic disease.
1072968	The goal of my research is to understand the molecular basis by which animals and their natural microbiota form specific, reproducible interactions. Microbial symbioses are prevalent in animal biology, and often, as in the case of humans, the animal host is born devoid of its natural symbionts and must acquire microbial partners from the environment. Pathogenic and beneficial bacteria share common mechanisms by which they colonize animal tissue. In spite of these parallels, relatively little work has been accorded to the beneficial associations, which are widespread, and critical to the lifecycles of both the bacterial and animal partners. I am studying the natural association between Vibrio fischeri and the Hawaiian bobtail squid to understand the processes that underlie host colonization in animal-associated bacteria. The system is particularly amenable to studying microbe-host interactions because V. fischeri is the only bacterial resident of the squid's light organ, and we seek to understand how V. fischeri specifically colonizes the host to the exclusion of other species. Each generation, the squid hatch without their microbial partners and must selectively recruit V. fischeri from the ocean. We use a combination of bacterial genetics and imaging to identify how the animal and bacteria communicate to reproducibly establish this productive relationship.
1072982	Signaling of death receptors with emphasis on Fas. The role of microRNA in tumor progression.
1073000	Interested in providing quality Pediatric Emergency care, to teach trainees, and to improve overall emergency care for children by contributing to research in this field with special interests in injury prevention, and Emergency Medical Services for Children (EMSC).
1073040	Dr. Cohn is an expert in HIV medicine, infectious disease, and HIV clinical trails and health services outcomes research.  She has been an active participant in the NIH/NIAID AIDS Clinical Trials Group since 1988, and has held numerous leadership positions including Vice Chair and Chair of the Womens Health Committee and the Outcomes Committee, Vice-Chair of the Underrepresented Populations Committee 2008-2010 and is now the Chair of the Womens Health Internetwork Scientific Committee (WHISC). She is chair and co-chair of major protocols pertaining to women's health, self-management and outcomes, recruitment of women and minorities into clinical trials, and optimizing ART, and is an active team member on many other protocols. Her current research areas have included optimizing the health of HIV-infected women, improving adherence to antiretrovirals, and improving access to health care and clinical trials for underrepresented populations. Dr. Cohn has maintained an active HIV clinical practice, has been a teacher of HIV medicine to medical students, residents, fellows, nurses and other care professors for over 20 years. She has mentored nurses, nurse practitioners, physician assistants, residents, and other faculty both in and out of her institution, helping to advance their careers in both research and clinical medicine.
1073157	Clinical evaluation methodology and clinical treatment trials of disorders of the motor unit are my primary areas of interest.  These include disorders of peripheral nerve, neuromuscular junction and muscle.  Characterization of autonomic nervous system in children and adolescents is an integral part of this effort. Characterization of the neuroimmunology of the peripheral and central nervous system provides direct and indirect treatment opportunities for many of these disorders.
1073269	I am a family physician caring for the vulnerable incarcerated population at Cook County jail, with special interests in adolescent and young adult medicine, women's health, and reducing health disparities. After 20 years as residency faculty, I retain a strong interest in graduate medical education. My research interest at the moment centers on contraceptive knowledge, attitudes and practices of newly incarcerated urban women. I serve as faculty advisor to the FSM Correction Medicine Interest Group.
1073480	Physician Assistant Education.
1073494	Dr. Rasmussen-Torvik is a genetic epidemiologist interested in genetic risk factors for common chronic diseases.   She is involved in large-scale genetic studies  designed to detect novel genetic risk factors for chronic diseases.   Dr. Rasmussen-Torvik is also interested in translating the results of GWAS and sequencing studies into clinical care by identifying variants associated with treatment response. As part of this work, she is also interested in developing methods to communicate information about testing for common genetic risk factors to the public.
1074035	I am a board certified pathologist with subspeciality interest in pulmonary pathology, ophthalmic pathology and transplant pathology. I am a College of American Pathologists(CAP) spokesperson and actively involved in many national and international pathology organizations. I am also involved in medical education and teach at the local, national and international levels.
1074090	Rehabilitation Technologies and Quantitative Clinical Outcomes
1074103	Antimicrobilal pharmacokinetics and pharmacodynamics. Antiretroviral therapy.
1074152	It is estimated that 90 million adults have difficulty understanding their own medical care.  Despite numerous studies on the literacy levels of written medical documents, very little research has focused on the if spoken medical conversations occur at a level that the patient can understand.  Our current research focuses on increasing patients' comprehension of their own medical care by examining multiple aspects of health communication in the hectic Emergency Department environment.
1074170	Dr Perez's research interest is in the area of persistent pulmonary hypertension of the newborn (PPHN). Specifically, Dr Perez's research focuses on the impact of hydrocortisone, a glucocorticoid commonly used in the NICU, on phosphodiesterase type 5 (PDE5) and PPHN.
1074269	Pediatric Hospital Medicine - intensive care, observation unit, and sedation
1074283	As the Director of Global Health Education, Dr. Pitt oversees a Bi-Directional Exchange program with Bugando Medical Center in Tanzania. He developed a medical simulation curriculum which he trains third year residents to implement for medical students while in Tanzania, and also oversees the Medical Exchange Development curriculum for visiting residents from Tanzania.  Dr. Pitt's interests in medical education focus on non-traditional didactics including game based learning and medical simulation.
1074284	I would like to work with underprivileged youth to increase violence prevention as well as alternative options.  I would like to work with youth in a multidisciplinary role with medical care vs counseling .
1074293	Functional gastrointestinal disorders including abdominal pain, constipation, nausea and vomiting in children. Gastrointestinal Motility Disorders.
1074327	My clinical interests inculde adolescent primary care, adolescent gynecology including menstrual irregularities and contraception, and prevention of adolescent risk behaviors.  My research interests include the epidemiology of adolescent risk behaviors and HPV vaccination.
1074348	My primary research interest is in understanding the biology behind acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) and what factors predispose someone to these syndromes.  My primary clinical interest is in treatment of patients in the critical care setting, but I also enjoy long term care of general pulmonary diseases.
1074349	Care of hospitalized medicine patients, medical student and resident education
1074404	Currently working at Children's Memorial Hospital in the Neonatal Intensive Care Unit.
1074456	Dr. Flemings research and training programs have focused on testing behavioral interventions in community-based primary care practices. He has also published dozens of studies on phospholipids, alcohol biomarkers, chronic pain, fetal alcohol spectrum disorder, pharmacotherapy trials, epidemiological studies and educational interventions. He has been the PI on over a dozen NIH grants and contracts. He is the director of the pain consult service and the inpatient addiction medicine consult service at the University of Wisconsin Hospital and Clinics.  More recently he has taken a leadership in the UW Institute for Clinical and Translational Research as the director of research education and career development programs.  In 2005 he was elected as a member of the prestigious Institute of Medicine.
1074485	My primary clinical interests include preventive care and injury prevention for children.  I also enjoy the continued educational opportunities for medical students and residents.
1074488	My research interests are in end-of-life decision making, cross-cultural issues, and provider-patient communication related to palliative care.
1074491	1. Drug Therapeutic Trials2. Psychosocial coping and support in oncology patients3. Early incorporation of palliative medicine in oncology care4. Improving decision making for oncology patients5. Improving monitoring and preventing chemotherapy toxicity
1074533	Daniel's research interests include assessing the cost-effectiveness of conservative interventions for the management of musculoskeletal conditions and the development and validation of patient-reported outcomes in the assessment of economic data.
1074548	Interested in clinical impact of abnormal cellular function in acquired or pre-existing neurologic disease, the effects in the ICU setting, and the interaction of the CNS with other organ system function/dysfunction.  Specific interest in acquired pediatric brain injury (Traumatic Brain Injury, Hypoxic Brain Injury) and investigation of new therapeutics - Hypothermia for Hypoxic-ischemic brain injury and traumatic brain injury.
1074557	My clinical and research interests focus on children and adults with congenital heart disease.  My specific areas of focus are pacemakers, defibrillators and other devices used in the evaluation and treatment of rhythm disorders as well as evaluation and catheter ablation of arrhythmias.
1074558	I am interested in general pediatric dermatology, acne, infectious diseases of the skin as well as surgery and laser therapy of the skin.
1074582	Our research is focused on the role of viral microRNAs in herpesviral oncogenesis
1074590	Dr. Robinson's interests include medical education, inpatient care and non-invasive cardiac imaging, particularly the application of magnetic resonance imaging to congenital heart disease. His research goal is to expand the use of MRI in patients with congenital and acquired heart disease to decrease the need for invasive procedures. To facilitate these efforts, he completed a post-graduate clinical research fellowship in the Biological Sciences Division at the University of Chicago and clinical fellowships in pediatric cardiology and non-invasive cardiac imaging at Childrens Hospital Boston, the primary pediatric teaching affiliate of Harvard Medical School. Recent projects include the clinical application of novel MRI techniques (e.g. 4D flow MRI and use of blood pool contrast agents) to congenital heart disease.
1074594	My primary clinical focus is treatment of type 1 and type 2 diabetes.  I see diabetic patients at our affiliate institution, La Rabida Children's Hospital, and at our off-site clinics in Hinsdale, New Lenox, and St. John Indiana.  I also enjoy educating families and healthcare providers about weight management and obesity prevention.
1074597	Current research projects focus on medical neglect.
1074664	General Therapeutic Radiological Physics; External Beam and Brachytherapy Physics; Gamma Knife Physics and Dosimetry
1074665	My current research concerns the role of intermediate filaments in innate immunity, particularly in inflammasome activation, as applied to acute lung injury.More broadly, I am interested in regulation of protein phosphorylation (particularly protein Ser/Thr phosphatases), G protein coupled signaling, as well as comparative and evolutionary aspects of eukaryotic signal transduction.
1074668	As a Clinical Health Psychologist, Dr. Coons research is focused on understanding the biological, cognitive, behavioral, and social mechanisms of health behavior change (e.g., physical activity, diet choice, medication adherence) for both primary prevention (i.e., among individuals at risk for developing chronic diseases) and secondary prevention (i.e., among individuals with Type 1 and Type 2 diabetes, cardiovascular disease). He also has a strong interest in developing and testing the efficacy of technology-supported interventions for health behavior change and maintenance. Dr. Coons is the Project Coordinator for the Make Better Choices  2 (MBC2) clinical trial, awarded to Dr. Spring, which is funded by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH).
1074715	My research is focused on understanding the pathophysiological mechanisms underlying the transition from acute to chronic pain following whiplash injury. Specifically, I utilize structural and advanced magnetic resonance imaging applications to quantify the temporal development of altered spinal cord biochemistry and neck muscle morphometry as potential cellular and molecular substrates of persistent pain. Broad applications of my work includes preventing, diagnosing, and treating whiplash related pain and its sequelae. This research is based on my clinical and research experience and has expanded through interdisciplinary efforts involving the fields of magnetic resonance physics, radiology, biomedical engineering, neurophysiology and physical therapy.
1074965	Dr. Kaisers research focuses on health disparities, health communication, patient understandings of disease, and patient experiences with serious illness. Dr. Kaiser has extensive training and experience in mixed methods research and she utilizes a variety of quantitative and qualitative research methods in her work.  Currently, Dr. Kaiser is the principal investigator of the study, Communicating Breast Cancer Disparity to Minority Populations, funded by the American Cancer Society, Illinois Division. This study examines minority womens knowledge of breast cancer disparities and their sources of information about breast cancer in the Chicago area.
1075145	I am a social epidemiologist, and my research focuses on understanding how contextual factors lead to disparities in cardiovascular outcomes. I am also interested in behavioral and biological pathways linking chronic exposure to psychosocial stressors to cardiovascular-related risk factors and outcomes.
1075164	Benign and malignant diseases of the lungs, esophagus, pleura and chest wall.
1075230	Medical student and resident clinical teaching.
1075271	My primary area of interest is Pediatric bleeding and clotting disorders.
1075386	Family physician at Erie Family Health Center.
1075439	My primary research interests are sleep disorders in multiple sclerosis, the neurological complications of obstructive sleep apnea and sleep perception.
1075457	My current research continues to focus on new ways to make health care computing more useful.  This includes developing intuitive, novel Human Computer Interfaces (HCI) for health care, including working the design of graphical icons for clinical applications, addressing data overload for clinicians and issues in affective computing.   A related line of research is developing methods for the integration of clinic research computing into clinical care.
1075501	I am heavily involved in our center's food allergy clinical trials.   I have a clinical interest in food allergy, primary immunodeficiencies and eosinophilic esophagitis.
1075699	Dr. Gillespie's clinical interest includes the treatment of thoracic malignancies, specifically with regard to the application of novel technologies in Interventional Pulmonology to improve the diagnosis and treat thoracic malignancies with minimal invasiveness.  He also has extensive experience in the bronchoscopic management of tracheal stenosis and the airway complications associated with Lung Transplantation. Dr Gillespie has advanced training in the following techniques: flexible and rigid bronchoscopy, balloon bronchoplasty, endobronchial stent placement (silicon, hybrid, and metallic), electrosurgery (including argon plasma coagulation, lasers, and cautery tools), endobronchial brachytherapy, photodynamic therapy, endobronchial ultrasound (both convex and radial imaging), navigational bronchoscopy, auto-fluorescence bronchoscopy (LIFE), multiple biopsy tools, percutaneous tracheotomy, and pleuroscopy.  His academic focus is on clinical research and education.  He was the principle investigator on a Phase III study looking at the placement of bilateral Intrabronchial Valves for the treatment of patients with heterogeneous emphysema.  Dr. Gillespie has also been involved in projects aimed to utilize advanced bronchoscopic techniques to improve diagnostic yield of lung nodules and masses, treat diseases such as tracheomalacia and severe asthma, as well as banking tissue samples for basic research.  As an educator, he has a keen interest in simulation based learning.  He has been working to develop simulations designed to accelerate the acquisition of advanced bronchoscopic and procedural skills.
1075710	Functional cardiovascular Magnetic Resonance Imaging (MRI) imaging. The focus is on basic MR methodology, development of novel MRI techniques and advanced data analysis strategies for the measurement and analysis of normal and pathological physiological processes in the human body. The evaluation of such methods in clinical studies and the implementation and evaluation of novel clinical applications represents an important aspect of past, ongoing and future scientific activities. Recent research projects focus on regional myocardial function and 4D flow MRI.
1075715	Cardiac surgery outcomes
1075967	Dr. McHugh is a health services researcher with an interest in quality improvement, patient flow and emergency department crowding, the safety net, and health policy/health reform. She has conducted a number of multi-method, multi-site evaluations and directed statistical analyses using data from large national data sets.  Currently Dr. McHugh is leading an evaluation of Urgent Matters, a program to improve patient flow and reduce crowding in emergency departments.
1076065	Social and racial health disparities, particularly among Hispanics/Latinos and African Americans; chronic diseases; women Health; tobacco control and prevention.
1076113	My clinical interests are the care of children with Type 1 diabetes, disorders of puberty, growth disorders and polycystic ovary syndrome.
1076226	Cell and molecular biology of inflammation and its resolution during disease.
1076296	Biomaterials, Drug delivery, cancer therapy, Nanoparticles
1076303	Primary area of interest is prevention of behavioral transmission of HIV infection in adolescent and young adult populations at high risk, including sexual and gender minorities.
1076308	My research focuses on using social networks and quantitative methodologies to understand the social contextual influences on LGBT adolescent health and well-being.
1076405	My primary research interests are in emergency medicine and health services research with the goal of a helping to develop a more patient-centered acute care system.  I am particularly interested in patients' use of the emergency department and transitions of care from the emergency department to either the community or hospital.  I am currently a health services research fellow at the Institute for Healthcare Studies and am working towards a Master's degree in Health Services and Outcomes research.  My research uses both quantitative methods such as large database and claims data analysis, and qualitative methods such as semi-structured interviews.
1076722	I am interested in using high-fidelity simulation to analyze and assess teamwork behaviors, communication and medical decision making during critical events.  I am primarly interested in studying these areas in the field of congenital heart disease and the cardiac intensive care unit.
1076934	Dr Maas is a Neurocritical Care specialist at Northwestern Memorial Hospital whose clinical interest focuses on the management of high-risk injuries and diseases of the brain, spinal cord and peripheral nervous system. Dr Maas's research has focused on the emergent evaluation and management of patients with stroke. In addition to clinical work and research, he has been a leader in the medical education field, serving as the chairman of the American Academy of Neurology's Consortium of Neurology Residents and Fellows and member of its Graduate Education Committee, and has lectured on topics ranging from neurological emergencies to neurology education policy.
1076993	Functional MRI (FMRI)Resting state FMRIDiffusion tensor imaging (DTI)
1077088	I have particular interests in the following areas in public health and global health research:  maternal-child health, infant and child malnutrition,child maltreatment and violence prevention.
1077123	I have a large interest in Healthcare Quality Improvement initiatives.  I work primarily in the inpatient setting and am actively involed in improvement modalities in both Pediatric Asthma Exacerbation Management and Breastfeeding Medicine.
1077136	.
1077139	Clinical interest in pediatric hospital based medicine including care of inpatient general pediatric patients, neonates in the well baby nursery as well as the NICU, and pediatric urgent care. Clinical interest in quality improvement in inpatient management as well as advocacy in the community.
1077331	Dr. Zhaos methodological research interests are in the areas of survival and event history analysis, longitudinal data analysis, and design and analysis of clinical trials. His current work has focused on methodology development to integrate information about patients baseline characteristics to individualize treatment choice. His collaborative work is in the areas Cardiovascular and HIV research.
1077442	My clinical interests include abdominal organ transplantation and living donation surgery. My research interests focus on developing tissue engineering and regenerative medicine based approaches for renal and hepatic replacement therapies.
1077452	My primary research interests involve integration of novel technologies to enhance the patient-clinician relationship. Anticipated benefits to surgical patient educational enhancements may improve patient quality of life,  minimize resource utilization, improve healthcare delivery efficiency, and decrease preventable complications.
1077483	Dr. Ackermann has advanced training in epidemiology, public health, and health policy as a past Robert Wood Johnson Foundation Clinical Scholar (2001-03) and Robert Wood Johnson Foundation Physician Faculty Scholar (2006-09).  He is Director for Northwestern University's Community Engaged Research Center.  Dr. Ackermann is considered a national expert in the development and evaluation of healthcare-community partnerships to improve the prevention and control of common chronic illnesses such as diabetes, congestive heart failure, and asthma. Since 2003, he has been the principal architect and director of a large ongoing research program to evaluate the feasibility, costs, and effectiveness of partnered approaches for preventing and managing type 2 diabetes in American adults. Additional interests include healthcare provider interventions, quality improvement, cost effectiveness analysis, behavioral economics, and strategies for engaging community members and policy decision makers in the full spectrum of research.
1077552	The principal goal of my research is to understand the nephritogenic immune response in autoimmune renal disease. This research runs the gamut of immunologic mechanisms to understanding the development or organ fibrogenesis and cellular transdifferentiation. Our studies critically analyze the immunogenetic and interactional events surrounding T cell activation, effector T cell differentiation, immune modulation of renal tubular cells and fibroblasts in anti-basement membrane diseases, and with this understanding, develop experimental strategies which can attenuate the expression of renal injury. We have a particularly active interest in the cell fate of fibroblasts during fibrogenesis in transgenic mice. More recently we have gotten interested in how breast cancer cells use the same programs when they metastasize. We use trangenic and knockin mice, cell sorting, biochemical methosds of protein identification, molecular cloning and mutagenesis, as well as cell culture and confocal microscopy.
1077723	Community hospital based pediatrics involving inpatient pediatric care, ER consultations and NICU.
1077889	I am a computational biologist with an interest in the development of methods for integrative, systems-level analysis of high-dimensional genomic and proteomic data.  These methods incorporate bioinformatic information with experimental data to characterize the networks of interactions that lead to the emergence of complex phenotypes, particularly cancers.
1077961	Pediatric airway evaluation and management, Subglottic Stenosis, Airway reconstruction, Pediatric voice disorders and surgery, Pediatric stroboscopy, Laryngology, Bronchoesophagology, Pediatric hoarseness, Vocal cord paralysis, Respiratory papillomatosis, Vocal cord nodules.
1077962	I practice pediatric otolaryngology, including diseases of the head and neck from birth to adolescence, with a particular interest in pediatric otology, congenital hearing loss, cholesteatoma, and microtia reconstruction. I am the otolaryngology representative on the Vascular Lesions team at Children's Memorial Hospital (Lurie Children's). Other interests include congenital head and neck masses, airway disorders and airway reconstruction, and sleep endoscopy/sleep apnea. Currently, I am currently developing a middle ear endoscopy program at Children's Memorial Hospital.
1078376	I have a broad interest in survival analysis and longitudinal data analysis, with applications to clinical and health services studies. I am particularly interested in the analysis of medical cost data and joint models of longitudinal and survival data. Recently I am working on non/semiparametric regression methods (e.g., penalized splines), causal inference in observational studies, and adaptive design in early phase clinical trials. I also collaborate with clinicians in cardivascular diseases, psychiatric medicine, asthma, infectious diseases, kidney diseases and diabetes.
1078493	My research involves translational approaches to age related macular degeneration and ischemic retinal diseases with a special focus on functional retinal imaging and image guided interventions.
1078641	Current research activities occur at the nexus of cardiovascular magnetic resonance imaging and biomedical engineering. Specific research projects investigate the relationship between vascular and valvular morphologic anomalies and their impact on blood flow. These projects decompose flow and anatomy into a mathematical framework, allowing for parameters such as pressure, resistance, impedance, drag forces, and energy loss to be extracted. These parameters are traditional, well-known engineering measures of system performance and ultimately powerful indicators of overall cardiovascular system health.
1079544	Health Information TechnologyConsumer Health Information TechnologyPatient Facing TechnologyDesignHuman Factors and ErgonomicsPatient safety
1079866	The primary goals of research projects in Cheng laboratory is to improve our understanding of the molecular mechanisms and signaling pathways of human cancer initiation, tumorigenesis, invasion, metastases and angiogenesis, and to develop novel approaches for anti-cancer therapies by targeting molecular pathways by which human tumors develop and progress.  Our approaches include molecular, cellular biology, histology, tumor xenografts in cell culture and animals model systems of human brain tumors (in particular, glioblastomas) and breast cancers.
1079955	My technical research interests include data mining, machine learning, and artificial intelligence. My application interests include various health care applications, mining big healthcare data, and developing sensor-based and ambient intelligence solutions for personal health and well-being.
1080020	Transesophageal echocardiography, Left ventricular assist devices
1080111	Research Interests:Our laboratory concentrates its efforts into the investigation of the mechanistic connection between aging, cellular and/or mitochondrial metabolism, and carcinogenesis focusing on the Sirtuin gene family. To address this idea, over the past five years, we have constructed mice that have the three primary (Sirt1-3) sirtuins genetically deleted.  The mice that lack Sirt1 (Wang et al., 2009, Cancer Cell), Sirt2 (Kim et al., 2011, Cancer Cell), and Sirt3 (Kim et al., 2010, Cancer Cell) each develop breast cancer, as well as other types of malignancies to varying degrees, and the levels of SIRT1-3 are also decreased in human cancer samples, as compared to normal tissues.  In addition, the mechanism connecting the tumor permissive phenotype and the aberrant regulation of mitochondrial ROS, at least in part, in the Sirt3 knockout mouse has recently been published (Tao et al., 2010, Molecular Cell).  Thus, based on these results it seems clear that the primary sirtuin deacetylase proteins are tumor suppressor in several breast cancers as well as to a lesser extent in several other human malignancies.  These results seemed logical, since human sirtuins are the human homologs for the yeast and C. elegans longevity genes, and breast cancers have one of the strongest correlations to age.  Thus, it is proposed that the primary sirtuin family knockout mice may present a novel group of models to establish, validate, and investigate the well established connection between aging, metabolism, and cancer.  These murine models are also used to pursue the laboratories interest and the identification and validation of chemopreventative agents and we currently have a DOD and R01 grants to pursue this for luminal B breast malignancies.  Finally, the laboratory has a series of murine in vivo and in vitro models to mechanistically connect Sirt2 and Sirt3 to cancers of the breast, pancreas, liver, and lung that are currently be used.
1080205	Breast cancer
1080338	I have an interest in the evaluation and management of sleep disorders, and the impact they can have on psychiatric symptomatology. Though there has been an increased awareness of sleep abnormalities, disorders related to sleep and their contribution to a broad range of health outcomes, these conditions are still significantly underdiagnosed. I am hoping to provide high quality, evidence baased care for all patients that I care for and thus be able to provide for good clinical outcomes.
1080342	Shoulder Arthroscopy<br>Total Shoulder Arthroplasty<br>Reverse Total Shoulder Arthroplasty<br>Revision Total Shoulder Arthroplasty<br>Total Elbow Arthroplasty<br>Elbow Arthroscopy<br>Revision Shoulder Surgery<br>Revision Elbow Surgery<p><p>Dr. Guido Marra is a Professor of Orthopaedic Surgery at Northwestern University Feinberg School of Medicine and the Director of Shoulder and Elbow Surgery in the Department of Orthopaedic Surgery.  He has been recognized as an international leader in the operative treatment of shoulder and elbow disorders, specializing in shoulder and elbow arthroscopy, shoulder and elbow replacement surgery.<p>  Dr. Marra has been awarded Best Doctor in America in 2011-12 and Best Doctor in 2009, the Whos Who in Medicine and Healthcare also in 2011-12, Americans Top Orthopedists in 2009.  In addition, he was recognized with a Patients Choice Award in 2008.<p>Dr. Marra is actively involved in orthopaedic education both nationally and internationally. He serves on several committees for the American Academy of Orthopaedic Surgery which focus on educating practicing orthopaedic surgeons. Dr. Marra regularly lectures both nationally and internationally on the surgical management of shoulder and elbow disorders.<p><h3>Membership</h3><small>American Academy of Orthopaedic Surgery<br>American Society of Shoulder and Elbow Surgeons<br>Association of Bone and Joint Surgeons<br>The American Orthopaedic Association</small><p><h3>Certification</h3><small>American Board of Orthopaedic Surgery 2001, Re-certification 2011</small>
1080344	Dr. Michael Stover is a graduate of University of Iowa College of Medicine, University Hospitals of Cleveland, Case Western Reserve University, residency, and fellowship trained in orthopaedic trauma at Carolinas Medical Center in Charlotte, N.C. He received additional fellowship training in Hip and Pelvic reconstruction, studying for a year with Joel Matta, MD at Good Samaritan Hospital in Los Angeles, CA, and a traveling fellowship to Switzerland working with Reinhold Ganz, MD. Dr. Stover joined Northwestern University after 14 years of clinical practice at Loyola University Health System where he was Associate Professor and Director of Trauma. His clinical and research interests include: anterior total hip replacement, acquired or congenital hip and pelvic abnormalities (especially hip dysplasia and hip impingement), fractures of the acetabulum and pelvis, and fractures that do not heal (nonunion) or heal incorrectly (malunion). He is an active member of the American Academy of Orthopaedic Surgeons (AAOS), the AO Foundation, Orthopaedic Trauma Association (OTA), and the Association of Bone and Joint Surgeons. Dr. Stover is an internationally recognized lecturer regarding topics in hip and pelvis reconstruction, especially fractures of the acetabulum and pelvis.
1080422	We study the role of RANTES, a chemokine, and granulysin, a proinflammatory molecule in health and diseases, including cancer, infection, transplantation and autoimmunity.
1080443	Dr. Schueller received his Ph.D. in Clinical Psychology from the University of Pennsylvania where his research focused on well-being, happiness, positive psychology interventions, and individualized intervention sequences. His current research interests include using Internet interventions in behavioral and mental health service delivery. Specifically, he is interested in how technology can aid users in receiving what they most need by providing opportunities to incorporate users choices, patterns of behavior, or characteristics to individualize care. He has conducted work on interventions to promote well-being, smoking cessation, and depression prevention with a strong focus on creating interventions that can be widely disseminated and thus provide services worldwide.
1080545	After completing a Master's in Medical Education through the University of Cincinnati Colleges of Medicine and Education, my research interests involve education in medicine, bedside teaching, and adult learners in medicine.  I also have an interest in medical ethics around research consent and pediatric patients; pediatric sedation; and attitudes related to simulation and how this affects learning.  Most recently, I have been invovled in clinical standard work for quality improvement and medical care delivery as well as peer mentoring and career advancement and satisfaction.
1080625	Preventive cardiology, clinical lipidology, and cardiac imaging.
1080640	As a specialized Women's Health Internist my interests include: Perimenopause, menopause and hormonal therapy; Prevention and treatment of osteoporosis and osteopenia; Contraceptive counseling, Office based gynecologic procedures (colposcopy, IUD, biopsy), preventative medicine and women's cardiovascular health.
1080739	Dr. Catherine Hunter was delighted to join the faculty at Lurie Children's Hospital of Chicago and Northwestern University in the summer of 2012.  Dr. Hunter is originally from Edinburgh, Scotland where she completed her undergraduate degree in Physiology.  She received the national physiology prize and first class honors for her work.  After a summer research internship at New York Presbyterian Hospital she decided to pursue a medical degree from Cornell University.  After medical school she completed her General Surgery training at Harbor-UCLA medical center in Los Angeles, and was awarded board certified in General Surgery in 2010. She completed her Pediatric Surgery Fellowship training at Children's Hospital of Los Angeles, where she gained expertise with all aspects of neonatal and pediatric surgery.  She received advanced training in minimally invasive surgical techniques. Dr. Hunter continued to dedicate time to basic science research during her clinical training.  Her area of research interest is necrotizing enterocolitis (NEC), a highly morbid intestinal disorder that typically afflicts premature infants.  The role of bacteria and Cronobacter sakazakii in the pathogenesis of NEC is a particular area of interest.  She is a primary investigator of basic science research at Northwestern University.
2008714	I enjoy caring for pediatric patients in the PICU, NICU, Medical Observation Unit and Procedural Sedation at Children's Memorial Hospital.
2012799	My research interest lies in exploring the relationship between SGA status and the development of endocrinpathies later in life, particularly diabetes mellitus during pregnancy.
2022084	My primary research interests are in health services research related to maternal-child health and gynecology. My previous research includes national projects (United Kingdom) on healthcare issues related to maternal and perinatal mortality, obesity in pregnancy, child head injury, and heavy menstrual bleeding. In the US, I have worked on the National Children's Study, as well as my previous work on maternal morbidity and mortality, education regarding menopause in minority groups, and genetic testing policies.
2027098	Dr. Denise Scholtens is interested in statistical problems arising from high-throughput genomics and proteomics data as they pertain to computational biology.   She is a member of the Robert H. Lurie Comprehensive Cancer Center Biostatistics Core and collaborates on a variety of basic science and clinical cancer studies.
2032191	I am primarily interested in research involving the optimization of care for children with special health care needs.
2033644	Dr. Watts' main research interest is in health outcome disparities in cystic fibrosis, focusing on the Latino cystic fibrosis population.  She currently runs a multi-center study investigating possible molecular and clinical causes for these health disparities.  Clinically, Dr. Watts is interested in cystic fibrosis, asthma, lung disease of prematurity and pediatric patients with complex pulmonary disease.
2033885	My research focuses on microRNA regulation of cholesterol metabolism.
2036777	Utilization of 3D echocardiography in quantifying ventricular function in single ventricles.
2038320	My primary research and clinical interests relate to neurosurgical anesthesiology, intraoperative neuromonitoring, and perioperative patient safety. 
2038629	Humanitarian Response and Crisis Mapping/Technology Research
2039416	I am a UVEITIS specialist.  I treat ocular manifestations of systemic inflammatory diseases such as rheumatoid arthritis, sarcoidosis, systemic lupus erythematosus, juvenile idiopathic arthritis, Crohn's disease, psoriatic arthritis, ankylosing spondylitis, etc.  I also treat infectious diseases of the eye such as herpetic keratitis and uveitis, herpes zoster ophthalmicus, toxoplasmosis retinochoroiditis, CMV retinitis and other HIV-associated eye diseases, acute retinal necrosis, etc.In addition, I also do CATARACT SURGERY and see GENERAL OPHTHALMOLOGY patients.  Finally, I am the ophthalmology residency program director.
2043334	My research focuses on the mental and behavioral health of lesbian, gay, bisexual, and transgender individuals, with a particular focus on youth.  The health issues I study include mental health, HIV/AIDS, and substance use.  My research spans the translational spectrum from epidemiological studies of prevalence, to longitudinal studies of risk and protective factors, to the development and testing of intervention, to the dissemination and implementation of these novel interventions.
2047557	Nanotechnology is the study of the fabrication, directed self-assembly, and characterization of materials that have size dimensions between 1 and 100 nanometers. In the context of biological nanostructures, this is the size regime of the molecular machinery that constitutes, for example, functional viruses, bacteria, and human cells. The challenge of bio-nanotechnology and the focus of The Thaxton Laboratory is to control the synthesis of structures that naturally interface with biological systems to develop exquisitely targeted, practical, safe, and effective nanoparticle therapeutics, imaging agents, and biosensors.
2049177	Primary interests include sports injuries in the young athlete, especially anterior cruciate ligament tears, and arthrocopic surgery
2059065	I am a dedicated surgeon-scientist committed to advancing the scientific basis of plastic surgery. My research interests include wound healing and tissue engineering. My clinical interests include all of plastic surgery, with an emphasis on cosmetic surgery, reconstructive surgery, and complex wound care.
2077751	I have a particular interest in urgent care/emergency medicine pediatric care.
2098866	I am a clinical psychologist interested in the neuroscience of the early attachment system and it's impact of the developmental subjective and interactional nature of the 'self' system of the human being.  I have studied attachment, neuroscience and attachment trauma during the past 5 years through a variety of forums at the University of Minnesotta, the University of California Los Angeles, the University of Chicago, and elsewhere.  I am interested in the molecular nature of attachment, as well as the impact of attachment upon developing language, motor, affective, and immune systems of the body.  I have a clinical practice with adults, children and families in which I incorporate my clinical skills with emerging knowledge in the field of attachment and neuroscience to implement practical and highly effective clinical interventions.
2103930	Dr. Belknap is interested in the prevention of fatal adverse drug events. His research involves developing better methods for detecting adverse drug events and adverse drug event signals and also in developing better means of preventing adverse drug events or reducing their severity.
2103930	I am interested in computational medicine and specifically pharmacoalgorithmics, informally defined as 'the study of what the drug prescription does to the patient.' Drug therapy is more than just drugs, it includes the instructions for safely and effectively using the drugs and the resources to support those instructions (e.g., nurses, pharmacists, physicians, infusion pumps, and drug concentration measurements).  A prescription is a health-care program implemented by a physician or other qualified practitioner in the form of instructions that govern the plan of care for an individual patient. Working with a team of investigators, I showed that application of computer programming design and debugging methods results in a marked increase in the safety of opioid prescriptions in hospitalized adults. The methods we have developed in pharmacoalgorithmics have application to reducing the risk of adverse drug events, optimizing the efficacy of drug therapy, and reducing the cost of medical care.
2108444	Assessment of ultrasound and MRI in screening for and diagnosis of breast cancer, Evaluating response to chemotherapy, imaging protocols for follow-up of breast cancer patients treated conservatively, Imaging-guided percutaneous biopsy and ablative techni
2113364	ED management of wound foreign bodies.Teaching emergency orthopedics both clinically and with an interractive on line teaching tool.Electronic teaching innovations.
2117014	Health communication, health disparities, message design, health promotion
2117014	Research activities are currently focused on addressing racial disparities in influenza prevention through the use of theoretically based multimedia messages.
2119379	I am a specialist in Psychosomatic Medicine, which is the practice of medical science, education, and healthcare for persons with comorbid psychiatric and general medical conditions. Within this I am particularly interested in medication nonadherence (or noncompliance), somatoform illnesses (or medically unexplained symptoms), recidivism in the general medical hospital, medical care of patients with severe mental illness, cardiac outcomes and neuroleptic medications, and patients with intellectual disabilities (or mental retardation).
2129733	Decision making and communication for cancer patients, those at increased risk for developing cancer, their families, and their healthcare providers.
2130945	I am Board Certified in General Psychiatry. I work with both adults and adolescents combining individual, family and couples therapy with pharmacotherapy.
2132783	The overall theme of Dr. Gupta's research is the application of clinical pharmacology to the individualization of the care of high-risk surgical patients, especially those undergoing spine and intracranial procedures.  To achieve these goals, Dr. Gupta is interested in understanding how the physiologic states of special populations contribute to the variability of the concentration-effect relationship.  In particular, Dr. Gupta is interested in the contribution of sex (the ultimate pharmacogenomic factor) and age on the pharmacokinetics and pharmacodynamics of opioids and how this may affect the safe delivery of adequate analgesia to opioids nave and opioids tolerant patients in the perioperative and palliative care arenas.Dr Gupta is also interested in pharmacologic strategies that attenuate the perioperative inflammatory response as a means of ameliorating the morbidity and improving outcome after surgery and anesthesia--postoperative cognitive dysfunction, neurologic injury, cancer metastases, pain, etc.
2139747	Physician Assistant utilization across clinical settings; Physician Assistant professional issues.
2146484	Neuroradiology
2146893	I am interested in Atopic Dermatitis and Eczema.  We have created a center called the Eczema Care and Education Center that is devoted to taking care of patients with eczema and their families, with an emphasis on education about the disease.  I am also very interested in connective tissue diseases such as lupus and dermatomyositis.  I am a medical acupuncturist and am interested in alternative medical approaches to dermatologic diseases.  Finally, I am interested in medical student and resident education.
2147664	Advanced minimally invasive surgery, Achalasia, POEM procedure, per-oral esophageal myotomy, Natural Orifice Translumenal Endoscopic Surgery (NOTES), surgical education and simulation, skills curriculum, Obesity and weight loss (bariatric) surgery
2159034	I am interested in the applied physiology of responses to injury and inflammation in patient care, and the process of improving outcomes in trauma and intensive care.
2161500	Dr Gossett's research interests include pediatric cardiac transplantation and outcomes and cardiotmopathy/heart failure. This includes multi-center projects with the Pediatric Heart Transplant Study investigating rejection as well as the outcomes of cardiac transplantation in patients with Plastic Bronchitis. He is also involved in research related to pediatric interventional cathterization.
2163848	I specialize in diseases of the retina.  These include: macular degeneration, diabetic eye disease, and retinal vascular occlusions.  I have an interest in ocular imaging techniques.
2171089	Abdominal imaging.
2171325	Dr. Singhs research interests are focused on the costs and quality of prevention and treatment of gynecologic malignancies.  Her research evaluates the costs of both high technology and low technology approaches to the prevention of cervical cancer in developing and developed countries. Her work addresses the need to tailor technology and screening techniques to specific settings and populations.  She continues to present nationally and internationally on HPV related disease and cervical cancer prevention.
2175090	Dr. Strauss focuses his clinical practice in radiation oncology for breast and gynecological malignancies.  He is an active clinical researcher and has published over 20 peer-reviewed articles.
2179943	Interferon, STAT 
2181733	Interests include quality improvement, global health, community based participatory research.
2181798	General cardiology: valvular heart disease, bicuspid aortic valveVascular medicine:peripheral arterial disease, aortic disease, carotid disease,genetic vascular diseases such as Marfan's syndromePrevention and Lipid managementCardiovascular imaging: echocardiography and cardiac MRI
2190212	My primary clinical interests include the care of pediatric patients with asthma, chronic lung disease and sickle cell anemia associated lung disease.My research interests include pediatric asthma with a special interest in the early evaluation of lung function changes in pediatric asthma and sickle cell disease.
2190500	My primary research and clinical interests are in the areas of emotional functioning and attachment. Specifically, I am interested in the influence of early attachment relationships and perceived experiences on subsequent adult individual and couple functioning.
2206725	Prolactin and Breast Cancer<BR><BR>The research focus in Dr. Clevengers lab is the characterization of prolactin (PRL) receptor signal transduction and function as it relates to breast cancer and mammary gland development. The PRL receptor (PRLr) is a member of the growth factor/cytokine receptor family, which includes the receptors for interleukin 2-7, GM-CSF, EPO, and GH. Within humans, PRL functions at the endocrine and autocrine/paracrine levels as a growth, differentiation, and motility factor within the breast, a hypothesis first postulated by our laboratory. Therefore, one of our major aims is the characterization of those mechanisms that regulate PRL/PRLr expression and action in both normal and neoplastic tissues. PRL action in human tissues is mediated by the PRLr. The molecular dissection of PRLr isoform structure/function is a research focus, utilizing both biochemical and biophysical approaches to examine PRL-PRLr binding and the interaction of the PRLr with its associated transduction pathways that include JAK/Stat, Nek3/Vav2/Rac, Fyn, SIRPa, NFAT, and c-myb. We have also recently identified a direct genomic action of PRL on gene expression. This action is mediated by the prolyl isomerase cyclophilin B (CypB), which retrotransports endocytosed ligand into the nucleus, where the PRL/CypB complex directly interacts with and activates the Stat5 transcription factor. Additional research by our lab on prolyl isomerases has found that cyclophilin A (CypA) is required for proximal PRLr transduction, functioning as the molecular switch facilitating ligand-induced conformational change of the PRLr enabling Jak2 activation. As such our findings present vantage points in the development of novel therapies aimed at modulating PRL action during the differentiation of the human breast and the pathogenesis of malignancy in this tissue.
2221104	Special interest in newborn care
2237248	Doing consulting and developing data analysis algorithms in Bioinformatics and Computational Biology with applications in biomedical research.
2238574	My research program concerns understanding principles of human motivation and applying those principles toward helping people make healthy choices.  In particular, my research is currently focused on developing more effective interventions for increasing physical activity, eating healthier, and for weight management in general.  One common feature of my research involves differentiating autonomous and controlled forms of motivation based on a self-determination theory framework. And I am especially interested in interventions that support a subset of autonomous motivation known as intrinsic motivation, a subcategory characterized by interest and enjoyment. My research program is currently exploring ways to leverage technology (e.g., smartphone apps & accelerometry), game design, social networks, choice, and financial incentives in ways that support autonomous motivation and lasting behavior change.  An underlying principle is that, if we can help people to value or even enjoy healthy behaviors, healthy changes will tend to come more easily and be more easily maintained.Another complimentary feature of this research program involves my orientation toward collaboration and crossdisciplinary team science.  Compelling empirical evidence suggests that, when done well, team science is more creative, more impactful, and more fun; and Ive found support for these principles in my experience, as well. You can find more information and training tools for crossdisciplinary researchers at TeamScience.net, a website co-developed with Drs. Spring, Falk-Krzesinski, and the team at NogginLabs, Inc.
2245338	My research falls under the broad umbrella of aging and dementia and uses a multimodal approach to investigate two aging perspectives: primary progressive aphasia (PPA) in which neurodegenerative disease invades the language network and SuperAging in which individuals are seemingly resistant to the deleterious changes in memory associated with normal or more typical cognitive aging. My investigations have provided new fundamental knowledge with translational implications for cognitive aging, dementia, and neurodegenerative disease as well as the cognitive neuroscience of language and memory. Since joining the faculty at the Cognitive Neurology and Alzheimers disease Center (CNADC) at Northwestern University Feinberg School of Medicine in 2008, I have led the neuroimaging arm of our NIDCD funded Language in PPA R01 project and the cognitive and neuroimaging arm of the SuperAging study. While structural neuroimaging is my primary method of investigation it is not the only tool I use. My other investigations have explored the role of genetic, developmental and acquired factors in aging and dementia, which demonstrates my capacity to collect and integrate multidisciplinary data. I have a successful history of funding and recently received R01 funding from the NINDS to examine the relationship between clinical decline, brain atrophy and putative underlying pathology using PET amyloid imaging.
2247422	Dr. Matic's research in therapeutic biomedical optics has involved lasers for skin incisions, low-level irradiation of periodontal bacteria and, most recently, optical stimulation of the cochlea.  She is a leading expert in the field of pulsed infrared neural stimulation (INS) and is currently studying INS in the auditory system to improve cochlear implants.  Currently, the function of cochlear implants is limited, in part, by the spread of electric current in the cochlea and, therefore, the restored hearing and speech perception to cochlear implant users is less than ideal.  Lasers can stimulate smaller populations of neurons than conventional electrical stimulation, likely improving the users' speech perception.  We are working towards a novel cochlear implant built on optical technology.  Dr. Matic is also interested in further therapeutic uses of biomedical optics in otolaryngology, and other intersections of optics and neurophysiology/neural engineering.  Dr. Matic received her B.E. in Biomedical Engineering from Vanderbilt University and her M.S. and Ph.D. in Biomedical Engineering from Northwestern University.
2261563	I am interested in hereditary cancer susceptibility, genetic counseling for hereditary cancer susceptibility and exploring the role of genetic counseling for heme malignancies.
2263241	Dr. Petrich is a clinical and translational researcher focusing on multiple types of lymphoma, including Hodgkin Disease, Non-Hodgkin Lymphoma, HIV/AIDS-related Lymphoma, and Transplant/Immunosuppression-related Lymphoma.
2265121	Clinical interests include adult and pediatric allergy & immunology.
2265126	My primary interests center around the use of simulation as a method of instruction.  Specifically, I am interested in curriculum development, assessment of students, and the development of novel teaching strategies.
2273478	Dr. Sensinger's research interests include body-powered and robotic prosthesis design and control, with particular interest in developing-world applications. He focuses on clinically relevant, low cost/weight systems.
2276944	Human neuroscience (MRI, EEG, eye tracking) of cognition impairments in neurological and neuropsychiatric disorder.
2286682	I am a biocultural anthropologist specializing in mixed-methods approaches to the measurement of social and cultural phenomena. My research deals with health inequalities and mechanisms of stress and embodiment that link social disadvantage with disease.
2294496	I specialize in the surgical management of gastrointestinal diseases. I am particularly interested in the surgical treatment of gastroesophageal reflux and hiatal hernia, esophagus and stomach cancer, morbid obesity, and minimally-invasive approaches to abdominal solid organs and abdominal wall hernias. I have completed advanced training in upper gastrointestinal surgery at Oregon Health & Science University under the mentorship of John G Hunter, a pioneer in laparoscopic surgery. I enjoy working with patients to treat their condition in a professional, personalized, and efficient manner.
2305553	Dr. Jensen has a strong research interest in biopsychosocial relationships in the context of medical illness and treatment.  Dr. Jensen has extensive training and experience in research focused on the interrelationships between psychosocial functioning, neuroendocrine/immune functioning, physical symptom onset, and patient-reported outcomes in oncologic and gynecologic surgery. This line of research is grounded in the hope that a better understanding of the relationships between psychosocial functioning and surgical outcome may help to identify optimal surgical candidates, identify biological mechanisms by which psychosocial functioning may affect health outcomes, and lead to the development of future interventions to improve psychosocial functioning and surgical outcomes. Dr. Jensen is increasingly interested in exploring the relationships between psychosocial functioning, physical symptoms, and medical decision-making with respect to innovative surgical and non-surgical treatments among other populations, including candidates for transplant surgery, candidates for reconstructive surgery, and individuals with upper limb amputations. Currently, she is involved in several research projects that seek to examine quality of life and patient-reported outcomes in composite tissue transplantation, including upper limb and abdominal wall transplantation/reconstruction.
2311744	As a clinical neuropsychologist in the Neurobehavior and Memory Clinic of the Cognitive Neurology and Alzheimers Disease Center, Dr. Medina specializes in the assessment of cognition and behavior in adults, particularly the evaluation of cognitive disorders related to aging and dementia.  Her current clinical and research interests include the co-morbidity of mood disorder and neurological conditions.  Dr. Medina has published papers related to education and support for patients and families coping with dementia, as well as in the area of depression in individuals diagnosed with Primary Progressive Aphasia.
2327449	Dr. Scarsi's research interests include the pharmacology of HIV medications in special populations, outcomes associated with HIV treatment, pharmacovigilance activities, and management of HIV related drug interactions, including immunosuppressant medications and medications used to treat co-infections with malaria and tuberculosis.
2333484	I study how healthcare delivery can become safer, faster, less costly and more satisfying. Of particular interest are the topics of handoffs, physician and nurse scheduling, eliminating redundant workflow, and surgical supply chain efficiencies.
2354170	Chris serves as a prosthetic & orthotic educator, clinical researcher, and practitioner with a strong interest in knowledge translation, stroke research, clinically relevant outcomes, and inpatient management.
2354896	Director, COPD Program;  Director, Alpha-1-Antitrypsin Deficiency Clinical Resource Center
2354896	Ravi Kalhan, MD, MS is Director of the Northwestern Asthma and Chronic Obstructive Pulmonary Disease (COPD) Program where comprehensive care is provided to patients with asthma and COPD at all stages of severity. Dr. Kalhan additionally serves as director of the Alpha-1-Antitrypsin Deficiency Clinical Resource Center at Northwestern and medical director of the lung volume reduction surgery (LVRS) program.Dr. Kalhan attended college at Brown University in Providence, RI where he majored in modern American history. He subsequently entered medical school at Case Western Reserve University School of Medicine and completed his internal medicine residency at the Hospital of the University of Pennsylvania. He then came to Chicago where he pursued his fellowship training in Pulmonary and Critical Care Medicine at Northwestern Memorial Hospital, and has been on the Northwestern faculty since 2006.Dr. Kalhan's clinical interests are in the care of patients with both asthma and COPD as well as alpha-1-antitrypsin deficiency. His research interests relate to respiratory epidemiology, in particular identification of early risk factors that impact the vulnerability of certain cigarette smokers to develop COPD. He is also involved in clinical trials of new therapies for both asthma and COPD.Dr. Kalhan additionally serves as Chairman of the Illinois COPD Coalition a multidisciplinary group including representatives from community-based organizations, public health departments, professional organizations, patients, caregivers, healthcare providers, pharmaceutical companies and home healthcare providers which has the goal of implementing sustainable solutions for reducing the burden of COPD in Illinois.
2376710	I have been studying the health disparities faced by minorities in prostate cancer, including Hispanics and African Americans. We have been looking at the role of vitamin D deficiency and of allostatic stress load on men diagnosed with prostate cancer.
2389320	My research and clinical interests focus on improving long-term health outcomes in children with chronic kidney disease and after kidney transplantation.
2389410	I'm working toward establishing more focused care of patients with interstitial lung disease, in particular, Idiopathic Pulmonary Fibrosis.  My research interests center on mechanisms of disease, prognostic factors and therapy in interstitial lung disease.
2391057	My research interests lie in the area of uterine leiomyomas (fibroids) primarily.  I conduct molecular studies on these tumors in an effort to understand how they are initiated and how they grow.  My clinical interests are infertility, fibroids, and patient education/communication.
2398380	Dr. Hamidovic conducts research in genetics of drug addiction. She has identified genes associated with behavioral, cognitive and subjective responses to acute amphetamine administration in humans. Her more recent work has contributed to identifying genomic loci associated with smoking persistence in African Americans.
2398475	I am interested in studying the contribution of the circadian system on asthma.
2436423	Anesthesia for Cardiac Procedures, Liver Transplantation, Cardiac Critical Care
2437731	My main research and clinical interests include long-acting reversible contraceptives, contraception in women with chronic medical problems, and preconception health care.
2470789	My clinical interests focus on cardiac intensive care, chiefly the post-operative care of neonates and children undergoing congenital heart surgery.My primary research interest involves HPA axis dysfunction post-surgery, during sepsis, ARDS and other conditions involving oxidative stress.
2475558	My clincial interests are in treating bleeding and clotting disorders in children and risk-based optimization of the treatment of Pediatric thrombosis. My research interest is in looking at thrombin generation in preterm infants with central venous lines.
2475578	Dr. Rosenbergs clinical interests are in the care of asthma, COPD and alpha-1 antitrypsin deficiency.  Her research interests relate to co-morbidities of COPD, asthma and COPD re-hospitalization risk factors and interventions, and air pollution.
2476467	Special interests: Advanced minimally invasive surgery, surgical critical care, outcomes research, pilonidal disease, surgery for cancer and developmental anomalies, neonatal surgery, resident education, international relief work
2484761	Special interests: Advanced minimally invasive surgery in neonates, infants, children and adolescents including congenital anomalies of the lung, esophagus, diaphragm and intestines; tumors of the chest and abdomen; pyloric stenosis; pectus deformities of the chest; inflammatory bowel disease; familial polyposis; splenectomy for hematologic disease.Research interests:  hypergranulation tissue formation after gastrostomy tube placement; resourse utilization after gastrostomy tube placement; MRSA skin and soft tissue infections in children; simulation medical education; virtual reality medical simulation
2515452	My clinical interests are in promotion of healthy behaviors and fostering clear communication with patients.  My research interests are in designing and evaluating systems-based approaches to health behavior counseling within primary care. I am particularly interested in improving the way that health care systems utilize information technology to facilitate and enhance communication between patients and physicians about unhealthy behaviors.
2564425	My research interest is fetal programming and the identification of infants and children at high risk of developing childhood-onset obesity. My long-term goal is to facilitate early intervention to prevent obesity and type 2 diabetes mellitus.
2573125	My main interest has been the investigation of mechanisms of regulation of aggressive behavior in peditaric solid tumors with focus on Malignant Rhabdoid Tumors, by exploring tissue biomarkers in frozen and formalin-fixed paraffin-embedded (FFPE) samples. My purpose has been to integrate pathological, clinical and molecular data in order to disclose diagnostic signatures and to discover novel targets for therapy development.  My effort takes advantage of my skills as a pediatric oncological pathologist. It includes the exploration of main processes, molecular networks and signaling pathways involved in the different aspects of these entities employing tools such as high throughput cDNA/miRNAs expression profiling and immunohistochemistry in tissue microarrays. To achieve my goals I have been establishing collaborations with major national and international biorepositories and collaborating with multidisciplinary teams of experts.
2575033	I am interested in the area of vitamin D and its many connections to human diseases and well being.  Taking advantage of an existing twin cohort aged 6-21 years (~2000 pairs) initially enrolled in 1998-2000 in Anqing, China, my project focuses on elucidating the longitudinal relationship of vitamin D status with known risk factors or biomarkers for metabolic syndrome (MS) in children and adolescents using a prospective co-twin design.  Relevant data from this cohort of pre-adolescent and adolescent subjects will be evaluated to test several hypotheses related to MS risk factors and biomarkers. I foresee that my research on vitamin D and human diseases will not only influence clinical and public health practice, but also contribute to policy discussions about diet and exercise in schools, the built environment, and vitamin D fortification in general populations.
2626307	My research focuses on measuring and reducing the use of low-value health care services in order to improve quality and decrease cost of health care.
2628248	I am interested in global cardiovascular health, epidemiology, outcomes, and prevention research with a particular emphasis on India.  I collaborate with a terrific mentor in New Delhi, Dr. D. Prabhakaran, who is the Executive Director of the Centre for Chronic Disease Control (ccdcindia.org) on several projects, including my NIH/NHLBI-supported K99/R00 Acute Coronary Syndrome Quality Improvement in Kerala cluster randomized, stepped wedge clinical trial.  We are developing a quality improvement toolkit with cardiologists from Kerala to improve acute coronary syndrome outcomes through the Cardiological Society of India-Kerala Chapter, led by Dr. P.P. Mohanan from Westfort Hi-Tech Hospital in Thrissur.  I also work closely with my Northwestern mentor, Dr. Donald Lloyd-Jones (K99/R00 co-mentor) in evaluating past and future trends in cardiovascular health using nationally representative US data in collaboration with Drs. Darwin Labarthe and Hongyan Ning (Northwestern), Professor Simon Capewell (University of Liverpool), and Dr. Earl Ford (CDC).  We have applied these projections to Prof. Capewell's IMPACT Coronary Heart Disease Policy model to evaluate future projections in coronary heart disease mortality based on plausible scenarios.  I have also begun performing systematic reviews and meta-analyses evaluating the role of statins in the primary prevention of cardiovascular disease and the efficacy of a polypill for primary prevention of cardiovascular disease as a member of the Cochrane Heart Group editorial board.
2697988	I am interested in neonatal lung disease and pulmonary hypertension. Within this, my focus is basic/translational and clinical research in the study of cellular and molecular pathways underlying hypoxia-induced pulmonary vascular remodeling and pulmonary hypertension, with the end goal of development of targeted preventative and therapeutic strategies.
2698074	I am interested in the initial interactions between the endothelium, pathogens, and innate immunity, interactions that initiate the inflammatory and coagulation cascades.  My current project uses the pathogen Trypanosoma cruzi, and aims to elucidate how the parasite interacts with and breaches the endothelial barrier. Defining T. cruzi interactions with the endothelium and the ensuing escape from the vasculature may reveal novel therapeutic targets for the prevention of the clinical sequelae of infection, as well as lend insight into the pathogens apparent tropism for specific tissues.  Elucidation of the mechanisms that enable pathogens to migrate across the endothelial barrier will also contribute to the broader understanding of endothelial permeability and its role in critical illness.
2698325	I am interested in the development and assessment of educational curricula, especially at the graduate medical level.  I use simulation often in these curricula to teach medical management, team communication and leadership skills.
2698352	My primary clinical interests include general pediatric gastroenterology, short bowel syndrome, and obesity.
2698369	I am a post-doctoral fellow at the Center for Healthcare Studies pursing a Masters in Health Service and Outcomes Research with a focus in pre-hospital medicine.  My interests include prehospital cardiac arrest and mass gathering medicine.  I have also studied palliative medicine topics in the Emergency Department setting.
2698403	My clinical and research interests include: degenerative disorders of the cervical, thoracic, and lumbar spine, complex adult spinal deformity, scoliosis, minimally invasive spine surgery, spine trauma, and spinal tumors.
2698421	My work aims to better understand the pathways involved in relaxation of the pulmonary vasculature that coincides with neonatal transition and how those pathways are disturbed in the setting of Persistent Pulmonary hypertension of the neonate.  More specifically I am currently studying the effects of mechanical stretch on soluble guanylate cyclase, a key enzyme that contributes to pulmonary vascular relaxation in an in vitro model using pulmonary artery smooth muscle cells isolated from lambs.
2698490	Dr. Patels research interests lie at the intersection of pediatric cardiology, epidemiology, and clinical ethics.  She has specific training in each of these fields to successfully implement projects.  Specifically, she is interested in the effects of multiple concomitant diagnoses (including genetic diagnosis) in neonates and its impact on outcomes of congenital heart surgery.   She is also exploring the societal, ethical, and legal implications of emerging screening protocols and interventions in the field of pediatric cardiology.
2698627	I am interested in the diagnosis, management, and treatment of children with cardiomyopathy, heart failure and those in need of heart transplantation.  This includes the use of advanced medical and mechanical management of severe heart failure and the long term management of heart transplant patients.
2698674	I believe women during their reproductive years deserve evidence-based information regarding mental health treatment so that they can be empowered to make confident choices about their treatment.  I enjoy collaborating with women in this process
2698712	Primary interests lie in the study of minimally invasive spine techniques for the treatment of all spinal pathologies, including degenerative disease, tumors, deformity, and trauma.    In addition, Dr. Smith's interests involve the study of spinal biomechanics and how trauma, malignancy, and aging effect movement in the spine.
EMPLOYEE_ID	DESCRIPTION3
1000176	Clinical:  Analytical flow cytometry.  I am the Medical Director of Flow Cytometry Laboratory at Northwestern Memorial Hospital.  <br><br> Research:  Investigation of the basic cell biology of B chronic lymphocytic leukemia (CLL) is the major research interest of the laboratory. B-CLL is characterized by malignant cells having an anti-apoptotic phenotype and the accumulation of malignant cells is thought to be primarily driven by a block in apoptosis. However, when B-CLL cells are placed in in vitro culture, rapid apoptosis occurs raising the question of whether there are inherent defects in the apoptotic regulatory machinery or whether the dysregualtion seen is due to paracrine and/or autocrine factors. We are currently investigating potential paracrine/autocrine loops regulating apoptosis in the malignant B cell population. Specifically, the potential role of altered cytokine production by tumor specific oligoclonal T cells in these patients and its relationship to apoptosis control in the malignant B cells is being studied.     Although proliferation centers are seen in B-CLL, an additional abnormality is dysregulation of proliferation control in the malignant B cells with few proliferating cells seen in vivo and a lack of proliferative response to a number of normal B cell mitogens. In fact, although non-proliferative, the B cells in B-CLL patients may not be blocked in G0 but rather at a later point in the cell cycle. The other major area of investigation in the laboratory is elucidation of the mechanisms of proliferation dysregulation in these patients.     The laboratory is also involved in development of a number of complex multiparametric flow cytometry based clinical analyses both for diagnostic purposes and for patient specific therapeutic decision/monitoring purposes including assessment of signal transduction pathways in the setting of kinase inhibtor therapies.
1000184	Autopsy pathology, Cardiac pathology <BR><BR> Lipids are important regulators of the activity of many proteins including those involved in cardiac, vascular, pulmonary, and neural regulation, yet little is known about the molecular mechanisms mediating these effects. My laboratory staff members are engaged in a program of basic research to elucidate the molecular mechanisms by which lipids act as specific ligands to regulate cellular responses, and to investigate in select areas of cardiovascular disease how aberrations of signaling pathways may play a vital role in the pathogenesis of human disease. We have used the family of phosphoinositide-specific phospholipase C isoforms as a model to study protein-lipid interactions. Upon stimulation by various hormones these membrane associated enzymes hydrolyze polyphosphoinositides to yield second messengers such diacylglycerol and inositol 1,4,5-trisphosphate. The determinants of enzyme function are complex and can be broken down into several primary components: substrate binding and catalysis, enzyme translocation, and regulation. During the past several years we have identified the structural motifs in the PLC delta 1 isoform that mediate each of the three primary functions. All three motifs require the binding of a specific lipid for function. The structural motif mediating translocation also modulates the rate catalysis, and is encoded by a unique domain termed the pleckstrin homology or PH domain. This newly discovered protein module of 100 amino acids exists in many molecules (including PLC d1) that participate in signal transduction. Our research is among the first to demonstrate a clear function in signal transduction for the PH domain, and serves a paradigm for the activation and regulation of many signaling molecules.
1000332	My primary focus is the development and application of neuroimaging methods to better understand human development and physiology. Work in the lab draws from many disciplines such as biomedical engineering, physics, biophysics, statistics, electrical engineering, computer science, neuroscience, physiology, biology, and anatomy. While typical development occurs in normal healthy volunteers, a major effort is made to investigate the underlying physiology and function in a variety of disease conditions.
1000359	Messenger RNA stability, regulation of gene expression by protein kinase; signal transduction 
1000436	neural networks, functional imaging, dementia, cerebral cortex, cholinergic pathways
1000444	Cell  movemnet, cytoskeleton, biological forces
1000475	Alzheimer's disease, Memory disorders, Neuropsychology, Early Onset Dementia, Primary Progressive Aphasia, Frontotemporal Dementia, Superaging. The ability to use language can be progressively disrupted by neurodegenerative diseases of the brain that target circumscribed regions that normally mediate language in healthy individuals.  My clinical and research interests focus on Individuals with Primary Progressive Aphasia, Frontotemporal Dementia and Alzheimer's Disease.  Research projects address the neuropsychological, neuroimaging and neuropathological variables associated with these syndromes, in order to contribute to our understanding of risk and the genetic factors that determine regional brain vulnerability to these diseases and to identify biomarkers that can be used in diagnosis during the patient's lifetime.  To date, there are no biomarkers that definitively predict the type of the neuropathology in these clinical syndromes in the individual patient.  Additional interests in the area of brain aging and its effects on cognition lie in determining factors associated with 'Superaging', the maintenance of a high level of cognitive ability into the 9th decade of life and beyond.
1000531	Acute medical problems in primary care, Palliative care
1000554	Gynecological malignancies, Gynecology early detection, Ovarian Cancer Early Detection
1000634	My main focus of interest is primary care pediatrics.  I practice at the Childrens Memorial Hospital Uptown Clinic, an academic community health center. I am also very committed to teaching residents and medical students. One of my main focus areas is literacy promotion in pediatrics.  I am the Medical Director of Reach Out and Read (ROR) Illinois.  I am also the Chairperson of the Leyendo Juntos (Reading Together) National Advisory Committee for Reach Out and Read, working to improve RORs impact in the Latino community.  My other primary area of interest is health literacy. From 2006-9 I was a member of the AAP Pediatric Advisory Committee on Health Literacy (HL), and helped develop a Pediatric HL guide with plain language handouts, and a Pedialink module.  My other areas of interest include health disparities in Latino families, monolingual and bilingual language development and improving links between pediatricians and schools.
1000654	Primary research focused on clinical outcome measures in SMA and surrogate outcomes for clinical trials
1000727	Dr. Leikin joined the administration of the Robert H. Lurie Comprehensive Cancer Center in 1989 and has served as the Scientific Program Director of the Lurie Cancer Center for more than twelve years. She has 16 peer reviewed publications from her laboratory research years.  Dr. Leikin has considerable expertise in integrating multi-investigator and training programs. She was instrumental in the Cancer Center obtaining a Breast Program Planning Grant (CA65764), a Prostate Program Planning Grant (CA69851), the SPORE in Breast Cancer (CA89018) and the SPORE in Prostate Cancer (CA90386).  Dr. Leikin has also served continuously as Administrative Director for the NCI-funded Training Program in Signal Transduction and Cancer (T32 CA070085), the Clinical Oncology Research Training Program (T32 CA079447), the Training Program in Oncogenesis and Developmental Biology (T32 CA080621) and the SPORE in Prostate Cancer (P50 CA090386).  Since 1999 Dr. Leikin has served as Director for the CURE  supplement to the Lurie Cancer Centers Core grant (P30 CA60553)that enables underserved minority undergraduate students to conduct biomedical research during the summer months. Over 100 students have participated in the CURE Program.
1000732	<p><b>Clinical Interests:</b>  Brain aneurysm, cerebral arteriovenous malformation, dural fistulas, cavernous malformations, hemifacial spasm, trigeminal neuralgia, Chiari I malformation</p> <p><b>Research Interests:</b>  High resolution imaging for hyperactive cranial nerve syndromes (trigeminal neuralgia and hemifacial spasm), volume staged radiosurgery for complex arteriovenous malformations</p>
1000734	Areas of interest and expertise include robotics, neurobiology of the sensory-motor system and computational neuroscience. Among Dr. Mussa-Ivaldis achievements are the first measurement of human arm multi-joint impedance, the development of a technique for investigating the mechanisms of motor learning through the application of deterministic force fields, the discovery of a family of  integrable generalized inverses for redundant kinematic chains, the discovery of functional modules within the spinal cord that generate a discrete family of  force-fields, the development of a theoretical framework for the representation, generation and learning of limb movements and the development of the first neurorobotic system in which a neural preparation in-vitro - the brainstem of a lamprey - controls the behavior of a mobile-robot through a closed-loop interaction.
1000810	Role of sonic hedgehog and Bmp4 in prostate development 
1000851	Comprehensive care of adults, Perioperative medical consultations, Preventive medicine
1000867	My research focuses on the evolutionary mechanisms underlying host-pathogen interactions, and their role in the emergence, spread, and containment of infectious diseases such as HIV/AIDS. The work seeks to understand how viral genetic variation, driven by host genetics and immunity, affects HIV infection dynamics and epidemic behavior. This connection is central to the evolution of virulence and drug resistance, and to vaccine design.
1000867	My research focuses on the evolutionary mechanisms underlying hostpathogen interactions, and their role in the emergence, spread, and containment of infectious diseases such as HIV/AIDS. Studies examine the nature and extent of HIV genetic variation, the biological and evolutionary processes that have produced the observed patterns, and the human genes and their relevant genetic variants that contribute to virus evolution. The work seeks to understand how viral genetic variation, driven by host genetics and immunity, affects HIV infection dynamics and epidemic behavior. This connection is central to the evolution of virulence and drug resistance, and to vaccine design.
1000886	Coagulation
1000906	Transcatheter valve therapy,Coronary angioplasty, Stents, Cardiac catheterization, Diabetic heart disease
1000909	Our research focuses on cell cycle deregulation by DNA tumor virus oncogenes (Adenovirus E1A, Simian virus 40 large T, and human papilloma virus E6 and E7).  In particular, we are interested to find out how binding of these viral tumor antigens to cellular proteins such as pRb, p300/CBP and other proteins affect G1/S phase transition.  We use molecular genetic approaches to study these aspects.
1000927	physician-patient communication and decision making 
1001011	Hematopathology
1001018	My research deals primarily with the characterization of morphological and chemical phenotypes of specific classes of neural cells, and how they develop and change under experimental conditions and disease processes.
1001027	Health services for college / graduate students, Hospital-based care of the medical patient, Perioperative medical consultations
1001035	My primary interest is in public health education of health care professionals.  My secondary interest is ethical conduct of human subjects research particularly in the area of medical research and Institutional Review Board (IRB) oversight of research.
1001070	Occupational lung disease
1001109	Depression, Eating Disorders
1001130	Prenatal screening and diagnosis of genetic disorders.
1001131	Gynecologic surgery, Gynecology
1001200	My primary research is in the area of health economics, applied to the specific areas of aging and disability, markets for hospital and rehabilitation care, cost effectiveness of medical procedures, and arthritis care. Much of my work has used large existing data sets, including Medicare claims data, to examine healthcare market performance in response to policy changes.   
1001204	Coronary critical care, Echocardiography, General and preoperative consultative cardiology
1001208	My primary research interest is the pathophysiology of viral infections in immunocompromised vs. normal hosts.  The main viruses with which I have worked include Epstein-Barr virus, adenovirus and the respiratory viruses (respiratory syncitial virus and influenza).  I also have done research on post-viral (chronic) fatigue syndrome and chronic granulomatous disease.
1001220	My primary research interests include developmental psychopathology, sensory processing disorders, therapeutic interventions and outcomes for children and adolescents, and family therapy. 
1001222	Research interests include medical student mental health, personality traits, and the limits of evidence-based psychotherapy.  Clinical interests include career consultation and individual psychotherapy.
1001264	Inflammatory and infectious diseases the the retina, hereditary diseases of the retina,macular degeneration, diabetic retinopathy 
1001320	The  generation and mechanism of activity of Angiostatin. 
1001348	I am interested in clinical skills assessment, standard setting and improving quality of care through medical education
1001386	My research and clinical intereats include topics in pediatric emergency medicine such as analgesia and sedation, pediatric resuscitation, asthma care, prehospital (EMS) care of children, and education of those involved in emergency care of children. I am involved in the Illinois Emergency Medical Services for Children program and have helped to establish prehospital pediatric protocols, and criteria to assure that emergency departments throughout Illinois are equipped to care for children (facility recognition).
1001402	My primary research and clinical interest centers around image guided therapy.  Specifically, its application to the treatment of uterine fibroids through minimally invasive techniques via uterine artery embolization.
1001411	My research interests have revolved around lung infections, particularly those involving mycobacteria, especially M. tuberculosis, and those occurring in association with human immunodeficiency virus (HIV) coinfection.  My focus has been on lung infections most closely related to epidemiologic questions as well as to methods for more efficiently diagnosing and allocating resources to dealing with these problems.
1001431	Tay-Sachs disease and other gangliosidoses Delineating the relationship between genetic abnormalities and specific phenotypes, with emphasis on the natural history of genetic disorders Methods and pitfalls in population screening for genetic disorders Natural history of neurofibromatosis-1 during childhood Natural history and treatment of Gaucher disease and other lysosomal storage diseases
1001443	Head and neck radiology, Interventional neuroradiology, Neuroradiology, Spine imaging / intervention, Vascular imaging 
1001472	electrocardiography, QT interval, heart rate, cardiology clinical trials
1001554	Hypertension, Obesity, Pheochromocytoma
1001574	We are using single photon confocal microscopy to measure intracellular Ca cycling in individual myocytes of intact rat and mouse hearts. Hearts are loaded with the Ca indicator fluo-4AM, allowing us to measure intracellular Ca at the submicron level. Ongoing projects include study of changes in Ca cycling in animal models of heart failure, catecholaminergic polymorphic ventricular tachycardia, spontaneous Ca release and cardiac arrhythmias.
1001575	Emergency medical services for children, emergency and disaster preparedness, health care access, pediatric trauma care, pediatric patient safety, pediatric emergency medicine
1001581	Valvular and Coronary heart disease. Cardiac Imaging.
1001613	adenosine, synaptic transmission, neurotransmitter release,  secretion, ion channels, neuromuscular junction,  
1001653	Our laboratory studies Legionella pneumophila, the bacterial agent of Legionnaires' Disease pneumonia and Pontiac Fever.  Research efforts include understanding the protein secretion systems and iron acquisition pathways that contribute to the organism's ability to infect host cells and the lung.  Our laboratory has also idsentified a new species of Legionella (L. cardiaca) that is linked to heart infection.  Finally, we study Stenotrophomonas maltophilia, a highly antibiotic resistant bacterium that is increasingly associated with human infections.
1001662	General surgical pathology, Gynecological pathology
1001676	Foot & ankle problems, General Orthopaedics, Limb lengthening & deformities, Osteomyelitis, Treatment of complex fractures
1001679	Dr. Goodman's research interests include health services research, evidence-based medicine, outcomes analysis, and clinical studies of new therapies.  She obtained her Masters of Science in Epidemiology from the Harvard School of Public Health in 2001.  She has most recently participated in several studies using large databases, such as the Pediatric Health Information System of the Child Health Corporation of America, and the Virtual PICU dataset.  She is an active member of the research network Pediatric Acute Lung Injury and Sepsis Investigators (PALISI).  She is the local PI for the NIH-funded study Therapeutic Hypothermia after Pediatric Cardiac Arrest (THAPCA, www.thapca.org). Dr. Goodman is also very involved in medical education, particularly graduate medical education.  She has participated in administrative, educational, and scholarly work in this area and oversees all fellowships at Children's Memorial Hospital. Clinical interests center around pediatric critical care medicine, pediatric cardiac critical care, ECMO, and cardiac and respiratory dysfunction and innovative approaches to management.
1001725	Colon cancer, Gastric cancer, Pancreas cancer, Rectal cancer
1001728	General cardiology, Preventive cardiology, Stress testing, Nuclear cardiology, Cardiac MRI
1001728	Research interests include testing of new pharmacologic stress agents, myocardial perfusion imaging (nuclear), and assessment of myocardial perfusion and viability by MRI. 
1001774	Alzheimer's and Frontal dementias, Other dementias, Aphasia, Learning disabilities and ADD/ADHD, Functional Brain Imaging, Disorders of higher cortical function (amnesia, agnosia, neglect, etc.) due to stroke, epilepsy, dementia, etc. 
1001785	Kidney transplantation, nephrotic syndrome, pediatric kidney diseases
1001786	I am interested in streptococcal pharyngitis, injury prevention, and medical education.
1001801	I study the natural history and treatment of optic pathway tumors in children who  have neurofibromatosis-1.
1001848	The focus of my clinical practice is general gynecology.  I treat the full range of gynecologic problems, including fibroids, ovarian cysts, sexually transmitted diseases, abnormal paps, post-menopausal bleeding, menopause, hormone replacement therapy, peri-menopause, & osteoporosis.
1001883	How memory is stored in the brain: molecular and cellular bases 
1001887	Autoimmunity & Tolerance to Nucleosomes, Apoptosis, Peptide Epitope Therapy, Signaling Threshold, Lupus. 
1001887	We have established that in systemic lupus (SLE), the immune system responds abnormally to nucleosomes, the major products of body's own cells undergoing apoptosis (J. Exp. Med. 177:1367, 1993). Our main research programs involve studies on the origins of autoimmune response to nucleosomes, and signaling defects in autoimmune T and B cells that lead to abnormal co-stimulation and apoptosis-resistance. Work is progressing in parallel in lupus patients and mouse models of lupus we developed (Nature 263:412, 1976).  We have identified nucleosomal peptide epitopes critical for cognate interactions between the autoimmune T helper (Th) cells and anti-DNA B cells in murine and human lupus (J. Exp. Med. 183:2459, 1996). Recognition of these autoepitopes by lupus T cell receptors (TCR) is highly promiscuous which makes the peptides extremely potent for therapy of established lupus autoimmunity by a mechanism we call 'tolerance spreading'. We have also developed transgenic mice, bearing nucleosome-specific TCR genes, to determine how the autoimmune T cells escape censorship in the thymus despite exposure to apoptosis products, and how they could be regulated in the periphery.  Moreover, we found that the Th and B cells of lupus have defects that lower their threshold for costimulatory signaling and make them resistant to anergy induction. These defects lead to sustained production of pathogenic autoantibodies. We are studying new pathways for resistance to anergy and activation induced death in autoimmune T cells of lupus, as revealed by differential gene expression profiling. 
1001926	I am interesting in medical education in the field of radiology at multiple levels, as well as overall health care policy and quality. Radiation exposure for medical imaging is becoming a big quality and safety issue. Within the field of radiology I am most interesed in ultrasound.  
1001944	My current research interests lie in 1) understanding the relationship between community factors and clinical ones, particularly related to childhood obesity; 2) early origins of childhood obesity; 3) means to intervene to reduce obesity and its co-morbidities in young children; 4) the effects of community based interventions on obesity prevalence and health behaviors.
1001981	We are primarily conducting translational research, some of which is in conjunction with a colleague in anthropology, Dr. Gillian Bentley.  We have studied hormone differences between populations of women in the developing countries of Bolivia and Bangladesh and the Western countries, US and UK.  Salivary progesterone concentrations are significantly lower in women of developing countries, and migrant studies show that the age of the migrants is critical in the adaptation of the Western hormone patterns.  Adult migrants do not adapt to the higher progesterone levels.  Salivary estradiol is not significantly different between these population groups.  We are interested in the relation of hormone levels to fertility and to breast cancer incidence.  Other studies involve Dr. Seema Khan, Department of Surgery.  We are studying hormone and products of hormone action in nipple aspirate fluid and breast random fine-needle aspirates from women with different levels of breast cancer risk to ascertain the associations of hormones with the potential for breast cancer development.  The very small samples obtained make the procedure more acceptable than other biopsy procedures but the amount of biomarkers in the samples are limiting.  For this purpose we are working with Dr. Chad Mirkin and others in the Nanotechnology Program to develop assays with several-fold greater sensitivities than the current immunoassays.  We are also funded to study the potential for transdermal application of the biologically active metabolite of tamoxifen to the breast as an alternative to oral administration of tamoxifen.  We are working with Dr. Dean Ho of the Bioengineering Faculty to develop more efficient delivery systems for this application.  Potentially, this will eliminate some of the undesirable side-effects of tamoxifen that cause a majority of women to reject the prophylactic use of tamoxifen.   
1002007	Interventional cardiology. Catheter closure of VSD, PDA, ASD, Arteriovenous malformations. Catheter therapy of valvar and vascular obstruction: pulmonary valve stenosis, aortic valve stenosis, coarctation of the aorta, pulmonary artery stenosis. Transcatheter implantation of the Melody Pulmonary Valve
1002030	Dr. Mala Shanmugams research focuses on targeting abnormal glucose metabolism in the hematologic malignancies: multiple myeloma, CLL and mantle cell lymphoma. Elevated glucose consumption is a hall mark of numerous cancers. This phenomenon while forming the basis for clinical imaging of cancer has not yet been targeted for therapy. Dr. Shanmugam has identified a uniquely regulated subset of tumor-specific glucose transporters that facilitate elevated glucose entry in myeloma and are proving to be promising targets for therapy. Suppression of these uniquely regulated/expressed transporters has been found to engage the intrinsic pathway of apoptosis via regulation of specific signaling cascades. Recent work has identified abnormalities in trafficking proteins that enable abnormal plasma membrane localization of these glucose transporters. She is also investigating metabolic reprogramming in resistance mechanisms elicited in response to glucose deprivation. Her research spans from understanding basic mechanism to pre-clinical translational studies in order to target tumor-specific glucose utilization. Dr. Shanmugams research has been funded by the Illinois Division of the American Cancer Society, the Wendy Wills Case Foundation and more recently the National American Cancer Society.
1002038	General cardiology, Heart failure, Ischemic heart disease, Prevention of heart disease
1002038	Mihai Gheorghiade, MD, FACC, FCCP, FACP Dr. Gheorghiade is currently Professor of Medicine and Surgery, Associate Chief of the Division of Cardiology, Chief of the Cardiology Clinical Service, and Director of the Telemetry Unit at Northwestern University Feinberg School of Medicine.  He obtained his MD, Magna Cum Laude, from the University of Rome in 1972 and did his training in internal medicine and cardiology at Brown University.  Subsequently, he moved to Virginia, where he became Chief of Cardiology at the Salem VA and Associate Professor of Medicine at the University of Virginia.  Then, he became Chief of the Cardiac Intensive Care Unit at the Henry Ford Hospital in Detroit, Michigan and Associate Professor of Clinical Medicine at the University of Michigan.  From there, he moved to his current position in Chicago.  Dr. Gheorghiade was a visiting professor at the major universities in the United States and abroad and received numerous awards for teaching from both medical students and residents.  He is a member of many national and international committees and serves on the editorial board of many journals including the American Heart Journal, The American Journal of Cardiology, and the Journal of the American College of Cardiology.  Dr. Gheorghiade served as a guest editor on numerous occasions for the American Journal of Cardiology, American Heart Journal, and American Journal of Medicine.  He was/is Chairman of the Steering Committee for many heart failure trials including OPTIME, ACTIV, IMPACT, PRESERVD, STEP-CHF, URGENT, and HORIZON.  He is co chairing the ongoing, international EVEREST trial and was a member of the Steering Committee of RADIANCE, FIRST, CARS, RITZ 4, EPHESUS,  OPTIMIZE-HF, and IMPROVE-HF Dr. Gheorghiade is the author of more than 300 publications.  He was the Chairman/Co-chairman of numerous international and national meetings.  At present, his research interests are related to the pathophysiology, prognosis, and management of hospitalized patients with heart failure and the roles of vasopressin antagonist in heart failure.   
1002042	Neuropathology
1002052	PACS, Workstation, RIS, DICOM, HL7, Data Mining,  
1002062	Hodgkin's disease, Leukemia, Lymphoma
1002062	I have been studying biologic correlates of outcome measures in the context of the US Intergroup CHOP vs. Rituximab(R)-CHOP clinical trial for diffuse, large B-cell lymphoma (DLBCL). The addition of R to conventional CHOP chemotherapy either as induction or maintenance has now been shown to improve outcome in patients with DLBCL (both US and European trials).  My findings suggest this improvement in outcome is primarily due to the beneficial effect of R added to CHOP in the bcl-6 negative subset of DLBCL. Furthermore, addition of rituximab to CHOP chemotherapy, does NOT benefit patients who are bcl-6+, the majority of cases.  Differences between the clinical behavior of bcl-6 positive and negative lymphoma provide clues to the underlying biologic nature of DLBCL. Different therapeutic strategies may be designed to specifically target bcl-6-positive and negative DLBCL based upon differences in their underlying cell survival mechanisms and sensitivity to chemotherapy and rituximab. Analysis of additional biologic markers (p53, p21) is in progress.  Along with Dr. John Reed of the Burnham Institute, a long-standing collaborator, we are investigating protein expression of paracaspase in  lymphomas.In collaboration with Dr. E. Terry Papoutsakis of the Department of Chemical Engineering, NU, we are creating  gene expression arrays on follicular lymphomas to identify patterns of gene expression reflective of the nonmalignant cells component of the biopsy specimen, and their relationship to clinical outcome. Radioimmunotherapy using anti-CD20 reagents targets radiation to the malignant lymphocytes and their immediate neighbors by means of the cross-fire effect.  To improve outcomes, we have added Y-90-ibritumomab tiuxetan to conventional BEAM chemotherapy for patients undergoing autologous stem cell transplant.  This was an investigator initiated phase I trial conducted under an investigator-held IND.  Colleagues at the Mayo Clinic were our co-investigators.  Forty-three patients were accrued to this study;  the maximal tolerated dose of Y-90-Ibritumomab tiuxetan is one that will deliver 1500 cGy to critical organs.  We are recommending a phase II trial of this radioimmunotherapeutic at 1.0 mCi/kg administering higher doses of Y-90-ibritumomab  tiuxetan be conducted prior to proceeding to a phase III randomized trial. Continuing in our efforts to develop novel therapies for patients with non-Hodgkin lymphoma, I have written a phase I trial to combine bortezomib, the proteosome inhibitor, with Y-90-ibritumomab tiuxetan for patients with follicular lymphoma. This study has just opened.   Other clinical investigations include anti-idiotype vaccines, novel targeted agents such as histone deacetylase inhibitors and new monoclonal reagents such as the  anti-CD40 monoclonal antibody and an anti-CD22 chemoimmunoconjugate. In the context of our recently submitted SPORE in Lymphoma application, I will lead studies of targeted 'nanobins' created by Dr. O'Halloran, and help to develop bcl-6 peptide inhibitors for clinical use with Drs. Licht and Melnick (Albert Einstein).   
1002064	Dr Kahrilas' research focus is on esophageal and oropharyngeal physiology and pathophysiology.  Oropharyngeal studies are aimed at describing the normal mechanics of swallowing and the modifiability that can be imposed therapeutically.  These studies use computerized analysis of manometric and videofluorographic swallowing studies.  Pathophysiologic studies of the oropharynx focus on mechanisms that result in dysphagia and the efficacy of volitional compensatory strategies in modifying these defects.  Esophageal research has centered on the motor activity of the upper esophageal sphincter, peristaltic function, the pathophysiology of esophageal motor disorders, and the pathophysiology of gastroesophageal reflux disease.  Upper esophageal sphincter investigations utilized manometry and videofluoroscopy to describe reflexive response to esophageal stimuli, as well as normal activity during sleep, acid reflux, meals, and swallowing.  Studies of the esophageal body have described the contractile pattern of longitudinal muscle during peristalsis and are examining the efficacy of peristaltic function in effecting volume clearance and relating this quantitative assessment of peristaltic efficacy to the subjective experience of dysphagia.  Investigations of reflux disease are examining the mechanisms by which anatomic variables, inclusive of but not limited to hiatus hernia, interact with physiological responses to modulate disease severity.  A current research focus is on applying high-resolution solid-state manometry to the analysis of esophagogastric junction pathophysiology both with respect to reflux disease and esophageal motor disorders.  Previous research interests have included central nervous system neurophysiology, autonomic nervous system neurophysiology as it relates to sodium homeostasis, and screening for esophageal cancer. 
1002064	Esophageal disorders, Gastroesophageal reflux disease, Swallowing disorders
1002079	competitive, inhibition, uterine, contractions, preterm- labor, peptides, oxytocin, antagonists, breakdown, metabolism
1002095	Adolescent Psychiatry, Normality, Longitudinal Studies
1002126	My research interests include co-occurring disorders (dual diagnosis), HIV prevention for high risk populations, health promotion with underserved populations, incarcerated or newly released individuals, post traumatic Stress disorder (PTSD) and other affective disorders
1002139	Asthma, Lung Function, Clinical Trials
1002139	I am exploring the role of diet in asthma severity, especially the effect of dietary antioxidants and soy isoflavones.
1002194	global control of cell function genome sequence architecture and genome navigation
1002205	My primary research/clinical interest of longest standing is in the area of medical anthropology; specifically, dealing with all of those factors, processes, and practices--biological and cultural--that are associated with either promoting or impeding healing in all of its aspects (i.e., from somatic wound healing to psychic healing).  Regarding healing, I have particular interest in mind-body integration and psychoneuroimmunology.  In the area of my own professional clinical activity, my longest standing interest is in bringing existentially informed approaches to the practice of making effective healing relationships with individuals and their families who are contending with serious medical problems and/or life-shattering events which have a medical dimension.  
1002238	Primary clinical interest is in administration of correctional psychiatry programs in the Cook County Jail and the Juvenile Temporary Detention Center.
1002248	My primary clinical interest is preventative health care strategies for women of all ages with a special focus on Menopause, Bone health/Densitomety and cardiovascular health. I am also very interested in minimally invasive surgery such as endometrial ablation for abnormal bleeding and hysteroscopic sterilization.
1002252	I am a clinical psychologist who is primarily interested in providing psychotherapy to individuals and couples coping with mental health symptoms, life transitions and the diagnosis and treament of cancer.   My research interests include psychological sequelae of a cancer diagnosis.
1002340	I have been interested in community mental health and have published in the field of rural psychiatry.  I am currently interested in cognitive disorders and associated psychiatric syndromes in my work at the Cognitive Neurology and Alzheimer's Disease Center.  
1002357	Development of novel therapeutics; cancer signaling; cancer metabolism
1002357	Steven Rosen, MD, FACP, is Genevieve Teuton Professor of Medicine, at the Feinberg School of Medicine, Northwestern University and Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Director of Cancer Programs at Northwestern Memorial Hospital.  Following his graduation with distinction from Northwestern University Medical School s Six-Year Honors Program in 1976, Dr. Rosen completed his residency in Internal Medicine at Northwestern and a fellowship in Medical Oncology at the National Cancer Institute. Dr. Rosen s laboratory research focuses on experimental therapeutics and hematologic malignancies.  Dr. Rosen has received numerous grants awards and contracts and has published more than 200 scientific papers.  As Director of the Cancer Center, Dr. Rosen has successfully competed for an NCI Cancer Center Support Grant, NCI grants for his laboratory research, an NCI RAID Contract grant for the development of a novel purine analog, and grants from the Leukemia and Lymphoma Society of America and the American Cancer Society. Dr. Rosen serves on several editorial boards and is editor of Cancer Treatment & Research.  He is a member of all major national associations that focus on oncology and has held leadership positions in the Eastern Cooperative Oncology Group, the American Association of Cancer Institutes and the National Comprehensive Cancer Network.  He serves on the advisory boards of several NCI-designated Cancer Centers, the Leukemia and Lymphoma Society of America, the Multiple Myeloma Research Foundation, the Lymphoma Research Foundation and the Wendy Will Cancer Research Foundation.  He has also served as an advisor to Great Britain s Cancer Research Campaign.  Dr. Rosen was the recipient of Northwestern University Medical School s Alumni Achievement Award (1994), the Martin Luther King Humanitarian Award from Northwestern Memorial Hospital (1995), the Marv Samuel Award from the Chicago Baseball Cancer Charities (1996) and recognition from the Women s Board of Northwestern Memorial Hospital for Compassionate Care (1996).  He is acknowledged in Best Doctors in America and Best Doctors in Chicago. 
1002413	transformation, mesothelioma, cyclins, phosphatases, apoptosis, transactivation 
1002417	Clinical research interests include pituitary disease leading to hypopituitarism or hormonal excess syndroms, such as acromegaly, hyperprolactinemia and Cushing's disease.  Basic research interests are focused on the growth hormone-IGF I axis.  Currently ongoing studies include the characterization of genetic GHRH receptor deficiency and the evaluation of tissue-specific growth hormone actions using a growth hormone receptor knockout model.
1002417	growth hormone, growth hormone action, growth hormone receptor, growth hormone binding protein, growth hormone releasing hormone receptor, insulin-like growth factor, growth, development, metabolism 
1002485	Dr. Rothke's clinical work and research involves professional issues in neuropsychology such as expert testimony, disability determination, competency evaluation (ability to work, manage finances, and manage personal affairs, and assessment of testamentary capacity), development of job modifications to accommodate a mental or emotional disability, evaluation of risk for violence and determination of fitness-for-duty, and assessment of malingering and exaggerated claims of impairment.   
1002521	learning and memory, multiple single-unit electrophysiology, behavior, classical conditioning, transgenic mice, knockout mice, alzheimer's disease, hippocampus, cerebellum, aging 
1002526	Research Interests: Comparative Anatomy of the Larynx                                     Neuromuscular Physiology of the Larynx                                      History of Medicine Clinical Interests:   Clinical Human Anatomy                                         Head & Neck Region
1002530	My research and clinical interests focus on children with arthritis, and the use of informatics to improve quality and research projects, by coordinating flow of data from diverse sources, including the electronic medical record.  I participate in a multi-center Quality Improvement network as well as multi-center trials of novel treatments of children with arthritis.
1002615	I am primarily involved in health literacy advocacy, research and incorporation of this into clinical care, as well as medical home and medical education about the medically complex child
1002617	Gonadal Development, Pituitary, Gonadotropins, Activin, LH, FSH
1002617	My overall interests are in mammalian reproduction. In previous years, I studied the regulation of pituitary gondaotropin gene expression and hormone secretion. More recently, I have been working on two topics. The first is trying to determine the genetic cascades involved in male/female sex determination and subsequent development of the gonad. Most of this time is spent on a genome-wide mutagenesis screen for genes involved in spermatogenesis. The second is the control of gene expression by estrogen receptor alpha via mechanisms that do not involve the classical estrogen response element in DNA (the so-called 'non-classical' mechanisms).
1002633	Angina with normal coronary arteries, Coronary artery disease, Coronary circulatory abnormalities
1002643	epidemiology of systemic lupus erythematosus, pregnancy and rheumatic diseases, osteoporosis, steroid-induced osteoporosis, clinical drug trials in lupus
1002644	gender and arrhytmias, dynamics of fibrillation
1002699	I. The Sonic hedgehog signal in vertebrates is mediated by three C2H2 zinc finger transcription factors, GLI1, GLI2 and GLI3. Near identity of gene sequence exists between mouse and human GLI1.  We have shown that GLI1 functions as a transcription factor and that a critical domain in the COOH end of the protein is a transactivator with VP16-like structure. We established that GLI1 protein regulates a set of genes that coordinately control proliferation and may in part explain malignant transformation by mis-expression of GLI1. Post-transcriptional regulation of protein levels of GLI1 occur via the 3UTR of the human gene and this is an active area of research in the lab.                      II. The use of genetic mosaics in developmental analysis has been important for over 80 years.  Recently however, it has been possible to use mammalian mosaics and to perform analysis in situ allowing identification of cell lineage in visceral organs.  I used this system to establish that chemical induced tumors and preneoplastic lesions are clonal. The patterns observed in tissues of these animals derive from the allocation of stem cells during development and are the result of the primary forces : cell death, cell movement, and cell division.  We have shown that the patterns are conserved and regulated within the various tissues of the animals examined.  By using a combination of geometric analysis and computer simulation we have shown that the patterns are fractal, likely arise from iterating simple division rules, and do not require cell movement for complex highly variegated patterns to form. One of the prototypical patterns is evident in the cornea where epithelial cells are assorted in a whorled or pinwheel distribution.  We are using a variety of models; rat chimeras, mouse transgenics, live whole animal second harmonic imaging and explant culture to try and understand how this distribution occurs.
1002702	Adrenal tumors, Endocrine tumors, Hyperparathyroidism, Islet cell tumors of pancreas, Laparoscopic adrenal surgery, Minimally invasive parathyroid surgery, Parathyroid tumors, Pheocromocytoma, Thyroid cancer, Thyroid tumors
1002719	Clinical research in methods of testing for diabetic peripheral neuropathy
1002721	Education Processes, Teaching Learning, Gender issues in Health care 
1002791	My primary research relates to the signaling pathways involved in hormone action on osteoblasts and osteoclasts, and its implications for osteoporosis, cancer metastases to bone and women's health.  More details are available on the Web page, http://www.feinberg.northwestern.edu/igp/facindex/SternP.html.
1002793	General practice of Adult Psychiatry, with concentration on Mood and Anxiety Disorders. I also have a particular interest in Alzheimers and other dementias.
1002798	Clinical interests include taking care of premature babies and other ill neanates in the Intensive Care Nursery, and in the process training medical students and other hospitalists. Of special interest is mastering procedures needed in the care of neonates.  A final priority is to continue to develop and execute a comprehensive approach to economically disadvantaged community youth
1002799	Comprehensive care of adults
1002801	I am a general child neurologist with particular interest in neurology of the newborn, and currently pursuing projects regarding treatment of hypoxic ischemic injury and stroke in the newborn.  I have research experience in the psychophysics of vision.
1002912	Bioreductive drugs, hypoxia, adjuvant therapy, radiosensitization, metalloproteinase-inhibitors, imaging for hypoxia, 19F-MRS, spermidine-derivatives, drug activation.
1002958	Cardiovascular healthcare quality, outcomes reserach, Hypertrophic cardiomyopathy, Valve disease, heart failure
1002979	Children in technology, POSTTRAUMATIC STRESS DISORDER INTERACTIVE DIGITAL TECHNOLOGY, CHILD DEVELOPMENT, FAMILY LIFE, VIDEO GAMES, INTERNET, CELL PHONES, COMPUTER
1003038	public psychiatry, behavioral health & human service systems, public health, public policy 
1003070	Hypertension; Racial differences in electrolyte metabolism and water balance.
1003094	Breast Surgical Oncology
1003154	Management of chronic ear disease in developing coutries Acoustic analysis of snoring and respiration and localization of site of airway restriction in sleep apnea.
1003171	Laura A Miller is a prosthetist at the Rehabilitation Institute of Chicago and an Assistant Professor in Physical Medicine and Rehabilitation at Northwestern University, participating in research through the Neural Engineering Center for Artificial Limbs (NECAL). She completed her MS and PhD in Biomedical Engineering at Northwestern University.  She has multiple publications in the area of normal gait and lower limb prosthetics.  She also has an interest in and has been an author in the area of high-level upper limb prosthetic fittings. Laura is an ABC and Illinois licensed prosthetist and a member of the AAOP and the ISPO.   
1003176	Regulation of the cardiac L-type calcium channel at the molecular level
1003231	Exploration of the clinical and epidemiologic significnce of the I1307K APC mutation associated with colorectal cancer in Ashkenazi Jews.
1003231	clinical significance of the I1307k APC mutation in colorectal carcinoma; aromatase inhibitors breast cancer 
1003275	Management of chronic pain (low back, neuropathic, cancer, myofascial). Management of acute postoperative pain. Regional anesthesia. Outcome measures in pain research. Safety and neuraxial and regional anesthesia (e.g. anticoagulation and regional anesthesia)
1003295	Dr. Molitch performs clinical research in the fields of pituitary hormone regulation, pathogenesis and treatment of pituitary tumors, and diabetes complications. His research is conducted primarily in the Clinical Research Center. 
1003295	Pathogenesis & treatment of pituitary tumors, treatment of diabetic complications  
1003302	Ambulatory anesthesia, Neurosurgical anesthesia
1003356	My clinical training is in cardiology and my research training is in stem cell therapies for cardiovascular diseases and molecular strategies to improve recovery after myocardial infarction.  I am interested in discovering novel treatments for myocardial infarction and heart failure.
1003361	Neuropsychology 
1003390	Health services research, Prostate, Public policy
1003403	Oral Pathology <BR> Diagnostic Oral & Maxillofacial Pathology
1003414	The body of work explores early detection of melanoma by skin self-examination (SSE) by those at risk to develop a melanoma. A research focus is the role of the dyadic relationship in performance of SSE. This research evolved from qualitative research in focus group testing of rulers and magnifying glasses to assist with SSE to a randomized trial of the educational and skills training intervention with qualitative measures by self-reported surveys and diaries. In order to improve the early detection of melanoma by physicians providing care, Dr. Robinson's research seeks to move beyond the usual didactic lectures with skin simulation models. The current model with multiple pigmented lesions affords medical students and primary care resident trainees the opportunity to learn the skills needed for early detection of melanoma. Simulation training modules build selfconfidence as the students and trainees master the skills of early detection of melanoma, counseling the patient, and performing a skin biopsy of a clinically suspicious pigmented lesion. The skin simulation interactive learning will enhance the reliability of healthcare provided by primary care physicians via opportunistic screening. Dr. Robinson's research interest over the last decade has also included prevention of skin cancer by harm reduction messages and educational interventions with teens and young adults with a particular focus on reducing indoor tanning and sun protection.
1003426	Neisseria gonorrhoeae, gonorrhea, pilus, antigenic variation, DNA transformation, DNA replication, DNA repair, antioxidant functions, neutrophil interactions. epithelium interactions
1003444	The laboratory is interested in understanding the mechanisms underlying the pathogenesis and immunoregulation of T cell-mediated autoimmune diseases, allergic disease, and rejection of tissue and organ transplants.  In particular, we are studying the therapeutic use of specific immune tolerance for the treatment of animal models of multiple sclerosis and type 1 diabetes, allergic airway disease, as well as using tolerance for specific prevention of rejection of allogeneic and xenogeneic tissue and organ transplants.
1003466	Clinical trials/ Women's health iniative.  
1003502	Expertise in care of children with a variety of cancers, especially pediatric leukemia, palliative care and hemophagocytic syndrome Expertise in palliative care and pain management Expertise in clinical bioethics
1003627	Research Interests: Treatment Outcome, Serious Mental Illness Clinical Interests: Depression, Anxiety, Relationship Issues
1003628	Sinus problems, trans nasal resection of skull base tumors, snoring and sleep apnea, Taste and smell disorders
1003634	Diabetes in pregnancy, High risk pregnancies
1003637	Male and female sexual dysfunctions ...   Erectile dysfunction ...  Low sexual desire ... Sexual arousal problems ... Sexual pain ... Compulsive sexual behavior / Sexual addiction ...  Gender identity issues ...  Professional sexual misconduct ...  Sexual abuse issues ... Sexual orientation isues ... Relationship and marital problems
1003653	Signal transduction, proteomics, systems biology, neurodegenerative disease, vascular disease
1003694	Dr. Young's research focuses on the sympathetic nervous system and the adrenal medulla. His laboratory is investigating the impact of environmental exposures during fetal and neonatal life on sympathoadrenal development. The hypothesis being tested is that development events 'program' how the sympathoadrenal system functions throughout life. Recently, the laboratory has begun to explore the role of estrogens in both male and female animals in this programming process. The implications of such changes during early development on the phenotypic expression of obesity and hypertension in adults are also under examination.
1003694	Physiological regulation of the sympathoadrenal system; Developmental neurobiology of the sympathoadrenal system; Physiological and pathophysiological roles of catecholamines in regulation of blood pressure and energy metabolism.
1003731	Breast cancer surgery
1003772	SOFT TISSUE AND BONE PATHOLOGY 
1003787	Breast cancer, General oncology
1003800	Dr. Chang is a rheumatologist with more than 20 years of clinical experience.  His major clinical interest is in rehabilitative rheumatology, and he is regarded as an expert in this field.  He is the Director of the Rehabilitation Institute of Chicago Arthritis Center and Immediate Past Chair of the Rehabilitation Section of the American College of Rheumatology.  He is co-author of the rehabilitation chapter in Koopman s and Moreland's textbook, Arthritis and Allied Conditions, one of the major international rheumatology textbooks.  Dr. Chang has been the Director of the Northwestern University Master of Public Health Program since its reorganization in 1996.   During this time he has led the program to achieve pre-accreditation by the Council on Education for Public Health in 2000 and full accreditation from CEPH in 2003.  The program focuses on public health education for medical students and health professionals and trains its students to become effective boundary-spanners between the fields of medicine and public health, an appropriate description of Dr. Chang's professional career.  In September, 2005, Dr. Chang was appointed Acting Chair of the Department of Preventive Medicine.   Dr. Chang is noted for his clinical epidemiologic/health services research focused on the outcomes of rehabilitation and orthopaedic surgical treatments for persons with arthritis and the determinants of functional limitation in clinical and community populations with arthritis.  Much of his community population work has been done in collaboration with Dorothy Dunlop, PhD and Larry Manheim, PhD.  He also has experience performing decision analysis and cost-effective analysis in collaboration with Dr. Manheim and Gordon Hazen, PhD.  With several research and clinical colleagues, Dr. Chang is currently developing and testing a physical activity promotion program for patients with arthritis.  Dr. Chang's public health oriented research, reflective of his formal public health training and interests, has also led to his prominence in the arthritis public health community both at the state and national level.  As a volunteer for the Arthritis Foundation as well as a representative of the Northwestern University Multidisciplinary Clinical Research Center in Rheumatology and the Rehabilitation Institute of Chicago's Arthritis Center, Dr. Chang is a major contributor to the new state-based arthritis prevention program based in the Illinois Department of Public Health.  He is an active volunteer for the Arthritis Foundation, where he is a Co-Chair of the National Office's Public Health Council and the immediate past Chair of the Foundation's Greater Chicago Chapter.
1003800	Dr. Chang is noted for his clinical epidemiologic/health services research focused on the outcomes of rehabilitation and orthopaedic surgical treatments for persons with arthritis and the determinants of functional limitation in clinical and community populations with arthritis.  Much of his community population work has been done in collaboration with Dorothy Dunlop, PhD.  He also has experience performing decision analysis and cost-effective analysis.  With several research and clinical colleagues, Dr. Chang developed and tested a physical activity promotion program for patients with arthritis, supported by a five-year investigator-initiated R01 grant funded by the National Institutes of Health. The project was titled, Improving Motivation for Physical Activity in Arthritis Clinical Trial (IMPAACT).  With the support of an R21 grant, Dr. Chang's team is now developing a worksite intervention that promotes healthy physical activity/dietary behaviors for overweight/obese persons with chronic knee symptoms called JointADventure.
1003810	prostate cancer, androgen-response genes, growth control 
1003837	The PI has three major areas of hypothesis-driven research hat are studied and supported:  urinary proteomics in genetic kidney stone diseases; genetic and environmental influences on vitamin D metabolism, osteoporosis, and cardio-renal diseases; mechanisms of vasculopathy in chronic kidney diseases.
1003863	Chrinic fatigue symdrome and chlamydia and adolescentimmunizations ,especially flu
1003874	Dr. Lowe's research focuses on various aspects of growth factors and metabolism.  He has a long-standing interest in the insulin-like growth factors and has recently investigated the role of the insulin-like growth factors in pancreatic islet cell biology, especially in the context of islet cell transplantation.  Other research interests include the generation of insulin-secreting cells from embryonic stem cells and the genetics of complex diseases. 
1003874	The Lowe lab has two areas of research interest.  One area of study is the genetics of maternal glycemia during pregnancy and fetal growth and their interaction.  A cohort of ~13,000 mothers and their babies are being used in genome wide association and related studies to define genetic variation affecting these traits.  A second area of study is the development of bioactive materials to enhance islet transplantation.  These studies are being conducted in the context of a research team that includes islet biologists, bioengineers and transplant surgeons.  In related studies, the mechanisms for islet expansion during pregnancy are being examined to define mechanisms for islet cell expansion.
1003883	I am interested in how neural networks control posture and balance.
1003916	Hepatic disease, Hepatitis B and C, Viral infections
1003916	Steven L. Flamm, MD is a Professor of Medicine in the Division of Hepatology at Northwestern University Feinberg School of Medicine in Chicago, Illinois.  He also serves as the Medical Director of Liver Transplantation. Dr. Flamm is a member of the American Gastroenterological Association (AGA) and the American Association for the Study of Liver Diseases (AASLD).  He has served as the Region 7 Representative to the UNOS Liver and Intestine Committee and on the Publication and Practice Guidelines Committees of the AALSD. Dr. Flamm has published widely in the field of hepatic diseases and has spoken both nationally and internationally on many other liver-related topics including viral Hepatitis, autoimmune hepatitis, hepatic encephalopathy, and liver transplantation.  He has an active clinical research program in chronic viral hepatitis (HBV and HCV) and autoimmune hepatitis. 
1003933	Independent work in Pharmacovigilance;  Post-Marketing Safety Surveillance of Drugs and Medical Devices 
1003978	Dr. Chmiels current research interests are in the epidemiology of HIV-1 infection, statistical methods for the design and analysis of clinical and epidemiological studies of cancer, osteoarthritis and AIDS, and clinical trial design and analysis.
1004010	Benign Hematology, Clotting, Phlebitis
1004010	Co-investigator in the MultiEthnic Study of Atherosclerosis (MESA) and Walking and Leg Circulation Study (WALCS) Laboratory evaluation of hemostasis and thrombosis in various clinical models
1004023	A Phase II, Randomized, Parallel-Group, Open-Label, Multicenter Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects with Active Rheumatoid Arthritis Receiving Background Methotrexate (Protocol# U3374g), Genentech, Inc. 
1004023	A Randomized, Placebo Controlled, Double-Blind, Parallel Group, International Study to Evaluate the Safety and Efficacy of Rituximab (MabThera /Rituxan) in Combination with Methotrexate, Compared to Methotrexate Monotherapy, in Patients with Active Rheumatoid Arthritis (Protocol Number U2973G), Genentech, Inc. 
1004023	A randomized, multifactorial, double-blind, parallel-group, dose ranging study of the efficacy and safety of Rituximab (mab Thera R/Rituxan) in combination with methotrexate in patients with active rheumatoid arthritis. Sponsored by Roche Products Ltd,/Genetech, Inc.
1004023	A randomized, phase 3, controlled, double-blind, parallel-group, multicenter study to evaluate the safety and efficacy of rituximab in combination with methotrexate (MTX) compared to MTX alone, in methotrexate-nave patients with active rheumatoid arthritis. (Protocol WA17047/U3373g), Genentech, Inc.
1004023	An Open-label Study of the Efficacy and Safety of Re- Treatment with Rituximab (MabThera/Rituxan) in patients with Active Rheumatoid Arthritis (Protocol WA 16855/U2653g). Roche Products Ltd,/Genetech, Inc..
1004023	Humira Efficacy Response Optimization Study in Subjects with Active Rheumatoid Arthritis (HERO). Abbott Laboratories M04-684,
1004025	I am a board certified Otolaryngologist, with subspecialty certification in Neurotology.  I completed a fellowship in Otology and Neurotology, which is a subspecialty in Otolaryngology that deals with disorders and surgery of the ear and ear related skull base structures.  My interests are in cochlear implants, cochlear implant research, middle ear implants, diseases of ear, skull base surgery, skull base tumors, Gamma Knife surgery, acoustic neuromas, neurofibromatosis type II, otosclerosis and facial nerve disorers.
1004037	Early phase cancer studies, diagnostic and screening studies, study design and smaple size determination, statistical analysis
1004062	I maintain a generalist psychotherapy practice, seeing patients with anxiety, depression, life transition, stress, and relationship problems.  I maintain an ongoing interest in substance use disorders.
1004070	Cardiovascular anesthesia, Thoracic anesthesia, Transplantation anesthesia, Pharmacokinetics of inhaled anesthetics
1004121	I am both a general and a child/adolescent psychiatrist.  I am interested in treating mood disorders in children and adults, especially bipolar disorder.  I emphasize medication management coupled with psychotherapy.  I also treat ADHD; it has a high frequency as a comorbidity with mood disorders.  
1004130	Application of technology within public mental health services systems to facilitate system planning, improve service accessibility and utilization, and monitoring of outcomes; as well as child welfare policy and administration.  
1004250	Epidemiology of gestational diabetes, relationship between blood glucose during pregnancy and various outcomes, including pediatric obesity.
1004289	     1.  2003-2004   Principal Investigator: A 52 week randomized, double-blinded, single dummy, parallel group, multi-center, Phase III study comparing the long-term safety of Symbicort pMBI 160/4.5 x 4 actuations twice daily to Symbicort pMDI 160/4.5 x 2 actuations twice daily, and Budesonide HFA pMDI 160 x 4 actuations twice daily, in adult and adolescent subjects with asthma.      ......2. 2001-2003  Principal Investigator:  A multi-center, randomized, double-blinded, double-dummy, parallel group, 16-week comparison of Asthma control in adolescents and adults receiving either Fluticasone/Salmeterol Discus combination, Fluticasone Discus, Salmeterol Discus or oral Montelukast.      .......3. 2001-2002  Principal Investigator:  An open label extension study of Omalizamab in Moderate to Severe , Persistent Asthma subjects who completed Study ALTO      .......4. 2000-2001  Principal Investigator:  A multi-center, randomized, controlled, open-label study to evaluate the safety of Omalizumab (monoclonal anti-IgE) in Moderate to Severe, Persistent Asthma subjects already treated with other therapies.      ...........5. 2000  Principal Investigator:  An observational study of the epidemiology and natural history of Asthma: outcomes and treatment regimens.      ......6. 2000  Principal Investigator:  A randomized, double-blind, placebo controlled, multi-center study of the efficacy and safety of Cetirizine-Sudafed vs. Loratadine-sudafed vs placebo in the treatment of Seasonal Allergic Rhinitis.      .........7. 1998  Principal Investigator:  A randomized, double-blind, placebo controlled, multi-center study of the efficacy, safety, and effect on quality of life, work productivity and activity impairment of Cetirizine vs. placebo in the treatment of Seasonal Allergic Rhinitis      ......8. 1998  Principal Investigator:  A multi-center, double-blind, placebo-controlled, randomized, parallel trial evaluating the efficacy and safety of HFA Flunisolide vs. CFC flunisolide in Pediatric patients with Mild to Moderate Asthma.
1004322	Benign hema, Blood coagulation
1004324	Effective psychological treatment today requires a flexibility of approach as well as the ability to ask the right psychological questions. By engaging patients quickly and thoroughly assessing clinical needs and resources, I am able to work with the patient in order to develop the proper mix of problem-focused interventions and more traditional psychotherapy. Each patient's problems and strengths must be evaluated on an individual basis. I view psychotherapy as a collaborative proceess in which the patient(s) and I work together in order to understand how current situations and past influences impact the well-being of the patient's current life and future goals. In addition to using a flexible approach to treatment, when appropriate, I communicate clearly with other professionals involved in treating the patient, couple, or family. I work with adults as individuals, couples, or parents, and with adolescents and families. Having trained in both clinical and developmental psychology gives me a unique life-span perspective in both normal and pathological psychological processes.  
1004331	Comorbid psychiatric disorders, Trauma and loss, Mental health needs, substance use and risky behaviors of offenders, HIV/AIDS/STIs, Criminalization of mentally ill
1004333	Primary care internal medicine, Women's healthcare
1004356	I am interested in identifying why learning becomes progressively more difficult with normal aging. With this broad goal in mind, I am studying the cellular properties of principle neurons of the hippocampus as an animal ages and after an animal has learned a task that involve the hippocampus. Thus far, my colleagues and I have identified that hippocampal pyramidal neurons (the principle output neurons of the hippocampus) become more excitable (that is, they are able to fire more action potentials) following successful learning. More importantly, the same population of neurons become less excitable with normal aging. Thus, it is our working hypothesis that the reduced excitability levels of the hippocampal pyramidal neurons with normal aging is a cause of the learning deficits observed in the aging population. We are currently using state of the art calcium imaging techniques to further characterize the changes in the hippocampal pyramidal neurons following learning and with normal aging. By systematically examining these cellular changes that occur following successful learning and with normal aging, a goal is to identify potential pharmacological targets to ameliorate and/or reverse the normal aging-related cognitive deficits. In addition, given that incidence of Alzheimer's disease increases with age, it is another goal of our research to translate our findings and approach to identify the cellular changes that occur in this debilitating condition.
1004377	My current clinical research interests include critical care medicine with a focus on the neurologically injured patient population.  However, as Medical Director of the Northwestern Memorial Hospital Emergency Response Team, I am also interested in the systems analyses of in-hospital resuscitation teams which are being described and investigated using an IRB approved research database.  Additionally, as Clerkship Co-Director of the NUFSM ICU M4 Clerkship, I have begun work on investigating the use of patient simulation in undergraduate medical education as an educational adjunct.
1004379	Carework, caring in long-term care, direct care workers, long-term care
1004379	Dr. Berdes, a sociologist, does research in the field of long-term care. She is involved in the study of person-centered care, particularly in the nature of caring relationships between people living in residential care and their paid caregivers.
1004381	I have focused my research and clinical career on the field of Pediatric HIV/AIDS, where I serve as Associate Director of the Section of Pediatric, Adolescent and Maternal HIV Infection at the Children's Memorial Hospital. As a member of the NIH-funded International Maternal Pediatric Adolescent AIDS Clinical Trial (IMPAACT) network, I am chairperson of domestic and international protocols investigating the pharmacokinetics, pharmacogenomics and efficacy of new antiretroviral agents and approaches to therapy for HIV-infected infants. In response to the growth of Pediatric AIDS in international settings, I have traveled to several African nations to train physicians about prevention of mother to child transmission of HIV and the scale-up of antiretroviral therapy for HIV-infected children. As Associate Chair for Education, I oversee the education mission for the Department of Pediatrics.
1004426	cancer, epidemiology, prevention, intermediate biomarkers, prostate cancer, breast cancer, diet, hormones 
1004472	Our laboratory has spent the past 15 years seeking to understand the mechanisms of fibrosis that occur in chronic, progressive kidney disease.  We have been studying the role of transforming growth factor (TGF-) because it has been associated with a number of kidney diseases.  However, the classically described TGF-/Smad signaling pathway is too simple to account for the multiple, sometimes contradictory effects of TGF- on cell function. Therefore, we have sought to understand how cell phenotype and the molecular signature of a cell determine whether TGF- signaling leads to fibrosis.  We have identified a number of non-canonical signaling pathways that interact with classical Smad signaling, and begun to establish the hierarchy among these pathways.  We are studying the manipulation of these pathways in vitro and in mouse models in an effort to translate our basic findings into therapeutic approaches to halting or preventing the progression of kidney disease.
1004570	Atopic dermatitis, blistering skin disease, basement membrane, animal model, cytokine, chemokine, autoimmunity, autoantibody, autoantigen, immunogenetic 
1004642	The research in the Ferreira lab is focused on the mechanisms underlying neurite degeneration and synapse loss in neurodegenerative diseases
1004646	Amyotrophic lateral sclerosis, Amyotrophic lateral sclerosis (ALS), Muscular dystrophies, Myasthenia gravis, Neurogenetic disorders, Neuromuscular diseases, Peripheral neuropathies
1004676	Neuroimmunology, demyelinating disease 
1004707	Dr. Levenson's laboratory concentrates on understanding the molecular mechanisms of development and progression of prostate cancer bone metastases. Her research focuses on understanding epigenic mechanisms of anticancer effects of the dietary compound resveratrol (found in red wine), and on exploring chemopreventive and chemotherapeutic potential of resveratrol in prostate cancer.
1004817	Dr. Lee's research interests include prostate biology, prostate cancer, cell differentiation, growth factor signaling, apoptosis, gene therapy, cell-cell interaction, TGF-beta, and benign prostate growth.
1004883	Dr. Jameson's research focuses on molecular endocrinology. His laboratory investigates fundamental mechanisms that control the transcription of endocrine genes. Concerted efforts are made to bridge laboratory studies with clinical endocrinology using recombinant DNA methods to investigate the pathophysiology of endocrine disorders.
1004883	Nuclear receptors, SF-1, Dax-1, Gonadal development, Transgenic mice, Reproduction, Thyroid
1004892	Care of patients with HIV infection, Primary care internal medicine
1004893	Dr. Kiang Liu received his BS degree in mathematics from Fu-Jen University, Taiwan, in 1970 and his PhD degree in statistics from the University of North Carolina, Chapel Hill, in 1976. That year, he joined the Northwestern University Feinberg School of Medicine as a postdoctoral fellow in the Department of Community Health and Preventive Medicine's training program in cardiovascular epidemiology, sponsored by the National Heart, Lung and Blood Institute (NHLBI). Following his post-doctoral training, he received a research career development award from the NHLBI in 1979 and became an assistant professor in the department. In 1983 he was promoted to associate professor, and since 1988 he has been a full professor in the renamed Department of Preventive Medicine. Dr. Liu's research interests are in cardiovascular epidemiology and statistical methodology for epidemiologic research, topics on which he has authored or co-authored more than 350 publications. He is Principal Investigator of the Chicago Field Center for the the Coronary Artery Risk Development in (Young) Adults (CARDIA) Study, an NHLBI-funded longitudinal collaborative study on lifestyle and evolution of cardiovascular risk factors in young adults.  He is also Principal Investigator of the Chicago Field Center of the Multi-Ethnic Study of Atherosclerosis (MESA), an NHLBI-funded longitudinal study on factors related to subclinical cardiovascular disease. He is also Principal Investigator of the MESA Family Study.
1004916	Flow Cytometry   Immunology<BR><BR> Diagnostic Test Development, Functional Flow Cytometry Test Development, Pediatric Immune Deficiency, Immune Regulation in Autoimmune disease
1005031	proteinase regulation, extracellular matrix proteolysis, adhesion molecules, ovarian cancer, oral squamous cell carcinoma, matrix metalloproteinases, plasminogen activators 
1005100	Research in the Longnecker laboratory focuses on herpes simplex virus (HSV) and Epstein-Barr virus (EBV).  These viruses typically cause self-limiting disease within the human population but both can be associated with serious complications. EBV is associated with variety of hematopoietic cancers such as African Burkitt's lymphoma, Hodgkin's and adult T-cell leukemia.  EBV-associated lymphoproliferative disease occurs in individuals with congenital or acquired cellular immune deficiencies.  The two notable epithelial diseases associated with EBV infection are nasopharyngeal cancer and oral hairy leukoplakia.  Similar to EBV, HSV latent infections are very common in humans.  HSV typically does not cause severe disease but is associated with localized mucocutaneous lesions, but in some cases can cause meningitis and encephalitis. The Longnecker laboratory focuses on several aspects of EBV and HSV replication and pathogenesis.  First, the molecular basis EBV transformation and how it relates to cancer is being investigated. The laboratory is currently screening selective inhibitors that may be beneficial in EBV-associated cancers such as Hodgkin's lymphoma and proliferative disorders that occur in HIV/AIDS and transplant patients.  Second, the laboratory is investigating herpesvirus latency in human host.  In this regard, the laboratory is developing animal models for EBV latent infections. Finally, the laboratory is investigating the function of herpesvirus encoded proteins that are important in for infection and the interactions required with cellular receptors required for pathogenesis. Ultimately, studies by the Longnecker may provide insight for the development of novel therapeutics for the treatment of herpesvirus infections in humans and better understanding of the herpesvirus life cycle in the human host.
1005132	depression, psychiatry, affective disorders, treatment, experimental models, circadian rhythms 
1005141	Clinical expertise: pain management. Populations include Complex Regional Pain Syndrome (also known as RSD), Fibromyalgia, neuropathic pain, pain in older patients, pain in rehabilitation diagnoses, Myofascial Pain Syndrome and headache. Research: primarily focused on the study of Post Amputation Pain, Spinal Cord Injury pain, Complex Regional Pain Syndromes, musculoskeletal pain, neuropathic pain, osteoarthritis and headaches. The Center for Pain Studies under his direction conducts pharmacological trials, outcomes development and validation and Model validation.
1005197	CLINICAL INTERESTS: Neuropsychological evaluation of adults including effects of subtance use and ADHD. Psychological evaluation of adults including psychotic, mood, and anxiety disorders. 
1005219	Organization, financing of health care, health law, child health 
1005227	Vestibular, Oculomotor, Vision, Otoliths, Neurophysiology, Neuroanatomy, Behavior, Electromyography
1005231	Gastrointestinal Disease and Surgery; Gallbladder Disorders, Hernia, Minimally Invasive Techniques, Skin Lesions
1005232	My current research interests include the administration of Substance P to improve allergen immunotherapy, the role of staphylococcal enterotoxins in the immunopathogenesis of chronic rhinosinusitis, TLR signaling in food allergy, and health disparities in asthma outcomes. Other research interests on which I have previously published include allergen immunotherapy, drug hypersensitvity, hypersensitivity pneumonitis, occupational asthma, and asthma in the disadvantaged elderly.
1005232	modification of allergen immunotherapy; immunopathogenesis of allergic diseases including asthma, rhinosinusitis & drug hypersensitivity; asthma disparities; asthma in the elderly; asthma & obesity
1005233	Full time Associate Director of the Integrated Graduate Program in the Life Sciences, the umbrella PhD program for the Feinberg School of Medicine at Northwestern University.
1005241	In vitro fertilization, Infertility, polycystic ovary syndrome, fertility preservation
1005250	Regulation of gene expression, especially functions and mechanisms of cis-acting elements; role of histone modifications in transcriptional regulation; functions of transcription factors; interactions between cis-acting elements, transcription factors and epigenetic changes
1005265	Our research aims to elucidate the mechanisms by which chronic activation of glia in the brain, especially astrocytes and microglia, leads to damage of the neurons and progressive neurodegeneration in diseases like Alzheimer's disease. The overall goal is to utilize knowledge of potentially 'druggable' pathways to develop new therapeutics. The normal role of the glia is to cooperate with the neurons to keep the brain operating smoothly. When an injury or change in the brain occurs, the glia mount an inflammation response to fight off the insult and restore the brain to its proper functioning. But in neurodegenerative diseases, the glia are over-activated, producing a state called neuroinflammation. Neuroinflammation can lead to nerve cell dysfunction or death, which is manifest as dementia. Although neuroinflammation appears to play a pivotal role in the development and progression of neurodegeneration, the molecular mechanisms underlying the process and approaches to downregulate the neuroinflammation have received little attention. 
1005304	The elucidation of eukaryotic signal transduction pathways, the study of signal transduction pathway perturbation in disease or injury, and the utilization of this knowledgebase for rational drug discovery and development.
1005318	herpesviruses, viral entry, cell fusion 
1005327	Treatment of arrhythmias in patients with repaired congenital heart disease, including adults. Surgical therapy of arrhythmias. Evaluation of autonomic dysfunction disorders in adolescents. Evaluation of patients with a family history of sudden cardiac death. Long QT syndrome.
1005411	Epidemiology of HIV infection Treatment of HIV infection
1005415	Sports Medicine
1005437	Clinical Interest:  Kawasaki Disease, Pediatric Infections, Infective Endocarditis, Rheumatic Fever, Group A Strep Infections, History of Medicine Research Interest: Dr. Shulmans research interest focuses on the epidemiology and antibiotic resistance of Group A streptococci and streptococcal and post-streptococcal illnesses. He is also involved in several aspects of Kawasaki Disease, including studies relating to the etiology, pathogenesis, and treatment of this disease. As chairman of the Infection Prevention and Control Committee, his interests also involve the areas of hospital and community epidemiology of pediatric infectious diseases and nosocomial infections. He is also interested in the history of medicine, particularly as relates to pediatrics and infectious diseases.
1005472	Abnormal PAP smears, Gynecologic surgery, Pelvic relaxation
1005483	Adolescent gynecology, General obstetrics and gynecology, Pediatric gynecology
1005622	Addictions psychiatry, Forensic psychiatry
1005723	Critical care medicine, Phrenic nerve pacers
1005724	Primary Care, Clinical Director, Resident and Medical Student Education 
1005807	Primary current concentration is in pediatric cardiology and echocardiography of congenital heart disease.  Interests also include telemedicine, outcomes research, epidemiology of congenital heart disease and medical education.
1005814	Diagnostic immunology, Renal pathology, Urologic cancers
1005815	Asthma, COPD
1005849	papillomaviruses, cervical cancer, epithelila cells, diffrentiation
1005925	Cataract surgery, Comprehensive ophthalmology
1005930	Gastrointestinal cancers, Breast cancer, Stereotactic Body Radiotherapy (SBRT), and Sarcomas
1005937	Surgical Pathology
1005994	Breast pathology, General surgical pathology
1006032	The Paller laboratory is investigating the role of gangliosides in keratinocyte function. Gangliosides are cell-specific sialylated glycosphingolipids of eukaryotic membranes that affect cell-cell recognition, cell-substratum interactions, cell growth regulation, differentiation, and oncogenic transformation.  Most recently, the Paller lab has been testing the role of gangliosides on wound healing.  In collaborative research with the Mirkin laboratory in the International Institute of Nanotechnology at Northwestern, the Paller lab is also investigating the ability of topically applied siRNA  conjugated gold nanoparticles as a single agent in gene suppression.  The laboratory has demonstrated ~100% uptake of the oligonucleotide- conjugated nanoparticles in cultured keratinocyte and excellent uptake through the epidermal barrier of mouse and human skin when topically applied, leading to gene knockdown in skin. Current studies are addressing knockdown through topical application of Ras-mediated epidermal hyperplasia, metastatic melanoma, diabetes, and genetic skin disorders.  Dr. Paller is also the director of cutaneous clinical trials research at Children's Memorial Hospital.  She has been involved in more than 70 clinical trials, and currently is conducting research on atopic dermatitis, psoriasis, localized scleroderma, and epidermolysis bullosa.
1006034	Stroke, Arm Dysfunction following stroke, Electrical Stimulation, Fitness following Stroke
1006055	1.  Clinical interests:  ' interstitial lung disease ' copd / asthma ' dyspnea ' drug-induced lung disease 2.  Research interests ' Mechanism of alveolar epithelial cell injury: role of iron-derived free radicals, the mitochondria, p53 and DNA damage ' Asbestos and airborne particulate matter
1006058	Dr. Greenland's research, teaching and clinical interests focus on the prevention of cardiovascular diseases. He has authored or coauthored 300 research papers, book chapters, and monographs on topics related to heart disease prevention, heart disease in women, and other aspects of heart disease. Dr. Greenland's current research involves heart diseases in women, risk factors for cardiovascular disease, peripheral vascular disease epidemiology, and prediction and early detection of CVD. Dr. Greenland was also Principal Investigator (PI) for several NIH-funded training programs including the Northwestern University Mentored Clinical Scholars Program (K12), and the Post-doctoral Training Program (T32) in Cardiovascular Disease Epidemiology and Prevention. He was PI for Northwestern's CTSA program from 2007-2012.
1006058	My research, teaching and clinical interests all focus on the prevention of cardiovascular diseases. My current collaborative research focuses on women's health, heart diseases in women, risk factors for cardiovascular disease, peripheral vascular disease epidemiology, and nutritional aspects of high blood pressure.  I am Principal Investigator for the NIH-funded 'CV and non-CV Risks in Four Cohorts.'I am also Principal Investigator of several NIH-funded training programs including the Clinical Research Curriculum Award (K-30), the Mentored Clinical Scholars Program (K-12), and the Post-doctoral Training Program (T32) in Cardiovascular Disease Epidemiology and Prevention. 
1006210	the role of nutrition in prevention and public health
1006247	Clinical Neurology with an emphasis on peripheral nerve disorders. We have also expanded our services to include pain management for those with neck and back disorders predominantly. Additionally, we have introduced vestibular testing and therapy for dizziness. Furthermore, we have a massage therapist who works with our pain patients and can also provide prenatal massage. Please check out our webpage: www.neurometriks.com
1006275	Blood banking, Transfusion medicine<BR><BR> Our transfusion service has a strong emphasis on the quality improvement of laboratory testing and clinical support. We were the first hospital in the US to install a newly approved system for full automation of pretransfusion testing, and we have implemented blood group genotyping in the transfusion service as a routine part of our antibody problem-solving. We have implemented innovative systems for managing blood component recalls and preventing errors in transfusions and organ transplants. Our work has been published in a broad range of areas in transfusion medicine and immunohematology, and we have contributed recurrent chapters to several widely read textbooks. Through various professional and federal committees, we have contributed to national forums for blood banking policies, accreditation, and disaster planning.
1006301	Chronic pain syndromes, Stereotactic radiosurgery, Tumors of the brain and spine
1006308	My primary research interest involves understanding the mechanisms by which extracellular matrix influences the behavior of keratinocytes and lung cells.
1006346	Inflammatory arthritis, General rheumatology, Regional musculoskeletal disorders
1006385	Dr. Zelko has conducted research on neurocognitive functioning with a number of pediatric populations including epilepsy, lupus, kidney disease, liver disease, and spina bifida, and has a number of publications and scientific presentations.  He is presently participating in multi-site studies of the cognitive sequalue of sickle cell disease, pediatric lupus, childhood absence epilepsy, chronic kidney disease, liver transplant, peditric cancer, and phenylketonuria.  His primary focus at present is upon pediatric epilepsy, with a particular emphasis upon attention and executive skills deficits.
1006470	Dr. Ford-Paz is the Coordinating Psychologist of the Mood & Anxiety Program at Children's Memorial Hospital and provides evidence-based evaluation and individual, family, and group cognitive behavioral therapy in Spanish and English for a variety of anxiety and depressive disorders.  Dr. Ford-Paz also has clinical and research interests in the reduction of mental health disparities for Latino youth and families. More specifically, she is interested in the cultural adaptation of evidence-based treatment to improve treatment retention and outcomes for Latino youth. Currently, she is involved in community-based participatory research with 3 agency partners: Healthcare Alternative Systems, Alternatives, Inc., and Alivio Medical Center to target the prevention of depression in Latino youth.
1006492	General diagnostic radiology
1006495	I am interested in the development of teaching resources for undergraduate medical education.  I have authored an embryology book and co-authored an imaging book, created two websites for imaging and radiologic anatomy, a website of electron micrographs, and converted the M1 histology laboratories from the use of microscopes to the study of digital slides.
1006570	CLINICAL: Melanoma and Skin Cancers; Sarcoma and Soft Tissue Tumors; Breast Cancer; Sentinel Node Biopsy, Locally and Regionally Advanced Melanoma, Isolated Limb Infusion                            RESEARCH: Surgical Health Services, Outcomes, and Quality Improvement Research; Oncology Quality Measurement; Melanoma Quality and Outcomes Assessment
1006593	Abdominal wall reconstruction, hernia repair, breast reconstruction, hand surgery, treatment of hand ischemia, peripheral nerve surgery, surgery for amputees, reconstructive microsurgery
1006601	Quantitative MR strategies for in vivo measurement of structural and functional status. Early HIV infection. Risk factors and biomarkers (particularly cytokines and chemokines)of brain injury and cognitive decline in HIV infection and in CNS disorders.
1006641	I am a member of a group of investigators under the leadership of Leema Sharma, MD and funded by the National Institutes of Health to study mechanical influences on the progression of knee osteoarthritis.  
1006773	1. Severe Asthma-We are investigating the associated conditions and immunologic mechanisms of excessive loss of lung function in patients wtih 'irreversible asthma'-a condition first described here.  2. Drug Allergy-We are continuing our series of penicillin testing and protocol development for patients allergic to newer agents including immunomodulatory therapies.  3. Allergic Bronchopulmonary Aspergillosis-Our series of patients is over 25; we are testing the notion that impaired responses by the innate immune defenses allow for Aspergillus fumigatus to escape containment and grow in the bronchial mucus. We continue to explore the utility of recombinant Aspergillus fumigatus allergens for diagnostic testing. 4. Reduction in allergic antibody in human allergic subjects- we are testing the notion that the combination of the neuropeptide, Substance P with low dose allergen administration can decrease the immediate cutaneous and clinical reactivity. The initial results of 8 allergic rhinitis subjects have been published. There is an active IND with the FDA, and we are enrolling more subjects for the controlled study and investigation into the mechanisms involved. 
1006773	Allergic bronchopulmonary aspergillosis, Anaphylaxis, Drug allergy, Severe asthma, Urticaria. Suppression of allergic antibodies in human subjects.
1006778	Addictions psychiatry, General adult psychiatry, Mood Disorders, Psychopharmacology
1006781	Family and Cosmetic Dentistry including veneers, crowns, implants, dentures, root canal, TMJ disorders, periodontal (gum) diseases, dentistry with sedation, sleep apnea , upper airway resistance syndrome, snoring
1006815	The three fundamental goals of my research are the following: 1) To understand the nature of the brain's own signals -- the 'language' in which movement commands are expressed by neurons in the central nervous system. 2) To understand the mechanisms by which these signals are produced -- the nature of the connections among networks of neurons, and the transformations that occur in the signals as they propagate throughout these networks. 3) To develop applications of these basic principles that could be of therapeutic value to human patients. Much of this work is done in collaboration with students and faculty from the Biomedical Engineering Department and the Interdepartmental Neuroscience Program (NUIN).
1006832	Injury epidemiology, injury prevention 
1006854	Patientsafety/medical error, Iatrogenesis
1006854	Research Interests include funding and delivery of health care and health disparities.
1006865	Neurobiology of the mammalian spinal cord 
1006981	Dr. Schaeffer's clinical and research interests involve urinary tract infections, prostatitis, and chronic pelvic pain syndrome.
1007010	I practice primary care sports medicine, a newer field geared towards the non-surgical management of muskuloskeletal complaints.  Currently a team physician for the Chicago Bears (NFL) and US Soccer Men's National Team.
1007084	ARDS, Sepsis, Cystic fibrosis, mechanisms of fibrosis in lung disease.
1007084	Director of Adult Cystic Fibrosis Services
1007103	Prevention, detection and treatment of child maltreatment with a special interest in clinical decision making in the office setting.  I am also interested in the influence of childhood adversities on child health.
1007161	Multiple pregnancy has long been a major focus of my work in which I have co-authored 5 definitive monographs.  Recently, my interests have turned to all aspects of the prevention and treatment of post-partum hemorrhage.
1007168	Dr. Pachman's translational team studies juvenile dermatomyositis (JDM), an often chronic pediatric systemic vasculopathy associated with skin inflammation and proximal muscle weakness of unknown etiology. Her laboratory has identified genetic and environmental factors that play a role in the onset of symptoms and govern outcome. The TNF-a-308 promoter A polymorphism is associated with prolonged disease course. Increased production of TNF-a protein is associated with the A allele throughout disease course, in contrast to serum levels of IFN-a activity, elevated early in the disease. Gene expression micro array studies of untreated children's diagnostic muscle biopsies identified massive dysregulation of IFN-a induced genes in JDM, similar to anti-viral immune model, which also shared features of the IFN-a signature characteristic of systemic lupus erythematosus (SLE). Epigenetic and miRNA studies of diagnostic muscle biopsies indicate critical differences associated with disease duration. Dr. Pachmans search for clinically useful biomarkers of immune activation has identified CD3- natural killer cells and von Willebrand factor antigen, released from damaged endothelial cells.  With chronic inflammation, progressive endothelial damage is reflected by loss of nailfold capillary end row loops (they developed a quantitative system of analysis)associated with lack of absorption of oral prednisone.  In addition, her lab maintains a patient-derived sample repository of diagnostic muscle and skin biopsies, sequential sera, peripheral blood lymphocytes, lymphocyte culture supernatant fluid, and dystrophic calcifications samples keyed to a sequential database and an analytical database software and bio-informatics system.  In summary, this intensive research effort broadens the clinical, genetic and immunological characterization of the child with JDM, which is a critical aid in guiding current therapy and may lead to novel targeted interventions.
1007177	I am interested primarily in the therapeutic action of psychoanalytic therapy.  I investigate from a clinical perspective what factors are decisive in changing psychic experience and psychic strucuture.  To this end, I use object relations theories.  My theoretical work has been focused on applying these theories, in all their iterations, to the therapeutic process.  My secondary interest is in the application of psychoanalytic thinking to social and cultural issues. 
1007180	Psychotherapy, Psychoanalysis 
1007188	General urology, Prostate cancer, Urologic oncology
1007196	My research interests include outcome measure development, evaluating the impact of chronic diseases (particularly neurological) and their treatments on patient-reported and clinical outcomes, and using health information technology to improve quality of care and patient outcomes.
1007298	Regional Anesthesia in Children Pain Management in Children 
1007337	breast, cancer, tumorigenesis, estrogen, receptor, coactivator, transcription, regulation, knockout, transgenic <BR><BR> To understand the role of nuclear receptor coactivators in regulation of cell specific gene transcriptional activation by estrogen receptor, and how the interruption to this regulation contributes to breast tumorigenesis.
1007375	Addictions psychiatry, Chemical dependence
1007378	Martin McCarthy is a health psychologist and a health services researcher with two main interests -- the use of behavioral and information technologies in health promotion and the assessment of patient-level outcomes of medical care. Dr. McCarthy holds an AB degree in History from Georgetown University, an MA in Experimental Psychology from Columbia University, a PhD in Community Psychology from New York University, and he completed a Post-Doctoral Fellowship in Health Psychology at Northwestern's Feinberg School of Medicine. He is a trained psychotherapist and is licensed to practice as a clinical psychologist in New York State and in Illinois. Previous academic appointments were at the Center for Health Services and Policy Research at Northwestern University, the Center for Geriatrics and Gerontology in the School of Public Health at Columbia University, and the Milhauser Laboratories at New York University Medical Center. Internet-based multimedia interventions have been developed for use in health plans, clinics, school systems, and patients' homes. Projects have focused on reducing childrens experimentation with tobacco products, preventing sexually transmitted diseases in adolescents, promoting skin cancer control in a range of age groups, improving management of risk factors in diabetic patients, promoting the early detection of breast cancer in older women, teaching multimodal pain management to patients with acute and chronic back injuries, and preventing and managing depression in patients with comorbid health problems. Health services research projects focus on the assessment of functional status, health-related quality of life, and psychosocial risk factors via Computerized Adaptive Testing. Previous studies have examined the impact of processes and structures of care on outcomes of cardiac surgery; outcomes of laparascopic and open surgical procedures; and behavioral risk factors in the epidemiology of cardiovascular disease. 
1007424	Doctor Spatafora is Assistant Professor of Clinical Psychiatry at Northwestern University Feinberg School of Medicine, and he supervises psychiatry resident trainees at Northwestern Memorial Hospital. He maintains a private psychiatric practice, seeing individuals both for psychotherapy and pharmacotherapy. His sub-specialty training is in Addiction Medicine, and he serves as the Medical Director of the National Football League Program for Substances of Abuse. In his clinical approach, he strives to understand individual patients based both upon science-based knowledge and upon the evidence that emerges within the care of the specific individual.
1007443	Clinical research involving tuberculosis and other HIV-related infections.  
1007508	Abnormal gynecological bleeding, Fibroids, Vaginitis
1007711	Stroke rehabilitation, neurorehabilitation, geriatric rehabilitation, outcomes research, medical comorbidities
1007774	My clinical interests are in pediatric neuro-oncology and tumors in patients with Neurofibromatosis Type I. The focus of my research is on biomarkers in CNS tumors.  In particular, I am interested in microRNAs as disease markers in central nervous system tumors.  I also conduct a research study investigating the utility of acupuncture in pediatric patients with CNS Tumors.   As a team, we also participate in phase I, II and III trials for new agents in the treatment pediatric brain and spinal cord tumors.
1007928	Dr. Kaplan specializes in pediatric urology, pediatric neurourology and urodynamics, and pediatric genitourinary reconstruction.
1007950	Medical care of the patient with diabetes, Medical care of the patient with hypertension, Primary care internal medicine
1007979	I maintain an active practice focusing primarily on Cornea and External Eye Disease.  I have a high volume of cornea transplantation patients and am amongst the first in the nation to perform modern endothelial keratoplasty surgery.  I also continue to explore areas of corneal stem cell transplantation and traditional corneal transplantation, infectious disease, and oncology of the ocular surface.
1007992	Erectile dysfunction (ED) is a significant medical condition and current treatment options are ineffective in diabetic patients and in prostate cancer patients treated by prostatectomy.  Sonic hedgehog (SHH) is an essential regulator of penile smooth muscle, cavernous nerve (CN) integrity and CN regeneration that has significant potential to be developed as a treatment to prevent ED by regenerating the CN and by suppressing penile apoptosis.  In our laboratory we examine fundamental mechanisms that underlie cavernous nerve regulation of penile morphology during development, how these mechanisms become altered with peripheral neuropathy of the cavernous nerve in diabetic rats and how manipulation of SHH signaling can be used to speed cavernous nerve repair in diabetic models.  
1008044	Dentin phosphophoryn (DPP), the major noncollagenous protein of tooth dentin matrix is synthesized as dentin sialophosphoprotein (DSPP) by the mesenchyme-derived odontoblasts. We have found a spatio-temporal expression during mouse embryonic development in cells of epithelial origin. At day-13 of embryonic gestation, DPP was localized to the enamel organ at  the developing tooth cap stage, with heaviest immuno-histochemical staining at the oral ectoderm but was also prominent in the inner enamel epithelium. Interestingly, at the same embryonic stage, DPP was also expressed in the ureteric bud branches of the metanephric kidney and in the alveolar epithelial buds of the developing lung. No expression was seen in the mesenchymal component of either organ. Interestingly inclusion of anti-DPP antibodies in E-13 organ cultures of kidneys harvested from wild type mice, altered ureteric bud morphogenesis and caused looseness of the metanephric mesenchyme. These findings suggest that besides its role in mineralization of the dentin, DPP modulates epithelial-mesenchymal interactions in meristic tissues during embryonic development. Another focus in our laboratory has been studies directed towards understanding the mechanism of mineralization in vertebrate tissues such as bone and tooth and in sea urchin tooth in invertebrates and the role of extracellular constituents of connective tissue in this complex process.  The acidic protein constituent part of extracellular matrix has been implicated in mineral deposition but the precise series of molecular reaction mechanism remains undefined. In invertebrate systems, where the mineral part is calcite or aragonite the mechanisms of molecular calcification remains even much less understood compared to vertebrates where mineral deposition is chiefly calcium hydroxyapatite. We are studying whether it is the nature of the protein or environment that determines whether we get Calcium Carbonate  or Calcium Phosphate crystals
1008161	Primary research interest in using structural biology to further understanding of signal transduction systems.
1008164	Breast cancer clinical/translational trials investigating novel chemotherapeutic agents , endocrine therapy and targeted therapy.  These trials are conducted in the advanced and early stage disease setting
1008164	Breast cancer, Sarcoma
1008165	Anxiety disorders, Medical education
1008334	Most of my research has focused on improving clinical care for obese children. Thus, I have first-hand experience in the bi-directional processes of integrating research knowledge into clinical care and developing research questions based on clinical experience. I have past experience mentoring research of students and young investigators. I have participated in pediatric practice-based research through the Pediatric Practice Research Group (PPRG) and have been the Associate Director of the PPRG for the past 9 years. As principal investigator and co-investigator for research projects funded by federal and private agencies. I have completed a wide range of studies through the PPRG, including studies of prevalence, natural history, perceptions, screening, and interventions evaluating changes to practice operations that foster clinical care improvements. I am particularly interested in identifying ways for effective preventive care delivery in primary care settings, with special emphasis on identifying clinical care concerns among Hispanic families and identifying ways to address their needs.
1008360	blood coagulation, thrombolysis, cataract, neurodegenerative disease, celiac disease, transglutaminases, cell aging, proteolytic enzymes, apoptosis, terminal differentiation 
1008377	As a practicing pediatrician, I spend a great deal of my time educating children and their families about good nutrition and weight management. 
1008387	My research and public policy interests include health informatics standards, security, and adoption; public health informatics; public health emergency preparedness and response; communicable disease epidemiology; and HPV immunization.
1008443	I am interested in pediatric emergency medicine.  My interests included, medical liability, disaster planning and appendicitis.
1008614	Primary research and clinical interest in female infertility including the impact of infertility on mood and functioning.  Also, psychological aspects of ooycte donation. 
1008667	Adult Congenital Heart disease Heart disease and Pregnancy with ongoing research in Preconception evaluation Women's cardiovascular health during her lifetime
1008692	General infectious disease, HIV infection
1008791	Prevention of traumatic brain injury induced immune cell apoptosis
1008881	Diabetes complications of the eye, PDT laser treatment, Vitreo-retinal diseases
1008921	Primary care internal medicine, Women's healthcare, intimate partner violence
1008931	Pediatric neurosurgery with special interest in pediatric brain tumors
1008950	I am interested in ensuring the health and well-being through my clinical care of newborns.  I am also interested in developmental outcomes of high-risk newborns.
1008963	Neurologic communication disorders, aphasia, traumatic brain injury, right hemisphere stroke, discourse, neglect
1008970	The major cause of mortality from prostate cancer is metastatic disease for which there is currently no effective cure.  For reasons that remain incompletely understood, bone is the most common site for prostate cancer metastasis.  Reciprocal signaling between invading prostate cancer cells and host bone stromal cells is central to metastatic tumor development.  Understanding these cell-cell interactions will lead to effective diagnostic and therapeutic strategies to prevent/arrest metastatic spread of prostate carcinoma. My current research stems from the hypothesis that prostate cancer cells and bone cells interact via the hedgehog signaling pathway to promote bone metastasis.  Sonic hedgehog (Shh) is a member of the hedgehog family of ligands that activate an intracellular signaling cascade upon binding to transmembrane receptors (Patched) leading to transcriptional regulation of specific target genes by the Gli family of transcription factors.  Our previous work has demonstrated that Shh-expressing epithelial cells and Gli-expressing mesenchymal cells in embryonic mouse prostate interact via the Shh-Gli pathway to promote cell proliferation and ductal morphogenesis.  We have also shown that the genes for Shh and Gli are expressed in human prostate cancer, and that Shh-expressing prostate cancer cells and Gli-expressing stroma collaborate to promote prostate tumor growth in a mouse xenograft model.  Our present research extends these observations and investigates signaling interactions via the Shh-Gli pathway between prostate cancer cells and bone cells to promote prostate carcinoma metastasis, using both in vitro and in vivo models.
1008991	Cutaneous T-cell lymphoma, Dermatopathology, Skin cancer prevention and detection
1009039	cancer, aging, senescence, stress resistance, cell death, life span, aging associated diseases. 
1009098	My clinical interests are in long- and short-term, psychodynamically informed psychotherapy with both high-functioning and severely mentally ill adult outpatients, marital/couples therapy and clinical supervision.  My research interests include psychoanalytic theory, gender theory, fantasy, creativity, psychodynamically-informed developmental theory, the relationships between clinical work, psychological theory, and the arts and humanities, psychoanalysis and culture theory, and psychoanalytic politics.
1009110	Investigations of nerve cell behavior in vivo and in vitro; live cell imaging; phototoxicity
1009129	Rheumatoid arthritis
1009168	aging, age-related memory loss, synapses, synapse number, synapse structure
1009325	Cosmetic, Reconstructive breast surgery, Reconstructive surgery
1009330	I am a computer programmer and database manager involved in long-term observational studies in the field of cardiovascular epidemiology.  I have been associated with the Western Electric Study (WE), Chicago Heart Association Detection Project in Industry (CHA), CARDIA, MESA, Womens Health Initiative, the Walking and Leg Circulation Studies, the Chicago Healthy Aging Study (continuation of CHA), and the Hispanic Community Health Study / Study of Latinos as well as many clinical trials in cardiovascular disease prevention.
1009340	I am interested in how robotic interactions can be used to improve reaching performance. My methods involve dynamic modeling, optimization, robotics, and adaptive control. Applications include rehabilitation of brain injured individuals. 
1009343	Antimicrobial resistance, Infection of the immunocompromised host, Nosocomial infections
1009343	My research interests have focused primarily on the epidemiology of healthcare associated infections and antimicrobial resistance.  Specifically, this includes investigations into the epidemiology, transmission and management of vancomycin resistant enterococci as well as other multidrug resistant bacteria.  More recently, my focus has expanded to include research into patient safety.  This includes understanding the epidemiology of medication errors and other adverse events associated with hospitalization.
1009346	My main clinical and research interests involve radionuclide imaging and therapy, including but not limited to general Nuclear Medicine imaging and therapy, positron emission tomography (PET) and PET-CT imaging, molecular imaging and Nuclear Cardiology. 
1009347	I am Chairman of Panel C of the Institutional Review Board at Northwestern, and CoChair of the combined Northwestern/University of Illnois VA IRB. I have a private practice with and emphais on Adult Attention Deficit Disorder and Mens Health.
1009379	My clinical interest is in long and short-term psychodynamic psychotherapy with adult outpatients.  I am particularly interested in the developmental sequelae of trauma and loss on later personality functioning and attachment/relationship patterns, as well as the therapeutic factors that affect change.  I am also interested in providing clinical supervision. 
1009475	Bone Health and Osteoporosis Clinical densitometry 
1009475	Dementia, Osteoporosis
1009528	I have a particular interest in anesthesia for ENT surgery and resident education.
1009559	Identify children at risk CAD.  Utlize the new NHLBI guidelines (member expert panel) to reduce cardiovascuar disease in children and adolescents. Provide tools, support, and acknnowledgement for pediatric office based education and to engage community pediatricians to provide more teaching to medical students, residents, and other trainees.
1009562	Epidemiologic characteristics and health service needs of special populations, HIV/AIDS risk behaviors, and mental health service utilization 
1009564	Chronic mental illness, General adult psychiatry, Schizophrenia
1009628	I am especially interested in anxiety disorders and their link to other health concerns, including cardiovascular risks, autoimmune diseases, and obesity.  I am also interested in an integrated approach to psychiatric problems that encompasses more in depth integration of biopsychosocial aspects.  Finally, I am especially interested in communicating effectively complex ideas related to my profession to medical/professional colleagues in related or other diverse fields and the public at large.  My published essays reflect my ability to reach a diverse audience.
1009779	Dr. Pope directs a basic science laboratory, which is focused on rheumatoid arthritis, a disease that affects women much more commonly than men.  Dr. Pope's laboratory has focused on characterizing the basic mechanisms that contribute to the pathogenesis of rheumatoid arthritis.  The work focuses on the role of macrophages and synovial fibroblasts.  His studies are directed at defining the mechanisms that promote resistance to apoptosis or programmed cell death.  They are aimed at defining the potential role of the induction of apoptosis as a therapeutic approach in this disease.  To this end his laboratory is characterizing the mechanisms that protect rheumatoid arthritis macrophages and synovial fibroblasts from apoptosis.  Investigators in his laboratory identified the upregulation of the anti-apoptotic protein, Flice Like Inhibitory Protein (FLIP), during monocyte to macrophage differentiation.  They have demonstrated that FLIP is highly expressed in the rheumatoid joint and is responsible for protecting rheumatoid arthritis macrophages from Fas-mediated apoptosis.  His laboratory is further characterizing the mechanisms for the basal expression of FLIP, and that observed following activation by cytokines and toll-like receptor ligands.  Further, studies are aimed at defining the mechanisms of macrophage cell death that occurs following TNF or Toll-like receptor ligation when NF-kB activation is suppressed.  The aim of these studies is to identify potential therapeutic targets for intervention in rheumatoid arthritis.  Additional studies are directed at determining the role of Fas-Fas ligand interactions on the promotion of chronic inflammation, which occurs by sensitizing the macrophages to activation through the Toll/IL-1 receptor pathway.  Additional studies have identified Mcl-1, another Bcl-2 family member, which is critical for the survival of macrophages and synovial fibroblasts.  Studies have demonstrated that Mcl-1 is highly expressed in the rheumatoid joint, in both macrophages and synovial fibroblasts.  Ongoing studies are directed at defining the unique mechanisms that control the expression of Mcl-1 in macrophages and synovial fibroblasts.  Both cell types appear critically dependent on Mcl-1 for survival and ongoing studies are aimed at defining the potential role of modulating mcl-1 expression or function as a therapeutic target in experimental models of rheumatoid arthritis.The goal of this program is to develop new therapies, employing apoptosis as a therapeutic tool.  Dr. Pope s laboratory also collaborates with Dr. Ramsey-Goldman, developing and performing some of the assays used to evaluate osteoporosis in her patients with lupus.  These include assays to quantitative osteoprotegerin and Rank ligand as well as microarray analysis of monocytes and macrophages from patients with lupus.  
1009779	Rheumatoid Arthritis, Macrophage, Apoptosis, Cytokine, Gene Regulation 
1009786	Primary interest is in childhood bereavement.
1009999	Extensive experience in Cleft Lip and Palate and Craniofacial Surgery. Director: Head Shape Evaluation Program This is a multispecialty clinic dedicated to the evaluation and treatment of children with congenital and acquired deformities of the craniofacial skeleton.
1010008	Research Interests: Organizational behavior, translational research/implementation of evidence into clinical practice, long-term care and utilization of health care services, including community care, assisted living and nursing home care. Spinal cord injury - variability in proactive, self-management, prevention of pressure ulcers.
1010177	genomics, genome, genome structure, genome annotation, transcriptome, SAGE, gene identification 
1010207	prosthetics, orthotics, rehabilitation engineering 
1010213	My primary clinical and research interests include Neuro-ophthalmologic problems such as double vision, optic nerve problems and vision problems related to neurologic or neurosurgical problems such as tumors, trauma and strokes.  My surgical interests include refractive procedures; such as LASIK and PRK, cataract surgery; including presbyopia (reading) corrective intraocular implants and eye muscle surgery; for patients with double vision or strabismus (abnormal eye alignment).
1010235	diet, nutrition, prevention, treatment, cardiovascular epidemiology, breast cancer, child health, obesity prevention, obesity treatment, maternal nutrition, nutritional assessment, diet intervention, Medical Nutrition Education
1010236	Acute myocardial infarction, Angioplasty, Coronary disease, Interventional cardiology, Rotablator, Stents
1010239	My primary clincal and research interest is in the field of fetal cardiology. I am interested in advancing screening fetal echocardiograms in addition to continuing my research in fetal arrhythmias, congenital heart disease, and pulmonary hypertension in the neonatal period.
1010249	Dr. Moretti has had a career-long interest in the applications of hypnosis, meditation, biofeedback, and relaxation training to various disorders. As a psychotherapist, he uses both analytic and cognitive behavioral methods, tailoring the approach to the individual needs of the patient.
1010263	Contributed a large body of work to the literature addressing the diagnosis, biology, and treatment of acute leukemia and other hematologic malignancies.  This work includes original research articles in peer-reviewed journals, textbook chapters and reviews, monographs, editorials and abstracts.  He has spoken as an invited lecturer and chair at many national and international symposia, conferences, and meetings, including the American Society of Hematology and American Society of Clinical Oncology Annual Meetings.   
1010263	Hodgkin's disease, Leukemia, Lymphoma, Transplantation
1010271	Psychological reactions and coping with medical problems; Biofeedback and Neurofeedback therapies; Health and wellness assessment; Health psychology program evaluation 
1010291	pediatric oncology, neuroblastoma, angiogenesis, clinical trials, tumor biology  
1010292	Cardiovascular anesthesia, Thoracic anesthesia, Transplantation anesthesia
1010302	My primary interests are in physical activity in aging. Promoting physical activity in the community in collaboration with community based organizations.  I am also interested in community based interventions for older adults with osteoarthritis.  Finally, how physical therapists can contribute to health promotion for older adults.
1010352	Gastrointestinal cancer surgery, Melanoma / sarcoma, Pancreatic / liver cancer  surgery, Surgical oncology
1010367	Bronchoscopy, Exercise physiology, Lung cancer
1010477	My research is focused on sensory neuroscience with special interest in espins, a novel family of multifunctional actin-bundling proteins. These proteins are present at high concentration in the parallel actin bundle of hair cell stereocilia, in the microvilli of taste receptor cells, solitary chemoreceptor cells, vomeronasal sensory neurons and Merkel cells. Mutations in espin gene cause deafness and vestibular dysfunction in mice and humans. I am investigating the effect of these mutations on the sensory systems during development and adulthood.  
1010479	Development of cochlear implants including novel devices based on neural infrared stimulation, use of laser in clinical settings, micromechanics of the cochlea, imaging
1010557	Ischemic heart disease
1010571	Certified Registered Nurse Anesthetist, Advance Practice Nurse; Liver Transplantation, Neurosurgical Spine Surgery, Outpatient Anesthesia and General Anesthesia.
1010600	Prosthetics, Orthotics, Mechanics, Rehabilitation
1010604	High risk pregnancies, HIV infection - perinatal, Perinatal infectious disease
1010952	Microbiology/Virology <BR><BR> My research work is focused on studying the mechanisms that regulate the transcriptional activities of nuclear receptors. Nuclear receptors are transcription factors involved in regulation of many biological processes. In order to initiate transcription, additional factors are required to interact with nuclear receptors and to regulate their activities. These factors are collectively called as nuclear receptor co-factors. Several such co-factors have been identified by our studies. Generating mouse models using gene targeting technology to investigate the functions of these genes is in progress.
1011026	Neonatal infectious diseases, anemia/erythropoietin, nutrition for sick newborns. 
1011040	Pre - hospital emergency care
1011074	CBT for mood and anxiety disorders in adolescence and adulthood 
1011077	Community health, safety-net health care, preventive services, health care delivery.
1011092	Dr. Lee is interested in coronary artery disease, ischemic and structural heart disease, cardiac stress testing, nuclear cardiology and cardiac magnetic resonance imaging (MRI). Dr. Lee has extensive experience with cardiac imaging and how it impacts the diagnosis and management of patients with cardiovascular disease. He is also the recipient of research grants from the American Heart Association and St. Jude Medical, Inc. His research focuses on cardiac MRI in acute and chronic ischemic heart disease, valvular heart disease, ischemia evaluation, drug/device treatments and prevention.
1011095	We are currently studying the anatomy and physiology of myocardial scar (infarction) and how this predisposes to ventricular tachycardia. We are utilizing advanced mapping systems to develop more effective ablation techniques for this arrhythmia.
1011128	General surgical pathology, Pulmonary pathology<BR><BR>
1011185	My research interests are to understand the neuro-mechanical factors related to disease onset, disease progression, physical function, and pain in knee osteoarthritis; and to develop and implement novel intervention strategies to address these underlying neuro-mechanical factors and to delay disease progression, improve function and pain.
1011244	Ethics & economics of organ transplantation, Kidney transplantation, Living donor kidney transplant
1011272	Atrial fibrillation, Arrhythmia detection, Computerized ECG, Arrhythmia mapping, Signal processing for arrhythmias
1011279	normal swallowing physiology, speech/swallowing dysfunction, voice disorders
1011314	The quality of parent-child relationships during infancy has long-term and significant implications for a child's healthy adaptation. Primary care pediatricians have unique opportunities to support early family relationships because of their repeated encounters with families for well child care. My research and teaching interests have been focused on how emerging parent-infant relationships can be supported by pediatricians and on the impact that the quality of those relationships can have on the practice of primary care pediatrics. In the initial phase of my research, I developed and validated a research protocol for observing and understanding meaningful patterns of interaction that occur between parents and infants during well child visits. Next, I modified the observational system for clinical use, integrated it into Developmental-Behavioral Pediatrics training for pediatric residents and studied its influence on recognition, guidance and documentation in well child care visits. My present interests revolve around exploring mechanisms by which the parent-child relationship may contribute to aspects of child health and behavior that are integral to the provision of comprehensive pediatric primary care. I am currently exploring whether there are pathways that include parent-child relationship quality that predict early childhood obesity. I hope this research will lead to identifying families with children at-risk for early obesity who might benefit from early intervention targeting parent-child interactions, parental sensitivity to infant cues and, more broadly, parent-child relationships in lieu of, or in addition to, traditional interventions for obesity. A second line of current research examines parental perceptions and actions around early infant regulation. The purpose of this study is to explore the relationship of feeding methods, parenting practices, parent and infant characteristics on the development of infant regulation over the first 18 months.
1011512	Arthritis disorders of the Hip and Knee including Joint Replacement surgery of the Hip and Knee; Bone health and Osteoporosis issues in orthopaedic patients
1011521	Dr. McGaghie's research and scholarship address medical and health professions education, esp. skill acquisition and maintenance, outcome measurement, simulation technology, faculty development, and team science. 
1011552	As a clinical psychologist, I am interested in growth and development throughout the life span.  My clinical training has ranged from childhood to older adult development and treatment.  My publications focus on child therapy as well as childless older adult women.
1011559	Project 1. Atherosclerosis - the main cause of cardiovascular disease - is now understood to result from a chronic inflammation of large arterial blood vessels superimposed upon by high plasma LDL levels, as well as other risk factors. Plasma LDL levels are controlled, in part, by the rate of their clearance from circulation. About 60% of the LDL cleared fron the plasma occurs through the mediation of the LDL receptor, mainly in the liver. The remaining is cleared by an as yet uncharacterized hepatic LDL receptor-independent mechanism. We are currently investigating the possibility that the LDL receptor-related protein 6 (LRP6), a trans-membrane co-receptor for Wnt signaling, mediates the clearance of LDL from the plasma.  Project 2. Considerable evidence suggests that auto-immunity plays a significant role in the development of atherosclerosis. In collaboration with Dr. Stephen Miller (Microbiology) we are investigating the effectiveness of tolerance-induced by atherosclerosis-specific antigen-coupled cells in preventing the formation of atherosclerotic lesions in mouse-models of this disease.  .
1011587	Psychomatic Obstetrics and Gynecology and Women's Developmental Issues during childbearing years:  Psychological aspects of fertility, pregnancy, loss, parenting, aging, breast and gynecological cancer; pharmacologic questions regarding psychotropic exposure in pregnancy and lactation; hormonally mediated mood disorders. Psychiatric care of medically ill patients.
1011595	Apinal oncology, Complex spine surgery, Deformity and reconstructive spine surgery, Rheumatoid diseases
1011618	Neuro-immune and bacterial mechanisms of bladder inflammation. 
1011643	Trauma psychiatry Interpersonal relationships Bipolar disorder Anxiety disorder Grief counseling  Career and peer issues/relationships Comprehensive Psychiatric Second opinion evaluations
1011657	Cardiovascular anesthesia, Thoracic anesthesia, Transplantation anesthesia
1011750	Dr. Ma' clinical and research interests are focused on chronic lymphoid malignancies,including chronic lymphocytic leukemia and non-Hodgkin lymphoma.  Dr. Ma directs the translational research initiatives in chronic lymphocytic leukemia (CLL) to develop and study novel treatment agents for the treatment of CLL. Her translational investigations have included novel biologic agents, mechanisms of drug resistance and immunotherapy. Dr. Ma is the Principal Investigator for a number of investigator-initiated and industry-sponsored clinical trials studying new exciting treatments agents for CLL and lymphoma. She collaborates with investigators at Northwestern University, other US institutions and international institutions in developing novel therapeutic approaches in hematologic malignancies.
1011815	Dermatopharmacology
1011821	AIDS / HIV related, Breast cancer, Palliative Care
1011822	My two current intersts/areas of subspecialization are working with adults who have personality disorders (usually people in their 30s who are having trouble sustaining intimate relationships or satisfying careers) and with couples.  I do both psychoanalysis and conjoint couples therapy.  My interest in the problems of couples has led to my creating and teaching an undergraduate course at Northwestern, 'Marriage 101: Building Loving and Lasting Relationships.'  I am a coauthor of a paper on how couples therapists and individual therapists can collaborate.
1011837	Cataract and Implant Surgery, Glaucoma Medical and Surgical Management, Laser Surgery, Early Detection Glaucoma
1011901	At Northwestern Memorial Hospital, Dr. Slutzky sees both general neurology and epilepsy patients. In addition to his clinical responsibilities, Dr. Slutzky pursues research interests in neural prosthetics, specifically brain-machine interfacing (BMI).  A device that records signals from the cerebral cortex, decodes them, and uses them to control a variety of outputs such as a computer cursor, prosthetic limb, or electrically-stimulated muscles in a paralyzed limb, a brain-machine interface could allow a severely motor impaired patient (quadriplegic or locked-in, for example from ALS or spinal cord injury) to interact with his or her environment and potentially regain the use of a limb again. In addition, this technology provides a powerful new way to study normal in vivo brain physiology. Dr. Slutzkys ultimate goal is to refine BMIs to the point that they can safely and effectively be used in humans for long-term applications. He recently received a NIH K08 career development award to investigate different brain signal sources as inputs to a BMI.
1011912	Woodruffs role in understanding inhibin fluctuation in the ovary led to questions about ovarian follicle formation and persistence, which provides new ways to think about fertility preservation for young women with fertility-threatening conditions (NEJM, 2009).  She examined the regulation of follicle function in vitro and established a collaboration with a biomaterial scientist, Lonnie Shea, to develop a 3-dimensional support system that would provide the necessary bio-integrity for follicle growth (Tissue Eng. 9:1013, 2003; News and Views in Nat. Med. 14:1178, 2008 and Nat. Med. 14:1182).  These studies have been very productive and the current culture system supports live births of mice. The system is being adopted to non-human primate and human ovarian follicles. She coined the term oncofertility to describe this work.  Finally, she has used physiological studies together with mathematical modeling to explore the kinetics of follicle formation and persistence in the mouse (Dev. Biol. 298:149 and Dev. Biol. 298:132). These studies reveal the necessary and sufficient nature of the initial follicle pool established in the ovary during the time of development (Nature Med, 14:1190, 2008). Hallmarks of Woodruff career have included a strong focus on ovarian biology, on interdisciplinary approaches to problems, and application of the overall health of women.
1011952	General surgical pathology
1012074	General diagnostic radiology
1012081	gross anatomy, histology, cellular electrophysiology, sinoventricular conduction system, muscular valvular apparatus, heart 
1012104	Pediatric anesthesiology
1012150	Comprehensive care of adults, Hospital-based care of the medical patient, Medical consultations
1012293	Lung surgery, Thoracic surgery
1012336	Cytomegalovirus is a ubiquitous herpesvirus which latently infects the majority of adults.  Reactivation of latent virus occurs frequently, and in immunocompromised individuals, such as recipients of solid organ and bone marrow transplants, reactivation of CMV is associated with significant morbidity and mortality. The primary focus of research in our lab is the elucidation of the molecular mechanisms by which cytomegalovirus (CMV) establishes latent infection, in which the DNA is present but no virus is produced, and the mechanisms by which the virus reactivates, starts actively replicating and induces disease in vivo.  Using murine CMV as a model system, our studies have shown that the virus establishes latency by shutting down viral gene expression through recruitment of transcriptional repressors to the viral genome.  We have developed a unique kidney transplant model for studying reactivation of the virus which closely approximates clinical settings in which reactivation occurs, and we are investigating molecular signaling pathways that lead to transcriptional reactivation of viral gene expression.  This may lead to identification of novel targets for therapeutic intervention which could prevent reactivation of CMV and its associated pathologies.
1012362	Interest includes the care and medical issues of adults with cerebral palsy. Also have interest  in spasticity management in a variety of upper motor neuron disorders.
1012450	cell-matrix adhesion, epithelial cells, pulmonary biology, mechanosignal transduction, hemidesmosomes, focal contacts, laminins 
1012547	child, adolescent, adult psychology.  Family and couples therapy
1012560	General obstetrics and gynecology, Ultrasound (obstetrics and gynecology)
1012562	Oculofacial and Reconstructive Plastic Surgery. Board Certified Ophthalmologist
1012563	The overarching goal of my involvement in translational research is to improve the outcome of patients with lymphoma.  With scientists in the US and abroad, we are currently investigating novel signaling pathways in lymphoma, using cell lines and animal model systems.  More specifically, our research focuses on the biology of reactive oxygen species signaling pathways in lymphoma.  Active investigations include: 1) the biology of the lactone diterpenoids in lymphoma; 2) the development of all trans retinoic acid (ATRA) and curcumin loaded nanodisks as a drug delivery vehicle in mantle cell lymphoma (MCL), in collaboration with investigators from the Childrens Hospital Research Institute (CHORI) in Oakland, CA  3) The characterization of cholesterol efflux pumps as a target in lymphoma, in collaboration with Dr Colby Shad Thaxton from the Department of Urology and the Northwestern University Center of Cancer Nanotechnology excellence; 4) the study of hypoxia inducible factor (HIF) in lymphoma, in collaboration with Dr. Paul Schumacker. Clinical research interests include the study of novel immune stimulatory strategies following stem cell transplant in lymphoma with collaborators in Israel, Europe and the US, new approaches to the use of radioimmunotherapy (RIT) in lymphoma, and new treatment paradigms based on the basic investigations described above  Clinical research studies are carried out through the Northwestern University Lymphoma Program and through national co-operative groups such as the Eastern Cooperative Oncology Group (ECOG), SPORE programs in lymphoma and through the NCI Phase II Consortium in collaboration with investigators at the University of Chicago.
1012563	We are investigating the mechanism of reactive oxygen species (ROS) mediated apoptosis in myeloma and lymphoma. We are looking at both the intrinsic and extrinsic caspase system and the role of ROS in cellular signalling
1012598	Clinically, I predominantly treat inflammatory bowel disease patients where I specialize in the use of immunomodulatory therapies. On a research level, my lab is involved in understanding the mechanisms for colitis-induced colon cancer. We focus on regulation of intestinal stem cells using genetically altered mouse models and analysis of human biopsy tissue.
1012598	The Barrett lab investigates mechanisms of epithelial stem cell activation in mouse and human models of Inflammatory Bowel Disease (IBD). Areas of interest include studying the cooperation between phosphoinositide 3-kinase (PI3K) and Wnt in activating beta catenin signaling (He et al Nat Gen 2007). We find that intestinal inflammation increases PI3K-activated beta catenin in intestinal epithelial progenitor and stem cell populations. We propose that this pathway will be a novel target in strategies for chemoprevention (e.g. colitis-induced cancer) and recovery from radiation-induced stem cell injury (e.g. after nuclear attack). In all projects of the lab we strive to have strong translational components by testing lab-generated hypotheses in patient material.
1012615	Preventive medicine, Primary care internal medicine, Women's healthcare
1012787	Dementia, Internal medicine
1012808	Dr. Dalton has special interest in the management of prostate, kidney, and bladder cancers with an emphasis on robotic surgery.
1012834	I've had thirty years of experience as a psychiatric clinician.  in addition to my private practice I work in two community programs providing treatment to individuals with chronic and severe mental illness, Trilogy and Housing Options for the Mentally Ill in Evanston. 
1013067	HIV infection, viral hepatitis, antiviral drug development, global health research
1013067	Principal Investigator, Northwestern AIDS Clinical Trails Group/NIH/NIAID. Principal Investigator, Northwestern AIDS International Training and Research Program, NIH/Fogarty International Center. Principal Investigator, Northwestern Strategy for Developing and Institutionalizing Global Health Programs, NIH/Fogarty International Center. Nigeria Country Director (Harvard University primary grantee), President's Emergency Program for AIDS Relief, DHHS. Clinical Director (David Kelso PI, Northwestern), Diagnostic point of care development,Gates Foundation. Clinical Director (James Baker PI, U Michigan), Intranasal vaccine administration.   
1013078	I help patients who struggle with emotional and compulsive overeating understand the connection between their experience of stress and their lack of control over their eating. Understanding this connection helps motivate patients to focus on the cause of the problem rather than the effect, and to develop more effective coping strategies to overcome their reliance on food as a short-term coping mechanism. My research interests include psychological models of behavioral self-control, motivation for healthy lifestyle change, and the causes and treatment of patient non-adherence.
1013105	We are using multiple myeloma as a model to understand the actions of glucocorticoids (GC) and the glucocorticoid receptor (GR).  Development of resistance to GCs remains a critical clinical problem which involves the loss of GR expression.  We are exploring post-transcriptional mechanisms to understand the loss of receptor expression.  In addition we are investigating new drugs for the treatment of myeloma.  We have discovered novel nucleoside analogs that are effective in both GC-sensitive and -resistant cells.  We are working on bringing these compounds to clinic. 
1013131	Coronary bypass surgery, Minimally invasive valve repair and replacement, Transmyocardial laser revascularization
1013138	Food Allergy: My interests include pathogenesis of allergen sensitization and food allergy, as well as research regarding immunomodulatory interventions for food allergy. Asthma: My interests lie in understanding the factors which contribute to inner-city asthma and its greater morbidity/mortality as compared to non-inner city populations.  I am especially interested in the relationships between allergen sensitization, exposure and morbidity for cockroach, rodents and fungi.  I am interested in psycho-social factors which contribute to the burden of asthma in this population.  I am also engaged in clinical trials to improve therapy for childhood asthma.
1013310	I have a variety of research interests with most relating to abdominal imaging (GI/GU) especially abdominal MR and CT.  These include pancreaticobiliary and hepatic imaging and new evolving imaging techniques related especially to MR.
1013336	Emergency Medicine, Hospital-based care of the medical patient
1013371	HIV infection, Sexually-transmitted diseases
1013382	Asthma, Hay fever, Idiopathic anaphylaxis, Sinusitis, Urticaria
1013382	I am conducting clinical research on chronic idiopathic urticaria and angioedema in collaboration with Marianna Kulka PhD who is a mast cell expert and has a mast cell line. We will attempt to elucidate the pathgenesis of the disease, identifying histamine releasing factor in the sera and also identifying mediators that may be released locally.  We will do this with a blister chamber that raises a small fluid filled blister.  We will identify cytokines and local mediators at the site of lesions and compare this with  unaffected skin.  We will also take biopsies of lesions.  We have IRB approval, have collected sera from several patienets and are recruiting for these further studies. I am working with several faculty in GI and Paul Bryce, PhD on developing research in eosinophilic esophagitis.
1013524	Psychiatric Treatment of Adults/Older Adults; Depression; Management and Treatment of Patients with medical illness, dementia, or end-of-life issuers; assistance to families and caretakers of such patients.
1013559	Being on the pioneering team of lasers in dental surgery and from co-authoring the first textbook on the subject, I have always been interested in Lasers and their clinical use in dental surgery. Also, their effects on tissues versus those effects of more conventional means and how lasers improve the quality of life of our patients.  I have another large interest in the use of Connective Tissue for Dental Surgical Grafting and further its use via minimally invasive surgical techniques.  With connective tissue we are now able to make complete repairs on exposed roots of teeth. With the Subepithelial Connective Tissue Graft and with the correct indicators we can create for a 100 per cent repair of tissue and bone and hence complete root coverage and the saving of teeth and surrounding structures.  Also, the use of mathematical formulas to create for correct width to length ratios when creating surgical aesthetic crown lengthening procedures as part of surgical-restorative procedures and reconstruction.  Finally, the use of immediate dental implants and their placement relative to the extraction socket and via the use of a minimally invasive technique (an atraumatic incisionless-flapless-no suturing technique) to yield predictable restorative outcomes and hence better aesthetics, minimal pain, bleeding and swelling and therefore a better quality of life for our patients.
1013561	My primary research interest is in development of better, cheaper, faster and greener appropriate prosthetics and orthotics technologies for low-income countries.
1013622	Research interests include use of innovative treatment modalities for head and neck cancer in order to obtain better tumor control and decrease toxicity of treatment.
1013766	Boyd Metzger, M.D. is the Tom D Spies Professor of Metabolism and Nutrition in the Division of Endocrinology, Metabolism & Molecular Medicine at Northwestern University Feinberg School of Medicine.  Dr. Metzger obtained his undergraduate education at the University of South Dakota and earned his M.D. at the State University of Iowa. He was an Intern, Medical Resident and Clinical Fellow in Metabolism at Michael Reese Hospital in Chicago and a Postdoctoral Fellow in Biological Chemistry at Washington University in St Louis. Dr. Metzger's memberships in professional organizations include: the Endocrine Society, the American Diabetes Association (ADA), the American Federation for Medical Research, the Central Society for Clinical Investigation and American Association for the Advancement of Science (Fellow).  Dr. Metzger has had a  career-long  interest in the impact of gestational diabetes pre existing diabetes and states of altered nutrition during pregnancy on the intrauterine, perinatal and lifelong health of offspring. He has served on the editorial board of Diabetes and of Diabetologia and has been a member of the Organizing Committee of each of the four ADA sponsored International Workshop Conferences on gestational diabetes mellitus (GDM) and Chairman and Proceedings Editor of the last two. He will serve in the same capacity for the upcoming fifth workshop conference to be held November 11-13, 2005. He has published more than 200 journal articles and book chapters. Currently, he is Principal Investigator of the NICHD/NIDDK funded  Hyperglycemia & Adverse Pregnancy Outcome (HAPO) study. The immediate objective of HAPO is to establish the level of maternal hyperglycemia that is associated with a clinically significant risk of adverse perinatal outcome. It is hoped that future risks for obesity and metabolic disturbances can also be established through long-term follow-up. 
1013766	Regulation of Fuel Metabolism, Hypoglycemic Disorders, Nutrition and Metabolism in Pregnancy, Diabetes and Pregnancy: Basic and Clinical Aspects, Gestational Diabetes mellitus, Diabetes mellitus, Thyroid disease
1013771	intensive care, respiratory failure, mechanical ventilation, chronic respiratory insufficiency, clinical pharmacology 
1013783	Blood group isoimmunization and other conditions requiring intruterine fetal transfusions
1013810	Evaluation and treatment of sports and musculoskeletal injuries
1013825	Research focused on health literacy within emergency room and office based waiting areas. Interests in community medicine and child legislative advocacy.
1013835	Upper and Lower Limb Prosthetics, Amputation Management 
1013854	Obstetric anesthesia
1013855	My major research interests are developing new therapies for cystic fibrosis, characterizing and treating early lung disease in infants and young children with cystic fibrosis, improving CF care and reducing outcomes disparities in high risk patients.
1013880	Comprehensive care of adults, Hospital-based care of the medical patient, Medical care of the patient with diabetes
1014038	Clinical dermatology and clinico-pathological correlations.
1014075	Aneursyms, venous problems, Arterial disease, General vascular surgery
1014076	Eyelid and orbital diseases and surgeries, Lacrimal[tearing] and reconstructive surgeries, Ophthalmic plastics / laser surgeries; Cosmetic fillers and Botox use; Cosmetic eyelid surgeies; ptosis[drooping lids]; Thyroid related eye disease;
1014079	Inpatient teaching attending at Jesse Brown VA; focus of teaching is hospital medicine and clinical problem solving
1014121	General surgical pathology, cytopathology, GI/liver, gynecologic pathology
1014287	diagnosis&treatment
1014300	Medical Education, particularly basic clinical skilla and medical education methodology.
1014318	Diagnostic radiology, General radiology, Outpatient radiology
1014338	Adoption and Foster Care, Fetal Alcohol Syndrome
1014350	Dr. George Cybulski is a National Cancer Institute investigator in Radiation Therapy Oncology Group trials for treatment of malignant gliomas.  His primary clinical interests include surgical treatment of diseases of the spine, surgical treatment of spinal cord injury, surgical treatment of tumors of the brain (including pituitary tumors and gliomas) and spinal cord (including schwannomas and meningiomas).
1014368	My primary clinical interests are in the area of complex urinary tract reconstructive surgery in children with a special emphasis on hypospadias and the neurogenic bladder.  My basic science focus is on tissue engineering of bladder tissue and bladder smooth muscle physiology.
1014483	My clinical specialties include psychological aspects of women's reporoductive health including treatment of post-partum depression, infertility, pregnancy loss, and psychological aspects of breast and gynecologic cancer.  In addition, my clinical practice focuses on the treatment of anxiety and depression, individual and couples psychotherapy. 
1014587	The treatment of Head and Neck Cancer challenges the oncologic and reconstructive skills of the surgeon as no other. Only through an experienced team approach can the patients recieve optimal disease control and functional and cosmetic results that allow them to resume their occupational and social roles in society. This has been my passion for over twenty five years.  
1014614	Health Services Research
1014614	Joe Feinglass, PhD is a Research Professor of Medicine in the Division of General Internal Medicine and the Institute for Healthcare Studies.  Dr. Feinglass is a health services researcher with a degree in Public Policy Analysis.  He has over 20 years of experience in health policy, quality improvement, health disparities, medical informatics, patient safety, and social epidemiology research with over 120 peer reviewed publications.
1014634	Dr. Kundu's research focuses on the diagnosis and therapy of skin disorders that occur more frequently in individuals with skin of color or ethnic skin.
1014824	Cytopathology, Fine needle aspiration of peripheral and deep organ(s)<BR><BR> Cytopathology
1014856	Treatment Resistant Depression, Bipolar Disorders, TMS, Psychopharmacology
1014857	Dr. McVary's primary clinical areas are prostate diseases, including prostate cancer and BPH, as well as the evaluation and treatment of sexual function. Dr. McVary has an active research laboratory that investigates the molecular mechanisms controlling the neural role in erectile dysfunction as well as the neural control of prostate development and function, and he is the principal investigator on two clinical trials studying medical and surgical therapies for prostate disease.
1014980	My primary research focus at FSM is placed on understanding cellular and molecular mechanisms underlying endogenous mediator-mediated protection against tissue injury and regulation of immunity at intestinal mucosa.  I have established and sustained an R01 research program in the area of gastroenterology.  My research group has shown that: (1) Trefoil factor 3 (TFF3), a goblet cell-derived protein, protects intestinal epithelial cells against injury through an NF-kappaB dependent mechanism.  Furthermore, we demonstrated that TFF3 triggers a transient activation of NF-kappaB and prolonged upregulation of Twist protein (a molecule essential for downregulation of NF-kappaB activity in vivo) in intestinal epithelial cells via an ERK kinase-mediated pathway. (2) Milk fat globule-EGF factor 8 (MFG-E8, macrophage-derived protein) promotes the migration of intestinal epithelial cells through a PKCepsilon-dependent mechanism.  It plays an important role in the maintenance of intestinal epithelial homeostasis and the promotion of mucosal healing. (3) Peptidoglycan, a potent immune adjuvant derived from bacterial cell walls, is taken up and crosses intestinal barrier by crypt-based immature intestinal epithelial cells.  Furthermore, we defined a novel cellular mechanism/pathway through which intestinal luminal peptidoglycan is transcytosed across intestinal epithelia.  In addition, we revealed that the absorbed peptidoglycan targets macrophages, which may facilitate intestinal immune homeostasis.  Together, our findings in conjunction with previous investigations, have elucidated molecular mechanisms underlying the trialogue occurred among lumenal contents, epithelial lining, and cells in lamina propria that directs process for the maintenance of intestinal barrier homeostasis, integrity, and immunity.
1015007	Dr. Kopp's research focuses on various forms of thyroid disease. Principal areas of interests are the molecular genetics of congenital hypothyroidism and Pendred's syndrome. Pendred's syndrome is an autosomal recessive disorder characterized by congenital sensorineural deafness, goiter and impaired iodide organification. It is caused by mutations in the PDS (Pendred syndrome) gene that encodes pendrin, an anion transporter belonging to the solute carrier family 26A (SCL26A).  Other areas of active research include the molecular genetics of endocrine diseases such as neurohypophyseal and nephrogenic diabetes insipidus, and the analysis of polymorphisms in genes involved in androgen metabolism in order to define determinants of steroid hormones and prostate cancer risk in men. His clinical activities are primarily focusing on patients with thyroid dysfunction, thyroid nodules and thyroid cancer.
1015007	Dr. Kopps research interests focus primarily on the genetic basis of endocrine disorders, in particular inborn errors of thyroid development and thyroid hormone synthesis, as well as disorders of water metabolism (diabetes insipidus). His clinical activities focus primarily on patients with thyroid dysfunction and thyroid cancer, but also include the care of patients with pituitary disorders, adrenal disorders and rare genetic endocrine disorders.
1015036	Neurogenic communication disorders, aphasia, right hemisphere stroke, neglect
1015048	neuroreceptor, ion channel, neuropharmacology, neurotoxicology, neurophysiology, electrophysiology, alcohol, insecticide, anesthetic, Alzheimer's drug
1015071	I work with both psychotherapy and pharmacotherapy, often combined.  Interests include depression, anxiety disorders, post-traumatic stress disorder, adult attention-deficit-disorder/attention-deficit-hyperactivity-disorder, and psychologic problems of persons coping with medical illness. 
1015091	Uterine Fibroid Embolization (UFE), Vascular and interventional radiology
1015102	Sarah L. Chamlin, M.D. is an Associate Professor of Pediatrics and Dermatology at Northwestern University Feinberg School of Medicine and an Attending Physician, Childrens Memorial Hospital specializing in Pediatric Dermatology.  Her clinical interests include hemangiomas and other vascular lesions, hair and nails and general Pediatric Dermatology.  Her research interests include quality-of-life measurement in children and teens with skin disease and hemangiomas.  She is an active member of the Hemangioma Investigator Group.
1015113	Colposcopy, Hysterectomy, Teen pregnancy
1015205	Cytopathology   Surgical Pathology   Pediatric Pathology Pediatric tumors, cytology
1015262	Dr. Volpert's main area of study focuses on the molecular mechanisms of angiogenesis, the process by which new vascular bed forms.
1015324	aaaaaaaaaaa 
1015337	mechansims underlying cytotoxic cell granule mediated apoptosis
1015340	Surgical Education Research at the Undergraduate or Graduate level; Faculty Development; Resident Recruitment; Technical Skill Acquisition; Curriculum and Instructional Design 
1015350	Dr. Lurain's primary research interests are related to the clinical factors associated with prognosis and treatment of gestational trophoblastic diseases (hydatidiform mole, choriocarcinoma, and placental site trophoblastic tumor) as well as  uterine and ovarian cancers.. He has received research support from the American Cancer Society, the National Cancer Institute, pharmaceutical companies, as well as charitable groups, such as the Chicago Baseball Cancer Charities, the Cancer Research Foundation, the Stenn Fund for Ovarian Cancer Research, the Holly Missner Fund for Ovarian Cancer Research, the Kathleen Warble Foundation, the Cheryl Halat Memorial Fund for Ovarian Cancer Research,  and the Eileen M. Arder Fund for Endometrial Cancer Research.  Dr. Lurain is an author on more than 190 publications, including scientific articles, reviews, chapters, and books.
1015379	Pain sensitivity & threshold and postoperative pain, Obesity and anesthesia, Sleep apnea and postoperative outcomes, Minimally invaseive surgery outcomes, faculty career development
1015450	All aspects of echocardiographic imaging.
1015471	Associate Clinical Director of the Northwestern Scleroderma (SSc) Program, Director of the Scleroderma Patient Registry and biorepository.   
1015529	Pain medicine
1015570	Anti-thrombotic therapy, Atrial fibrillation, Cardiac stress testing, Cardiovascular critical care, Coronary heart disease, Ischemic heart disease, Nuclear cardiology 
1015570	My research interests are in the areas of antithrombotic therapy, particularly in the acute coronary syndrome patient, lipid management and reduction of cardiac risk, antihypertensive therapies, and nuclear cardiac imaging.
1015615	Echocardiography, Valve disease, Women's cardiovascular health
1015615	The assessment if valvular regurgitation using 2D and 3D echocardiography
1015812	Preschooler's behavior problems;  Psychological interventions in pediatric primary care 
1015829	Spinal cord injury, rehabilitation, male infertility 
1016037	Professor Emeritus 
1016048	Preventive medicine through lifestyle counseling, early detection, and treatment to achieve optimal control and avoid complicatons.
1016050	I have taught a 3 quarter course: The Opening Phase of the Psychoanalytic Process: Basic Concepts and Fundamental Principles from 1996 to the present in the Chicago Institute Analytic training program. I have presented a series of symposia, The Reluctant Patient, to a number of mental health agencies in the Chicago area.  I am a member of the American Psychoanalytic Association and the Chicago Psychoanalytic Society and serve as a clinical assistant professor in the Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University. My clinical focus is the psychoanalytic and psychotherapeutic treatment of adolescents and adults.  
1016062	Dr. Carol Rosenberg serves as the Director of Preventive Health Initiatives for Evanston Northwestern Healthcare. She is Chair of the Cancer Survivorship Program task force for Evanston Northwestern Healthcare. Dr. Rosenberg is a lead investigator and writing group chair for the national Women's Health Initiative Study. Dr Rosenberg is the founder and Director of the Living in the Future (LIFE) Cancer Survivorship Program of Evanston Northwestern Healthcare, for which she was awarded a Lance Armstrong Foundation grant during the program's implementation phase.
1016078	Dr. Garnett has special interest in the management of prostate, kidney, and bladder cancers with an emphasis on robotic surgery.
1016113	My clinical interests are Pediatric and Adult Neuro-Oncology, Thoracic Oncology, Cranial and Body Sterotactic Radiosurgery, Palliative/Hospice/End of Life Care and Medical Ethics as Related to Death and Dying.
1016221	My primary research interest is in mechanisms of low bone density at diagnosis of acute lymphoblastic leukemia in pediatric patients.  I hypothesize that dysregulation of mesenchymal stem cells in the bone marrow microenvironment leads to aberrant preference for adipocyte development over osteoblast development.  I also do clinical research related to long-term outcomes after cancer therapy and stem cell transplant during childhood.
1016296	Glomerular diseases, Hypertension, Transplant Nephrology
1016299	Echocardiography, General cardiology, Prosthetic heart valve disease
1016313	Comprehensive care of adults, Preventive medicine
1016319	My primary area of research in recent years has been in the use of simulation for training medical care givers in their various fields.
1016392	My primary research interests include unique combinations of radiotherapy with biologically targeted agents, the amelioration of radiation toxicity and unique method of delivering radiotherapy. I currently focus on gynecological, gastrointestinal and breast cancers. I have been committed to advancing our understanding and treatment of gynecological, gastrointestinal and breast cancers, particularly through clinical trials.  I have national and international leadership positions and I am actively working on improving cancer care, especially cervical cancer, throughout the world with particular emphasis on underdeveloped countries.  Being active in the field of oncologic research, I am eager to explore new solutions to improve the efficacy and side-effects caused by radiation therapy and to improve access to clinical trials and state of the art therapies.  My interest in radiation oncology and research is exemplified through my clinical work, research, and continuing education.
1016513	Voluntary psychiatric consultations. 
1016521	I am interested in all types of abdominal wall, incisional and inguinal hernias.
1016527	Lipid Disorders, Cardiovascular Nutrition, Coronary Disease in Women, Premature Coronary Disease
1016527	Lipid metabolism, cardiovascular nutrition; premature coronary heart disease
1016528	Achalasia, Gallstones, GERD, Hernia, Laparoscopic cholecystectomy, Laparoscopic Heller myotomy, Laparoscopic Nissen fundoplication, Laparoscopic Splenectomy, Laparoscopic ventral hernia repair, Pancreatitis and Pancreatic Cancer
1016548	Pediatric spine/spine deformity; growth and etiology of idiopathic scoliosis; medical education/surgical skills acquisition training.
1016555	Myeloma Research, Stem Cell Transplant
1016711	To clarify function of ion channels, physiological snd pharmacological research are on going using various techniques including patch-clamp, and live cell imaging.
1016756	International Healthcare Systems, Health Insurance, Healthcare Quality, Ambulatory Care
1016759	Clinical treatment and translational research in Multiple Sclerosis, CNS Demyelinating disease, Neurologic complications of AIDS 
1016762	Family decision-making, protective services for the elderly, disability and public policy, community services evaluation 
1016763	Endoscopic ultrasound, Ulcer disease
1016763	General gastroenterology, colon cancer screening is a particular interest. In addition, acid peptic disease and gastrointestinal complications of NSAIDS. 
1016768	Acne, Chemical peels, Tumescent liposuction
1016805	Cataract surgery, Cornea disease, Cornea transplant surgery, Lasik surgery, Refractive surgery
1016930	NFAT, Calcineurin, Transcription Factors, Signal transduction, Gene Regulation, T cell activation, Th1/Th2, Adipogenesis, Cancer, Oncogenes
1016969	Dr. Lee s research focuses on regeneration therapy of endocrine insufficiency. He uses gene therapy tool (Adenovirus and Ad/AAV hybrid vectors) for the directed differentiation of adult stem cells.  He is also currently interested in pre-mRNA splicing in human cancer cells. 
1016969	Gene tharpy, regeneration therapy,  endocrine insuffciency, diabetes, endocrine cell differentiation, endocrine tumor 
1017008	My research interests include the development of mesh for hernia repair.  Our polyurethane coated polypropylene mesh at PSD, LLC was given 510K FDA approval for marketing in January 2010. The polyurethane material has been licensed to K2M in Canada for repair and replacement of nucleus pulposus in the human spine. My work on the SAGES Laparoscopic Cholecystectomy Pearls series proceeds nicely.  Last year I satisfied the credentialing requirements of the ARDMS for the RVT and RPVI credentials.  These ultrasound credentials are beneficial to another of my interests, the diagnosis and treatment of venous disorders using ultrasound guided endovenous treatments. I remain active in committees CME and Patient Safety and Outcomes for SAGES and for American College of Phlebology where I chair the Distance Learning Committee and as a member of the CME/outcomes committee.
1017032	Pediatric radiology, Pediatric nuclear medicine, Metabolic bone disease 
1017036	Dr. Avrams research interests include pharmacokinetics (PKs) and pharmacodynamics (PDs) of hypnotics, sedatives, opioids, analgesics, non-depolarizing neuromuscular blockers, chemotherapeutics, etc.  His major research focus has been the development and evaluation of detailed PK models of rapidly acting intravanously administered drugs from the moment of injection to serve as the basis for understanding the PK basis of interindividual variability in response to these agents, which often have low clinical margins of safety.
1017061	Chorea, Dystonia, Essential tremor, Multiple systems atrophy (MSA), Myoclonus, Neuro-ophthalmology, Parkinson's disease, Progressive supranuclear palsy ( PSP), Tics
1017082	Comprehensive care of adults, Occupational medicine
1017092	Herpes Virus, HIV Infection
1017153	intercellular junctions, adhesion, desmosomes, adherens junctions, signal transduction, cell motility, skin disease, cadherins, cancer metastasis.<BR><BR> I am interested in the regulation of the intercellular adhesive junction, the desmosome, during processes such as wound healing and morphogenesis. Currently my studies are focused on the plakin protein, desmoplakin, an obligate member of the desmosomal plaque, which mediates the interaction between the plaque and the intermediate filament network. This interaction with the intermediate filament network is required for maintaining tissue integrity, particularly those tissues undergoing large amounts of stress, such as the heart and skin. The importance of desmoplakin in maintaining adhesive strength is highlighted by cardiomyopathies and skin diseases, which result from desmoplakin mutations. Utilizing biochemistry and fixed and live cell imaging techniques we are analyzing the dynamics of desmoplakin during desmosome formation and the roles the intermediate filament and microfilament networks play in that process.
1017219	Intervention cardiology
1017224	Spinal disorders, Spinal reconstruction, Sports medicine
1017234	Dr. Sharon Unti is currently the Director of the Pediatric Residency for Northwestern University Feinberg School of Medicine based at Children's Memorial Hospital.  Her interests include both graduate and undergraduate medical education, particularly curriculum design and evaluation processes.
1017247	retinal detachment, diabetic retinopathy, macular degeneration, uveitis/retinitis, intravitreal injections, laser treatment, Retina diseases and surgery
1017256	I carry out clinical and basic research related to dizziness and vocal motor control.  My clinical research mainly concerns vestibular evoked myogenic potentials and cervical vertigo.  My basic science research mainly concerns mathematical modeling of feedback control of voice F0 and amplitude. Clinically, I am the 'dizzy doctor' at Northwestern, and see a large array of patients with inner ear disorders as well as more complex pictures.
1017340	Comprehensive care of adults, Women's healthcare
1017341	Advanced laparoscopic surgery, In-vitro fertilization, Infertility 
1017403	Primary current research interests are the mechanisms of biomineralization in bones and teeth, and the role of non-collagenous 'SIBLING' proteins in regulation of mineral placement in collagen matricies. The second major interest is in the structure and assembly of collagen molecules and fibrils. We have recently completed studies of the role of amelogenin splice product peptides in the epithelial-mesenchymal signaling during embryonic tooth formation.
1017423	My research focuses on adaptation of stroke survivors and their family caregivers, including prevention and amelioration of depression and promoting preparedness for the caregiving role.  In addition, I am interested in prevention of pressure ulcers in persons with spinal cord injury.
1017499	nuclear transport, nuclear structure, nuclear pore complex, nuclear envelope, nuclear lamins
1017506	General diagnostic radiology
1017510	Dr. Nadlers specific areas of interest include robotic prostatectomy, concentrating his efforts on outcomes of robotic prostatectomy patients specifically pertaining to erectile function and margin rates. He is also pioneering a technique of robotic partial nephrectomy, which avoids clamping the renal hilum to better preserve kidney function during robotic partial nephrectomy for renal cell cancer. He also continues to do work in the minimally invasive surgical management of complex kidney stones and renal pelvis tumors.
1017531	Perinatal pathology
1017687	I mainly work with adult individuals suffering from treatment resistant mood and anxiety disorders. In addition, I work with a number of patients with chronic pain issues.  
1017700	Comprehensive care of adults, Preventive medicine
1017700	Within Medical Humanities, my interest is in the use of reflective writing in the education and professional development of physicians.   
1017737	Cancer prevention and screening, Primary care internal medicine, Women's healthcare
1017743	Neuropathology<br><br> As a neuropathologist with principal clinico-academic effort in diagnostic surgical neuropathology, my research interest encompasses translational-collaborative  studies related to bio-predictive markers for adult diffuse-type gliomas.
1017877	My primary interest is the psychiatric care of the older adult with chronic or new onset mental illness.  My work includes providing consultations to  physicians requesting recommendations regarding the care of their older adult patients with mental illness.  Another focus involves teaching geriatric fellows, psychiatry residents and medical students in a biopsychosocial approach to the diagnosis and treatment of older adults with mental illness. I am also interested in developing interventions addressing geriatric anxiety and depression.
1017968	Comprehensive care of adults, Medical care of the patient with hypertension, Preventive medicine
1017971	Comprehensive care of adults, Medical care of business executives, Perioperative medical consultations
1017983	Certified Registered Nurse Anesthetist, Advance Practice Nurse in IL and MI Oupatient Anesthesia,  Positioning and safety issues for both the OR Staff and Patient, and preventive methods for pain management.
1018009	A primary goal of my work is to establish the approaches and benefits of genomics informed personalized medicine.  A key element of this is participation in the eMERGE consortium (http://gwas.net), where I serve as the steering committee chair.  This project uses Electronic Health Records linked biobank samples (www.nugene.org) to study the genetics of disease susceptibility, therapeutic outcomes and pharmacogenomics.  My group is also interested in genome informatics, particularly genome annotation and visualization technology.
1018012	During her years of work in pediatric practice-based research, Dr. Binns has participated in research studies on a wide array to topics relevant to primary care practice.  Studies she has led in community primary care settings have focused on preventive care delivery, lead poisoning, obesity, and tobacco addiction.  Other research studies she has completed on these topics gathered samples from hosiptal and out-patient clinical settings.
1018049	Dr. Fiebig coordinates the Cochlear Implant Program at Northwestern.   She has worked with the program since it began in 1993.
1018091	Acid-base and electrolytes, Hypertension; diabetic nephropathy, Nephrology
1018091	Dr. Batlle's research interests are in the area of acid/base and potassium physiology and pathophysiology, with special emphasis in the area of distal renal tubular acidosis. At the bench level, Dr. Batlle's research team is interested in examining the cellular and molecular events involved in the development of hypertension and nephropathy in patients with diabetes. His laboratory has taken a holistic research approach that incorporates modern techniques of molecular biology, cell biology, whole animal studies, and studies using cells derived from human subjects. The predisposition to the development of kidney disease in some diabetic patients is being examined at the level of cell cycle regulatory proteins using skin fibroblasts as a surrogate cell model.  More recent work is focusing on ACE2 and its interaction with ACE in animal models of diabetes.
1018134	Immunotherapy strategies for treatment of melanoma, renal cell cancer, other urologic tumors and  Mycosis fungoides
1018134	Interests include experimental therapeutics for the treatment of genitourinary malignancies and skin lymphomas and cancers.  Immunotherapeutic and anti-angiogenic approaches remain a major focus for such diseases as renal cell carcinoma, melanoma and cutaneous T-cell lymphomas.
1018163	Previous research has focused on investigations of the Physical Therapist Clinical Performance Instrument, mentoring of physical therapist students, balancing career and family choices in female physical therapists and physical therapist students, osteoporosis, and using online resources in patient and clinical education. Current research the development of international health opportunities for physical therapist students.
1018167	Clinical Interests: asthma, chronic obstructive oulmonary disease (COPD), interstitial Lung Disease, sarcoidosis.  Research Interests: airway inflammation and remodeling in asthma and COPD; effects of hypercapnia (elevated levels of CO2) on innate immunity and host defense in the lung.
1018168	Metabolic bone diseases, kidney stones, hyperparathyroidism, glomerulonephritis, renal osteodystrophy
1018220	Chemical dependence, Medical / surgical psychiatry
1018246	The long-term goal of my lab is to identify and investigate molecules that play important roles in mammalian hearing, thus to enrich our understanding of cochlear physiology, and to further develop a better strategy to prevent hearing loss.  Outer hair cells (OHCs) are essential for providing high sensitivity and frequency selectivity of hearing.  They are also the most vulnerable cells in the inner ear and are involved in most sensorineural hearing loss that affects the hearing of millions of people.  It is known that OHC death is strongly connected with the generation of reactive oxygen species (ROS).  Yet, it is not fully understood why OHCs, as compared to other cells in the organ of Corti, are more vulnerable to ROS.  The main function of OHCs is to amplify mechanical signals through their somatic electromotility.  This exclusive property is executed by a unique motor protein called prestin (Zheng et al., Nature, 2000).  We are currently investigating prestins protective role against oxidative stress in the ear using different prestin-expressing cell lines and prestin-knockout/prestin-knockin animal models.  We are focused on understanding the molecular mechanism of motor protein prestin using various cellular, biochemical and molecular biological methods including high throughput small molecule compound library screening procedures.  These studies will not only expand knowledge of prestin as the OHC-based cochlear amplifier at the molecular level, but also produce a deeper understanding of mechanisms associated with outer hair cells loss, and may offer new methods for the prevention of OHC damage.
1018341	Preventive medicine, Women's healthcare
1018377	Airway management Education in airway management Education in Simulation Research
1018454	Cross-sectional imaging of the body, CT angiography, Multislice computed tomography (CT)
1018461	Dr Kibbe is the principal investigator for the Patient Study Calendar module software development project, the caBIG development project that has developed a syntactically and semantically harmonized interoperable patient study calendar using agile design practices. Dr. Kibbe is the co-PI of the NIH-funded Dictyostelium Model Organism Database dictyBase. He is a proponent of Agile software development methodologies and the Agile Unified Process Framework and the application of these to biomedical research problems. Dr. Kibbe's group has developed NOTIS, the clinical trial information management system used for all cancer trials at Northwestern and by the genotype/phenotype biorepository NUgene (http://www.nugene.org) as the source of identified information on participant in NUgene. In NUCATS, the Northwestern CTSA organization, Dr. Kibbe recently received ARRA funding to extend NOTIS to all disease areas at Northwestern, and release the eNOTIS project as a CTSA-sponsored open source project. He is also a key participant in building a computable research representation of clinical data, through his work with the Northwestern Medicine Enterprise Data Warehouse, the caBIG Clinical Annotations Engine (which is designed to build a computable representation of pathology reports from the Cerner and Epic EMR systems), and ontology efforts, including being a co-founder of the Disease Ontology (http:/diseaseontology.sourceforge.net) and the semantically computable BRIDG domain analysis model that is being jointly developed by members of HL7, CDISC and caBIG to represent clinical research information and the semantics necessary to conduct clinical trials.
1018513	My clinical interests include working with individuals and couples experiencing problems with communication, intimacy, sexuality, sexual functioning, and psychological or sexual aspects of reproductive health care; such as fertility, menopause, gynecological or urological disorders.  I also see couples for premarital counseling.  
1018581	Comprehensive care of adults, Peripheral vascular disease, Preventive medicine
1018597	As Director of Gynecologic Endoscopy at Northwestern since 1995, I have developed an expertise in advanced minimally invasive surgeries including laparoscopy, hysteroscopy for conditions of endometriosis, fibroids, adhesions, tubal disease and ovarian cysts.  I perform laparoscopic total and subtotal hysterectomy, myomectomy, cystectomy and hysteroscopic removal of fibroids and adhesions.
1018621	Research in the Turek laboratory is focused on the study of sleep and circadian rhythms, with special interest in identifying genes that regulate sleep and circadian rhythms. Ongoing work on sleep and circadian rhythms includes an investigation of: (1) the neurochemical, molecular, and cellular events involved in the entrainment, generation and expression of circadian rhythms arising from a central biological clock located in the suprachiasmatic nucleus (SCN) of the hypothalamus, (2) the genetics of the circadian clock system and the molecular genetic mechanisms underlying the sleep-wake cycle, (3) the feedback effects of the sleep-wake cycle on the circadian clock regulating the timing of that cycle, (4) the effects of advanced age on the expression of behavioral and endocrine rhythms, and on the expression of circadian clock genes, 5) the links between sleep, circadian rhythms and energy metabolism and, (6) the role of melatonin in modulating sleep and circadian rhythms. In addition to our work on rodents, we have established extensive collaborations with clinical researchers. Studies in humans are aimed at shifting the human clock in an attempt to alleviate mental and physical problems that are associated with disorders in circadian time-keeping, particularly in the elderly and in shift-workers. In addition, we are using both pharmacological and non-pharmacological approaches to determine if we can reverse the effects of aging on the circadian clock system in both rodents and humans. Our sleep, circadian and metabolic studies are focused on how disruption in these interactions can lead to obesity, diabetes and CVD.
1018693	My primary research interest is in perinatal epidemiology. I have an investigational interest in understanding the social determinants of racial and ethnic group disparties in birth outcome(preterm delivery, low birth weight, neonatal and post-neonatal mortality) in the United States.
1018694	As a member of the soft tissue sarcoma committee of the Children's Oncology Group (COG), my primary clinical research interest lies in the area of clinical trials for pediatric patients with soft tissue sarcomas.  I am study chair for a group-wide phase III COG clinical trial for rhabdomyosarcoma.  I also serve as Institutional Principal Investigator for COG.  My primary basic  research interest lies in understanding the regulation and function of the GLI1 oncogene, as well as understanding the role of Hedgehog-GLI1 signal transduction in pediatric solid tumors.
1018707	My primary research interest lies in clinical neuroscience in neonatology.  I have spent time looking at physiologic stability in preterm infants relating to cerebral oxygen levels.  I have also correlated cerebral oxygenation with short term neuromotor outcomes.
1018729	Our lab is interested in how the cytoskeletal protein tau is altered from its normal soluble state to oligomeric and fibrillar states.  We also are interested in aggregated tau's function in neurons and glia during the course of Alzheimer's disease and related tauopathies. 
1018731	In my laboratory we study the cellular and molecular  mechanisms of immunopathogenesis of T cell-mediated central nervous system (CNS) demyelinating diseases, the  chemokine regulation of cell migration and host responses to mucosal bacterial infection, and the role of chemokines in the migration of B cell lymphoma.  The laboratory employs two mouse models of multiple sclerosis (MS): Theiler's virus-induced demyelinating disease (a virus-induced model of MS) and experimental autoimmune encephalomyelitis (EAE) (an autoimmune model of MS). In particular, the laboratory is examining the chemokine and chemokine receptor biology of T cell, monocyte, and dendritic cell recruitment during CNS demyelinating disease.  In addition, we are examining the balance between cellular and molecular mechanisms of oral tolerance induction and generation of mucosal immunity/host defense to bacterial and viral pathogens.  Finally, the laboratory uses a model of murine B cell lymphoma to study the mechanisms of tumor cell migration to lymphoid and extra-lymphoid tissues.  The approaches utilized in the laboratory are applicable to both the understanding of basic biologic mechanisms of  disease progression and treatment of autoimmune diseases, enhancement of immunity to pathogens, and treatment of cancer.
1018772	Dysmorphology
1018819	Hospital-based care of the medical patient
1018820	Cosmetic Plastic Surgery with emphasis on  optimization of results in Aesthetic Plastic surgery
1018857	neurophysiology, neurocomputation, neuroanatomy, modularity, signals, information, learning, plasticity, engineering, adaptation
1018864	Circadian Rhythms, Sleep, Aging, Phase Shifting, Light, Exercise, Melatonin, Circadian Rhythm Disorders, Sleep Disorders, Delayed Sleep Phase Syndrome 
1018947	clinical supervision,supervision,genetic counseling 
1019040	Clinical focus on the assessment and outpatient treatment of mood and personality disorders with a special interest in the psychological sequela of disorders of attention and non-verbal learning.
1019117	My perimary clinical interests are in the area of general clinical pediatric neurology as well as neurodevelopmental disabilities.  This involves disorders affecting the developing brain and their links  with genetics and behavior.
1019129	Carl L. Backer, MD is the A.C. Buehler Professor of Surgery, Division Head of Cardiovascular-Thoracic Surgery, and Surgical Director of the Cardiac Transplant Program at Children's Memorial Hospital in Chicago.  He is a world-renowned pediatric cardiovascular-thoracic surgeon.  Dr. Backer specializes in the surgical treatment of congenital heart disease in infants and children and also performs complex re-do procedures in adults.  His primary interests are:  adults with congenital heart disease, arrhythmia surgery, heart transplantation, vascular ring surgery, tracheal reconstruction, and pacemakers.  He has authored or co-authored over 180 refereed articles, 68 book chapters, and 4 textbooks.  He is the co-editor of the 2nd and 3rd editions of the well-known textbook, Pediatric Cardiac Surgery.   His research incorporates over 40 years of database material from Children's Memorial Hospital.  Future research endeavors will focus on cardiac stem cell therapy for pediatric cardiomyopathies.  
1019185	Interventional radiology; use of real-time ultrasound for vascular and inteventional procedural guidance, transplant interventions, tumor ablation, lymphatic system interventions, percutaneous biopsy, chest interventional procedures, biliary and renal interventions, TIPS
1019312	Cervical and lumbar degenerative disc disease, Spinal cord injury, Spinal disorders, Spinal reconstruction
1019313	Back pain and chronic pain, Brain tumors, Headache, Neuro-oncology
1019370	clinical pharmacology, pharmacokinetics, pharmacodynamics, drug effect, dose-response, intravenous anesthetics, medical technology
1019437	To be completed. 
1019504	Neural control of breathing, Respiratory rhythm generation, Reflex control of breathing
1019546	The overarching goals of our research program are to identify targets for novel strategies to prevent disease and disability development and progression in persons at risk for or with knee osteoarthritis.
1019567	I am very interested in minimally invasive surgery, including laparascopic hysterectomy, hysteroscopic fibroid resection, hysterscopic sterilization (Essure), and hysterscopic endometrial ablation (Novasure).
1019577	Research and clinical interests include clinical trials for Alzheimers disease and other forms of dementia, frontotemporal dementia and primary progressive aphasia, changes in cognition associated with aging, rehabilitation of memory and other cognitive disorders.  
1019636	Oral & Maxillofacial Surgery, with emphasis on orthognathic surgery,facial reconstruction, facial trauma, surgical correction of obstructive sleep apnea, implant surgery and wisdom tooth removal
1019664	Clinical Pharmacology, Colposcopy, Hysteroscopy, Laparoscopy, Medical termination of pregnancy, Medication use in pregnancy
1019731	My primary clinical interests revolve around neurosurgical anesthesia, management of the difficult airway, and the perioperative stress response.  Other focus centers on patient safety and quality improvement.
1019792	Communication in Medicine, Clinical Skills Teaching, Graduate Medical Education, general medical education 
1019797	Sinus problems, chronic sinusitis, sinonasal polyps. Sinus and nasal skull base tumors. Computerized image guided sinus and skull base surgery. Intraoperative CT scanning. Research:  Better diagnosis and treatment of chronic sinusitis. Research:  Immunologic basis of chronic sinusitis. Research:  Clinical and research trials - goal: improved diagnosis and treatment of chronic sinusits. General otolaryngology.
1019856	We develop single and multi-joint intelligent rehabilitation robotics to diagnose, treat and evaluate neurologicla disorders and musculoskeletal injuries, investigate reflex/non-reflex and dynamic/static factors contributing to impaired motor control, and study injury and compensation mechanisms of pathological knee conditions.
1019882	Primary care internal medicine, Women's healthcare
1019972	My main research interest is the elucidation of molecular mechanisms uderlying cell motility with particular focus on the motile reactions of cardiovascular cells such as vascular endothelial and smooth muscle cells and cardiomyocytes. Another interest related to previous one is to discover and design substances which affect cells motile reactions and which could be applied as the novel therapies to the wide range of diseases where the motile behaviour of cells is compromised. Additionally, my lab is interested in discovery of master genes of cardiomyogenesis that could be used to govern directed differentiation of precursor cells into cardiomyocytes for the sake of therapeutic heart repair.
1020003	Adjunct Instructor in FSM Nutrition Curriculum 
1020163	Mood and anxiety disorders, particularly pregnancy-emergent and postpartum disorders. Forensic psychiatry. 
1020213	Stem Cell Transplantation for Pediatric diseases Minimal residual disease in leukemia Neuroblastoma and its treatment Stem Cell differentiation Tumor vaccines. 
1020281	Clinical Interests: Methicillin-Resistant Staphylococcus Aureus Infections (MRSA), Pertussis (Whooping Cough), Travel Immunizations, International Adoption, Pneumococcal Infections, Antibiotic Resistance Research Interest: Dr. Tans research interests focus on the epidemiology of pneumococcal infections and antibiotic resistance and is a principal investigator in the U.S. Multicenter Pneumococcal Surveillance Study Group; pertussis disease epidemiology and preventative vaccines; community-acquired methicillin resistant Staphylococcus aureus (CA-MRSA) infections and the transmission dynamics between pregnant women and their newborn infants (in collaboration with investigators in the Department of OB/GYN, Prentice Northwestern Memorial Hospital in Chicago). She has participated in both vaccine and antibiotic clinical trials as a Principal-Investigator and is also involved in several vaccine survey studies which examine the awareness, acceptance, barriers and utilization of recommended preventative vaccines among healthcare consumers and primary healthcare physicians. These studies are being conducted in collaboration with Dr. Melvin Gerbie in the Department of OB/GYN.
1020328	My work focuses on G protein coupled receptors (GPCRs).  This large family of nearly 1000 receptors is responsible for critical signaling components in normal cellular physiology responses such as differentiation, chemotaxis, and apoptosis.  In fact, nearly half the drugs an the market today are directed at members of this important family of receptors.  I study how they signal to the cognate partner, the heterotrimeric G protein using novel tools (ie US patent 6,559,128) as well as other signaling partners such as arrestin.  A key part of my research is directed at allosteric modulators, compounds which can modulate GPCR signaling at a site distinct from the ligand binding site.
1020334	I am interested in the beliefs and behaviors that influence exercise and physical activity decisions of breast cancer survivors. Specifically, I am looking at fear as a barrior to activity and exercise. Lymphedema, a co-morbility of breast cancer treatment, is another area of interest. I have studied exercise as a risk factor for development of lymphedema and quantitative methods of measuring lymphedema.
1020712	My primary clinical interests are the treatment of couples and the evaluation and treatment of posttraumatic disorders
1020720	Autonomic nervous system disorders, Electroencephalography, Electromyography
1020738	neurodegeneration, Alzheimer's disease, tau protein, immunohistochemistry, neuropathology, protein structure 
1020762	My long-term goal is to obtain knowledge to treat certain types of cancers that show dysregulated HH signaling activities. The first goal is to analyze the transcriptional role of GLI1 in oncogenesis and to identify potential downstream target of human oncogene GLI1 that mediates the oncogenic role of GLI1 in specific cancers. The second goal of my research is to analyze and to identify potential regulators of human oncogene GLI1 that affects the oncogenic role of GLI1 in specific cancers. The third goal of my research is to understand the regulation of GLI1 expression in specific tumors using inhibitors and activators of the SHH-GLI1 signaling pathways for potential treatment of these tumors.
1020837	High risk pregnancies, clinical trials in pregnancy, thrombophilias and pregnancy, obesity and weight gain during pregnancy
1020838	signal transduction, G protein-coupled receptors, ovary, receptor desensitization, phosphorylation, 
1020875	Brain tumors / neuro-oncology, Cerebrovascular disorders, Spine diseases
1020945	Diarrheal diseases, Tropical medicine
1020947	My clinical, research and teaching interests center around the treatment of breast diseases and more specifically breast cancer.   
1021011	Preventive medicine, Primary care internal medicine, Women's healthcare
1021028	intestinal failure, liver transplantation, small bowel transplantation 
1021035	Infection Control, Antimicrobial Resistance, Data Mining, Infectious diseases, Medical Microbiology, Epidemiology, Emerging Pathogens, Biodefense, Emerging Diagnostics, Molecular Epidemiology 
1021074	Endoscopic surgery, Leiomyomas / laser surgery/infertility, Reproductive Surgery
1021148	I see patients in our general endocrinology and thyroid nodule fine needle biopsy clinics. My major research focus is translational breast cancer research in collaboration with my fellowship mentor Dr. Vince Cryns and Professor Sam Stupps nanotechology laboratory.
1021232	Hematology, Hematopathology<BR><BR> I am Director of Hematopathology at Feinberg Medical School of Northwestern University and Northwestern Memorial Hospital.
1021239	My primary area of research interest is clinical obstetric anesthesiology, including the effects of labor analgesia on the progress and outcome of labor, specific neuraxial techniques for labor analgesia, and post-cesarean analgesia. 
1021275	Islet transplantation, engraftment, tissue engineering, imaging 
1021278	Clinical outcomes in Vascular Surgery
1021319	Structural Genomics, X-ray crystallography, Protein-nucleic acid interactions
1021428	Hepatobiliary Surgery, Living Donor Transplant, Pediatric Transplant
1021446	Adult congenital heart disease, Echocardiography, Valvular heart disease
1021467	Learning, Biophysics, Neurophysiology, Eyeblink Conditioning, Aging, Hippocampus, Alzheimer's Disease, Potassium Currents, Calcium, fMRI 
1021469	Hypertensive emergencies
1021653	RESEARCH TEAM. Our team of ~15 scientists works in close collaboration to tackle a wide variety of research problems in infection, immunity, endothelial biology and critical care medicine. Professors David Engman, MD, PhD, Conrad Epting, MD, and Bria Coates MD, lead the team.   TROPICAL DISEASE RESEARCH. Trypanosomes are single-celled parasites that cause human illnesses such as African sleeping sickness and Chagas disease. These illnesses cause tremendous morbidity and death among millions in the tropical world and Chagas is an emerging infection in the U.S. with an estimated half-million infected residents. We study the molecular genetics and cell biology of these organisms both to understand fundamental processes of cell function and to identify novel targets for drug discovery.  AUTOIMMUNE DISEASE RESEARCH. A variety of infections and other insults to the heart can cause cardiac autoimmunity, a process by which the immune system mistakenly attacks the heart as if it were an infectious agent. We study both infectious and purely autoimmune models of autoimmune myocarditis in a global effort to understand the development of autoimmunity and mechanisms of autoimmune tissue destruction, and to use this knowledge to develop novel strategies to prevent autoimmune damage. We are also interested in the interactions of infectious agents and cells of the immune system with the endothelium, the lining of blood vessels across which both need to cross to mediate or fight disease.
1021673	Hepatobiliary Surgery, Liver Transplantation, Living Donor Liver Transplant, Pancreatic Surgery
1021688	Anaphylaxis-Clinical updates on epidemiology and pathophysiology The underarm as an axillary organ and the possible role of antiperspirants in hormone dependent disorders
1021694	My research is focused on ways to improve treatment and outcomes of patients with HIV on antiretroviral therapy.  In particular, I am interested in strategies of HIV eradication, broadly neutralizing HIV antibodies, and the epidemiology of HIV-associated cancers.
1021715	I am interested in human movement, particularly those that pertain to rehabilitation. Many of the projects that Im involved with focus on the biomechanics of able-bodied and pathological gait. Our goal is to better understand normal gait, and to use that knowledge to evaluate and improve the gait of persons who walk with prosthetic or orthotic devices. Results from our work may enable us to develop more functional lower-extremity prosthetic and orthotic components.
1021758	Bone density testing, Musculoskeletal radiology
1021759	Coronary bypass surgery, Pacemakers, Valve repair and replacement
1021762	The research in my lab is centered on the espins, a novel family of multifunctional actin-bundling proteins, and the elucidation of their roles in the organization and function of the actin cytoskeleton of hair cell stereocilia and sensory cell microvilli. Espins are produced in multiple isoforms from a single gene. They are present in the parallel actin bundle of hair cell stereocilia and are the target of mutations that cause deafness and vestibular dysfunction in mice and humans. For example, the jerker frameshift mutation in the espin gene of mice causes recessive hereditary deafness and vestibular dysfunction accompanied by abnormal stereociliary morphogenesis and accelerated stereociliary degeneration. In particular, the stereocilia of jerker homozygotes, which lack espin proteins, fail to increase in diameter, suggesting that espins are required for the appositional growth of the stereociliary parallel actin bundle. Espins are also present at high concentration in the microvilli of taste receptor cells, solitary chemoreceptor cells, vomeronasal sensory neurons and Merkel cells, raising the possibility that these proteins play important, general roles in the microvillar projections of vertebrate sensory cells. Unlike other actin-bundling proteins found in the microvilli and stereocilia of vertebrates, espins are potent actin-bundling proteins that are not inhibited by calcium ion. In addition, espins are unusually effective at over-twisting actin filaments in parallel actin bundles and can do so even at low stoichiometry. In cells, espins efficiently elongate parallel actin bundles and, thereby, help determine the dimensions of microvilli and stereocilia. Espins can also bind actin monomer via their Wiskott-Aldrich Syndrome protein homology 2 (WH2) domain in vitro and in vivo and can assemble actin bundles in cells. These biological activities distinguish espins from other actin-bundling proteins and may make them especially well-suited to sensory cells.
1021800	Glaucoma: surgical, laser, and medical treatment outcomes. Low-pressure Glaucoma Treatment Study (LoGTS) 
1021803	My research is on the cause, treatment and prevention of glaucoma and Alzheimer's disease.  My laboratory specializes in discovering biomarkers of these disease processes.
1021859	General surgical pathology, GI / pancreatic pathology<BR><BR> Experimental: Hepatocarcinogenesis in rats and mice: nongenotoxic models peroxisome proliferator-induced hepatocarcinogenesis. AOX null mice model of spontaneous hepatocarcinogenesis. Study of liver stem cells in rat pancreas. Experimental models of nonalcoholic steatohepatitis.  Clinical: Pancreatic tumors: evaluation of prognostic markers. Hepatic tumors: characterization of morphological, phenotypic and prognostic factors. Colonic tumors: characterization of carcinomas arising in inflammatory bowel disease.
1021955	My practice is limited to general obstetrics and gynecology with special interest in the menopause and premalignant conditions of the uterine cervix.  
1021958	Dr. Hammond practices General Obstetrics and Gynecology and also directs the Northwestern Center for Family Planning and Contraception. Subspecialty interests include contraception and abortion among medically compromised patients; first and second trimester medical and surgical abortion; sterilization, including Essure and Adiana Hysteroscopic Sterilizations; gynecologic care of women with HIV; contraception, sterilization and abortion among women with physical and cognitive disabilities. Dr. Hammond's current research focuses on how contraceptives modify transmission of HIV virus.
1021982	Dr. Dunlop is a health services researcher with expertise in statistical methodology.  Her applied research interests include the investigation of physical activity to prevent disability in older adults and to understand the consequences of arthritis and other musculoskeletal disorders.  She co-authored a book on statistical methodology; she has published and applied statistical methods for analyzing longitudinal data.  Dr. Dunlop is the principle investigator on an NIH-funded epidemiologic study on the relationship of physical activity to reduce disability and an NIH-funded study to evaluate the cost effectiveness of a physical activity intervention. She has served on data safety monitoring boards,  on executive committees of federally funded clinical trials, and on the editorial boards of medical journals.
1021985	sexual function, erection, ejaculation, orgasm, erectile dysfunction, prostate
1022091	Aortic surgery, Maze procedure, Minimally invasive valve surgery, Ross procedure
1022107	IMRT techniques, Gamma Knife, Hyperthermia, Radiation dosimetry, Patient safety and Quality assurance
1022350	Autopsy pathology, Liver and pancreatic pathology<BR><BR> Our current work focuses on the molecular mechanisms responsible for PPAR action. Transcription of specific genes initiated by transcription factors/nuclear receptors is a complex process and involves the participation of multiprotein complexes composed of transcription coactivators. Coactivators contain one or more highly conserved LXXLL (L, leucine; X, any amino acid) motif for direct interaction with AF-2 (activation function 2) region in nuclear receptor.  Our laboratory cloned PBP, PRIP, PIMT, PRIC285 and PRIC320 using either yeast two-hybrid screening or by isolating receptor binding proteins and their identification by MALDI-TOF analysis. We are generating gene knockout mouse models to elucidate the role of these coactivators in the regulation of specific gene transcription. Our work demonstrated that the deletion of PBP, PRIP PIMT and PRIC320  genes in the mouse results in embryonic lethality, indicating that these are vital for development and they alter the function of many nuclear receptors and other transcription factors during critical developmental stages. Recent developments in the area of conditional targeted somatic mutagenesis have opened new avenues for analyzing the physiological functions of coactivator signaling in a variety of tissues and cell types during early development and in the adult.
1022359	As a career pediatric hospitalist, I enjoy all aspects of pediatric care at both academic and community sites.  I have a strong interest in education and development of future hospitalists as the field is developing and exciting.  I have clinical interests in pediatric emergency medicine, inpatient care including ICU, and procedural sedation.
1022425	Medical publishing, Comprehensive care of the adult, Medical decision making, Preventive care
1022554	The Division of Immunotherapy and Autoimmune Diseases (DIAD) is the only center in the world devoted to a unique area of treatment and research utilizing stem cell transplantation in clinical trials for autoimmune diseases and vascular diseases. DIAD pioneered and performed Americas first hematopoietic stem cell transplants to treat: Multiple Sclerosis (MS), Diabetes, Lupus, Crohns, Rheumatoid Arthritis, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Phemphigus, Dermatomyositis, Devics, Myasthenia Gravis, Polymositis and Scleroderma
1022576	Diabetes insipidus, Fluid and electrolyte disorders, Pituitary hypothalamic disease
1022579	Vasoactive molecules in the pathobiology of adverse pregnancy outcome, Receptors 
1022677	My interest is in understanding mechanism of disease. Our approach is gene discovery, animal and cell culture  modeling and therapeutic application in disorders of the nervous system. My specific emphasis is on neurodegenerative  conditions and those affecting the neuromuscular system. We have focused on amyotrophic lateral sclerosis, the spastic parapareses, primary lateral sclerosis and frontal-temporal lobe dementias as protoptypic neurodegenerative disorders. We have identified several gens that cause these disorders and have made  animal models to study their pathogenesis. In addition I collabotate with colleagues in the study of mitochondrial disorder of muscle and the peripheral neuropathies.
1022758	Diagnostic mycobacteriology, Microbiology / infectious disease
1022771	Asthma, Emphysema, Chronic Bronchitis 
1022771	Our group is interested in studying the outcomes of educational strategies (including patient simulation) used for teaching critical care to medical students and interns.
1022774	Vascular health including aortic aneurysms,amputation prevention, critical limb ischemia, peripheral vascular surgery, and disorders of the veins (varicose veins and vascular malformations). 
1022800	melatonin, dopamine, neuropharmacology, melatonin receptors, signaling, circadian rhythms, depression, sleep, drug discovery,  
1022881	I am interested in infantile hemangiomas, common vascular tumors seen in up to 10% of infants.  This is both a clinical and research interest.  I am involved in multicenter, collaborative clinical research regarding the epidemiology, natural history, risk factors and treatments for these lesions, with colleagues from around the U.S. and in Europe.  I also have clinical and research interests in neonatal skin maturation and development and neonatal skin disorders.  Other clinical interests are infectious skin disorders and exanthems in children.
1022955	Causes and treatment of attention-deficit-hyperactivity-disorder, learning disabilities, and related disorders in children and adolescents. Utility of the EEG in medical management of ADHD.
1023189	Health services research related to disability and chronic illness; psychosocial aspects of disability 
1023190	Dr. Dyer conducts research that focuses on cardiovascular and nutritional epidemiology, particularly the role of nutritional factors in the development of high blood pressure and obesity; prevention and control of overweight and obesity in both adults and children; the development of empirically-based criteria for the diagnosis of gestational diabetes; and assessment of the impact of measurement error and regression dilution bias on associations in observational epidemiologic studies.
1023212	Relationship between employee health risks and medical conditions and direct and indirect medical, disability and productivity costs to an employer
1023232	Molecular docking, enzyme structure and function, structure-based inhibitor discovery, beta-lactamases, protein stability-function tradeoffs, enzyme evolution. 
1023239	HIV infection, HIV-1 Vpr, Viral pathogenesis, Cell cycle G2/M control, Viral oncogenesis, Anti-cancer therapy 
1023356	Clinical cardiac electrophysiology, Heart rhythm problems
1023528	Stroke recovery and rehabilitation especially in the area of upper limb motor control.  I am interested in the epidemiology of neurorecovery after stroke, genetic markers of recovery and cortical stimulation for motor recovery after stroke. 
1023562	role, of, nuclear, lamins, in, transcription, and, DNA, replication
1023575	My clinical interests lie in developmental anomalies, prenatal counseling for fetal anomalies, minimally invasive surgery, endocrine surgery, hernias, undescended testes, inflammatory bowel disease; surgery for tumors or cancers of the neck, chest and abdomen.
1023584	Theoretical statistics, operations research, numerical optimization, behavioral medicine, health psychology
1023591	Dr. Sheehan is interested in youth development and community based injury and violence prevention.
1023744	Dr. Matsumura is a practicing vascular surgeon at Northwestern Memorial Hospital and is an Associate Professor of Surgery at the Northwestern University Feinberg School of Medicine. He is board certified in Surgery with added qualifications in Vascular Surgery.  His clinical interests are centered on endovascular treatment of all aspects of peripheral vascular disease, including carotid stenosis, thoracic aortic disease, lower extremity ischemia, deep venous thrombosis, and abdominal aortic aneurysm.  His research interests are concentrated on clinical trials of endovascular treatment of carotid stenosis and aortic aneurysm. He is involved regularly in the educational curriculum of medical students, residents, and fellows at Northwestern, but also frequently participates in continuing medical education of physicians in practice.  He organizes several educational programs each year and has been involved in the endovascular training of physicians from more than a hundred hospitals around the world. He has published over 65 peer-reviewed articles, 35 chapters, and ten books.  
1023778	My lab focuses on understanding discoordination of the upper limb after stroke, learning the involvement of brain plasticity in recovery, and developing novel neurotherapeutic training programs to enhance motor control of the upper limb even years after a stroke.  Additional research interests involve pharmacological interventions that seek to alter spinal interneuronal bias. 
1023834	collagen, nidogen, dystroglycan, extracellular matrix, basement membrane, axon guidance, cell migration, development, C. elegans 
1023841	Aesthetic surgery, Breast surgery, Reconstructive microsurgery
1023908	Primary clinical research efforts focus on pediatric onset systemic lupus. Active clinical research projects include development of tools to assess cognitive changes in pediatric lupus, development of best tools to assess disease flare and remission, best practices for treatment of lupus nephritis and development of biomarkers for nephritis and overall disease activity. Other clinical lupus studies have included assessment of corticosteroid therapy practices, assessment of ovarian suppression during treatment with cytotoxic agents, and multicenter studies to identify important genetic risks for pediatric lupus. I participate in studies of the genetics of pediatric arthritis as well as new therapies and phase IV drug registries. I have also participated in vasculitis registries in North America and Europe. Lastly, I have an interest in cost effectiveness and initiatives in health quality of care.
1023922	The epistemology of medicine--how physicians think--and how this affects medical education, professionalism, and patient safety.
1024002	Hepatology - liver
1024003	Dr. Maizels specializes in fetal urology, hypospadias, reflux, urine infection, enuresis, and hydronephrosis.
1024039	stress hypersensitivity, depressive disorders, genetic vulnerability, QTL, neuroendocrinology, hypothalamic-pituitary-thyroid, hypothalamic-pituitary-adrenal, emotional behavioral tests
1024043	Pain medicine
1024091	Dr. Carter's clinical interests cover a range of urologic conditions. General Urology, urologic cancers, urologic prosthetics, BPH, Stones
1024251	intercellular junctions, adhesion, desmosomes, adherens junctions, signal transduction, cell motility, skin disease, cadherins, cancer metastasis<br><br> Our laboratory is interested in the function and regulation of intercellular junction molecules in desmosomes and adherens junctions that act to mediate cell-cell adhesion and attachment of the cytoskeleton to the cell surface. Defects in junctional components caused by mutation or post-translational modification result in a variety of pathologies ranging from skin and cardiac disease to cancer. In addition, junction-associated molecules are involved in non-junctional functions such as signaling in development and differentiation. The lab uses a multi-faceted approach to dissect the function of cadherins, armadillo and plakin family junction components including but not limited to collaborative atomic structure determinations, molecular genetics, live cell imaging and trangenic mouse approaches.
1024254	Polysomnography 
1024281	Laboratory research focuses on the genetic regulation and phosphorylation of contractile proteins during cardiac development and in ishcemic and stunned heart.
1024369	Antenatal diagnostic testing, Fetal anomaly, High risk pregnancies, Obstetric and gynecologic ultrasound
1024438	Psychosomatic Medicine; Depression and heart disease; Psycho-oncology; Stroke related mood disorder; Multiple Sclerosis related mood disorder; Mood disorders; Anxiety Disorders; Evidence Based Medicine as applied in Psychopharmacology  
1024471	Attention deficit/hyperactivity disorder, child psychiatric epidemiology 
1024477	Circadian rhythm disorders, Insomnia, Nocturnal seizures, Parsomnias, Restless leg, Sleep apnea, Sleep disorders, Snoring and increased upper airways
1024510	pathophysiogy, stroke, spinal cord injury, spinal circuits,biomedical engineering, neural signal processing 
1024642	My research interest has been focused on pharmacology and biophysics of ion channel functions, which are either activated by voltage changes or mediated by ligand receptor binding.  Drugs of interest include, but not limited to, general anesthetics, local anesthestics, ethanol and drugs used to the treatment of Alzeheimer's diseases.
1024706	to come
1025014	Nanobiotechnology and Mantle Cell Lymphoma
1025371	Dr. Gershon is a leading expert in the application of Item Response Theory (IRT) in individualized and large scale assessments. He has developed item banks and Computerized Adaptive Testing (CAT) for educational, clinical, and health applications - including cognitive, emotional, and motor applications.  He is currently principal investigator on three projects with the NIH - Toolbox for the Assessment of Neurological Function and Behavior, the NIH Roadmap Patient  Reporting Outcomes Measurement Information System (PROMIS) Technical Center and the National Institutes on Aging Genetic Norming project.  He is also co-investigator and measurement development expert on numerous smaller projects including: NINDS sponsored project Quality of Life Outcomes in Neurological Disorders (Neuro-QoL), and the cancer-specific supplement to PROMIS.
1025562	1) Neuropsychological assessment of cognitive and memory impairment and changes in mood, behavior, and personality due to a neurologic disorder. 2) Identifying Adult ADHD and psychological difficulties associated with ADHD to assist in treatment planning. 3) Differential diagnosis of psychiatric disorders and identification of individual's strengths and weaknesses to tailor treatment to the needs of the individual patient.
1025760	Bleb leaks and wound revision; Intraocular pressure testing methods; Traumatic Hyphemas; Glaucoma Drainage Devices, patch grafts, and  complications; Diode Cyclophotocoagulation 
1025762	Clinical Interests: Congenital Infections, Fungal Infections, Kawasaki Disease, and Methicillin-Resistant Staphylococcus Aureus Infections (MRSA); Research Interest: Medical Education: I am currently involved in research on professionalism, patient safety, survey design and simulation education for Pediatric medical students
1025764	i currently direct the kidney and pancreas transplant programs at Northwestern University. My clinical interests include Kidney / pancreas transplantation, Laparoscopic surgery, Living donor kidney transplant, Vascular access, and desensitization for kidney transplant recipients. My research interests include developing cell based therapies to achieve tolerance induction in solid organ transplant recipients.
1025933	The research goal of myself, with the Schnaper lab, is to elucidate a cellular mechanism by which renal fibrosis progress and to seek for potential therapeutic/preventive approach, with focus on molecular mechanisms for function of a fibrogenic cytokine, TGF-. Due to a pleiotrophic nature of this cytokine, multiple factors other than directly downstream transcription factor, Smad, are involved in its regulation.   I have characterized several of those pathways using cultured kidney epithelial or mesangial cells as model systems. My recent work that connected those signaling events with a function of cellular receptor of the extracellular matrix, integrins, has added a new dimension to the project.  The lab is now applying our previous findings in vitro in a mice model of renal fibrosis. Our recent data (unpublished) show that the renal fibrosis in this model is dependent on both TGF- and PI3K pathways.  Interestingly, a d isoform of PI3K appears to play a role for podocyte damage, whereas up-regulation of TGF- followed by the initial podocyte damage mediates fibrotic processes.   These data are critical to further understanding of multiple steps involved to achieve final image of renal fibrosis.
1025958	Interaction of Sleep Disorders and Cardiovascular disease, CHF Disease Management 
1025998	Ambulatory anesthesia, Cardiovascular anesthesia, Thoracic anesthesia
1026001	Geriatrics, Hospital-based care of the medical patient, Preventive medicine
1026204	Although I see patients with a variety of endocrine conditions (including growth and thyroid disorders, diabetes), my clinical interests specifically include pubertal disorders, adrenal disorders, PCOS
1026219	The role of PTH and thyroid hormone in cell proliferation 
1026346	neonatology 
1026364	Science outreach, scientific literacy 
1026377	At present, my research program focuses on assessment and rehabilitation of cognitive impairment in brain injury. Current funded projects include the following. 1) A clinical trial of a virtual reality treatment protocol for patients with brain injury. 2) Examinations of interventions for sleep disorders in patients with brain injury. 3) A study of the validity of instruments for assessment of brain injury and posttraumatic stress disorder. 
1026382	Body imaging, Cardiac magnetic resonance imaging (MRI), Fast magnetic resonance imaging, Magnetic resonance angiography (MRA), Neuroradiology
1026388	Clinical interests include the care of children with growth disorders, disorders of puberty, adrenal disorders and the care of children with long-term endocrine sequelae of cancer treatment and brain tumors.
1026394	Blending an in depth psychological approach with appropriate psych meds, only as needed
1026398	Dr. Whitington's research involves the study of immune mechanisms of pediatric liver diseases.  Our lab has identified an alloimmune mechanism of fetal liver injury, a process we call gestational alloimmune liver disease, which is the cause of most or all cases of neonatal hemochromatosis and is the likely cause of most cases of liver failure in the first 3 months of life.  We also suspect it to be a major cause of intrauterine fetal demise.  We are also investigating the immune mechanisms of biliary atresia and idiopathic neonatal hepatitis, as well as mechanisms of fibrogenesis (a byproduct of immune activation) in genetic cholestasis, neonatal hepatitis, fatty liver disease, and hepatic allografts.
1026399	Interventional radiology 
1026407	Research activities of our group focus on two major clinical areas: musculoskeletal pain and bone.  In the area of musculoskeletal pain, the development and characterization of analgesic agents for the management of osteoarthritis has been a major focus for over the past decade.  We have helped design and implement phase 2 studies of many of the major classes of drugs currently in use, including NSAIDs, cox-2 selective inhibitors, opioids, topical analgesic agents and novel approaches to pain including antibodies to NGF (nerve growth factor) and other agents active on the peripheral nervous system.  In the areas of chronic low back pain and osteoarthritis, our group has worked closely with Dr. A. Vania Apkarian in the Department of Physiology to describe and understand spontaneous chronic pain with a particular focus of the role of the cerebral cortex.  Current NIH-funded studies are evaluating the transition that occurs in some individuals who progress from acute to chronic pain in order to understand the changes that occur with the hope of eventually being able to modulate cortical activity to produce better clinical outcomes. Bone loss is known to be a major problem for individuals with disabilities, particularly those who are not able to ambulate or bear weight normally.  Our group has initiated studies aimed at treating patients with acute spinal cord injury to attempt to maintain bone mass during their immediate post-injury period.  In those individuals with SCI who have already lost significant bone mass, we have undertaken a second set of studies aimed at evaluating approaches to increase bone mass in these individuals, using physical and pharmacological interventions.
1026407	Research interests focus on the development and evaluation of new therapeutics for the treatment of osteoarthritis, osteoporosis and pain through clinical trials in phases I-IV.  These studies include both investigator- and industry-initiated investigations and are funded by NIH and industry sources.  
1026444	In vitro fertilization, Infertility
1026447	computational neuroscience, information processing, complex systems, neuronal code, systems neuroscience  
1026461	I am interested primarily in school health issues and those that affect children and adolescents.
1026590	Hand and upper extremity conditions (shoulder, elbow, forearm, wrist, and hand).
1026870	Primary research interests involve:  caregiver stress, psychosocial adjustment to chronic illness and disability, men's health, stroke and brain injury, aging Clinical assignments include:  stroke, pulmonary rehab, brain injury
1026925	Brain tumors / neuro-oncology, Spine diseases, Stereotactic radiosurgery
1027058	Utilizing minimally invasive techniques to treat spine disease including degenerative, trauma, tumor and deformity.  Development of new techniques to facilitate minimally invasive spine access.  Treatment of spinal cord injury.
1027068	My passion is for general medical dermatology and ways to improve the patient experience through technology and education.
1027156	Clinical microbiology, General infectious disease, Transplant infectious disease
1027175	Asthma, Idiopathic pulmonary fibrosis, Pulmonary embolism, Sarcoidosis
1027175	Dr. Budinger's laboratory is interested in the mechanisms by which oxidant stress activates signaling pathways in the lung. A particular area of interest is the mechanisms by which oxidants generated in response to exposure to airborne particulate matter air pollution activates signaling pathways in the lung that might contribute to particle related morbidity and mortality.
1027212	...
1027219	Mood disorders, Psychopharmacology
1027224	Obstetric, Gynecologic and Ambulatory Anesthesia
1027227	My clinical research focuses on three areas: 1.  Hospital epidemiology 2.  Antimicrobial resistance, especially in    immunocompromised patients 3.  Emergency preparedness for emerging pathogens and those with bioterrorism potential. 
1027227	Opportunistic infections, Transplant infectious disease
1027269	We are in the process with NCQA of starting a Patient-Centered Medical Home demonstration project within Northwestern Memorial Physicians Group at our internal medicine office site.
1027396	My research focuses on sensorimotor control of the hand and its rehabilitation following neuromuscular injury, such as stroke.  Toward this end, my research group and I are pursuing three interdependent lines of research in the Coleman Hand Rehabilitation Laboratory: description of hand neuromechanics, quantification of the mechanisms of hand impairment following stroke, and the development of mechatronic devices for hand therapy following stroke.
1027416	Blood group isoimmunization, Fetal anomaly, Hypertension in pregnancy, Prenatal diagnosis
1027425	Movement Science, Balance, Aging, Parkinson's Disease, Functional Outcomes, Cultural Competence
1027426	Bladder drop, Gynecologic surgery, Laparoscopic surgery, Minimally invasive surgery, Special female pelvic surgery, Urinary incontinence, Urogynecology, Vaginal hysterectomy, Vaginal prolapse, Vaginal repair
1027428	High Impact Education Dissemination;  Palliative and End-of-life Care Research;  Geriatrics and Aging Research;  Patient Safety;  Family Caregiver Education;  Economic Resilience for Caregivers
1027443	The Bohn lab is developing gene and stem cell therapies for Parkinsons disease (PD) and amyotrophic lateral sclerosis (ALS)using experimental rodent models of these diseases. Previous studies  focused on gene therapy with the neurotrophic factor, glial cell line derived neurotrophic factor (GDNF) which the group has shown slows the progression of dopamine neuron loss in rat models of PD.  A phase I clinical trial testing GDNF gene therapy will commence soon. The lab is currently studying viral vector mediated gene silencing of alpha-synuclein, a gene linked to familiar forms of Parkinsons disease.  In addition, the lab is generating neuroprogenitor-like cells and neurospheres from rat and mouse bone marrow and determining whether this interesting source of stem cells can be developed as a novel therapy for PD.  Studies of the effects of rat bone marrow derived neurospheres are also being tested for effects on traumatic brain injury.  Viral vectors harboring neurotrophic factors are also being made for studies aimed at reversing aging of dopamine neurons in rat hypothalamus and targeting upper motoneurons in mouse models of ALS.  The experimental approaches in the lab are multi-faceted and employ techniques ranging from making viral vectors to molecular and morphometric assays  to behavioral testing.
1027447	My primary clinical interest is to use minimally invasive magnetic resonance imaging techniques to guide and monitor localized treatment of tumors, especially for liver and pancreatic cancer. I have an active laboratory that has translated a number of developments from our animal lab to the clinical arena.
1027454	Picture Archiving and Communication Systems Display Systems for Medical and Image Information Imaging Informatics Integrating Medical Information Systems Data Mining Operational analysis Improving workflow efficiency 
1027497	Autoimmune skin diseases, Non - melanoma skin cancer, Psoriasis
1027734	Diagnostic ultrasound, Fetal anomaly, High risk pregnancies
1027926	Research interests include neurodevelopmental correlates of craniosynostosis, quality of life for individuals with cleft and craniofacial conditions, and correlates of learning disabilities in children with cleft lip and palate.  I am part of a multi-disciplinary, multi-site research team that is following a cohert of children born with a single suture craniosynostosis and controls who do not have this condition.  With NIH funding, we have evaluated these children at diagnosis, 18 months, 3 years and are beginning a 7-year-old evaluation.   Differences in facial appearance affect social and emotional development in children with orofacial clefts and other craniofacial conditions.  I am investigating the impact of these conditions, stigma, and quality of life.
1027933	Dr. Cryns is an endocrinologist whose research focuses on the genes and signaling pathways that cause breast cancer. The overall goal of his research is to translate molecular insights into better therapies and prognostic markers for breast cancer patients. 
1027933	Dr. Cryns leads a multidisciplinary team of scientists who focus on understanding how cells die. His group is especially interested in elucidating how abnormalities in cell death contribute to the pathogenesis of breast cancer and in translating these insights into improved predictive markers and therapies. He is also founding Director of the SUCCEED Breast Cancer Survivorship Program at Northwestern, an innovative clinical program that provides personalized health care for breast cancer survivors.
1027947	Co-Director of Clinical Education Center:  Fostering innovative ways to improve clinical skills of our medical students and use of technology to enhance clinical skills. Clinical Practice:  Diagnositic dilemmas, health promotion 
1027947	Comprehensive care of adults, Hospital-based care of the medical patient, Medical consultations and diagnostic dilemmas
1027951	I am a board certified pathologist with subspeciality certification in cytopathology. My primary intereststs are  gynecologic cytology, fine nedle aspiration of head & neck/thyroid, breast, and general cytopathology. Advocacy for cytopathology and women in medicine as well as medical education are my other interests. I am active in organized medicine and have leadership roles in many national and international cytopathology/pathology organizations. I teach at the local, national and international levels.
1028063	cytoskeleton, myosin phosphorylation, self-assembly, cell motility, signal transduction 
1028321	Ancillary techniques, Cytopathology, Pulmonary pathology
1028424	Our group studies the structural basis for interactions between proteins, and between proteins and small molecules, that play important roles cell biology.  We have focused on the GTPases of the Signal Recognition Particle (SRP), Ffh and FtsY, currently seeking to understand the structural basis for regulation of the assembly of their heterodimeric targeting complex. Our lab is also initiating a proposal to determine the structures of novel members of the trypanosome surface coat proteins (VSGs).
1028426	Nucleolus, nucleus, chromatin, nuclear structure and function, cancer, growth-regulations, signal-transductions, 
1028607	Care of adults with a history of childhood cancer, Preventive medicine
1028619	Genetic counseling; informed consent for genetic testing; medical decision-making, health care communication, ethics, specifically around areas of genetic testing and research.  
1028771	Current research activity is focused upon the psychological functioning of children and adolescents with HIV infection/AIDS, risk behavior in adolescents with HIV exposure/HIV infection, and individual and psychosocial factors mediating HIV medication adherence.  
1029113	Musculoskeletal imaging
1029130	epithelial cells, membrane traffic, GPCR, arrestins, epithelial polarity, mucosal biology, mucosal inflammation, apoptosis 
1029134	My primary research interest is in health outcomes following pediatric liver transplantation and acute liver failure.  I lead a research group that studies all aspects of outcomes from survival to health related quality of life (HRQOL).  The largest current projects examine HRQOL and cognitive outcomes in pediatric liver transplant survivors, long term complications related to immunosuppressive medications and the causes and treatment of acute liver failure.
1029137	I have a strong interest in medical ethics, especially ethical issues in pediatrics, end-of-life care, research on human subjects, transplantation, children with disorders of sex development (DSD) and gender identify nonconformity, medical and surgical innovation, transplantation and conscientious objection to requested care by health care professionals.  My main clinical interests are in pediatric palliative and hospice care, multidisciplinary care of children with DSD/GID and parent support for difficult decisions under conditions of uncertainty.
1029164	Primary research interests are in adult and pediatric genito-urinary and CNS cancers including prostate cancer, Wilms tumor and brain tumors. The other areas of interest include development of novel therapies for recurrent tumors including prostate, brain and neuroblastoma. Radiosurgery, hyperthermia,intra-operative radiation therapy, brachytherapy, novel IMRT techniques and nanoparticle-mediated delivery of novel radiosensitizing therapy are areas of ongoing clinical and basic research.
1029324	Adolescent gynecology, Colposcopy, Menopause
1029534	Special interest in working with chronic pain and with anxiety disorders. Experienced in Mindfulness-based Psychotherapies and Acceptance and Commitment Therapy.
1029833	I am both a clinician and a researcher as well as an educator. I am interested in studying the impact of chronic illness on the adaptation and coping of children, adolescents and their families. I am also interested in the area of transitioning from pediatric to adult care among youth with chronic illness.
1029930	My current research focus is on characterizing the signaling pathways that regulate endothelial cell behavior leading to the process of blood vessel development (angiogenesis).  In particular, I am interested in characterizing the role of the a4 laminin subunit, a component of the basement membrane of endothelial cells in blood vessel development.  I have previously demonstrated that a4 laminin contributes to angiogenesis by interacting with avb3 integrin and b1 integrin containing heterodimers.  I plan to further unravel the signaling mechanisms underlying a4 laminin dependent angiogenesis, to identify the critical phosphorylation events and to determine the role of apoptosis in the endothelial cell response to a4 laminin.  I am also interested in characterizing the signaling pathways that are involved in either enhancing or blocking the differentiation process of endothelial progenitor cells to endothelial cells.  Endothelial progenitor cells have been implicated in the development of new blood vessels during normal and pathological angiogenesis.  However, the mechanism and extracellular signals that initiate and regulate this process are poorly understood.
1030012	fluorescence microscopy, live cell imaging, endothelial cell, 3D vasculature enogineering, tumor-endothelial interaction, hemodynamics.
1030041	Dr Kuikens research group is working developing bionic technologies to improve the function of artificial limbs for people with very proximal amputations.  The main research focus of the lab is developing a technique using nerve transfers to improve of myoelectric prosthesis control called targeted reinnervation.  By transferring the residual arm nerves in an upper limb amputee to spare regions of muscle it is possible to make new signals for the control of robotic arms. This allows simultaneous control of multiple joints in a natural way.  The procedure has been very successful in patients with increases in speed of 50- 500%. Similarly, hand sensation nerves can be directed to reinnervate spare skin in or near the residual limb so that when this skin is touched, the amputee feels like their missing hand is being touched including light touch, graded pressure hot/cold, sharp/dull and vibration. This is an exciting pathway to producing true sensory feedback to amputees from their prosthesis.
1030273	I work with trauma and mental illness in children's mental health, juvenile justice, child welfare and education programs.  As Clinical Director of the Illinois Childhood Trauma Coalition we are focusing on developing a statewide system of care with appropriate professional development to address child trauma.  Within research, we are looking at children in the public sector who suffer from complex trauma and attempting to understand what treatments are effective with these children.  We are also engaged in supporting a movement to include a developmental trauma disorder diagnosis in DSM-V. 
1030597	Primary research interest involves identifying key molecule pathways (e.g. TLRs signaling pathways) leading to allograft rejection following organ transplantation using small animal transplant models.
1030626	Forensic Neuropsychology Traumatic Brain Injury Postconcussion Syndrome Posttraumatic Stress Disorder Violent Behavior 
1030644	Prostate cancer, angiogenesis inhibitors, PEDF, TSP 
1030765	CT,MRI, Image processing, Oncologic imaging, Abdominal imaging, Cardiac imaging.
1030810	Fitness, Nutrition and Weight Management, Medical care of the obese patient, Preventive medicine
1030810	Obesity, nutrition and lifestyle clinical care; clincal research in diet, body composition and weight mangement methods; and medical education in nutrition and lifestyle medicine
1031011	My primary research is in the field of biostatistics with particular emphasis in the areas of 1) longitudinal data analysis, 2) generalized linear and nonlinear mixed-effects models and 3) outcomes research as it pertains to survival analysis and causal inference.
1031145	Dr. Smith, who is a trained prosthetist, currently serves and has served as Principle Investigator on a number of research grants relating to the delivery of rehabilitation services and technologies to war wounded populations internationally. In particular he has been involved in the development and delivery of appropriate prosthetics and rehabilitation technologies and distance learning to land mine victims in low income countries. In addition, Dr. Smith has led the development and commercialization of a number of health informatics applications including store-and-forward telemedicine, personal health record (PHR) and clinical decision support (CDSS) systems. 
1031152	The focus of the work in my lab is directed towards the understanding of neuromusculoskeletal control during active movement in persons with brain injury.  In particular, studies seek to understand the control mechanisms underlying locomotor behavior in persons with post-stroke hemiplegia.  Related to this objective, the work is attempting to understand underlying mechanisms of poor control and to develop quantitative evaluation and intervention tools for the amelioration of locomotor deficits post-stroke.  The experimental approach includes measurement of electrical muscle activity, lower limb force and movement trajectories, and electro-physiological reflex testing during cyclical locomotor movements such as walking and pedaling. 
1031187	Clinical interests include diagnosis and treatment of kidney diseases, hypertension, acute kidney injury and chronic kidney disease, and management of patients on dialysis.
1031217	CLINICAL NEONATOLOGY
1031304	My research focuses on spinal motor-system. I am interested in the interaction between pre-motor interneurons and motoneurons; the synaptic plasticity of motoneurons for peripheral and brainstem descending pathways; and the mechanisms of amyotrophic lateral sclerosis (ALS).  Using a root recording system I developed for mouse spinal cord study, I have demonstrated the existence of two forms of short-term plasticity in the spinal motoneurons in response to different source of synaptic inputs. Further studies in this direction will move toward the cellular level to understand their pre- and post-synaptic mechanisms.  In an animal model of ALS (mSOD1 mouse), I have found that NMDA receptors in the spinal interneurons might be an important component contributing to motoneurons' excitotoxicity. Further studies will apply intracellular recording and calcium image techniques to answer that through what ions, channels and/or receptors the interneurons interact with motoneurons in mSOD1 mouse in order to determine new therapeutic targets for this disease. 
1031419	My clinical practice is focussed on treating adult and older adult individuals and couples with relational problems, depression, anxiety, and addicitions. I frequently work closely with primary care physicians to treat patients with medical disorders. My research interests are in psychotherapy and psychotherapy integration
1031423	My primary clinical interest is the field of Thoracic Imaging.  Within the field, imaging of lung cancer and imaging of pulmonary embolism are particular interests. My primary research interest at this time is lung cancer screening.  I am one of the Investigators for the National Lung Screening Trial (NLST), an ongoing multi-institutional trial funded by the National Cancer Institute (NCI) to try to determine if lung cancer screening decreases lung cancer mortality.  For more information on NLST, see www.ACRIN.org.
1031537	Medical disorders of the breast, Woman's health
1031630	Dr. Pinski practices general and cosmetic dermatology. He has a particular interest in facial rejuvenation with Botox, filler substances and liposuction. He is also a national instructor for Botox, Restylane and Juvederm.
1031667	I have just written a book on psychiatry, 'The Origin of Symptoms': cultural aspects, clinical intensive pschotherapy case studies, the brain, genetics overview ( review of journals), animal studies. My interests are pschoanalytic.
1031759	Lasik surgery, Ophthalmic plastic surgery, Refractive surgery, Refractive surgery
1031779	Implementation science and critical care outcomes.
1031800	I am currently searching for new and innovative methods for incorporation in the teaching of residents and medical students. In addition to teaching the science and the art of medicine, it is incumbent upon us, as faculty, to lead the way in providing service to community and to those who are less fortunate.     
1031839	Psychotherapy, child psychopharmacotherapy and school consultation.
1031841	Developmental Disabilities (Clinical)
1031867	I am interested in studying the experiences of families who have children hospitalized in a neonatal intensive care unit.  My focus is on medical decision-making and the interactions of families with medical providers in the process of decision-making.
1031869	Dr Reids research interests are aimed at gaining a greater understanding of the relationship between the sleep and circadian systems with health and safety. Current research areas include, understanding the basis and treatment of circadian rhythm sleep disorders, the effects of sleep loss on performance and safety, and the relationship between sleep and risk for metabolic and cardiovascular disease.  Dr Reid also has extensive experience in the study of the impact of shift work on sleep, performance and health in the workplace.  
1032015	Gynecologic infections, Menopause, Vaginal problems, Vulvar problems
1032029	Breast Imaging: mammography, ultrasound, MRI Breast Image-guided procedures
1032035	Breast imaging, Digital mammography, Radial scars
1032044	I have been deeply involved in medical decision making from the perspective of psychological and fact driven decisions.  I enjoy nearly all aspects of managing general medical problems from cholesterol to autoimmune disease to travel medicine... I try to maximize my patients health and quality of life.
1032062	My research is focused on the mechanisms underlying Parkinson's disease and schizophrenia. This pursuit employs a combination of electrophysiological, optical, genetic and behavioral approaches.
1032088	Biomedical signal processing, cardiac arrhythmias, computer modeling 
1032158	Interventional Oncology offers various treatment therapies to cancer patients using minimally invasive angiographic techniques and treatment options at various stages in cancer treatment. These treatments may be used alone, in combination, or in conjunction with standard of care cancer treatments such as chemotherapy and radiation, as a palliative treatment, or may be used as a bridge to organ transplantation
1032326	magnetic resonance imaging, cardiovascular imaging, technical developments, heart, interventional, coronary artery disease, oxygenation,contrast agent, angiography,perfusion 
1032446	Dr. Brian Helfand is a research assistant professor in the Department of Urology.  He completed his MD/PhD at Northwestern University and is continuing with his clinical education in urology.  His research focus is directed towards identifying the cellular and molecular mechanisms underlying prostate cancer.  Specifically, he is interested in the changes in both the cytoskeletal and nucleoskeletal intermediate filament proteins which promote metastases and disease progression.  In addition, he is focused upon elucidating the mechanisms by which intermediate filaments control the expression of DNA (transcription) and their combined influence on cell behavior.
1032461	Integrin regulation of proteases in oral keratinocytes (special focus on urokinase receptor-integrin interaction and consequent intracellular signaling events). Effects of altered expression of proteases on tumorigenecity/invasion of oral cancer. 
1032738	Fetal Brain Injury, Oxidants, Neuroprotection, Cerebral Palsy, Fetal Alcohol Syndrome 
1032739	Acute coronary care, Coronary angioplasty, stenting, and atherectomy, General cardiology, Peripheral vascular interventions
1032743	Abdominal aortic aneurysms, Angio / stents, Endovascular, Extracranial cerebrovascular disease 
1032810	Cardiac electrophysiology
1032869	Body imaging
1032893	Cardiac rehabilitation, Echocardiography, Vascular biology
1032940	Integrated systems, Neuroanatomy, respiration, amygdala, basal ganglia, cerebellum,  
1032946	Acute renal failure, Pre and end stage renal disease care
1033130	Glycolipid and cell behavior/skin cancers.
1033185	Dr. Hirano is Associate Professor of Medicine and Director of the Gastroenterology and Hepatology Fellowship Program at Northwestern University Feinberg School of Medicine.  He attended medical school at the University of Pennsylvania and completed his medical residency and GI fellowship at Beth Israel Hospital in Boston. He took a faculty position at Harvard Medical School working in esophageal physiology before coming to Northwestern in 1998. His academic interests focus on eosinophilic esophagitis and swallowing, motility,  and esophageal disorders.
1033185	Eosinophilic Esophagitis, Eosinophilic Gastroenteritis, Esophageal motility disorders, Gastroesophageal reflux disease, Swallowing disorders
1033220	Clinical research Development of devices facilitating the plastic surgery field
1033261	From 1987-1997, I built a clinical service and research program at Rush University with an emphasis on quality of life and outcome evaluation in cancer treatment research.  I developed and am continually refining the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System for outcome evaluation in patients with chronic medical conditions. I have focused my career studying questions regarding quality of life measurement in clinical trials, cross-cultural equivalence of quality of life measurement, efficacy of psychosocial interventions in oncology, and medical outcomes research. I am the principal investigator of the statistical coordinating center for the NIH Roadmap Initiative to build a Patient Reported Outcome Measurement Information System (PROMIS). I am also the principal investigator of a contract to develop item banks for the clinical trials supported by the National Institute of Neurological Disorders and Stroke.
1033359	informed consent in the clinical arena, health policy development, classificatory theory, medical education and patient safety research
1033423	Building And Re-Building Of Limbs And Hearts. The Simon Laboratory has identified regulartory genes that play key roles in limb development in virtually all vertebrates, including humans. Surprisingly, these genes are also critical for the shaping of the heart during embryogenesis and when mutated in humans, they lead to birth defects of the arms and heart. Using zebrafish and mouse models, the lab tries to gain a deeper understanding of common genetic pathways in limb and heart development and disease. In addition to these developmental studies, the lab is interested in discovering the genes that are involved in regenerative processes. As models for these investigations, zebrafish and newts are employed, which can regenerate limbs and heart ventricles throughout their life times. The identification of genetic pathways that are operational in these regenerating species but not in mammals, will provide new insights how to restore regenerative abilities in non-regenerating species including humans.
1033524	My primary interest is the diagnosis and treatment of pain disorders pertaining to the spine.
1033629	Chronic inflammatory demyelinating neuropathy (CIDP); Guillain-Barre syndrome (GBS; Chemotherapy induced neuropathy; Myasthenia gravis; Muscular dystrophy; Electrophysiology in peripheral nervous system diseases
1033859	Dr. Rudicks research focuses on characterizing the peripheral and central (spinal cord and brain) neuronal mechanisms of acute and chronic pain in interstitial cystitis, chronic prostatitis/chronic pelvic pain syndrome and urinary tract infection.  Dr. Rudick is currently investigating the transition from acute pain to chronic pain and developing novel therapies to treat both acute and chronic pain associated with the urinary tract.
1034093	Current clinical practice utilizes a multidisciplinary team approach to the diagnosis and treatment of pediatric epilepsy and comorbidities.  Dr. Millichap has over 20 peer-reviewed medical publications and serves as the Deputy Editor of the Resident and Fellow Section of the journal Neurology.  As a member of the academic faculty of Northwestern University, he is involved in the education of trainees and grant-funded clinical research concerning epileptic encephalopathies.
1034109	biomedical communications, biomedical policy, biomedical literacy, health literacy, scientific literacy, cancer communications, public health communications, information technologies, multivariate analysis 
1034453	Our group seeks to elucidate the molecular mechanisms by which human prostate cancer cells regulate motility (and thus ultimately metastasis), to identify new drugs which target regulatory elements, and to evaluate their efficacy in humans.  Studies employ basic cell and molecular biology based investigations, animal models of metastasis, and early phase clinical trials involving cell and molecular based endpoints.  A central focus is upon the role of transforming growth factor beta (TGFb) associated signaling members.  Through these studies we have been able to link TGFb super family receptors, Smad proteins, members of the p38 MAP kinase signaling pathway, small heat shock proteins (in particular, HSP27), and matrix metalloproteinases (MMPs), into an inter-linked regulatory network within the cell, which together regulates cell motility, invasion, and metastasis.  We have identified a lead compound that effectively blocks activation of the key regulatory elements.  Our lead compound inhibits metastasis in murine orthotopic models, was well tolerated in human phase I trials, and demonstrates mechanistically relevant cell and molecular efficacy in phase II human trials.  
1034453	Phase 1 & 2 clinical trials, Prostate cancer
1034459	Development and validation of instruments to measure quality of life and rehabilitation outcomes
1034616	Dr De Plaens research focuses on the developmental aspects of the inflammatory mechanisms contributing to necrotizing enterocolitis, a devastating disease of the premature infant, causing sudden bowel inflammation and necrosis.   
1034656	A major pediatric research priority and the long-term goal of my laboratory is the identification of the etiology and pathogenesis of Kawasaki Disease (KD), the leading cause of acquired heart disease in children in developed nations. KD can result in coronary artery aneurysm (CAA) formation with resultant myocardial infarction and/or sudden death. Clinical and epidemiologic data are consistent with an infectious cause of KD, but conventional methods have not yielded the etiologic agent. We discovered that oligoclonal IgA plasma cells, CD8 T lymphocytes, and macrophages infiltrate CAA and other tissues in acute KD, indicating an antigen-driven response to an intracellular pathogen, such as a virus, with a mucosal portal of entry. We made oligoclonal KD antibodies in vitro and used them as tools to identify their target antigens. Immunohistochemistry revealed that KD synthetic antibodies detected antigen in acute KD but not control bronchial epithelium and in a subset of macrophages in acute inflamed KD tissues. In acute KD ciliated bronchial epithelium, antigen localized to distinctive perinuclear intracytoplasmic spheroids. Light and electron microscopy revealed that the spheroids in ciliated bronchial epithelium were cytoplasmic inclusion bodies (CIB). The CIB were most consistent with aggregates of protein and associated nucleic acid and likely derive from the KD etiologic agent. These data support the hypothesis that the KD agent enters via the respiratory tract, infects bronchial epithelium, and travels in macrophages to targeted tissues including coronary arteries, with antigen-specific IgA plasma cells and other inflammatory cells entering the tissues to combat the pathogen and resulting in tissue damage. The presence of CIB consistent with aggregates of microbial, likely viral, proteins and nucleic acids in acute KD lung provides a structural and molecular footprint that could lead to identification of the KD etiologic agent.
1034762	<BR><BR> My research work is focused on studying the mechanisms that regulate the transcriptional activities of nuclear receptors. Nuclear receptors constitute a large superfamily of transcription factors that regulate a diverse array of biological processes, including development and neoplasia, as well as energy and xenobiotic metabolism. In order to initiate transcription, some more factors are required to interact with nuclear receptors and to regulate their activities. These factors are collectively called 'nuclear receptor co-factors'. Several co-factors have been identified by our studies. Generating mouse models using gene targeting technology to investigate the functions of these genes is in process.
1035505	retrovirus replication, reverse transcription, integration, virus assembly mechanisms, molecular genetics
1035506	Primary Research Interest: Gene Regulatory and microRNA networks during neural tube development Clinical Research Interest: Biomarker discovery and validation in Spina Bifida. 
1035648	Dr. Holly Falk-Krzesinski is the Director of the Office for Research Development.  In this position, Dr. Falk-Krzesinski and her team support and advance faculty research and the Northwestern's collective research enterprise through strategic alignment of vision, priorities, capabilities, and opportunities to enable pursuit of large, multi- and interdisciplinary research initiatives that garner national and international recognition.  Dr. Falk-Krzesinski specifically focuses on life and biomedical sciences initiatives and works closely with five of the research schools: arts & sciences, engineering, communication, education & social policy, and medicine.  As Director, Office for Research Development, Dr. Falk-Krzesinski has successfully catalyzed and fostered a number of major multi- and interdisciplinary research projects:  The NIAID-funded contract award for a large-scale Structural Genomics Center of Infectious Diseases is a Center that applies state-of-the-art high-throughput structural biology technologies to experimentally characterize the three-dimensional atomic structure of targeted proteins from pathogens in the NIAID Category A-C priority lists and organisms causing emerging and re-emerging infectious diseases.  The Center provides a high throughput pipeline for structure determination that will carry out all steps of the process from target selection through structure deposition and will determine over 375 structures during the five-year period of the contract.  This initiative strengthened the partnership with the Advanced Photon Source and structural biologists at Argonne National Laboratory.  The NCI-funded Nanomaterials for Cancer Diagnostics and Therapeutics Center for Cancer Nanotechnology Excellence (CCNE) that advances nanotechnology as a critical driver of advances in oncology and cancer research leading to near-term benefits for patients. The new Center capitalizes on the very strong partnership between the University's International Institute for Nanotechnology and the medical school's Robert H. Lurie Comprehensive Cancer Center.   The Oncofertility Consortium: Fertility Preservation for Women, a program through the NIH Roadmap for Medical Research Interdisciplinary Research Consortium initiative.  The inter-institutional consortium is a framework into which new discipline of oncofertility will be fostered  to create new knowledge about the process of ovarian follicle development and provide the medical solution to fertility preservation for women with a fertility-altering cancer diagnosis.  The Regenerative Medicine Training Program, an interdisciplinary research training program of the NIH Roadmap for Medical Research Training for a New Interdisciplinary Workforce initiative.  The training program is for pre- and postdoctoral trainees and provides integrated training in the physical sciences, life sciences, and engineering with the goal of creating a new generation of scientists in regenerative medicine who can focus on overcoming the obstacles to developing techniques for repairing or regenerating damaged tissues and organs.   Participated as a co-organizer and engaging Northwestern faculty to participate in the regional partnership to bring university and industry research together: Catalyzing Collaboration between Industry and Academia in the Life SciencesNeurodegenerative Medicine, Regenerative Medicine/Stem Cell Biology, and Women's Health Research.  The NIDDK-funded NIH Islet Cell Resource as the lynchpin activity of the Chicago Islet Consortium, which Northwestern University, the University of Chicago, and the University of Illinois at Chicago comprise.  The overall goal of the Resource is to advance the field of human islet isolation for basic research and clinical transplantation.&.TRUNCATED
1035648	Holly Falk-Krzesinski, PhD, is Research Assistant Professor and Director, Research Team Support & Development at the NIH CTSA-supported Northwestern University Clinical and Translational Science (NUCATS) Institute.  My research activities involve collaboration enhancement and research development and grantsmanship for clinical and translational team-based, cross-disciplinary research.  Connecting the science of team science (research on scientific teams) with the praxis of team science (the practical aspects of science performed in teams), I translate empirical research findings about team science into evidence-based effective practices for scientific teams, institutions, and funders of collaborative team science.  Two areas of application on which I focus are tools and training.  I have been working on the development and implementation of research networking tools, knowledge management systems for the research enterprise, to support the efforts of researchers and research development professionals to initiate and nurture new interdisciplinary partnerships and secure collaborative extramural research funding.  And, in an effort to prepare trainees and investigators to engage effectively in collaborative research and team science, I have recently developed two interdisciplinary, team science training resources: a graduate-level Team Science course and TeamScience.net, an online learning tool.  I am now developing a workshop series focused on leadership and team science.  Finally, I chair the Annual International Science of Team Science (SciTS) Conference, through which I am working to develop a strong, interdisciplinary community of practice for team science, SciTS, and interdisciplinary research training.
1035819	I am committed to a career in patient-oriented research related to pulmonary vascular disease. Exploring the clinical impact and the mechanisms of pulmonary hypertension (PH) in patients with underlying lung disease is my primary research interest. This interest stems from my clinical experience over the last several years developing and building the Northwestern Pulmonary Hypertension Program. Pulmonary hypertension is a common complication seen in patients with lung disease, specifically chronic obstructive pulmonary disease (COPD). Although the association between the presence of PH in COPD and increased mortality has been well described, we have recently explored the impact of PH on patient-centered outcomes. I am interested in exploring the mechanisms of PH and identifying the disease as it presents early in the course of lung disease when interventions could potentially alter disease progression.
1035946	Samuel Stupp's research is focused on self-assembly and supramolecular materials with special emphasis in regenerative medicine, organic electronics, solar energy, and cancer therapies.
1035953	Neuromuscular Disorders: Amyotrophic Lateral Sclerosis Muscular Dystropy Peripheral Neuropathy
1036098	Traumatic Brain Injury, Outcomes, Measurement, Assistive Technology 
1036119	Our laboratory investigates the pathogenesis of the gram-negative bacterium Pseudomonas aeruginosa.  We focus on this organism's type III secretion system, an apparatus that injects toxins directly into host cells.  A second interest is the identification of novel virulence determinants.  Our studies utilize a broad range of approaches, including molecular and cellular techniques as well as animal models and epidemiologic studies on human populations.
1036135	The major focus of my academic interest has been the study of newborn vascular biology. I spent my fellowship and early faculty years studying extracorporeal life support (ECMO) in newborn infants under the direction of Dr. Thomas P. Green. I entered the laboratory of Dr. James Russell in 1990 and learned techniques to investigate basic mechanisms regulating vascular tone. I have gone on to apply this knowledge to better understand the normal development of the perinatal pulmonary circulation, and to determine specific abnormalities that result in persistent pulmonary hypertension. My recent work has utilized intact animal and bench approaches to investigate the role of oxidant stress in the vascular dysfunction and remodeling that characterizes PPHN. We have not only identified enzymatic sources of reactive oxygen species, but have also shown that antioxidant strategies reverse the physiologic and enzymatic abnormalities of PPHN. In collaboration with Dr. Paul Schumacker, my laboratory group has recently incorporated novel in vitro techniques to better understand specific cellular sources of oxidant stress during hyperoxic ventilation, which paradoxically is the most commonly used clinical treatment for respiratory failure and PPHN. Our work provides the scientific foundation for revising the current AHA recommendations to resuscitate critically ill newborns with 100% O2. I recently served as a lead investigator for a Phase I/II trial of intravenous sildenafil for the treatment of PPHN, and plan to proceed to a randomized multicenter clinical trial of intravenous sildenafil for infants with PPHN, beginning late in 2010.
1036144	My primary clinical and research interests lie in pediatric body imaging, especially CT and MRI with a specialty interest in cardiovascular imaging.
1036213	Rheumatoid arthritis, Scleroderma, Systemic lupus, Vasculitis, Wegener's Granulomatosis
1036243	Diagnostic ultrasound (obstetrics and gynecology), Fetal anomaly, High risk pregnancies
1036357	Primary research interests include critical evaluation of clinical research, post-graduate education, adverse drug reactions,and safety outcome measures.
1036557	Dr. Epsteins laboratory is engaged in the study of the impact of viral infections on the developing nervous system.  Currently we are investigating the role of Human Herpesvirus 6, and 7 (HHV-6 and HHV-7) as potential causes of hippocampal injury during febrile status epilpepticus (FSE).  Dr. Epstein is a co-investigator and the study neurovirologist for the ten year NINDS funded multicenter longitudinal FEBSTAT study of  200 children with FSE.   To date we have found that HHV-6B is the most common cause of FSE in children accounting for nearly 30% of the infants that present with FSE.  This longitudinal study will allow us to determine if FSE caused by HHV-6B or HHV-7 is more likely to result in mesial temporal sclerosis and temporal lobe seizures.  Intractable temporal lobe seizures are the most common reason for epilepsy surgery in adolescents and young adults.   If  HHV-6B or HHV-7 prove to be responsible for hippocampal damage it is possible that the injury could be prevented by treatment with anti-viral or anti-infammatory medications at the time of presentation with FSE.
1036558	Acute lung injury and the impact of mechanical ventilation on the injured lung have been a central focus of my laboratory work.  Particular attention to free radical production and inflammation are important are of interest.  The impact of critical illness on the metabolic response of young children has been a persistent interest of mine.
1036566	Current main research interests include: (1) patient safety, primarily risk assessment and in-situ simulation to improve team work and communication in pediatrics, obstetrics, transplant surgery, and family planning; (2) National Children's Study: child health outcomes; (3) healthcare quality indicators pediatric); (4) role of chronic stress in premature labor; (4) contribution of clinician and system factors to clinician-initiated deliveries; (5) prevalence and severity of food allergy and health services.
1036593	Complex dermatological cases, Cutaneous infectious disorders, General dermatology
1036661	Chemical pathology<BR><BR> Plasma lipoprotein metabolism and the pathogenesis of atherosclerosis.
1036691	Breast cancer, General Oncology
1036692	Placenta, Perinatal outcomes, Hypoxia, Angiogenesis 
1036702	Benign hematology, Disorders of thrombosis and hemostasis 
1036707	Cell signaling and breast cancer progression; Molecular staging of breast cancer; Fertility preservation for young patients with cancer; Impact of fertility treatment on mammary gland  
1036743	Colon cancer, Esophagus cancer, Gastric cancer, Hepatocellular cancer, Pancreas cancer, Rectal cancer
1036746	Specializing in the non-operative management of musculoskeletal conditions, joint injections, spinal injection.  Research interests include outcomes of spinal injections  
1036771	Hepatitis, HIV
1036775	Swallowing Disorders, GERD, Surgical complications and General GI 
1036779	High Fidelity Simulation, Virtual reality, Advanced Technologies in Medical Education
1036796	Cardiac imaging, Diabetes mellitus, Kidney failure
1036807	Research and clinical interests of the role of non-invasive cardiovascular imaging in acute coronary syndromes, coronary artery disease, ischemic and structural heart disease, and pre-operative cardiac evaluation. Specific focus on nuclear cardiology and cardiac magnetic resonance imaging.
1036807	Research in the noninvasive clinical utility of cardiac magnetic resonance and nuclear cardiology in the treatment, diagnosis and management of patients with cardiovascular disease.
1036812	Incontinence, Neurogenic bladder, Complex voiding dysfunction, Pelvic reconstruction 
1036816	We are involved in a variety of bimomechanical research projects in order to compare and optimize the biomechanics of fracture fixation. I am also collaborating with Sam Stupp at IBNAM looking at ways to enhance bone regeneration in a traumatic defect animal model using nanotechnology.
1036821	1 Failure to extubate / re-intubation rate in our institution (incidence, risk factors, complications, outcomes).    2 Special interest in ARDS (Adult Respiratory Distress Syndrome).  3 Gender difference in propofol-induced pain. 4 Developing teaching videos (in English and French) on hot topics of Neuro-Anesthesia and Neuro-critical care.  5 Electrolyte abnormalities seen after bladder reconstruction surgery 6 Surgical airways in our institution (incidence, risk factors, complications, outcomes). 7 Private and institutional Investors: Please note that your contributions are welcome to support our research efforts.
1036822	My  interests include defining the non-medical factors associated with clinician-initiated obstetric deliveries, specifically as it applies to birth prior to 39 weeks' gestation.  Our group has recently focused on racial disparities and the trends in these disparities for women who received induction of labor at both early-term (37-38) and late preterm (34-36) gestations.  Additionally, we have studied the associated between medico-legal pressures and regional rates of clinician initiated delivery including primary cesarean delivery and late preterm induction of labor in Illinois.   Another set of projects are within the Children's Hospital Neonatal Consortium (CHNC), an organization dedicated to improving care and outcomes for infants in Childrens Hospital NICUs through sharing of data, information  and ideas for benchmarking, research, and development of safety and quality improvement initiatives.  With the close collaboration of the Child Health Corporation of America, the CHNC has developed and deployed a database focusing on the population ill infants requiring medical/surgical subspecialty care due to congenital anomalies, preterm-associated consequences that were admitted to 22 US children's hospitals' NICUs since 2010.   Over 17,000 infants have been captured, and we aim to describe the care and outcomes for a population of infants that has not been focused on in traditional neonatal databases.  These include, for example, children requiring surgical care, those with congenital anomalies, and/or those with uncommon medical problems that are not necessarily associated with preterm birth.
1036826	Allergic rhinitis, Angioedema, Asthma, Drug allergy, Idiopathic anaphylaxis, sinusitis, Urticaria 
1036826	My main research interest is in the subject of chronic rhinosinusitis.  Chronic rhinosinusitis is one of the most common medical condition seen in the U.S.  We are currently investigating the role of Staphylococcus aureus in the pathogenesis of chronic rhinosinusitis.  We have demonstrated the presence of IgE allergic antibody in the serum of patients' with chronic rhinosinusitis.  We have also implied a superantigen  effect in the pathogenesis of nasal polyps by demonstrating clonal expansion of staphylococcal toxin specific T cell receptor (TCR) V-b domains in the polyp lymphocytes of individuals with chronic rhinosinusitis and nasal polyps.
1036835	Dr. Costellos research interests focus on clinical investigations in critically ill children with congenital and acquired cardiac disease. He is currently involved in perioperative clinical trials investigating natriuretic hormone infusions and strict glycemic control following pediatric cardiac surgery. He is also interested in the epidemiology and prevention of healthcare associated infections in critically ill children, and outcomes studies in neonates with critical congenital heart disease.
1036839	My primary research interests are in translational efforts in GI oncology.
1036841	Please visit our Sinus & Allergy Center website. www.northwestern-sinus.com
1036853	1. Targetting frail elderly in acute care setting using EMR and developing interventions to improve hospital and posthospitalization outcomes 2. Hospital wide QI project of recognition of cognitively impaired patients, and recognition and prevention of delirium
1036859	Electroencephalography, Epilepsy, Seizure disorders
1036916	Dr. Gonzalez's clinical interests include male reconstructive surgery and health policy.  He was awarded an NIH SPORE project pilot grant to study prostate cancer screening trends in Chicagos Hispanic community. He has also received funding from the Grant Healthcare Foundation for the development of electronic pre-visit software in order to improve the quality of patient care, reduce errors, control costs, and facilitate patient flow. Dr. Gonzalez is the Vice Chairman of Health Policy for the Americna Urological Association.
1036943	My laboratory focuses on understanding pathways relevant to the recruitment and trafficking of leukocytes within the intestines. Our goal is to understand how altering this recruitment can influence states of intestinal inflammation, specifically Inflammatory Bowel Disease (IBD).  My primary clinical interest is IBD (Crohn's disease and ulcerative colitis). I am also interested in understanding the relationship of the intestinal immune system to GI symptoms in rheumatologic disorders, specifically Juvenile Dermatomyositis.
1036974	Management of thyroid cancer, its recurrence process and associated neck dissections and advanced thyroid cancer with special interest in young adults.
1036989	My primary interest is in the career advising of medical students.
1037005	The diagnosis and treatment of bleeding disorders and their complications.  Evaluation of causes of thrombosis and education regarding treatment and prevention of thrombosis.
1037017	As a pediatric electrophysiologist, I follow pediatric and adult congenital patients with all types of arrhythmias.  In addition, I have a complex cardiomyopathy clinic to address the electrophysiologic issues in patients with heart failure and cardiomyopathy.  I am interested in the prevention of sudden cardiac death in the pediatric population, pediatric ECG screening (newborn, sports and ADHD ECG screening), and public use of AEDs.  In addition, I am interested in the cardiac changes from intense sports training and in cardiac rehabilitation in the pediatric population.
1037039	Dr. Mary Beth Madonna is a pediatric surgeon with expertise in minimally invasive surgery, hernias, undescended testes, gynecologic diseases, neonatal surgery, neck masses, cancer surgery and emergency consultations. Special interest in diseases of the intestines, specifically anorectal malformations and Hirschsprungs disease. Founded a special bowel management clinic for patients with these diseases  the second of its kind in the country.
1037049	I am a general Pediatrician who sees children from birth through college.  I have a clinical interest in breastfeeding and also in allergies, eczema, and asthma.  I speak Polish.   
1037051	Asthma and allergic diseases in the elderyly-project studied how to empower low income elderly patients to obtain appropriate asthma care. Role of innate immunity in asthma exacerbations: project involves measuring innate immune markers in asthmatics with high and low frequency of exacerbations.
1037051	Asthma, Hypersensitivity pneumonitis, Urticaria
1037113	Stem cell regulation in diabetic nephropathy 
1037136	Dr. Hairstons clinical interests include male and female incontinence, voiding dysfunction and pelvic reconstruction. He holds a particular interest in voiding dysfunction from neurologic causes such as spinal cord injury, multiple sclerosis, stroke, etc. His research efforts have included trials encompassing the prevention of UTIs in spinal cord injury patients, a placebo-controlled trial for treating Interstitial Cystitis, and investigation on the safety and efficacy of the urethral bulking agent Macroplastique for the treatment of female urinary stress incontinence.
1037160	Patient Safety, Interdisciplinary Teamwork, Hospital-based Care of the Medical Patient
1037160	Using enhancements in interdisciplinary teamwork to reduce adverse events in the hospital. 
1037226	Endoscopic Ultrasound (EUS), ERCP
1037232	Aestetic-cosmetic, Breast surgery, Eyelid, Oculoplastic, Orbit reconstrunction
1037259	Dr. Story is intersted in asthma and food allergy.  In the area of asthma she is particularly interested in the relationship between asthma and obesity.  In the area of food allergy she is interested in prevention and treatment of food allergy as well as eosinophilic esophagitis.
1037261	My clinical interest is the diagnosis and management of patients with hypertrophic cardiomyopathy and my research interest is the application of noninvasive imaging techniques such as cardiac MRI to HCM and the evaluation of their utility in risk stratification for sudden death/ adverse outcomes in HCM.
1037261	My research interest is in the relationship of clinical outcomes in Hypertrophic cardiomyopathy patients with their cardiac imaging findings. My clinical interests include, the care of patients with hypertrophic cardiomyopathy, family history of sudden cardiac death, left ventricular hypertrophy, valvular heart disease, coronary artery disease and preoperative cardiac evaluation.
1037262	Clinical Interests: Cerebrovascular surgery; skull base surgery; interventional neurosurgery. Research Interests: Outcome studies in vascular neurosurgery and stroke; simulation in neurosurgical education; advanced imaging of neurovascular diseases and brain ischemia.
1037264	General gastroenterology
1037282	The majority of my clinical research spans the areas of type 2 diabetes in youth, insulin resistance, metabolic syndrome and polycystic ovary syndrome.  My research explores both pathophysiology as well as treatment options.  I am also involved in TrialNet, a national consortium exploring avenues to prevent type 1 diabetes.
1037285	Anesthesia for High Risk Spine Surgery Anesthesia for Urological Surgery
1037296	Rheumatoid arthritis pathophysiology, cytokine biology, inflammatory arthritis, general rheumatology 
1037305	My primary clinical interests relate to hemoglobin disorders, specifically pediatric and adult sickle cell disease and thalassemia.  I also engage in clinical investigation in these areas.  I am currently the principal investigator of an NHLBI K23 award (K23HL094376), entitled, 'The Physiologic Assessment of Exercise Capacity in Pediatric Sickle Cell Anemia'.  This study aims to examine the cardiopulmonary determinants of exercise limitation, the acute inflammatory response to exercise and longitudinal changes in fitness in children and young adults with sickle cell anemia.  I am the principal investigator of several other protocols at Children's Memorial Hospital related to the detection of early cardiopulmonary disease and the assessment of free-living physical activity in this population.  I am also interested in the use of qualitative methods to study parental decision making as it relates to pediatric research participation as well as the socio-cultural barriers that face Asian and Asian Indian families affected by thalassemia.
1037308	Abnormal uterine bleeding, Adolescent health, Annual gynecological examinations, Menopause and menopausal symptoms, Minimally invasive treatment options, Osteoporosis and bone health, Uterine fibroids
1037345	Neuroradiology
1037363	My clinical interests encompass the Genitourinary malignancies including kidney cancer, bladder cancer, prostate cancer, penile and testis cancer with special interest in kidney cancer. My primary research interests involve translational applications of novel nanotechnology in the genitourinary cancers. 
1037372	Dr. Perry is Co-Director of the Minimally Invasive Surgery Program and is a nationally recognized expert in minimally invasive approaches to kidney cancers and other malignancies.  He has focused on treating renal and prostate tumors via robotic, laparoscopic and percutaneous approaches in order to reduce bleeding, complications, post-operative pain and recovery time.
1037374	regional: peripheral nerve blocks, transverse abdominus plane block, continuous peripheral nerve catheters obstetrics: epidural anesthesia, risk factors for postpartum hemorrhage
1037428	General neurosurgery, Neuro-oncology, Spine disease
1037482	Interventional Cardiology
1037512	Dr. Rinella's research interests primarily include non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).  She is engaged in both laboratory and clinical investigation of the pathophysiology of these diseases.  Her patient oriented research focuses on new treatments and understanding the factors responsible for the progression of NASH.
1037526	hematopoietic stem cell transplantation for autoimmune diseases. stem cell based therapy for incurable diseases. gene and immune therapy for malignancies.
1037526	stem cell based therapy and stem cell transplantation for non-malignancies.
1037532	Critical Care Medicine
1037537	Benign breast disease, Breast cancer surgery
1037549	We are interested in understanding the mechanisms leading to newborn brain injury, especially preterm brain injury. Our research focuses on the impact of hypoxia-ischemia on the development of cells of the oligodendroglial lineage. Our strategy is to genetically manipulate BMP signaling in an attempt to regenerate white matter lost to perinatal hypoxic-ischemic brain injury. Currently, we are exploring the role of microRNAs in modulating BMP signaling.
1037573	1.  Evaluation of Resident Physicians in their  performance of Internal Medicine Procedures using simulation 2. Congestive Heart Failure Outcomes at discharge and congestion relief 
1037573	Hospital Medicine, Medical Procedures, Simulation, Heart Failure, Medical Ethics / Religion, Patient-Physician Relationship
1037583	Clinical Interests:  Interventional Cardiology, Valvular Heart Disease, Radial Artery Angiography, Peripheral Artery Disease Research Interests:  Ischemic Cardiomyopathy, Diabetes and Coronary Artery Disease
1037583	Dr. Flaherty is an Assistant Professor of Medicine in Interventional Cardiology.  His clinical interests include coronary and peripheral intervention, PFO and ASD closure, heart failure, valvular heart disease, cardiac CT angiography and critical care.  His research interests include coronary revascularization in patients with heart failure and diabetic patients with coronary artery disease.  In 2008, he was recognized as the Teacher of the Year in the Division of Cardiology. Dr. Flaherty is board certified in Internal Medicine, Cardiovascular Disease and Interventional Cardiology.  Prior to joining the faculty in 2006, he completed residency and fellowship training at Northwestern Memorial Hospital.  He received additional training in Left Main Coronary Artery Stenting in Seoul, Korea.  He was graduated with honors from the State University of New York at Buffalo School of Medicine and Biomedical Sciences in 1999.   
1037585	Eosinophilic esophagitis, eosinophilic gastrointestinal disease, gastroesophageal reflux disease, esophageal disorders, food allergy and gastrointestinal disease, celiac disease, general gastroenterology
1037662	Perioperative Pulmonary Disease Management, Aneurysmal Subarachnoid Hemorrhage, Mechanical Ventilatory Support End of Life, Do Not Resuscitate
1037673	I am interested in Neonatal-Perinatal Medicine, especially congenital cardiac defects and their management. I am also interested in the use of computers in medicine related to improving efficiency and quality in clinical medicine. 
1037769	Airway Stenosis, Chest Wall and Mediastinal Tumors, Esophageal Cancer, Lung Cancer, Minimally Invasive Thoracic Surgery
1037813	I have a busy clinical cardiology practice in Glenview and Evanston as well as teaching responsibilities at Evanston and Glenbrook Hospitals.
1037814	Abdominal and thoracic aneurysm repair, Carotid angioplasty and stenting, Endovascular surgery 
1037814	Dr. Eskandari is a vascular surgeon at the Bluhm Cardiovascular Institute of Northwestern Memorial Hospital with a special interest in endovascular surgery and stent technology. He is also an associate professor of Surgery and Radiology, co-director of the Northwestern Endovascular Center, director of Carotid and Peripheral Artery Interventions, assistant director of the Blood Flow Laboratory and is on staff at Evanston Hospital. Dr. Eskandari has a special interest in carotid stenting. He developed the Carotid Stent Program at Northwestern Memorial and is the site principal investigator for the National Institutes of Health-sponsored CREST trial comparing carotid stenting with endarterectomy. He also specializes in abdominal and thoracic aneurysm repair.  An associate professor at Northwestern University's Feinberg School of Medicine, Dr. Eskandari has educational experience as an instructor for both the Resident Core Curriculum and the Scientific Basis of Medicine course. He has served on the faculty of Northwestern University's annual Vascular Surgery Symposium, the Midwestern Vascular Surgical Society's endovascular training course, and the Vascular Interventional Advances peripheral vascular interventions course. He is also course director for several national carotid stent and thoracic stent graft training programs.  Dr. Eskandari currently serves as Northwestern's primary investigator for four trials investigating the use of stent grafts in the treatment of thoracic and abdominal aortic aneurysms. He is the Northwestern Vascular Surgery Fellowship Program Director and serves as the director of the Department of Surgery Morbidity and Mortality Conference.  His bibliography includes 55 peer-reviewed manuscripts, 17 book chapters, and over 60 international presentations. In addition, he has received three awards for excellence in research endeavors and is the recipient of the Lifeline Foundation's Wylie Traveling Fellowship.  Dr. Eskandari serves as reviewer for Journal of Endovascular Therapy, Journal of Vascular Surgery, Journal of Vascular and Interventional Radiology, Journal of the American Medical Association, Expert Opinion on Therapeutic Targets and Future Cardiology. He is associate editor for the Yearbook of Vascular Surgery and on the editorial board the Journal of Endovascular Therapy.  He currently sits on the Society for Vascular Surgery Practice Guidelines Committee, and is a representative to the Intersocietal Commission for the Accreditation of Computed Tomography Laboratories for the Society for Vascular Surgery. Dr. Eskandari also serves on several quality management and leadership committees for Northwestern Memorial Hospital.  Dr. Eskandari completed his undergraduate and medical schooling at the University of Michigan. He completed his general surgery residency at the University of Pittsburgh Medical Center and his vascular fellowship at Northwestern University Medical School in 1999. He is board certified in general surgery and vascular surgery.  
1037905	Skin Cancer, Facial Aging
1037926	Research is primarily concerning food allergy, but clinical interests also include asthma, atopic dermatitis (eczema), and allergic rhinosinusitis.
1037928	My primary areas of research interests and clinical expertise are psychiatric and cognitive problems of children with epilepsy and other neurological disorders, as well as diagnosis and treatment of psychogenic non-epileptic seizures.  I have developed multidisciplinary clinical service model to provide effective comprehensive treatment for children suffering from comorbid neurological and psychiatric illnesses.  This clinical program provides guidance and assistance in their transition to adulthood. It also offers a unique training environment for fellows in child psychiatry and neurology. 
1037962	Cardiac magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), Coronary CT angiography, Cardiac CT, CT angiography, Vascular and interventional radiology
1038130	Otolaryngology, Surgery, sinus, Surgery, voice, Voice disorders 
1038180	My clinical interests are pulmonary vascular disease and cardiovascular disease. I am specifically interested in the evaluation and treatment of children with pulmonary vascular disease, and infants with anatomic or functional cardiovascular disease. My research interests include clinical characterization and management strategies of children with pulmonary vascular disease, and basic evaluation of cardiac remodeling in response to pulmonary vascular pressure overload.
1038351	Advanced laparoscopic procedures, Gastroesophageal reflux disease, Inguinal hernias, Laparoscopic Anti-Reflux Surgery, Laparoscopic Bariatric Surgery, Laparoscopic Heller Myotomy
1038505	Asthma, Chronic obstructive pulmonary disease (COPD), Interstitial lung disease
1038702	Dr. Robert E. Brannigan's clinical concentration is male reproductive medicine and surgery. His surgical interests included performing: microsurgical vasectomy reversal; microsurgical varicocelectomy; micro-TESE for sperm extraction; and vasectomy. He treats hypogonadism (low testosterone) in males, including hypogonadism associated with aging and congenital causes such as Klinefelter's syndrome. His primary research focuses on fertility preservation (oncofertility) in adolescent and adult male patients with cancer.
1038726	Currently my research focuses on the development and validation of magnetic resonance imaging techniques for optimal delivery and functional guidance of minimally invasive therapies, early prediction of therapy response, and non-invasive staging of carcinogenesis. My most recent efforts are focused on the development of imaging methods for primary and metastatic tumors of the liver. Our group deliberately emphasizes a bench-to-bedside translational approach to research. Working closely with a multi-disciplinary group of clinical collaborators, methods first developed and validated in phantoms and animal models are rapidly translated to the clinical setting at Northwestern Memorial Hospital.
1038918	Research expertise and area of interest is the measurement and promotion of lifestyle physical activity among persons with arthritis, to alleviate symptoms of arthritis and delay the onset and progression of arthritis-related disability.
1039131	Cardiac arrhythimias, General cardiology
1039265	mood disorders, including depression and bipolar disorder; treatment of psychiatric illness in patients with coexisting medical and neurologic disease
1039271	Transplant Nephrology, Role of immunosuppressive medications in modulating the immune system, Genomic of chronic renal allograft rejection, Chronic kidney disease after liver transplant, Prednisone-free and Calcineurin inhibitors free immunosuppressive protocols, new immunosuppressive strategies
1039271	Unos Medical Director Renal Transplant Program. Unos Medical Director Pancreas Transplant Program. Director and Course developer for Renal Transplant Fellowship. Director, Transplant Nephrology. Research: Impact of different immunosuppressive protocols on kidney function. Immunobiology of kidney allograft rejection. NIH sponsored trials: Genomics of chronic renal allograft rejection. Impact of Folic acid supplementation on cardiovascular disease of renal transplant patients (Favorit Trial). Immunophenotypig and functional profiles of peripheral lymphocytes in renal transplant recipients after T-cell depletion.  Course Director for Monthly Clinical Transplant Conference
1039301	Congestive heart failure, Heart transplantation
1039330	Clinical interests: Glaucoma and cataract.  Normal-Tension Glaucoma, Pigmentary Glaucoma, Pseudoexfoliation Glaucoma.  Early Diagnosis of Glaucoma. Research interets: Selective Perimetry for the Early Diagnosis of Glaucoma, Optic Nerve and Retinal Nerve Fiber Layer Imaging, Tonometry, Efficacy and Safety of Glaucoma Medications, Epidemiology of Glaucoma.
1039411	Chronic viral hepatitis, Post liver transplant medical issues
1039479	Lasik surgery, Ophthalmic pathology, Refractive surgery, Refractive surgery
1039486	I have had a long-standing interest in studying RNA regulatory mechanisms in development.  My lab has focused on studying the mechanism of action of Evfs, novel long non-coding RNAs that regulate transcription factors essential for proper GABAergic interneuron development.  Although a critical role for developmentally regulated transcription factors in patterning and differentiation has been established for some time, the role of long, polyadenylated non-coding RNAs (lpncRNAs) is only beginning to be understood.  A handful of lpncRNAs play roles in X-inactivation, imprinting, and germ cell development, raising the question of whether lpncRNAs constitute a common or rare gene regulatory mechanism in the developing embryo.  We recently showed that the novel lpncRNA, Evf2 is conserved across vertebrates (ultraconserved), and is a sonic hedgehog target in the developing forebrain.  We also showed for the first time that the lpncRNA Evf2 complexes with the Dlx2 homeodomain transcription factor and regulates Dlx 5/6 enhancer activity in vitro (Feng et al. 2006).  Through analysis of an Evf2 loss-of-function mouse model developed in my lab, we now find that the Evf2ncRNA is not only required for proper regulation of genes in the Dlx 5/6 region, but also for proper GABAergic interneuron development in the embryonic brain and adult hippocampal circuitry (Bond et al. 2009).  This provides a novel mechanism in which a DNA regulatory element is regulated by a complementary lpncRNA critical for proper interneuron development. Future work focuses on the mechanism of Evf2-dependent interneuron loss and mechanisms involved in long ncRNA transcriptional control. In addition, the importance of GABA in orchestrating multiple developmental events and maintaining homeostasis in adult brain circuitry is leading us to test whether Evf2-mutants exhibit specific behavioral phenotypes.  Results support the idea that a single ncRNA controls a  complex behavior.
1039527	My research interests are ecclectic and varied.  
1039528	Dyspnea / exercise physiology, Interstitial lung disease, Lung cancer
1039530	Pathogenesis of Legionella pneumophila, intracellular parasitism and protein secretion. 
1039566	Leukemia (CLL), Lymphoma
1039668	Body imaging, Cross sectional imaging of the body, Genitourinary radiology, Ultrasound, Ultrasound evaluation in organ transplantation, Ultrasound evaluation in prostate imaging
1039670	General gastroenterology, acid-peptic disease, functional gastrointestinal disorders, Helicobacter pylori infection
1039670	Pharmacology of gastrointestinal disorders, Upper gastrointestinal tract disorders, functional gastrointestinal disorders, Helicobacter pylori infection, colorectal cancer screening and educaiton
1039677	General gastroenterology.
1039815	I am a consulting biostatistician, with focus on clinical trials, basic science and epidemiology.
1039923	Developmental nephrology, endothelial cells, mesangial cells, gene regulation 
1040000	Improving both the short and long-term outcomes for critically ill and premature infants, tracking the neurodevelopmental outcomes in these patients throughout the developemental period, ensuring that the same level of quality is provided to each patient in both of the neonatal intensive care units at Children's Memorial Hospital and Prentice Women's Hospital from the moment of birth throughout their hospital course
1040160	We study the regulation of alveolar fluid clearance under hypoxia. In particular we study the signal transduction mechanisms that regulate the activity of the Na,K-ATPase in alveolar epithelial cells
1040637	Anatomic Pathology, Neuropathology, Neuromuscular pathology<BR><BR> The early growth response (Egr) family of transcription factors are involved in cellular growth and differentiation and may play a role as initiation and propagation factors in some cancers. A major focus of our research is to understand the role of Egr transcription factors during development of the mammalian nervous system. We and others have discovered that these transcription factors regulate a variety of developmental processes including hindbrain organization, peripheral nerve myelination, sympathetic nervous system development, male and female fertility, induction of late phase long term potentiation (a form of synaptic plasticity) and muscle mechanoreceptor development. In the nervous system, Egr transcription factors are downstream signaling mediators of neuronal activity and growth factor molecules known as neurotrophins. We are actively exploring their role in mediating a variety of neurotrophin actions that include neurite outgrowth, synaptic vesicle protein regulation and muscle stretch receptor development. As plasticity related transcription factors, Egr genes are important for mediating nervous system adaptation to a variety of developmental and environmental stimuli. Egr transcription factors are also essential for some non-nervous system related developmental processes. For example, they are involved in monocyte and thymocyte development, and they are involved in growth and differentiation of pheochromocytoma and neuroblastoma tumors. Using these model systems of differentiation, we are exploring the varied developmental pathways and target genes regulated by Egr transcription factors to elucidate their roles in cancer and developmental biology.
1040956	Cancer pain, chemotherapy-induced peripheral neuropathy, neuropathic pain syndromes and their prevention or management, analgesic agents for relief of pain, international efforts to relieve pain and improve end-of-life care
1040956	Dr. Paice's clinical work is in the management of cancer-related pain. Current research is in the study of chemotherapy-induced peripheral neuropathy associated with paclitaxel.
1041070	Epstein-Barr virus, viral genome replication, viral genome maintenance, latency, transformation 
1041107	Clinical interests: include all of anesthesiology with a particular interest in securing airway management and anesthesia in the most difficult airway patients as well as providing anesthesia and monitoring for patients needing brain or spinal column surgery.  Primary research interests: involve improving education of airway management among anesthesiology trainees.  This has encompassed various facets, including the following:  development of an assessment tool for determination of baseline knowledge in trainees, production of checklists for different airway management techniques, construction of computer-based modules for teaching airway management, organization of simulation sessions in the specific area of endotracheal extubation, and a continuing study to improve American Society of Anesthesiologists attendees skill and self-confidence in adult flexible fiberoptic intubation.
1041128	Patient-reported outcomes and patient-provider communication in chronic illnesses, with a focus on underserved populations and health disparities.
1041130	Psychometrics, Informatics, Clinical Infometrics, Quality of Care, Patient Safety, Quality Improvement, Patient Satisfaction, Aging, Palliative and End-of-Life Care Research, Patient-Reported Outcomes (PRO), Health-Related Quality of Life (HRQOL), Caregiver Health, Clinical Decision Making, Health Literacy, Item Response Theory (IRT), Rasch Measurement Models, Item Banking and Computerized Adaptive Testing (CAT)
1041142	Research areas of interest include: public health genomics, ethical/legal/social issues in genetics/genomics, translational genomics, community-based participatory research interventions and education models, community consultation methods, client-derived outcome measures, and cross-cultural issues with underserved populations in health care.  
1041268	Medical Physics, Digital Imaging, Cancer Detection, Clinical Image Quality 
1041308	Healthy lifestyles, Medical care of the obese patient, Preventive medicine
1041441	My research agenda lies in the area of Experimental and Clinical Neuroscience, and involves mainly the study of spinal neuronal mechanisms/circuits coupled with motor control and locomotion. The main driven force for my studies is to better understand the functional units of motor control in humans so to develop rehabilitation protocols that promote sensorimotor recovery in people with a spinal cord injury (SCI). I employ non-invasive electrophysiological techniques incorporating also engineering elements to fully describe the above concepts. Currently, my research studies are concentrated on examining the reorganization of spinal reflex circuits after intensive locomotor training in people with SCI.  
1041463	My research interests are to understand how cells in the body can contribute to the heart and lungs during our lives. This process starts during fetal development and is often inhibited by disease. So I am studying cells that make blood vessels in the fetus and how this is controlled by signaling pathways. Then I would like to figure out how to activate these fetal programs in adults with heart and lung disease.
1041493	Hematopathology <BR><BR> Cytogenetics, hematologic malignancies
1041494	Migration of subventricular zone cells. 
1041544	We investigate the roles of reactive oxygen species (ROS) in the pathogenesis of pulmonary hypertension. ROS alter gene expression, enzyme activity and vascular cell growth, leading to impaired vasorelaxation and vascular remodeling. Our goals are to identify the sources of ROS and their downstream targets, thus identifying potential therapeutic targets for the treatment of pulmonary hypertension.
1041556	Pediatric Nephrology, Lupus Nephritis and Vasculitis, Nephrotic Syndrome, FSGS (Focal Segmental Glomerulosclerosis), Hypertension, Dialysis and Continuous Renal Replacement Therapy, Prenatal Counseling regarding congenital kidney conditions, Polycystic Kidney Disease
1041624	Our research closely links to the clinical problem of pressure induced soft tissue injury, commonly seen as the pressure sore in SCI individuals. To test our hypotheses that the mechanical properties are altered in wounded and denervated tissues, soft tissue samples (skin, fat, muscle) freshly collected from able-bodied, SCI individuals, and wounded tissues are being tested for compressive mechanical properties. Rat models of chronic SCI and pressure sore are being used to characterize the mechanical property change in vivo and ex vivo. A finite-element model for buttock-thigh has been developed specifically for the condition of sitting, is used as a tool to bridge the lab-acquired basic knowledge of the soft tissues and the clinical problems in reality. The effect of different sitting configuration on the buttock-thigh tissue loading, tissue perfusion, and skin temperature elevation are evaluated. We found that sitting greatly impeded tissue perfusion in buttock tissue and the pressure relief push-ups did not provide adequate recovery for tissue perfusion. Also, SCI individuals needed longer time for buttock tissue perfusion to recover after a long time sitting. We developed an Intelligent Automated Pressure Relief Seat  IAPRS which detects the seat-buttock contact and automatically relieves the buttock loading by lowering down the back part of the seat. IAPRS is being tested in clinical setting on SCI individuals and sitting related pressure sore. Preliminary results show that IAPRS promotes the pressure ulcer healing in sitting area, while maintaining the mobility for wheelchair users during the treatment of pressure ulcers. To test the feasibility of early detecting of pressure induced deep tissue injury under intact skin; an ultrasound tissue palpating probe (TUPS) has been adapted for in vivo testing of soft tissue gross stiffness on human subjects and on our animal models to differentiate injured from healthy tissue by detecting their stiffness difference
1041683	Ambulatory anesthesia, Regional anesthesia
1041733	I am primarily interested in the diagnosis and treatment of patients with inherited metabolic disorders and in clinical trials of new therapies for rare disorders. I have particular interest and expertise in disorders daignosed through newborn screening (phenylketonuria and others) and in lysosomal storage disorders.
1041762	Alveolar epithelial cell function, Gene transfer, epithelial beta-adrenergic receptors
1041909	Pediatric oculoplastic disease, ocular involvement in cGVHD, adult strabismus 
1041920	hypoxia 
1042081	My work focuses on cancer stem cells (CSCs) found in patients with primary brain tumors, in particular, Glioblastoma multiforme (GBM). Despite aggressive treatment including surgery, radiation and chemotherapy, the average survival of patients with GBM is just over one year.  I believe that tumor progression in driven by glioma stem cells that are intrinsically resistant to cell death secondary to radiation- and chemotherapy-induced DNA damage. In collaboration with Drs John Kessler and Sam Stupp, I am working on a self-assembling nanogel conjugated to a biologically active molecule that can diminish the stem-ness of these cells, and render them more susceptible to current treatments.
1042149	I am interested in the treatment of spinal column and cord disease, specifically traumatic, degenerative, and neoplastic processes. I am currently investigating the outcomes of people with post-traumatic syringomyelia. In addition, I am studying the effect of surgical treatment on basal energy expenditure in those with lumbar spondylolisthesis. I am a member of the Spine Oncology Study Group, an international multidisciplinary group dedicated to the furthering of our understanding reagrding the care of people with tumors of the spinal column. Lastly, I have a number of studies at present regarding both undergraduate and gradute medical education.
1042263	Crohn's disease, IBD - Inflammatory Bowel Disease, Ulcerative colitis
1042273	Dr Meiers research interests lie in the fields of functional evaluation of prosthetic components, the development of appropriate prosthetic/orthotic components and technology for economically disadvantaged countries, and the successful dissemination of such technology through the development of appropriate education materials (knowledge transfer). She is further interested in the development of alternative and intelligent materials and their application in the field of prosthetics and orthotics. Dr Meier also has an interest in motor control and the adaptations that occur during the rehabilitation process. 
1042296	Dr. Andrew Evens is Assistant Professor of Medicine at the Feinberg School of Medicine, Northwestern University and member of the Robert H. Lurie Comprehensive Cancer Center. Following graduation with honors from Chicago College of Osteopathic Medicine, Dr. Evens completed an Internal Medicine residency at Lutheran General Hospital and he served an additional year as Chief Resident.  Dr. Evens subsequently completed his Hematology/Oncology fellowship at Northwestern University and is board certified in Hematology and Medical Oncology.  During fellowship, Dr. Evens also completed a Masters of Science in Clinical Investigation at Northwestern University. Dr. Evens' clinical and research interests are in lymphoma: non-Hodgkin lymphoma and Hodgkin disease, including stem cell transplantation (SCT).  Dr. Evens is also involved in a translational lymphoma laboratory to develop and study novel treatment agents for the treatment of lymphoma. His translational investigations have included research of free radical-mediated biology and the study of apoptotic pathways in hematologic malignancies.  Dr. Evens was awarded a 5-year NIH/NCI K23 grant towards the study of targeting the mitochondria for the treatment of lymphoma.   Dr. Evens is Principal Investigator for several investigator-initiated clinical trials including the combination of motexafin gadolinium with zevalin radioimmunotherapy for relapsed lymphoma, proteasome inhibitor/rituximab therapy for untreated indolent lymphoma, gemcitabine/bortezomib for T-cell lymphoma, chemoimmunotherapy for Burkitt's lymphoma, and a novel therapeutic regimen for the treatment of primary CNS lymphoma.  He has also published data regarding the prognosis and treatment of mantle-cell lymphoma and treatment of newly diagnosed and relapsed/refractory Hodgkin disease. Dr. Evens is a member of the Core lymphoma committee of the Eastern Cooperative Oncology Group (ECOG) and he is Principal Investigator for national ECOG clinical trials. Dr. Evens is involved in collaborations with investigators at Northwestern and throughout the region regarding post-transplant related lymphoma, drug safety, and epidemiologic lymphoma research.  He also co-chairs an annual Chicago Lymphoma Symposium along with the University of Chicago. Dr. Evens was recipient of the 2002 ECOG Translational Research Award and received the Compassionate Care award from the Women's Board of Northwestern Memorial Hospital in 2005.  Dr. Evens is also highly interested in mentoring residents and fellows at Northwestern University for translational and clinical research. 
1042296	Dr. Evens' clinical and research interests are in lymphoma: non-Hodgkin lymphoma and Hodgkin disease, including stem cell transplantation (SCT). Dr. Evens is also involved in a translational lymphoma laboratory to develop and study novel treatment agents for the treatment of lymphoma. His translational investigations have included research of free radical-mediated biology and the study of apoptotic pathways in hematologic malignancies. Dr. Evens is Principal Investigator for a multitude of investigator-initiated and industry-sponsored clinical trials studying new exciting treatments agents for lymphoma. Dr. Evens is a member of the Core lymphoma committee of the Eastern Cooperative Oncology Group (ECOG) and he is Principal Investigator for several national ECOG clinical trials. He is also involved in collaborations with investigators at Northwestern and throughout the world regarding post-transplant related lymphoma, drug safety, and epidemiologic lymphoma research.
1042297	Dr Kaklamani has been working on the role of TGF-&#946; and its polymorphisms in breast and colon cancer risk. She is currently conduction two clinical trials enrolling patients with a person and/or family history of breast and colon cancer. The objectives of these trials are to identify genetic markers which will lead to earlier detection and prevention of breast and colon cancer.  Dr Kaklamani is also conduction clinical trials with a focus of treatment of breast cancer. More specifically she is the principal investigator of a trial evaluating an investigational agent, RSR-13, in patients receiving brain radiation for breast cancer. 
1042297	Dr Kaklamani's research interest is novel genes related to breast, colon and prostate cancer
1042299	General Gastroenterology Colon cancer screening Biliary disease--ERCP Viral hepatitis B and C
1042299	My interests include colon cancer sceening, GERD, inflammatory bowel disease, viral hepatitis, autoimmune liver disease, hemochromotosis, complications of cirrhosis including and liver cancer.
1042402	Child health within the context of the family, with particular emphasis on the role of fathers and special attention to the ability of techonology to support parenting.
1042418	Preventive medicine, Primary care internal medicine
1042558	Obstetric Anesthesiology
1042563	Dr. Kyriacou is Professor of Emergency Medicine and Preventive Medicine at the Northwestern University Feinberg School of Medicine.  His medical degree is from the University of Michigan and his residency training was in emergency medicine at the Los Angeles County + University of Southern California Medical Center.  He also has a Master of Public Health degree from the University of Michigan and a Doctor of Philosophy degree in epidemiology from the UCLA School of Public Health where his dissertation project was on risk factors for injury from domestic violence.  In addition, Dr. Kyriacou has a Diploma in Tropical Medicine and Hygiene from the London School of Hygiene and Tropical Medicine.  Dr. Kyriacous research interests also include injury prevention, clinical infectious diseases, and health services.  Dr. Kyriacou has mentored numerous medical students, residents, and junior faculty on clinical and epidemiological research methods, resulting in several publications and the awarding of numerous masters degrees.  Dr. Kyriacous research endeavors have been recognized with awards from the Emergency Medicine Foundation and the University of California/California Wellness Foundation.  Dr. Kyriacou has also international experience, having worked in Ghana and Ethiopia.  He was recently appointed to the Fulbright Specialist Roster. 
1042630	My clinical and research areas of interest include RETINOBLASTOMA, LYMPHOMAS(both Non-Hodgkin and Hodgkin subtypes) and post-transplantation lymphomas, and the HISTIOCYTOSES.  Our retinoblastoma team includes oncologists, ophthalmologists, a social worker, a genetics counselor, clinical research specialists, as well as researchers in the laboratory.  We are currently working on novel approaches to treating retinoblastoma, the most common intraocular tumor of childhood.
1042631	Radiofrequency Ablation - Tumors, Sympathectomy/ Hyperhidrosis, Thoracic Oncology, Bronchoscopy, Brachytherapy, Robotic Thoracic Surgery, Lobectomy, Esophagectomy, Airway/Esophageal Stenting, Medistinal Tumors, Gastroesophageal Reflux Disease (GERD), Esophageal Cancer, Esophageal Disorders, Minimally Invasive Surgery, Mesothelioma, Lung Cancer, Chest Wall/Mediastinal Tumors, Tracheal Surgery, Video-Assisted Thoracoscopic Surgery
1042734	Advanced minimally invasive surgery in infants and children, neonatal surgery, tumors and developmental anomalies, surgery for hernias and undescended testes, thyroid disease, chest wall deformities, anorectal malformation, hirschsprung's disease, ovarian and breast diseases, surgical ultrasound, and healthcare quality and patient safety.
1042758	Hematopathology <BR><BR> Diagnostic and prognostic markers for lymphoma and leukemia.
1042765	Dr. Koski has a strong interest in adult spinal deformity, spine tumors, and complex revision surgeries. He is actively involved in research focused on patient outcomes, spinal sagittal alignment, and quality of life in adults with spine deoformity.
1042768	My research focuses on the migratory/invasive behavior of brain tumor cells that results in increased resistance of these cells to chemotherapy and radiation therapy.  I am addressing this question through molecular biology and genetic techniques with the aim of finding ways to reverse resistance to these therapies and thus improving patient outcomes.  My clinical interest is synergistic with that of my research, in the surgical care of patients diagnosed with brain tumors. 
1042791	Primary interests include ambulatory regional anesthesia and obstetric anesthesia. 
1042806	My primary research interest surrounds the physiologic and pathophysiologic regulation of the fetoplacental vasculature and its contribution to short- and long-term pregnancy outcome.
1042840	My clinical and research career has focused on diseases of the pancreas. In recent years, I have focused on medical education, and led a multi-organizational program to develop a national curriculum for general surgery training in the U.S. For the past year, I have worked with the Patient Safety Education Program, centered in the Buehler Center on Aging, Health, and Society at Northwestern.
1042973	My research interests include rehabilitation outcomes and health policy research. In particular, I have expertise in the design, development, selection, and enhancement of rehabilitation outcomes measures using contemporary psychometric approaches. My research compares access and outcomes of across post-acute care rehabilitation settings. My health policy research involves examining the impact of Medicare post-acute care policy on service utilization, costs, and patient outcomes.  I have been a licensed occupational therapist for over 20 years working in the areas of both older adults and pediatrics. My particular clinical interest is behavior change and human motivation.  I am certified as a trainer in Motivational Interviewing. I am a charter member of the AOTA Research Advisory Panel and serves as an AOTA representative to the Preventive Care and Screening workgroup of the American Medical Associations (AMA) Physician Consortium on Performance Improvement (PCPI) which is responsible for developing quality indicators in health promotion and prevention. 
1042976	Pancreatic ductal adenocarcinoma is currently the fourth leading cause of cancer-related death in the US, with a median survival time after diagnosis of less than 6 months and a 5-year disease-free survival of less than 5%. Pancreatic cancer is commonly associated with pronounced collagen-rich fibrotic reaction. We have found that there is significant cross-talk between type I collagen and the key proteinase membrane type 1-matrix metalloproteinase (MT1-MMP, MMP-14) in regulating pancreatic cancer invasion. MT1-MMP is overexpressed in human pancreatic tumors particularly in areas of pronounced fibrosis. To better understand the role of MT1-MMP in vivo, we have created transgenic mice that can be targeted to express MT1-MMP in the pancreas, and have crossed these mice with mice expressing mutant KrasG12D. Excitingly, co-expression of human MMP-14 and K-rasG12D in the pancreas results in large, cystic, papillary lesions consistent with human intraductal papillary mucinous neoplasms. Surprisingly, these lesions have very pronounced fibrotic reaction and are associated with increased TGF- signaling and activation of stellate cells.  We have also been examining whether the interplay between collagen and MT1-MMP is involved in resistance of pancreatic cancer cells to gemcitabine chemotherapy. Recent reports have suggested that the fibrotic reaction limits the delivery and effectiveness of current therapies in pancreatic cancer. Consequently, my research group has been examining the extent to which type I collagen contributes to gemcitabine resistance. We have found that cells grown in 3D type I collagen are less likely to respond to gemcitabine compared to cells grown atop 3D collagen or on tissue culture plastic. Significantly, we have found that the effect is mediated in part via MT1-MMP. We are currently in the process of characterizing the detailed signaling pathways downstream of MT1-MMP that are involved in chemotherapy resistance in the 3D microenvironment.
1042976	The major focus of my lab is to understand the mechanisms utilized by invading and metastasizing tumor cells to promote expression and activity of extracellular matrix-degrading matrix metalloproteinases (MMPs). The lab currently has two projects. In our oral cancer project, we are interested in understanding how TGF-b1 signaling through Snail family of transcription factors increases MMPs and promotes invasion of oral cancer cells in 2D and 3D organotypic models of oral cancer. We have also established an orthotopic model for oral cancer wherein OSCC cells expressing GFP-tagged Snail or Slug are injected directly into the tongue to examine the role of these key proteins in promoting tumor growth and invasion in the in vivo microenvironment.  In addition to our work in oral cancer, we have also been examining the contribution of fibrosis to pancreatic cancer progression. Fibrosis, also known as desmoplastic reaction, is a very prominent feature of almost all human pancreatic tumors, and earlier reports suggested that this desmoplasia in fact contributed to pancreatic cancer progression. We recently published that the pancreatic cancer cells adjacent to areas of fibrosis exhibit increased expression of membrane type 1-MMP (MT1-MMP). We are particularly interested in understanding how the desmoplastic reaction increases the expression of MT1-MMP in the cancer cells, thus enabling the pancreatic cancer cells to invade through a collagen-rich extracellular matrix. In addition to utilizing in vitro models to examine the cross-talk between type I collagen and MT1-MMP, we have also established a transgenic mouse model in which MT1-MMP is selectively and under regulated conditions expressed in the pancreas to examine the effect of MT1-MMP on tumor growth and on the generation of desmoplastic reaction. 
1043077	We are interested in understanding how the lung responds to injury and the process of normal healing, in order to develop novel therapies for treating patients with pulmonary fibrosis and similar types of lung disease.
1043078	Geriatric Medicine, Geriatric Education, Discharge Processes/ Transitional Care, Paid Caregivers of Seniors, Patient Safety, Medical Education
1043078	Lee Lindquist, MD, MPH is an Assistant Professor of Medicine at Northwestern University Feinberg School of Medicine.  She is a member of the Division of Geriatrics and her clinical practice primarily revolves around care of those aged 65 yrs and older.  Dr. Lindquist is a graduate of Northwestern University Feinberg School of Medicine and completed her internal medicine residency and her fellowship training in geriatrics at Northwestern University. She is board certified in internal medicine and geriatrics.  She also completed her Masters in Public Health during her participation in the NRSA fellowship program. Her research has focused on issues of transitional care among the elderly, particularly in improving the safety between the hospital discharge to outpatient care settings. She has also performed work on assisted living and alternatives to assisted living for the elderly as well as improving geriatric education for medical students.  
1043177	Surgical Pathology <BR><BR>
1043288	Breast imaging
1043300	Clinical cancer/cancer health disparities research with focus on improving patient safety for older individuals with cancer. I am primarily engaged in active pharmacovigilance, including the detection and assessment of safety signals related to drugs and devices and the timely dissemination of findings to relevant stakeholders. A related research focus is comparative and cost effectiveness analyses of cancer related therapies targeted at older cancer patients and safe and cost-effective transitions of care for this cohort. I am also engaged in a collaborative NCI sponsored minority biobanking/biospecimen collection initiative with colleagues at several comprehensive cancer centers across the country. Future studies in pharmacogenomics are expected to aid in prescribing decisions and will likely predict older cancer patients who will respond appropriately to a given cancer-related medication or experience severe adverse drug reactions.
1043300	Serious adverse drug reactions in elderly cancer patients in the oncology setting are not being regularly identified, evaluated and reported.  When adverse events are reported for older cancer patients, the reports are often incomplete and hence causality assignment is delayed, leading to increased morbidity and mortality. A  clinically-based, hypothesis-driven approach to pharmacovigilance will improve the completeness of reporting and the assignment of causality, resulting in improved health outcomes for older cancer patients. In summary, I aim to 1) Identify, evaluate, and report on serious adverse reactions to drugs used in cancer patients age 65 and older;  2) Assess the completeness of adverse event reports for patients 65 years and older and  3) Assess both causality assignment and the timeliness of causality assignment in  patients <65 years with those >65 years
1043341	The Li laboratory is interested in dissection of molecular mechanisms that regulate cellular stress response and cell death signaling.  We have recently identified Cdk5 activator binding protein C53 as a novel regulator of cell cycle and DNA damage response.  We are currently investigating how C53 regulates normal cell cycle progression and DNA damage response.  
1043419	Dr. Green's research employs murine models of cholestatic liver disease and fatty liver disorders in order to determine the pathogenesis of liver injury, and  thus devise rational therapies for these common liver diseases.  In addition, he participates in clinical trials on the treatment of hepatic disorders with other members in the Division of Hepatology. 
1043419	Hepatology (liver)
1043443	Perinatal brain injury including hypoxic-ischemic encephalopathy and neonatal stroke
1043458	Body imaging, Ultrasound (US)
1043560	Ethics, professionalism and communication in the healthcare setting. Achieving measurable efficacy, safety, efficiency and satisfaction in a complex healthcare delivery system.
1043570	1.  The role of EEG in the evaluation of children with febrile status epilepticus.   2.  The classification and characterization of infantile epilepsies. 3.  The correlation between EEG findings and cognition. 4.  Epilepsy surgery in children.
1043582	Master of Science: Healthcare Quality and Patient Safety 2011
1043621	Neuroradiology
1043672	Neuroanesthesia
1043708	Menopause, Minimally invasive surgery, Perimenopause management, Vaginal pain, Vaginal plastic repairs
1043952	General pediatric endocrinology and diabetes patients with a specific interest in disorders of sexual development and puberty.
1044194	Thyroid disease, Fine needle aspiration thyroid nodules, pituitary disease 
1044200	Our laboratory investigates stem cell biology and approaches to regeneration of the damaged or diseased nervous system.   I have had two R01 grants for more than 25 years that are focused on the biology of stem cells and growth factors, and on potential clinical applications.   I direct the Northwestern University Stem Cell Institute and have established a hESC and iPS cell core laboratory for the University. I am also the Chairman of the Neurology Department at Northwestern University and an active clinician.  Our research has focused extensively on the regulation of gene expression by neural stem/progenitor cells and their differentiated progeny. We have defined signaling pathways that direct glial and neuronal lineage commitment and characterized patterns of gene expression that coordinate these processes in both the developing and adult nervous system. I am also running clinical gene therapy trials in neuropathy.
1044214	My focus and expertise as a clinical psychologist is in the practice of cognitive-behavioral therapy (as clinician, instructor, and supervisor). Within that paradigm, my research and clinical interests are in the treatment of anxiety and mood disorders, particularly obsessive-compulsive disorder.  Also, I am interested in the use of technology for self-help and the treatment of mental health problems. 
1044272	Susan Yount, Ph.D., is a licensed clinical health psychologist and associate professor in the Department of Medical Social Sciences (MSS), Northwestern University Feinberg School of Medicine. Her research interests include the development and application of measures of quality of life, symptoms, and health status in chronic illness; and adjustment to and coping with chronic illness. Her clinical research interests include chronic pulmonary diseases, oncology and organ transplant as well as a range of other chronic illnesses.
1044275	Hematopathology<BR><BR> Lymphoproliferative disorders
1044490	I am a surgeon; my main professional goal is to provide surgical treatment for women with breast cancer, those at high risk for it, and those with benign breast problems. To deliver the best surgical care, I strive to help women with breast cancer and those with benign breast conditions understand their disease so that they will make informed treatment decisions that give them the best chance of cure with the best quality of life.  In addition to treatment of breast diseases, I have a major clinical and research interest in understanding breast cancer risk and finding safe ways of preventing breast cancer so that I can accurately identify high risk women and help them make the decisions that will leave them with the lowest risk of breast cancer with the best quality of life.
1044494	Dr. Lin has special interest in the mangement of prostate, kidney, and bladder cancers with an emphasis on robotic surgery.
1044533	Emergency Ultrasound & Resident Education
1044534	Medical disorders of the breast, Primary care internal medicine, Women's health care
1044537	Advanced Laparoscopic Procedures, Gallstones, Hernia, Obesity Surgery, Pancreas
1044550	Human brain imaging of chronic pain conditions. Animal studies of crtical dynamics of pain. 
1044559	clinical trial design, vaccines, epidemiological methods 
1044682	Regional Anesthesia 
1044711	Adrenal tumors, Female hernias, Galbladder disease, Gallstones, Incisional hernias, Laparoscopy, Minimally invasive endocrine surgery, Parathyroid Disease, Thyroid tumors, Ventral hernias
1044739	Hematopathology, leukemia, nucleoporins, NUP98 
1044955	Calcium Disorders, Hyperparathyroidism, Metabolic Bone Diseases, Osteoporosis
1044980	Cancer genetics, Colon cancer 
1045018	Genitourinary Imaging, Gynecologic Imaging, Gastrointestinal Imaging, Pelvic MRI, Body MRI, Hepatobiliary MRI, Computed Tomography
1045019	Cancer early detection, Colposcopy, Ovarian cancer
1045030	Articular cartilage repair, General orthopaedics, Shoulder problems / injuries, Sports medicine 
1045124	My clinical interests are in pediatric neurocritical care including stroke, traumatic brain injury, refractory status epilepticus and the neurologic complications of critical illness. The activity of my research group is focused on the glial responses to traumatic brain injury and the role of activated glia in the mechanisms of epileptogenesis and blood brain barrier dysregulation following acute brain injury. Our clincal research is focused on the application of bioinformatics to pediatric critical care with the goal of developing fully integrated  real-time physiologic and laboratory data collection and analysis in the pediatric intensive care unit.
1045145	Atrial fibrillation, Biventricular pacing, Cardiac arrhythmias, Catheter ablation, Implantable defibrillators
1045159	Early detection, biomarkers, epigenetics, drug resistance, DNA methylation 
1045163	Head & neck cancer, Lung cancer
1045197	Movement disorders including chorea, Dystonia, Essential tremor, Multiple systems atrophy (MSA), Myoclonus, Parkinson's disease, Progressive supranuclear palsy (PSP), Tics. Interest is focused on clinica management, clinical pharmacology, clinical trials desifn, experimental pharmacology
1045213	Mechanisms of action of the naturally occurring inhibitors of angiogenesis; endocrine therapy for breast cancer
1045293	Current research is focused on Interventional Spine Care.   Clinical interests include diagnosis and treatment of spine disorders, including cervical and lumbar degenerative disc disease, radicular pain/sciatica, facet joint mediated pain, and other causes.  Treatment is focused on rehabilitation, including physical therapy and occupational therapy. Complementary treatments offered include acupuncture and chiropractic.  All treatments are offered on site at the Rehabilitation Institute of Chicago.  Interventional spine procedures include cervical and lumbar epidural steroid injections/selective nerve root blocks, facet injections and radiofrequency neurotomy(rhizotomy), facet cyst aspiration/rupture, sacroiliac joint injections, discography, percutaneous disc decompression, and sympathetic blocks
1045433	Outcome based researches on educational interventions to create better physicians of the future.
1045466	Our laboratory investigates the role of the nuclear factor Ikaros in T cell development and leukemogenesis. Ikaros is a nuclear factor that is a component of two chromatin remodeling complexes associated with gene activation as well as gene repression.  Genetically engineered Ikaros null mice develop T cell leukemia with 100% penetrance suggesting that Ikaros is a tumor suppressor.  In addition, lack of Ikaros results in multiple defects in T cell development that include a decrease in the number of T cells, an increased potential to differentiate into the CD4 lineage and a complete lack of fetal T cell development. In addition, they are unable to undergo negative selection, a checkpoint that is required to prevent the inappropriate maturation of autoreactive T cells.  In order to determine mechanisms for Ikaros role in T cell biology, we are studying the role of Ikaros in regulating Notch and TCR signaling pathways, as well as in regulating early developmental decisions from the level of early lymphoid progenitors.  We are also interested in investigating the role of Ikaros in regulation of T helper fate decisions during an immune response.  
1045574	I am interested in how early events and environments shape later outcomes of preterm births.  For example, babies who were small at birth seem to be at high risk for complications such as high blood pressure, diabetes and obesity in adulthood.  Why?  There are many theories, but a biological explanation is still missing.  I study prenatal environments such as maternal health, biological markers such as cord blood and placenta, and early neonatal experiences for clues as to and how they relate to later outcomes, especially obesity.  At present, I focus on outcomes during the neonatal period, but eventually I would like to follow growth and health of these babies into adulthood.
1046251	Major focus of my research program is a translational approach to study of valvular heart disease basic and clinical research.
1046467	Diseases of ear, Ear surgery, Otology
1046492	Ablations, Arrhythmias, Defibrillators, EP studies, Pacemakers, Syncope 
1046519	Gene delivery, nuclear transport, intracellular trafficking of DNA, gene therapy
1046717	Dr. Trainor is a board certified in Pediatrics and Pediatric Emergency Medicine.  She is director of the M4 Pediatric Sub-internship for the Feinberg School of Medicine, and is in charge of the M4 electives in Pediatric medicine at Children's Memorial Hospital.  In addition, she is the Associate Fellowship Director in Pediatric Emergency Medicine.  Her primary research interests involve medical education and the use of simulation to teach medical students, residents, and fellows clinical pediatrics and pediatric emergency medicine.
1046718	My primary interest is family therapy and family-based treatments for a variety of disorders.
1046736	Application of Hematopoietic Stem Cell Transplantation to treat pediatric diseases--cancers, hematologic and immunologic diseases. Expand the indications for Stem Cell transplantation as cellular therapy for other diseases/organ dysfunction.
1046741	Rheumatoid Arthritis, Psoriatic Arhritis (combined program with Dermatology), Spondyloarthopathies 
1046744	My research examines the effects of prostheses and orthoses on human locomotion in order to increase understanding, establish efficacy, and improve effectiveness of prosthetic and orthotic interventions for people with disability.
1046905	My research focuses on the role of secreted protein toxins on bacterial pathogenesis.  The toxins we study are  members of the MARTX family and are produced by Vibrio cholerae, a pathogen important for the diarrheal disease cholera, and Vibrio vulnificus, a pathogen that causes septicemia and necrotizing fasciitis from seafood consumption.  Our group studies both the role of these toxins in evasion of the innate immune response using mouse models and the mechanism of action of these toxins using a combination of cell biology, biochemistry, and structural biology.
1047087	Resident education, Student education
1047088	Neuroradiology
1047091	Hepatology
1047131	MaryBeth Lake, MD, a former chief resident at Western Psychiatric Institute and Clinic (WPIC) at the University of Pittsburgh, is associate professor and the director of education in the Division of Child and Adolescent Psychiatry, which is housed at Childrens Memorial Hospital. Prior to joining Northwestern and Children's Memorial in 2000, Dr. Lake worked briefly in the private sector providing inpatient, outpatient and partial hospitalization program services. She is a member of several regional and national professional organizations and was previously a member of the American Academy of Child and Adolescent Psychiatry (AACAP) Committee for Liaison with Primary Care. Dr. Lake is a co-author of the Concise Guide to Child and Adolescent Psychiatry, as well as other publications. In addition to her focus on graduate medical education, Dr. Lake has a special interest in family therapy and cognitive behavioral therapy.  
1047160	For several years, I have been interested in the professional development of physical therapists working in different roles. This led to an interest in physical therapists' development of cultural competence and provision of patient-centered care. Currently, my work is examining physical therapists' knowledge, attitudes, and practices regarding patients' health literacy.
1047214	Laboratory investigations of the molecular basis of disease progression in myeloid malignancies.
1047214	Leukemia, Lymphoma, Myeloma
1047272	General gastroenterology
1047289	Coronary disease, Lipid management, Prevention of heart disease, Preventive cardiology
1047291	Cellular immunology, macrophage-virus interactions, apoptosis induction 
1047292	Dr. Weiss is Director of the medical school's Institute for Healthcare Studies.  The Institute conducts research and education in the area of health care quality, patient safety, healthcare equity, and policy.  Dr. Weiss' research includes more than 100 publications in the area with a focus no chronic respiratory disease and clinical guidlines.  Dr. Weiss is involved in the development of national healthcare policy related to measurement of physician quality of care.
1047321	Primary Research Interests Focus Upon Pediatric Kidney Disease Specific to: (1) Methylated arginine derivatives and kidney disease progression; (2) Methylated arginine derivatives and cardiovascular remodeling;   (3) Proteomic markers for prediction of kidney disease progression; (4) Use of ambulatory blood pressure monitoring (ABPM) for undiagnosed hypertension and progressive loss of nocturnal BP dip; (5) Hemodynamic and rheologic responses during hemodialysis, including use of conventional and non-conventional markers in evaluation of hypervolemic states in end stage kidney disease.
1047445	We are interested in the universal patterns of organization of complex systems in nature.   Previous work includes the  mathematical modeling of cardiac arrhythmias, the study of molecular motors and ion channels as  stochastic ratchets, cooperative role of nonlinearities and noise in neural coding, self-organization and collective phenomena in ants swarms, brains and communities of natural and artificial agents. 
1047485	Headaches, Primary care internal medicine
1047485	Health care policy Health care operational and financial administration
1047547	Pediatric liver disease
1047657	I am a pediatric neuropsychologist and conduct clinical neuropsychological evaluations on school age children and adolescents.  My clinical interests include brain tumor and other cancers, brain injury, solid organ transplant, lupus, encephalitis, epilepsy, sickle cell, stroke, genetic disorders, as well as learning disability and attention deficit hyperactivity disorder (ADHD).  My research is primarily on neurocognitive outcomes in patients with liver disease and liver transplant. 
1047664	Dr. Cartland is the Director of Child Health Data Lab at Children's Memorial Research Center, where her time is split between epidemiological and evaluation research. Dr. Cartland is a public policy analyst with twenty years of experience working on child and adolescent health and welfare issues. Her areas of expertise include health care financing, community-based interventions, and child and adolescent injury. Much of her current work involves expanding the capacity of the State of Illinois to conduct public health surveillance for children and adolescents.  ------     Monthly CHDL Data Briefs can be found at http://www.childrensmrc.org/chdl/Publications/.
1047667	Characterization by x-ray computed tomography (microtomography), x-ray phase contrast imaging, x-ray microbeam diffraction, synchrotron x-radiation of mineralized tissue in mammals and echinoderms.
1047682	Myeloma, Transplantation
1047683	Myeloma, Transplantation
1047866	Obstetric anesthesiology
1047935	Cytotoxic killing mechanisms, Apoptosis, Tumor Immunology, Neuroimmunoendocrinology. 
1047949	RNA interference - Molecular biology and Therapeutics
1047986	Pregnancy outcomes, infectious disease in pregnancy
1047987	Pathogenesis of preterm labor, infection in pregnancy, prenatal genetic diagnosis 
1048034	My lab studies the structure and function of ion channels, a family of membrane proteins that play many key roles in neuroscience and which are a major target of essential drugs used in clinical medicine. About a third of all genes in a typical genome code for membrane proteins, yet we know very little about their structure and function. Because ion movement across membranes can be measured with exquisite sensitivity, ion channels have always been at the vanguard of functional studies of membrane proteins, and as a consequence we have learned a great deal about how they function. Until recently, however, ion channels, like so many other membrane proteins, had proven very difficult to study at the structural level. The recent high-resolution description of several ion channels has opened up the field of structure-function in ion channels, and we are now in a position to ask detailed questions about how function is achieved through structure in this essential class of proteins. How do voltage-dependent ion channels sense the membrane potential? Through what structural rearrangements do these channels achieve voltage-dependent ion flow across the membrane? How can highly dynamic proteins maintain such outstanding control of what sorts of ions are allowed to pass? These are some of the questions that we attempt to answer.
1048036	Our research focuses on molecular and cellular mechanisms of Alzheimer's disease. In particular, we investigate the beta-secretase enzyme BACE1, which initiates the production of the beta-amyloid peptide that plays a central early role in the pathogenesis of Alzheimer's. We use a combination of biochemical, cell culture and animal model approaches to investigate the role of BACE1 in health and disease.   
1048050	Sleep disorders, epilepsy, narcolepsy, sleep apnea, restless legs, clinical pharmacology 
1048055	Arterial dissections, Carotid artery disease, Cerebral hemorrhage, Familial strokes, Inherited strokes, Mini-strokes, Stroke, Subarachnoid hemorrhage, Vascular dementia
1048162	Contraception and Family Planning 
1048277	Female bladder problems, Female pelvic floor disorders and pain, Female pelvic surgery, Gynecologic surgery, Recurrent bladder infections, Urinary incontinence, Urogynecology, Vaginal prolapse, Minimally invasive surgery
1048362	Magnetic resonance imaging, kidney, renal medulla, blood flow, oxygenation, acute renal failure, hypertension, endothelial dysfunction 
1048363	Magnetic Resonance Imaging 
1048496	Interventional Cardiology, angioplasty, stents, treatment of acute myocardial infarction, angiogenesis, valvular heart disease
1048574	The laboratory is interested in determining the role of intermediate filament proteins (IF) in prostate cancer. There are two main goals. First, can the development and progression of prostate cancer and patient outcome be determined be determined by the IF expression profile. This hypothesis is based on the observations that expression patterns of IF change when cells differentiate. Second, does the organization of nuclear lamins in prostate cancer cells affect DNA replication and transcription. We have previously determined that lamins directly bind proliferating cell nuclear antigen and expression of dominant negative mutant lamins affects DNA replication. Furthermore, we have shown that lamin expression affects RNA Pol II transcription. Nuclear microdomains can also influence the transcription potential of chromosomes in the region.
1048590	PCOS (poly cystic ovary syndrome)
1048590	Phenotyp-genotype studies in PCOS, mapping PCOS susceptibility genes, Specialized Center of Research (SCOR) on sex and gender factors affecting women's health, fetal origins of PCOS
1048758	Sepsis, macrophage, endotoxin tolerance, lipopolysaccharide, cell biology, signal transduction, MODS, surgical infections, critical illness  
1048762	Cells contact and communicate with their neighbors via specialized cell surface receptors.  This intimate exchange of information controls morphogenetic events during embryonic development and maintains tissue organization in adults.  Birth defects and cancer commonly result when cells fail to recognize and respond appropriately to their environment.  The work in my laboratory is guided by the hypothesis that epithelial cells receive and interpret contextual information through the coordination of adhesion and signaling receptor systems present on the cell surface.  To test this idea, we manipulate the ability of epithelial cells to interact with one another and measure their capacity to transduce intracellular signals that regulate cell fate and behavior.  In parallel, we assess the potential of cell surface signaling receptors to alter the manner in which epithelial cells adhere to their partners.  A three-dimensional in vitro model of the human epidermis is used to help define these adhesion-signaling networks during epithelial tissue morphogenesis.  
1048927	Comprehensive Ophthalmology, Meidcal Ethics
1049188	Advanced laparoscopic surgery, In vitro fertilization, Infertility, Polycystic ovary syndrome
1049211	Primary interests are looking at the use of mindfulness meditation within an intensive chronic pain management program.
1049219	n/a
1049330	Gastrointestinal Cancer Surgery, Melanoma / Sarcoma, Pancreatic / Liver cancer surgery, Surgical Oncology
1049332	Primary interests include:  pediatric radiology, cross sectional imaging, education, digital teaching files and website design and management
1049389	Pain medicine
1049440	Interventional spine procedures, Spine Pain Management, Neuroradiology, CT Angiography, CT/MR Perfusion, MR Spectroscopy, 3D Imaging 
1049457	Facial plastic, Facial reconstruction, Facial surgery 
1049458	Patient safety, Health Services, Operations, Quality
1049461	Anal incontinence, Benign anorectal disorders, Colon and rectal cancer, Colon and rectal surgery, Hereditary colon cancer syndromes, Ileal pouch surgery, Inflammatory bowel disease, Laparoscopy
1049467	Retina, synaptic transmission, glutamate, vision 
1049549	Pancreatic cancer, cancer biology, growth factors, novel therapeutics, cachexia, eicosanoid metabolism 
1049606	Dr. Kumar is interested in asthma health disparities. He is particularly interested in the effects of ther interaction of genetic factors and early life exposures on the development of asthma and allergies.
1049626	Difficult Airway Predication, Obstetric Anesthesia, Intravascular Volume Monitoring and Management
1049668	My overall research and clinical goals have been focused on the development of NICU graduates, particularly during the first three years of life.  The overarching theme of my research has been to improve understanding about how high risk conditions affect brain development and function in newborn infants.  Since brain development is also affected by nutrition and the environment, I have been particularly interested in those topics and the relationship between infant brain development and tests of development, including event-related potentials (a neurophysiologic technique), conventional infant testing, and now computerized evaluation of infant movement patterns.
1049685	sickle cell pain management, hypertension screening in the emergency department, pain management, triage systems
1049703	Dr. Yan is a cardiovascular epidemiologist with a background in demography and health economics. Her main research interests are prevention and control of cardiovascular diseases (including diabetes).  She has been involved in investigating associations of major modifiable risk factors and psychosocial factors with long-term coronary and cardiovascular morbidity and mortality. She is highly interested in and committed to translating best evidence into policy and practice globally, especially in China. She is currently the head of the Research and Development Division at the George Institute for International Health, China (www.george.org.cn) and the director of the NHLBI/UHG Center of Excellence for Chronic Disease Prevention and Control in China.
1049780	Mucosal immunology; Intestinal epithelial biology;  Pathogenesis of intestinal injury; Probiotics and immunity.
1049781	My research interests lie in the area of neurodegenerative disease, particularly Alzheimer's disease and related disorders such as the frontotemporal lobar degenerations and motor neuron disease. My focus is on the role of genetics and morphologic abnormalities such as parenchymal vacuolation and ubiquitin, TDP-43, and tau positive inclusions in frontotemporal lobar degenerations and related disorders such as primary progressive aphasia, progressive supranuclear palsy, corticobasal degeneration, and motor neuron disease-associated dementia. In addition, I continue my role of Neuropathology Core leader in the NIH-supported Cognitive Neurology and Alzheimer Disease Center at Northwestern University Feinberg School of Medicine. Within the framework of the Core-related Laboratory for Cognitive and Molecular Morphometry, the Neuropathology Core is actively involved in assisting basic science researchers investigate the applicability of their findings to human tissue.
1049798	Electroencephalography, Epilepsy, Seizure disorders
1049802	Limb Reconstruction, Metastic Disease, Musculoskeletal Oncology, Soft Tissue Sarcoma
1049813	Adult and Pediatric Spine Disorders, Cervical and Degenerative, Minimally Invasive Procedures, Scolosis and Deformity
1049887	Functional outcomes in patients with amputation and cancer
1049949	I am interested most in the optimal acute diagnosis and therapy of venous thromboembolic disease.
1049950	Cardiac Transplantation, Heart Failure, Signal Transduction (research)
1050035	Auditory nociception, brain evolution and development, mechanosensory transduction, sensory organ development, function and degeneration.
1050041	Interventional Radiology including oncologic management and venous access.
1050056	Interventional Radiology
1050075	My primary clinical and research activities relate to the care of marginalized youth populations including HIV+ and LGBT young people. Our research is largely HIV prevention in nature, mostly targeting either young men who have sex with men or transgender individuals. A new area of research and clinical interest involves working with young gender variant children and families
1050146	Ms. Trivedi has a special research interest in how hereditary cancer may affect the social and reproductive options of young women at high risk for cancer.
1050169	My interests are in clinical outcomes following anesthesia and surgery. 
1050189	Air pollution, ischemic cardiovascular events, acute lung injury, adipokines
1050264	Neuroanesthesiology, Pain Medicine
1050302	Our laboratory studies the neuroinvasive herpesviruses with a focus on the molecular mechanisms by which these pathogens propagate and disseminate within the nervous system. The outcome of infection is closely tied to the route the viruses spread within the nervous system, with outcomes typically relative benign but sometimes producing blindness and lethal encephalitis. We use a combination of live-cell fluorescence microscopy, molecular genetics and neuronal cell biology to examine the dynamics of viral particle assembly and intracellular axon transport. These molecular mechanisms are then examined in the larger context of neuroinvasion and pathogenesis. Two long-term goals of our research are to identify novel targets in the viral infectious cycle for development of antivirals, and engineering recombinant viral particles as effective gene delivery vehicles. (Keywords: neuron, axon, microtubule, cytoskeleton, dynein, kinesin, transport, virus, virion, herpesvirus, herpes, capsid, tegument, egress, nucleus, GFP, BAC, bacmid, recombination, GS1783)
1050367	Interested in the use of high-fidelity medical simulation to improve individual and team performance in acute emergencies, in particular, the amount and frequency of training needed. 
1050433	Dr. Urbanek's research focuses on the identification of susceptibility genes for complex diseases.  Her approach to this research is to use family based gene-mapping techniques and population based association studies in conjunction with molecular techniques to identify and verify genes and pathways contributing to the pathogenesis of genetically complex diseases. Specifically she is carrying out studies to identify susceptibility genes for polycystic ovary syndrome (PCOS) that map to Chr19p3.13.  She has previously shown that this region shows linkage and association with PCOS in a large set of families.   Other projects focus on identifying candidate genes for gestational diabetes and  glycemic control during pregnancy,  and identifying genetic variation contributing to extreme obesity 
1050433	Genetics of complex diseases, PCOS, Obesity, Metabolic syndrome, diabetes
1050501	HIV infection, Orthopedic-related Infections, Travel-related infections
1050564	My research focuses on molecular evolutionary mechanisms of HIV/SIV in host defense, antiretroviral drug resistance and genetic variation in HIV, HIV susceptibility to HIV infection and disease progression, and how host genetics and immunity affects HIV infection and dynamics. Researches include next generation sequencing of HIV and host genes and transcriptome to pursue a detailed genetic interrogation of the human extended Major Histocompatibility Complex (xMHC) and host genes involved in multiprotein virus-host interactions that regulate HIV infection.
1050565	Adolescent depression and suicide, Adult depression, Anxiety disorders, Obsessive Compulsive disorder, Panic disorders
1050642	My research interests center on better understanding the cellular and molecular building blocks that make up the basal ganglia macrocircuit as well as their implications on neural activity level, pattern and plasticity in the basal ganglia in health and disease. My long-term research goal is to elucidate cellular components involved in the pathophysiology and motor symptoms of Parkinson's disease and other related disorders. We hope to translate our insight into developing novel treatments for neurological disorders of the basal ganglia such as Parkinson's disease.
1050663	The mission of the Center for Global Initiatives is to create self-sustaining programs that improve access to healthcare in underserved communities throughout the world.  
1050725	Head and Neck Radiology
1050787	The principal focus of this laboratory is the examination of the spatial and temporal patterns of motor cortical activity preceding voluntary movement and the function of this activity in shaping and controlling movement initiation.  In particular we are interested in the function of the primary and supplementary motor areas and their interactions with the basal-ganglia in the feedforward and feedback control of movement.  We use a variety of non-invasive techniques to assess these systems in humans such as:  high-resolution EEG recordings and MRI-based source reconstruction techniques, transcranial magnetic stimulation, peripheral nerve stimulation, multi-channel EMG, and measures of movement kinematics and kinetics.  Experiments are currently being conducted to examine the role of the primary and supplementary motor areas and brainstem in the preparation and release of voluntary movements. Neurological diseases that affect the basal ganglia have a significant impact upon the function of the primary and supplementary motor areas.  For this reason, our research is also focused on the assessment of motor cortical function in neurological disorders such as Parkinsons disease and dystonia.  This work is conducted in collaboration with The Parkinsons Disease and Movement Disorders Center at Northwestern.  We are currently examining the control of repetitive movements in patients with Parkinsons disease and the effects of dopaminergic replacement therapy and deep brain stimulation of the subthalamic nucleus (a neurosurgical treatment for advanced Parkinsons disease) on the control of these movements.
1050821	I am interested in investigating the role of musculoskeletal biomechanics on the upper extremity movement deficits following stroke based on experimental methods and computer modeling. I am also interested in the design of robotic devices for therapeutic applications in stroke. 
1050876	I am interested in designing new experimental methods to understand basic neuromechanisms underlying movement disorder following injuries to the nervous system; and in developing new rehabilitation methods based on the improved understandings of neuromechanisms. More specifically, I am interested in using multi-modality functional brain imaging and modeling based signal processing to further explore the neuromechanisms underlying movement disorder following injuries to the nervous system. By combining these understandings with advanced biomedical engineering techniques, such as neural machine interface, I hope to regain the functional control of the impaired hand in moderately to severely impaired stroke survivors.
1050919	Major Psychotic Disorders, Women's Mental Health
1050964	Pediatric Cardiology, Electrophysiology, Education, Syncope, arrhythmias, sudden cardiac death, ventricular fibrillation 
1051094	I am interested in child and adolescent well-being as fostered by community conditions.  As a sociologist I work to understand environmental, cultural, institutional and social influences on child and adolescent well being in low resourced and minority communities.  I have experience and interest in community engaged scholarship.
1051123	skin inflammation research, melanoma immunotherapy research, skin neuroinflammation research, clinical treatment of general dermatology 
1051160	Cardiovascular outcomes, Quality of Care, atrial fibrillation, ablation, defibrillators, anticoagulants, pacing
1051160	Cardiovascular outcomes, atrial fibrillation, implantable devices, quality of care, ablation, anticoagulants, antiarrhythmic drugs
1051248	Pediatric Pathology<BR><BR> Wilms tumors, germ cell tumors, genitourinary development
1051269	Brain functions are the result of the coordinated activity of large networks of neurons, which are composed by many different cell types. As a consequence, the specific properties of synaptic communication between different types of neurons play a pivotal role in shaping the computational power and network activity of specific brain regions. Research in my laboratory is focused on the hippocampus, which is an area of the brain involved in higher cognitive functions, such as learning and memory, and is often affected by important neurological illnesses like epilepsy, schizophrenia and Alzheimers disease. In particular, we are interested in the synaptic properties of GABAergic inhibitory interneurons, which are a very heterogeneous cellular population, with wide anatomical and functional diversity. Additionally we are trying to unravel the network properties of Cajal-Retzius cells, which are a neuronal population involved in guiding cortical development, whose computational functions remain poorly understood. Methodologically, we use state-of-the-art electrophysiological techniques in vitro such as paired recordings from anatomically identified connected neurons and optogenetic control of specific cellular populations. We hope that relating different neuronal types to clear network functions may lead to a better understanding of the cellular and molecular basis of hippocampal activity, and generate important insight into the organizing principles of cortical networks in the normal brain and during disease.
1051280	MRI, stroke, perfusion, angiography,  
1051283	My research is focused on two general areas: radiobiology and bionanotechnology. Work in radiobiology includes studies of the molecular biology of radiation responses, particularly radiation toxicities, radiation effects, dose-, dose-rate, and radiation quality issues and other general areas of radiobiology. In addition, my laboratory houses the tissues and data from mojority of  the radiobilogical experiments conducted in US between 1950-1990's (http://janus.northwestern.edu). In addition to sharing these data and materials with the radiobiological community, my group is investigating the archive as well; we are applying new statistical approaches on old datasets and new experimental approaches for investigation of formalin fixed and paraffin embedded materials. Work with micro-RNA microarrays, and use of X-ray fluorescence microscopy for histopathological analysis fall into this research. Work in bionanotechnology includes development and investigation of multifunctional nanoconstructs, increasing contrast for biomedical imaging (MRI and CT), enabling delivery of small molecules (such as chemotherapeutic drugs, flavonoids etc.) and producing cytotoxic reactive oxygen species to fortify effect of radiotherapy.
1051295	Why do some premature infants experience adverse outcomes, while others do not? Dr. Mestan is an attending neonatologist at Children's Memorial and Northwestern's Prentice Women's Hospital, whose research focuses on identifying biochemical, environmental, and genetic markers for preterm birth and its complications. Understanding these markers could allow clinicians to predict which babies are most at risk for preterm birth and its complications, such as chronic lung disease, poor growth, and developmental problems in children.
1051375	prevention / reduction of postoperative nausea/vomiting and pain, Sports medicine principles applied to musical performance and training
1051378	Research interest is focused on the evaluation of electronic systems and their abilities to support safe and efficient clinical care and in the design of new electronic systems.
1051378	The impact of focused clinical decision support at the point of care.
1051485	Our laboratory studies the regulation of DNA Replication during the cell cycle. 
1051485	We study how stem cell division and differentiation are coordinated.  Cell division and differentiation are in many ways mutually exclusive. Most cells stop dividing as they adopt a specific fate, while relatively undifferentiated stem cells are able to divide throughout the lifetime of the organism. Cancer cells are characterized by both poorly controlled proliferation and a loss of the differentiated phenotype. During regeneration, quiescent differentiated cells revert to a stem cell phenotype and begin dividing anew.  Our research focuses on hematopoietic stem cells, germline stem cells, and myocardial stem cells.  Our central approach is to construct knockout mouse models to study proteins that regulate stem cell division and differentiation patterns.  We also study the mechanism of nuclear reprogramming using Xenopus eggs.
1051542	pancreas, cancer, transgenic, mice, models, detection, chemoprevention, diet, immunology, therapy 
1051571	Dr. Boberg has spent 12 years studying the development and evaluation of computer-based systems for patient education and support.  His research career spans basic, clinical, and health services/outcomes research.  He is author of over 25 peer-reviewed publications and book chapters, and has made dozens of presentations across the United States, Canada, and Europe.  Since 1999, he has been a member of NIH Small Business Innovation Research (SBIR), NCI, and NIDA study sections.  Dr. Boberg s research interests focus on needs assessment and design of web-based interventions to meet patient and caregiver needs.
1051571	patient needs assessment, web-based patient information and support
1051610	The research interests of my group are in the field of cytokine-signaling in malignant cells.  We have previously identified and characterized several novel signaling cascades activated by the Type I interferon receptor downstream of Jak-kinases in leukemia and other neoplastic cells, including the insulin receptor substrate (IRS)-pathway, the Crk-pathway and the p38 Map kinase signaling cascade.  These studies have been expanded in efforts to determine the mechanisms by which chronic myelogenous leukemia (CML) cells become refractory to the antiproliferative effect of interferons and the mechanisms of synergy between interferon and STI571 (Gleevec) in CML cells.  We have also recently identified the kinase that mediates phosphorylation of Stat1 on serine 727 as the protein kinase C-delta (PKC&#61540;).   Other research areas in which our laboratory is actively engaged are the mechanisms of signal transduction of all-trans-retinoic acid (ATRA) and arsenic trioxide in acute promyelocytic leukemia.  We have recently shown that ATRA activates the Rac1/p38 Map kinase pathway and that pharmacological inhibition of this pathway enhances its effects on leukemia cells, raising the prospect of development of translational studies combining ATRA with pharmacological inhibitors of Map kinases for the treatment of acute promyelocytic leukemia.  Finally, our group also studies the signaling mechanisms of regulation of normal hematopoiesis by myelosuppressive cytokines, including interferons, tumor necrosis factor-alfa and transforming growth factor-beta.  
1051610	chronic leukemias, multiple myeloma, non-hodgkin's lymphoma
1051628	My research interests include surgical simulation in undergraduate and graduate medical education specifically, skill development and assessment.  Clinically, early diagnosis of retinal disorders as well as optic neuropathy are the focus of my practice.
1051734	The laboratory has a long standing interest in the biology of epithelial stem cells. To this end, in collaboration with Tung-Tien Sun (NYU Medical School) we have identified and characterized epithelial stem cells of the epidermis, corneal epithelium and hair follicle       Another research focus of the laboratory is the characterization of epithelial-enriched  microRNAs (miRNAs) to understand how these miRNAs regulate epithelial stem cell behavior and epithelial differentiation. We have demonstrated the presence of several miRNAs that are specifically localized in the corneal epithelium of adult mice; other miRNAs are found in many stratified squamous epithelia including the epidermis. Recently we have found that the lipid phosphatase SHIP2 is a target for miRNA- 205 (miR-205), which is expressed in many stratified squamous epithelia. We have also found that miR-184, which is exclusively found in the corneal epithelium, antagonizes miR-205 to help maintain the levels of SHIP2. This is the first example of a miRNA negatively regulating another to maintain levels of a target protein. 
1051743	My current research interests include radiation biology and nanotechnology and development of a new instrument for high resolution microscopy--Bionanoprobe.  In the field of radiation biology, my primary focus is on mechanisms underlying development of genomic instability caused by ionizing  irradiation. This investigation includes work with cells in culture and animal models as well as exploration of archival animal tissues collected from large scale animal experiments, currently located in Woloschak laboratory. My efforts in the field of biomedical nanotechnology include development and investigation of nanoconstructs suitable for biomedical imaging and cancer therapy. Different metals and metal oxides are combined to form the compact center of nanocomposites; their outer layer(s) are made by conjugation of biomolecules and small molecules which enable nanoconstruct targeting and use in vitro and in vivo.  Study of interactions between nanoconstructs and cells and tissues requires high throughput and high resolution imaging that co-registers both biological material and nanoconstructs. Only technique that can fulfill all of these requirements is X-ray fluorescence microscopy. A grant awarded to our laboratory was used for custom construction of unique new instrument--Bionanoprobe. This instrument is now installed at the Advanced Photon Source synchrotron and will be used for imaging for bio-nanotechnology.
1051757	Neuropsychological Testing, Geriatrics, Medical Rehabilitation Populations, LD/ADHD, Nervous System Diseases, Alcohol/Substance Abuse, Bariatrics 
1051857	My overall interests lie in the translation of evidence-based practices into integrated clinical care. More specifically, I am involved in clinical, training, and programmatic activities designed to extend the access of cognitive-behavioral therapies to individuals with psychotic and bipolar disorders.
1051986	Criminal Competency, Disability, Fitness for Duty, Race Discrimination, Sexual Harassment, Violence and Risk Assessment
1052027	Breast Imaging including ultrasound, magnetic resonance imaging and breast intervention.
1052037	Dr. Kibbe is an Associate Professor of Surgery at the Northwestern University Feinberg School of Medicine, Division of Vascular Surgery as well as Staff Physician and Director of the Vascular Laboratory at the Jesse Brown VA Medical Center.  She received her MD degree from the University of Chicago in 1994, completed her general surgery residency at the University of Pittsburgh in 2002, and vascular surgery fellowship at Northwestern University in 2003.  She is board certified in both General Surgery and Vascular Surgery.  She received her RVT certification in 2003. Dr. Kibbes clinical efforts focus on open and endovascular surgery, with a particular interest on carotid and peripheral arterial endovascular interventions.  Her research interests focus on nitric oxide vascular biology.  Specifically, she is studying how nitric oxide inhibits vascular smooth muscle cell proliferation by focusing on the role of nitric oxide in regulating the cell cycle, the ubiquitin-proteasome pathway, and apoptosis.  She is also developing and testing nitric oxide-based pharmacological approaches to inhibit neointimal hyperplasia following vascular bypass grafting.  Her hope is to have a positive effect on patency rates of both vein and prosthetic bypass conduits, thereby effecting millions of patients that undergo coronary artery or peripheral artery bypass procedures.
1052057	Interested in understanding the informed consent process around genetic research and predictive genetic testing. Additionally, I am interested in how patients choose to use information from predictive testing to manage their health.  Also, interested in understanding what the general patient population understands about genetic testing, genetic research, and personalized genetic medicine and how best this information can be communicated.
1052125	Emergency Medicine, Medical Toxicology, Innovative Scholarship
1052190	Dr. Chetkovich practices general neurology at Northwestern Memorial Hospital and at the Northwestern Medical Faculty Foundation Neurology Clinic.  Dr. Chetkovichs current research focuses on the molecular mechanisms that underlie the targeting of ion channels to synapses and other specialized areas of the dendrites of neurons.  In particular, the lab is interested in the synaptic targeting of ligand and voltage-gated ion channels, molecules responsible for controlling communication in the brain of mammals.  The laboratorys approach utilizes a variety of cellular, molecular and electrophysiological tools to address the mechanisms by which ion channels are targeted to dendrites, as well as the role that this targeting plays in synaptic structure and function as it pertains to epilepsy and brain injury, as well as in disorders of learning and memory such as Autism and Alzheimers disease.  Dr. Chetkovich is also the Director of the Northwestern University Feinberg School of Medicine Medical Scientist Training Program (MSTP).
1052193	Treatment of leukemias, myelodsyplastic syndromes and myeloproliferative disorders.  Management of non-Hodgkin and Hodgkin lymphomas. 
1052202	Neurovascular Critical CAre, Stroke
1052228	College Mental Health, General Adult Psychiatry
1052334	Both my clinical and research interests are in nutrition of critically ill neonates, including early institution of parenteral nutrition, use of human milk, and the effect of early growth patterns on subsequent health and neurodevelopment.
1052335	Dr. Farrow's research focuses on the tissue-specific and developmental regulation of phosphodiesterases (PDEs) in the pulmonary vasculature, both in normal transition after birth, as well as in the context of persistent pulmonary hypertension of the newborn (PPHN) and bronchopulmonary dysplasia (BPD). Dr. Farrows laboratory has demonstrated that exposure to high levels of oxygen, which is a common treatment for both PPHN and BPD, leads to increased PDE5 expression and activity in the pulmonary vascular smooth muscle of neonatal sheep and mice. This increased PDE5 expression and activity leads to decreased pulmonary vascular relaxation in response to nitric oxide, a common pulmonary vasodilator.  In the future, new drugs such as PDE5 inhibitors or anti-oxidants may play an important role in the treatment of infants with PPHN or BPD.
1052350	Dr. Bakers research has focused on access to health care, racial and ethnic disparities in care, health communication, and interventions to improve quality of care for chronic diseases.  In the area of access to care and health care delivery for vulnerable populations, his interests include health literacy, language barriers, the effect of lack of insurance on health care use and health outcomes, and racial and ethnic differences in health care use and outcomes.  He has led studies examining many aspects of quality, including whether hospital mortality report cards lead to changes in market share for hospitals and improvements in outcomes, the effect of disease management programs for patients with heart failure, and the effectiveness of learning collaboratives.  His current work is examining quality measurement and quality improvement using electronic health record systems.
1052350	My research has focused on access to health care, racial and ethnic disparities in care, health communication (including health literacy and language as barriers to care), and quality of care for chronic diseases.  I was Principal Investigator for the Literacy in Health Care Study, the first study of the prevalence of inadequate health literacy, and Principal Investigator for the Prudential Health Literacy Study, the largest study ever conducted of the relationship between literacy, health status, and use of health care services.  I was also the Principal Investigator for a study examining health outcomes for the uninsured among a national sample of adults in late middle-age.  In the area of quality of care, I served as the Associate Project Director for the AHCPR-funded Heart Failure guideline and was lead author for a series of manuscripts in JAMA on quality of care for patients with heart failure. I was Principal Investigator for the largest study conducted to date to determine whether publicly reporting hospital mortality rates led to improvements in outcomes My current projects are examining 1) the relationship between reading comprehension, cognitive function, and mortality among the elderly, 2) methods to improve health communication through multimedia, 3) the relationship between race, ethnicity, and language and quality of care for patients hospitalized with myocardial infarction, heart failure, and pneumonia, 4) racial/ethnic differences in subjective versus objective health status (i.e., physical functioning) measures, and 5) use of electronic health records to measure quality of care and to improve healthcare quality and safety. 
1052351	My current research efforts employ several innovative methods for quantifying multi-joint upper extremity movement control during both postural and movement tasks in individuals with stroke. I utilize the same quantitative methods to instrument direct impairment-targeted interventions in an effort to elucidate neural mechanisms underlying impaired movement and subsequent restoration of normal movement in individuals with stroke. This research is in collaboration with Julius P.A. Dewald, PT, PhD and is further augmented by collaborations with colleagues with expertise in neural imaging techniques such as magnetic resonance imaging, electroencephalography, and transcranial magnetic stimulation. I also specialize in the training of Physical and Occupational Therapists in the administration of impairment, activity, and participation limitation assessments for individuals with stroke and the subsequent processes necessary for standardized delivery of assessments in clinical trials. Through my clinical research efforts I hope to contribute to the evolution of rehabilitation medicine and science by advancing neurological rehabilitation principles and techniques. The key component most likely to impact rehabilitation in this magnitude is the elucidation of the neurological underpinnings responsible for movement discoordination and through the subsequent development of more effective rehabilitation therapies for individuals with functionally debilitating movement impairments. 
1052368	Blood Bank   Hemostasis-Coagulation<BR><BR> Our laboratory focuses on the mechanisms by which prostate cancer cells invade surrounding tissues and spread to distant sites in the body, leading to prostate cancer morbidity and death. We have characterized prostate cancer cell lines and found that the ras homolog RhoA and the nuclear transcription factor NF-kappaB are active and necessary for highly invasive prostate cancer cell behavior. Tumor-associated macrophages (TAMs) may promote tumor progression and stimulate tumor growth and angiogenesis. We have found that co-cultures with monocyte-derived THP-1 and U-937 cells or peripheral blood monocytes stimulated PC-3, DU145 and LNCaP prostate cancer cell basement membrane invasion. The monocyte-derived cells also stimulate prostate cancer cell NF-kappaB activity.  Prostate cancer cell invasion and NF-kappaB activity in the co-cultures is inhibited by dominant negative I-kappaBalpha transfection or treatment with biochemical NF-kappaB inhibitors. These studies provide evidence that human monocyte-derived cells cross-communicate with prostate cancer cells and stimulate cancer cell invasion requiring cancer cell NF-kappaB activity. This model has the potential to identify treatments that may target the effect of monocyte-derived cells on cancer cell invasion and progression.  By identifying the mediators of prostate cancer cell invasion and metastasis, we hope to discover critical steps of cancer cell invasion and metastasis and find targeted strategies to block malignant prostate cancer progression.
1052521	General Gastroenterology
1052551	Botox, Chemical Peels, Collagen, Cosmetics Surgery, Excisional Surgery for atypical moles, Fat Transplantation, Laser Surgery, Liposuction, Melanoma Surgery, MOHS Surgery for the removal of basal and squamous cell cancers
1052573	Medical education, faculty development, effective teaching and learning, education measurement and evaluation 
1052623	Dr. Kielb's clinical interests include female urology, pelvic floor dysfunction, vaginal prolpase, male and female urinary incontinence, and neurourology/urodynamics. She also has interests in minimally invasive/laparoscopic surgery, robotic surgery, sacral nerve stimulator therapy, and orthotopic neobladder construction.
1052633	Botox, Collagen, Cosmetic Surgery, Excision of atypical moles, Fat transplantation, Glycolic Peels, Laser Surgery, Liposuction, Melanoma Surgery, MOHS Surgery
1052665	consultative cardiology, echocardiography, women's cardiovascular health
1052726	Epidemiologic studies of diabetes, obesity, cardiovascular disease, fitness, and autonomic function.
1052740	Prion proteins are capable of existing in multiple stable conformations, at least one of which is infectious. It is generally accepted that prion (PrPSc) is the responsible agent for the devastating neurodegenerative disorders known as transmissible spongiform encephalopathies or prion diseases. Our laboratory is interested in using yeast and other model organisms to understand how a prion protein acquires its infectious prion conformations and how such conformations are maintained in vivo. Our ultimate goal is to dissect the initiation and propagation processes of prionogenesis, and to identify important cellular factors required in each of these processes
1052793	I currently have three primary lines of research interests.   Gymnastics: Development and analysis of the Gymnastics Functional Measurement Tool (GFMT). The GFMT is a reliable and valid field test for assessing the physical fitness levels of high level gymnasts.  I am currently researching its ability to be a predictor of gymnastics injury. Development of a Men's Gymnastics Functional Measurement Tool Analysis of injury occurrence in women's Division 1 college gymnastics Performing Arts:  I am currently looking at the jump landing mechanics in professional dances in an effort to decrease knee injuries. Orthopedic Rehabilitation: I am doing an outcomes analysis of 3 common rehabilitation treatments for Achilles Tendonopathy
1052813	developmental neurobiology molecular diagnostics clinical pathology Research Interests <BR> <BR> Our major research interest is understanding the factors that control cell proliferation and differentiation in the developing mammalian central nervous system. Although the mechanisms that regulate cell proliferation during neural development are poorly understood, studies in other tissues suggest that loss of normal cell polarity and tissue architecture play crucial regulatory roles in cell proliferation and cancer. Our most recent work suggests that beta catenin, an integral component of the adherens junction, can regulate cell cycle re-entry and differentiation in the developing mammalian brain. Transgenic mice expressing a truncated, stabilized form of beta catenin develop massively enlarged brains with increased cerebral cortical surface area and folds resembling sulci and gyri of higher mammals. Understanding the biology of epithelial organization can lend insight onto the regulation of proliferation during neural development and ultimately reveal mechanisms underlying developmental brain disorders and tumors in the central nervous system.
1052862	Dr. Jacobsohn is an attending in the Stem Cell Transplant Program at Children's Memorial Hospital.  He is actively involved in clinical research in the area of stem cell transplantation.  His main interests are graft-versus-host disease (GVHD) and reduced intensity transplantation.  He is involved in the conduct and design of novel clinical trials to prevent and treat graft-versus-host disease.  For example, he currently heads a national, multi-institutional trial, through the Pediatric Blood and Marrow Transplant Consortium, to treat children with chronic GVHD with pentostatin.  Dr. Jacobsohn is also leading a novel transplant protocol at Children's Memorial Hospital that utilizes photopheresis post-transplant to prevent graft-versus-host disease.  In addition, he is involved with the NIH Consortium for Chronic GVHD, specifically leading an effort to design and validate grading criteria for pediatric patients on chronic GVHD clinical trials.  He has numerous publications in the field of stem cell transplantation and GVHD.
1052876	Airway Management, Cardiothoracic Anesthesiology, Regional Anesthesiology
1052935	I am interested in the larger topic of social justice in health care, and in the ethical issues in how we conceive, direct and regulate the teaching of medicine and science, the research praxis, and the policy that shapes and funds research. I primarily am interested in basic and translational research. While I have focussed my attention on issues in stem cell research, AIDs, synthetic biology and neuroscience, I am also interested in the issue of foster care. I study at the intersection of religious studies, theology and moral philosophy.
1053088	As many as 20% of breast cancer patients have brain metastases, with women surviving only 2-16 months after diagnosis of this metastasis. Thus, resolving the mechanisms of metastasis to the brain is clinically important. In invasive breast carcinomas, Syndecan (Sdc) 1 is observed in stromal fibroblasts and endothelial cells where it is involved in tumor growth and angiogenesis. Staining for Sdc1 in both the tumor and stromal cells has been reported to be a negative predictor of disease free and overall survival in estrogen receptor (ER) negative breast tumors, and expression of Sdc1 and 4 is associated with increased proliferation index in breast tumors. A direct connection between these receptors and breast cancer metastasis has not been shown. The reduced expression of Sdc1 or 4 in MDA-231 breast cancer cells and reduced expression of Sdc4 in CN34Brm breast cancer cells significantly decreased metastases to only the brain but had no effect on bone, lung, or ovarian metastases when the cells were injected into the left ventricle of the mouse heart (nude mice). Additionally, metastases to the brain was reduced when these cells were injected in the orthotopic site of NSG mice, however, primary tumor growth and metastases to the lung, liver, ovaries, and lymph nodes were not affected in this model. These results suggest Sdc1 and 4 facilitate breast cancer organotropism to the brain. We are currently examining the mechanism of how Sdc1 and 4 affects breast cancer organotorpism to the brain. These results may explain the correlative observations of Sdc expression with poor clinical outcome. These studies may lead to development of new biomarkers and/or treatment for breast cancer metastasis to the brain.
1053089	Microbiology/Virology <BR><BR> Molecular diagnostics, mechanisms of bacterial antibiotic resistance
1053099	.
1053305	I am interested in signal transduction in cancer biology, development of new strategies for cancer prevention and identification of novel targets for better treatment. Currently my studies are focused on different pathways in response of keratinocytes to ultraviolet (UV) irradiation and development of novel chemopreventive agents against UV-induced skin cancer.
1053369	Our research is focused on issues of immune regulation. A long-standing effort has been to understand the how IL-4 is regulated in T and mast cells. We have identified that Ikaros, a transcription factor that regulates chromatin conformation, has distinct cell-type specific effects on the IL-4 gene locus in these cells. We are trying to understand the underlying mechanism of this unique repression of transcription in mast cells and activation of transcription in T cells. Another major project involves the study of mast cells in the autoimmune diseases MS and type 1 diabetes. Althoug well-established mediators of allergic responses, mast cells are potent sources of many immunomodulatory molecules cells that can modulate disease course. Using mast cell-deficient mice, we have established that mast cells are required for fulminant EAE (MS) and NOD mouse diabetes. We are investigating the mechanism of action of these cells in disease pathogenesis.
1053382	I work on modeling complex systems with an emphasis on biological and social systems. I am interested in understanding the relationship between the network of interactions between the units of the system and the function the system wants to perform.  In the case of biological systems, I am interested in developing systems level phenomenological theories for cellular processes that are generalizable and have predictive power.  In the case of social systems, I am interested in understanding the scientific process, how high quality research arises and how to locate and evaluate high quality research.  
1053420	Clinical: General psychiatry including psychotherapy and psychopharmacology. Medical psychiatry including consultation for and treatment of psychiatric conditions in the setting of co-occurring medical conditions. Forensic psychiatry, both civil and criminal issues, including malpractice, disability, competency, and mitigation.
1053631	Women's Health, primary care, osteoporosis.
1053660	General Surgical Pathology and Urological Surgical Pathology Diagnosis of genital urinary cancers including prostate, bladder, kidney, testis and other GU organs Immunohistochemistry<BR><BR> Pathogenesis of prostate cancer, kidney cancer and bladder cancer Identification of new molecular markers of GU cancers Solid tumor banking for biological studies
1053762	Mood Disorders, Depression, Treatment and Outcome, Remission, Treatment of Depression Subtypes. 
1053859	My area of academic interest focuses on pediatric neurocritical care especially as it pertains to epilepsy, status epilepticus, coma, brain injury, and neurophysiology.
1053905	Dr. Catalona is currently conducting research into the genetics of prostate cancer which could lead to new tests for the disease as well as possible new means of treating or preventing prostate cancer. He specializes in prostate cancer surgery and is recognized as an expert in performing the 'nerve-sparing' radical prostatectomy that can preserve sexual potency.
1053924	Disability Research 
1053926	1. Long-term cellular and molecular consequences of early-life seizures 2. Inflammation and immunity in epileptic brain 3. Novel therapies to block epileptogenesis in genetic models of childhood epilepsy
1053946	My lab has two main research lines: one is cellular neurophysiology, with particular emphasis on the mechanisms of action potential generation and propagation and on the role of dendrites in post synaptic signal integration. The second research line of the lab focuses on the role of ion channels in neurological disease, and in particular on the central (brain) mechanisms mediating chronic pain.  
1053957	My research efforts focus on identification of risk factors for injury in youth sports and investigating strategies for prevention.  My 2006 research demonstrating that a coach-led neuromuscular warm-up can significantly reduce knee injuries in girls soccer and basketball players at Chicago Public High Schools won two awards.  In conjunction with the CMH Motion Analysis Center, we are using 3D motion analysis to investigate the role of pitching technique on the risk of overuse injuries in youth pitchers. I am also involved in research investigating the risks of early sports specialization in young athletes and establishing age-appropriate clinical evaluation tools for sports-related concussions.
1053987	I am a scientific annotator working mainly on the dictyBase database, whose goal  is to provide the scientific community with a centralized resource containing all the information available about Dictyostelium discoideum. I analyze and annotate genes of the Dictyostelium genome, which includes: verifying and modifying gene models, descriptions and classifications of the biological roles, molecular functions, and subcellular localizations of predicted and known gene products using the Gene Ontology (GO) controlled vocabulary, adding links to literature information, classifying phenotypes, and cataloging Dictyostelium strains.   I also work on biomedical ontologies: I work on the Gene Ontology and have developed the Dictyostelium Anatomy Ontology (Gaudet et al, 2008, BMC Genomics. 18;9:130. PMID: 18366659), and I manage a project of the Gene Ontology group called the GO Reference Genome where we annotate in parallel the orthologs from multiple species (Gaudet et al 2009 PLoS Computational Biology).
1054108	non-Hodgkin lymphoma, etiology, diet, obesity, pesticides, lifestyle factors, chromosomal abnormalities, molecular epidemiology, gene-environment interactions 
1054111	I am interested in ethical issues associated with conducting large-scale genetic research including consenting, data sharing, privacy, return of results, recontact and education of research participants.
1054143	Interferon signal transduction, MAPK signaling, CML, MDS, myeloproliferative disorders, cellular proliferation and apoptosis signaling, cytokine signaling   
1054153	I have had the opportunity to study problems in a number of areas of endocrinology and metabolism. Recent efforts have included studies of the evolution of the metabolic syndrome led by Dr. Xiaobin Wang.  I have been continuing work on thyroid disease including thyroid cancers.
1054166	I specialize in Neonatal-Perinatal medicine with particular interest in persistent pulmonary hypertension of the newborn. I helped establish the head-cooling program for hypoxic ischemic encephalopathy at Central DuPage Hospital.  I also have special interest in the nutritional needs of the term and preterm newborn.
1054182	Spinal cord stimulation is a fascinating modality for treatment of chronic pain which is finding new applications in medicine, yet the physiology of the spinal cord and dorsal root ganglion is not comletely elucidated in this milieu. Chronic abdominal pain and other intestinal disorders are being treated with spinal cord stimulation with increasing success. Current clinical research is in the field of injection related anxiety, cervical epidural injection safety, hormonal changes with epidural steroid injections, and novel use of stellate ganglion injections for non-pain related syndromes.
1054188	Co-P.I. for SHAPE study evaluating use of gastric pacemaker for obesity (21 patients implanted at NMH)- Transneuronix is sponsor 
1054188	obesity/weight management, nutrition in chronic diseases, diabetes 
1054303	Clinical and Research interests include Eosinophilic Esophagitis (EoE) in pediatric populations including studying the mechanisms of fibrosis and remodeling,identifying non invasive biomarkers to assess recurrence of esophageal inflammation. Also interested and I am studying the impact of elimination diets in inducing and maintaining clinical and histological remission in children with EoE.
1054309	Hospital based treatment of children and adolescents 
1054320	leukemogenesis, NUP98-HOXA9, AML, MDS, CD45-AP, CD45, PTP, signal transduction, hematopoiesis, nucleoporins
1054387	Primary interests in dysmorphology and chromosome abnormalities (specifically 22q11 deletion syndrome)
1054404	Psychiatry, genetics, schizophrenia 
1054412	T cells, immunology, skin, NKT cells, signal transduction, tyrosine kinases
1054508	Mass event management. issues and circumstances with Sudden Cardiac Death in the Community
1054599	My laboratory research has focused on noninvasive prenatal genetic diagnosis using fetal cells and nucleic acids in maternal blood. I also have an interest in medical ethics as related to prenatal genetic screening and diagnosis and reproduction. 
1054782	My interests include mental health treatment and evaluation of children and adolescents. I am also interested in the development of antisocial behaviors and substance abuse, pediatric bipolar disorder, non-suicidal self-injury, and racial/ethnic disparities among youth in the juvenile justice system.
1054853	I am a health services researcher and primary care internist. My research involves the design, implementation and evaluation of electronic health records-based quality improvement tools, practice redesign techniques and methods for clinician performance measurement. I have performed multiple studies using data from clinical information systems to assess various aspects of cardiovascular disease, hypertension and preventive care. I have an AHRQ career development award examining how to improve the practice of preventive cardiology by predicting patients cardiovascular risk using electronic health record data and integrating this information into clinical use for both clinicians and patients. I am co-investigator and playing a leading role in the UPQUAL Study, Using Precision Performance Measurement to Conduct Focused Quality Improvement, from AHRQ. This multi-site study uses precision quality measurement embedded within clinical information systems to deliver focused quality improvement for multiple chronic disease and prevention targets.
1054853	My research focuses on several related areas:  1) quality improvement for outpatient care of cardiovascular disease and diabetes mellitus including changing the healthcare delivery system and patient communication, 2) the way patient knowledge and attitudes influence health behaviors in chronic illnesses such as diabetes and cardiovascular disease, and 3) issues surrounding the measurement of healthcare provider performance for public accountability.
1054857	My primary research interests include medical education, curriculum design and career development with residency and faculty learners. I am also interested in education and research driven practice improvement in the care of emergency department patients with palliative and end-of-life care needs.
1054860	The laboratory research of Serdar E. Bulun, MD, focuses on studying estrogen biosynthesis and metabolism, in particular aromatase expression, in hormone-dependent human diseases such as breast cancer, endometriosis and uterine fibroids. A team of investigators works on understanding the epitheial-stromal interactions and aromotase overexpression in breast cancer tissue. Since aromatase inhibitors treat breast tumors primarily via suppressing intratumoral estrogen biosynthesis, these efforts are important for discovering new targets of treatment. Another team studies endometriosis. Basic data from this laboratory led to the introduction of aromatase inhibitors into endometriosis treatment. Human tissues and a primate model are used to elucidate cellular and molecular mechanisms responsible for the development of endometriosis. Regulation of aromatase expression is also studied in uterine fibroids, benign tumors that are dependent on estrogen for growth, by a third team. A fourth team is investigating the link between progesterone action and estrogen inactivation in normal endometrium and endometriosis. Lastly, a fifth team has identified novel mutations that cause familial excessive estrogen formation syndrome. This syndrome is characterized by short stature, gynecomastia, and hypogandism in males and early breast development and irregular menses in females. In this syndrome, heterozygous inversions in chromosome 15q21, which cause the coding region of the aromatase gene to lie adjacent to constitutively active cryptic promoters that normally transcribe other genes, result in estrogen excess owing to the overexpression of aromatase in many tissues. 
1054986	Autopsy   Sub-specialty Hematology, Sub-specialty Transfusion Medicine  <BR><BR> Hematology, Transfusion Medicine
1055017	Alcohol and prescription drug abuse among college students; Sexual assault
1055047	Schizophrenia is a devastating neurodevelopmental illness, which affects 1% of the population and is associated with high rates of morbidity and mortality.  We focus our research on the cellular mechanisms by which DISC1, a schizophrenia susceptibility gene, affects neurodevelopment. DISC1 was initially identified in a large Scottish family with members who suffered from schizophrenia, bipolar disorder and recurrent major depression. DISC1s association with schizophrenia has been confirmed in other population and family studies. Genetic studies have also indicated a DISC1 association with bipolar affective disorder and with autism and Asperger syndrome. Understanding the genetic and developmental basis of schizophrenia is critical for discovering treatments.  Two recent publications by the Morris laboratory focus on the role of Disc1 in development, particularly the migration of cells to their proper location in the brain and subsequent differentiation into their intended fate.
1055048	My lab studies the processes that regulate the early development of the embryo, including cell movements, survival, proliferation, and differentiation.  We focus on a number of proteins which are linked to human birth defects, to try to understand these abnormalities.  In order to observe changes in cells and gene expression, we model human birth defects in both chicken and zebrafish embryos.  This combination of systems allows us to have rapid interrogation of developing embryos as well as large supplies of tissues for comparative studies.  We focus on the Sonic Hedgehog signaling pathway, which plays multiple roles in establishing cell fates, as well as regulating cell numbers by controlling both proliferation and survival.Current studies in my lab include exploring the gene expression changes produced by embryonic exposure to ethanol, and developing novel therapeutics that can restore normal development without causing harm to non-affected embryos.
1055051	zebrafish, glypican, Wnt, morphogenesis, developmental biology, heparan sulfate proteoglycans
1055119	Dr. Xu's primary research work focus on therapeutically prevention of prostate cancer metastasis.
1055143	Hypertension, diabetes, migraine, women's health, medical education 
1055145	My research focuses on the basal ganglia, a group of subcortical brain nuclei that are critical for voluntary movement and associative learning and are the primary sites of dysfunction in Parkinsons disease, Huntingtons disease, obsessive-compulsive disorder and addiction. My objectives are to define the principles underlying the normal and pathological operation of the basal ganglia.  My hope is that this information will provide the foundation for the rational development of corrective or neuroprotective therapies.
1055146	My primary clinical interests are in the care of the frail elderly. I am particularly interested in memory disorders, dementia, gait disorders and falls, failure to thrive, Parkinson's Disease, and medication management in the older adult.
1055267	Dr. Rosenow is the Director of Functional Neurosurgery in the Northwestern University Feinberg School of Medicine Department of Neurosurgery and at Northwestern Memorial Hospital. He specializes in the treatment of movement disorders such as Parkinsons disease, tremor, and dystonia, as well as the surgical treatment of epilepsy and chronic pain. He works as part of a coordinated multidisciplinary team that includes physicians in neurology, neurophysiology, neuropsychology, neuroradiology, physical therapy, speech pathology, and social work. My research revolves around restorative neurosurgery. This includes neurostimulation (deep brain, cortical, transcranial magnetic), brain-machine interface (both cortical chip and EEG-based), and gene therapy methods. Our group currently has active projects investigating cortical-basal ganglia interactions in Parkinson's disease patients with externalized deep brain stimulating electrodes as well as computer modeling of both cortical-basal ganglia interactions and novel paradigms of deep brain stimulation.  We are also involved in a project using an animal model of neuropathic facial pain to discern and refine motor cortical stimulation for facial pain. We have an active protocol for transcranial magetic stimulation for recovery for brain injury. Another area of interest is image-guided surgery. We pioneered frameless deep brain stimulation surgery and have several projects investigating new methods of intraoperative localization and navigation.
1055282	Family health and mental health, impact of chronic illness on the family, biological and psychological measures of stress, health disparities 
1055316	As the tracheostomy specialist for the medical center, tracheostomy management is a key research interest.  Other research interests include exercise programs to prevent venous thrombosis and other sequelae related to critical illness, and a new method of training for critical care nurses.
1055329	Risk factors and outcomes of traumatic illness, racial disparities in trauma, intimate partner violence
1055338	Brain Tumors, Spinal Cord Tumors, Neurologic Complications of Cancer
1055338	Development of clinical trials for primary brain tumors, brain metastases, leptomeningeal metastases.
1055434	Study of the mechanisms underlying atrial fibrillation. We are currently investigating the autonomic profile of the the pulmonary veins and the rest of the left atrium in a canine model, especially as it relates to the genesis of atrial fibrillation. Our laboratory is also investigating the mechanisms underlying atrial fibrosis (and resulting substrate for atrial fibrillation). 
1055441	Osteoporosis, Systemic Lupus Erythematosus, Inflammatory myositis, Clinical Outcomes 
1055487	My primary research interest is the interface between cognition and emotion. This includes the relationship between mental illness and memory, attention, and other cognitive processes. I am also interested in applied statistics and the application of psychometric theories to the development of better measurement tools for use in health research.
1055505	Dr. Huang's research interests lie in functional genomics. A main focus of his research has been on identifying novel biomarkers for disease disgnosis and prognosis. He is also interested in integrating bioinformatic and epidemiological/clinical data resources to accelerate translational discovery.
1055535	nutrients, diet, trace elements, lifestyle factors, cardiovascular diseases, stroke, obesity, metabolic syndrome, nutrition, epidemiology. 
1055581	Synapses, plasticity, learning 
1055592	My broad research interest lies in understanding the molecular basis of human genetic diseases and developing therapeutics for their treatment. Specifically, my research primarily focuses on neuromuscular diseases, which are those that affect muscle, the nerves that innervate muscle or the neuromuscular junction, which is the connection between the two. One way to approach this problem is to study mutations that disrupt normal neural development. Proximal spinal muscular atrophy (SMA) is a prime example. After cystic fibrosis, SMA is the most common autosomal recessive childhood disease. The disease affects 1/10,000 live born children. It is characterized by degeneration of the a-motor neurons in the spinal cord, which causes proximal, symmetrical limb and trunk muscle weakness that progresses to paralysis and ultimately death. Currently, there is no available treatment for SMA patients.  Mutations in survival motor neuron 1 (SMN1) gene are responsible for SMA. In humans, two virtually identical copies of SMN are present, SMN1 and SMN2. SMN1 produces only full-length transcripts (FL-SMN) and is therefore the SMA-determining gene, whereas the predominant transcript from SMN2 is an exon 7 alternatively spliced form. The SMN2 gene also produces a low level of FL-SMN transcript, which explains why SMA is not embryonic lethal in humans. Nevertheless, lower motor neurons eventually succumb to the reduced SMN dosage and degenerate. Why motor neurons are specifically affected is not clear but it has been proposed that this may be due to a distinct role for SMN in this cell type.  We have developed a translational research program for SMA. The research is multi-faceted and uses biochemistry, cell biology, molecular biology, and animal modeling. We use these approaches to decipher SMN function within nerve and muscle, the two tissues affected in SMA. We have also generated a hypomorphic allelic series of Smn mutations in mice that mimic human SMN2 splicing.
1055613	Kinesin motors drive intracellular transport of many different cargoes along microtubules, and they are critical to trafficking in the nervous system as well as cell division.  Antimitotic drugs that act on two kinesin motors, Eg5 and CENP-E, are currently in phase I and II clinical trials.  Several kinesin motors, including Eg5 and CENP-E, are intrinsically regulated in the cell by their C-terminal tail domains. Our laboratory's work is inspired by the fact that there appear to be multiple, highly effective mechanisms that nature has developed for regulating kinesin kinesin motors. Our hope is that once we understand these natural regulation mechanisms, they can be mimicked to develop new and better antimitotic drugs, resulting ultimately in a larger number of treatment options.
1055648	SYNAPTIC STRUCTURAL PLASTICITY: FROM MOLECULES TO  COGNITIVE FUNCTIONS AND DISEASE Research in my lab centers on signal transduction networks that regulate the structural and functional plasticity of excitatory synapses. Synaptic communication between neurons within brain circuits underlies cognitive functions, and is disrupted in numerous neurodevelopmental and neuropsychiatric disorders. Most central excitatory synapses are located on dendritic spines, and spine structure is essential for normal and pathological brain function. Spine dynamics is crucial for the establishment, maintenance, and experience dependent modification of connectivity in neural circuits. Conversely, abnormal dendritic spine morphology occurs in patients with neurodegenerative, psychiatric, and neurodevelopmental disorders, including schizophrenia, autism, and Alzheimers disease. As spine morphology is closely associated with cognitive functions, understanding the mechanisms of regulation and dysregulation of spine plasticity is necessary to elucidate the neural bases of cognitive functions and disorders. The long-term goals of my research are: 1) to identify and characterize the molecular mechanisms that control synaptic structural plasticity. 2) to determine how they influence the development, functioning, and plasticity of brain circuits underlying cognition. 3) to uncover the molecular mechanisms underlying synaptic pathology and determine their impact on disease endophenotypes. To to achieve these objectives, we employ a multidisciplinary array of molecular, cellular, imaging, transgenic, electrophysiological, and behavioral approaches, and have assembled an outstanding team of collaborators.
1055794	Antimicrobial Resistance, Antimicrobial Utilization, Nosocomial Infections, Geriatric Infections, MRSA 
1055794	Clinical responsibilities include inpatient general infectious diseases consultation and outpatient HIV and general infectious diseases care.   Research projects include:  MRSA colonization in HIV-infected individuals; Antimicrobial utilization in hospitalized elderly population; Evaluation of surveillance methods to identify surgical site infections following total hip arthroplasty.
1055878	My research interests lie in the epidemiology of heart failure and sudden cardiac death in patients with heart failure. My research is funded by grants from the National Institutes of Health and the American Heart Association.
1055878	My research is aimed at understanding heart failure, atrial fibrillation and sudden cardiac death in women. In addition, I am interested in pharmacogenomics in relation to heart failure medications. My research is funded through grants from the National Institutes of Health and the American Heart Association.
1055931	Breast cancer, oncogenes, tumor suppressors, p16, pRB, p53 
1055970	My clinical expertise is in Rheumatology and I treat all types of rheumatologic problems.  My research focuses on the epidemiology of rheumatoid arthritis and the relationship between autoimmune rheumatic diseases and cardiovascular disease. I have conducted studies identifying preclinical rheumatoid arthritis-related autoantibodies measured in stored serum from asymptomatic individuals prior to their subsequent rheumatoid arthritis development.  Currently, I am conducting two large ancillary studies sponsored by the National Heart, Lung, and Blood Institute and the Arthritis Foundation.  In those studies, I am examining autoantibodies as risk factors for subclinical atherosclerosis and clinical cardiovascular outcomes in two large general population cohorts, the Coronary Artery Risk Development in Young Adults (CARDIA) Study  and the Multi-Ethnic Study of Atherosclerosis (MESA).  I am interested in this area of research because there is a well-established association between coronary heart disease and autoimmune rheumatic diseases including rheumatoid arthritis and lupus, but the exact cause is not known. In addition, I am also examining the influence of race and gender on rheumatic disease related autoantibodies in the CARDIA and MESA participants in order to better understand risk factors for rheumatic disease development.
1055971	My research has focused on the application of pharmacokinetics and drug metabolism to problems in clinical pharmacology.  When at NIH I also established an interest in the development and proper use of biomarkers in drug development.
1056003	Obesity in children Health Care in Underserved Populations
1056004	My basic research interest is on the delineation of the mechanism of cell fate determination in blood and marrow stem cells and the development of novel cell-based therapy based on this knowledge. We recently discovered that blood stem cells maintain a balance between self-renewal and maturation through asymmetric cell division and we are develop methods to manipulate this process and expand blood stem cells.  My clinical research interest is on the application of an effective but less toxic method of stem cell transplant to treat children with severe inborn immunological defects. Using this method, we have achieved a cure rate of 100% in these patients, if they are diagnosed and treated early.
1056039	Our laboratory is interested in a range of issues related to the development, physiology and pathology of the 'neurovascular unit' (NVU) (neurons, vessels, pericytes, astrocytes). We also devise new approaches to study at high spatio-temporal resolution, cellular interactions within the NVU, using optical imaging techniques such as two photon microscopy, genetic tools and experimental disease models
1056043	In my lab we are interested in delineating the molecular mechanisms of progesterone action through its receptor, PR in the uterus.  This is done in the context of normal endometrial differentiation, specifically, decidualization, as well as in uterine pathologies, such as endometriosis, endometrial cancer and uterine fibroids.  Specifically, we are interested in studying PR function in relation to other signaling pathways and transcription factors.  
1056074	Dr Carla Pugh is currently Associate Professor of Surgery and Director of the Center for Advanced Surgical Education at Northwestern University. She also holds an appointment in the School of Education at Northwestern.  Dr. Pugh has a broad interest in the use of technology for medical and surgical education. http://www.npr.org/templates/story/story.php?storyId=18939055
1056108	I have a general interest in medical informatics and am interested in applications of informatics and information systems to the care of critically ill children.
1056109	My area of expertise is Pediatric Cardiology with a focus on non-invasive imaging (transthoracic, transesophageal, and fetal echocardiography) and connective tissue disorders.  I am the principal investigator at Children's Memorial Hospital for the Marfan Trial, which is a multi-center study sponsored by the Pediatric Heart Network and NIH/NHLBI assessing the long-term effects of atenolol versus losartan in patients with Marfan syndrome.
1056118	My primary interests are in the minimally-invasive repair of abdominal and thoracic aortic aneurysms as well as the minimally-invasive reconstruction of lower extremity arterial occlusive disease. I am also an investigator for the ATTRACT trial looking at early thrombolytic therapy of DVT to precvent the development of post-thrombotic syndrome. In addition, I have considerable experience in the use of electronic health records in clinical practice.
1056153	John A. Martin, MD, is Associate Professor of Medicine and Surgery, Director of Endoscopy, and Medical Director of the Gastroenterology Laboratory and Endoscopy Unit in the Division of Gastroenterology at the Northwestern University Feinberg School of Medicine and Northwestern Memorial Hospital. His clinical, research, and medical education efforts and interests are focused in endoscopic retrograde cholangiopancreatography (ERCP), advanced interventional endoscopy, surgical endoscopy, hepato-biliary disorders, pancreatico-biliary diseases, transplantation surgery, natural-orifice transluminal endoscopic surgery (NOTES), and the development of novel endoscopic devices for advanced therapeutic endoscopy, as well as interdisciplinary investigation of new advanced multimodal molecular imaging technologies in the laboratories of Drs. Khashayarsha Khazaie and Elias Gounaris. He is also involved in interdisciplinary study, application, and validation of new simulation models and devices for use in endoscopic training and education. With Drs. Nathaniel Soper and Eric Hungness in the Department of Surgery, he is co-founder of the Northwestern NOTES Investigation Group commenced in 2006. In 2007, he initiated the third-tier, fourth year fellowship program in Advanced Therapeutic Endoscopy at Northwestern. Dr. Martin is a graduate of the University of Virginia College of Arts and Sciences and of the University of Virginia School of Medicine. He served his internship and residency at the University Hospitals of Cleveland, Case Western Reserve University. He received his fellowship training in Gastroenterology and Hepatology at the University of Pittsburgh, where he concentrated in pancreatico-biliary disorders, hepatobiliary disorders, and therapeutic endoscopy. He then undertook third-tier fellowship training in advanced interventional endoscopy under the direction of Dr. Gregory Haber and Dr. Norman Marcon at The Wellesley Hospital, University of Toronto, Ontario, Canada. Dr. Martin was appointed to the faculty at the University of Pittsburgh School of Medicine in July, 1997. He joined the faculty of the Division of Gastroenterology at the Northwestern University Feinberg School of Medicine in 2003.
1056183	Transplant rejection and tolerance 
1056185	Our primary research interests are in epigenetics, or how changes in gene expression can impact neurodevelopmental disorders such as autism, epilepsy, Rett and Angelman syndromes; and in how general or specific environmental factors such as fetal alcohol exposure can work through epigenetics to impact outcome.
1056241	My research interests revolve around understanding the risk factors and improving outcomes of critically ill patients with serious infections. This includes severe community-acquired pneumonia, sepsis of all causes, and nosocomial infections, particularly ventilator-associated pneumonia.
1056270	Dr. Lloyd-Jones research interests lie in cardiovascular disease epidemiology, risk estimation, and prevention. A main focus of his research has been investigation of the lifetime risks for various cardiovascular diseases, and factors which modify those risks. Other areas of interest include CVD risk estimation using novel biomarkers, imaging of subclinical atherosclerosis, and the epidemiology of hypertension. His clinical and teaching interests lie in general cardiology, with a focus on prevention.
1056292	The use of simulation technology to improve team training and resident education in neonatal resuscitation.   Other interests include neonatal brain injury and neuroprotection. Neonatal Infectious Diseases.
1056312	Dr. Soper's research interests have revolved around the applications of minimally invasive surgery for gastrointestinal disease, laparoscopic ultrasound, alternative treatments for gallstones and motility of the gastrointestinal tract. More recently he has been involved in the early clinical experience with Natural Orifice Transluminal Endoscopic Surgery (NOTES) and Per Oral Endoscopic Myotomy(POEM) surgery.
1056397	The scientific objectives of our laboratory include identifying genes that contribute to cancer metastasis. The major goal of this research is to define important structure/function relationships and provide the biological basis for new therapeutic strategies. Recent studies have generated molecular classification(s) of specific tumors, and have provided new prognostic markers and novel targets for therapeutic intervention based on the convergence of embryonic and tumorigenic signaling pathways. Current research activities focus on elucidating how regulatory molecules and phenotype control genes govern cell-to-cell and cell-to-matrix interactions, epithelial/mesenchymal transitions, and motility. Specific projects include signal transduction events initiated by cell adhesion molecules and growth factors; factors regulating interconversion of the tumor cell phenotype; novel three-dimensional analysis of cellular invasion through extracellular matrices; regulation of matrix metalloproteinases by tumor and stromal cell interactions; tumor angiogenesis and vasculogenesis; and role of the microenvironment in epigenetic reprogramming of cellular phenotypes.
1056406	Dr. Wang is a board certified pediatrician and a molecular epidemiologist whose work unites molecular biology, population genetics, clinical medicine, and epidemiology and brings together investigators and health professionals from multiple disciplines. Her research has covered a broad scope of health issues ranging from adverse reproductive outcomes, child growth and development, allergy and respiratory health, and childhood precursors of adult diseases, including obesity and metabolic syndrome. Dr. Wang has authored and co-authored over 100 publications in peer-reviewed scientific journals, and many of them appear in prestigious journals, including New England Journal of Medicine, Journal of American Medical Association, and Lancet. At present, Dr. Wang is the principal investigator of multiple large-scale molecular epidemiological studies funded by the National Institute of Health, with a particular focus on environmental factors, genetic variants, epigenomic alterations, and their interactions in adverse reproductive outcomes, food allergy and related conditions, and obesity and metabolic syndrome. Dr. Wang received her MD from Beijing Medical University in Beijing, China, and a master of public health from the School of Public Health and Tropical Medicine at Tulane University in New Orleans. She also received a doctor of science degree from the Department of Maternal and Child Health at the Johns Hopkins University School of Hygiene and Public Health in Baltimore. Dr. Wang completed a three-year research fellowship in Environmental Epidemiology at the Harvard University School of Public Health and a residency in pediatrics at Boston Medical Center.
1056422	My research is focused on studying the role of glial cells in the response to brain injury and blood brain-brain barrier dysfunction.
1056446	Preschool children with behavioral and emotional problems, anxiety disorders, parent training, developmental assessments for educational and treatment planning 
1056465	Primary interests center around investigations into immunologic correlates of fatigue in individuals with multiple sclerosis and chronic fatigue states. Also interested in immunologic correlates of disease in individuals with MS.
1056593	The major focus of our laboratory is to elucidate the mechanism of signal transduction by which nuclear receptor and associated coactivators regulate gene expression in tissue/cell specific manner. To understand the biological role of nuclear receptors and coactivators, our lab is using genetically modified (transgenic and gene knock-out) mouse models of novel coactivators which are identified and characterized in our lab and study their biological significance in mammalian development and various diseases like obesity, diabetes and cancer.
1056682	muscle, contractility, cardiac function, troponin, calponin, transgenesis, gene targeting, protein structure-function relationship
1056693	Dr. Scandrett works primarily at a subacute and long-term care nursing facility near Northwestern Memorial Hospital.  Her clinical and research interests include care quality and improvement, and helping individuals maintain their quality of life in long-term care.  
1056693	My primary research and clinical interest is improving the healthcare-related quality of life for elderly patients residing in nursing facilities toward the end of life. My research examines the factors associated with high quality nursing home care, with the goal to improve the skills of the interdisciplinary team working in the long-term care setting.
1056697	Dr. Schleimer has a longstanding interest in the mechanisms of action of glucocorticoids in allergic diseases.  Past studies have ranged from translational investigations in human subjects to molecular biological assessment of glucocorticoid action.  Mechanisms of the pathogenesis of allergic diseases including asthma, rhinosinusitis, dermatitis and others have also been an area of investigation.  Recent studies have focused on the role of airway epithelial cells as integrators of responses in the airways, including inflammation, innate immunity and adaptive immunity.
1056697	I am interested in the mechanisms of pathogenesis and treatment of a variety of allergic and inflammatory diseases associated with allergy.   These include chronic rhinosinusitis, asthma, hay fever, rhinitis, food allergy and others.   We also study the mechanisms of action of antiinflammatory glucocorticoids.   Our studies focus on the molecular and cellular mechanisms underlying disease and steroid action as well as developing strategies to for new treatments.
1056714	Multiphoton Microscopy of living cells and tissues.  See NINDS P-30 grant.
1056726	I am developing non-invasive transcranial brain stimulation as an adjuvant to lower and upper limb movement therapy following stroke. Adjuvants include transcranial magnetic stimulation, transcranial direct current stimulation, and spike-timing dependent plasticity which uses transcranial magnetic stimulation paired with electrical stimulation of a peripheral nerve. 
1056845	My lab is interested in how cell-cell adhesion and differentiation are controlled and coordinated by the multifunctional protein, beta catenin. In particular, we are interested in how the signaling form of beta catenin becomes activated, and how phosphorylation modulates beta catenin's various functions.  Molecular insights into the fine regulation of beta catenin signaling and adhesion will be relevant to pulmonary fibrosis and cancers.
1056845	My research centers on understanding mechanisms of cell-cell adhesion, and how adhesive information is conveyed to the cell's interior.  We focus on the cytoplasmic protein, b-catenin, which plays essential roles in both intercellular adhesion and nuclear signaling.  At the cell surface, b-catenin binds the cytoplasmic domain of cadherin-type adhesion receptors, which allows cells to engage their neighbors through robust intercellular adhering junctions.   In the cytoplasm and nucleus, a cadherin-independent pool of b-catenin transduces extracellular Wnt signals by interacting with TCF-type transcription factors to activate target genes. The Wnt/b-catenin signaling cascade activates genes that allow cells to adopt particular identities throughout development.  In adult tissues, activation of this pathway maintains the 'progenitor' phenotype, while inhibition of this pathway promotes differentiation.  In the lung alveolus, type 2 epithelial cells are thought to give rise to type 1 cells, but the signaling mechanisms which drive this process remain poorly defined.  We reason that modulation of Wnt/b-catenin signaling controls type 2 differentiation into type 1 cells, and experiments are currently underway to address this hypothesis.  Defining the signaling pathways that control AT2 maintenance and differentiation may aid our understanding of the pathophysiology of pulmonary fibrosis and COPD. 
1056853	Richard C. Meagher, Ph.D. is Associate Research Professor in the Division of Hematology/Onocology and Director of the Cell Therapy Processing Facility at the Feinberg School of Medicine.  Dr. Meagher's primary research interests include the role of the hematopoietic microenvironment (stroma) on the regulation of proliferation and differentiation of stem cell progenitors and precursors, especially the role it plays in directing the immune arm of the hematopoeitic system.  In addition, Dr. Meagher has studied the mechanisms of action of hematopoietic growth factors and cytokines and the control they exert on stem cell precursors.  These interests have led him to develop novel translational methods and procedures for the collection and long-term cryopreservation of human stem cell sources including bone marrow, peripheral blood progenitors and umbilical cord blood cells.  He is currently investigating novel replacement agents for dimethyl sulfoxide (DMSO) that is considered the gold standard for cryopreservation of human blood products intended for clinical transplantation.  
1056890	Valve Repair/Replacement, Mitral Valve Repair, Atrial Fibrillation Surgery, Maze Procedure, Aortic Aneurysm, Coronary Bypass Surgery, Hypertrophic Cardiomyopathy / Myectomy, Minimally Invasive Surgery  
1057015	Cancer Survivorship
1057063	The innovation of pediatric specialty clinicians has extended the lives of children with complex medical needs, neurological impairment, and technology dependence.  However, our systems of care have difficulty meeting the complex needs of this emerging population.  Challenges lie in coordination of care through a vast continuum that includes hospital systems, primary care, home health, etc.  My interests lie in defining this population of patients; studying their needs on a clinical and systems level, and advocating for quality improvement.  A new area of focus is the potential for electronic health information exchange, now a national priority, to facilitate the coordination of care for these patients.
1057152	Clinical interests included Mood and Anxiety disorders in adults and older adults, as well as the evaluation and treatment of the behavioral and psychological symptoms of Dementia.
1057261	Dr. Podojils work has focused on the role of costimulatory molecule expression and function on both CD4+ T cells and APC populations during autoimmune diseases, such as multiple sclerosis, and he has a particular interest in neuroimmunology.  His primary research focus is to determine the cellular and molecular mechanisms underlying the differential effect of structurally modified forms of anti-CD80 monoclonal antibody (mAb) in the CD4+ Th1 cell mediated disease model of PLP139-151-induced EAE. His current findings suggest that stimulation of CD80 on a CD4+ T cell activated in Th1-promoting conditions induces an increase in the amount of IFN- produced per cell and increases Th1 cell survival within the CNS.  These findings suggesting a mechanism by which anti-CD80 mAb treatment of PLP139-151-primed mice exacerbates disease, while treatment with anti-CD80 Fab fragments decrease disease severity.  In line with his research studying the role of CD80 expression and reverse signaling to the cell expressing CD80, he has also been studying the role of B7-H4 in CD4+ T cell function.  B7-H4 is a recently discovered B7-family member molecule hypothesized to inhibit effector CD4+ T cell responses.  Since current approaches for regulation of human autoimmune diseases are largely broad-based immunosuppressive strategies necessitating the physical deletion/inhibition of entire subsets of T cells or non-specific inhibition of antigen presentation or pro-inflammatory cytokine production which could compromise the hosts ability to combat opportunistic pathogens and/or increase risk of neoplasia, therefore we are currently investing the ability of short-term therapy with B7-H4 Ig may prove to be clinically viable.
1057352	I am interested in clinical research centered on cardiac imaging and valve disease.
1057436	Clinical outcomes for thyroid cancer, hyperparathyroidism, and adrenal tumors including pheochromocytoma and adrenal cancers. Decision analysis. Cost-effectiveness analysis. Database analysis.
1057622	Dr Naidech's primary research and clinical interests include life threatening neurologic diseases such as intracerebral (brain) hemorrhage, subarachnoid hemorrhage, status epilepticus (continual seizures) and traumatic brain injury. Dr. Naidech manages several prospective outcomes databases; these data may be linked with the Enterprise Data Warehouse for quality and academic purposes. Administratively, he is a Medical Director of the Neuro/Spine ICU at Northwestern Memorial Hospital. Dr. Naidech is a frequent peer-reviewer for academic journals.
1057695	Outcomes of novel techniques in breast cancer reconstruction, aesthetic surgery, general reconstruction. Medical device innovation and biodesign.
1057699	The focus of research in my laboratory is to understand the immune basis of prostate disease in humans. We have a particular emphasis on chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), a debilitating medical condition characterized by dysuria and pelvic pain.  My laboratory is very interested in understanding the mechanism underlying inflammation of the human prostate and it's impact on prostate diseases. The laboratory utilizes comparative animal models that closely track human prostate disease to examine prostate disease mechanisms and also as tools for translational research. Some specific areas of research interest are as follows - 1. Th1/Th17 mechanisms in chronic pelvic pain: We are interested in understanding the mechanism of T cell mediated pain, the effectors of the pain pathway and measures to modulate Th1/Th17 immune response in animal models and ultimately in humans. 2. Chemokine mechanisms in chronic pelvic pain:We are in the process of identifying the mechanisms that appear to mediate chemokine mediated pelvic pain by focusing both on the prostate as well as on neuronal mechanisms of central sensitization. A further focus of this project is the role of mast cells and mast cell-released intermediates in the pathogenesis of chronic pelvic pain. Identification of biomarkers for CP/CPPS in humans is also an emphasis of this project. 3. Pattern recognition receptors in prostate inflammation: Deficiencies in TLR4 signaling pathways result in increased susceptibility to bacterial infection, and profound defects in innate and adaptive immunity. We are  in the process of studying the microbial pathogenesis of prostatic bacterial isolates and dissecting TLR signaling pathways in prostate cells.
1057718	I am interested in Pediatric pulmonology, specifially looking at cystic fibrosis and interstitial lung disease. I am also interested in lung function testing from birth to adulthood. I also have an interest in Healthcare Quality and outcomes research.
1057749	I am a general internist with advanced training in epidemiology, public health, and health communication. After completing my residency in Primary Care/Internal Medicine at New York University/Bellevue Hospital, I was a Robert Wood Johnson Foundation Clinical Scholar at the University of Chicago.  My expertise is in cross-cultural communication and health promotion for minority communities. I am a recipient of a Mentored Patient-Oriented Research Career Development Award (5K23HL084177-04) from the National Heart, Lung, and Blood Institute to develop and evaluate culturaly targeted heart disease prevenetion messages for South Asians. I currently direct an ongoing research program to develop, implement, and evaluate literacy and culturally appropriate health education materials on heart disease and diabetes.
1057754	health-related quality of life, symptom evaluation, functional status, primary care
1057770	Of the one million hospitalizations for acute heart failure (AHF) that occur every year, 80% are initially managed in the Emergency Department.  Despite tremendous advances in cardiovascular management, these patients have a very high post-discharge mortality and re-hospitalization rate, approaching 35% within 90 days.  The financial costs are also enormous, consuming more than half of the 40 billion spent annually on HF care.  Attempts to improve post-discharge outcomes with novel therapies have all failed, in  spite of 10 years of efforts.  Current therapeutic management in the ED is the same today as 40 years ago.   I firmly believe we can improve these dismal outcomes.   At Northwestern, it has been a tremendous privilege to have mentors/partners/and collaborators who are experts in Cardiology and Medicine both locally, nationally, and internationally to improve the care of AHF patients.  We are actively working to better understand the pathophysiology of early AHF in order to improve post-discharge outcomes for all AHF patients.  Through public/private partnerships, we are actively engaged in the discovery of novel therapies to help patients feel better and live longer.  Through both clinical research as well as quality improvement efforts, we hope to achieve our goal of reducing the morbidity and mortality associated with AHF.
1057792	Dr. Rahul Khare has recently received a K08 grant 'Improving Emergency Department (ED) Quality and Safety by Enhancing Operations and Quality Management' from the Agency for Healthcare Research and Quality.  For this five-year project Dr. Khare will focus on one key quality indicator score in the ED:  time-to-percutaneous intervention (PCI) quality indicator score for acute ST-elevation myocardial infarction (STEMI) patients. Patients with STEMI have increased mortality if reperfusion or PCI is not achieved within 90 minutes.   Although there is an extensive literature about implementation of this process, the time-to-PCI quality indicator is achieved only 70% of the time.  Dr. Khare will develop and implement process improvements to address the most serious time-to PCI process concerns and  develop a toolkit, based on the findings that will assist hospitals and EDs in assessing opportunities for operational improvement and offer an approach for assessing and resolving quality management issues for time-to-PCI.
1057805	Ruchi Gupta, M.D., M.P.H, is Assistant Professor of Pediatrics and a health services researcher at Northwestern University and Childrens Memorial Hospital.  Dr. Gupta has significant interest and experience with community-based research.  Her research and clinical interests include childhood food allergy and childhood asthma.  Dr. Gupta has more than 25 first-authored peer-reviewed publications and grant support through the Food Allergy Initiative, the National Children's Study and the Robert Wood Johnson Physician Faculty Scholars award.
1057813	We study the molecular and cellular mechanisms by which memories of stressful events contribute to anxiety- and depression-like behavior.  Specifically, our interest lies in neuronal receptors, signal transduction pathways and gene responses mediating: (i)  formation and extinction of aversive memory; (ii)  delayed enhancement of fear memory in the aftermath of stressful experiences; (iii) social modeling of fear; and (iv) the relationship between aversive memories and depression.  Our long-term goal is to elucidate the key brain mechanisms linking cognitive and emotional processes and identify novel targets for treatment of anxiety and depression.
1057824	Dedicated to the care of hospitalized patients.  Additionally works as the Assistant Medical Director of Clinical Information Services for Northwestern Memorial Hospital.
1057832	TRANSPLANT IMMUNOLOGY, ANTIGEN PROCESSING AND PRESENTATION, HUMORAL IMMUNOTY, HLA ANTIBODEIS, NON-HLA ANTIBODIES
1057873	Primary interests: Education of medical students and residents, Otitis Media
1057874	Denys T. Lau, Ph.D., joins the Buehler Center on Aging, Health & Society as Assistant Professor and Director of Health Services Evaluation and Policy Research Section. As a health services and outcomes researcher, Dr. Lau applies various types of quantitative and qualitative research methods to study the quality and safety of health services provided to older populations. 
1057874	quality and safety of medication use among older adults
1057883	I am a cardiovascular epidemiologist with particular interest in obesity-specifically associations of physical activity with weight gain and cardiovascular consequences of obesity.
1057890	-Strain imaging in coronary heart disease -Stress echo in valvular heart disease -Patient Prosthesis mismatch. -Advanced heart failure supportive therapies
1057897	<BR><BR> Our laboratory is investigating the response of keratinocytes to ultraviolet (UV) irradiation. We are investigating the role of JNK, p38 and ERK signal transduction pathways in response of cells to UV light and have recently demonstrated that JNK enzyme co-associates with p53 protein and p21Waf cyclin inhibitor. Other studies in the laboratory focus on development of novel chemopreventive agents against UV-induced skin cancer. Apigenin is a plant flavonoid which has been shown to inhibit UV- and chemically-induced mouse skin tumorigenesis and we believe it shows promise for development as a protective agent against human skin cancer. We have demonstrated that apigenin induces G1 and G2/M cell cycle arrest in keratinocytes and other cell lines by inhibiting both accumulation of cyclins and the cyclin dependent kinase activities of cdc2p34 and cdk2. We have also demonstrated that apigenin induces expression of the cell cycle inhibitor WAFp21 in a p53-dependent manner, and that the half-life of p53 protein is extended, due to stabilization via site-specific phosphorylation. Experiments are underway to characterize the kinase(s) involved in p53 phosphorylation. Our laboratory is also investigating the mechanisms by which apigenin inhibits UV-induction of the cyclooxygenase-2 (COX-2) pathway, an enzyme important for prostaglandin production and cell transformation. Experiments are underway to characterize transcription factors which are involved in UV-induction of COX-2 and which may be modulated by apigenin treatment.
1057915	Pediatric Urgent Care
1057921	pediatric emergency medicine ultrasound to reduce radiation exposure, improve patient safety, expedite care, and decrease waiting time
1057996	Dr. Chin is a pediatric surgeon with interests in minimally invasive surgery, critical care, neonatal surgery, congenital anomalies, tumors of the chest and abdomen, endocrine surgery, hernias, undescended tests and ovarian disease.
1058027	Clinical interests: 1- Outcomes after Solid organ transplantation in Hispanics 2- Health communication and literacy in Solid Organ transplantation 3- Quality of Life in Solid Organ transplantation 
1058057	Preventive health, health care disparities, immigrant health, cancer care, communications 
1058111	Our research focuses on fibrosis and tissue repair. Fibrosis and aberrant tissue repair are prominent in autoimmune diseases (scleroderma, myositis, lupus) and in organ-based disorders (pulmonary fibrosis, glomerulosclerosis, hypertrophic scar), and are considered intractable. Aberrant tissue regeneration also underlie aging and obesity. Fibrosis contributes to 30% of all death worldwide, and thus represents a compelling and urgent scientific challegen. We believe that fibrosis is in fact potentially reversible. Our research takes a 'systems-biology' multi-disciplinary approach to fibrosis, utilizing human tissue, DNA, serum, and animal models and cell biology studies to identify and validate novel targets for therapy, discover genetic risk factors and useful biomarkers. we then attempt to translate these discoveries into clinically relevant approaches.
1058111	Our research focuses on the pathogenesis and treatment of fibrosis. We focus on the  interplay between vascular and autoimmune/inflammatory events in pathological fibrosis.  Our clinical research is focused on the development and evaluation of novel treatments for scleroderma, in using functional genomics to identifying novel biomarkers, and in identifying the genetic bases for fibrosis and systemic sclerosis.
1058170	Areas of interest include heart failure, heart transplantation, ventricular assist devices, disease management programs, health-related quality of life, psychosocial outcomes, patient adherence with therapeutic regimens, patient decision-making, caregiver burden, health literacy, nutrition, palliative care, and transition from pediatric to adult care.
1058191	Dr. Jordans work spans several areas, including quality and cost of care for persons with chronic illnesses, financing and outcomes of mental health and child welfare services, and health economics.
1058264	I enjoy caring for children with disorders of growth, puberty and the adrenal, pituitary and thyroid gland.  I also enjoy care of children with diabetes
1058270	My primary interests involve parental education on health maintenance for their children, preventative medicine, and child safety/injury prevention.  Also, due to the prevalence of childhood obesity in our community, education on proper nutrition and exercise has become another focus of interest in my practice.
1058291	Dr. Michelsons research interests include end-of-life decision making, palliative care, and ethics. Currently, her research focuses on communication and decision making in end-of-life care among patients, family caregivers, and professional caregivers in the pediatric intensive care unit.
1058311	My research focuses on understanding how the human brain transforms odor inputs into olfactory percepts (such as the smell of mint, banana, or wet dog), and how learning, memory, and experience modulate odor perception at the neural and behavioral levels. To address these questions we use a combination of techniques including high-resolution olfactory functional magnetic resonance imaging (fMRI), multivariate statistical analyses, psychophysical paradigms, and physiological recordings.  Given that patients with Alzheimers disease (AD) exhibit profound impairments in the sense of smell, I am also investigating whether olfactory fMRI techniques can be effectively used as a non-invasive diagnostic biomarker to identify asymptomatic individuals at risk for developing AD. 
1058513	Our lab is interested in the effects of oxygen on cell metabolism, and in the molecular mechanisms underlying cellular oxygen sensing.  The signaling pathways activated by hypoxia, and their regulation of transcriptional and post-translational responses in diverse cell types are also of major interest. 
1058524	neuroscience 
1058559	Functional gastrointestinal disorders including abdominal pain, nausea, vomiting and constipation in children. Gastrointestinal motility.
1058585	Coinvestigator. A study looking at strain, strain rate, and changes in left ventricular volumes and geometry with 3D echocardiography in patients with chronic valvular regurgitation and in patients with valvular regurgitation before and after surgery. Coinvestigator. A study looking at strain, strain rate, and myocardial viability with dobutamine stress echo in patients with congestive heart failure before and after placement of biventricular pacemaker for resynchronization therapy. MADIT-CRT, coinvestigator. Will be overseeing and directing the acquisition of echocardiogram studies for all recruited patients in our center. 
1058594	As a certified sex therapist, I treat a wide range of sexual disorders, including problems with desire, arousal and orgasm, as well as pain disorders, sexual compulsivity and paraphilias. As a clinical psychologist I also treat individuals and couples with relationship problems, depression and anxiety.
1058614	My research interest focuses on the role of acetyltransferase p300 in collagen synthesis and tissue fibrosis. Excessive synthesis and deposition of extracellular matrix proteins especially Type I collagen in the tissues causes fibrosis. TGF-beta stimulates collagen synthesis and has been implicated in fibrosis. We recently demonstrated that i) acetyltransferase p300 is essential for TGF-beta-induced collagen synthesis, ii) TGF-beta induces the levels of p300 in fibroblasts, and iv) most importantly, p300 level is significantly elevated in fibrotic tissues. We are interested i) to determine the molecular basis of elevation of p300 in fibrotic tissues, ii) to determine the contribution of elevated level of p300 in the development of fibrosis, and iii) to develop novel therapeutic approaches to control tissue fibrosis  
1058614	My research interest focuses on the role of acetyltransferase p300 in collagen synthesis and tissue fibrosis. Excessive synthesis and deposition of extracellular matrix proteins especially Type I collagen in the tissues causes fibrosis. TGF-beta stimulates collagen synthesis and has been implicated in fibrosis. We recently demonstrated that i) acetyltransferase p300 is essential for TGF-beta-induced collagen synthesis, ii) TGF-beta induces the levels of p300 in fibroblasts, and iv) most importantly, p300 level is significantly elevated in fibrotic tissues. We are interested i) to determine the molecular basis of elevation of p300 in fibrotic tissues, ii) to determine the contribution of elevated level of p300 in the development of fibrosis, and iii) to develop novel therapeutic approaches to control tissue fibrosis. We are also interested to delineate the role Plasminogen Activator Inhibitor-1 (PAI-1) in tissue fibrosis. PAI-1 inhibits uPA/tPA and plasmin-mediated activation of MMP activities. PAI-1 level is elevated in different fibrotic tissues and implicated in fibrosis. Paradoxically, PAI-1 deficiency is associated with cardiac fibrosis in aged mice. We are investigating the molecular basis of cardiac fibrosis in PAI-1 deficient mice.
1058641	Clinical research: focus on new drug and device development in dermatology, skin oncology, and cosmetic surgery. Technology & educational interests: clinical imaging and surgical simulation in graduate and postgraduate medical education.   Volunteer interests: free clinics for the underserved, skin cancer screenings, skin cancer detection and prevention education, and sports dermatology for professional and amateur leagues.
1058663	Dr. Schink has been a principal investigator on several clinical trials related to ovarian cancer, specifically on chemotherapy for the treatment of ovarian cancer.  Currently, Dr. Schink is working on a number of gynecologic oncology projects, including a clinical trial involving treatment for patients with stage III or stage IV ovarian epithelial cancer.  This particular study is a multi-center clinical trial to test the capabilities of three different combinations of chemotherapy drugs.  The three combinations will be compared based primarily on the survival of patients, but also on the incidence of toxicity and the quality of life of the patients.  The goal of Dr. Schink's project is to find the most effective treatment for women with late-stage ovarian cancer.   
1058670	Mitochondrial transport, preconditioning, ion transport 
1058681	Neuropathology <BR><BR> Molecular genetics of brain tumor (by FISH)
1058758	Our research focuses on pathologic mechanisms of asthma. We use in vivo mouse models involving allergen sensitization of wildtype, transgenic and gene knockout mice. We also focus on mucosal immunity, specifically the role of secretory IgA, 12/15-lipoxygenase and intelectin in asthma. We augment these in vivo studies by studying the responses of cultured normal human primary airway epithelial cells to the effects of allergic mediators. Experimental measurements include in vivo airway physiology (the development of airway hyperresponsiveness to bronchoconstrictors), lung inflammation, airway goblet cell hyperplasia (excessive mucus production), sub-epithelial fibrosis (excessive collagen), and airway smooth muscle increases in mass or contractility. We use quantitative RT-PCR (Taqman) to measure expression of genes. We use computer-assisted stereology to quantify pathologic changes observed in sections of mouse lungs. We use ELISA to measure protein levels of specific mediators in mouse lung lavage samples and serum.
1058758	Our research focuses on pathologic mechanisms of asthma. We use in vivo mouse models involving allergen sensitization of wildtype, transgenic and gene knockout mice. We also use classical genetic studies to identify asthma susceptibility genes in mice and we focus on mucosal immunity, specifically the role of secretory IgA in asthma. We augment these in vivo studies by studying the responses of cultured normal human primary airway epithelial cells to the effects of allergic mediators.  Experimental measurements include in vivo airway physiology (the development of airway hyperresponsiveness to bronchoconstrictors), lung inflammation, airway goblet cell hyperplasia (excessive mucus production), sub-epithelial fibrosis (excessive collagen), and airway smooth muscle increases in mass or contractility. We use quantitative RT-PCR (Taqman) to measure expression of genes. We use computer-assisted stereology to quantify pathologic changes observed in sections of mouse lungs. We use ELISA to measure protein levels of specific mediators in mouse lung lavage samples and serum. We perform gene expression studies in cultured normal human primary airway epithelial cells. 
1058781	My primary research interest is centered on tumor cell and extracellular matrix (ECM) interactions associated with cancer progression. These studies involve analyzing how tumor cells affect/alter their ECM, as well as respond to their changing environment using in vitro model systems based on an underlying concept of dynamic reciprocity.  
1058800	metabolic syndrome, cholesterol, lipids, menopause, CVD 
1058949	Major Research Interests: Global Mental Health, Psychology of Justice, Transmission of Post-Traumatic Stress Disorder, Psychology of Diversity, Cultural Issues in Clinical Psychology, Predictors of Psychotherapy Outcome,
1058962	Research in our laboratory is focused on the molecular and cellular mechanisms of intracellular calcium (Ca2+) signaling. Ca2+ is a ubiquitous intracellular signaling messenger, mediating many essential functions including gene expression, chemotaxis, and neurotransmitter release. Cellular Ca2+ signals generally arise from the opening of Ca2+ permeable ion channels, a diverse family of membrane proteins. We are studying Ca2+ signals arising from the opening of Store-Operated channels (SOCs), a family of plasma membrane Ca2+ channels activated by a decrease in the calcium content of the endoplasmic reticulum (ER). Human patients with mutations in SOCs suffer from a devastating immunodeficiency, underscoring their vital importance for human immunity. We are studying the molecular and cellular mechanisms by which SOCs are activated and the mechanisms by which they regulate gene expression, immune cell function, and the development of neural stem cells.
1058964	cytoskeleton, motor proteins, cell movement, microtubules, actin, kinesin, dynein, myosin, neurodegenerative diseases
1058994	Dr. Laumann's clinical interests include the diagnosis and treatment of complex  medical dermatologic disorders including collagen vascular, psychocutaneous, and genital diseases. She has a particular interest in fibrosing, pruritic and other disorders related to renal dysfunction, as well as Raynaud's syndrome. She has an ongoing interest in the various aspects of the application of body art and how this may be used to help functioning. Currently, she is involved with other research studies related to psoriasis, atopic dermatitis, nephrogenic systemic fibrosis, and lupus erythematosus, as well a study using a magnetic tongue stud to activate the tongue drive system to help those with neurological disorders access their environments.
1059008	Immunosuppression Withdrawal for Pediatric Living-donor Liver Transplant Recipients. Currently a Co Investigator in a study sponsored by the National Institute of Allergy and Infectious Diseases, National Institutes of Health.                          The primary objective of this study is to determine the proportion of participants successfully withdrawn from immunosuppression and to measure the outcome of immunosuppression withdrawal. Interest also in immune pathogenesis of late allograft dysfunction post liver transplantation.  Currently PI in a study evaluating immune pathogenesis of post transplant allograft hepatitis. Center PI on an NIH sponsored study (U01 NIAID) - Immunosuppression Withdrawal for stable pediatric liver transplant recipients. The primary objective of this study is to assess the efficacy of immunosuppression withdrawal (ISW) in pediatric liver transplant (tx) recipients.
1059041	Comparative medicine and pathogenesis, preclinical testing and toxicology, nanotoxicology
1059090	Epithelial cells, which are positioned at the line of first exposure to many pathogens, regulate both innate and adaptive immunity through production of functional molecules and via physical interactions with cells of the immune system. We are currently investigated on the epithelial factors which activate and/or regulate immune cells. We are also focusing on the pathogenesis of chronic rhinosinusitis.
1059090	Local immunity in the airway; airway epithelial cell biology; mast cell biology; the pathogenesis of chronic rhinosinusitis.     A long-recognized property of airway epithelial cells is their function as a complex physical barrier that defends against exposure to potentially harmful inhaled substances and microbial pathogens. It is now clear that airway epithelial cells also regulate both innate and adaptive immunity through production of functional molecules and via physical interactions with immune cells. Our laboratory is focused on the role of epithelial cytokines including BAFF, TSLP and IL-1 family cytokines in the initiation and activation of airway inflammation.                  Chronic rhinosinusitis (CRS) is a chronic inflammatory disease of the sinuses and upper airways that affects over 30 million Americans. Current medications have variable efficacy and over 250,000 surgical procedures are performed annually in the United States on patients who failed maximal medical therapy. Our laboratory investigates the pathogenesis of CRS. We are currently focused on the role of epithelial cells and inflammatory cells including B cells, T cells, macrophages, eosinophils and mast cells in patients with CRS.
1059114	Functional and molecular imaging application on radiation treatment planning 
1059133	My research interest is primarily on the structural mechanisms of activation of the cell-surface receptors in cancer and neural development. We try to obtain atomic-resolution views, using X-ray crystallography and biochemical/biophysical tools, on how the transmembrane receptors recognize their ligands, and how these recognition/activation processes can be modulated for clinical purposes.
1059140	My research interest lies in identification and characterization of cell surface carbohydrates and proteins required for herpes simplex virus (HSV) viral entry and cell fusion. I have been focusing on glycoprotein B (gB) and gL, two of four glycoproteins essential for HSV entry and cell fusion. I have been studying the interaction between gB and gB entry receptor, paired immunoglobulin like-type 2 receptor (PILRa). I am also interested in the interactions among gB, gD, gH and gL.
1059149	Gastroesophgeal reflux disease; Esophageal motility; Mathematical modeling; 
1059178	1. Genomics for Kidney Transplantation - a collaboration to find genetic predispositions to various clinical outcomes in transplantation. 2. Non-invasive diagnosis of renal allograft rejection - Urine based assays for mRNA to diagnose rejection and predict outcomes. 3. A randomized controlled trial of Rituximab vs. Placebo for treatment of de novo donor specific antibodies detected post renal transplant.
1059178	Living Kidney Donation, Kidney allocation, Highly Sensitized and incompatible patients, Kidney Paired Donation, Transplant Genomics and Biomarker Development, acute renal failure, humoral allograft rejection
1059251	My primary clinical interests are in the cognitive-behavioral treatment of anxiety and mood disorders.  I am a certified affiliate with the Academy of Cognitive Therapy (ACT).
1059267	Gregory B. Waypa, Ph.D. received his B.S. in Biomedical Engineering Sciences from the University of California, San Diego in 1991.   He then enrolled as a graduate student at Albany Medical College in Albany, New York, where, under Fred L. Minnear, Ph.D., he studied increased pulmonary vascular permeability associated acute respiratory distress syndrome (ARDS) and explored the possibility of using cAMP-enhancing agents as a possible therapy for the disease.  Dr. Waypa received his M.S., and later his Ph.D., in Physiology and Cell Biology from Albany Medical College in 1997 and 1998, respectively. From 1998 to 2002, Dr. Waypa was a postdoctoral fellow with Paul T. Schumacker, Ph.D. at The University of Chicago.  In 2002, Dr. Waypa received an appointment from The University of Chicago as a Research Associate (Assistant Professor) where he continued to work with Dr. Schumacker.  In 2004, Dr. Waypa received an appointment from Northwestern University as a Research Assistant Professor where he is continuing his collaboration with Dr. Schumacker.  Currently, Dr. Waypa is studying hypoxic pulmonary vasoconstriction (HPV), which is a physiological response to low alveolar oxygen tension and, in cases where a small percentage of the lung alveoli are hypoxic, HPV improves lung gas exchange by redistributing blood flow away from those areas toward regions with better oxygenation.  Key to this research is understanding the mechanism of O2 sensing by the pulmonary vasculature and how this results in the generation of the HPV response. 
1059270	cell cycle, knockout mice, breast cancer, cyclin, diabetes, pituitary, development, reproductive biology
1059361	Research interests include: Efforts include (1) basic biophysical mechanisms contributing to oxygen-sensitive contrast in MRI; (2) fast imaging methods to detect and stage coronary artery disease; (3) development of MR-based methods to understand and evaluate the mechanisms governing ischemic heart failure; (4) utilization of interventional MRI methods for delivering therapeutic substrates (stem cells, growth factors, etc.) following myocardial infarctions; and (5) development of MR molecular imaging methods in the assessment of cardiovascular disease.
1059384	Clinical and Translational Bioinformatics
1059611	Dr. Lebowitz is the founder and director of Cardiac Behavioral Medicine at the Bluhm Cardiovascular Institute at Northwestern. She is a licensed clinical health psychologist specializing in the heart-mind connection. She works exclusively with cardiac patients and helps them prepare for surgery, adjust to a new diagnosis, and cope with common emotional consequences of cardiac disease or cardiac surgery, including stress, depression, and anxiety. She teaches stress managment techniques, treats cardiac-related depression and anxiety and helps individuals initiate and maintain lifestyle changes to reduce their risk of heart disease.  Her research interests focus on the interplay between depression, stress, and cardiac health.    
1059636	My research activities focus mainly on asthma. Asthma exacerbations are mostly precipitated by common cold viruses. I am interested in elucidating the early mechanisms of respiratory viral infections that determine the severity of exacerbations in people with asthma. In addition, in collaboration with Dr. Esteban G. Burchard, M.D. from the University of California San Francisco and other investigators accross the US and abroad, we participate in a network of centers studying the genetic and environmental factors that influence the development and the severity of asthma in minority groups. Other research interests include pathogenesis of airway inflammation in allergic rhinitis and in asthma, and research in primary immunodeficiencies.
1059636	My research interests include investigations on how respiratory viruses cause asthma exacerbations, influenza virus infection, airway epithelial cells, asthma management and genetics of asthma.  My clinical interests include allergic conditions such as allergic rhinitis, asthma, sinusitis, urticaria, skin allergic diseases, food allergy, insect allergy, as well as primary immunodeficiencies.
1059640	Dr. Weltys research interests are in the application of biostatistics to psychiatric epidemiology and environmental research.  She is the lead statistician for the Northwestern Juvenile Project, a large-scale longitudinal study of psychiatric disorders and risky behaviors in delinquent youth.   Her work on the on the National Morbidity Mortality and Air Pollution Study (NMMAPS) used Bayesian methods to estimate generalized linear models with distributed lags to capture short term effects of air pollution on mortality.  She has also worked on formulating covariance models for random fields and estimating likelihoods for very large data sets, using algae levels in Lake Michigan.
1059658	Clinical interests are in General Internal Medicine/Primary Care, Community Health and Hospital Medicine.   Research Interests are in Medical Education, Medical Decision Making, Simulation, Quality Improvement and Patient Safety.
1059672	test
1059840	Diabetic Nephropathy, Albuminuria, VEGF, TGF-beta, mouse models, MCP-1, podocyte motility, multiphoton microscopy
1059840	I work in the field of diabetic kidney disease, specifically looking at the role of vascular endothelial growth factor (VEGF) and podocytes in the pathogenesis of albuminuria. We have made some exciting discoveries that are being pursued with genetic mouse models.
1059841	My laboratory is interested in understanding the mechanisms behind allergic diseases...<p><b>Why do they develop? <p>What controls them? <p>How can we stop them?</b> <p>We are interested in understanding this from the point of view of the immune system and have several projects that focus on the mast cell. This tissue-resident cell is best known for being able to release histamine but we believe it plays a much more complex role that just this final part in an allergic reaction. <p><center><img src='http://www.brycelab.com/Science_files/Mast%20Cells.jpg' alt='mast cell degranulation'/> <p><i><font color='0066cc'>A mast cell releasing its preformed granules.</i></font color></center> <p>We employ both preclinical studies and clinical work in our studies. One of our main goals is to better understand food allergy and we use animals models of anaphylaxis, as well as clinical studies on patient biopsy material to explore this. <p>More information about us and our research is available at our personal webpage above.
1059841	We are interested in the mechanisms that regulate allergic sensitization. Using mouse models of allergic diseases, such as asthma, eczema and allergy to food, our research is focusing on how histamine and histamine receptors might influence the progression of allergic sensitization.
1059844	Local synaptic circuits in motor-frontal cortex engage in neural operations underlying many aspects of cognition and behavior  motor control, executive functions, working memory, and more  yet circuit organization at the synaptic, cellular, and molecular levels remains poorly understood in this agranular cortex. What is the functional organization of these synaptic pathways? What cellular and circuit-level operations do neurons in these perform? How do these local circuits communicate with each other and how do they interact with subcortical systems in the basal ganglia and thalamus? The focus of our laboratory is to apply multiple tools of quantitative synaptic circuit analysis to elucidate the functional wiring diagrams of neocortical neurons in motor-frontal cortex. We use laser scanning photostimulation (LSPS) microscopy, based on glutamate uncaging and channelrhodopsin-2 excitation, for rapid functional mapping of synaptic pathways onto single neurons in brain slices of motor-frontal cortex. We are also applying a variety of circuit analysis tools in efforts to identify circuit-level mechanisms in mouse models of disease, including autism, Rett syndrome, epilepsy, and motor neuron diseases. Our lab is also involved in the development and maintenance of software tools for imaging and electrophysiology applications: www.scanimage.org, www.ephus.org.
1059857	Research on motor control and learning with the use of computational tools, virtual reality, whole body machine interfaces and dance for physical rehabilitation of cerebral palsy and movement disorders.
1059894	Skin toxicities, chemotherapy, targeted agents, rash, paronychia, EGFR, side effects 
1059904	Surgical Pathology<BR><BR> The long-term objective of our research is to study molecular mechanism and chemoprevention of chronic inflammation-driven carcinogenesis. The specific areas of interest are 1) to develop a molecular mimicking model of ulcerative colitis-associated carcinogenesis in rodents, and further to elucidate the role of inflammation-caused and dietary iron-enhanced nitro-oxidative stress and inflammatory mediators in DNA damage, cell proliferation and inflammation-driven carcinogenesis; 2) to study the pathogenesis and molecular biomarkers of pancreatic carcinoma in genetically engineered mouse model and in human; and 3) to develop an efficient strategy on the prevention of chronic inflammation-driven carcinogenesis, particularly interested in dietary nutrients, antioxidants, green tea and inositol compounds and specifically targeted on colorectal, pancreatic, and liver carcinogenesis.
1059913	Synaptic plasticity is the process by which the strength of communication between neurons is modulated in response to stimuli. This process has emerged as the strongest candidate mechanism underlying information storage and processing. In the cerebral cortex, the majority of excitatory synapses found on pyramidal neurons occur on dendritic spines. Dendritic spines are highly dynamic structures and undergo many forms of structural modification. Spine remodelling occurs in concert with changes in post-synaptic function, driven by the trafficking of synaptic glutamate receptors. Thus, structural plasticity is thought to control neural circuit refinement and information storage. Neuromodulators, including dopamine, noradrenaline and neurosteroids, can dramatically influence synaptic plasticity, but much less is known about mechanisms by which these modulators control structural plasticity. Aberrant structural plasticity and neuromodulatory signalling have been extensively associated with neuropsychiatric disorders, including schizophrenia, autism spectrum disorders and mental retardation. Conversely, increased structural plasticity, and regulation of neuromodulatory signals, can promote functional recovery from neurological disorders. Thus, one of the most important challenges in neuroscience is to uncover the mechanisms underlying structural plasticity during brain development. My work is centered on understanding how neuromodulators and neurosteroids control structural plasticity and the mechanisms that underlie these effects.
1060183	The overarching objective of the research ongoing in my laboratory is the identification of protein networks and signaling pathways that are functionally compromised in pediatric brain tumors to enable development of effective and safe individualized targeted therapies. Toward this goal, we are conducting a comprehensive integrative analysis of the genome, epigenome and transcriptome of these tumors and mapping all identified structural/functional alterations to protein networks and cellular processes with the aid of system's biology databases.
1060189	i am particularly interested in family and marital therapy and clinically am interested in childhood anxiety disorders and the autistic spectrum disorders. 
1060317	My interests include osteoarthritis of the knee and hip and how dynamic loading (such as gait) can effect progression of the disease.   
1060325	<BR><BR> My research interests are in the relationship between diet and cancer, particularly focusing on elucidating the role of dietary iron on inflammation-driven carcinogenesis in a molecular mimicking model of ulcerative colitis associated carcinogenesis in IL-2 deficient mice. I am also working on developing efficient chemopreventive agents in the inhibition of ulcerative colitis associated carcinogenesis. I am particularly interested in dietary nutrients, antioxidants, and green tea.
1060327	Mucosal Innate and adaptive immunity  
1060327	My research interests center on the immunological mechanisms involved in infectious and allergic diseases. My previous studies have ranged from investigations of infectious diseases in tropical endemic areas to molecular diagnosis and translational science. The shared mechanisms of pathogenesis between allergic and infectious diseases have been an active area of investigation. Recently, I have focused on epithelial cells biology and their role in inflammation, innate immunity and adaptive immunity.
1060342	Primary Clinical Interest: Provide clinical care to Pediatric Oncology patients at Lurie Children's and to Pediatric Hematology patients at the New Lenox Outreach Clinic.
1060364	Recently, Dr. Buttin received a two-year award from the Sidney Kimmel Foundation for Cancer Research for her work studying molecular mechanisms that influence cell growth and metastasis in an aggressive subtype of endometrial cancer, uterine papillary serous carcinoma (UPSC). This work has since led to an additional grant from the National Cancer Institute as well as several smaller, foundation grants. She has authored several research articles on a novel biomarker to predict chemosensitivity and prognosis in UPSC as well as the role of defective DNA mismatch repair and hereditary cancer susceptibility in endometrial cancer focusing specifically on the MSH6 DNA mismatch repair gene.  Her current basic research includes the elucidation of pathways of carcinogenesis in uterine papillary serous carcinoma, its association with inherited cancer syndromes, as well as the prevalence of defective DNA mismatch repair in type II endometrial cancer.  Her clinical research focuses on the development of synuclein-gamma (SNCG) as a novel prognostic biomarker for high risk endometrial cancer and its association with chemoresistance.  Dr. Buttin is collaborating with the Gynecologic Oncology Group (GOG) and has a special interest in novel chemotherapy and targeted agents for endometrial, cervical and ovarian cancer, treatment strategies for uterine sarcomas, as well as the role of radical surgery and minimally invasive surgery in the management of gynecologic malignancies.
1060466	My interests include:  - Adults with congenital heart disease with arrhythmias, particularly, which type of device (pacemakers/defibrillators) is indicated in patients to prevent sudden cardiac death. - Management of arrhythmia in patients of all ages, from fetal arrhythmias to adult congenital patients. - Catheter ablation. - Utilization of resynchronization in single ventricle patients and in patients with cardiomyopathy. - Screening athletes and patients on ADHD medications. - Prevention of sudden death in congenital central hypoventilation patients.
1060531	My primary clinical and research area focuses on infections in transplant recipients.  My research is futher focused on viral infections, specifically respiratory viral infections (influenza, adenovirus) in transplant recipients.
1060553	My primary research interest is in promotion of healthy lifestyle (physical activity and nutrition) in persons with arthritis utilizing motivational interviewing.
1060566	I am currently a hepatologist with a strong interest in liver transplantation & complications. My main research interests are minimization or withdrawal (tolerance) of immunosupression and infection complications
1060566	Infectious disease, liver transplantation, immunosuppression, cirrhosis, bacterial infections, intestinal permeability
1060579	Clinical interests include pediatric pancreatic disorders and pediatric feeding/swallowing dysfunction
1060618	My laboratory conducts research on behavioral risk factors (obesity, poor quality diet, physical inactivity, tobacco use). We also develop cutting-edge handheld technologies that support self-regulation and healthy behavior change.  Finally, we create on-line learning tools to support skill mastery in evidence-based practice and team science.
1060619	The overall goal of my research program is to understand the mechanisms of mammalian reproduction, in particular, how germline stem cells, meiosis and gamete differentiation, are regulated in mammals, using combined genetic, development and evolutionary approaches. We work with both mouse and Drosophila systems as well as cell culture to characterize the roles of highly conserved components of regulatory machinery for stem cell and reproductive development. We are also interested in translational research which extends our findings from animal models into reproductive medicine, in particular in our battles against reproductive cancers and infertility.
1060635	In additional to his clinical practice as a pediatric emergency medicine physician, Walter is Core Faculty at the Feinberg School of Medicine and Northwestern Simulation and leads a university-wide faculty development program on improving medical faculty feedback skills. He has been a co-investigator on simulation-related research grants dealing with curriculum development in pediatric emergency medicine, risk-informed in situ simulations and the effect of scripted debriefing on learning outcomes. He has taught on many basic and advanced simulation instructor courses as an international partner of EuSim, a European Simulation Collaborative led by Dr. Peter Dieckmann, and through strong collaborations with the Harvard-affiliated Center for Medical Simulation, as well as PAEDSIM, a German-speaking Paediatric Simulation Working Group. He currently serves on the Board of Directors for the Society for Simulation in Healthcare.
1060674	Cognitive-Behavioral and Mindfulness- and Acceptance based Behavioral therapies for depression and anxiety disorders in adolescents and adults. Cognitive-behavioral stress management for multiple sclerosis and pain. 
1060686	Exercise and Fitness in Women Preventive Cardiology Metabolic Syndrome
1060686	Principal Investigator of the St. James Women Take Heart Project Principal Investigator of STILETTO (Syndrome X Trial: Identifying underLying Endothelial dysfunction and Testing Treatment Outcomes in women) Study
1060688	CT and MR imaging of the central nervous system including the brain and spinal cord. Advanced neuroimaging techniques including CT and MR perfusion, time-resolved MR angiography, CT angiography, CSF flow imaging, and functional MRI. Spine procedures including myelography, vertebroplasty, diskography, image-guided biopsy, and steroid injections. Cerebral angiography
1060697	I am primarily interested in loco-regional therapies to treat primary and secondary liver cancers. I am involved in both pre-clinical and clinical studies along these lines. I am also very interested in the use of IVC filters in patients with venous thromboembolic disease.
1060922	My clinical areas of interest is peri-operative quality of care of the cardiac and thoracic surgical patients. My primary areas of research interest are the control of breathing, peri-operative metabolic disorders, critical care outcomes, and resuscitation. My primary areas of education include curriculum design and problem-based learning discussions.
1060934	Dr. Sheeans research goals are to combine clinical nutrition and epidemiology. Her general interests include evaluating nutrition therapies during illness, treatment and recovery, where she has specifically focused on the impact of parenteral nutrition on stem cell transplant outcomes and on enteral nutrition during critical illness. She is especially interested in translation research; exploring the impact of hospitalization on nutritional status and nutrition behaviors and increasing the recognition of these acute declines across disciplines. Dr. Sheean is also a Research Editor for the Journal of the American Dietetic Association and assists with the coordination and implementation of medical nutrition education at the Feinberg School of Medicine.
1061090	ENDOTHELIAL CELL FUNCTION DURING ALLERGIC DISEASE. Leukocyte migration from the blood into tissues is vital for immune surveillance and inflammation.   Specificity for the site of leukocyte migration is determined by the combination of adhesion molecules, cytokines and chemokines in the microenvironment.  We have focused on the function of the endothelial cell adhesion molecule VCAM-1.  VCAM-1 is expressed on endothelial cells during atherosclerosis, allograft rejection, infection, and asthmatic responses. Furthermore, disruption of the mouse VCAM-1 gene impairs placentation and cardiac development resulting in embryo death.  Thus, VCAM-1 has important functions in development and disease.  As little was known regarding VCAM-1 signaling, we studied the molecular mechanisms for VCAM-1 signal transduction in endothelial cells in vitro and in vivo. Although it has traditionally been thought that VCAM-1 simply serves as a scaffold for leukocyte binding to endothelium, we have reported that it activates endothelial cell intracellular signal transduction pathways which result in endothelial cell shape changes and leukocyte passage. VCAM-1 activates endothelial cell NADPH oxidase resulting in the generation of low non-toxic levels of reactive oxygen species (ROS).  These ROS rapidly stimulate endothelial cell-associated  matrix metalloproteinases (MMP) which are required for VCAM-1-dependent lymphocyte migration. We have also demonstrated that in vivo administration of the antioxidant bilirubin blocks VCAM-1-dependent leukocyte migration into the lung in experimental asthma.  Currently, there are two main research directions.   1. We are examining mechanisms for VCAM-1-stimulated activation of endothelial cell NADPH oxidase, including studies of the structure/function of the cytoplasmic tail of VCAM-1.  We are also examining the mechanisms for ROS function in regulating endothelial cell intracellular signals. 2.  To further determine whether these VCAM-1 signals function in vivo, we are utilizing knockout and transgenic mouse models to examine VCAM-1-dependent infiltration of eosinophils in experimental asthma.  Pulmonary eosinophilia is one of the most consistent hallmarks of asthma.  Information about the mechanisms that control leukocyte infiltration will provide a basis towards proposing interventions in VCAM-1-mediated processes in disease.    Moreover, limiting VCAM-1 dependent inflammation in chronic disease may be an advantageous target as it could spare VCAM-1-independent inflammation such as neutrophil clearance of infections. 
1061090	LEUKOCYTE RECRUITMENT DURING ALLERGIC DISEASE.  White blood cell (leukocyte) migration from the blood into tissues is vital for immune surveillance and inflammation.   Specificity for the site of leukocyte migration is determined by the combination of adhesion molecules, cytokines and chemokines in the microenvironment.  We have focused on regulation of allergic inflammation by vascular cell adhesion molecule (VCAM-1).  VCAM-1 is expressed on blood vessel endothelial cells during atherosclerosis, allograft rejection, infection, and asthmatic responses. Furthermore, disruption of the mouse VCAM-1 gene impairs heart development resulting in embryo death.  Thus, VCAM-1 has important functions in development and disease.   We are examining the molecular mechanisms for VCAM-1 signal transduction in endothelial cells in vitro and in vivo.  We have reported that VCAM-1 signals through reactive oxygen species such as hydrogen peroxide.  These reactive oxygen rapidly stimulate endothelial cell-associated  matrix metalloproteinases (MMP) and protein kinase Ca, resulting in endothelial cell contraction for the opening of passageways through which leukocytes migrate.  Blocking this signaling pathway in vivo inhibits allergic inflammation. Currently, there are three main research directions regarding regulation of allergic inflammation.  1. Mechanisms for VCAM-1 signaling.   2. Vitamin E regulation of leukocyte recruitment in allergen responses. 3. Amino Acid (5HTP)/Neurotransmitter regulation of inflammation.
1061208	My research interests are in 2 areas: 1. Tissue-specific regulation of gene expression, chromatin structure and modification in the context of the CFTR gene, that when mutated causes the common inherited disease Cystic Fibrosis. We identified and are characterizing intronic and extragenic elements that control CFTR gene expression, modulate the 3D structure of the locus and mediate tissue specificity.  2. Pancreas Cancer. We are investigating the role of secreted proteoglycans (collagen XV and the MUC6 mucin) in initiation, invasion and metastasis of human pancreatic adenocarcinoma.
1061219	Russell G. Robertson, MD, is professor and chair of the Department of Family and Community Medicine at Northwestern University Feinberg School of Medicine.  He joined the Feinberg Schools leadership in October 2005.  He holds a B.A. in elementary education from Michigan State University and an MD from Wayne State University.  He completed his family medicine residency in Grand Rapids, Michigan before joining the Medical College of Wisconsin (MCW) in Milwaukee.  He was recruited from MCW, where he had served as interim chair of the Department of Family and Community Medicine and most recently as the associate dean for faculty affairs.  He began his professional career as an elementary and junior high school teacher in suburban Detroit. Dr. Robertson was one of 17 physicians nationwide appointed to the Council on Graduate Medical Education by the U.S. Secretary of Health and Human Services in 2003.  Now chair of the Council since 2008, Dr. Robertson and his fellow members advise Congress and the Department of Health and Human Services on issues related to physician supply and distribution.  In this capacity he has been invited to serve on a number of national and international workforce bodies. Dr. Robertsons interest in medical education has evolved to an international level.  He is the Associate Director for Global Education for Northwesterns Center for Global Health.  He also serves as president of the board of Hillside Healthcare International, which supports a clinic in Punta Gorda, Belize, Central America. Dr. Robertson also holds a certificate of added qualification in geriatrics.
1061234	My central clinical interests are trauma-related disorders (acute stress disorder, post-traumatic stress disorder, complex trauma), mood disorders, and physician health and wellness.  I am very involved in graduate medical education and educational research in medical education, especially clinical skills training and evaluation and the development of professionalism during residency.
1061449	I have done numerous vaccine studies and have a continued interest in vaccine preventable disease
1061501	Dr. Yerkes primary concentrations are reconstruction of complex genitourinary anomalies, medical and surgical management of neurogenic bladder, disorders of sex development,  hypospadias, and congenital vaginal anomalies and urogynecology.
1061503	Dr. Chaviano's clinical concentrations include pediatric urologic reconstruction, hypospadias, hydronephrosis and fetal urology.
1061575	Psychosomatic medicine: psychiatric issues in those with co-occurring medical illnesses 
1061598	Dr. Rothrocks research interests include psychosocial aspects of chronic illness, psychosocial oncology, quality of life, patient-provider communication, and distress and symptom management.
1061609	Dr. Pellegrini is an exercise physiologist with research interests in behavioral weight loss, physical activity, and sedentary behaviors.  Dr. Pellegrini's research has compared the use of a technology-based system and standard behavioral weight loss program on weight loss and physical activity.  Dr. Pellegrini is the Project Coordinator for the ENGAGED (E-Networks Guiding Adherence to Goals in Exercise and Diet) clinical trial (PI: Bonnie Spring, Ph.D.).
1061645	Reproductive genetics; graduate training and education, finance and reimbursement, genetic service delivery models, psychosocial issues and decision making in genetic counseling.
1061682	Understanding the group dynamics and interpersonal processes in group decision-making as it relates to IRB and IACUC review and approval processes.  Development of effective programs for the protection of human subjects.  Research on attitudes about spirituality and religiosity in psychology graduate students as well as graduate students in other health sciences, and research on training programs in multi-culturalism as they relate to spirituality in the clinical domain.
1061719	Dr. Keefer is an NIH-funded investigator with a research interest in the application of behavioral interventions to chronic gastrointestinal diseases including Ulcerative Colitis, Crohns Disease and Irritable Bowel Syndrome.  
1061719	I am funded by the NIH to design and test behavioral interventions for chronic gastrointestinal disorders, including Inflammatory Bowel Disease (Ulcerative Colitis, Crohns Disease) and Irritable Bowel Syndrome.  My most recent interests include the effects of a brief self-management program for patients with Crohns Disease and the behavioral phenotyping of esophageal disorders.
1061813	Primary research interests include any rehabilitation topics involving brain injury and stroke survivors.
1061814	My clinical and research pursuits have focused on improving health-related quality of life (HRQL) in people with cancer, neurological disorders and other chronic medical conditions (e.g., Spinal Cord Injury, Traumatic Brain Injury, Burn/Orthopedic Injury, COPD, Sarcoidosis, HIV, Coronary Heart Disease). Specific interests include stress reduction and CAM-based interventions in oncology, self management support interventions using health information technology, and developing patient reported outcomes measures in HRQL, disease symptoms, coping/adjustment and resilience. I was the Principal Investigator on a 1-year hospital funded Pilot Grant to examine HRQL and self management support preferences in a prostate cancer sample and am currently the Principal Investigator of a hospital-funded RCT examining the effects of a mindfulness-based stress reduction intervention for men diagnosed with prostate cancer who are on active surveillance. I am the site Principal Investigator on two NIH-funded grants (NCI: Reflexology for Women with Advanced Breast Cancer; NCMRR: Quality of Life for SCI Clinical Trails: Development of the SCI-QOL;). In addition, I serve as a Co-Investigator on an NINDS-funded study (Neuro-QOL; PI: D Cella) to develop patient reported outcomes measures for neurology clinical trials research. Since 2003 I have led a mindfulness-based stress management class at Evanston Hospital for people with chronic medical conditions and their caregivers.
1061842	PI in Fetal data base
1061843	The primary thrust of our research team has focused on studies to identify the basic biological processes that regulate adaptation of malignant tumor cells to stressful environments, such as those produced by anti-cancer drugs, and thereby permit their survival in the presence of agents that would normally kill them. Understanding these processes will help cancer researchers develop novel chemotherapeutic strategies. Our group has directed our recent attention to the understanding of cancer cell behavior and in particular on the molecular basis underlying resistance of neuroblastoma cells to chemotherapy. 
1061875	The Molecular Basis of Wilms' Tumor The Sprouty  Proteins The Molecular Biology of Acute Promyelocytic Leukemia The Molecular Basis of Multiple Myeloma Molecular Basis of Myeloproliferative Disease
1061890	I currently serve as the Medical Director of Sports Medicine for the United States Navy Recruit Training Command/CAPT James A. Lovell Federal Health Care Center.   I am Board Certified in Family Medicine and hold a Certificate of Added Qualifications in Sports Medicine.
1061894	Onset of pediatric brain tumor formation; generation of human induced Pluripotent Stem cells (hiPSCs), neuronal differentiation of hiPSCs, particularly into radial glia; in-vivo brain tumor modeling; molecular characterization of the onset of early neuronal differentiation in hiPSCs as well as in human Embryonic Stem cells.
1061897	Pediatric solid tumors Fertility preservation
1061909	I am a Research Assistant Professor in Feinberg School of Medicine, Northwestern University, with the research focuses on age-related eye disease, such as age-related macular degeneration, diabetic retinopathy.   I am an advanced degree professional in this field by virtue of the M.S. and Ph.D. degrees in Ophthalmology from Weifang Medical College and Peking University, respectively. Recent growth in clinical and translational research has heightened the need for a competent clinical research workforce in industry and academia. I am currently in the Graduate Certificate Program in the School of Continuing Studies-Clinical Research and Regulatory Administration. 
1061921	Neural degeneration, glial responses, signal transduction, gene expression profiling, genetic susceptibility, optic neuropathy,transcriptional regulation.  
1062000	Elizabeth R. Ryan, Ed.D. graduated from Loyola University of Chicago with a doctorate degree in Education in May 2006.  She has worked in both family medicine and surgical education, holding administrative staff positions in both graduate and undergraduate programs, from April 1995  February 2006.   Dr. Ryan contributed to the Department of Surgerys redesign of the undergraduate and graduate program curriculum; was an invited member of the Department of Surgerys Think Tank Consortium; is a Co-Leader for Northwestern University Feinberg School of Medicines Community Engagement and Service Competency; is the Teaching Selective Course Director; and the Co-Course Director for Patient Physician and Society IV.  Dr. Ryan joined the Department of Family and Community Medicine faculty as an Assistant Professor and the Vice Chair of Education in March 2006. 
1062051	End of Life care; medication compliance, depression, clinical and economic evaluation, patient report outcome
1062103	Surgical Pathology
1062105	Epigenetic regulation of Cytomegalovirus(CMV) gene transcription during establishment of latency and reactivation from latency.
1062189	The primary research is in the field of neurophysiologic monitoring during cerebral aneurysm surgery in particular and neurophysiologic monitoring in head and spine surgeries in general.
1062254	I currently work as an internist in Preventive Medicine and have many other interests within the health care field including technology development (including electronic health records), health care quality, health literacy and communication in patient encounters
1062414	My area of interest is in health care disparities research and assessment of policy and pratice to advance equity. I serve as the principal investigator for a number of national studies examining quality of care for diverse populations. I am currently an investigator for the Robert Wood Johnson Foundations national initiative, Aligning Forces for Quality, and  lead the disparities/equity component of this project. My research also focuses on quality of care in the health care safety net and integrating equity into performance measurement and reporting.
1062458	I serve as Director of Chicago Cardiac Arrest Resuscitation Education Service. We are a not-for-profit organization housed within NUFSM Department of Emergency Medicine dedicated to improving survival from sudden cardiac arrest through community education about CPR and AEDs. Please visit our website at www.ccares.northwestern.edu.
1062841	Primary clinical interests involve hospital-based medicine in pediatrics. In particular, the application of evidence-based medicine to changes in disease management is a major focus. The role of the hospitalist in medical education, both undergraduate and graduate, is a secondary area of focus.
1062847	To provide quality patient care, contribute to pediatric emergency medicine literature and participate in the education of medical students, residents and fellows.
1062886	My research is focused on the mechanisms and prevention of sudden unexplained death in epilepsy (SUDEP). I am also interested in cortical plasticity and functional mapping in patient undergoing epilepsy surgery.  Outside of epilepsy, I am involved in clincal care and research of musicians with medical problems related to their instrument, in particular focal task specific dystonia.  
1062956	I am interested in research involving novel technologies in neurosurgery.
1062975	neural-machine engineering, myoelectric control, EMG modeling, biomedical signal processing, Bioelectromagnetism 
1063005	Dr. Simon's primary research interests are aimed at eliminating health disparities among low income, medically underserved women across the lifespan.  Integrating health services research with social epidemiologic models, Dr. Simon's research focuses on interventions (such as patient navigation and community health outreach workers) that aim to reduce and eliminate such disparities.  Within this context, Dr. Simon prefers to leverage culture and community to achieve these goals and thereby integrates community based participatory research framework into her work.
1063045	My primary academic/clinical interest is in quality, information systems, patient safety, care-pathways and administrative medicine relating to; creating/supporting evidence-based approaches to patient care, establishing standards, developing process/protocols to support the standards and globally reducing multidisciplinary practice variance.
1063052	I have been interested in both clinical and basic research. My clinical research interest includes Echocardiography especially in the field of 3D Echocardiography; valvular heart disease, woman's heart disease, coronary artery disease and cardiomyopathy. My basic research interest is in hypertension and heart failure.
1063096	Jason Kane is an Attending Physician in the division of Pediatric Critical Care Medicine at Childrens Memorial Hospital and an Assistant Professor of Pediatrics at Northwestern Universitys Feinberg School of Medicine.  He graduated from the Medical College of Rush University in Chicago, completed his training in Pediatrics at Indiana University and Riley Hospital for Children in Indianapolis, and attended the Medical College of Wisconsin and the Childrens Hospital of Wisconsin in Milwaukee where he completed his Fellowship in Pediatric Critical Care.  In 2009, Doctor Kane obtained his Masters of Science Degree in Patient Safety and Healthcare Quality from Northwestern University.  Doctor Kanes primary clinical focus is cardiac intensive care where he is responsible for directing the recovery and ICU management of children who have undergone open-heart surgery to repair congenital heart defects.  His research interests include pediatric patient safety, healthcare quality, and near-infrared spectroscopy monitoring in the intensive care unit.
1063131	Dr. Kho's research involves the creation of electronic networks spanning multiple institutions.  He developed an electronic network to enable infection control providers to share infection data across the major healthcare providers within Indianapolis.  The system currently tracks thousands of patients with drug-resistant infections in the region and provides secure real-time admission alerts to infection control providers.   He continues this AHRQ funded research as a Regenstrief Affiliated Scientist.  His research interests also include the application of geographic information systems, and large dataset driven decision support to improving infection control processes.  He is actively involved in project linking Electronic Medical Record data with genomic data across multiple institutions.
1063149	My research interests revolve around the neural mechanisms supporting selective attention and cognitive control, and their interaction with motivational/emotional factors. 
1063190	My primary clinical and research interests are in HIV and HBV and HCV viral co-infections in both domestic and international settings. I am currently collaborating on research projects in the US, Tanzania and Nigeria in the following focus areas: HIV/Hepatitis co-infection, HIV drug resistance, antiretroviral treatment outcomes, non-communicable diseases (NCD's), and qualitative studies of patient and healthcare worker satisfaction.
1063212	Dr. Fangusaro has an expertise and specialty training in treating children with central nervous system malignancies, including brain and spinal cord tumors.  His primary area of research interest is in the development of clincal trials, novel therapeutics and relevant biologic correlates in pediatric brain tumors in an effort to improve survival outcomes and minimize toxicities.  He devotes much of his time to clinical trial research and has developed numerous collaborations with basic scientists in an effort to advance translational and clinical initiatives.
1063230	The research of the Economics of Movement group shows that movement and movement learning are similar in many respects. Our Sensors (Eyes, Ears, Skin etc) are not perfect but are noisy. Moreover, our muscles are noisy and if we try to do the same movement over and over it will be different each time. This means that if we make a movement, say swing a golf club, we will have uncertainty in the potential movement outcomes. Our group studies how people make movement decisions in the presence of such uncertainty. Our research has three main thrusts. (1)We study experimentally how people move and how their movements are affected by uncertainty. (2) We build computational models using Bayesian statistics to calculate how people could move optimally or learn to move optimally. (3) We build Bayesian Algorithms to solve problems that we find interesting. For example we analyze how neurons are connected in the nervous system. (4) We use mobile phone and gaming technology to improve rehabilitation and to improve diagnoses. The main thrust of our current research is to allow for better rehabilitation procedures through an understanding of motor learning.
1063244	Dr. Mauvais-Jarvis is internationally recognized for the discovery of estrogen receptors activation in protecting insulin-producing pancreatic beta-cells in type 1 and type 2 diabetes using pre-clinical models. He has authored over 50 publications and book chapters dealing with novel mechanisms and therapeutic perspectives for diabetes and obesity. He is the principal investigator of federal research grants from the National Institutes of Health and has received national and international awards from organizations including the Juvenile Diabetes Research Foundation, the American Heart Association, the March of Dimes and Birth Defects Foundation and the French Diabetes Association. He is an elected member of the American Society for Clinical Investigation.
1063244	Our laboratory is interested in understanding the mechanisms by which energy homeostasis is differencially regulated in males and females and how does this influence the risks of obesity and diabetes. We currently focus on identifying the cellular and molecular mechanisms by which estrogens and androgens program and regulate energy metabolism in a gender-specific manner. We use genetic, physiological, molecular, and pharmacological tools to study mice with conditional knockouts of the sex steroid receptors as well as cell culture models in highly controlled environments.  Our goal is 1) to obtain a better understanding of the biological processes at the root of diabetes and obesity and the role of gender in this process 2) to determine whether modulating estrogen/androgen actions in a tissue-specific manner can have a therapeutic impact on diabetes and obesity.
1063304	Over the last 10 years, I have gained considerable experience with both MRI and MRS in clinical practice and research; in research settings my primary interest has been the development of molecular and cellular imaging methods. I am also very familiar with small animal tumor models and have conducted extensive molecular and cell biology research; I am highly proficient in the use of optical imaging, cell culture, gene expression techniques and FACS analysis. I was appointed to my current faculty position at NWU after a short time working for VirtualScopics where my role was to direct the imaging component of clinical trials. Given my multi-disciplinary background (and the broad range of skill-sets provided by my close collaborators) I am ideally suited to develop MRI-monitored cellular therapies for the treatment of pancreatic cancer.
1063334	I am examining issues relating to neuromusclular control of voice pitch and volume. I am also examining the use of novel carbon dioxide laser technologies in the surgical management of laryngeal and trachel pathologies
1063382	My clinical interests encompass all of general obstetrics and gynecology, including well-woman care, obstetric care, office procedures, contraception, and women's mental health issues, to name a few. My research projects focus on delivery of health care and patient outcomes. The large obstetric volume at Prentice Women's Hospital allows us to perform large, high-quality studies to answer important questions about pregnancy and delivery care.  We recently completed a large study looking at epistaxis (nose-bleeds) during pregnancy, and found that women with more nose bleeds were more likely to suffer excessive bleeding at delivery. n another project, we examined women with infections during labor (chorioamnionitis) to create a scoring system that allows us to predict which women will become septic. I am also interested in the social and psychological aspects of reproduction and childbearing,and just completed another project looking prospectively at obsessive-compulsive disorder in pregnancy and postpartum, which turns out to be unexpectedly common. I will next be creating a 'Global Assessment of the Postpartum Woman' to get a more comprehensive picture of the mental health challenges women face postpartum.
1063384	As a clinical psychologist, I direct NMFF's Women's Behavioral Health Clinic, which offers pharmacotherapy and psychotherapy for women during pregnancy and postpartum phases. Also, I direct a clinical research lab with five Ph.D. students. Our current research projects include (a) identifying predictors of response to Behavioral Activation using HLM analyses (NIMH-funded project), and (b) identifying differences in emotional responses using functional magnetic resonance imaging (fMRI) among women with and without major depression.
1063448	Developing, implementing and evaluating patient-centered primary care as an integrated and evidence-based system in underserved settings, with the goal to improve outcomes while reducing or eliminating disparities, with an emphasis on maternal child health and chronic conditions. Clinical and research interests in these areas are focused around performance improvement, health care reform, and community-based training for tomorrows health workforce.
1063452	My primary interests are in Community Medicine and Health Disparities, from a public and global health perspective. As the Vice Chair of Community Medicine and Director of the Chicago Community Engagement Program at the Department of Family and Community Medicine, I advise and mentor students interested in developing local and global community-engaged projects, with a dual focus on education and community service.
1063472	Lynette Craft, PhD is a Kinesiologist and her research interests focus on the relationships among physical activity and mental and physical health.  Specifically, Dr. Craft examines the use of structured exercise interventions to reduce symptoms of depression and improve quality of life.  In addition, she investigates the potential mechanisms underlying these relationships.   She has examined these associations in several patient populations such as individuals with clinical depression, cancer survivors, and smokers attempting smoking cessation. A secondary interest in her current work is identifying the psychosocial factors that predict exercise adherence in these various groups.
1063490	Sonya Rasminsky is the Director of Medical Student Education in psychiatry at Northwestern Feinberg School of Medicine. She sees patients for psychotherapy and medication management.  Her clinical interests include women's mental health and student mental health. 
1063502	My graduate work so far has been directed at health professional epistemology in context - the relationship among clinicians, academics and political actors and its effects on clinical decision making. I hope to continue this in my dissertation (in disability studies) in relation to understandings of disability within curriculum development in healthcare professions and medicine.
1063635	Medical Director of Consultation-Liason and Emergency Services Dept of Child and Adolescent Psychiatry Clinical interests include the recognition and treatment of delirium in medically hospitalized patients.  
1063665	Glucocorticoids are the most frequently prescribed medicine today and they are indispensable in the treatment of asthma, inflammation, and cancer.  However, two concerns regarding glucocorticoid use remain unresolved.  One is that high-dose or long-term glucocorticoids result in troublesome side effects such as metabolic syndrome and osteoporosis; the other is that some patients do not respond to glucocorticoids.   We tackle both questions by examining the glucocorticoid receptor.  Translational isoforms of glucocorticoid receptors were recently discovered in our lab and they provide insights into the mechanisms of action of glucocorticoids.  Ribosomal shunting and leaky scanning processes generate translational glucocorticoid receptor isoforms. These receptor isoforms have distinct cell-killing and cytokine-suppression capabilities in a bone cancer cell model system.  Currently, we are identifying and characterizing the receptor isoforms in different populations of immune cells in diseases such as asthma and cancer. This line of research has implications in several other fields in addition to immunology and oncology.  For instance, our findings in glucocorticoid receptor biology have significant impact on research in endocrinology as well. 
1063665	Glucocorticoids are the most frequently prescribed medicine today and they are indispensable in the treatment of asthma, inflammation, and cancer. However, two concerns regarding glucocorticoid use remain unresolved. One is that high-dose or long-term glucocorticoids result in troublesome side effects such as metabolic syndrome and osteoporosis; the other is that some patients do not respond to glucocorticoids. We tackle both questions by examining the glucocorticoid receptor. Translational isoforms of glucocorticoid receptors were recently discovered in our lab and they provide insights into the mechanisms of action of glucocorticoids. Ribosomal shunting and leaky scanning processes generate translational glucocorticoid receptor isoforms. These receptor isoforms have distinct cell-killing and cytokine-suppression capabilities in a bone cancer cell model system. Currently, we are identifying and characterizing the receptor isoforms in different populations of immune cells in diseases such as asthma and cancer. This line of research has implications in several other fields in addition to immunology and oncology. For instance, our findings in glucocorticoid receptor biology have significant impact on research in endocrinology as well.
1063685	Cancer and blood diseases; sickle cell disease (with research focus on pain); blood donations for patients with sickle cell disease; immune thrombocytopenic purpura, iron deficiency anemia, hemolytic anemias
1063818	Special interests include respiratory and autonomic disorders in Pediatrics with attention to cardio-respiratory monitoring and physiology, specifically, Congenital Central Hypoventilation Syndrome (CCHS) and Rapid-onset Obesity with Hypothalamic dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD); Alterations in sleep physiology in Pediatric disease; Response of the autonomic nervous system in children to environment.
1063829	My research focuses on the utilization of agent-based modeling for multi-scale modeling of acute inflammation. Agent levels include cells and molecules, with the goal of simulating organ- and organism-level behaviors from these generative mechanisms. While the focus of my models have primarily been on the pathophysiology of sepsis and multiple organ failure, in a more general sense I am interested in using agent-based modeling as a means of dynamic knowledge representation to augment the biomedical research process. With respect to acute inflammation, the ubiquitousness of the underlying cellular and molecular mechanisms suggest the application of this methodology to such area as oncogenesis, transplant immunology/rejection, autoimmune disease, wound healing/scarring, atherosclerosis and aging. I am currently using NetLogo as my primary agent-based modeling platform, but am involved with the development of SPARK (Simple Platform for Agent-based Representation of Knowledge http://www.pitt.edu/~cirm/spark/ ) currently being done at the University of Pittsburgh. I am also interested in automated text analysis/information extraction from biomedical texts, formal knowledge representation in biomedicine and the development of methods for evolving biomedical ontologies. These goals form a 'front-end' to high-level modeling tools (such as MetaABM http://www.metascapeabm.com/ ) and are intended to facilitate the ability for biomedical knowledge to be represented, communicated and evaluated via executable models. I am also involved in projects directed at developing methods to execute ABMs on massively parallel computing platforms. I believe this is a vital development necessary for true, multi-scale, biologically relevant simulation. 
1063851	neurocritical care, status epilepticus, subarachnoid hemorrhage, neurogenic respiratory failure, intracerebral hemorrhage, Guillain-Barre syndrome, central nervous system infections, clostridial diseases, bioterrorism 
1063926	My primary interests lie in the assessment, diagnosis and treatment of trauma in the lives of children and women, with an emphasis on serving traditionally under served populations.  I have a particular interest in efforts to make services maximally culturally sensitive and relevant for various (sub)cultures.
1063999	My primary research/clinical interests are children's mental health, issues related to gender and health disparities and public policy.
1064003	Dr. Kwiatek's research interests are in the area of the gastrointestinal motility with special focus on the clinical physiology of the esophagus and stomach, monitoring of gastroesophageal reflux, use of manometry and novel technologies to define the extent of gastrointestinal disorders and potential future diagnostic parameters.
1064120	My primary interest is developing and evaluating technology-assisted behavioral and psychological interventions.  I am also interested in the relationship between stress, depression and inflammation, particularly in multiple sclerosis.
1064162	Early intervention and prevention of kidney disease
1064178	Interests in clinical quality improvement
1064217	Interesting in identifying and developing novel therapeutics in patients with advanced cardiac and vascular diseases.
1064232	Primary research interest include the quality of life related to families of children with feeding disorders, clinical imaging related to non-alcoholic fatty liver disease in children, and lifestyle interventions used to treat childhood and familial obesity.
1064279	Mechanisms of normal and malignant blood cell development 
1064279	Research in the Crispino lab is focused on investigating the regulatory mechanisms governing normal and malignant blood cell development, with an emphasis on understanding the growth of erythroid cells (red blood cells) and megakaryocytes (platelet-producing cells). In addition, we are greatly interested in learning how changes in normal essential regulatory molecules lead to human blood diseases, including leukemias, myelodysplastic syndromes (MDS) and myeloproliferative diseases (MPD).  
1064350	* Promotion of collaborative studies in stem cell biology     * Focus on genetic regulations of stem cell lineages, directed differentiation and utilization for therapy     * Study of human diseases using hESCs and iPSCs with genetic genetic mutations     * Development of repository of hESCs and iPSCs
1064357	I am interested in the mechanisms of neuronal and glial lineage specification from neural progenitor cells during normal development and after injury.
1064405	Our research is dedicated to bring molecular advances in the pathogenesis and therapy of human brain tumors to clinical application. Our laboratory aims to identify new therapeutic leads for patients with high-grade gliomas and to develop tools that allow predicting an individual patients likelihood to benefit from a certain treatment regimen. Our work integrates complex molecular tumor data generated by the complementary and iterative application of data-driven (genome-wide analysis) and hypothesis-driven research approaches and corresponding clinical patient profiles. 
1064439	I am a licensed clinical psychologist and Research Assistant Professor in the Department of Medical Social Sciences, Department of Surgery, and the Institute for Healthcare Studies at Northwestern University. In this position, my research focuses on the development and application of patient reported outcomes (PROs) in the postsurgical context, with specific emphasis on organ donation and transplantation. I lead the Quality of Life Workgroup of the Northwestern University Transplant Outcomes Research Collaborative (NUTORC) to foster multidisciplinary research and to provide research mentorship to postdoctoral fellows in this area.  In addition, I am Co-Chair of the Health-Related Quality of Life Group of the NIH A2ALL study, providing leadership in the assessment of living liver donors well-being across 9 transplant centers. Earlier this year, I was selected to be co-PI of a contract from the Patient-Centered Outcomes Research Institute (PCORI) to establish minimal guidelines for the design and selection of patient-reported outcomes in patient-centered outcomes research. In addition to my work on NIH- and industry-funded grants and contracts, I am on the editorial board of the journal Assessment and section editor of the American Psychological Association (APA) Division 12s The Clinical Psychologist. I serve as the first Chair of the Early Career Professionals Council of APA Division 38 (Health Psychology) and was elected to the Executive Committee of the Allied Health Community of Practice of the American Society of Transplantation. I also serve as an ad hoc reviewer for a number of journals, conferences, and grant task forces to provide expertise in health psychology and psychometrics.
1064445	My research interest is to evaluate the effects of genetic, epigenetic, and environmental factors as well as gene-environment (GxE) interactions on complex human diseases, with a particular focus on allergic diseases, preterm birth, and obesity-related phenotypes.
1064467	My main clinical interest is the diagnosis and treatment of primary immunodeficiency diseases and my research interest is focused on elucidating the pathogenesis of primary immune deficiency diseases, understanding the natural history of these diseases and developing novel approaches to their therapy. Lymphocyte development is another area of interest, which ties in closely with primary immunodeficiency disease as many of these diseases results from failure of lymphocyte development.  In addition, I am also interested in the immunopathogenesis of allergic diseases especially food allergy and the mechanisms involved in the development of tolerance to allergens.
1064580	The main focus of my research program is to study roles of tumor suppressors in normal development and in breast and prostate cancer progression, focusing on Maspin and an Ets transcription factor PDEF. Maspin is a unique member of SERPIN family that plays roles in normal tissue development, tumor metastasis, and angiogenesis. Genetic studies by my laboratory using maspin transgenic and knockout mice demonstrated an important role of maspin in normal mammary, prostate, and embryonic development. Recently, we have identified several new properties of maspin. As a protein that is present on cell surface, maspin controls cell-ECM adhesion. This function is responsible for maspin-mediated suppression of tumor cell motility and invasion. We have also discovered that maspin is involved in the induction of tumor cell apoptosis through a mitochondrial death pathway. The long-term goals of these projects are to elucidate the molecular mechanisms by which maspin and PDEF control tumor metastasis and to identify their physiological functions in development.  Another focus of research in Zhang lab is to identify immune components that control breast cancer metastasis. Chronic inflammation not only increases neoplastic transformation but also drives the inhibition of the immune response in a protective negative-feedback mechanism. Suppressive immune cells are recruited to the sites of inflammation and function to inhibit both innate and adaptive immune responses, enabling tumor tolerance and unmitigated tumor progression. To study the interplay between tumor and immune cells, Zhang lab has developed a unique animal model of breast cancer that reproduces different stages of breast cancer bone metastasis. Molecules that control tumor-immune cell interaction and immunosuppression have been identified. We are currently studying roles of these genes in tumor-driven evolution that control chronic inflammation and immunosuppression.
1064642	Research interests  Dr. Hou was trained as a physician in China with several years of clinical experience in internal medicine.  Dr. Hous graduate training includes a Master of Medical Science degree in epidemiology and community medicine and a MD & PhD combined degree in molecular genetics in Japan. Dr. Hou further received her postdoctoral training in molecular cancer epidemiology in the Division of Cancer Epidemiology and Genetics (DCEG) at the National Cancer Institute (NCI).  With a multidisciplinary background in medicine, basic science, and epidemiology, Dr. Hous research interest lies in integrating traditional epidemiologic methods with the ever-advancing molecular techniques in multi-disciplinary research focusing on identifying key molecular markers and understanding their potential impact on disease etiology, detection, and prevention.  Dr. Hous major research efforts to date have focused on two areas: 1) identification of risk factors that may cause chronic diseases; and 2) identification of biomarkers that serve as indicators of an individuals past exposure to disease risk factors and/or predict future disease risks and/or prognosis. The environmental/lifestyle risk factors that Dr. Hou has studied include air pollution, pesticides, overweight, physical inactivity, and reproductive factors in relation to chronic diseases.  The biomarkers that Dr. Hou has investigated include genetic factors (i.e., polymorphisms, telomere length shortening, mitochondria DNA copy number variations); and epigenetic factors (i.e., DNA methylation, histone modifications, and microRNA profiling).  Her over-arching research goal is to understand the biological mechanisms linking environmental risk factors with subclinical or clinical disease development, which ultimately lead to development of effective strategies for prevention of chronic diseases.
1064657	1. Mechanisms and physiology of Interleukin-10 mediated attenuation of cardiovascular injury and inflammation. These studies have an overall focus to understand the role of inflammation in exacerbating post-injury myocardial functions and tissue repair. The strategy involves utilizing IL-10, a potent anti-inflammatory cytokine, to inhibit the expression of pro-inflammatory mediators. Past studies delineated the mechanisms by which IL-10 imparts its inhibitory action and showed that on molecular level, IL-10 acts mainly via post-transcriptional de-stabilization of mRNA half-life by suppressing mRNA stabilizing protein HuR which binds to mRNAs harboring specific A+U rich sequences in their 3 untranslated regions.  Current studies are expanded utilize IL-10 and its direct downstream target HuR, as potential therapeutic approaches to inhibit inflammation in post-myocardial infarction in animal models and to elucidate signaling pathways that govern IL-10 actions both in vitro and in vivo (Rajasingh et al, FASEB J, 2006; Krishnamurthy et al, Circ Res., 2009, Krishnamurthy et al., FASEB J, 2010). 2. Epigenetic reprogramming of somatic cells to generate induced pluripotent cells and mechanisms of embryonic stem cell differentiation into cardiovascular linage cells. One component of this research focuses on to understand the molecular and signaling mechanisms governing directed differentiation of mouse embryonic stem cells into cardiomyocytes (Rajasingh J et al, Circ. Res., 2007).  The second project in regenerative and stem cell biology that we have developed is to epigenetically reprogram adult somatic cells into ES-like cells (iPS cells) by utilizing cell-free ES cell protein extracts thereby bypassing the use of retroviral mediated forced expression of exogeneous transgenes (Rajasingh J et al, Circ Res., 2008). Studies are ongoing to address the mechanisms of somatic cell reprogramming and to define the role of critical epigenetic factors required for this transition.
1064657	CURRENT RESEARCH INTERESTS 1 )  To understand molecular mechanisms and signal transduction involved in the inflammatory cytokines (e.g. TNF-alpha)-induced dysfunction of endothelial cells (EC) in cell culture model system and the mechanisms of cytokine regulation on the healing of endothelium in vivo in moue models of carotid artery denudation (equivalent to balloon angioplasty in patients). We have established that locally secreted TNF acts to inhibit endothelial recovery leading to restenosis, partly via inducing cell cycle arrest in ECs (Kishore, Circulation Research 2002, 2003; JCI, 2005),although complete molecular mechanisms and signal transduction pathways involved therein are yet to be deciphered. Understanding of EC gene regulation may potentially help finding target molecules whose modulation can nullify deleterious effects of TNF. Another component of this project involves elucidating trans-factors involved in posttranscriptional (mRNA stability) regulation of TNF by anti-inflammatory cytokine IL-10 (Rajasingh, Kishore, FASEB J, 2006). 2)  To understand the molecular and signaling mechanisms governing directed differentiation of mouse embryonic (Rajasingh, Circulation Research; 2007) and adult stem cells and oocyte-independent means for the de-differentiation of adult somatic cells to generate stem-like cells and to assess the therapeutic efficacy of these cells towards tissue repair in mouse models of surgically induced myocardial infarction and other ischemic injuries. 3) To study and understand the role of long-term alcohol consumption (chronic alcoholism) on cardiovascular system. Chronic ethanol inhibits cell survival signaling by various mechanisms, including but not limited to the enhanced release of TNF and other pro-inflammatory cytokines. Our studies indicate that in vitro chronic ethanol exposure exerts inhibitory effects on EC proliferation and survival (Luedemann, Kishore, Alco Clin Exp Res, 2005; Rajasingh, Kishore, Endocrinology, 2007). Chronic ethanol not only elevates agonist-induced TNF expression in EC but also exacerbates TNF-mediated EC dysfunction, synergistically. Our current studies are focused toward understanding the biology of ethanol-induced EC dysfunction in ethanol-fed rodent models as wells as towards understanding the underlying molecular mechanisms in cell culture model system. 
1064699	Working with children suffering from diminished daily school and social performance as evidenced, perhaps in ADD/ADHD, perhaps relating to allergy, or both, by attempting to objectively quantify clinical findings through computerized continuous performance testing (MMAT/Quotient ADHD System)  approved by the Food and Drug Administration in 2002, and invented by Dr. Martin Teicher at McLean Hospital in Belmont, MA (McLean is a psychiatric hospital affiliated with Harvard Medical School).
1064705	My primary research and academic interests are in the development of young scientists. My work in this arena spans the continuum including: the 'basic science' of how undergraduate and PhD student fine tune career decision with a longitudinal study of 500 students; application and study of new coaching-based models to support early PhD students; use of group-based modesls to assist junior faculty develop as scientists; a randomized controlled trial of a totaly different approach to fostering diversity in academia.
1064835	My primary research interests include HIV treatment outcomes in resource-limited settings, as well as antiretroviral clinical pharmacology research, particularly in special patient populations, such as pregnant women. I am also interested in pharmacist-initiated program implementation, including community pharmacy-based rapid HIV testing models and HIV-related pharmacovigilance activities.
1064839	Within the field of Otolaryngology, my area of interest and expertise is in head and neck surgery specifically for cancer.  I am particularly interested in trans-oral endoscopic removal of tumors, as well as reconstructive surgery following tumor removal including free tissue transfer.  I have also recently expanded surgical services to include trans-oral robotic surgery (TORS) at Northwestern, by which tumors can be removed through the mouth with robotic assistance.
1064942	My primary interest is pediatric airway obstruction and pediatric upper airway reconstruction specifically laryngomalacia and its surgical treatment - supraglottoplasty. I am also interested in the Diagnosis and Medical and Surgical Treatment of Pediatric Dysphagia.  Specifically, I am interested in how congenital and acquired airway lesions affect a childs ability to eat and swallow.        My interest also include the medical and surgical treatment of pediatric obstructive sleep apnea and sinusitis.
1064948	Educational Research, Curriculum Development, Technology Enhanced Instruction, Faculty  Development, Program Evaluation;  Public Health, Food Access, Nutritional Environment, Workforce Development
1064963	I have a primary interest in the evaluation of assessment and reduction of risk for harm to self or others; psychic harm; boundary issues; disability; fitness for duty; closed head injury; competence to stand trial; sanity/mitigation in criminal cases; and correctional mental health. 
1064977	I provide inpatient pediatric care and term infant nursery care at a community hospital.
1064985	Research interest: Examining the potential benefits of integrative medicine therapies (complementary and alternative medicine) for a range of conditions.
1065018	Integrative medicine (complementary/alternative medicine) in pediatrics. I have training in medical acupuncture, medical hypnosis and homeopathy and am interested in the use of integrative medicine.
1065021	Measuring health outcomes using modern psychometrics including item response theory and computerized adaptive testing
1065026	Genetics, Hereditary breast and ovarian cancer, Minimally invasive surgery (Robotics, laparoscopy, management of pelvic masses, endometrial ablation, tubal ligation/sterilization), In-office procedures (Essure, Novasure), Management of abnormal pap smears, Menopause, Fibroids, Contraeption, Normal and complicated pregnancies (twins, advanced maternal age)
1065034	Developmental biology of urogenital organs.
1065059	Hypochondriasis as psychiatric diagnosis; hypochondria/disease anxiety as a problem for primary care; cultural narratives regarding health/disease and their role in fostering anxiety about disease and about health care. The role of narrative in patients', physicians', and biomedical scientists' thinking about the inside of the living human body. The place of fear and uncertainty in medical epistemology.
1065060	My clinical and research interests pertain to the nutritional support of newborns.  I am currently collecting fatty acid levels of premature neonates with long exposures to intravenous lipid emulsions.  My long term goal is to improve the quality of the constituents of parenteral nutrition that we provide to neonates, both preterm and term populations.  I also work to promote the provision of breast milk as a newborns primary form of nutrition.
1065061	Dr. Richard Lee practices the full spectrum of adult cardiac surgery and has special interests in surgical treatments of atrial fibrillation, mitral valve repair, tricuspid valve repair, and surgical alternatives to heart transplantation.
1065062	Dr. Andrew J. Fishman is an Otologist/Neurotologist, Skull Base Surgeon, and Cochlear Implant specialist at Northwestern Memorial Hospital. Dr. Fishman holds an appointment to the departments of Otolaryngology and Neurosurgery at Northwestern Memorial Hospital.          He has performed pivotal research with Dr. Claus-Peter Richter M.D. Ph.D. -Director of the Otolaryngology Laser Research Laboratory on laser nerve stimulation for hearing, and clinical research, which ultimately lead to the development of one of the cochlear implant electrodes currently in use today.     In 2005, he went on a yearlong medical mission to South India, where he developed a Transtemporal Cranial Base Surgery Program at the Amrita Institute of Medical Sciences (AIMS) in the city of Cochin, Kerala. He was appointed as Consultant in the disciplines of Otolaryngology, Head & Neck Surgery and Skull Base Neurosurgery.  During that time, he also worked as a surgical consultant for one of the major cochlear implant companies, training doctors in surgical implantation techniques.           In 2007 Dr. Fishman was granted the honorary appointment of International Professor at the Nicolas Copernicus University in Poland for his work in that country over the past 10 years.  Today, he continues to be an active participant in the development of acoustic neuroma, neurofibromatosis II, and skull base tumor surgery in a center which he developed at the University Hospital of Dr Jurasz in Bydgoszcz, making invited visits to lend surgical support and training to the physicians of the Neurosurgery and Otolaryngology Departments.  In 2007 Dr. Fishman organized a joint international surgical mission where he and the members of the Indian Cranial Base Surgery Team from the Amrita Institute came to perform a series of challenging surgeries on patients in Poland with rare and unusual tumors.  Observers were invited from the local area hospitals including the regional NATO medical center. 
1065069	As Associate Director of Surgical Clerkship, interests and research are focused on Curriculum Development and Case-based learning. Thesis research focused on cultural diversity within a community college health career program.   Clinical background is in Trauma and Emergency Medical Services.
1065133	1. The use of clinical use of echocardiography in pediatric cardiovascular disease.  2. The use of exercise testing in pediatric cardiovascular disease and the development of a wellness center.  
1065171	MRI, Functional Neuroimaging, Head & Neck
1065185	Glaucoma Research Coordinator 
1065196	As the Associate Director of the Pediatrics Clerkship for NUFSM, Dr. Greenberg's interests in medical education include medical simulation, innovative curriculum design, and hand-off communication skills.  Dr. Greenberg also directs the Medical Observation Unit (MOU) in the Ann and Robert H. Lurie Children's Hospital of Chicago.  His clinical and research interests include observation care in pediatric populations, quality improvement, and medical informatics.
1065215	Dr. Lowe is a nationally and internationally recognized expert in robotic and minimally invasive surgery for gynecologic cancers. He has been honored at the national/international level with numerous presentations on minimally invasive surgery. For several years, Dr. Lowe has taught laparoscopy and robotics throughout the United States and recently Italy to gynecologic surgeons and oncologists.  His surgical videos (on YouTube) have been selected for presentation at national/international meetings for the American Association of Gynecologic Laparoscopists, Society of Gynecologic Oncologists, and the American College of Surgeons. Additionally, he was one of the first gynecologic oncologists to receive certification on the da Vinci Surgical System in the United States in 2006 and performed the first robotic surgery for endometrial cancer in the Mid-South region of the United States.
1065270	Dr. Hos primary interests involve improving the accessibility to mental health services and prevention programs in ethnic minority populations. She is especially interested in exploring new ways to achieve these goals, including how communications technology may be used to promote health and prevent mental illness.
1065283	I am a hospitalist working in General Medicine (inpatient service),Medical Observation Unit, Pediatric Intensive Care Unit and Sedation for Medical Imaging.  I am involved in resident and medical student education during service time on General Medicine and Sedation.
1065385	My clinical interests involve the inpatient care of Hematology and Oncology patients as a Hospital Medicine and Infectious Diseases specialist.
1065474	I work as a pediatric hospitalist in a community hospital, and asthma is one of my primary clinical interests.
1065656	My research involves the substantiation that bone marrow derived cells have an immunoregulatory capacity that can influence the induction of clinical tolerance (the elimination of maintenance immunosuppressive drugs).  This includes the development of sophisticated monitoring techniques to detect the immune status of the recipient and the appearance of these regulatory cells in the bone marrow, peripheral blood, and transplanted organ in the recipient.   I am currently conducting a clinical trial at Northwestern in 20 such HLA-identical living donor kidney transplant recipients of donor stem cells, along with the transplanted organ, and following the recipient for the detection of these immune regulatory functions.
1065729	My lab studies the inflammatory response at the cellular and molecular level.  We are focused on the process of diapedesis, the 'point of no return' in inflammation where leukocytes squeeze between tightly apposed endothelial cells to enter the site of inflammation.  We have identified and cloned several molecules that are critical to the process of diapedesis (PECAM (CD31), CD99, and VE-cadherin) and are studying how they regulate the inflammatory response using in vitro and in vivo models.  We have recently described the Lateral Border Recycling Compartment, a novel para-junctional organelle that contains PECAM and CD99 and is critical for diapedesis to occur. We are currently investigating how this compartment regulates diapedesis in the hope of finding novel targets for anti-inflammatory therapy.
1065744	My clinical and research interests involve my primary specialty, Pediatric Emergency Medicine.  I am interested in youth firearm injury epidemiology and prevention and am currently involved in database research examining firearm injury among youth in Cook County.  I am also actively involved in the medical education of residents and medical students in the emergency department, PBL, and resident lectures.
1065776	Clinical Interests: Musculoskeletal injuries, Sporting Event coverage, mass participation events. Research Interests: Clinical Operations in the Emergency Department, Patient Satisfaction, Mass participation events, Sports Injuries, Procedural teaching.
1065793	Clinical interests include percutaneous aortic valve replacement, minimally-invasive aortic valve replacement, aortic valve repair, valve-sparing aortic root replacement, aortic arch repair, endovascular stent-grafts, thoracoabdominal aortic aneurysm repair. Research interests include Marfan syndrome, bicuspid aortic valve, thoracic aortic aneurysm. 
1065795	Pediatrics and Urgent Care
1065796	Fetal echocardiography 
1065799	My laboratory has two main research interests. The first is to understand how retinal ganglion cells (RGCs) acquire their dendritic morphology during postnatal development. We focus on understanding how neurotrophins, specifically, Brain-derived neurotrophic factor (BDNF) and Neurotrophin 3 (NT-3),  affect RGC dendritic development and function. The second is to determine how neurotrophins can be used to protect RGCs in glaucoma, a group of neurodegenerative diseases characterized by RGC death.
1065833	<BR><BR> Cytopathology
1065940	My primary interest is in pathogenesis of herpes simplex (HSV) disease, focusing on development of vaccine candidates.  I also study herpes simplex disease in newborns, specifically focusing on the role of the different entry receptors in disease pathogenesis.  Additionally, I have projects related to use of HSV an oncolytic virotherapy and projects intended to increase our understanding of immune responses to skin and mucosal infections.
1065960	Clinically, my interests encompass all classical hematology, including thrombosis/clotting disorders, thrombophilia/inherited clotting disorders.  Bleeding disorders.  Platelet disorders including ITP/autoimmune thrombocytopenia.  Anemias (including sickle cell anemia, autoimmune hemolytic anemia, pure red blood cell aplasia, etc). Aplastic anemia.  Chronic myeloproliferative disorders including polycythemia vera, essential thrombocythemia, eosinophilia, & myelofibrosis.  Hematologic issues in unique patient populations, including solid organ transplant and autoimmune/rheumatologic diseases.  Research interests include evaluating mechanisms of thrombosis particularly in malignancy, investigating new ways to evaluate the clotting system/platelet function, identification of those patients at high risk for thrombosis & thrombosis recurrence.
1065989	Research interests include hair loss and its impact on quality of life, immunobiology of inflammatory hair loss conditions, impact of diet and nutrition on hair loss.   Clinical and administrative interests in medical student education, establishing uniform education and testing in dermatology among medical students. 
1066028	Clinical trials in early lung cancer diagnosis and minimally invasive surgical techniques for lung cancer treatment.
1066072	1.Patients with diabetes and obesity have increased risk for cardiovascular disease. These metabolic conditions are associated with chronic inflammation, oxidative stress, and insulin resistance leading to severe coronary events and worse clinical outcomes. The long-term goal of our research is to determine mechanisms by which diabetes/obesity increase risk for coronary artery disease and the resulting pathophysiological consequences. In this context, macrophages (part of the innate immune system) have emerged as a key pathogenic link between diabetes/obesity and the resulting coronary artery disease. Macrophages play critical role in regulating the body's inflammatory response to environmental stimuli, pathogen recognition, clearing cellular debris and inflammatory cytokine secretion. However, their chronic activation in diabetes/obesity might induce endothelial dysfunction, cardiac cell death, extracellular matrix remodeling and contractile dysfunction leading to heart failure. Our research efforts are focused on understanding the cellular and molecular connections between macrophage biology, chronic inflammation, oxidative stress and insulin resistance, and diabetes/obesity-induced cardiovascular disease. These studies will facilitate development of novel therapies that specifically target recruited macrophages to treat the underlying inflammation and insulin resistance in patients with type 2 diabetes/obesity. 2. Acute ischemic injury and chronic cardiomyopathies lead to permanent loss of cardiac tissue. Transplantation of bonemarrow (BM)-derived progenitor cells has the potential to improve cardiac function after ischemic injury. However, number and functional capacity of these cells are impaired in diabetes. Our objectives are to determine the impact of the diabetic milieu (high glucose and fatty acids) on progenitor cell biology and function and their contribution to myocardial repair in response to ischemic injury.
1066075	My research for the past 20 years has been in the areas of immune responsiveness and tolerance induction in clinical organ transplantation.  These studies have resulted in more than 200 publications including book chapters, review articles and editorials, original papers and presentations.  The major thrust of these has been on the immunological effects of donor bone marrow cell (DBMC) and donor hematopoetic stem cell (DHSC) infusions in organ transplant patients using in vitro and ex vivo culture systems. It has been observed that using multiple assays for donor specific unresponsiveness may identify potentially tolerant recipients who may be candidates for immunosuppressive drug (IS) withdrawal. Recent studies have also assessed the role of CD4+CD25High FoxP3+ regulatory T cells as potential tolerance inducers in kidney and liver transplant patients, as well as the differential susceptibility these cells to various immunosuppressive drugs used in clinical transplantation.
1066091	My clinical interests include neonatal stroke, congenital brain malformations, perinatal hypoxic  ischemic injury and the neurological complications that arise from these insults.  My research focuses on mechanisms regulating glial progenitor cell response to perinatal injury.
1066093	Primary research interest focuses on optimizing value in health care delivery through evaluating quality of care delivery and costs. Additional interests include health literacy, patient centered care, and relevant medical education.
1066134	My research interests exist in the interaction between the epidemiology of pediatric and adult infectious diseases.  Many infectious pathogens pass between the two populations and can be impacted by vaccination or other infection control strategies.  In particular, I have been interested in the burden of gastroenteritis in adults that is due to rotavirus and norovirus.  Additionally, I am currently part of a multicenter study of community-acquired pneumonia in children and adults.
1066173	Incoorporating prevention services to hospitalized patients 
1066178	I am interested in clinical research that focuses on echocardiography and valvular heart disease, as well as prevention of coronary artery disease. I am currently developing a study to evaluate the effects of a comprehensive lifestyle behavioral program in women with the metabolic syndrome.
1066198	Sports Medicine 
1066200	I have three main intersts:  Surgical education (curriculum design) and Faculty development Critical Care and Trauma outcomes research
1066201	Clinical and research interests include thyroid cancer, thyroid nodules and other benign disorders of the thyroid gland, hyperparathyroidism, functional and nonfunctional adrenal tumors, inherited endocrine disorders, and minimally invasive methods of treatment including minimally invasive thyroidectomy and parathyroidectomy as well as laparoscopic adrenalectomy. 
1066214	Dr. Devries specializes in preventive cardiology and noninvasive cardiac testing with echocardiography.  Prevention interests focus on an integrative approach to treatment emphasizing nutrition and innovative uses of non-pharmacologic therapies-in addition to conventional treatment. 
1066217	Dr. Kim's research interests involve statistical problems that arise in genetics and genomics research. He is particularly interested in developing statistical methods and computational tools to identify genes involved in Mendelian and complex genetic disorders. His work emphasizes the importance of characterizing gene-gene and gene-environment interactions in successfully identifying disease genes. Dr. Kim's research can be applied to various types of experiments, including genomic studies with high-throughput microarray data. His recent work has contributed in understanding the regulation of gene expression in the mammalian eye.
1066226	Dr. Schlossers areas of interest include acne, rosacea, polycystic ovary syndrome, excess hair disorders in women, skin disorders in pregnancy, female genital mucosal disorders and adolescent dermatology.  As the Director of the Womens Skin Health Initiative, Dr. Schlosser leads a team of expert physicians in providing outstanding and comprehensive care in medical, surgical and cosmetic dermatology to women of all ages and stages of life.  In addition, Dr. Schlosser directs the Vulvar Mucosal Specialty Clinic, a multidisciplinary clinic dedicated to the expert care of women with genital (vulvar) disorders including inflammatory skin diseases (lichen planus, lichen sclerosus, pemphigus, Hailey-Hailey disease, lichen simplex chronius, eczema and others), infections, and chronic irritation, pain and/or itching. She currently sees patients at the Northwestern Medical Faculty Foundation outpatient dermatology clinic and performs inpatient consultations at Prentice Womens Hospital.
1066253	My laboratory's research focuses on understanding how dysregulated cell cycle controls promote tumorigenesis and alter normal, lineage-specific transcriptional programs in hematopoietic stem and progenitor cells as well as in epithelial cells. We also study basic mechanisms of cyclin regulation. In my laboratory, we utilize primary and organotypic cell culture, mouse models, and live cell imaging. Discovery projects underway involve the use and study of small regulatory RNAs and synthetic lethality screens.
1066274	flourescence endoscopy (Imaging proteolytic activity in cancer) cancer vaccines immunetherapy
1066309	1. Echocardiographic diagnosis of Diastolic dysfunction. 2. Prognosis associated with asymptomatic diastolic dysfunction. Evaluation of the CARDIA study 3. Echocardiographic determinants of Heart transplant rejection 4.Right ventricular area normative data from CARDIA study 5. Prognostic value of Right ventricular area 6. Echocardiographic core lab for MARVEL study
1066309	Diastology, Hypertension, Tissue Doppler Imaging, Echocardiography 
1066351	Traumatic Brain injury
1066379	We are interested in the functional roles of chondroitin sulfates and chondroitin sulfotransferase genes in mammalian development, disease, and cellular signaling pathways. Specifically, we are currently investigating the roles of the sulfotransferase C4ST-1  and its chondroitin sulfate products in breast cancer progression, in the pediatric disease Costello syndrome, in developmental processes including ES cell differentiation and cell lineage determination, and in the control of Wnt signaling. Our long-term goal is the development of carbohydrate-based pharmacological interventions for the treatment of cancer and cardiovascular disease.
1066385	I am interested in diabetes, thyroid, growth, and pubertal disorders. I have an interest in the planning for transition between pediatric and adult medical care. I am also interested in integrative diabetes therapies. I am also insterested in disorders of sexual development.
1066395	Dr. Duffecys research background is in behavioral medicine. Her specific interests include methods to improve weight loss as well as using technology to reduce barriers to receiving behavioral and mental health care.
1066403	My primary clinical and research interests are in the early diagnosis of autism spectrum disorders in young children.
1066404	Leukemia, Lymphoma, new agents and survivorship in children
1066435	Bone Health in Children and Adolescents - using fractures to predict low bone density Fracture management Hip dysplasia Hip preservation techniques
1066440	Clinical and genomic modifiers of cardiac conduction
1066440	I am interested in caring for and treating patients with acquired and inherited arrhythmias and understanding the underlying reasons for this susceptibility.  In addition, I treat patients with these arrhythmias either through ablation, or with devices, such as pacemakers and defibrillators.
1066455	Clinical educator in the Division of Endocrinology, Metabolism and Molecular Medicine
1066455	Dr. Hahr is interested in endocrinologic disorders.  She specializes in disorder of calcium and bone, including osteoporosis, hyperparathyroidism and vitamin D deficiency.  She also cares for patients with thyroid disorders and Polycystic Ovary Syndroma.
1066458	Regulatory mechanisms of inflammatory and apoptotic responses during pathogen infection and inflammatory disease
1066503	Clinical interest in surgical and non-surgical treatment of Female Pelvic Floor Disorders including pelvic organ prolapse, urinary and fecal incontinence, genitourinary and rectovaginal fistulas, complicated obstetrical lacerations.
1066654	I am interested in the process of communication that occurs between patients, families and providers in the acute care setting. In particular, my focus is on the impact of communication and information exchange on patient satisfaction, comprehension and outcomes following an ED visit. I am committed enhancing the discharge process for patients when they leave the ED.  In addition, I am very interested in the intersection between emergency medicine and palliative care. I feel that education and training in EM must include an emphasis on quality of life and end of life issues which have traditionally be underrepresented.
1066664	Primary research interests are in the applications of minimally invasive surgery to spine.  Secondary research interest is in stem cell transplantation for spinal cord injury. 
1066665	My laboratory explores the cell surface as a dynamic platform regulating cell behavior.  Specifically, we seek to understand how surface glycoproteins regulate cell-cell fusion in muscle cells, and to determine how pathogens target cardiac muscle.  Using surface modification, we then hope to re-engineer stem cells to improve tissue targeting and tissue integration.  To accomplish these broad aims, our current research projects are exploring the following research issues:  (1) Tissue tropism of Trypanosoma cruzi.  T. cruzi demonstrates tissue tropism during both the acute and chronic phases of infection, targeting cardiac, skeletal, and smooth muscle.  Patients with chronic T. cruzi infection may develop clinical symptoms related to target tissue infection, notably myositis, dilated cardiomyopathy, and megasyndromes.  The molecular basis for these clinical observations is incompletely understood.  My research hopes to define and characterize the cell surface proteins important during the initial host-parasite interaction enabling myogenic specificity.  (2) Drug discovery for African Trypanosomiasis. T. brucei behaves as an eukaryotic tumor in the host. We are exploring the use of traditional cytotoxic chemotherapy, as well as targeting bioactive lipid pathways, to discover potential inhibitors. (3) Cell-cell fusion and GPI-anchored proteins during skeletal myogenesis.  Secondary skeletal myogenesis, the process of differentiation of dividing, mononuclear myoblast into quiescent, multinucleate myotubes is critical for maintenance of skeletal muscle during aging and after injury.  GPI-anchored cell surface proteins appear to be critical for these regulated membrane-membrane fusion events.  Our research hopes to dissect the molecular choreography occurring at the site of opposing membranes which enables cell fusion.
1066671	Urgent Care pediatrics/general pediatrics
1066766	My primary research interest focuses on the mechanisms of actin cytoskeletal remodeling.
1066898	All clinical supports in diagnostic radiological physics at Northwestern campus; Applied research in medical imaging, mainly in CT, X-ray, mammographic, ultrasound, MR and PET imaging, and radiation shielding/protection.
1066951	Dr Berkelhamer researches oxidative lung injury with an interest in the metabolic consequences of hyperoxia on the developing lung. In addition, she is interested in gender differences in pulmonary morbidity and the potential role of estradiol in protecting against oxidative lung injury.
1066962	Tumor recurrence and metastasis represent the major causes of cancer related deaths. Studies aimed at understanding how cancer cells grow and spread can help identify novel anti-cancer targets. Dr. Strizzi's research involves the study of how the extracellular microenvironment is capable of regulating cancer related mechanisms including matrix remodeling, cellular invasion and angiogenesis known to play important roles during cancer spread. More recently his work has focused on the role of embryonic morphogens, Cripto-1 and Nodal during tumorigenesis. Both Cripto-1 and Nodal are involved in early development and have been shown to be re-expressed in human cancers like breast cancer and melanoma. Dr. Strizzi is currently studying how Cripto-1 and Nodal signaling can affect differentiation, migration and invasion of cancer cells and identify molecules and molecular pathways capable of regulating these Cripto-1/Nodal-dependent activities in cancer.
1067116	Dr. Evans has expertise in epidemiologic methods, health outcomes, and infectious disease related research. Her past and current research has focused on the secondary complications of persons with spinal cord injury and disorder (SCI&D) and women with HIV. Her major research interests include the epidemiology of infectious diseases (particulary healthcare associated infections) and outcomes as related to these infections, antimicrobial prescribing and its effects on patient outcomes, and uptake of influenza and pneumococcal pneumonia vaccinations.
1067124	Epilepsy in children and adults, the pharmacology of anticonvulsant medications, vagus nerve stimulation in epilepsy, epilepsy surgery, the neurophysiology of epilepsy. Intra-operative neurophysiological monitoring.
1067182	Yersinia pestis and Yersinia pseudotuberculosis are two bacterial pathogens that are very closely related, yet cause vastly different diseases in the mammalian host. Y. pestis is infamous for causing the devastating disease plague, while Y. pseudotuberculosis infection often results in a mild, self-limiting gastrointestinal illness. While genetically similar, the distinct mechanisms by which these two bacterial species interact with the host is of great interest to our group. Shared amongst both pathogens is a protein called Hfq, which serves as a chaperone for small, non-coding regulatory RNAs (sRNAs). One set of projects in the lab centers on understanding the post-transcriptional regulatory networks controlled by Hfq and sRNAs in both Yersinia species, particularly as they relate to virulence. We anticipate that the similarities and differences we identify between Y. pestis and Y. pseudotuberculosis in this regard will provide keen insight into how a relatively mild pathogen evolved into one of the most deadly known to mankind. We are also interested in determining the mechanisms by which Y. pestis specifically causes primary pneumonic plague, a respiratory form of disease that Y. pseudotuberculosis does not produce. Another set of projects in the lab focuses on dissecting the mechanisms by which the Y. pestis virulence factor Pla controls the development of pneumonic plague. These include understanding the interaction of Y. pestis and Pla with the mammalian fibrinolytic and coagulation cascades, the identification of additional host substrates cleaved by Pla that lead to the development of a severe pneumonia, and the mechanisms by which Pla specifically induces an overwhelming inflammatory response in the lungs during infection.
1067233	Acute liver failure predictors of recovery and need for liver transplantation
1067233	Principal Investigator NMH site Acute Liver Failure NIH sponsored grant.  Principal Investigator NMH site study name:SANVAR . Completed July 2008 sponsored by DEBIO  
1067235	Interested in diagnosis and treatment of ectopic pregnancy' gynecologic surgical techniques and preinvasive neoplasia if cervix, vagina and vulva
1067245	Debra E. Weese-Mayer, M.D. is a Professor of Pediatrics at Northwestern University Feinberg School of Medicine and Director of the first Center for Autonomic Medicine in Pediatrics (CAMP) at Childrens Memorial Hospital. She is recognized internationally for her expertise as a leader in clinical and research advances in respiratory and autonomic disorders of infancy, childhood, and adulthood (RADICA)--including Sudden Infant Death Syndrome (SIDS), Congenital Central Hypoventilation Syndrome (CCHS), Rapid-onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD), Rett Syndrome and Familial Dysautonomia. She has authored more than 250 peer-reviewed articles, reviews, chapters, and abstracts. Her clinical and research programs have grown to include a wide-ranging referral base (48 states; 49 foreign countries). Dr. Weese-Mayer was awarded the March of Dimes Jonas Salk Health Leadership Award in Research for 2005. She patented a genetic test to diagnose CCHS, allowing early confirmation of diagnosis, and prenatal testing (patent proceeds support CCHS research). Dr. Weese-Mayer's long term career objectives are to 1)build the model Autonomic Medicine program in Pediatrics---with wholly innovative protocols and technology for in and out-patient application; 2)develop norms for all age groups, ethnicities, and by gender for pediatric-friendly autonomic testing protocols; 3)continue to characterize CCHS and ROHHAD; 4)identify the genetic or epigenetic basis of ROHHAD, SIDS, and stillbirth; 5)develop a Neurocristopathy Consortium to expand knowledge of rare disorders in the context of related disorders (ex. Hirschsprung disease, neural crest tumors, CCHS, MEN2A, pheochromocytoma, ROHHAD, and more)--to improve visibility of Rare Disease Medicine and value of study of rare diseases to understand basic systems in health; and 6)train the next generation of experts in respiratory and autonomic control.
1067322	Research focuses on: 1) evaluating combination psychological and pharmacological treatments for tobacco dependence; 2) characterizing smoker- and treatment-related factors that influence smokers adherence to treatment and likelihood of quitting; and 3) developing an understanding though human laboratory and genetic epidemiologic studies of psychological, biological, and genetic factors that convey risk for smoking persistence. Primary end-point is to decrease risk of tobacco attributable disease through long-term smoking cessation.
1067418	Our lab is interested in studying signaling pathways that regulate cancer progression. One of our current projects looks at the role of the extracellular matrix protein, collagen, a major component of the fibrosis associated with pancreatic cancer, in promoting chemotherapy resistance. We have recently found that collagen up regulates expression of the matrix metalloproteinase MT1-MMP (MMP14), which in turn induces expression of the chromatin modeling protein HMGA2. This results in pancreatic cancer cells escaping the proliferation arrest on gemcitabine treatment.
1067420	Renal and transplant pathology.
1067449	My research focuses on the immune function of major histocompatibility complex (MHC) class Ib molecules in normal and diseased states. My lab is interested in understanding how MHC class Ib-restricted T cells are selected and regulated during development and how they contribute to the control of autoimmunity, anti-tumor immunity and infectious diseases.  My lab is also interested in identifying microbial antigens recognized by MHC class Ib-restricted T cells with the goal of developing new T cell-based vaccines for microbial infection.
1067451	Microbiology/Virology  <BR><BR>  am interested in the ecology of infectious diseases, especially those that are zoonotic (transmitted from animals to humans) or involve pathogens that have transmission dynamics strongly influenced by environmental conditions. This type of research requires a wide variety of techniques ranging from basic field studies to molecular epidemiology. Ecologic modeling of these diseases is aided by computerized mapping with geographic information systems (GIS) and much of the data we analyze is acquired by remote sensors on earth-orbiting satellites.
1067515	My laboratory is interested in identifying new biomarkers for psychosis and dementia, using biomarkers to develop new treatment approaches for the disorders, and developing more informative animal models of neuropsychiatric disorders.
1067525	My laboratory has a longstanding interest in mast cell and eosinophil biology. We have developed specific and novel in vivo approaches for the analysis of mast cell function in experimental gastrointestinal inflammatory and allergic reactions. We can apply this model to determine the precise influence of mast cells and mast cell-derived cytokines/chemokines in gastrointestinal inflammation.
1067560	I am mainly involved in uncovering the mechanisms of endoplasmic reticulum stress in regulation of metabolic disorder and hepatocarcinogenesis based on the acyl-CoA oxidase 1 deficient (Acox1-/-), leptin and Acox1 double deficient (ob-/-Acox1-/-), and Promethin deficient (Prom-/-) mice.
1067632	Dr. Hagerty is a pediatric urologist.
1067664	My current works focus on cancer related translational studies (from bench to bed) by means of developing algorithm and analyzing high-thoughput genomic and transcriptomic data, such as next-generation sequencing and microarrays, as well as pipeline construction for drug discovery and repositioning by integration of varies of tools (developed by others and us) and datasets including clinical data, genomic data, etc, with annotations, like functions, pathways, diseases, compounds, etc. I am also interested in molecular modeling, such as molecular dynamics simulation, coarse grain simulation, etc, which is also widely applied for compounds screening at atomic level.
1067808	Primary interest is health psychology/behavioral medicine with specific interest in psycho-oncology.  
1067860	Adjunct Instructor in FSM Nutrition Curriculum
1067861	Adjunct Instructor in FSM Nutrition Curriculum Interests include Cystic Fibrosis (CF) nutruton 
1067862	Adjunct Instructor in FSM Nutrition Curriculum Interests include neonatal nutrition 
1067863	Cancer of the Skin
1067914	Adjunct Instructor in FSM Nutrition Curriculum 
1067916	Adjunct Instructor in FSM Nutrition Curriculum  
1067917	Adjunct Instructor in FSM Nutrition Curriculum
1067927	My major research interests are on identification of molecular biomarkers that are associated with tumor growth and progression in benign and malignant uterine smooth muscle tumors. In addition, I am interested in characterization of the role of microRNAs in the pathogenesis of benign and malignant tumors in women's reproductive organs through regulation of the target gene expression.
1067953	My research interests involve resident education and development utilizing medical simulation.  I am involved with simulation at a national level.  I also instruct simulation courses for Maintenance of Certification in Anesthesiology (MOCA); such courses are required by the American Board of Anesthesiology.  The over-arching theme is increased patient safety with the goal of enhanced/improved resident education.  To that end, I also participate in anesthesiology Resident Recruitment for Northwestern, as well as our department's Clinical Competence Committee.
1068004	Dynamics of lateral Border recycling compartment during leukocyte transmigration
1068072	Dr. Vaughan directs a multidisciplinary research group focused on investigating the role of the plasminogen activator system in cardiovascular disease. Active experimental programs are underway at the molecular and cellular level in animals and in humans. Transgenic and knockout mice are used in a variety of studies designed to explore the tissue-specific expression of PAI-1 in vivo and the role of the fibrinolytic system in vascular disease and tissue remodeling. 
1068072	My primary clincial interest is in adult cardiovascular disease.  My practice has focused on the management and treatment of patients with coronary artery disease.  I am also interested in the diagnosis and management of arterial thrombosis.  My research interests align with these clinical interests.  My primary investigative focus is and has been on the mammalian plasminogen activator system and the role this system plays in cardiovascular disease.  We apply a multidisciplinary approach in this effort, and utilize molecular and cellular approaches, as well as animal and human studies.
1068073	Barrett's Esophagus; Biliary Tract Disease; ERCP; Endoscopic Mucosal Resection; Endoscopic Surgery; Endoscopic Ultrasound; Gastrointestinal Cancer; Pancreatitis; Radiofrequency Ablation
1068073	Dr. Komanduri is an Interventional Gastroenterologist. His interests include pancreaticobiliary disease, Barrett's esophagus, and gastrointestinal oncology. His expertise includes: Endoscopic Retrograde Cholangiopancreatography, ERCP, Endoscopic Ultrasound (EUS), Endoscopic Mucosal Resection (EMR), and Radio Frequency Ablation for Barrett's Esophagus (RFA). Dr. Komanduri serves as an integral part of the comprehensive GI cancer team.
1068089	Dr. Keswani is an interventional gastroenterologist who focuses on minimally invasive procedures. Clinical interests include the use of endoscopic ultrasound in tumor diagnosis and staging, palliation of gastrointestinal malignancy, pancreaticobiliary endoscopy (ERCP), endoscopic mucosal resection for early gastrointestinal malignancy, and small bowel endoscopy including single balloon enteroscopy. Research interests focus on clinical outcomes of interventional endoscopic procedures including EUS, ERCP, and stent placement.
1068120	While I practice general Gastroenterology, my primary clinical and research interests focus on gastrointestinal pelvic floor disorders (e.g. constipation/fecal incontinence)and irritable bowel syndrome. I also specialize in treating gastrointestinal disorders associated with Scleroderma.
1068128	Clinical interests include treatment and diagnosis of food allergy, childhood wheezing and asthma, eczema and drug allergies. Current research interests include involvement in food allergy and asthma clinical trials. Prior research focused on the epidemiology of early childhood wheezing.
1068131	Dr. Smith's primary research interests are the neurobiology and treatment of social cognitive deficits in schizophrenia and other psychiatric disorders.
1068135	Gamma Knife Radiosurgery, Intensity Modulated Radiation Therapy, High Dose Rate Brachytherapy 
1068180	Surgical Oncology. Liver/hepatic surgery. Pancreatic surgery. Biliary surgery. Pancreatic cancer, liver cancer, gastric cancer, gastrointestinal cancer.
1068246	My clinical and laboratory-based research centers on why white blood cells fail to proliferate or differentiate normally. When these fundamental processes go awry, there is either bone marrow failure or leukemia. I have established a multi-disciplinary clinic at Children's Memorial Hospital for Bone Marrow Failure and Myelodysplastic Syndromes. In my lab, we are studying the roles of protein tyrosine kinases and PI 3-kinase in acute myeloid leukemia, myelodysplasia, and granulopoiesis. In particular, we are investigating the signal transduction biochemistry of the granulocyte colony-stimulating factor receptor. While studying Src kinases, we discovered a cytoskeletal protein, Cdc42 Interacting Protein 4 (CIP4). We made the CIP4 knockout mouse and discovered that the mouse strain displays thrombocytopenia. We have made other unique knockout mouse strains to study the role of CIP4 in normal physiology and disease.  Understanding the roles and components of kinases will translate to improve drug therapies for a variety of human cancers.  Cancer biology and therapeutics is complex, thus I have been developing a program in systems biology so to reveal new insights.  Bone Marrow Failure syndromes, acquired or inherited;  Neutrophil Defects;  Myeloid leukemias (acute or chronic);  Myelodysplastic Syndromes;  Myeloproliferative Syndromes;  Juvenile Myelomonocytic Leukemia (JMML); Ataxia Telangiectasia;  Neutropenia;  Thrombocytopenia; Systems Biology Molecular Targeted Therapy
1068247	I have a wide range of clinical interests including ADHD, mood, and anxiety disorders in children and adolescents.  In addition, I am particularly interested in psychiatric education and training. 
1068287	<B>CLINICAL:</B>  Dr. Mandelin provides general rheumatology care, and has an interest in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. His practice philosophy is: <I>'Patients do better if they can participate in their own care, and to do that they need to be given an understanding of their disease.'</I>  <P> <B>RESEARCH:</B>  Dr. Mandelin conducts basic science research into the disease mechanisms of rheumatoid arthritis, and he participates in clinical trials of new and existing medications for the treatment of rheumatoid arthritis and ankylosing spondylitis. <P> Dr. Mandelin also serves as the editor of Division's website and as the liason for our electronic medical records system.
1068287	My 'bench' research interests include the control of apoptosis in rheumatoid arthritis (RA) fibroblasts via a the mitochondrial pathway. My clinical research interests are in the field of medical informatics / electronic medical records / data mining.
1068431	I am a clinical instructor within the Division of Hospital Medicine. I work primarily on the heme-onc floors as an oncology hospitalist. I serve as the Director of Hospital Medicine for Oncology Services. Additionally, my clinical and non-clinical interests include women's health, global health, physician work force issues, and health and provider disparities.
1068433	My clinical practice is focused on inpatient care of oncology patients and attending on our palliative care services.  I'm working with my colleagues in palliative care to develop improved techniques for teaching medical students and residents how to effectively use opioids for pain control.
1068435	My primary clinical interests include sleep disorders in children and adults, insomnia in children and adolescents, and patients with control of breathing deficits.
1068449	I specialize in neuropsychiatry, the mental and behavioral disorders due to brain diseases such as epilepsy, movement disorders, dementias, or autoimmune diseases. 
1068455	Dongs lab research interesting focuses on the mechanisms of neurodegeneraton and related disorders. Two on going NIH funded projects are: using a combination of human and mouse genetics to identify novel genes and pathways that give rise to schizophrenia; also using a transgenic mouse model of Alzheimers disease to investigate the relationship and mechanisms between stress and Alzheimers pathogenesis.
1068527	Neurovascular diseases; neurointerventional surgery; development of new devices 
1068541	Interested in clinical research on polycystic kidney disease.
1068542	Dr. Uchida is experienced at caring for patients with complex medical illnesses. She practices evidence-based medicine which includes treating each patient as a unique individual. She also focuses on health promotion and the care of the whole person.
1068542	Toshi Uchida is a clinician-educator in the Division of General Internal Medicine.  Her clinical work in primary care focuses on promoting wellness and outpatient care of patients with complex medical illness.  Her educational work includes clinical skills education, assessment and dissemination.  She is a member of the Research and Education for Academic Achievement (REACH) Team which is developing a practice-based research network through the Northwestern University Clinical and Translational Science (NU-CATS) Institute.
1068543	Hematopathology
1068545	My primary focus is in maternal/child health including high risk obstetrics. My background in public health provides me opportunity to use my statistical knowledge in data analysis and review. I have published and presented papers relating to women's health, pediatrics and obstestrics. 
1068571	<BR><BR> Surgical Pathology
1068572	Clinically, I am interested in early detection and early treatment of emerging psychotic disorders to protect cognition and prevent disability.  My primary research interest interest is in biological markers of neuropsychiatric conditions, especially anatomical and neurocognitive endophenotypes of severe mental illnesses such as schizophrenia. Recent projects have used structural magnetic resonance imaging to correlate cognitive performance and symptoms with anatomical changes. Ongoing projects include longitudinal studies of subjects at risk for developing schizophrenia and clinical research into strategies for enhancing cognition in schizophrenia.
1068577	Our lab's research is focused on the development of multidimensional and multimodal neuroimaging biomarkers using the tools of computational anatomy. Working with collaborators from engineering, mathematics, psychology and clinical specialties, we focus on the following major areas:<br /> Mapping of Brain Structures using MRI: We develop automated pipelines to delineate brain structures based on simultaneous mappings of multiple structures from multiple atlases. This includes deep brain structures (such as the hippocampus, amygdala, thalamus, and basal ganglia) and cortical structures. <br /> <br /> <b>Complex Neuroimaging Biomarkers:</b> We develop modeling and statistical approaches for the analysis of these maps. We develop frameworks for joint, integrated analyses of multidimensional, multimodal information based on the structural mapping of the brain. These include:<br />  ' Multimodal MRI analysis: structural MRI, functional MRI, diffusion MRI, perfusion MRI, PET <br />  ' Network analysis<br />  ' Structure-function relationship<br />  ' Subtyping and dimensional analysis<br />  ' Prediction and longitudinal analysis<br /> <br /> <b>Clinical Applications:</b> We are interested in developing neuroimaging markers to characterize neuropsychiatric disorders, disease progression and prediction, and monitoring of treatment:<br />  ' Mild cognitive impairment (MCI), dementia<br />  ' Breast cancer-related MCI<br />  ' Psychosis/Schizophrenia/Mood Disorders<br />  ' Imaging Genetics<br /> <br /> <b>Neuroinformatics:</b><br />  ' Data sharing<br />  ' Data mediation<br /> <br /> <b>Preclinical Applications:</b> Neuroimaging of Animal Models<br />  ' Schizophrenia, Dementia, Mood Disorders, Memory<br />  ' Mouse, rat, rabbit<br />
1068651	In efforts to understand how to prevent sexual transmission of HIV-1, our lab is studying how mucosal transmission occurs in both the male and female genital tracts. Using ex vivo tissue explant cultures, we are able to identify viral particles that have breached the protective layers of the squamous epithelium to reach potential underlying target cells. 
1068651	Sexual Transmission of HIV (female-to-male and male-to-female).
1068678	My research interests are in utilizing various neuroimaging techniques to study relationships between cognitive functioning and brain structure in schizophrenia populations. I also investigate cortical changes in primary progressive aphasia, a language-based dementia. As a clinical neuropsychologist, I evaluate the cognitive functioning of various brain injuries and illnesses, including adult ADHD, autoimmune disorders, hepatic encephalopathy, traumatic brain injury, epilepsy, tumors, as well as the influence of psychiatric illness on cognition.
1068691	Dr. Sarah Kinsingers background and training is in health psychology and she has experience providing cognitive-behavioral therapy (CBT) interventions to a variety of medical populations, including cancer, obesity, acute rehabilitation, and gastroenterology.  Her research interests include the influence of partner support on adjustment to illness, sexual functioning following cancer treatment, and coping with chronic illness.  Dr. Kinsinger is also experienced in using CBT to treat depression and is approved by the Beck Institute of Cognitive Therapy and Research to provide CBT.
1068720	The overarching goal of our research is to improve upon current methods of bone healing.  In particular, we hope to develop more efficient and cost-effective methods of spine fusion that are associated with fewer adverse effects.  We utilize several different approaches to accomplish these goals. One research arm involves the use of mesenchymal stem cells isolated from human adipose tissue to elicit spine fusion in a point-of-care protocol.  In this research, we isolate mesenchymal stem cells from human liposuction aspirates and evaluate their capacityin conjunction with both standard and novel, nanotechnology-based carriersto elicit bone formation.  A second arm of our research utilizes a novel nanotechnology developed by our collaborator, Dr. Samuel Stupp, Director of the NU Institute for Bionanotechnology in Medicine (IBNAM).  Here, we employ a self-assembling, biodegradable nanogel composed of cylindrical nanofibers which contain an epitope directed at bone morphogenic protein-2 (BMP-2) in an attempt to facilitate spine fusion in our rat posterolateral spinal arthrodesis model.   Our research also focuses more broadly on mechanisms of bone healing.  In these studies, we investigate the molecular pathways by which normal bone healing occurs, as well as mechanisms by which these processes are disrupted, such as under osteoporotic conditions and after exposure to smoke and other environmental contaminants. Our goals are to elucidate these mechanisms of bone healing inhibition and develop novel methods to prevent such effects.
1068930	Cilia Polarity. The ability of ciliated epithelia to generate directed fluid flow is an important aspect of diverse developmental and physiological processes including proper respiratory function.  To achieve directed flow, ciliated cells must generate 100-200 cilia that are polarized along a common axis both within and between cells.  My lab is currently working towards understanding the molecular mechanisms for how cell polarity is coordinated as well as how individual cilia interpret the cells polarity.   Centriole Duplication. Centrioles are microtubule based structures with nine fold symmetry that are involved in both centrosome organization and aster formation during cell division.  During the normal cell cycle centrioles duplicate once, generating a mother / daughter pair, and in most post-mitotic vertebrate cells the mother centriole then goes on to form the basal body of a sensory cilium.  Abnormalities in the duplication of centrioles (and centrosomes) are prevalent in many cancers suggesting a link between centriole duplication and cancer progression.  My laboratory is addressing this fundamental question in cell biology from a novel direction with the use of Xenopus motile ciliated cells.  Ciliated cells are unique among vertebrate cells in that they naturally generate hundreds of centrioles therefore providing a great system for studying the regulation of centriole duplication.  Understanding how nature has overcome the typically tight regulation of centriole duplication will lend insight into the molecular mechanisms of cancer progression.
1068940	My research is focused on the evaluation of health information technology-enabled methods to assess and address disparities in the quality of chronic disease and preventive care.
1068950	Global Health/International Health, Tropical Medicine, Bacterial Infections, Parasitic Infections, Viral Infections, Diabetic Foot Infections, Osteomyelitis, Sexually Transmitted Diseases,  Tuberculosis, Travel Medicine
1068957	General neurology disorders, multiple sclerosis, transverse myelitis and other demyelinating diseases
1068982	Oral and Maxillofacial Surgery including orthognathic surgery, microneurosurgical reconstruction of trigeminal nerve injuries, temporomandibular joint surgery, distraction osteogenesis, alveolar cleft repair, neonatal distraction osteogenesis for airway management (e.g. Pierre-Robin sequence), endoscopic-assisted maxillofacial surgery, maxillofacial trauma, dental implants and reconstruction of alveolar ridge defects and sinus augmentation, and extraction of wisdom teeth.
1068983	To investigate the role of soluble epoxide hydrolase in the development of type 2 diabetes. To investigate the interaction between the plasminogen activation system and the arachidonic acid pathway in the context of fibrinolysis/thrombosis and this in normal and obese subjects.
1068995	I am primarily interested in treating benign and malignant diseases of the colon and rectum.  I have a particular interest in pelvic floor disorders and surgery for these problems.  I utilize laparoscopic and advanced endoscopic techniques in the treatment of the entire spectrum of colon and rectal problems, including cancer.   
1069004	My clinical interests are in the physical therapy management of adults with neurological conditions (particularly stroke, MS, and Parkinson's) and elders with imbalance and falls.  My research interests are in identification and treatment of imbalance and falls in elders and individuals with neurological conditions, and outcome measurement in neurological physical therapist practice.
1069041	My clinical interests include pregnancy care, routine gynecologic care, contraceptive management and the evaluation/management of abnormal Pap smears. I am actively involved in medical student education as the third year medical student clerkship director for Obstetrics and Gynecology. Additionally, I am one of two staff gynecologists for the HIV clinic.
1069043	My research is to understand molecular mechanisms that govern the biological functions of the intracellular signaling network in both physiological and pathological events.  We focus on regulation of JNK, which is member of the mitogen-activated protein kinase (MAPK) superfamily.  JNK is activated by a MAP kinase module through sequential protein phosphorylation in response to a variety of extracellular stimuli, including proto-oncogens, growth factors, inflammatory cytokines, and physical stresses.  Once activated, JNK phosphorylates its cytoplasmic target proteins such as members of the Bcl-2 family proteins, Itch, tau, IRS-1, or its nuclear target proteins such as the transcription factors c-Jun, ATF2, Elk-1, Stat3 and p53, thereby controlling proliferation, differentiation, programmed death and transformation.  Not surprisingly, JNK is involved in the process of many human diseases including lung diseases and lung cancer.   Through its involvement in regulation of airway smooth muscle cell proliferation, cell death, myofibroblasts proliferation, cytokine synthesis and transformation, JNK is likely to play a critical role in asthma, ischemia/reperfusion damage, pulmonary fibrosis, allergic inflammation in lung and NSCLC.  However, the challenge is how to selectively modulate JNK activity in vivo.  We have evidence that JNK functions as a protein complex, i.e., the JNK signalsome that is composed of both known JNK activators and novel stimulus-dependent modulators or regulators (SMOR).  SMORs are selectively recruited to or dissociated from the JNK signalsome in a stimulus-dependent manner, thereby specifying the activation of JNK by various extracellular stimuli.  It is possible that one can target a unique SMOR to selectively regulate JNK activation by a specific stimulus without affecting JNK activation by other stimuli or affecting activation of other singling pathways by that stimulus.  Our study on the JNK signalsome should shed light on our understanding of the molecular mechanism of pulmonary diseases including lung cancer and provide potential therapeutic targets.
1069054	I am investigating the impact of perioperative lidocaine infusion on the incidence of post-mastectomy pain syndrome.
1069067	Current research projects involve developing a clinical decision tool to differentiate abusive fractures from accidental fractures in infants and studying the natural history of scalp swelling following accidental head trauma.
1069068	Retinoblastoma, the most common pediatric cancer of the eye, is a devastating and sometimes fatal pediatric cancer. Within the United States, the majority of retinoblastoma patients are diagnosed before their 2nd birthday, and many lose their sight due to this disease. Outside of the United States, advanced retinoblastoma is an even greater clinical challenge in developing countries, where the mortality rate among children diagnosed with advanced metastatic retinoblastoma is as high as 80%.     Our laboratory mission is to understand the molecular mechanisms associated with retinoblastoma progression in order to facilitate the identification of novel therapeutic targets.  We are accomplishing our mission by studying both genetic and epigenetic changes that occur during retinoblastoma progression in human retinoblastoma tumors, and in retinoblastoma model systems.  Defining these changes is particularly valuable for the purposes of identifying novel targets for chemotherapeutic interventions.
1069069	Pediatric Orthopaedic Surgery 
1069071	Clinical and research interests include sports concussion management, treatment of congenital clubfoot deformity, preparticipation evaluation for sports.
1069073	Dr. Gordon is Research Associate Professor in the Institute for Healthcare Studies and Department of Surgery, Division of Organ Transplantation at the Feinberg School of Medicine at NorthwesternUniversity. Dr. Gordon completed her doctorate in Medical Anthropology at Case Western ReserveUniversity. Thereafter, she completed a Fellowship in Clinical Medical Ethics at the University of Chicago. Dr. Gordon obtained her Masters in Public Health from University of Illinois, Chicago, specializing in Community Health Sciences. Dr. Gordons research interests include: ethics of organ transplantation and donation, determinants of disparities in access to health care and health outcomes, health literacy, human subjects research ethics, self-care & chronic illness management, and qualitative research & mixed methods. Dr. Gordon received a Career Development Award from the NIDDK to examine self-care and outcomes among kidney transplant recipients. Dr. Gordon currently serves on the Ethics Committee of UNOS and has been actively involved in the American Society for Bioethics and Humanities. 
1069089	My clinical interests lie within the field of neuroradiology, including head and neck radiology, pediatric neuroradiology, functional MRI, MR spectroscopy and perfusion imaging.
1069105	Interventional Radiology
1069212	Stem cell dysfunction likely plays a central role in the pathogenesis of certain human diseases, particularly aging and cancer.  The use of simple eukaryotic model organisms in aging research has led to the identification and characterization of many genetic and environmental factors that modulate longevity.  The classic invertebrate model organisms, such as nematodes and fruit flies , however, are not ideal models for investigating the role of stem cells in human disease because of the relative absence of adult stem cells in these species.   My research program combines interests from my graduate research (stem cell biology) and postdoctoral work (basic biology of aging) using the freshwater planarian, Schmidtea mediterranea, as a model system. Our goal is to establish S. mediterranea as a model for the study of aging and age-related disease, with emphasis on the role of stem cells in longevity. S. mediterranea represents an excellent model for investigating mechanisms of longevity because of their apparent immortality and remarkable capacity to repair and regenerate tissues .  Regeneration in planarians is due to the presence of neoblasts, a pluripotent stem cell population in the adult.   To investigate the relationship between stem cells and longevity, we are using known longevity determinants to characterize age-related phenotypes in planaria, paying particular attention to regeneration and tissue homeostasis. We are also investigating telomere homeostasis and it's role in stem cell function in planaria.  Together, these efforts will establish S. mediterranea as a powerful model for the study of aging and age-related disease, and bring new understanding into the role of stem cells in longevity.
1069358	My main clinical interests/responsibilities are in perinatal pathology which includes placental pathology and perinatal autopsy pathology. My research interests are in correlating placental pathology with neonatal outcomes and investigating the causes of stillbirth.
1069409	Calvin R. Brown Jr., M.D. is Professor of Medicine in the Division  of Rheumatology of The Feinberg School of Medicine of Northwestern University.  He also serves as director of the rheumatology training program there. Dr. Brown is a member of a number of professional organizations, including the American College of Rheumatology, the American College of Physicians, and is past president of the Chicago Rheumatisim Society.  His research has been published in such journals as Arthritis and Rheumatisim and The Journal of Rheumatology.  He is author of several textbook chapters dealing with arthritis and allied conditions. His areas of focus include education in the rheumatic diseases, sports medicine, and disability evaluation. Dr. Brown received his medical degree from Wayne State University.  He completed his internship and residency at Northwestern Memorial Hospital.  He also completed fellowships in rheumatology at the University of Michigan and in sports medicine at Rush University Medical Center. 
1069409	Calvin R. Brown Jr., M.D. is Professor of Medicine in the Division  of Rheumatology of The Feinberg School of Medicine of Northwestern University.  He also serves as director of the rheumatology training program there. Dr. Brown is a member of a number of professional organizations, including the American College of Rheumatology, the American College of Physicians, and is past president of the Chicago Rheumatisim Society.  His research has been published in such journals as Arthritis and Rheumatisim and The Journal of Rheumatology.  He is author of several textbook chapters dealing with arthritis and allied conditions. His areas of focus include education in the rheumatic diseases, sports medicine, and disability evaluation. Dr. Brown received his medical degree from Wayne State University.  He completed his internship and residency at Northwestern Memorial Hospital.  He also completed fellowships in rheumatology at the University of Michigan and in orthopaedics at Rush University Medical Center.
1069420	I am interested in understanding the cellular and molecular mechanisms for cell-type specific degeneration in neurodegenerative diseases. I am mainly focused on corticospinal motor neurons that degenerate in ALS, and HSP. 
1069448	My primary clinical and educational efforts have been devoted to promoting the subspecialty of Pediatric Emergency Medicine in the Community Hospital setting through the development of partnerships between community hospitals and academic Pediatric centers.
1069481	My laboratory studies the regulation of spinal motor neuron and ventral midbrain dopaminergic neuron differentiation in development and disease. We want to understand what genetic and epigenetic mechanisms are utilized to regulate motor neuron and dopaminergic neuron differentiation and why these specific type of neurons degenerate in spinal muscular atrophy (SMA) and Parkinson's disease. To address these questions, we use a combination of biochemical, genetic and cell biological approaches, and utilize induced pluripotent stem (iPS) cells reprogrammed from fibroblasts, genetically modified mice, and zebrafish as model systems. Based on our findings, we hope to develop new therapeutic strategies for treating SMA and Parkinson's disease.
1069524	Palliative Care is a subspecialty that focuses on the relief or prevention of suffering -- physical, psychological, or spiritual -- in patients or families facing a life-threatening illness.  My interests lie in advanced symptom management and the role palliative care can play in an intergrated healthcare system.
1069530	Dr. Thompson has strong interests in the areas of quality improvement, patient satisfaction, medical documentation/coding, and telephone triage.  He has served as both chair and/or member of hospital-based and national quality assurance committees. He has developed databases and educational tools to promote benchmarking and quality improvement for emergency departments and medical call centers. Working in collaboration with nationally-known pediatrician Dr. Barton Schmitt, Dr. Thompson has authored a comprehensive set of telephone triage protocols for use in medical call centers and physician offices.
1069629	I am primarily interested in family and community medicine, with an interest in community assessment and clinical program development.  I have also done research in the area of physician stress and burnout. 
1069689	My current research involves a variety of statistical issues arising in non-randomized observational studies, with particular emphasis on the causal inference of the effects of naturalistic lifestyles such as diet behaviors and physical activities on various cardiovascular diseases outcomes. One area of interest in statistical methods is combining parsimonious classification model of naturalistic behaviors and the lifetime outcome model of cardiovascular diseases. I am also interested in developing a methodological framework to infer causal links between gene expression, lifestyle behaviors and incidence of cardiovascular disease.
1069709	My primary research presently focuses on the examination of safety vulnerabilities in kidney and liver transplantation. I have received a Dixon Innovation Award to study safety in kidney transplantation and am R01 funded to examine safety in living donor liver transplantation.  Furthermore, I study geographic inequity in kidney organ allocation in close collaboration with NU Industrial Engineers.  I serve as the Director of the Northwestern University Transplant Outcomes Research Collaborative (NUTORC) which reaches across campus to bring together disparate expertise in order to address pertinent questions in transplantation.
1069730	My main interest is in spatial perception and control of movements in both healthy individuals and in stroke and traumatic brain injury survivors. Specially, Im interested in perception and action in spatial neglect following stroke. Im also interested in using virtual reality and robotics technologies for treatment and rehabilitation of individuals with cognitive and physical disabilities following brain injuries.
1069775	Dr. Siddiques methodological research interests are in the area of incomplete and latent data. His recent work has focused on multiple imputation for missing data and latent variable modeling in comparative effectiveness research. His collaborative work is in the areas of behavioral medicine and health services research.
1069836	My primary area of clinical interest is pediatric cardiac anesthesia and pediatric fellow education. My main area of research interest revolve around safety in pediatric cardiac anesthesia
1069882	Most of the research that I have been involved with through Northwestern University has been in the arena of lower limb prosthetics; utilizing motion analysis to determine differences in component usage.  Currently I am working with the Nueral Engineering Center for Artificial Limbs at the Rehabilitation Institute of Chicago in the 'Revolutionizing Prosthetics' project which has been primarily focussed on creating new upper extremity prosthetics components and controls.  Similarly, we are also investigating the capabilities of controlling lower limb prostheses with the use of residual limb EMG. 
1069886	One of the focuses of my laboratory is to elucidate inflammatory signals induced in mucosal innate and T cells by bacterial products (e.g., peptidoglycan, lipoteichoic acid, surface layer proteins) leading to intestinal colitis. Using gene targeting in probiotic bacteria we clearly show the mitigation of colitis progression. Additionally, to mobilize mucosal and systemic immunity against microbial challenge we further optimize various aspects of our mucosal multivalent-vaccine platform against a broad range of pathogens such as HIV, H1-N1, and Biodefense. This goal is achieved by directly targeting immunogens to small peptides derived from a phage display peptide library leading to efficiently capture by dendritic cells when expressed by probiotic bacteria at the mucosal side.
1070050	Dr. Rowell is a pediatric surgeon with expertise in minimally invasive surgery; congenital anomalies; anorectal malformations; prenatal counseling for fetal anomalies; hernias and undescended testes; tumors of the chest, abdomen and pelvis; thyroid disease; and ovarian and breast disease
1070120	My major research interest has been to identify the pathophysiology of clinical features of severe psychiatric illness. I have focused most of my career on linking the water imbalance that is found in about 25% of schizophrenic patients to structural and functional deficits in the central nervous system. Our current efforts are focused on establishing whether  neuroendocrine deficits, particularly oxytocin, are responsible for increased vulnerability to psychological stress and impaired emotion recognition and social functioning in this patient population, and may be reversible with neuropeptide therapy.
1070355	Our research program is aimed at understanding the genetic program that underlies the pathogenesis of Glioblastoma multiforme (GBM), the most prevalent and malignant form of brain cancer. Applying a combination of cell/molecular biology, oncogenomic and mouse engineering approaches, we are dedicated to systematically characterize novel gliomagenic oncogenes and tumor suppressors. We will functionally delineate and validate these pathways towards pharmaceutical opportunities using sophisticated cell culture and animal models.
1070358	(1) Research how to better apply the EEG in the diagnosis and treatment of children with epilepsy. (2) Learn and develop better ways to provide comprehensive, compassionate, and technically superior care for children with epilepsy.
1070381	I currently specialize in genetic counseling regarding Neurofibromatosis and Jewish genetic disorders, including hereditary cancers.
1070382	Dr. Lee's research interests include statistical methods in epidemiology, longitudinal data analysis, and multilevel analysis. Her recent work on partial population attributable fraction has focused on estimating variance and computing confidence intervals to make inference on competing risk factors. She is currently interested in methodological issues relevant to the development and evaluation of risk prediction models for various study designs and data for model building, including cohort, nested case-control, case-control data combined with registry data, and kin-cohort data.
1070472	Transcranial Magnetic Stimulation, Electroconvulsive Therapy, Cancer Psychiatry, Psychosomatic Medicine.
1070473	Breast imaging and interventional procedures Breast disease 
1070490	Dr. Hargroves research interests include signal processing, pattern recognition and myoelectric control of powered prostheses.  Dr. Hargrove focuses on research and development of clinically realizable myoelectric control systems in hopes that the systems can be made available to amputees in the near-term.
1070492	Dr. Saroli's clinical interests include echocardiography in congenital heart disease, both by transthoracic and transesophageal echocardiography. She is the Associate Director of the Echocardiography Laboratory at Children's Memorial Hospital. She has additional training in Fetal Cardiology and performs and interprets fetal echocardiograms. In addition to her imaging committment, she runs a weekly general outpatient pediatric cardiology clinic, and provides attending service coverage in the pediatric Cardiac Intensive Care Unit. She is particularly interested in patients with single ventricle physiology and attends in the Transitional Clinic that allows transition of complex cardiac patients from the ICU to care by their own cardiologist. Her research interests currently include projects investigating the association between biochemical markers and post-Fontan cardiac index, as well as quality of life assessment in the pediatric cardiac population. She is also interested in research involving fetal cardiology patients and is involved in maintaining the fetal cardiac patient database.
1070520	' Auditory and vestibular neural prostheses and therapeutics ' Auditory processing in the inferior colliculus and its significance in multisensory perception ' Optical stimulation of neurons and cardiomyocytes ' Biomechanical and biophysical underpinnings of vestibular disorders
1070746	Primary clinical interests include cardiac intensive care, single ventricle physiology, and neurodevelopment in children with severe congenital heart disease.
1070859	My primary clinical interest is grounded in primary care sports medicine.  My clinical interests include caring for endurance athletes, athletes who suffer from concussions, and athletes affected by the female athlete triad.  I also actively practice osteopathic manipulative techniques to aid in the recovery and rehabilitation of musculoskeletal injuries and dysfunction. 
1070862	In Dr. Bohns laboratory, I  lead the research project focused on potential therapeutic effects of bone marrow-derived neuroprogenitor-like cells in a rat model of Parkinsons disease (PD). In our experiments we use human and rat mesenchymal stem cells (MSC) genetically modified with the intracellular domain of the Notch1 (NICD) gene, a modification that up-regulates expression of certain neuroprogenitor phenotypic markers. We are studying the neuroprotective potential of these bone marrow-derived neuroprogenitor-like cells (MSC-NICD) in a rat model of PD. In addition, we are exploring the potential of MSC-NICD cells to deliver glial cell line-derived neurotrophic factor (GDNF), a well known dopaminergic neurons trophic factor, to the lesioned rat striatum.
1071074	Dr. Kumes research interests focus on cardiovascular development, cardiovascular stem/progenitor cells, and angiogenesis.  Current studies include the role of Foxc transcription factors in cardiovascular development and disease.
1071116	My primary research interests are in the fields of emergency medicine and health services research with a goal of improving healthcare quality and patient safety.  I have a background in operations research as well as health services research and have completed a Masters in Business Administration and a formal health services research fellowship.  My work uses innovative methodologies, such as in situ simulation and failure mode effects analysis, to assess and improve care delivery.  I also have experience with large database analysis.   I am particularly interested in improving the delivery of severe sepsis and septic shock resuscitation in the emergency department.
1071132	My primary area of research is in women's reproductive and sexual health, from 1900 to the present. I am also a thesis advisor for Medical Humanities and Human Sexuality research for the Area of Scholarly Concentration at FSM.
1071143	I am interested in medical education and quality improvement as it relates to the inpatient management of pediatric patients. I am interested in the quality improvement of inpatient asthma management.
1071151	My research interests lie in elucidating the pathophysiological and clinical consequences of lung dysfunction in patients with diabetes.
1071327	Dr. Salsman is a Principal Investigator on an ACS-Illinois Division grant titled No Worries? Adaptation and Health Behaviors among Young Adult Survivors. This project explores the positive effects and special needs of young adult cancer survivors during the transition from active treatment to survivorship. He is also a Co-Investigator on an NIH-funded contract titled The Toolbox of the Assessment of Neurological and Behavioral Function.' The goal of the Toolbox is to assemble a brief battery of measures for the assessment of cognitive, emotional, sensory, and motor health and function across the lifespan (ages 3-85) for use in longitudinal studies and clinical trials. Dr. Salsman  is the emotional health domain manager for Toolbox, liaising with senior project personnel and facilitating the instrument and item selection process for the emotional health subdomains of negative affect, positive affect, stress & self-efficacy, and social relationships. Dr. Salsman also serves as a Co-Investigator on an NIH-funded project developing a Patient Reported Outcomes Measurement Information System (PROMIS), providing input on existing item banks for cancer patients and reviewing negative and positive Illness Impact items. Other areas of research interest include positive-psychological functioning, religious and spiritual well-being, and patient-physician communication.
1071375	The focus of research is the role of plasmin activator inhibitor-1 (PAI-1) in the pathogenesis of airway remodeling in asthma. In this aspect, I am clinically interested in steroid-resistant asthma, asthmatic smokers and asthmatic patients with obesity. As a board certified otolaryngologist (Korean Board) and allergist (American Board), my another clinical interest is in chronic rhinosinusitis (CRS), especially the pathogenesis of CRS in elderly population.
1071421	Methodologic research interests include issues related to data misclassifiction or mismeasurement especially in regards to anthropometric measures, and changes in those measures over time.  Current research also includes research in Gastroenterology, Dermatology, and Congestive Heart Failure.
1071429	Non-invasive evaluation of heart transplant rejection.
1071433	My primary research interest focuses on elucidating mechanisms by which genetic variations in the zinc transporter gene ZnT8 influences beta cell function.
1071451	Dr. Allen specializes in cardiovascular epidemiology with a focus on health services research.  Her research interests include the effect of neighborhood and environment on cardiovascular disease, disparities in quality of care and outcomes as well as the use of large databases to examine these questions.
1071472	My research focuses on understanding the principles governing neuromechanical control of human locomotion and applying this knowledge to promote walking recovery following neurological injury. I employ an interdisciplinary experimental approach using robotic tools to examine whole-body human movement from a biomechanics and motor control perspective. I also do research on bone health following spinal cord injury with an emphasis on the role of mechanical loading on the prevention and treatment of bone loss.
1071490	Dr. Maxwell has special interest in the management of prostate, kidney, and bladder cancers with an emphasis on robotic surgery.
1071500	Problem-based learning
1071516	I have a special clinical interest in juvenile dermatomyositis, but also enjoy seeing patients with all types of autoimmune conditions including systemic lupus erythematosus, juvenile idiopathic arthritis, vasculitis, scleroderma, and periodic fever syndromes.   My research interests in pediatric rheumatology reside in the field of medical education.  My goal is to improve medical student, resident, and fellow education about pediatric rheumatology.  I am presently undertaking a research project to define rheumatology educational goals and objectives for pediatric residents.  I am also surveying pediatric residency program directors about their current practices in rheumatology education and their perceived needs.  With this information and through funding through the American College of Rheumatology Research and Education Fund Clinician Scholar Educator Award, I plan to develop and collect educational materials that can be taught within existing lecture time and rotations.   The materials will be taught by non-rheumatologist physicians in programs where no pediatric rheumatologist is available for teaching, approximately 40% of all pediatric training programs.
1071527	Research interests: 1.The long term effects of critical illness on children including any impact on functional ability, quality of life and neurocognition. 2. The causes and effects of delirium on patients in the pediatric intensive care unit.
1071552	Heart rhythm disorders mechanisms and therapy, atrial fibrillation, cardiac autonomic nervous system, cardiac sarcoidosis, complex arrhythmia, radiofrequency ablation
1071571	My research thus far has focused on the following issues: 1) clinical trials of computerized, Internet, and mobile phone treatments for anxiety and depression; 2) the relationship of mental health with minority stress and related cognitions; 3) cognitive processes involved in anxiety disorders; and 4) co-occurring psychiatric disorders and outcomes for underserved populations in randomized controlled psychotherapy trials. I am particularly excited about the potential of mobile mental health interventions to provide real-time outreach and feedback to patients in their unique environments, and overcome barriers to traditional psychotherapy in hidden, underserved communities.
1071582	My broader research interest is in collaborative care.  I hope to better understand coordination among providers from various disciplines that converge on the care of a hospitalized patient.  Specifically, I am currently examining the role of internal medicine physicians in the care of medically complex surgical patients.
1071751	Sinusitis, chronic sinusitis, nasal polyps, nasal tumors, smell and taste disturbances, minimally invasive approaches to the skull base, inflammation, mechanisms of smell loss from inflammation, therapeutics and diagnostic approaches for sinus disease
1071785	The human immune system must be kept in a state of constant balance to remain healthy.  Elevated immune responses are needed to fight harmful pathogens, yet those responses have to be kept from overreacting and attacking the bodys normal tissues.  A complex mix of immune cells is known to influence this balance.  My research interest is to understand the crosstalk among different cell types, especially focusing on two types of immune cells, Th17 cells and Treg cells, in the maintenance of immune homeostasis.  Our laboratory is studying the molecular mechanisms by which different transcription factors influence the differentiation of Th17 and Treg cells, and examine the Th17-Treg balance in immunity and autoimmune diseases using a combination of molecular, cellular and mouse genetic approaches.
1071795	Inflammatory bowel disease, Crohn's disease and Ulcerative colitis Women's Health issues in Gastroenterology
1071803	Dr. Hemmer's primary clinical and research interests include neurosurgical anesthesiology, intraoperative neuromonitoring, and perioperative patient safety.
1071822	Dr. Matthew D. Saltzman is an Orthopaedic Surgeon at Northwestern Memorial Hospital and an Assistant Professor on faculty at Northwestern University Feinberg School of Medicine. He specializes in shoulder and elbow surgery. His clinical interests include biomechanical evaluation of rotator cuff repair techniques, reverse shoulder arthroplasty, and sports related injuries.
1071859	Parkinson's disease results from the degeneration and frank loss of dopamine-releasing neurons in the substantia nigra. Interestingly, a nearby population of dopamine-releasing neurons in the ventral tegmental area remains unaffected by this degenerative process.  Recent studies have suggested that this degenerative process, and the onset of Parkinson's disease, are preceded by a similar process that takes place in other brain regions, wherein only a particular class of neurons is affected while others are spared. I am interested in understanding whether there is a common mechanism underlying the selective nature of these neurodegenerative processes. A hypothesis put forward by Dr. D. James Surmeier points to a common property shared by the various neurons that degenerate. They are all perpetually active neurons whose output is necessary for basic physiological functions carried out by such systems as the cardiovascular system or the gastrointestinal tract. According to this hypothesis the ongoing activity of these cells comes at a metabolic cost leading to their premature 'aging' and death. In particular I am studying the machinery that enables neurons in the dorsal motor nucleus of the vagus, that innervate the heart and the GI tract, to maintain their perpetual activity, and how this may cause them to be particularly vulnerable to neurodegeneration.  My research combines neurophysiological techniques, live cell imaging, molecular biological tools and computational modeling. Additional interests: 1. the cellular basis for the role played by cholinergic interneurons of the striatum, in health where their activity comprises a neural correlate of classical conditioning, and in the pathophysiology of Parkinson's disease where their release of acetylcholine is upregulated. 2. The biophysics underlying collective dynamics of perpetually active neurons. 3. Design and development of electrodes for functional electrostimulation. 4. Deep brain stimulation.
1071912	My clnical and research interests overlap in the areas of hereditary cancer genetics and preimplantation/prenatal genetic diagnosis.
1071921	Head and Neck and Skin Cancers, Genitourinary Malignancies (Prostate Cancer, Testicular Cancer, Bladder Cancer), Lung Cancer, Proton Therapy, SBRT
1071945	My major research interests are collaborative research with biomedical investigators in areas of clinical trials, microarray data analysis, imaging analysis, non-linear fitting, and genomics studies such as methylation. I am also interested in statistical methodology research. I have published methodology research papers in peer-reviewed journals, including JASA, BMC Bioinformatics, Journal of Biopharmaceutical Statistics, and Annals of Human Genetics. I am also a co-author of a wide range of collaborative papers published in peer reviewed journals. I served as the primary statistician for NIH funded grants, including R21, R34, R01, U19, UO1 and some foundation grants.
1072008	Dr. Roehrig is a clinical health psychologist with a specialization in obesity and disordered eating.  Her research aims to (1) examine behavioral risk factors associated with obesity (i.e., poor diet, inactivity, binge eating), (2) develop and test novel treatment approaches to produce sustained weight loss and health behavior change, and (3) understand the links between behavior and health outcomes.
1072048	My primary clinical interest is in the care of individuals infected with HIV and the complications of HIV infection, including oppurtunistic infections, cancers and metabolic disease.  I also specialize in the care of infections seen in recipients of solid organ and stem cell transplants and teh evaluation of persons prior to transplantation.  Other specific interests that I have are sexually transmitted infections and fungal infections.
1072101	I see patients in with General Pediatric Neurology concerns, including epilepsy, headaches, abnormal movements, muscle weakness, and neuropathies.
1072116	As a member of a work group, funded by the National Coalition for Health Professional Education in Genetics, Ms. Healy is an author of a web-based, interactive genetics curriculum for physician assistants. It is available at: http://pa.nchpeg.org/
1072154	My lab focuses on how genetic and epigenetic modulators promote the development and maintenance of adult stem cells. Microenvironments, or niches, support the maintenance of stem cells and facilitate the development of tumors through largely unknown mechanisms. Cell-autonomous genetic pathways and epigenetic networks have emerged as important determinants for the self-renewal and differentiation of stem cells in embryonic, juvenile, and adult issues. The importance of non-cell autonomous genetic and epigenetic factors is less well established. Our goal is to identify and characterize the genetic and epigenetic mechanisms utilized by both stem cells and their surrounding niche in supporting the stem cell program. For these studies, the developing mouse testis is used to examine interactions between male germline stem cells (GSCs) and their somatic niche.
1072174	Dr. Krichavsky is board certified in Interventional Cardiology, Endovascular Peripheral Interventions, Cardiovascular Disease, Nuclear Cardiology, and Internal Medicine.  His clinical interests include coronary, carotid, renal, upper extremity, and lower extremity angioplasty and stenting, vascular medicine, percutaneous valve therapy, closure of patent foramen ovale and atrial septal defects, percutaneous ventricular assist devices, catheter directed arterial and venous thrombolysis, and inferior vena cava filters.  In addition to performing procedures in the Cardiac Catheterization Laboratory, he serves as an attending physician on the Coronary Care Unit (CCU), In-patient Cardiology, and Cardiology Consultation services at Northwestern Memorial Hospital. His research interests include investigation of novel devices and therapies, including stem cell, and cell-based therapies for cardiac and vascular disease.
1072212	Neurological Clinical Specialist (NCS), primary interest in recovery of locomotion following spinal cord injury and stroke
1072275	Regional anesthesia, ultrasound guided procedures in anesthesia, acute postoperative pain, opioid free analgesia
1072546	My Clinical expertise and research primarily occurc in the Prosthetics-Orthotics field.  I am a Prosthetist and Orthotisr and I have spent the majority of my career in clinical practice. I have come to Northwestern to pursue a vairety of goals.
1072619	Dr. Siziopikou's subspecialty focus is on breast tumor markers and molecular diagnostics in breast cancer. Her research interests center around molecular markers of prognostic and predictive significance in breast cancer.
1072644	As the Medical Director of Cardiac Electrophysiology at Northwestern Memorial Hospital since November 2009, Dr. Knight remains clinically acitive with a broad range of clinical and research interests in the field of Heart Rhythm Disorders. These interests range from catheter ablation for complex arrhythmias, such as atrial fibrillation, to fundamental issues related to the basic mechanisms of various types of heart rhythm disorders, and the use of imaging in the electrophysiology laboratory to guide ablation procedures and device implantation. He is involved in several multicenter clinical trials that are evaluating novel ablation tools and implantable devices, including a totally subcutanous implantable defibrillator. He has coauthored over 200 scientific papers and is on the editorial board of several high-impact medical journals.
1072806	Emphysema (COPD), Esophageal Cancer, Minimally Invasive Thoracic Surgery, Thymoma, Lung Volume Reduction Surgery (LVRS), Chest Wall Tumors, Tracheal Surgery, Pleural Disease, Video-Assisted Thoracic Surgery, Mediastinal Tumors, Lung Cancer, Lung Transplantation
1072813	My primary interest is in the evaluation and treatment of children with intractable epilepsy. I have done research on the ketogenic diet. I am particularly interested in treating children with Tuberous Sclerosis.
1072872	Cardiac Assessment; Congestive Heart Failure; Echocardiography; Exercise Training/Sports Fitness; General Cardiology; Ischemic Heart Disease; Pre-Operative Evaluation; Prosthetic Valve Dysfunction; Trans-Esophageal Echocardiography; Valvular Heart Disease
1072922	I am interested in understanding the initiation of childhood atopic disorders, such as food allergies, eczema and asthma.  Early life events play an important role in the maturation of the immune system.  I am interested in understanding the role of environmental factors and exposures that play a role in the development of allergic disease.
1072968	The goal of my research is to understand the molecular basis by which animals and their natural microbiota form specific, reproducible interactions. Microbial symbioses are prevalent in animal biology, and often, as in the case of humans, the animal host is born devoid of its natural symbionts and must acquire microbial partners from the environment. Pathogenic and beneficial bacteria share common mechanisms by which they colonize animal tissue. In spite of these parallels, relatively little work has been accorded to the beneficial associations, which are widespread, and critical to the lifecycles of both the bacterial and animal partners. I am studying the natural association between Vibrio fischeri and the Hawaiian bobtail squid to understand the processes that underlie host colonization in animal-associated bacteria. The system is particularly amenable to studying microbe-host interactions because V. fischeri is the only bacterial resident of the squid's light organ, and we seek to understand how V. fischeri specifically colonizes the host to the exclusion of other species. Each generation, the squid hatch without their microbial partners and must selectively recruit V. fischeri from the ocean. We use a combination of bacterial genetics and imaging to identify how the animal and bacteria communicate to reproducibly establish this productive relationship.
1072982	Signaling of death receptors with emphasis on Fas. The role of microRNA in tumor progression.
1073000	Interested in providing quality Pediatric Emergency care, to teach trainees, and to improve overall emergency care for children by contributing to research in this field with special interests in injury prevention, and Emergency Medical Services for Children (EMSC).
1073040	Dr. Cohn is an expert in HIV medicine, infectious disease, and HIV clinical trails and health services outcomes research.  She has been an active participant in the NIH/NIAID AIDS Clinical Trials Group since 1988, and has held numerous leadership positions including Vice Chair and Chair of the Womens Health Committee and the Outcomes Committee, Vice-Chair of the Underrepresented Populations Committee 2008-2010 and is now the Chair of the Womens Health Internetwork Scientific Committee (WHISC). She is chair and co-chair of major protocols pertaining to women's health, self-management and outcomes, recruitment of women and minorities into clinical trials, and optimizing ART, and is an active team member on many other protocols. Her current research areas have included optimizing the health of HIV-infected women, improving adherence to antiretrovirals, and improving access to health care and clinical trials for underrepresented populations. Dr. Cohn has maintained an active HIV clinical practice, has been a teacher of HIV medicine to medical students, residents, fellows, nurses and other care professors for over 20 years. She has mentored nurses, nurse practitioners, physician assistants, residents, and other faculty both in and out of her institution, helping to advance their careers in both research and clinical medicine.
1073157	Clinical evaluation methodology and clinical treatment trials of disorders of the motor unit are my primary areas of interest.  These include disorders of peripheral nerve, neuromuscular junction and muscle.  Characterization of autonomic nervous system in children and adolescents is an integral part of this effort. Characterization of the neuroimmunology of the peripheral and central nervous system provides direct and indirect treatment opportunities for many of these disorders.
1073269	I am a family physician caring for the vulnerable incarcerated population at Cook County jail, with special interests in adolescent and young adult medicine, women's health, and reducing health disparities. After 20 years as residency faculty, I retain a strong interest in graduate medical education. My research interest at the moment centers on contraceptive knowledge, attitudes and practices of newly incarcerated urban women. I serve as faculty advisor to the FSM Correction Medicine Interest Group.
1073480	Physician Assistant Education.
1073494	Dr. Rasmussen-Torvik is a genetic epidemiologist interested in genetic risk factors for common chronic diseases.   She is involved in large-scale genetic studies  designed to detect novel genetic risk factors for chronic diseases.   Dr. Rasmussen-Torvik is also interested in translating the results of GWAS and sequencing studies into clinical care by identifying variants associated with treatment response. As part of this work, she is also interested in developing methods to communicate information about testing for common genetic risk factors to the public.
1074035	I am a board certified pathologist with subspeciality interest in pulmonary pathology, ophthalmic pathology and transplant pathology. I am a College of American Pathologists(CAP) spokesperson and actively involved in many national and international pathology organizations. I am also involved in medical education and teach at the local, national and international levels.
1074090	Rehabilitation Technologies and Quantitative Clinical Outcomes
1074103	Antimicrobilal pharmacokinetics and pharmacodynamics. Antiretroviral therapy.
1074152	It is estimated that 90 million adults have difficulty understanding their own medical care.  Despite numerous studies on the literacy levels of written medical documents, very little research has focused on the if spoken medical conversations occur at a level that the patient can understand.  Our current research focuses on increasing patients' comprehension of their own medical care by examining multiple aspects of health communication in the hectic Emergency Department environment.
1074170	Dr Perez's research interest is in the area of persistent pulmonary hypertension of the newborn (PPHN). Specifically, Dr Perez's research focuses on the impact of hydrocortisone, a glucocorticoid commonly used in the NICU, on phosphodiesterase type 5 (PDE5) and PPHN.
1074269	Pediatric Hospital Medicine - intensive care, observation unit, and sedation
1074283	As the Director of Global Health Education, Dr. Pitt oversees a Bi-Directional Exchange program with Bugando Medical Center in Tanzania. He developed a medical simulation curriculum which he trains third year residents to implement for medical students while in Tanzania, and also oversees the Medical Exchange Development curriculum for visiting residents from Tanzania.  Dr. Pitt's interests in medical education focus on non-traditional didactics including game based learning and medical simulation.
1074284	I would like to work with underprivileged youth to increase violence prevention as well as alternative options.  I would like to work with youth in a multidisciplinary role with medical care vs counseling .
1074293	Functional gastrointestinal disorders including abdominal pain, constipation, nausea and vomiting in children. Gastrointestinal Motility Disorders.
1074327	My clinical interests inculde adolescent primary care, adolescent gynecology including menstrual irregularities and contraception, and prevention of adolescent risk behaviors.  My research interests include the epidemiology of adolescent risk behaviors and HPV vaccination.
1074348	My primary research interest is in understanding the biology behind acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) and what factors predispose someone to these syndromes.  My primary clinical interest is in treatment of patients in the critical care setting, but I also enjoy long term care of general pulmonary diseases.
1074349	Care of hospitalized medicine patients, medical student and resident education
1074404	Currently working at Children's Memorial Hospital in the Neonatal Intensive Care Unit.
1074456	Dr. Flemings research and training programs have focused on testing behavioral interventions in community-based primary care practices. He has also published dozens of studies on phospholipids, alcohol biomarkers, chronic pain, fetal alcohol spectrum disorder, pharmacotherapy trials, epidemiological studies and educational interventions. He has been the PI on over a dozen NIH grants and contracts. He is the director of the pain consult service and the inpatient addiction medicine consult service at the University of Wisconsin Hospital and Clinics.  More recently he has taken a leadership in the UW Institute for Clinical and Translational Research as the director of research education and career development programs.  In 2005 he was elected as a member of the prestigious Institute of Medicine.
1074485	My primary clinical interests include preventive care and injury prevention for children.  I also enjoy the continued educational opportunities for medical students and residents.
1074488	My research interests are in end-of-life decision making, cross-cultural issues, and provider-patient communication related to palliative care.
1074491	1. Drug Therapeutic Trials 2. Psychosocial coping and support in oncology patients 3. Early incorporation of palliative medicine in oncology care 4. Improving decision making for oncology patients 5. Improving monitoring and preventing chemotherapy toxicity
1074533	Daniel's research interests include assessing the cost-effectiveness of conservative interventions for the management of musculoskeletal conditions and the development and validation of patient-reported outcomes in the assessment of economic data.
1074548	Interested in clinical impact of abnormal cellular function in acquired or pre-existing neurologic disease, the effects in the ICU setting, and the interaction of the CNS with other organ system function/dysfunction.  Specific interest in acquired pediatric brain injury (Traumatic Brain Injury, Hypoxic Brain Injury) and investigation of new therapeutics - Hypothermia for Hypoxic-ischemic brain injury and traumatic brain injury.
1074557	My clinical and research interests focus on children and adults with congenital heart disease.  My specific areas of focus are pacemakers, defibrillators and other devices used in the evaluation and treatment of rhythm disorders as well as evaluation and catheter ablation of arrhythmias.
1074558	I am interested in general pediatric dermatology, acne, infectious diseases of the skin as well as surgery and laser therapy of the skin.
1074582	Our research is focused on the role of viral microRNAs in herpesviral oncogenesis
1074590	Dr. Robinson's interests include medical education, inpatient care and non-invasive cardiac imaging, particularly the application of magnetic resonance imaging to congenital heart disease. His research goal is to expand the use of MRI in patients with congenital and acquired heart disease to decrease the need for invasive procedures. To facilitate these efforts, he completed a post-graduate clinical research fellowship in the Biological Sciences Division at the University of Chicago and clinical fellowships in pediatric cardiology and non-invasive cardiac imaging at Childrens Hospital Boston, the primary pediatric teaching affiliate of Harvard Medical School. Recent projects include the clinical application of novel MRI techniques (e.g. 4D flow MRI and use of blood pool contrast agents) to congenital heart disease.
1074594	My primary clinical focus is treatment of type 1 and type 2 diabetes.  I see diabetic patients at our affiliate institution, La Rabida Children's Hospital, and at our off-site clinics in Hinsdale, New Lenox, and St. John Indiana.  I also enjoy educating families and healthcare providers about weight management and obesity prevention.
1074597	Current research projects focus on medical neglect.
1074664	General Therapeutic Radiological Physics; External Beam and Brachytherapy Physics; Gamma Knife Physics and Dosimetry
1074665	My current research concerns the role of intermediate filaments in innate immunity, particularly in inflammasome activation, as applied to acute lung injury. More broadly, I am interested in regulation of protein phosphorylation (particularly protein Ser/Thr phosphatases), G protein coupled signaling, as well as comparative and evolutionary aspects of eukaryotic signal transduction.
1074668	As a Clinical Health Psychologist, Dr. Coons research is focused on understanding the biological, cognitive, behavioral, and social mechanisms of health behavior change (e.g., physical activity, diet choice, medication adherence) for both primary prevention (i.e., among individuals at risk for developing chronic diseases) and secondary prevention (i.e., among individuals with Type 1 and Type 2 diabetes, cardiovascular disease). He also has a strong interest in developing and testing the efficacy of technology-supported interventions for health behavior change and maintenance. Dr. Coons is the Project Coordinator for the Make Better Choices  2 (MBC2) clinical trial, awarded to Dr. Spring, which is funded by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH).
1074715	My research is focused on understanding the pathophysiological mechanisms underlying the transition from acute to chronic pain following whiplash injury. Specifically, I utilize structural and advanced magnetic resonance imaging applications to quantify the temporal development of altered spinal cord biochemistry and neck muscle morphometry as potential cellular and molecular substrates of persistent pain. Broad applications of my work includes preventing, diagnosing, and treating whiplash related pain and its sequelae. This research is based on my clinical and research experience and has expanded through interdisciplinary efforts involving the fields of magnetic resonance physics, radiology, biomedical engineering, neurophysiology and physical therapy.
1074965	Dr. Kaisers research focuses on health disparities, health communication, patient understandings of disease, and patient experiences with serious illness. Dr. Kaiser has extensive training and experience in mixed methods research and she utilizes a variety of quantitative and qualitative research methods in her work.  Currently, Dr. Kaiser is the principal investigator of the study, Communicating Breast Cancer Disparity to Minority Populations, funded by the American Cancer Society, Illinois Division. This study examines minority womens knowledge of breast cancer disparities and their sources of information about breast cancer in the Chicago area.
1075145	I am a social epidemiologist, and my research focuses on understanding how contextual factors lead to disparities in cardiovascular outcomes. I am also interested in behavioral and biological pathways linking chronic exposure to psychosocial stressors to cardiovascular-related risk factors and outcomes.
1075164	Benign and malignant diseases of the lungs, esophagus, pleura and chest wall.
1075230	Medical student and resident clinical teaching.
1075271	My primary area of interest is Pediatric bleeding and clotting disorders.
1075386	Family physician at Erie Family Health Center.
1075439	My primary research interests are sleep disorders in multiple sclerosis, the neurological complications of obstructive sleep apnea and sleep perception.
1075457	My current research continues to focus on new ways to make health care computing more useful.  This includes developing intuitive, novel Human Computer Interfaces (HCI) for health care, including working the design of graphical icons for clinical applications, addressing data overload for clinicians and issues in affective computing.   A related line of research is developing methods for the integration of clinic research computing into clinical care.
1075501	I am heavily involved in our center's food allergy clinical trials.   I have a clinical interest in food allergy, primary immunodeficiencies and eosinophilic esophagitis.
1075699	Dr. Gillespie's clinical interest includes the treatment of thoracic malignancies, specifically with regard to the application of novel technologies in Interventional Pulmonology to improve the diagnosis and treat thoracic malignancies with minimal invasiveness.  He also has extensive experience in the bronchoscopic management of tracheal stenosis and the airway complications associated with Lung Transplantation. Dr Gillespie has advanced training in the following techniques: flexible and rigid bronchoscopy, balloon bronchoplasty, endobronchial stent placement (silicon, hybrid, and metallic), electrosurgery (including argon plasma coagulation, lasers, and cautery tools), endobronchial brachytherapy, photodynamic therapy, endobronchial ultrasound (both convex and radial imaging), navigational bronchoscopy, auto-fluorescence bronchoscopy (LIFE), multiple biopsy tools, percutaneous tracheotomy, and pleuroscopy.   His academic focus is on clinical research and education.  He was the principle investigator on a Phase III study looking at the placement of bilateral Intrabronchial Valves for the treatment of patients with heterogeneous emphysema.  Dr. Gillespie has also been involved in projects aimed to utilize advanced bronchoscopic techniques to improve diagnostic yield of lung nodules and masses, treat diseases such as tracheomalacia and severe asthma, as well as banking tissue samples for basic research.  As an educator, he has a keen interest in simulation based learning.  He has been working to develop simulations designed to accelerate the acquisition of advanced bronchoscopic and procedural skills.
1075710	Functional cardiovascular Magnetic Resonance Imaging (MRI) imaging. The focus is on basic MR methodology, development of novel MRI techniques and advanced data analysis strategies for the measurement and analysis of normal and pathological physiological processes in the human body. The evaluation of such methods in clinical studies and the implementation and evaluation of novel clinical applications represents an important aspect of past, ongoing and future scientific activities. Recent research projects focus on regional myocardial function and 4D flow MRI.
1075715	Cardiac surgery outcomes
1075967	Dr. McHugh is a health services researcher with an interest in quality improvement, patient flow and emergency department crowding, the safety net, and health policy/health reform. She has conducted a number of multi-method, multi-site evaluations and directed statistical analyses using data from large national data sets.  Currently Dr. McHugh is leading an evaluation of Urgent Matters, a program to improve patient flow and reduce crowding in emergency departments.
1076065	Social and racial health disparities, particularly among Hispanics/Latinos and African Americans; chronic diseases; women Health; tobacco control and prevention.
1076113	My clinical interests are the care of children with Type 1 diabetes, disorders of puberty, growth disorders and polycystic ovary syndrome.
1076226	Cell and molecular biology of inflammation and its resolution during disease.
1076296	Biomaterials, Drug delivery, cancer therapy, Nanoparticles
1076303	Primary area of interest is prevention of behavioral transmission of HIV infection in adolescent and young adult populations at high risk, including sexual and gender minorities.
1076308	My research focuses on using social networks and quantitative methodologies to understand the social contextual influences on LGBT adolescent health and well-being.
1076405	My primary research interests are in emergency medicine and health services research with the goal of a helping to develop a more patient-centered acute care system.  I am particularly interested in patients' use of the emergency department and transitions of care from the emergency department to either the community or hospital.  I am currently a health services research fellow at the Institute for Healthcare Studies and am working towards a Master's degree in Health Services and Outcomes research.  My research uses both quantitative methods such as large database and claims data analysis, and qualitative methods such as semi-structured interviews.
1076722	I am interested in using high-fidelity simulation to analyze and assess teamwork behaviors, communication and medical decision making during critical events.  I am primarly interested in studying these areas in the field of congenital heart disease and the cardiac intensive care unit.
1076934	Dr Maas is a Neurocritical Care specialist at Northwestern Memorial Hospital whose clinical interest focuses on the management of high-risk injuries and diseases of the brain, spinal cord and peripheral nervous system. Dr Maas's research has focused on the emergent evaluation and management of patients with stroke. In addition to clinical work and research, he has been a leader in the medical education field, serving as the chairman of the American Academy of Neurology's Consortium of Neurology Residents and Fellows and member of its Graduate Education Committee, and has lectured on topics ranging from neurological emergencies to neurology education policy.
1076993	Functional MRI (FMRI) Resting state FMRI Diffusion tensor imaging (DTI)
1077088	I have particular interests in the following areas in public health and global health research:  maternal-child health, infant and child malnutrition,child maltreatment and violence prevention.
1077123	I have a large interest in Healthcare Quality Improvement initiatives.  I work primarily in the inpatient setting and am actively involed in improvement modalities in both Pediatric Asthma Exacerbation Management and Breastfeeding Medicine.
1077136	.
1077139	Clinical interest in pediatric hospital based medicine including care of inpatient general pediatric patients, neonates in the well baby nursery as well as the NICU, and pediatric urgent care. Clinical interest in quality improvement in inpatient management as well as advocacy in the community.
1077331	Dr. Zhaos methodological research interests are in the areas of survival and event history analysis, longitudinal data analysis, and design and analysis of clinical trials. His current work has focused on methodology development to integrate information about patients baseline characteristics to individualize treatment choice. His collaborative work is in the areas Cardiovascular and HIV research.
1077442	My clinical interests include abdominal organ transplantation and living donation surgery. My research interests focus on developing tissue engineering and regenerative medicine based approaches for renal and hepatic replacement therapies.
1077452	My primary research interests involve integration of novel technologies to enhance the patient-clinician relationship. Anticipated benefits to surgical patient educational enhancements may improve patient quality of life,  minimize resource utilization, improve healthcare delivery efficiency, and decrease preventable complications.
1077483	Dr. Ackermann has advanced training in epidemiology, public health, and health policy as a past Robert Wood Johnson Foundation Clinical Scholar (2001-03) and Robert Wood Johnson Foundation Physician Faculty Scholar (2006-09).  He is Director for Northwestern University's Community Engaged Research Center.  Dr. Ackermann is considered a national expert in the development and evaluation of healthcare-community partnerships to improve the prevention and control of common chronic illnesses such as diabetes, congestive heart failure, and asthma. Since 2003, he has been the principal architect and director of a large ongoing research program to evaluate the feasibility, costs, and effectiveness of partnered approaches for preventing and managing type 2 diabetes in American adults. Additional interests include healthcare provider interventions, quality improvement, cost effectiveness analysis, behavioral economics, and strategies for engaging community members and policy decision makers in the full spectrum of research.
1077552	The principal goal of my research is to understand the nephritogenic immune response in autoimmune renal disease. This research runs the gamut of immunologic mechanisms to understanding the development or organ fibrogenesis and cellular transdifferentiation.  Our studies critically analyze the immunogenetic and interactional events surrounding T cell activation, effector T cell differentiation, immune modulation of renal tubular cells and fibroblasts in anti-basement membrane diseases, and with this understanding, develop experimental strategies which can attenuate the expression of renal injury. We have a particularly active interest in the cell fate of fibroblasts during fibrogenesis in transgenic mice.  More recently we have gotten interested in how breast cancer cells use the same programs when they metastasize.  We use trangenic and knockin mice, cell sorting, biochemical methosds of protein identification, molecular cloning and mutagenesis, as well as cell culture and confocal microscopy.
1077723	Community hospital based pediatrics involving inpatient pediatric care, ER consultations and NICU.
1077889	I am a computational biologist with an interest in the development of methods for integrative, systems-level analysis of high-dimensional genomic and proteomic data.  These methods incorporate bioinformatic information with experimental data to characterize the networks of interactions that lead to the emergence of complex phenotypes, particularly cancers.
1077961	Pediatric airway evaluation and management, Subglottic Stenosis, Airway reconstruction, Pediatric voice disorders and surgery, Pediatric stroboscopy, Laryngology, Bronchoesophagology, Pediatric hoarseness, Vocal cord paralysis, Respiratory papillomatosis, Vocal cord nodules.
1077962	I practice pediatric otolaryngology, including diseases of the head and neck from birth to adolescence, with a particular interest in pediatric otology, congenital hearing loss, cholesteatoma, and microtia reconstruction. I am the otolaryngology representative on the Vascular Lesions team at Children's Memorial Hospital (Lurie Children's). Other interests include congenital head and neck masses, airway disorders and airway reconstruction, and sleep endoscopy/sleep apnea. Currently, I am currently developing a middle ear endoscopy program at Children's Memorial Hospital.
1078376	I have a broad interest in survival analysis and longitudinal data analysis, with applications to clinical and health services studies. I am particularly interested in the analysis of medical cost data and joint models of longitudinal and survival data. Recently I am working on non/semiparametric regression methods (e.g., penalized splines), causal inference in observational studies, and adaptive design in early phase clinical trials. I also collaborate with clinicians in cardivascular diseases, psychiatric medicine, asthma, infectious diseases, kidney diseases and diabetes.
1078493	My research involves translational approaches to age related macular degeneration and ischemic retinal diseases with a special focus on functional retinal imaging and image guided interventions.
1078641	Current research activities occur at the nexus of cardiovascular magnetic resonance imaging and biomedical engineering. Specific research projects investigate the relationship between vascular and valvular morphologic anomalies and their impact on blood flow. These projects decompose flow and anatomy into a mathematical framework, allowing for parameters such as pressure, resistance, impedance, drag forces, and energy loss to be extracted. These parameters are traditional, well-known engineering measures of system performance and ultimately powerful indicators of overall cardiovascular system health.
1079544	Health Information Technology Consumer Health Information Technology Patient Facing Technology Design Human Factors and Ergonomics Patient safety
1079866	The primary goals of research projects in Cheng laboratory is to improve our understanding of the molecular mechanisms and signaling pathways of human cancer initiation, tumorigenesis, invasion, metastases and angiogenesis, and to develop novel approaches for anti-cancer therapies by targeting molecular pathways by which human tumors develop and progress.  Our approaches include molecular, cellular biology, histology, tumor xenografts in cell culture and animals model systems of human brain tumors (in particular, glioblastomas) and breast cancers.
1079955	My technical research interests include data mining, machine learning, and artificial intelligence. My application interests include various health care applications, mining big healthcare data, and developing sensor-based and ambient intelligence solutions for personal health and well-being.
1080020	Transesophageal echocardiography, Left ventricular assist devices
1080111	Research Interests: Our laboratory concentrates its efforts into the investigation of the mechanistic connection between aging, cellular and/or mitochondrial metabolism, and carcinogenesis focusing on the Sirtuin gene family. To address this idea, over the past five years, we have constructed mice that have the three primary (Sirt1-3) sirtuins genetically deleted.  The mice that lack Sirt1 (Wang et al., 2009, Cancer Cell), Sirt2 (Kim et al., 2011, Cancer Cell), and Sirt3 (Kim et al., 2010, Cancer Cell) each develop breast cancer, as well as other types of malignancies to varying degrees, and the levels of SIRT1-3 are also decreased in human cancer samples, as compared to normal tissues.  In addition, the mechanism connecting the tumor permissive phenotype and the aberrant regulation of mitochondrial ROS, at least in part, in the Sirt3 knockout mouse has recently been published (Tao et al., 2010, Molecular Cell).  Thus, based on these results it seems clear that the primary sirtuin deacetylase proteins are tumor suppressor in several breast cancers as well as to a lesser extent in several other human malignancies.  These results seemed logical, since human sirtuins are the human homologs for the yeast and C. elegans longevity genes, and breast cancers have one of the strongest correlations to age.  Thus, it is proposed that the primary sirtuin family knockout mice may present a novel group of models to establish, validate, and investigate the well established connection between aging, metabolism, and cancer.  These murine models are also used to pursue the laboratories interest and the identification and validation of chemopreventative agents and we currently have a DOD and R01 grants to pursue this for luminal B breast malignancies.  Finally, the laboratory has a series of murine in vivo and in vitro models to mechanistically connect Sirt2 and Sirt3 to cancers of the breast, pancreas, liver, and lung that are currently be used.
1080205	Breast cancer
1080338	I have an interest in the evaluation and management of sleep disorders, and the impact they can have on psychiatric symptomatology. Though there has been an increased awareness of sleep abnormalities, disorders related to sleep and their contribution to a broad range of health outcomes, these conditions are still significantly underdiagnosed. I am hoping to provide high quality, evidence baased care for all patients that I care for and thus be able to provide for good clinical outcomes.
1080342	Shoulder Arthroscopy<br>Total Shoulder Arthroplasty<br>Reverse Total Shoulder Arthroplasty<br>Revision Total Shoulder Arthroplasty<br>Total Elbow Arthroplasty<br>Elbow Arthroscopy<br>Revision Shoulder Surgery<br>Revision Elbow Surgery<p><p>Dr. Guido Marra is a Professor of Orthopaedic Surgery at Northwestern University Feinberg School of Medicine and the Director of Shoulder and Elbow Surgery in the Department of Orthopaedic Surgery.  He has been recognized as an international leader in the operative treatment of shoulder and elbow disorders, specializing in shoulder and elbow arthroscopy, shoulder and elbow replacement surgery.<p>   Dr. Marra has been awarded Best Doctor in America in 2011-12 and Best Doctor in 2009, the Whos Who in Medicine and Healthcare also in 2011-12, Americans Top Orthopedists in 2009.  In addition, he was recognized with a Patients Choice Award in 2008.<p> Dr. Marra is actively involved in orthopaedic education both nationally and internationally. He serves on several committees for the American Academy of Orthopaedic Surgery which focus on educating practicing orthopaedic surgeons. Dr. Marra regularly lectures both nationally and internationally on the surgical management of shoulder and elbow disorders.<p> <h3>Membership</h3><small>American Academy of Orthopaedic Surgery<br>American Society of Shoulder and Elbow Surgeons<br>Association of Bone and Joint Surgeons<br>The American Orthopaedic Association</small><p><h3>Certification</h3><small>American Board of Orthopaedic Surgery 2001, Re-certification 2011</small>
1080344	Dr. Michael Stover is a graduate of University of Iowa College of Medicine, University Hospitals of Cleveland, Case Western Reserve University, residency, and fellowship trained in orthopaedic trauma at Carolinas Medical Center in Charlotte, N.C. He received additional fellowship training in Hip and Pelvic reconstruction, studying for a year with Joel Matta, MD at Good Samaritan Hospital in Los Angeles, CA, and a traveling fellowship to Switzerland working with Reinhold Ganz, MD. Dr. Stover joined Northwestern University after 14 years of clinical practice at Loyola University Health System where he was Associate Professor and Director of Trauma. His clinical and research interests include: anterior total hip replacement, acquired or congenital hip and pelvic abnormalities (especially hip dysplasia and hip impingement), fractures of the acetabulum and pelvis, and fractures that do not heal (nonunion) or heal incorrectly (malunion). He is an active member of the American Academy of Orthopaedic Surgeons (AAOS), the AO Foundation, Orthopaedic Trauma Association (OTA), and the Association of Bone and Joint Surgeons. Dr. Stover is an internationally recognized lecturer regarding topics in hip and pelvis reconstruction, especially fractures of the acetabulum and pelvis.
1080422	We study the role of RANTES, a chemokine, and granulysin, a proinflammatory molecule in health and diseases, including cancer, infection, transplantation and autoimmunity.
1080443	Dr. Schueller received his Ph.D. in Clinical Psychology from the University of Pennsylvania where his research focused on well-being, happiness, positive psychology interventions, and individualized intervention sequences. His current research interests include using Internet interventions in behavioral and mental health service delivery. Specifically, he is interested in how technology can aid users in receiving what they most need by providing opportunities to incorporate users choices, patterns of behavior, or characteristics to individualize care. He has conducted work on interventions to promote well-being, smoking cessation, and depression prevention with a strong focus on creating interventions that can be widely disseminated and thus provide services worldwide.
1080545	After completing a Master's in Medical Education through the University of Cincinnati Colleges of Medicine and Education, my research interests involve education in medicine, bedside teaching, and adult learners in medicine.  I also have an interest in medical ethics around research consent and pediatric patients; pediatric sedation; and attitudes related to simulation and how this affects learning.  Most recently, I have been invovled in clinical standard work for quality improvement and medical care delivery as well as peer mentoring and career advancement and satisfaction.
1080625	Preventive cardiology, clinical lipidology, and cardiac imaging.
1080640	As a specialized Women's Health Internist my interests include:  Perimenopause, menopause and hormonal therapy; Prevention and treatment of osteoporosis and osteopenia; Contraceptive counseling, Office based gynecologic procedures (colposcopy, IUD, biopsy), preventative medicine and women's cardiovascular health.
1080739	Dr. Catherine Hunter was delighted to join the faculty at Lurie Children's Hospital of Chicago and Northwestern University in the summer of 2012.   Dr. Hunter is originally from Edinburgh, Scotland where she completed her undergraduate degree in Physiology.  She received the national physiology prize and first class honors for her work.  After a summer research internship at New York Presbyterian Hospital she decided to pursue a medical degree from Cornell University.  After medical school she completed her General Surgery training at Harbor-UCLA medical center in Los Angeles, and was awarded board certified in General Surgery in 2010. She completed her Pediatric Surgery Fellowship training at Children's Hospital of Los Angeles, where she gained expertise with all aspects of neonatal and pediatric surgery.  She received advanced training in minimally invasive surgical techniques.  Dr. Hunter continued to dedicate time to basic science research during her clinical training.  Her area of research interest is necrotizing enterocolitis (NEC), a highly morbid intestinal disorder that typically afflicts premature infants.  The role of bacteria and Cronobacter sakazakii in the pathogenesis of NEC is a particular area of interest.  She is a primary investigator of basic science research at Northwestern University.
2008714	I enjoy caring for pediatric patients in the PICU, NICU, Medical Observation Unit and Procedural Sedation at Children's Memorial Hospital.
2012799	My research interest lies in exploring the relationship between SGA status and the development of endocrinpathies later in life, particularly diabetes mellitus during pregnancy.
2022084	My primary research interests are in health services research related to maternal-child health and gynecology. My previous research includes national projects (United Kingdom) on healthcare issues related to maternal and perinatal mortality, obesity in pregnancy, child head injury, and heavy menstrual bleeding. In the US, I have worked on the National Children's Study, as well as my previous work on maternal morbidity and mortality, education regarding menopause in minority groups, and genetic testing policies.
2027098	Dr. Denise Scholtens is interested in statistical problems arising from high-throughput genomics and proteomics data as they pertain to computational biology.   She is a member of the Robert H. Lurie Comprehensive Cancer Center Biostatistics Core and collaborates on a variety of basic science and clinical cancer studies.
2032191	I am primarily interested in research involving the optimization of care for children with special health care needs.
2033644	Dr. Watts' main research interest is in health outcome disparities in cystic fibrosis, focusing on the Latino cystic fibrosis population.  She currently runs a multi-center study investigating possible molecular and clinical causes for these health disparities.  Clinically, Dr. Watts is interested in cystic fibrosis, asthma, lung disease of prematurity and pediatric patients with complex pulmonary disease.
2033885	My research focuses on microRNA regulation of cholesterol metabolism.
2036777	Utilization of 3D echocardiography in quantifying ventricular function in single ventricles.
2038320	My primary research and clinical interests relate to neurosurgical anesthesiology, intraoperative neuromonitoring, and perioperative patient safety.  
2038629	Humanitarian Response and Crisis Mapping/Technology Research
2039416	I am a UVEITIS specialist.  I treat ocular manifestations of systemic inflammatory diseases such as rheumatoid arthritis, sarcoidosis, systemic lupus erythematosus, juvenile idiopathic arthritis, Crohn's disease, psoriatic arthritis, ankylosing spondylitis, etc.  I also treat infectious diseases of the eye such as herpetic keratitis and uveitis, herpes zoster ophthalmicus, toxoplasmosis retinochoroiditis, CMV retinitis and other HIV-associated eye diseases, acute retinal necrosis, etc. In addition, I also do CATARACT SURGERY and see GENERAL OPHTHALMOLOGY patients.  Finally, I am the ophthalmology residency program director.
2043334	My research focuses on the mental and behavioral health of lesbian, gay, bisexual, and transgender individuals, with a particular focus on youth.  The health issues I study include mental health, HIV/AIDS, and substance use.  My research spans the translational spectrum from epidemiological studies of prevalence, to longitudinal studies of risk and protective factors, to the development and testing of intervention, to the dissemination and implementation of these novel interventions.
2047557	Nanotechnology is the study of the fabrication, directed self-assembly, and characterization of materials that have size dimensions between 1 and 100 nanometers. In the context of biological nanostructures, this is the size regime of the molecular machinery that constitutes, for example, functional viruses, bacteria, and human cells. The challenge of bio-nanotechnology and the focus of The Thaxton Laboratory is to control the synthesis of structures that naturally interface with biological systems to develop exquisitely targeted, practical, safe, and effective nanoparticle therapeutics, imaging agents, and biosensors. 
2049177	Primary interests include sports injuries in the young athlete, especially anterior cruciate ligament tears, and arthrocopic surgery
2059065	I am a dedicated surgeon-scientist committed to advancing the scientific basis of plastic surgery. My research interests include wound healing and tissue engineering. My clinical interests include all of plastic surgery, with an emphasis on cosmetic surgery, reconstructive surgery, and complex wound care.
2077751	I have a particular interest in urgent care/emergency medicine pediatric care.
2098866	I am a clinical psychologist interested in the neuroscience of the early attachment system and it's impact of the developmental subjective and interactional nature of the 'self' system of the human being.  I have studied attachment, neuroscience and attachment trauma during the past 5 years through a variety of forums at the University of Minnesotta, the University of California Los Angeles, the University of Chicago, and elsewhere.  I am interested in the molecular nature of attachment, as well as the impact of attachment upon developing language, motor, affective, and immune systems of the body.  I have a clinical practice with adults, children and families in which I incorporate my clinical skills with emerging knowledge in the field of attachment and neuroscience to implement practical and highly effective clinical interventions. 
2103930	Dr. Belknap is interested in the prevention of fatal adverse drug events. His research involves developing better methods for detecting adverse drug events and adverse drug event signals and also in developing better means of preventing adverse drug events or reducing their severity.
2103930	I am interested in computational medicine and specifically pharmacoalgorithmics, informally defined as 'the study of what the drug prescription does to the patient.' Drug therapy is more than just drugs, it includes the instructions for safely and effectively using the drugs and the resources to support those instructions (e.g., nurses, pharmacists, physicians, infusion pumps, and drug concentration measurements).  A prescription is a health-care program implemented by a physician or other qualified practitioner in the form of instructions that govern the plan of care for an individual patient. Working with a team of investigators, I showed that application of computer programming design and debugging methods results in a marked increase in the safety of opioid prescriptions in hospitalized adults. The methods we have developed in pharmacoalgorithmics have application to reducing the risk of adverse drug events, optimizing the efficacy of drug therapy, and reducing the cost of medical care.
2108444	Assessment of ultrasound and MRI in screening for and diagnosis of breast cancer, Evaluating response to chemotherapy, imaging protocols for follow-up of breast cancer patients treated conservatively, Imaging-guided percutaneous biopsy and ablative techni
2113364	ED management of wound foreign bodies. Teaching emergency orthopedics both clinically and with an interractive on line teaching tool. Electronic teaching innovations.
2117014	Health communication, health disparities, message design, health promotion
2117014	Research activities are currently focused on addressing racial disparities in influenza prevention through the use of theoretically based multimedia messages.
2119379	I am a specialist in Psychosomatic Medicine, which is the practice of medical science, education, and healthcare for persons with comorbid psychiatric and general medical conditions. Within this I am particularly interested in medication nonadherence (or noncompliance), somatoform illnesses (or medically unexplained symptoms), recidivism in the general medical hospital, medical care of patients with severe mental illness, cardiac outcomes and neuroleptic medications, and patients with intellectual disabilities (or mental retardation).
2129733	Decision making and communication for cancer patients, those at increased risk for developing cancer, their families, and their healthcare providers.
2130945	I am Board Certified in General Psychiatry. I work with both adults and adolescents combining individual, family and couples therapy with pharmacotherapy.
2132783	The overall theme of Dr. Gupta's research is the application of clinical pharmacology to the individualization of the care of high-risk surgical patients, especially those undergoing spine and intracranial procedures.  To achieve these goals, Dr. Gupta is interested in understanding how the physiologic states of special populations contribute to the variability of the concentration-effect relationship.  In particular, Dr. Gupta is interested in the contribution of sex (the ultimate pharmacogenomic factor) and age on the pharmacokinetics and pharmacodynamics of opioids and how this may affect the safe delivery of adequate analgesia to opioids nave and opioids tolerant patients in the perioperative and palliative care arenas. Dr Gupta is also interested in pharmacologic strategies that attenuate the perioperative inflammatory response as a means of ameliorating the morbidity and improving outcome after surgery and anesthesia--postoperative cognitive dysfunction, neurologic injury, cancer metastases, pain, etc.
2139747	Physician Assistant utilization across clinical settings; Physician Assistant professional issues.
2146484	Neuroradiology
2146893	I am interested in Atopic Dermatitis and Eczema.  We have created a center called the Eczema Care and Education Center that is devoted to taking care of patients with eczema and their families, with an emphasis on education about the disease.  I am also very interested in connective tissue diseases such as lupus and dermatomyositis.  I am a medical acupuncturist and am interested in alternative medical approaches to dermatologic diseases.  Finally, I am interested in medical student and resident education.
2147664	Advanced minimally invasive surgery, Achalasia, POEM procedure, per-oral esophageal myotomy, Natural Orifice Translumenal Endoscopic Surgery (NOTES), surgical education and simulation, skills curriculum, Obesity and weight loss (bariatric) surgery
2159034	I am interested in the applied physiology of responses to injury and inflammation in patient care, and the process of improving outcomes in trauma and intensive care. 
2161500	Dr Gossett's research interests include pediatric cardiac transplantation and outcomes and cardiotmopathy/heart failure. This includes multi-center projects with the Pediatric Heart Transplant Study investigating rejection as well as the outcomes of cardiac transplantation in patients with Plastic Bronchitis. He is also involved in research related to pediatric interventional cathterization.
2163848	I specialize in diseases of the retina.  These include: macular degeneration, diabetic eye disease, and retinal vascular occlusions.  I have an interest in ocular imaging techniques.
2171089	Abdominal imaging.
2171325	Dr. Singhs research interests are focused on the costs and quality of prevention and treatment of gynecologic malignancies.  Her research evaluates the costs of both high technology and low technology approaches to the prevention of cervical cancer in developing and developed countries. Her work addresses the need to tailor technology and screening techniques to specific settings and populations.  She continues to present nationally and internationally on HPV related disease and cervical cancer prevention. 
2175090	Dr. Strauss focuses his clinical practice in radiation oncology for breast and gynecological malignancies.  He is an active clinical researcher and has published over 20 peer-reviewed articles.
2179943	Interferon, STAT  
2181733	Interests include quality improvement, global health, community based participatory research.
2181798	General cardiology: valvular heart disease, bicuspid aortic valve Vascular medicine:peripheral arterial disease, aortic disease, carotid disease,genetic vascular diseases such as Marfan's syndrome Prevention and Lipid management Cardiovascular imaging: echocardiography and cardiac MRI
2190212	My primary clinical interests include the care of pediatric patients with asthma, chronic lung disease and sickle cell anemia associated lung disease. My research interests include pediatric asthma with a special interest in the early evaluation of lung function changes in pediatric asthma and sickle cell disease.
2190500	My primary research and clinical interests are in the areas of emotional functioning and attachment. Specifically, I am interested in the influence of early attachment relationships and perceived experiences on subsequent adult individual and couple functioning.
2206725	Prolactin and Breast Cancer<BR><BR> The research focus in Dr. Clevengers lab is the characterization of prolactin (PRL) receptor signal transduction and function as it relates to breast cancer and mammary gland development. The PRL receptor (PRLr) is a member of the growth factor/cytokine receptor family, which includes the receptors for interleukin 2-7, GM-CSF, EPO, and GH. Within humans, PRL functions at the endocrine and autocrine/paracrine levels as a growth, differentiation, and motility factor within the breast, a hypothesis first postulated by our laboratory. Therefore, one of our major aims is the characterization of those mechanisms that regulate PRL/PRLr expression and action in both normal and neoplastic tissues. PRL action in human tissues is mediated by the PRLr. The molecular dissection of PRLr isoform structure/function is a research focus, utilizing both biochemical and biophysical approaches to examine PRL-PRLr binding and the interaction of the PRLr with its associated transduction pathways that include JAK/Stat, Nek3/Vav2/Rac, Fyn, SIRPa, NFAT, and c-myb. We have also recently identified a direct genomic action of PRL on gene expression. This action is mediated by the prolyl isomerase cyclophilin B (CypB), which retrotransports endocytosed ligand into the nucleus, where the PRL/CypB complex directly interacts with and activates the Stat5 transcription factor. Additional research by our lab on prolyl isomerases has found that cyclophilin A (CypA) is required for proximal PRLr transduction, functioning as the molecular switch facilitating ligand-induced conformational change of the PRLr enabling Jak2 activation. As such our findings present vantage points in the development of novel therapies aimed at modulating PRL action during the differentiation of the human breast and the pathogenesis of malignancy in this tissue.
2221104	Special interest in newborn care
2237248	Doing consulting and developing data analysis algorithms in Bioinformatics and Computational Biology with applications in biomedical research.
2238574	My research program concerns understanding principles of human motivation and applying those principles toward helping people make healthy choices.  In particular, my research is currently focused on developing more effective interventions for increasing physical activity, eating healthier, and for weight management in general.   One common feature of my research involves differentiating autonomous and controlled forms of motivation based on a self-determination theory framework. And I am especially interested in interventions that support a subset of autonomous motivation known as intrinsic motivation, a subcategory characterized by interest and enjoyment. My research program is currently exploring ways to leverage technology (e.g., smartphone apps & accelerometry), game design, social networks, choice, and financial incentives in ways that support autonomous motivation and lasting behavior change.  An underlying principle is that, if we can help people to value or even enjoy healthy behaviors, healthy changes will tend to come more easily and be more easily maintained. Another complimentary feature of this research program involves my orientation toward collaboration and crossdisciplinary team science.  Compelling empirical evidence suggests that, when done well, team science is more creative, more impactful, and more fun; and Ive found support for these principles in my experience, as well. You can find more information and training tools for crossdisciplinary researchers at TeamScience.net, a website co-developed with Drs. Spring, Falk-Krzesinski, and the team at NogginLabs, Inc.
2245338	My research falls under the broad umbrella of aging and dementia and uses a multimodal approach to investigate two aging perspectives: primary progressive aphasia (PPA) in which neurodegenerative disease invades the language network and SuperAging in which individuals are seemingly resistant to the deleterious changes in memory associated with normal or more typical cognitive aging. My investigations have provided new fundamental knowledge with translational implications for cognitive aging, dementia, and neurodegenerative disease as well as the cognitive neuroscience of language and memory. Since joining the faculty at the Cognitive Neurology and Alzheimers disease Center (CNADC) at Northwestern University Feinberg School of Medicine in 2008, I have led the neuroimaging arm of our NIDCD funded Language in PPA R01 project and the cognitive and neuroimaging arm of the SuperAging study. While structural neuroimaging is my primary method of investigation it is not the only tool I use. My other investigations have explored the role of genetic, developmental and acquired factors in aging and dementia, which demonstrates my capacity to collect and integrate multidisciplinary data. I have a successful history of funding and recently received R01 funding from the NINDS to examine the relationship between clinical decline, brain atrophy and putative underlying pathology using PET amyloid imaging.
2247422	Dr. Matic's research in therapeutic biomedical optics has involved lasers for skin incisions, low-level irradiation of periodontal bacteria and, most recently, optical stimulation of the cochlea.  She is a leading expert in the field of pulsed infrared neural stimulation (INS) and is currently studying INS in the auditory system to improve cochlear implants.  Currently, the function of cochlear implants is limited, in part, by the spread of electric current in the cochlea and, therefore, the restored hearing and speech perception to cochlear implant users is less than ideal.  Lasers can stimulate smaller populations of neurons than conventional electrical stimulation, likely improving the users' speech perception.  We are working towards a novel cochlear implant built on optical technology.  Dr. Matic is also interested in further therapeutic uses of biomedical optics in otolaryngology, and other intersections of optics and neurophysiology/neural engineering.  Dr. Matic received her B.E. in Biomedical Engineering from Vanderbilt University and her M.S. and Ph.D. in Biomedical Engineering from Northwestern University.
2261563	I am interested in hereditary cancer susceptibility, genetic counseling for hereditary cancer susceptibility and exploring the role of genetic counseling for heme malignancies.
2263241	Dr. Petrich is a clinical and translational researcher focusing on multiple types of lymphoma, including Hodgkin Disease, Non-Hodgkin Lymphoma, HIV/AIDS-related Lymphoma, and Transplant/Immunosuppression-related Lymphoma.
2265121	Clinical interests include adult and pediatric allergy & immunology.
2265126	My primary interests center around the use of simulation as a method of instruction.  Specifically, I am interested in curriculum development, assessment of students, and the development of novel teaching strategies.
2273478	Dr. Sensinger's research interests include body-powered and robotic prosthesis design and control, with particular interest in developing-world applications. He focuses on clinically relevant, low cost/weight systems.
2276944	Human neuroscience (MRI, EEG, eye tracking) of cognition impairments in neurological and neuropsychiatric disorder.
2286682	I am a biocultural anthropologist specializing in mixed-methods approaches to the measurement of social and cultural phenomena. My research deals with health inequalities and mechanisms of stress and embodiment that link social disadvantage with disease.
2294496	I specialize in the surgical management of gastrointestinal diseases. I am particularly interested in the surgical treatment of gastroesophageal reflux and hiatal hernia, esophagus and stomach cancer, morbid obesity, and minimally-invasive approaches to abdominal solid organs and abdominal wall hernias. I have completed advanced training in upper gastrointestinal surgery at Oregon Health & Science University under the mentorship of John G Hunter, a pioneer in laparoscopic surgery. I enjoy working with patients to treat their condition in a professional, personalized, and efficient manner.
2305553	Dr. Jensen has a strong research interest in biopsychosocial relationships in the context of medical illness and treatment.  Dr. Jensen has extensive training and experience in research focused on the interrelationships between psychosocial functioning, neuroendocrine/immune functioning, physical symptom onset, and patient-reported outcomes in oncologic and gynecologic surgery. This line of research is grounded in the hope that a better understanding of the relationships between psychosocial functioning and surgical outcome may help to identify optimal surgical candidates, identify biological mechanisms by which psychosocial functioning may affect health outcomes, and lead to the development of future interventions to improve psychosocial functioning and surgical outcomes. Dr. Jensen is increasingly interested in exploring the relationships between psychosocial functioning, physical symptoms, and medical decision-making with respect to innovative surgical and non-surgical treatments among other populations, including candidates for transplant surgery, candidates for reconstructive surgery, and individuals with upper limb amputations. Currently, she is involved in several research projects that seek to examine quality of life and patient-reported outcomes in composite tissue transplantation, including upper limb and abdominal wall transplantation/reconstruction.
2311744	As a clinical neuropsychologist in the Neurobehavior and Memory Clinic of the Cognitive Neurology and Alzheimers Disease Center, Dr. Medina specializes in the assessment of cognition and behavior in adults, particularly the evaluation of cognitive disorders related to aging and dementia.  Her current clinical and research interests include the co-morbidity of mood disorder and neurological conditions.  Dr. Medina has published papers related to education and support for patients and families coping with dementia, as well as in the area of depression in individuals diagnosed with Primary Progressive Aphasia.
2327449	Dr. Scarsi's research interests include the pharmacology of HIV medications in special populations, outcomes associated with HIV treatment, pharmacovigilance activities, and management of HIV related drug interactions, including immunosuppressant medications and medications used to treat co-infections with malaria and tuberculosis.
2333484	I study how healthcare delivery can become safer, faster, less costly and more satisfying. Of particular interest are the topics of handoffs, physician and nurse scheduling, eliminating redundant workflow, and surgical supply chain efficiencies.
2354170	Chris serves as a prosthetic & orthotic educator, clinical researcher, and practitioner with a strong interest in knowledge translation, stroke research, clinically relevant outcomes, and inpatient management.
2354896	Director, COPD Program;  Director, Alpha-1-Antitrypsin Deficiency Clinical Resource Center
2354896	Ravi Kalhan, MD, MS is Director of the Northwestern Asthma and Chronic Obstructive Pulmonary Disease (COPD) Program where comprehensive care is provided to patients with asthma and COPD at all stages of severity. Dr. Kalhan additionally serves as director of the Alpha-1-Antitrypsin Deficiency Clinical Resource Center at Northwestern and medical director of the lung volume reduction surgery (LVRS) program. Dr. Kalhan attended college at Brown University in Providence, RI where he majored in modern American history. He subsequently entered medical school at Case Western Reserve University School of Medicine and completed his internal medicine residency at the Hospital of the University of Pennsylvania. He then came to Chicago where he pursued his fellowship training in Pulmonary and Critical Care Medicine at Northwestern Memorial Hospital, and has been on the Northwestern faculty since 2006. Dr. Kalhan's clinical interests are in the care of patients with both asthma and COPD as well as alpha-1-antitrypsin deficiency. His research interests relate to respiratory epidemiology, in particular identification of early risk factors that impact the vulnerability of certain cigarette smokers to develop COPD. He is also involved in clinical trials of new therapies for both asthma and COPD. Dr. Kalhan additionally serves as Chairman of the Illinois COPD Coalition a multidisciplinary group including representatives from community-based organizations, public health departments, professional organizations, patients, caregivers, healthcare providers, pharmaceutical companies and home healthcare providers which has the goal of implementing sustainable solutions for reducing the burden of COPD in Illinois.
2376710	I have been studying the health disparities faced by minorities in prostate cancer, including Hispanics and African Americans. We have been looking at the role of vitamin D deficiency and of allostatic stress load on men diagnosed with prostate cancer.
2389320	My research and clinical interests focus on improving long-term health outcomes in children with chronic kidney disease and after kidney transplantation.
2389410	I'm working toward establishing more focused care of patients with interstitial lung disease, in particular, Idiopathic Pulmonary Fibrosis.  My research interests center on mechanisms of disease, prognostic factors and therapy in interstitial lung disease.
2391057	My research interests lie in the area of uterine leiomyomas (fibroids) primarily.  I conduct molecular studies on these tumors in an effort to understand how they are initiated and how they grow.  My clinical interests are infertility, fibroids, and patient education/communication.
2398380	Dr. Hamidovic conducts research in genetics of drug addiction. She has identified genes associated with behavioral, cognitive and subjective responses to acute amphetamine administration in humans. Her more recent work has contributed to identifying genomic loci associated with smoking persistence in African Americans.
2398475	I am interested in studying the contribution of the circadian system on asthma. 
2436423	Anesthesia for Cardiac Procedures, Liver Transplantation, Cardiac Critical Care
2437731	My main research and clinical interests include long-acting reversible contraceptives, contraception in women with chronic medical problems, and preconception health care.
2470789	My clinical interests focus on cardiac intensive care, chiefly the post-operative care of neonates and children undergoing congenital heart surgery. My primary research interest involves HPA axis dysfunction post-surgery, during sepsis, ARDS and other conditions involving oxidative stress.
2475558	My clincial interests are in treating bleeding and clotting disorders in children and risk-based optimization of the treatment of Pediatric thrombosis. My research interest is in looking at thrombin generation in preterm infants with central venous lines.
2475578	Dr. Rosenbergs clinical interests are in the care of asthma, COPD and alpha-1 antitrypsin deficiency.  Her research interests relate to co-morbidities of COPD, asthma and COPD re-hospitalization risk factors and interventions, and air pollution.
2476467	Special interests: Advanced minimally invasive surgery, surgical critical care, outcomes research, pilonidal disease, surgery for cancer and developmental anomalies, neonatal surgery, resident education, international relief work
2484761	Special interests: Advanced minimally invasive surgery in neonates, infants, children and adolescents including congenital anomalies of the lung, esophagus, diaphragm and intestines; tumors of the chest and abdomen; pyloric stenosis; pectus deformities of the chest; inflammatory bowel disease; familial polyposis; splenectomy for hematologic disease. Research interests:  hypergranulation tissue formation after gastrostomy tube placement; resourse utilization after gastrostomy tube placement; MRSA skin and soft tissue infections in children; simulation medical education; virtual reality medical simulation
2515452	My clinical interests are in promotion of healthy behaviors and fostering clear communication with patients.  My research interests are in designing and evaluating systems-based approaches to health behavior counseling within primary care. I am particularly interested in improving the way that health care systems utilize information technology to facilitate and enhance communication between patients and physicians about unhealthy behaviors.
2564425	My research interest is fetal programming and the identification of infants and children at high risk of developing childhood-onset obesity. My long-term goal is to facilitate early intervention to prevent obesity and type 2 diabetes mellitus.
2573125	My main interest has been the investigation of mechanisms of regulation of aggressive behavior in peditaric solid tumors with focus on Malignant Rhabdoid Tumors, by exploring tissue biomarkers in frozen and formalin-fixed paraffin-embedded (FFPE) samples. My purpose has been to integrate pathological, clinical and molecular data in order to disclose diagnostic signatures and to discover novel targets for therapy development.  My effort takes advantage of my skills as a pediatric oncological pathologist. It includes the exploration of main processes, molecular networks and signaling pathways involved in the different aspects of these entities employing tools such as high throughput cDNA/miRNAs expression profiling and immunohistochemistry in tissue microarrays. To achieve my goals I have been establishing collaborations with major national and international biorepositories and collaborating with multidisciplinary teams of experts.
2575033	I am interested in the area of vitamin D and its many connections to human diseases and well being.  Taking advantage of an existing twin cohort aged 6-21 years (~2000 pairs) initially enrolled in 1998-2000 in Anqing, China, my project focuses on elucidating the longitudinal relationship of vitamin D status with known risk factors or biomarkers for metabolic syndrome (MS) in children and adolescents using a prospective co-twin design.  Relevant data from this cohort of pre-adolescent and adolescent subjects will be evaluated to test several hypotheses related to MS risk factors and biomarkers. I foresee that my research on vitamin D and human diseases will not only influence clinical and public health practice, but also contribute to policy discussions about diet and exercise in schools, the built environment, and vitamin D fortification in general populations.
2626307	My research focuses on measuring and reducing the use of low-value health care services in order to improve quality and decrease cost of health care.
2628248	I am interested in global cardiovascular health, epidemiology, outcomes, and prevention research with a particular emphasis on India.  I collaborate with a terrific mentor in New Delhi, Dr. D. Prabhakaran, who is the Executive Director of the Centre for Chronic Disease Control (ccdcindia.org) on several projects, including my NIH/NHLBI-supported K99/R00 Acute Coronary Syndrome Quality Improvement in Kerala cluster randomized, stepped wedge clinical trial.  We are developing a quality improvement toolkit with cardiologists from Kerala to improve acute coronary syndrome outcomes through the Cardiological Society of India-Kerala Chapter, led by Dr. P.P. Mohanan from Westfort Hi-Tech Hospital in Thrissur.  I also work closely with my Northwestern mentor, Dr. Donald Lloyd-Jones (K99/R00 co-mentor) in evaluating past and future trends in cardiovascular health using nationally representative US data in collaboration with Drs. Darwin Labarthe and Hongyan Ning (Northwestern), Professor Simon Capewell (University of Liverpool), and Dr. Earl Ford (CDC).  We have applied these projections to Prof. Capewell's IMPACT Coronary Heart Disease Policy model to evaluate future projections in coronary heart disease mortality based on plausible scenarios.  I have also begun performing systematic reviews and meta-analyses evaluating the role of statins in the primary prevention of cardiovascular disease and the efficacy of a polypill for primary prevention of cardiovascular disease as a member of the Cochrane Heart Group editorial board.
2697988	I am interested in neonatal lung disease and pulmonary hypertension. Within this, my focus is basic/translational and clinical research in the study of cellular and molecular pathways underlying hypoxia-induced pulmonary vascular remodeling and pulmonary hypertension, with the end goal of development of targeted preventative and therapeutic strategies.
2698074	I am interested in the initial interactions between the endothelium, pathogens, and innate immunity, interactions that initiate the inflammatory and coagulation cascades.  My current project uses the pathogen Trypanosoma cruzi, and aims to elucidate how the parasite interacts with and breaches the endothelial barrier. Defining T. cruzi interactions with the endothelium and the ensuing escape from the vasculature may reveal novel therapeutic targets for the prevention of the clinical sequelae of infection, as well as lend insight into the pathogens apparent tropism for specific tissues.  Elucidation of the mechanisms that enable pathogens to migrate across the endothelial barrier will also contribute to the broader understanding of endothelial permeability and its role in critical illness.
2698325	I am interested in the development and assessment of educational curricula, especially at the graduate medical level.  I use simulation often in these curricula to teach medical management, team communication and leadership skills.
2698352	My primary clinical interests include general pediatric gastroenterology, short bowel syndrome, and obesity.
2698369	I am a post-doctoral fellow at the Center for Healthcare Studies pursing a Masters in Health Service and Outcomes Research with a focus in pre-hospital medicine.  My interests include prehospital cardiac arrest and mass gathering medicine.  I have also studied palliative medicine topics in the Emergency Department setting.
2698403	My clinical and research interests include: degenerative disorders of the cervical, thoracic, and lumbar spine, complex adult spinal deformity, scoliosis, minimally invasive spine surgery, spine trauma, and spinal tumors.
2698421	My work aims to better understand the pathways involved in relaxation of the pulmonary vasculature that coincides with neonatal transition and how those pathways are disturbed in the setting of Persistent Pulmonary hypertension of the neonate.  More specifically I am currently studying the effects of mechanical stretch on soluble guanylate cyclase, a key enzyme that contributes to pulmonary vascular relaxation in an in vitro model using pulmonary artery smooth muscle cells isolated from lambs.
2698490	Dr. Patels research interests lie at the intersection of pediatric cardiology, epidemiology, and clinical ethics.  She has specific training in each of these fields to successfully implement projects.  Specifically, she is interested in the effects of multiple concomitant diagnoses (including genetic diagnosis) in neonates and its impact on outcomes of congenital heart surgery.   She is also exploring the societal, ethical, and legal implications of emerging screening protocols and interventions in the field of pediatric cardiology.
2698627	I am interested in the diagnosis, management, and treatment of children with cardiomyopathy, heart failure and those in need of heart transplantation.  This includes the use of advanced medical and mechanical management of severe heart failure and the long term management of heart transplant patients.
2698674	I believe women during their reproductive years deserve evidence-based information regarding mental health treatment so that they can be empowered to make confident choices about their treatment.  I enjoy collaborating with women in this process
2698712	Primary interests lie in the study of minimally invasive spine techniques for the treatment of all spinal pathologies, including degenerative disease, tumors, deformity, and trauma.    In addition, Dr. Smith's interests involve the study of spinal biomechanics and how trauma, malignancy, and aging effect movement in the spine.
